data_1z9b_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1z9b _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.455 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 89.0 m-20 . . . . . 0 CA--C 1.504 -0.826 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -155.27 165.62 36.1 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-O 121.513 0.673 . . . . 0.0 112.191 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.56 HD12 ' CD2' ' A' ' 75' ' ' HIS . 0.1 OUTLIER -118.43 134.56 61.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 174.591 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 65.5 t -103.84 129.99 55.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.414 -178.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.439 ' HE2' ' HB1' ' A' ' 77' ' ' ALA . 64.4 mttt -141.38 139.27 33.46 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 121.442 0.639 . . . . 0.0 111.149 176.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.72 166.38 33.01 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -82.22 -21.77 36.2 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.996 0.427 . . . . 0.0 110.082 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 94.3 t -99.25 124.09 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 174.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.76 ' O ' HG21 ' A' ' 54' ' ' VAL . 17.3 tt0 -63.77 -40.87 97.74 Favored 'General case' 0 C--O 1.2 -1.546 0 CA-C-O 120.871 0.367 . . . . 0.0 111.56 -174.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.02 5.18 63.27 Favored Glycine 0 C--N 1.278 -2.683 0 C-N-CA 117.639 -2.22 . . . . 0.0 113.647 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.9 t -84.26 -32.28 24.51 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 173.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.76 HG21 ' O ' ' A' ' 51' ' ' GLN . 4.0 m -72.71 -46.8 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.766 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.772 177.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -63.4 -39.48 94.63 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.504 -177.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.42 -37.47 87.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.825 0.345 . . . . 0.0 110.695 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.437 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 31.3 tp -75.08 -42.02 57.6 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.423 HG21 ' HB1' ' A' ' 76' ' ' ALA . 70.3 t -58.78 -42.48 85.57 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.52 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.948 177.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.423 ' O ' ' HE3' ' A' ' 63' ' ' LYS . . . -65.11 -16.87 63.96 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.99 -25.25 14.38 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 122.187 0.994 . . . . 0.0 108.399 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.437 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.6 OUTLIER -83.13 -36.26 24.93 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.168 -176.197 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -71.91 -22.35 61.5 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 122.801 0.44 . . . . 0.0 111.228 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.423 ' HE3' ' O ' ' A' ' 59' ' ' ALA . 19.0 ptpt . . . . . 0 C--N 1.329 -0.283 0 CA-C-O 121.201 0.524 . . . . 0.0 110.772 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 39.5 t . . . . . 0 N--CA 1.439 -0.995 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -147.98 154.31 40.15 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.365 0.603 . . . . 0.0 110.776 -175.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.413 HG12 HG12 ' A' ' 58' ' ' VAL . 1.6 pp -93.9 147.94 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.68 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.625 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.8 mm -112.5 -22.18 5.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.978 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.56 ' CD2' HD12 ' A' ' 45' ' ' ILE . 5.3 t60 -162.48 149.11 13.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -172.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.423 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -140.41 144.34 36.11 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 178.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.439 ' HB1' ' HE2' ' A' ' 47' ' ' LYS . . . -165.52 149.78 8.49 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 117.904 0.32 . . . . 0.0 110.874 177.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.2 p -94.31 93.67 4.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 122.604 1.192 . . . . 0.0 109.083 177.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -177.09 176.4 48.05 Favored Glycine 0 N--CA 1.408 -3.192 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -177.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' A' ' 102' ' ' ARG . . . -93.11 -175.35 3.83 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 176.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.531 ' O ' ' HA ' ' A' ' 103' ' ' PRO . 3.0 mp -77.83 110.9 14.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.064 -0.655 . . . . 0.0 110.016 -176.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.7 p -110.74 147.81 33.62 Favored 'General case' 0 N--CA 1.408 -2.543 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.187 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -45.7 -44.49 13.59 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 125.125 1.37 . . . . 0.0 112.95 -178.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.9 t -64.15 -33.96 76.96 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 122.556 0.342 . . . . 0.0 111.785 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -78.18 -26.21 47.52 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 121.007 0.432 . . . . 0.0 111.718 -177.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.459 ' CG2' ' HA ' ' A' ' 111' ' ' ALA . 50.8 mt -64.71 -35.48 75.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.952 177.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 57.6 m -61.17 -24.55 66.39 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 175.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -74.96 -37.63 61.9 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 173.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.588 ' HA ' ' O ' ' A' ' 94' ' ' ALA . . . -55.22 -51.23 67.23 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.9 -177.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.479 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 8.9 t -77.14 -15.98 59.33 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 120.596 -0.441 . . . . 0.0 111.099 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.69 -62.13 1.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.062 0.458 . . . . 0.0 111.102 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 68.1 m -91.6 1.3 57.24 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.954 -177.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.2 m120 69.35 23.33 6.22 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.907 0.86 . . . . 0.0 109.38 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.588 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . -94.72 117.2 29.75 Favored 'General case' 0 C--O 1.194 -1.844 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.688 -177.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 44.3 pt -92.38 156.69 3.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 118.378 -1.329 . . . . 0.0 109.782 -177.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.5 t -94.45 116.92 36.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.215 -173.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 6.5 tp -101.08 109.25 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.928 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 173.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -105.9 140.57 15.19 Favored Glycine 0 N--CA 1.414 -2.789 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.047 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -98.68 94.4 6.63 Favored 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 118.238 -1.385 . . . . 0.0 109.281 -176.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 66.8 t30 58.61 14.78 3.27 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 125.489 1.516 . . . . 0.0 111.822 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.465 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 6.5 m -78.91 -49.6 19.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -173.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.65 ' O ' ' HB3' ' A' ' 80' ' ' ALA . 62.6 mtm180 77.87 158.96 0.15 Allowed Pre-proline 0 N--CA 1.482 1.17 0 O-C-N 123.818 0.699 . . . . 0.0 112.756 174.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.531 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 15.4 Cg_endo -100.16 178.79 0.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.546 2.164 . . . . 0.0 114.934 -176.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -73.83 159.91 32.21 Favored 'General case' 0 C--O 1.25 1.084 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 167.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.516 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -67.63 -28.22 67.54 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.079 0.466 . . . . 0.0 109.892 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.638 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 20.0 t-20 -85.9 -36.32 19.99 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.796 176.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.51 -43.81 93.3 Favored 'General case' 0 C--O 1.207 -1.152 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.823 176.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 105' ' ' ALA . 0.0 OUTLIER -57.83 -30.04 65.43 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-O 120.785 0.326 . . . . 0.0 111.602 179.08 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.638 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 91.1 mtt180 -76.29 -52.31 10.24 Favored 'General case' 0 N--CA 1.386 -3.638 0 C-N-CA 125.29 1.436 . . . . 0.0 108.385 178.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -52.73 -45.96 67.21 Favored 'General case' 0 C--O 1.201 -1.484 0 CA-C-N 113.672 -1.603 . . . . 0.0 110.577 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.459 ' HA ' ' CG2' ' A' ' 86' ' ' ILE . . . -47.68 -53.06 16.12 Favored 'General case' 0 CA--C 1.501 -0.936 0 O-C-N 124.749 1.281 . . . . 0.0 110.915 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -78.55 -25.52 45.45 Favored 'General case' 0 C--N 1.271 -2.841 0 CA-C-N 114.558 -1.201 . . . . 0.0 112.529 -173.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 41.6 t -86.39 5.34 35.4 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 177.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.572 ' O ' ' HB2' ' A' ' 115' ' ' LYS . 19.2 mt-10 -123.3 13.11 9.54 Favored 'General case' 0 CA--C 1.462 -2.409 0 CA-C-N 114.612 -1.176 . . . . 0.0 111.737 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.572 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 56.4 mtpt 68.85 12.61 8.7 Favored 'General case' 0 N--CA 1.417 -2.086 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 175.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 3.0 m -126.16 112.49 30.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -93.87 141.07 28.93 Favored 'General case' 0 CA--C 1.498 -1.022 0 C-N-CA 118.29 -1.364 . . . . 0.0 108.352 177.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 6.3 pt -102.06 145.01 12.53 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.601 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.541 -174.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 57.3 mtp180 -122.03 128.48 51.46 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -178.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.499 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.309 -1.165 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.621 -177.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.485 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 94.1 m-20 . . . . . 0 CA--C 1.503 -0.843 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 89.6 mt -135.29 169.65 17.14 Favored 'General case' 0 C--O 1.252 1.194 0 CA-C-O 122.016 0.912 . . . . 0.0 111.894 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -131.61 139.73 49.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 114.259 -1.337 . . . . 0.0 109.944 177.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 93.7 t -117.88 130.67 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-O 121.161 0.505 . . . . 0.0 110.775 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.46 ' HZ2' ' CG ' ' A' ' 85' ' ' ASP . 35.5 mtmm -142.35 144.47 33.2 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.017 173.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -150.48 170.77 18.29 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -82.7 -19.7 37.53 Favored 'General case' 0 C--N 1.313 -1.007 0 O-C-N 124.065 0.853 . . . . 0.0 110.227 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.468 ' HB ' ' OG ' ' A' ' 53' ' ' SER . 95.3 t -110.54 124.26 67.16 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.971 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 173.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.704 ' O ' HG22 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -54.77 -46.61 74.41 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 123.898 0.879 . . . . 0.0 112.61 -176.348 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.19 1.7 79.44 Favored Glycine 0 C--N 1.285 -2.264 0 C-N-CA 118.099 -2.001 . . . . 0.0 114.06 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.468 ' OG ' ' HB ' ' A' ' 50' ' ' VAL . 49.1 m -82.63 -26.78 31.89 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 176.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.704 HG22 ' O ' ' A' ' 51' ' ' GLN . 3.7 m -68.57 -45.08 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.099 0 CA-C-N 114.398 -1.274 . . . . 0.0 107.885 176.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -67.09 -32.33 73.42 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.939 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.56 -34.22 77.32 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.179 0.514 . . . . 0.0 110.29 177.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.4 tp -84.01 -39.13 20.05 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.605 178.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 54' ' ' VAL . 55.6 t -55.44 -45.56 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.033 0.533 . . . . 0.0 112.029 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.19 -15.71 63.38 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.509 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -100.9 -22.16 14.89 Favored 'General case' 0 C--O 1.2 -1.521 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.27 -38.24 17.76 Favored 'General case' 0 N--CA 1.421 -1.919 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.873 -177.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -72.13 -10.02 59.22 Favored 'General case' 0 C--N 1.317 -0.82 0 O-C-N 122.073 -0.392 . . . . 0.0 110.723 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 19.1 pttp . . . . . 0 C--O 1.243 0.745 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.9 t . . . . . 0 CA--C 1.499 -1.019 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -130.23 155.26 46.56 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-O 121.457 0.646 . . . . 0.0 111.231 -173.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.4 pp -94.74 148.64 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.499 176.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 76.5 mt -113.5 -30.5 2.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-O 121.478 0.656 . . . . 0.0 110.582 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -151.29 133.4 15.2 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.337 -172.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.567 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -134.96 129.49 34.3 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -151.46 159.86 43.99 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 120.53 0.205 . . . . 0.0 110.547 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.2 p -94.08 98.61 8.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-O 121.887 0.851 . . . . 0.0 108.803 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.415 ' O ' ' HB3' ' A' ' 47' ' ' LYS . . . -176.92 175.45 47.66 Favored Glycine 0 N--CA 1.414 -2.779 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.578 ' HB2' ' O ' ' A' ' 102' ' ' ARG . . . -98.41 -170.56 1.97 Allowed 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 174.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.7 mp -84.99 119.04 33.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 C-N-CA 119.725 -0.79 . . . . 0.0 111.374 -176.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.0 p -121.65 162.0 21.48 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.018 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.476 ' H ' ' CD ' ' A' ' 83' ' ' GLU . 2.3 mp0 -53.89 -43.82 69.98 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 124.759 1.223 . . . . 0.0 111.655 -178.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.9 t -68.72 -27.06 65.6 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.28 0.562 . . . . 0.0 110.544 -176.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.46 ' CG ' ' HZ2' ' A' ' 47' ' ' LYS . 9.8 t70 -74.7 -44.26 50.93 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.326 178.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.448 HG23 ' HA ' ' A' ' 111' ' ' ALA . 56.9 mt -60.2 -27.75 40.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.448 177.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.0 t -61.07 -21.58 63.8 Favored 'General case' 0 CA--C 1.563 1.45 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.779 177.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -82.46 -37.35 25.52 Favored 'General case' 0 C--O 1.245 0.863 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 174.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.68 -60.31 3.48 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.555 -176.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.586 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 8.6 t -70.45 -22.2 62.72 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.677 178.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.6 -60.69 2.34 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 20.0 m -97.86 5.23 49.28 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.115 0.484 . . . . 0.0 110.787 -178.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 66.64 37.52 4.36 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.189 0.996 . . . . 0.0 111.203 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -94.86 139.39 31.37 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 114.363 -1.29 . . . . 0.0 108.591 178.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 49.4 mm -94.86 142.23 13.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.486 ' HB ' HG23 ' A' ' 118' ' ' ILE . 36.2 t -94.2 117.29 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.625 0 CA-C-O 121.276 0.56 . . . . 0.0 110.843 -175.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.49 130.92 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.016 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 176.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -136.01 175.38 20.9 Favored Glycine 0 N--CA 1.423 -2.197 0 N-CA-C 108.846 -1.701 . . . . 0.0 108.846 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . 0.288 21.8 p90 -141.66 107.28 5.08 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 119.084 -1.047 . . . . 0.0 113.294 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.2 t30 67.15 9.17 6.73 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 126.069 1.748 . . . . 0.0 111.373 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.431 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 4.9 m -84.12 -48.69 16.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.824 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.578 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 9.1 mtm180 73.07 163.75 0.14 Allowed Pre-proline 0 N--CA 1.485 1.307 0 C-N-CA 124.165 0.986 . . . . 0.0 111.251 176.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -95.25 168.61 1.47 Allowed 'Trans proline' 0 N--CA 1.437 -1.811 0 C-N-CA 121.901 1.734 . . . . 0.0 113.342 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -79.2 161.2 26.56 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 170.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.451 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -63.09 -24.3 67.84 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 122.713 0.405 . . . . 0.0 111.47 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.662 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 68.8 m-20 -85.68 -38.2 18.59 Favored 'General case' 0 C--O 1.206 -1.214 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 176.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.04 -41.51 99.52 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.86 0.362 . . . . 0.0 111.451 -178.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -59.87 -22.06 61.83 Favored 'General case' 0 CA--C 1.559 1.293 0 CA-C-O 121.111 0.481 . . . . 0.0 111.075 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.662 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 38.1 mtm105 -88.46 -51.78 5.54 Favored 'General case' 0 N--CA 1.38 -3.975 0 C-N-CA 125.523 1.529 . . . . 0.0 109.227 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -51.9 -47.01 64.77 Favored 'General case' 0 C--O 1.201 -1.474 0 C-N-CA 125.032 1.333 . . . . 0.0 111.171 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.448 ' HA ' HG23 ' A' ' 86' ' ' ILE . . . -49.42 -43.37 44.58 Favored 'General case' 0 CA--C 1.494 -1.187 0 O-C-N 124.279 0.987 . . . . 0.0 111.078 -179.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -82.89 -23.96 33.36 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-N 114.839 -1.073 . . . . 0.0 113.137 -173.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 38.6 t -89.07 5.89 42.37 Favored 'General case' 0 C--N 1.277 -2.565 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 175.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.586 ' O ' ' HB ' ' A' ' 90' ' ' THR . 23.7 mt-10 -125.27 15.62 8.36 Favored 'General case' 0 N--CA 1.408 -2.533 0 CA-C-N 113.953 -1.476 . . . . 0.0 112.437 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 56.2 mtpt 66.14 3.31 2.64 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 172.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.8 m -114.21 169.03 5.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 121.945 -0.472 . . . . 0.0 111.69 -176.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -130.77 137.71 49.6 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.486 HG23 ' HB ' ' A' ' 96' ' ' VAL . 10.4 pt -107.86 127.35 64.01 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.163 -178.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -129.18 136.96 50.85 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.492 -0.883 . . . . 0.0 113.24 -175.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.411 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.436 -1.144 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.341 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 . . . . . 0 CA--C 1.504 -0.813 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 70.9 mt -131.25 165.61 23.01 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.545 HD11 ' CD2' ' A' ' 75' ' ' HIS . 0.2 OUTLIER -131.65 136.83 56.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-N 112.817 -1.992 . . . . 0.0 107.26 175.753 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 92.1 t -117.31 128.18 74.67 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 176.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.556 ' HE3' ' CG ' ' A' ' 85' ' ' ASP . 12.8 ptmm? -159.43 128.06 5.14 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.44 176.28 9.49 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.894 -171.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -74.68 -32.0 62.08 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 123.948 0.78 . . . . 0.0 109.412 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 86.3 t -94.71 122.04 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.137 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.736 ' O ' HG21 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -61.48 -47.84 83.82 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 124.347 1.059 . . . . 0.0 112.595 -174.776 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.87 5.01 84.06 Favored Glycine 0 C--N 1.278 -2.684 0 C-N-CA 118.049 -2.024 . . . . 0.0 113.003 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.0 t -83.36 -29.09 28.5 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.736 HG21 ' O ' ' A' ' 51' ' ' GLN . 6.0 m -70.87 -45.87 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.397 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.653 176.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -60.24 -40.44 90.24 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.178 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.66 -39.97 95.57 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 123.574 0.546 . . . . 0.0 110.825 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 38.3 tp -75.46 -39.34 58.83 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.177 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 54' ' ' VAL . 54.6 t -57.11 -37.99 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.128 0.571 . . . . 0.0 111.44 178.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.4 -19.14 63.81 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.03 -30.23 12.81 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.17 -36.15 64.05 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.615 -175.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -68.89 -21.23 64.25 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.134 178.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt . . . . . 0 CA--C 1.548 0.904 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 179.959 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.7 t . . . . . 0 N--CA 1.428 -1.551 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -149.43 158.17 43.94 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.141 0.496 . . . . 0.0 110.241 -178.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.42 HG12 HG11 ' A' ' 58' ' ' VAL . 1.5 pp -94.54 144.17 10.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.073 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.5 mp -112.69 -22.73 4.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-O 122.058 0.933 . . . . 0.0 109.438 177.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.545 ' CD2' HD11 ' A' ' 45' ' ' ILE . 2.0 t60 -148.13 139.05 23.17 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -172.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.602 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -140.33 136.69 33.46 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 177.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -163.2 156.93 19.83 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 118.608 0.64 . . . . 0.0 111.426 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.3 p -101.04 94.42 3.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-O 121.774 0.797 . . . . 0.0 109.273 175.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -177.02 173.31 46.2 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 119.365 -1.398 . . . . 0.0 113.304 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 102' ' ' ARG . . . -81.58 170.02 16.36 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 124.159 0.984 . . . . 0.0 108.856 176.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.8 mp -72.82 118.21 17.62 Favored 'Isoleucine or valine' 0 C--O 1.245 0.816 0 CA-C-N 118.505 0.593 . . . . 0.0 110.363 -177.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 70.7 p -118.7 158.58 25.26 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -50.19 -34.22 21.91 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.23 0.612 . . . . 0.0 112.089 176.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.9 m -62.2 -40.28 95.55 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.127 0.489 . . . . 0.0 110.43 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.556 ' CG ' ' HE3' ' A' ' 47' ' ' LYS . 46.5 m-20 -71.88 -38.96 69.91 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.321 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.447 ' CG2' ' HA ' ' A' ' 111' ' ' ALA . 58.8 mt -67.2 -29.75 46.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.977 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 27.8 m -58.08 -35.17 71.0 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.194 174.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -72.44 -34.37 67.73 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.149 177.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.09 -61.96 1.97 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.028 -176.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.577 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 9.2 t -69.5 -21.31 63.69 Favored 'General case' 0 CA--C 1.568 1.655 0 O-C-N 121.583 -0.698 . . . . 0.0 111.054 177.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.89 -52.62 34.38 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 54.1 m -98.78 -2.87 36.93 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.721 178.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.1 m120 68.65 37.32 2.53 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 122.36 1.076 . . . . 0.0 109.376 -176.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.99 155.93 16.53 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 113.99 -1.459 . . . . 0.0 108.401 178.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.4 HG23 ' O ' ' A' ' 117' ' ' ASP . 46.2 mm -111.67 135.06 52.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.483 ' HB ' HG23 ' A' ' 118' ' ' ILE . 19.4 t -93.59 123.62 45.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.218 0.532 . . . . 0.0 109.834 -174.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 35.6 pt -104.55 157.63 5.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.65 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -171.66 172.93 44.88 Favored Glycine 0 N--CA 1.419 -2.449 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 175.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -161.54 133.38 5.63 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 73.28 -41.08 0.49 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.26 1.424 . . . . 0.0 111.872 177.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.6 m -65.59 -51.17 66.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 C-N-CA 124.339 1.055 . . . . 0.0 111.631 176.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.468 ' O ' ' HB3' ' A' ' 80' ' ' ALA . 35.4 mtm180 66.72 178.97 0.05 OUTLIER Pre-proline 0 CA--C 1.566 1.576 0 C-N-CA 123.364 0.666 . . . . 0.0 112.051 174.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.402 ' CD ' ' HB3' ' A' ' 102' ' ' ARG . 21.6 Cg_endo -99.48 176.21 0.35 Allowed 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 122.327 2.018 . . . . 0.0 113.865 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -82.16 156.94 24.21 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 168.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.574 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -61.82 -31.18 71.39 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 120.849 0.357 . . . . 0.0 110.489 178.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.589 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 5.4 m-20 -77.8 -36.31 50.44 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.269 175.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.09 -44.06 97.48 Favored 'General case' 0 C--O 1.211 -0.948 0 O-C-N 121.981 -0.45 . . . . 0.0 111.27 176.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.511 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 14.4 ptmm? -59.83 -29.21 68.1 Favored 'General case' 0 CA--C 1.563 1.445 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.589 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 95.4 mtt180 -73.03 -51.37 18.44 Favored 'General case' 0 N--CA 1.395 -3.179 0 C-N-CA 124.643 1.177 . . . . 0.0 108.997 176.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -52.86 -49.03 66.63 Favored 'General case' 0 C--O 1.194 -1.852 0 CA-C-N 113.7 -1.591 . . . . 0.0 110.226 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.447 ' HA ' ' CG2' ' A' ' 86' ' ' ILE . . . -47.99 -50.76 26.4 Favored 'General case' 0 CA--C 1.483 -1.613 0 O-C-N 124.717 1.26 . . . . 0.0 111.2 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -81.24 -24.77 37.12 Favored 'General case' 0 C--N 1.27 -2.873 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.915 -172.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 38.3 t -87.66 5.45 39.58 Favored 'General case' 0 C--N 1.275 -2.646 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 175.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.577 ' O ' ' HB ' ' A' ' 90' ' ' THR . 24.7 mt-10 -123.35 19.43 9.75 Favored 'General case' 0 CA--C 1.466 -2.255 0 CA-C-N 114.411 -1.268 . . . . 0.0 111.572 177.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.532 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 65.6 mttm 67.0 4.63 3.65 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 173.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.4 m -113.98 163.94 10.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 121.683 -0.635 . . . . 0.0 112.106 -175.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.4 ' O ' HG23 ' A' ' 95' ' ' ILE . 4.0 m-20 -125.89 142.96 51.27 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 177.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.483 HG23 ' HB ' ' A' ' 96' ' ' VAL . 4.8 pt -105.05 138.74 28.56 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.914 178.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -104.64 112.83 26.06 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.519 -175.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.433 ' CD1' ' HA ' ' A' ' 102' ' ' ARG . 3.1 mm? . . . . . 0 C--N 1.299 -1.601 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.475 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.41 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 92.0 m-20 . . . . . 0 N--CA 1.441 -0.899 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.3 mt -134.42 164.91 26.39 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 122.304 1.05 . . . . 0.0 113.51 -176.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.619 HD12 ' CD2' ' A' ' 75' ' ' HIS . 0.2 OUTLIER -123.01 139.79 48.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.356 175.63 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 66.4 t -112.23 130.02 66.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.342 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -136.93 144.4 43.41 Favored 'General case' 0 CA--C 1.492 -1.277 0 C-N-CA 123.926 0.89 . . . . 0.0 109.951 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.18 165.1 29.95 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 177.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -84.97 -17.08 38.76 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 120.924 0.392 . . . . 0.0 110.699 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 87.3 t -101.69 127.09 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 173.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.724 ' O ' HG21 ' A' ' 54' ' ' VAL . 49.7 tt0 -61.41 -51.69 67.72 Favored 'General case' 0 C--O 1.196 -1.725 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -173.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.51 0.94 53.78 Favored Glycine 0 C--N 1.28 -2.539 0 C-N-CA 118.205 -1.95 . . . . 0.0 113.724 -175.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.4 t -82.88 -24.98 32.95 Favored 'General case' 0 N--CA 1.417 -2.081 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 177.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.724 HG21 ' O ' ' A' ' 51' ' ' GLN . 5.2 m -77.37 -46.45 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.256 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.355 176.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -66.12 -38.61 88.62 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.442 -176.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.85 -38.23 87.44 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.926 0.393 . . . . 0.0 110.548 177.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.469 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 34.9 tp -73.85 -42.25 61.08 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.428 HG21 ' O ' ' A' ' 54' ' ' VAL . 53.5 t -57.0 -41.12 76.77 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 C-N-CA 123.16 0.584 . . . . 0.0 111.335 177.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.05 -24.21 67.62 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.38 -20.35 17.2 Favored 'General case' 0 C--O 1.207 -1.173 0 CA-C-O 121.511 0.672 . . . . 0.0 109.39 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -90.75 -28.1 18.5 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.073 -175.4 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -77.94 -24.06 48.36 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 122.157 -0.34 . . . . 0.0 110.409 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt . . . . . 0 C--N 1.322 -0.628 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.123 -178.481 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 32.8 t . . . . . 0 N--CA 1.442 -0.841 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.8 ttmp? -167.59 162.71 14.37 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 pp -93.69 150.5 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.606 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.42 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 37.2 mm -115.28 -28.93 2.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 CA-C-O 121.365 0.602 . . . . 0.0 109.666 178.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.619 ' CD2' HD12 ' A' ' 45' ' ' ILE . 3.8 t60 -149.39 140.4 22.92 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -171.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.67 135.15 38.0 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -158.54 141.55 14.72 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.652 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.444 ' HB ' ' HA ' ' A' ' 51' ' ' GLN . 4.5 p -93.86 93.98 4.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-O 122.793 1.282 . . . . 0.0 108.822 175.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.89 175.08 47.51 Favored Glycine 0 N--CA 1.409 -3.103 0 CA-C-N 113.855 -1.521 . . . . 0.0 109.554 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 102' ' ' ARG . . . -83.07 -176.93 6.58 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 177.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.433 HG22 HG22 ' A' ' 118' ' ' ILE . 3.3 mp -78.56 110.91 14.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.5 HG23 ' OD2' ' A' ' 85' ' ' ASP . 14.0 t -113.56 165.56 12.38 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 119.576 -0.849 . . . . 0.0 109.374 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -56.92 -35.06 68.59 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.614 0.765 . . . . 0.0 111.182 -176.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.4 m -67.13 -28.54 68.23 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.523 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.5 ' OD2' HG23 ' A' ' 82' ' ' THR . 17.4 m-20 -77.37 -28.53 52.95 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-O 121.175 0.512 . . . . 0.0 110.408 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.484 ' CG2' ' HA ' ' A' ' 111' ' ' ALA . 46.0 mm -65.54 -33.15 61.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.111 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.9 m -57.01 -39.54 74.93 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.364 177.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -73.94 -39.03 64.06 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.981 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.23 -55.29 22.13 Favored 'General case' 0 C--N 1.316 -0.887 0 O-C-N 123.926 0.766 . . . . 0.0 111.877 -177.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.494 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 10.9 t -77.48 -19.01 56.58 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.419 178.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.79 -66.24 0.58 Allowed 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.057 0.456 . . . . 0.0 111.685 -177.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.6 m -95.41 2.06 54.41 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.409 -177.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.5 m120 62.43 62.92 1.08 Allowed 'General case' 0 CA--C 1.497 -1.079 0 CA-C-O 122.366 1.079 . . . . 0.0 112.332 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -120.24 134.56 55.23 Favored 'General case' 0 N--CA 1.417 -2.092 0 CA-C-N 113.244 -1.798 . . . . 0.0 107.179 176.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 32.2 pt -94.13 141.92 14.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.505 ' HB ' HG21 ' A' ' 118' ' ' ILE . 12.1 t -94.16 116.6 35.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-O 121.192 0.52 . . . . 0.0 110.149 -173.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.513 ' HA ' ' O ' ' A' ' 119' ' ' ARG . 58.0 mt -112.78 125.71 70.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 120' ' ' LEU . . . -132.24 170.25 21.9 Favored Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.441 ' C ' ' H ' ' A' ' 101' ' ' VAL . 66.9 t80 -145.42 117.68 8.42 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -178.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 72.72 -29.34 0.2 Allowed 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 124.78 1.232 . . . . 0.0 113.099 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.447 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 4.6 m -66.34 -48.11 81.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.563 176.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.545 ' O ' ' HB3' ' A' ' 80' ' ' ALA . 59.8 mtm180 66.94 179.37 0.05 OUTLIER Pre-proline 0 CA--C 1.551 1.015 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.878 174.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -98.84 168.72 0.58 Allowed 'Trans proline' 0 N--CA 1.44 -1.663 0 CA-C-N 120.838 1.335 . . . . 0.0 114.568 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -79.48 152.19 30.38 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 113.005 -1.907 . . . . 0.0 106.448 167.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.44 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -61.62 -21.07 64.05 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -176.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.552 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 54.9 t30 -94.47 -28.28 15.55 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.945 -0.702 . . . . 0.0 109.747 177.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.72 -40.8 95.95 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-O 120.965 0.412 . . . . 0.0 110.557 177.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 21.9 ptmt -61.72 -28.5 69.46 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.07 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.552 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 70.7 mtp180 -81.01 -53.09 6.72 Favored 'General case' 0 N--CA 1.385 -3.689 0 C-N-CA 125.918 1.687 . . . . 0.0 109.097 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -52.79 -45.26 67.11 Favored 'General case' 0 C--O 1.196 -1.73 0 CA-C-N 113.85 -1.523 . . . . 0.0 110.457 -178.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.484 ' HA ' ' CG2' ' A' ' 86' ' ' ILE . . . -48.58 -49.28 37.38 Favored 'General case' 0 CA--C 1.49 -1.355 0 O-C-N 124.524 1.14 . . . . 0.0 111.381 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -77.25 -35.2 55.53 Favored 'General case' 0 C--N 1.281 -2.399 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.539 -174.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 35.5 t -79.56 5.47 12.94 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-O 122.374 1.083 . . . . 0.0 108.979 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.494 ' O ' ' HB ' ' A' ' 90' ' ' THR . 19.3 mt-10 -123.75 14.54 9.36 Favored 'General case' 0 CA--C 1.46 -2.504 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.845 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 64.4 mmtt 65.85 17.94 10.98 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 173.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.0 m -120.73 171.41 9.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.362 177.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -137.15 142.35 42.22 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.505 HG21 ' HB ' ' A' ' 96' ' ' VAL . 10.3 pt -107.97 134.52 49.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 121.32 0.581 . . . . 0.0 111.044 -178.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 21.5 mmm180 -113.3 125.04 53.85 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -178.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.548 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.717 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -178.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.538 ' HA ' ' O ' ' A' ' 72' ' ' LYS . 36.5 m-80 . . . . . 0 N--CA 1.433 -1.319 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.8 mt -134.27 163.6 29.26 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.66 0.743 . . . . 0.0 112.012 -177.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.95 135.12 61.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.576 174.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 94.3 t -112.49 123.73 68.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 121.314 0.578 . . . . 0.0 111.401 -176.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -133.51 147.79 51.64 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 124.504 1.122 . . . . 0.0 109.668 176.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.39 161.87 33.19 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -81.65 -9.25 59.71 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 122.283 1.039 . . . . 0.0 109.52 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 96.1 t -114.96 123.73 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 176.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.652 ' O ' HG23 ' A' ' 54' ' ' VAL . 48.2 tt0 -58.24 -49.77 75.93 Favored 'General case' 0 C--O 1.205 -1.259 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -176.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.59 4.0 52.62 Favored Glycine 0 C--N 1.289 -2.059 0 C-N-CA 118.58 -1.772 . . . . 0.0 113.887 -176.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.9 t -86.17 -19.46 30.05 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 176.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 51' ' ' GLN . 4.9 m -81.19 -46.35 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.266 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 174.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -57.43 -50.35 73.3 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.384 -1.28 . . . . 0.0 111.968 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.05 -40.76 81.76 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 123.371 0.42 . . . . 0.0 111.594 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.407 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 36.8 tp -74.34 -43.06 58.24 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.071 -178.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.432 HG13 HG12 ' A' ' 73' ' ' ILE . 54.6 t -59.08 -40.14 80.11 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.595 0 C-N-CA 122.885 0.474 . . . . 0.0 111.071 177.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.62 -12.08 60.89 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.6 -31.72 10.25 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 176.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.407 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -75.71 -28.48 58.6 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 114.235 -1.348 . . . . 0.0 110.923 -175.41 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -83.14 -14.19 54.04 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.682 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.486 0 C-N-CA 119.863 -0.735 . . . . 0.0 111.947 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.5 t . . . . . 0 N--CA 1.441 -0.888 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 24.9 ttpp -139.83 160.37 40.05 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.238 0.542 . . . . 0.0 110.174 -176.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.432 HG12 HG13 ' A' ' 58' ' ' VAL . 1.6 pp -94.89 162.34 2.45 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.003 175.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.45 HD11 ' HB3' ' A' ' 43' ' ' ASN . 1.7 mp -120.52 -33.39 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 174.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -152.38 122.14 6.96 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.341 -166.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -110.81 139.48 46.08 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 176.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -156.42 132.1 9.57 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 120.178 -0.609 . . . . 0.0 111.529 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.414 ' HB ' ' HA ' ' A' ' 51' ' ' GLN . 4.4 p -93.93 93.86 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.887 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 172.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -177.53 175.86 47.77 Favored Glycine 0 N--CA 1.399 -3.814 0 N-CA-C 108.319 -1.912 . . . . 0.0 108.319 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 102' ' ' ARG . . . -86.41 -170.63 3.17 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.163 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.401 ' CD1' HD11 ' A' ' 120' ' ' LEU . 21.2 mt -94.1 105.7 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.007 0 CA-C-O 121.213 0.53 . . . . 0.0 109.6 -173.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.4 t -106.89 162.68 13.6 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -60.79 -35.22 75.9 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 123.109 0.564 . . . . 0.0 111.109 -176.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.7 m -69.83 -10.95 60.35 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.664 -177.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -95.69 -31.66 13.13 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 121.6 0.714 . . . . 0.0 109.796 175.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.486 HD13 ' HB3' ' A' ' 111' ' ' ALA . 59.7 mt -69.8 -25.76 28.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.939 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.0 p -56.75 -37.19 70.7 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.7 175.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -70.86 -36.97 73.05 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 123.278 0.631 . . . . 0.0 110.191 175.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.01 -58.46 6.47 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.222 -175.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.551 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 7.0 t -71.46 -30.12 65.64 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 119.594 -0.842 . . . . 0.0 110.919 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.19 -53.08 62.35 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.061 0.545 . . . . 0.0 112.313 -177.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 31.7 t -101.44 6.91 42.68 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.432 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 9.9 p30 60.11 29.6 19.15 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.791 1.236 . . . . 0.0 111.648 177.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.47 131.64 39.96 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 113.545 -1.661 . . . . 0.0 108.632 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.4 pp -93.87 143.65 11.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.623 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.421 ' HB ' HG21 ' A' ' 118' ' ' ILE . 21.2 t -94.49 113.86 29.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.622 -174.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 119' ' ' ARG . 43.2 mm -112.91 123.41 68.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 175.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -115.08 168.79 12.65 Favored Glycine 0 N--CA 1.423 -2.212 0 C-N-CA 120.231 -0.985 . . . . 0.0 110.666 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -114.84 93.34 4.28 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.111 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 62.7 t30 60.78 10.02 2.49 Favored 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 125.796 1.639 . . . . 0.0 112.583 178.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.506 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 3.8 m -69.87 -47.97 66.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.792 -175.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.512 ' O ' ' HB3' ' A' ' 80' ' ' ALA . 55.9 mtm180 74.8 143.57 0.1 OUTLIER Pre-proline 0 CA--C 1.548 0.873 0 O-C-N 124.251 0.969 . . . . 0.0 111.522 175.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -86.5 169.66 8.14 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 121.753 1.635 . . . . 0.0 114.11 -175.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -77.89 152.16 33.46 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 169.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.479 ' O ' ' HG3' ' A' ' 108' ' ' LYS . . . -60.41 -28.56 68.35 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.479 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 91.3 m-20 -85.3 -29.27 24.69 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.237 177.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.49 -45.71 86.15 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 177.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 105' ' ' ALA . 0.0 OUTLIER -59.95 -29.63 68.54 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.265 179.761 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 62.3 mtt180 -73.1 -52.17 15.27 Favored 'General case' 0 N--CA 1.393 -3.289 0 C-N-CA 124.445 1.098 . . . . 0.0 109.62 178.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.88 -51.23 64.32 Favored 'General case' 0 C--O 1.197 -1.661 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.126 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.486 ' HB3' HD13 ' A' ' 86' ' ' ILE . . . -46.44 -48.77 18.81 Favored 'General case' 0 CA--C 1.494 -1.188 0 O-C-N 124.736 1.272 . . . . 0.0 112.52 -178.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -79.34 -32.34 43.29 Favored 'General case' 0 N--CA 1.407 -2.611 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.396 -171.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 26.0 t -79.58 -1.74 39.25 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.551 ' O ' ' HB ' ' A' ' 90' ' ' THR . 25.9 mt-10 -116.49 14.18 15.53 Favored 'General case' 0 N--CA 1.418 -2.067 0 C-N-CA 125.028 1.331 . . . . 0.0 112.454 -178.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 10.0 mtpm? 66.6 9.5 6.66 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 172.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.7 m -116.8 132.83 65.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-O 121.602 0.715 . . . . 0.0 112.277 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -97.55 127.13 43.26 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.421 HG21 ' HB ' ' A' ' 96' ' ' VAL . 25.9 pt -106.56 128.99 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.018 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.056 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.475 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 12.0 ptt180 -142.21 149.37 39.58 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 121.118 0.485 . . . . 0.0 110.338 -178.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.445 ' N ' HD13 ' A' ' 120' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.59 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.175 -171.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.427 ' HA ' ' O ' ' A' ' 72' ' ' LYS . 14.8 m120 . . . . . 0 CA--C 1.498 -1.046 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -154.01 165.25 36.74 Favored 'General case' 0 C--O 1.257 1.453 0 CA-C-O 121.486 0.66 . . . . 0.0 111.375 177.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -116.34 126.57 73.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 CA-C-N 114.638 -1.165 . . . . 0.0 108.986 175.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 73.2 t -95.77 121.08 45.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.696 -176.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.9 mtpm? -134.61 140.98 46.48 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -147.66 175.07 11.18 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -86.33 -13.46 46.5 Favored 'General case' 0 C--N 1.315 -0.934 0 O-C-N 123.813 0.696 . . . . 0.0 109.999 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 79.2 t -120.3 129.56 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 177.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.709 ' O ' HG21 ' A' ' 54' ' ' VAL . 16.1 tt0 -58.7 -48.3 81.59 Favored 'General case' 0 C--O 1.193 -1.904 0 O-C-N 123.291 0.369 . . . . 0.0 111.834 -175.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -73.26 -0.57 53.57 Favored Glycine 0 C--N 1.283 -2.379 0 C-N-CA 118.893 -1.622 . . . . 0.0 114.477 -175.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.3 t -86.48 -20.37 28.19 Favored 'General case' 0 N--CA 1.415 -2.221 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 177.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.709 HG21 ' O ' ' A' ' 51' ' ' GLN . 6.0 m -76.8 -44.22 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.181 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 173.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -63.04 -48.06 80.33 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.215 -1.357 . . . . 0.0 111.321 -177.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.42 -35.23 78.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.583 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.496 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 40.3 tp -78.56 -37.86 41.64 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.239 -178.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.448 HG13 HG12 ' A' ' 73' ' ' ILE . 49.8 t -58.44 -44.66 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 120.625 0.25 . . . . 0.0 110.452 176.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.0 -22.26 66.72 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.676 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.53 -16.01 20.29 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.712 0.768 . . . . 0.0 109.951 -177.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.496 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -97.13 -32.84 11.75 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.25 -175.261 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -73.02 -20.33 61.02 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.028 0.442 . . . . 0.0 110.586 177.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt . . . . . 0 C--N 1.326 -0.449 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.194 -177.55 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.44 -0.951 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 57.3 tttp -150.38 154.55 37.97 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.448 HG12 HG13 ' A' ' 58' ' ' VAL . 1.4 pp -93.69 154.45 3.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.635 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 40.3 mm -115.69 -33.32 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-O 121.142 0.496 . . . . 0.0 111.1 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -160.83 134.52 6.83 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -171.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.416 ' HB2' HG23 ' A' ' 58' ' ' VAL . . . -113.51 133.44 55.23 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 176.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -151.94 130.64 12.35 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.307 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.4 p -93.39 93.89 4.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-O 123.2 1.476 . . . . 0.0 110.148 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -177.84 175.49 47.55 Favored Glycine 0 N--CA 1.403 -3.558 0 CA-C-N 113.68 -1.6 . . . . 0.0 109.488 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.489 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -74.11 178.48 5.02 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 174.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 103' ' ' PRO . 3.5 mp -84.27 108.83 16.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 69.6 p -101.04 166.92 10.56 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.512 -0.875 . . . . 0.0 108.992 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -59.53 -33.78 71.82 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.775 0.798 . . . . 0.0 109.508 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.1 m -67.44 -31.44 71.62 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.877 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -73.15 -34.76 66.26 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 121.901 0.858 . . . . 0.0 109.828 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.7 mt -66.55 -26.84 38.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 114.524 -1.216 . . . . 0.0 112.846 -176.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 88.3 p -55.49 -38.32 68.99 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 120.823 0.344 . . . . 0.0 110.507 175.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -73.14 -33.55 65.57 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.028 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.98 -62.16 1.89 Allowed 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.54 -177.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.527 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 4.3 t -70.58 -17.09 62.91 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-O 121.306 0.574 . . . . 0.0 111.129 178.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.82 -55.08 9.33 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 32.6 p -97.53 -8.32 29.38 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 121.017 -0.273 . . . . 0.0 110.767 -176.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . 0.265 0.0 OUTLIER 78.84 30.45 0.35 Allowed 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 127.021 2.128 . . . . 0.0 110.241 -176.799 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -92.6 140.56 29.42 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 113.969 -1.469 . . . . 0.0 110.23 -176.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.4 HG22 ' O ' ' A' ' 117' ' ' ASP . 43.0 mm -94.02 140.44 16.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.528 ' HB ' HG21 ' A' ' 118' ' ' ILE . 11.5 t -95.8 129.5 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -177.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 13.1 tt -127.78 135.99 61.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -137.24 158.23 24.25 Favored Glycine 0 N--CA 1.417 -2.61 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 177.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.412 ' C ' ' H ' ' A' ' 101' ' ' VAL . 91.7 m-85 -117.25 102.7 9.49 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -176.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 59.0 t30 69.75 -31.55 0.21 Allowed 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 124.222 1.009 . . . . 0.0 112.924 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.428 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 1.7 m -49.51 -42.58 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 C-N-CA 124.028 0.931 . . . . 0.0 113.396 177.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.508 ' HA ' ' HG ' ' A' ' 120' ' ' LEU . 49.9 mtp180 69.94 176.44 0.07 OUTLIER Pre-proline 0 CA--C 1.537 0.456 0 O-C-N 123.886 0.741 . . . . 0.0 112.65 175.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.424 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 9.3 Cg_endo -99.25 177.55 0.33 Allowed 'Trans proline' 0 N--CA 1.432 -2.104 0 C-N-CA 121.828 1.685 . . . . 0.0 112.581 178.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -82.84 155.5 24.13 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 168.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.443 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -59.09 -28.84 66.87 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 120.755 0.312 . . . . 0.0 111.642 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.562 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 28.1 m-80 -81.1 -35.39 31.71 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 177.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.4 -42.9 95.85 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 120.799 0.333 . . . . 0.0 110.843 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 17.0 pttp -62.98 -20.69 65.51 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-O 121.089 0.471 . . . . 0.0 110.91 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.562 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 24.8 mtm180 -84.25 -51.68 6.83 Favored 'General case' 0 N--CA 1.392 -3.372 0 C-N-CA 124.593 1.157 . . . . 0.0 109.228 175.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -51.33 -51.52 53.66 Favored 'General case' 0 CA--C 1.477 -1.841 0 C-N-CA 125.34 1.456 . . . . 0.0 110.503 -178.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -49.49 -48.55 47.86 Favored 'General case' 0 CA--C 1.502 -0.877 0 O-C-N 124.842 1.339 . . . . 0.0 112.206 -177.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -78.14 -33.02 50.64 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.384 -172.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 48.0 t -81.44 5.77 16.65 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 176.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.527 ' O ' ' HB ' ' A' ' 90' ' ' THR . 12.3 mt-10 -123.46 12.76 9.41 Favored 'General case' 0 N--CA 1.417 -2.105 0 C-N-CA 124.771 1.228 . . . . 0.0 112.339 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 10.4 mmmm 65.62 10.81 7.01 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 174.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.3 m -115.69 132.97 63.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-O 121.574 0.702 . . . . 0.0 112.492 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.4 ' O ' HG22 ' A' ' 95' ' ' ILE . 28.1 t70 -94.81 126.16 39.94 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.367 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.528 HG21 ' HB ' ' A' ' 96' ' ' VAL . 7.8 pt -94.11 131.86 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-O 121.408 0.623 . . . . 0.0 110.518 178.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 7.0 tpp180 -102.7 115.85 31.41 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.958 -177.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.508 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.307 -1.239 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 177.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.565 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 57.7 m-80 . . . . . 0 N--CA 1.432 -1.358 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 78.7 mt -138.59 164.57 29.13 Favored 'General case' 0 C--O 1.245 0.849 0 CA-C-O 121.814 0.816 . . . . 0.0 112.35 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.507 HD13 ' O ' ' A' ' 75' ' ' HIS . 0.2 OUTLIER -127.0 135.39 63.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 174.464 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 92.1 t -118.61 127.91 75.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.048 -177.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 41.5 mtpt -144.92 140.89 28.59 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.76 175.18 13.14 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -178.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -84.47 -25.68 28.73 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 122.2 1.0 . . . . 0.0 108.94 177.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 99.0 t -101.61 122.54 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.246 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 174.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.701 ' O ' HG23 ' A' ' 54' ' ' VAL . 17.4 tt0 -62.9 -40.72 98.43 Favored 'General case' 0 C--O 1.192 -1.941 0 CA-C-O 120.602 0.239 . . . . 0.0 111.411 -175.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -73.75 -3.03 62.28 Favored Glycine 0 C--N 1.29 -2.0 0 C-N-CA 118.314 -1.898 . . . . 0.0 114.151 -177.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.4 m -80.72 -24.02 39.08 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 176.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 51' ' ' GLN . 3.3 m -77.14 -47.09 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.767 0 CA-C-N 114.579 -1.191 . . . . 0.0 107.827 176.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -57.13 -48.04 79.64 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.295 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.48 -31.2 72.15 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.333 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.434 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 24.3 tp -79.78 -41.3 26.81 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.239 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 54' ' ' VAL . 53.2 t -53.56 -43.96 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.512 0.725 . . . . 0.0 111.921 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.88 -29.07 70.29 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.44 -13.07 28.39 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 121.325 0.583 . . . . 0.0 110.106 -177.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -96.13 -33.65 11.98 Favored 'General case' 0 N--CA 1.418 -2.064 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.494 -176.174 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -75.52 -14.69 60.42 Favored 'General case' 0 C--N 1.313 -1.002 0 O-C-N 122.066 -0.396 . . . . 0.0 111.59 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt . . . . . 0 C--N 1.308 -1.238 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -178.157 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.7 t . . . . . 0 N--CA 1.423 -1.817 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 58.8 tttp -153.06 158.5 42.05 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.844 -174.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.423 HG12 HG11 ' A' ' 58' ' ' VAL . 1.2 pp -93.94 152.29 3.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 -177.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.451 HD12 ' OD1' ' A' ' 43' ' ' ASN . 27.7 mm -115.69 -27.26 2.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.839 177.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.507 ' O ' HD13 ' A' ' 45' ' ' ILE . 3.5 t60 -157.69 135.91 11.0 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -169.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -142.48 129.34 20.58 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 47' ' ' LYS . . . -161.91 159.37 26.63 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 120.714 0.293 . . . . 0.0 110.477 -178.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.8 p -94.58 103.46 14.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 175.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -175.88 175.81 47.42 Favored Glycine 0 N--CA 1.425 -2.08 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -177.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.542 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -90.19 178.62 6.12 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 103' ' ' PRO . 3.7 mp -82.38 108.16 15.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 69.5 p -100.42 169.13 9.3 Favored 'General case' 0 N--CA 1.421 -1.885 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -58.83 -28.66 66.25 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.804 0.842 . . . . 0.0 110.254 176.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.0 t -71.58 -37.41 71.02 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.485 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -70.93 -36.05 72.49 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 121.634 0.73 . . . . 0.0 110.225 -177.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.454 HD12 ' HB1' ' A' ' 111' ' ' ALA . 54.3 mt -69.35 -34.6 63.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.426 -177.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 66.5 m -63.99 -19.36 65.11 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 120.471 -0.492 . . . . 0.0 112.152 174.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -79.9 -36.04 37.05 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 173.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.93 -54.18 49.83 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.31 -177.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.534 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 10.1 t -74.52 -12.88 60.59 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.917 178.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.76 -58.7 3.12 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.95 0.405 . . . . 0.0 111.815 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 26.4 m -98.12 5.14 48.92 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.432 -177.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.1 m120 72.43 33.05 1.51 Allowed 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 122.094 0.949 . . . . 0.0 110.041 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.565 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -94.75 170.26 9.57 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 113.938 -1.483 . . . . 0.0 109.71 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 36.6 pt -130.93 148.08 33.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 173.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.423 ' HA ' HG22 ' A' ' 45' ' ' ILE . 3.4 t -100.62 126.79 54.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.973 -175.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.589 ' HA ' ' O ' ' A' ' 119' ' ' ARG . 66.0 mt -112.13 135.78 50.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -132.55 140.16 11.58 Favored Glycine 0 N--CA 1.434 -1.486 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.745 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.418 ' C ' ' H ' ' A' ' 101' ' ' VAL . 97.9 m-85 -107.36 100.12 9.58 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -176.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.2 t30 72.91 -36.19 0.35 Allowed 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 125.332 1.453 . . . . 0.0 111.922 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.418 ' H ' ' C ' ' A' ' 99' ' ' PHE . 3.5 m -50.76 -50.63 22.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 124.698 1.199 . . . . 0.0 112.664 177.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.542 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 76.4 mtp180 67.73 177.21 0.06 OUTLIER Pre-proline 0 CA--C 1.559 1.312 0 O-C-N 123.731 0.644 . . . . 0.0 111.541 176.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 5.3 Cg_endo -94.82 173.58 1.31 Allowed 'Trans proline' 0 CA--C 1.5 -1.183 0 C-N-CA 121.59 1.527 . . . . 0.0 113.985 -177.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -77.48 160.91 28.33 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 113.965 -1.471 . . . . 0.0 107.335 168.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.466 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -67.35 -29.68 69.29 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -176.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 10.3 m-80 -86.72 -35.55 19.17 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.08 -50.42 66.83 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.441 175.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 61.2 pttt -56.97 -24.71 55.16 Favored 'General case' 0 CA--C 1.565 1.527 0 C-N-CA 122.697 0.399 . . . . 0.0 112.075 -178.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.567 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 14.1 mtm180 -86.27 -46.84 9.96 Favored 'General case' 0 N--CA 1.386 -3.628 0 C-N-CA 125.201 1.401 . . . . 0.0 108.93 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.11 -42.39 69.39 Favored 'General case' 0 C--O 1.201 -1.477 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.425 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.454 ' HB1' HD12 ' A' ' 86' ' ' ILE . . . -48.78 -44.86 39.27 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 124.475 1.109 . . . . 0.0 111.406 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -77.82 -32.83 52.46 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 114.874 -1.057 . . . . 0.0 112.277 -175.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 48.3 t -83.13 4.86 24.66 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 176.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.534 ' O ' ' HB ' ' A' ' 90' ' ' THR . 23.2 mt-10 -123.1 12.08 9.57 Favored 'General case' 0 CA--C 1.464 -2.341 0 C-N-CA 124.496 1.118 . . . . 0.0 112.883 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.517 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 26.7 mtpp 66.25 7.99 5.28 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 173.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.1 m -115.41 155.47 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.324 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -174.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -111.99 124.68 52.92 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.457 -178.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 9.3 pt -96.16 133.07 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.626 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.589 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 41.0 ttt85 -119.36 125.32 48.74 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.405 ' HG ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.285 -2.209 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.085 -177.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.2 t30 . . . . . 0 N--CA 1.419 -1.994 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 93.8 mt -123.36 172.86 8.36 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 122.146 0.974 . . . . 0.0 113.106 -172.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.437 HG22 ' HA ' ' A' ' 96' ' ' VAL . 1.1 tt -122.21 134.99 63.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 114.55 -1.204 . . . . 0.0 110.162 178.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 98.6 t -110.14 120.94 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 CA-C-O 121.496 0.665 . . . . 0.0 110.543 -177.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -140.62 114.61 9.06 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.289 1.036 . . . . 0.0 109.614 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -131.05 167.02 19.78 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.575 -176.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -73.08 -35.59 66.68 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.997 0.903 . . . . 0.0 109.02 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 88.5 t -95.56 124.7 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 176.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.716 ' O ' HG22 ' A' ' 54' ' ' VAL . 24.1 tt0 -62.63 -40.52 97.26 Favored 'General case' 0 C--O 1.194 -1.858 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.071 -177.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -75.67 0.67 60.55 Favored Glycine 0 C--N 1.279 -2.617 0 C-N-CA 118.241 -1.933 . . . . 0.0 114.071 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.4 t -87.53 -22.77 24.66 Favored 'General case' 0 N--CA 1.418 -2.059 0 N-CA-C 106.036 -1.839 . . . . 0.0 106.036 174.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.716 HG22 ' O ' ' A' ' 51' ' ' GLN . 3.9 m -73.0 -43.81 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.847 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 174.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -57.57 -54.87 41.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.222 -1.354 . . . . 0.0 110.636 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.65 -41.05 89.68 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.211 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.504 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 40.3 tp -73.38 -37.92 65.83 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 120.049 -0.661 . . . . 0.0 110.67 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.475 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 39.9 t -59.01 -45.17 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.58 -19.73 64.01 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.661 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.3 -10.91 20.79 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.697 0.76 . . . . 0.0 109.957 -177.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.504 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -105.27 -27.94 11.23 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 114.638 -1.164 . . . . 0.0 110.21 -175.125 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.475 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 4.2 pt20 -84.16 -11.35 56.72 Favored 'General case' 0 C--N 1.315 -0.904 0 O-C-N 121.904 -0.497 . . . . 0.0 111.422 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt . . . . . 0 C--N 1.317 -0.809 0 CA-C-O 121.327 0.584 . . . . 0.0 110.038 179.906 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 39.0 t . . . . . 0 N--CA 1.417 -2.109 0 N-CA-C 103.237 -2.875 . . . . 0.0 103.237 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -141.04 164.04 31.34 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.661 -171.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.6 pp -100.03 158.35 3.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.714 176.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.3 mt -117.62 -41.57 2.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.999 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -154.56 131.42 10.82 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.626 -169.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -124.99 125.12 43.39 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 124.215 1.006 . . . . 0.0 108.449 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -148.57 145.91 28.04 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.3 p -94.87 94.83 4.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-O 122.754 1.264 . . . . 0.0 110.049 177.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.24 175.09 47.36 Favored Glycine 0 N--CA 1.404 -3.445 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 102' ' ' ARG . . . -89.22 175.47 7.34 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.4 ' CG2' HD11 ' A' ' 86' ' ' ILE . 1.7 mp -72.87 116.95 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 CA-C-O 121.19 0.519 . . . . 0.0 110.151 -177.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.9 t -123.43 155.51 37.3 Favored 'General case' 0 N--CA 1.403 -2.778 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.48 -26.98 68.67 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -173.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.4 t -65.14 -29.0 69.81 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.278 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -82.04 -32.58 30.39 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.542 0.687 . . . . 0.0 109.522 177.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.473 HG22 ' HA ' ' A' ' 111' ' ' ALA . 41.5 mt -68.17 -29.87 45.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.253 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.414 ' HA ' ' OE2' ' A' ' 114' ' ' GLU . 42.6 m -58.8 -24.31 61.67 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 174.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -76.54 -34.45 58.53 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 175.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.42 -57.23 13.21 Favored 'General case' 0 C--O 1.191 -1.984 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.039 -177.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.628 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 1.9 t -66.29 -30.63 71.09 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 120.37 -0.532 . . . . 0.0 112.095 176.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.02 -55.83 25.23 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -177.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 33.7 m -101.34 5.11 42.13 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.972 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 64.36 37.71 8.22 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.828 0.851 . . . . 0.0 109.965 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -93.78 156.47 16.65 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.284 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.1 mp -108.19 136.5 43.5 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 176.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.476 ' HB ' HG21 ' A' ' 118' ' ' ILE . 14.3 t -93.58 103.93 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -176.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 51.4 mt -94.82 112.37 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.824 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -103.18 134.98 12.07 Favored Glycine 0 N--CA 1.414 -2.777 0 N-CA-C 109.984 -1.247 . . . . 0.0 109.984 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.458 ' C ' ' H ' ' A' ' 101' ' ' VAL . 98.4 m-85 -104.15 94.45 5.38 Favored 'General case' 0 C--N 1.281 -2.399 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.237 -173.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 71.69 -22.72 0.19 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 125.626 1.571 . . . . 0.0 112.995 178.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.516 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 2.7 m -54.62 -48.99 70.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 178.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.585 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 37.2 mtp180 72.6 171.14 0.11 Allowed Pre-proline 0 CA--C 1.552 1.048 0 O-C-N 123.863 0.727 . . . . 0.0 111.822 178.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -100.62 -173.17 0.11 Allowed 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.43 2.087 . . . . 0.0 113.504 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -106.75 176.89 5.02 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.275 -1.33 . . . . 0.0 107.444 170.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.514 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -74.2 -12.11 60.48 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 113.701 1.001 . . . . 0.0 113.701 -173.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.512 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 8.8 t30 -101.33 -40.35 7.16 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.07 -46.12 82.74 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 123.355 0.41 . . . . 0.0 110.882 175.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -54.38 -34.56 61.46 Favored 'General case' 0 CA--C 1.562 1.433 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.798 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.514 ' HG3' ' O ' ' A' ' 105' ' ' ALA . 15.7 mtm180 -79.45 -49.77 11.8 Favored 'General case' 0 N--CA 1.386 -3.642 0 C-N-CA 126.118 1.767 . . . . 0.0 109.541 -178.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.55 -43.69 68.64 Favored 'General case' 0 C--O 1.203 -1.355 0 CA-C-N 113.944 -1.48 . . . . 0.0 110.53 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.473 ' HA ' HG22 ' A' ' 86' ' ' ILE . . . -50.56 -47.22 57.88 Favored 'General case' 0 CA--C 1.489 -1.382 0 O-C-N 124.532 1.145 . . . . 0.0 111.356 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -79.23 -30.59 43.28 Favored 'General case' 0 C--N 1.277 -2.583 0 CA-C-N 114.754 -1.112 . . . . 0.0 112.691 -172.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 35.2 t -84.68 4.72 31.21 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-O 122.069 0.937 . . . . 0.0 108.511 176.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.628 ' O ' ' HB ' ' A' ' 90' ' ' THR . 23.3 mt-10 -118.21 17.01 14.02 Favored 'General case' 0 CA--C 1.46 -2.493 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.581 177.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.557 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 47.7 mtmt 66.55 7.83 5.37 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 174.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.3 m -117.62 171.92 5.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.951 -176.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -131.67 143.68 50.46 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.476 HG21 ' HB ' ' A' ' 96' ' ' VAL . 5.6 pt -101.98 138.01 27.78 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.519 179.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 13.6 ttm180 -114.46 111.84 22.05 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -172.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.437 ' CD1' ' HA ' ' A' ' 102' ' ' ARG . 3.1 mm? . . . . . 0 CA--C 1.478 -1.818 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.067 -174.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.445 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 40.7 m-80 . . . . . 0 CA--C 1.494 -1.179 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.1 mt -138.21 167.97 20.71 Favored 'General case' 0 C--O 1.249 1.042 0 CA-C-O 122.212 1.006 . . . . 0.0 112.595 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -130.79 140.11 49.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-N 113.865 -1.516 . . . . 0.0 108.243 176.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.421 ' CG1' ' HA ' ' A' ' 54' ' ' VAL . 95.4 t -111.24 124.48 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.751 0 CA-C-O 121.538 0.685 . . . . 0.0 111.642 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 68.2 mttm -134.92 144.25 47.36 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.354 -1.294 . . . . 0.0 108.573 176.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -163.38 159.73 22.73 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 177.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -69.06 -32.98 72.83 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.584 0.706 . . . . 0.0 111.051 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 76.2 t -91.96 126.08 44.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.689 ' O ' HG21 ' A' ' 54' ' ' VAL . 13.6 tt0 -62.15 -50.21 72.78 Favored 'General case' 0 C--O 1.198 -1.631 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -173.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.65 0.4 56.39 Favored Glycine 0 C--N 1.29 -2.006 0 C-N-CA 118.537 -1.792 . . . . 0.0 114.427 -175.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 43.0 m -82.09 -24.87 34.96 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 175.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.689 HG21 ' O ' ' A' ' 51' ' ' GLN . 4.1 m -74.97 -46.67 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.313 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.194 175.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -63.37 -46.37 86.81 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.989 -177.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.35 -36.78 84.85 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.241 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 34.4 tp -73.26 -39.98 64.98 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.809 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 54' ' ' VAL . 53.3 t -57.95 -40.01 74.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 122.738 0.415 . . . . 0.0 110.912 176.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.88 -6.98 45.67 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -105.28 -34.9 7.73 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.401 ' HB3' HG13 ' A' ' 73' ' ' ILE . 0.4 OUTLIER -72.49 -32.43 66.18 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.987 -175.48 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -73.02 -18.07 61.38 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.046 0.451 . . . . 0.0 110.812 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.444 -0.76 0 CA-C-O 121.319 0.58 . . . . 0.0 111.199 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.1 t . . . . . 0 N--CA 1.438 -1.03 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -139.94 158.0 44.77 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.604 0.716 . . . . 0.0 111.78 -173.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.401 HG13 ' HB3' ' A' ' 61' ' ' LEU . 1.7 pp -94.42 159.68 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.301 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.6 mp -125.66 -28.49 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.814 175.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -150.41 132.76 15.54 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 120.882 0.372 . . . . 0.0 110.121 -170.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -123.86 140.48 52.94 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 47' ' ' LYS . . . -159.08 140.79 13.39 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.402 ' HB ' ' HA ' ' A' ' 51' ' ' GLN . 3.6 p -94.67 92.93 3.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-O 122.785 1.279 . . . . 0.0 107.552 175.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -177.36 176.2 47.95 Favored Glycine 0 N--CA 1.398 -3.899 0 CA-C-N 114.427 -1.26 . . . . 0.0 110.643 -177.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.632 ' HB2' ' O ' ' A' ' 102' ' ' ARG . . . -83.96 -168.98 2.36 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.514 ' O ' ' HA ' ' A' ' 103' ' ' PRO . 3.3 mp -86.57 108.32 17.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.584 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 18.3 p -101.78 151.15 22.4 Favored 'General case' 0 N--CA 1.414 -2.253 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.111 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -45.59 -53.94 8.38 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.341 1.457 . . . . 0.0 113.618 -177.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.3 t -76.08 -14.43 60.2 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 120.68 0.276 . . . . 0.0 111.516 -174.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -77.57 -35.34 53.19 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.443 HG22 ' HA ' ' A' ' 111' ' ' ALA . 40.7 mt -59.73 -26.62 35.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-N 114.379 -1.282 . . . . 0.0 112.078 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.7 m -58.18 -21.57 47.95 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 175.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -80.22 -35.69 35.86 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 174.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.01 -53.54 55.74 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.577 -176.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.534 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 3.3 t -70.58 -24.7 62.82 Favored 'General case' 0 CA--C 1.557 1.247 0 O-C-N 122.017 -0.427 . . . . 0.0 111.707 177.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.32 -52.57 38.83 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -175.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.6 p -105.26 -2.37 24.14 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 122.05 0.929 . . . . 0.0 109.231 -176.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.405 HD21 ' HA ' ' A' ' 93' ' ' ASN . 1.9 t-20 66.73 41.17 3.02 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.223 -1.808 . . . . 0.0 109.365 -177.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -94.24 130.18 40.59 Favored 'General case' 0 N--CA 1.413 -2.32 0 CA-C-N 113.597 -1.638 . . . . 0.0 106.952 177.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 37.8 pt -93.89 142.66 13.0 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.375 0 C-N-CA 119.112 -1.035 . . . . 0.0 108.996 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.401 ' HB ' HG21 ' A' ' 118' ' ' ILE . 10.6 t -93.53 106.37 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.316 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -175.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.497 ' HA ' ' O ' ' A' ' 119' ' ' ARG . 65.5 mt -101.58 117.6 47.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 177.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 120' ' ' LEU . . . -123.32 176.32 16.67 Favored Glycine 0 C--N 1.289 -2.037 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -178.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.419 ' C ' ' H ' ' A' ' 101' ' ' VAL . 32.8 t80 -148.09 115.93 6.39 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.359 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 8.4 t30 73.91 -27.56 0.19 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 125.586 1.554 . . . . 0.0 113.09 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.427 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 7.8 m -60.92 -53.17 52.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 C-N-CA 124.382 1.073 . . . . 0.0 113.778 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.632 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 61.9 mtp180 73.83 168.47 0.12 Allowed Pre-proline 0 N--CA 1.482 1.132 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 176.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.514 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 9.4 Cg_endo -98.41 176.04 0.45 Allowed 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 122.036 1.824 . . . . 0.0 115.006 -177.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.415 ' HB2' ' H ' ' A' ' 107' ' ' ALA . 65.5 m-20 -67.82 159.43 30.35 Favored 'General case' 0 C--O 1.249 1.067 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 168.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.444 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -66.74 -29.43 69.4 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 176.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.608 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 83.9 m-20 -84.95 -27.22 26.68 Favored 'General case' 0 C--O 1.205 -1.27 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.541 175.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.415 ' H ' ' HB2' ' A' ' 104' ' ' ASP . . . -70.11 -41.46 73.96 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.458 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 13.7 ptmm? -59.75 -21.65 61.01 Favored 'General case' 0 CA--C 1.556 1.174 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.404 178.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 96.1 mtt180 -87.28 -53.8 4.64 Favored 'General case' 0 N--CA 1.384 -3.741 0 C-N-CA 125.44 1.496 . . . . 0.0 109.849 177.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -50.28 -45.27 54.25 Favored 'General case' 0 C--O 1.196 -1.72 0 C-N-CA 124.978 1.311 . . . . 0.0 111.036 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.443 ' HA ' HG22 ' A' ' 86' ' ' ILE . . . -50.49 -46.69 57.2 Favored 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 124.194 0.934 . . . . 0.0 111.886 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -79.75 -29.52 40.55 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.949 -172.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 32.5 t -82.67 3.23 29.87 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.534 ' O ' ' HB ' ' A' ' 90' ' ' THR . 19.1 mt-10 -122.39 11.84 10.05 Favored 'General case' 0 CA--C 1.474 -1.972 0 C-N-CA 124.896 1.278 . . . . 0.0 112.82 -178.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.515 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 56.9 mttp 65.89 12.21 8.22 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 174.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.4 m -120.62 135.28 61.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-O 121.454 0.645 . . . . 0.0 112.557 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -96.51 124.4 40.49 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.455 176.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.401 HG21 ' HB ' ' A' ' 96' ' ' VAL . 9.6 pt -92.91 124.55 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.029 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 176.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.497 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 41.5 mtm180 -123.23 103.61 8.64 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-O 122.207 1.003 . . . . 0.0 111.494 -171.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.531 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.411 -2.387 0 CA-C-N 113.943 -1.481 . . . . 0.0 110.802 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.527 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 57.5 m-80 . . . . . 0 CA--C 1.493 -1.228 0 CA-C-O 120.441 0.162 . . . . 0.0 111.419 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 91.4 mt -136.8 160.31 39.23 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-O 122.042 0.925 . . . . 0.0 112.28 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.473 HG23 ' HA ' ' A' ' 96' ' ' VAL . 0.1 OUTLIER -121.14 130.38 74.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 171.434 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 81.4 t -105.19 133.28 49.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.763 -177.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -144.63 134.38 23.6 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -150.9 168.46 24.44 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -80.39 -28.37 37.93 Favored 'General case' 0 C--N 1.316 -0.854 0 O-C-N 123.971 0.794 . . . . 0.0 109.279 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 90.0 t -96.3 124.88 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 174.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.706 ' O ' HG22 ' A' ' 54' ' ' VAL . 16.2 tt0 -64.22 -49.28 72.6 Favored 'General case' 0 C--O 1.19 -2.075 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -173.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.57 1.94 33.79 Favored Glycine 0 C--N 1.292 -1.886 0 C-N-CA 119.278 -1.439 . . . . 0.0 113.648 -177.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.2 t -83.49 -22.19 32.58 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 177.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.706 HG22 ' O ' ' A' ' 51' ' ' GLN . 4.7 m -81.91 -45.8 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.967 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.263 175.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -60.48 -47.49 85.88 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 114.691 -1.141 . . . . 0.0 111.536 -177.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.69 -32.27 73.7 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.087 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.515 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 25.8 tp -76.47 -39.81 52.19 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.882 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 54' ' ' VAL . 24.8 t -53.3 -44.71 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 123.652 0.781 . . . . 0.0 111.573 177.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.84 -21.25 65.2 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.27 -8.52 21.19 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.401 0.62 . . . . 0.0 110.433 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.515 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -97.67 -43.04 7.35 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-N 115.03 -0.987 . . . . 0.0 108.876 -176.879 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -66.06 -20.01 66.03 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.859 0.361 . . . . 0.0 111.414 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.3 pttp . . . . . 0 N--CA 1.439 -0.983 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.99 -175.155 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 41.4 t . . . . . 0 N--CA 1.424 -1.763 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -140.39 153.6 46.4 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 120.069 -0.653 . . . . 0.0 111.021 -175.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.4 HG12 HG13 ' A' ' 58' ' ' VAL . 1.5 pp -94.32 141.77 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.071 175.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 67.4 mt -111.23 -25.44 3.52 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.472 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.537 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.445 ' O ' HD12 ' A' ' 45' ' ' ILE . 6.1 t60 -161.56 142.86 11.28 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -171.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -146.4 127.32 14.49 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -147.78 153.35 39.11 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.225 -176.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.2 p -94.06 94.57 4.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 122.207 1.003 . . . . 0.0 110.848 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.09 174.43 46.77 Favored Glycine 0 N--CA 1.42 -2.421 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 176.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.53 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -85.58 176.66 8.07 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 173.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.0 mt -79.2 112.55 17.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 122.07 0.148 . . . . 0.0 110.74 -170.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 67.6 p -107.76 165.93 11.07 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.421 ' O ' ' HB ' ' A' ' 86' ' ' ILE . 13.1 pt-20 -66.69 -23.83 66.18 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -174.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.2 t -76.35 -24.82 54.24 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.151 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -70.37 -37.81 74.64 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.493 ' CG2' ' HA ' ' A' ' 111' ' ' ALA . 48.2 mm -56.59 -38.86 59.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 113.868 -1.514 . . . . 0.0 111.35 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.7 m -58.66 -28.37 65.66 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.29 -178.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -76.02 -37.22 58.67 Favored 'General case' 0 C--O 1.251 1.157 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.97 -46.98 87.69 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.135 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.538 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 7.5 t -77.8 -23.06 49.21 Favored 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.138 177.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.04 -67.68 0.43 Allowed 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -176.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 33.5 t -99.01 4.88 47.29 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.283 -175.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 70.76 68.64 0.19 Allowed 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 124.405 1.082 . . . . 0.0 112.189 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -119.86 166.87 12.72 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 113.992 -1.458 . . . . 0.0 108.546 174.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 47.9 mm -121.38 144.49 30.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 174.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.473 ' HA ' HG23 ' A' ' 45' ' ' ILE . 19.9 t -94.63 119.76 43.09 Favored 'Isoleucine or valine' 0 C--O 1.249 1.035 0 CA-C-O 120.974 0.416 . . . . 0.0 110.097 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.1 mp -107.94 111.32 35.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 174.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -99.5 136.39 12.66 Favored Glycine 0 N--CA 1.413 -2.89 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -95.41 93.37 7.19 Favored 'General case' 0 C--N 1.29 -1.996 0 C-N-CA 118.543 -1.263 . . . . 0.0 109.665 -176.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 54.59 28.91 10.52 Favored 'General case' 0 C--O 1.212 -0.918 0 C-N-CA 123.856 0.862 . . . . 0.0 111.621 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 m -96.58 -46.71 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.984 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -175.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.53 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 63.5 mtm180 75.39 155.09 0.15 Allowed Pre-proline 0 N--CA 1.471 0.583 0 C-N-CA 124.0 0.92 . . . . 0.0 111.455 178.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -89.59 167.73 5.0 Favored 'Trans proline' 0 N--CA 1.432 -2.099 0 C-N-CA 121.475 1.45 . . . . 0.0 115.269 -175.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -75.36 156.66 35.24 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 112.6 -2.091 . . . . 0.0 106.906 170.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.491 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -61.27 -32.72 72.55 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.513 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 77.6 m-20 -87.01 -24.9 24.49 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.63 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.41 -44.03 79.8 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.609 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 17.2 ptpt -57.67 -35.2 70.25 Favored 'General case' 0 CA--C 1.562 1.437 0 O-C-N 123.575 0.547 . . . . 0.0 110.465 177.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.513 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 98.2 mtt180 -72.49 -55.91 6.24 Favored 'General case' 0 N--CA 1.385 -3.686 0 C-N-CA 125.762 1.625 . . . . 0.0 109.402 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -53.82 -47.47 70.86 Favored 'General case' 0 C--O 1.198 -1.626 0 CA-C-N 113.806 -1.543 . . . . 0.0 110.067 -177.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.493 ' HA ' ' CG2' ' A' ' 86' ' ' ILE . . . -48.54 -48.09 38.78 Favored 'General case' 0 CA--C 1.489 -1.386 0 O-C-N 124.618 1.199 . . . . 0.0 111.47 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -77.36 -35.44 54.57 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.872 -174.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 45.4 t -77.61 -3.13 39.3 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 177.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.538 ' O ' ' HB ' ' A' ' 90' ' ' THR . 16.3 mt-10 -113.28 11.94 18.78 Favored 'General case' 0 CA--C 1.468 -2.188 0 C-N-CA 124.388 1.075 . . . . 0.0 112.386 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 55.3 mttp 67.48 11.77 8.55 Favored 'General case' 0 N--CA 1.416 -2.148 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 174.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.7 m -119.85 118.77 58.18 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 121.769 0.795 . . . . 0.0 112.602 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -94.22 124.92 38.55 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.4 pt -94.21 144.29 9.95 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-O 121.182 0.515 . . . . 0.0 111.059 -176.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -126.91 132.59 50.85 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.204 0.526 . . . . 0.0 109.87 -176.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.526 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.3 -1.574 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.028 -173.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 . . . . . 0 N--CA 1.439 -0.979 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 95.8 mt -137.19 158.34 44.66 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.613 0.72 . . . . 0.0 112.114 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.492 HD11 ' CD2' ' A' ' 75' ' ' HIS . 0.4 OUTLIER -122.04 132.73 70.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.808 170.509 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 97.7 t -111.05 126.84 68.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.944 -176.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.478 ' O ' ' HA2' ' A' ' 98' ' ' GLY . 74.1 mttt -137.0 147.7 46.43 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.283 -0.872 . . . . 0.0 108.964 173.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.21 170.74 19.81 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 120.827 0.346 . . . . 0.0 110.562 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -72.7 -29.87 63.74 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.438 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 75.8 t -113.32 134.15 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.644 ' O ' HG21 ' A' ' 54' ' ' VAL . 12.4 tt0 -60.36 -52.37 65.55 Favored 'General case' 0 C--O 1.2 -1.514 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -175.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.65 5.15 31.75 Favored Glycine 0 C--N 1.292 -1.875 0 C-N-CA 118.327 -1.892 . . . . 0.0 114.305 -176.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.0 m -88.38 -21.03 24.54 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 174.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.644 HG21 ' O ' ' A' ' 51' ' ' GLN . 3.6 m -76.26 -46.04 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 174.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -67.0 -35.6 80.29 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.475 -1.239 . . . . 0.0 112.079 -176.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.73 -33.65 75.57 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.303 0.573 . . . . 0.0 110.257 176.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 31.3 tp -79.87 -45.99 17.64 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 54' ' ' VAL . 56.1 t -55.88 -44.21 77.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 124.037 0.935 . . . . 0.0 112.264 179.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.66 -20.84 65.23 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -177.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.1 -28.78 13.59 Favored 'General case' 0 C--O 1.202 -1.426 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.71 -33.82 60.35 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 114.023 -1.444 . . . . 0.0 110.265 -176.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -72.64 -20.66 61.23 Favored 'General case' 0 C--N 1.315 -0.908 0 O-C-N 122.061 -0.399 . . . . 0.0 111.159 177.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? . . . . . 0 C--N 1.318 -0.761 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 179.109 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.432 -1.354 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -137.5 157.48 46.46 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-O 121.803 0.811 . . . . 0.0 110.589 -174.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 pp -93.83 157.97 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.177 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.413 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 74.3 mt -119.99 -31.04 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.463 177.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.492 ' CD2' HD11 ' A' ' 45' ' ' ILE . 6.4 t60 -151.55 131.97 13.78 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -171.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -139.24 129.31 25.15 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.108 0.963 . . . . 0.0 109.458 -175.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -154.08 157.59 39.21 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.505 -178.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.44 ' HB ' ' HA ' ' A' ' 51' ' ' GLN . 5.1 p -94.49 94.99 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-O 122.132 0.968 . . . . 0.0 108.611 176.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -175.57 175.95 47.33 Favored Glycine 0 N--CA 1.401 -3.698 0 C-N-CA 120.186 -1.006 . . . . 0.0 110.858 -177.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 102' ' ' ARG . . . -87.46 173.12 9.31 Favored 'General case' 0 C--N 1.282 -2.35 0 O-C-N 124.112 0.536 . . . . 0.0 109.721 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.9 mp -75.49 107.76 6.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.65 152.66 22.85 Favored 'General case' 0 N--CA 1.401 -2.91 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.047 -178.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -54.24 -45.39 72.31 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 124.029 0.831 . . . . 0.0 112.547 -174.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.9 p -69.8 -18.71 63.49 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -81.51 -25.37 36.01 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-O 121.603 0.716 . . . . 0.0 110.128 177.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.441 HG22 ' HA ' ' A' ' 111' ' ' ALA . 42.0 mt -72.51 -20.57 19.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.681 178.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.0 m -60.13 -26.8 66.55 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.05 175.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -79.64 -38.58 33.46 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.97 177.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.01 -58.68 6.4 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.338 -176.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.632 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 2.3 t -68.15 -28.22 67.11 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.507 177.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.04 -65.49 0.68 Allowed 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.19 0.519 . . . . 0.0 111.514 -177.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.5 m -93.69 6.0 49.78 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.888 -176.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 67.87 33.0 4.94 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.901 0.858 . . . . 0.0 109.937 177.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.53 153.1 18.05 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.439 -178.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 41.4 mm -107.72 141.21 23.52 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.146 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.466 ' HA ' HG21 ' A' ' 45' ' ' ILE . 10.7 t -94.8 120.47 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 65.8 mt -112.94 120.28 62.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 177.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 47' ' ' LYS . . . -139.83 171.06 24.0 Favored Glycine 0 N--CA 1.427 -1.902 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 178.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.476 ' C ' ' H ' ' A' ' 101' ' ' VAL . 30.4 p90 -158.77 134.57 8.87 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 117.66 0.73 . . . . 0.0 111.324 -178.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 72.84 -23.46 0.21 Allowed 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 125.403 1.481 . . . . 0.0 112.874 178.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.489 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 2.3 m -77.64 -49.71 21.56 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.099 177.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.583 ' O ' ' HB3' ' A' ' 80' ' ' ALA . 53.0 mtm180 72.68 170.82 0.11 Allowed Pre-proline 0 C--N 1.352 0.692 0 O-C-N 124.164 0.915 . . . . 0.0 111.368 177.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -91.99 169.46 2.92 Favored 'Trans proline' 0 N--CA 1.443 -1.455 0 CA-C-N 120.534 1.226 . . . . 0.0 113.718 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -79.0 149.61 32.17 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 169.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.576 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -59.3 -26.53 65.05 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.629 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 16.7 m120 -80.01 -30.7 39.66 Favored 'General case' 0 C--N 1.315 -0.926 0 O-C-N 121.847 -0.533 . . . . 0.0 109.863 177.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.67 -43.05 63.62 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.256 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 21.2 ptmt -59.81 -24.71 64.36 Favored 'General case' 0 CA--C 1.559 1.324 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.735 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.629 ' HB2' ' O ' ' A' ' 106' ' ' ASN 0.287 38.4 mtm180 -77.51 -56.77 4.25 Favored 'General case' 0 N--CA 1.395 -3.176 0 C-N-CA 125.935 1.694 . . . . 0.0 108.217 175.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.46 -47.88 48.02 Favored 'General case' 0 CA--C 1.482 -1.648 0 CA-C-N 113.545 -1.661 . . . . 0.0 111.362 -176.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.441 ' HA ' HG22 ' A' ' 86' ' ' ILE . . . -48.07 -42.76 29.51 Favored 'General case' 0 CA--C 1.505 -0.777 0 O-C-N 124.518 1.136 . . . . 0.0 111.349 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -84.29 -23.7 30.19 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -173.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 30.8 t -85.59 -1.67 57.36 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-O 123.173 1.463 . . . . 0.0 107.254 174.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.632 ' O ' ' HB ' ' A' ' 90' ' ' THR . 35.2 mt-10 -120.56 13.0 11.65 Favored 'General case' 0 N--CA 1.404 -2.754 0 CA-C-N 113.638 -1.619 . . . . 0.0 112.811 -177.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.506 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 92.4 mttt 63.09 13.0 6.42 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 172.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.2 m -119.14 138.53 49.53 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-O 121.875 0.845 . . . . 0.0 112.777 -176.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -99.52 126.57 45.49 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.919 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 6.5 pt -94.05 133.79 33.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.255 0.55 . . . . 0.0 111.369 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -98.39 122.01 41.04 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.652 -177.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.402 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 3.8 mm? . . . . . 0 C--N 1.307 -1.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.617 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 . . . . . 0 CA--C 1.486 -1.504 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 74.7 mt -140.15 155.19 47.07 Favored 'General case' 0 C--O 1.258 1.51 0 O-C-N 123.717 0.636 . . . . 0.0 110.513 174.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.468 HD11 ' CD2' ' A' ' 75' ' ' HIS . 0.4 OUTLIER -120.6 135.07 62.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.03 176.63 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 72.5 t -109.7 126.87 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.869 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.334 -176.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.414 ' O ' ' HA2' ' A' ' 98' ' ' GLY . 23.1 mmtp -142.06 119.35 11.5 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 125.09 1.356 . . . . 0.0 109.858 -179.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -140.18 164.42 30.1 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -178.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.17 -17.08 44.13 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -178.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 86.1 t -105.03 122.59 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.354 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 175.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.738 ' O ' HG23 ' A' ' 54' ' ' VAL . 15.4 tm0? -58.14 -48.88 78.88 Favored 'General case' 0 C--O 1.202 -1.421 0 C-N-CA 122.948 0.499 . . . . 0.0 111.686 -174.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.77 0.8 81.06 Favored Glycine 0 C--N 1.285 -2.273 0 C-N-CA 117.693 -2.194 . . . . 0.0 113.912 -176.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 70.7 m -86.96 -20.86 26.68 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 176.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 51' ' ' GLN . 9.3 m -72.23 -43.23 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.449 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 172.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -62.68 -42.81 99.82 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.968 177.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.04 -35.05 78.95 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.923 0.392 . . . . 0.0 110.676 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.466 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 24.8 tp -76.57 -38.96 54.1 Favored 'General case' 0 C--O 1.208 -1.112 0 C-N-CA 120.456 -0.497 . . . . 0.0 109.711 177.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.423 HG21 ' O ' ' A' ' 54' ' ' VAL . 45.2 t -57.8 -44.49 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 122.746 0.419 . . . . 0.0 110.693 175.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.67 -18.18 64.74 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 123.229 0.612 . . . . 0.0 111.62 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.56 -19.71 15.37 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.153 0.501 . . . . 0.0 109.799 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -88.85 -36.85 15.77 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.034 -175.523 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -65.43 -26.16 67.84 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.011 0.434 . . . . 0.0 110.328 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.47 ' HB2' ' HZ2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.879 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.027 -179.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.9 t . . . . . 0 N--CA 1.471 0.589 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -139.58 160.34 40.09 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 175.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.4 pp -94.43 164.05 2.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.828 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 70.7 mt -120.24 -41.67 2.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 121.523 0.677 . . . . 0.0 110.453 175.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.468 ' CD2' HD11 ' A' ' 45' ' ' ILE . 2.4 t60 -144.17 131.92 21.31 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.909 -168.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.574 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -142.88 134.96 27.18 Favored 'General case' 0 CA--C 1.503 -0.848 0 C-N-CA 124.26 1.024 . . . . 0.0 108.472 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.479 ' O ' HG11 ' A' ' 54' ' ' VAL . . . -160.82 164.86 31.08 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.439 ' HB ' ' HA ' ' A' ' 51' ' ' GLN . 7.1 p -93.34 98.51 8.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-O 122.423 1.106 . . . . 0.0 109.542 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.25 172.93 45.9 Favored Glycine 0 N--CA 1.406 -3.341 0 C-N-CA 120.052 -1.071 . . . . 0.0 110.572 -178.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.615 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -88.68 -166.86 1.7 Allowed 'General case' 0 N--CA 1.412 -2.33 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.6 mp -91.33 120.81 40.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 177.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.9 p -121.23 158.32 28.35 Favored 'General case' 0 C--N 1.317 -0.833 0 O-C-N 123.314 0.384 . . . . 0.0 110.157 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.73 -39.57 77.6 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -176.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.1 m -75.59 -8.74 57.53 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 120.913 0.387 . . . . 0.0 111.544 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -95.51 -30.99 13.55 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.418 ' CG2' ' HA ' ' A' ' 111' ' ' ALA . 31.0 mm -58.18 -31.96 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-N 114.46 -1.245 . . . . 0.0 111.355 174.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 25.8 m -58.53 -31.57 68.05 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.603 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -72.86 -35.23 67.16 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 176.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 94' ' ' ALA . . . -58.03 -52.92 63.54 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.29 -178.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.515 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 3.4 t -71.93 -30.96 65.87 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.995 177.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.76 -63.05 1.43 Allowed 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 40.6 m -97.62 5.26 49.68 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -175.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.1 m120 67.34 28.07 8.0 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.629 0.728 . . . . 0.0 110.88 178.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.436 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . -94.46 129.85 41.07 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 36.2 pt -93.47 150.52 3.91 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.407 ' HA ' HG23 ' A' ' 45' ' ' ILE . 18.3 t -94.11 112.56 27.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-O 121.349 0.595 . . . . 0.0 109.551 -176.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 54.9 mt -98.88 98.1 6.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 47' ' ' LYS . . . -94.78 151.57 20.16 Favored Glycine 0 N--CA 1.427 -1.965 0 C-N-CA 119.998 -1.096 . . . . 0.0 111.852 -176.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.444 ' C ' ' H ' ' A' ' 101' ' ' VAL . 23.8 m-85 -125.22 118.37 25.87 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -176.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 64.8 t30 70.08 -33.22 0.25 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 125.449 1.5 . . . . 0.0 113.018 178.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.444 ' H ' ' C ' ' A' ' 99' ' ' PHE . 0.7 OUTLIER -53.35 -71.74 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 117.739 2.496 . . . . 0.0 117.739 -177.673 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.615 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 0.0 OUTLIER 84.33 164.03 0.11 Allowed Pre-proline 0 N--CA 1.478 0.949 0 C-N-CA 124.573 1.149 . . . . 0.0 111.178 -170.225 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -88.65 171.43 5.08 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 C-N-CA 121.446 1.431 . . . . 0.0 113.509 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -83.33 155.46 23.55 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 113.728 -1.578 . . . . 0.0 107.142 169.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.475 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -60.64 -24.39 65.51 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -178.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.586 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 22.3 m-80 -89.81 -27.8 19.73 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.77 -38.39 70.36 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.163 -178.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -61.79 -27.04 68.47 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.961 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.586 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 62.6 mtp180 -79.38 -55.22 5.23 Favored 'General case' 0 N--CA 1.383 -3.779 0 C-N-CA 125.382 1.473 . . . . 0.0 109.623 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -53.18 -46.54 69.01 Favored 'General case' 0 C--O 1.198 -1.623 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.872 -178.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.418 ' HA ' ' CG2' ' A' ' 86' ' ' ILE . . . -48.53 -48.29 38.49 Favored 'General case' 0 CA--C 1.491 -1.319 0 O-C-N 124.413 1.071 . . . . 0.0 111.918 -178.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -78.7 -33.91 46.51 Favored 'General case' 0 N--CA 1.401 -2.884 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.844 -172.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 32.2 t -77.2 -0.38 24.91 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.515 ' O ' ' HB ' ' A' ' 90' ' ' THR . 21.0 mt-10 -120.23 11.47 11.57 Favored 'General case' 0 N--CA 1.405 -2.684 0 CA-C-N 114.389 -1.278 . . . . 0.0 112.558 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 52.8 mttp 67.68 8.86 6.67 Favored 'General case' 0 N--CA 1.42 -1.955 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 173.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.1 m -112.32 127.1 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.63 0 CA-C-O 121.722 0.773 . . . . 0.0 112.413 -178.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -94.75 122.66 37.6 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.011 -178.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 16.8 pt -106.59 138.44 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.465 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -151.51 147.22 26.56 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.433 ' HG ' ' HG3' ' A' ' 102' ' ' ARG . 2.9 mm? . . . . . 0 C--N 1.292 -1.906 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -170.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.41 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.9 OUTLIER . . . . . 0 CA--C 1.502 -0.879 0 N-CA-C 111.226 0.084 . . . . 0.0 111.226 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.436 ' HA ' ' HB1' ' A' ' 94' ' ' ALA . 4.4 pp -158.56 167.21 30.21 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 177.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.408 HG22 ' HA ' ' A' ' 96' ' ' VAL . 0.5 OUTLIER -119.5 137.21 54.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 C-N-CA 123.536 0.734 . . . . 0.0 110.889 179.151 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 65.3 t -109.1 125.35 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.282 -177.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.426 ' O ' ' HA2' ' A' ' 98' ' ' GLY . 14.6 mmmm -138.02 122.42 18.32 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -137.92 169.04 18.48 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -177.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -81.49 -32.2 32.57 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 123.984 0.802 . . . . 0.0 109.099 -177.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 96.2 t -98.08 128.75 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.985 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 174.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.763 ' O ' HG21 ' A' ' 54' ' ' VAL . 16.3 tt0 -62.3 -43.62 98.4 Favored 'General case' 0 C--O 1.191 -1.987 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.305 -175.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -75.19 -0.13 60.56 Favored Glycine 0 C--N 1.291 -1.924 0 C-N-CA 118.388 -1.863 . . . . 0.0 113.268 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.0 t -83.88 -23.36 31.29 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 178.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.763 HG21 ' O ' ' A' ' 51' ' ' GLN . 9.2 m -74.8 -46.54 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.158 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 172.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -56.44 -46.42 80.3 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.328 1.051 . . . . 0.0 112.241 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.88 -43.68 81.5 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.801 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.492 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 27.3 tp -74.14 -45.43 48.84 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.202 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 54' ' ' VAL . 46.6 t -54.05 -43.77 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.128 0.971 . . . . 0.0 112.493 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.42 -28.18 69.8 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.94 -26.9 18.2 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.492 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -76.1 -39.02 56.21 Favored 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 113.962 -1.472 . . . . 0.0 110.37 -176.126 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -69.88 -21.74 63.3 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.822 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? . . . . . 0 N--CA 1.444 -0.771 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -178.295 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.8 t . . . . . 0 N--CA 1.425 -1.719 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -151.15 153.22 34.58 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.415 0.626 . . . . 0.0 110.306 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 pp -94.11 155.86 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.792 176.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.415 ' N ' HD12 ' A' ' 74' ' ' ILE . 3.4 mp -115.79 -41.72 3.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-O 121.438 0.637 . . . . 0.0 109.466 177.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -143.27 122.76 13.17 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.93 -169.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.512 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -131.69 135.57 46.98 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 124.422 1.089 . . . . 0.0 108.496 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.417 ' O ' HG11 ' A' ' 54' ' ' VAL . . . -161.84 163.03 29.57 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 -178.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.6 p -93.51 96.93 6.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 122.405 1.098 . . . . 0.0 109.651 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.81 175.08 47.49 Favored Glycine 0 N--CA 1.406 -3.334 0 N-CA-C 108.332 -1.907 . . . . 0.0 108.332 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.583 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -89.78 -160.72 0.71 Allowed 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 177.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.528 ' O ' ' HA ' ' A' ' 103' ' ' PRO . 33.6 mt -89.12 105.89 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.008 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -176.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 70.6 p -99.43 156.75 16.86 Favored 'General case' 0 N--CA 1.411 -2.411 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -53.14 -32.69 48.93 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 123.473 0.709 . . . . 0.0 109.947 175.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.1 m -67.42 -30.79 70.63 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.048 0.939 . . . . 0.0 111.593 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -71.98 -35.02 69.39 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-O 121.849 0.833 . . . . 0.0 109.055 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.403 HD13 ' HB1' ' A' ' 111' ' ' ALA . 61.2 mt -68.97 -31.65 51.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.749 -178.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.4 m -54.21 -35.13 62.05 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.567 174.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -75.5 -34.84 60.87 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.256 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.71 -56.96 15.19 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.611 -176.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.55 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 5.8 t -71.51 -19.83 62.14 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.822 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.99 -62.62 1.36 Allowed 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.227 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.9 m -95.36 6.5 48.84 Favored 'General case' 0 C--O 1.201 -1.462 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.425 -174.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . 0.272 0.0 OUTLIER 69.89 30.19 3.78 Favored 'General case' 0 N--CA 1.505 2.306 0 C-N-CA 126.213 1.805 . . . . 0.0 111.33 177.033 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.436 ' HB1' ' HA ' ' A' ' 44' ' ' LEU . . . -94.23 162.5 13.83 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 113.186 -1.824 . . . . 0.0 109.183 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.427 HD11 ' H ' ' A' ' 95' ' ' ILE . 0.2 OUTLIER -121.66 156.29 25.83 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 173.414 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.422 ' HB ' HG23 ' A' ' 118' ' ' ILE . 29.3 t -94.41 126.84 46.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -175.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 11.6 tt -125.69 116.08 45.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 175.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 47' ' ' LYS . . . -120.66 161.15 14.91 Favored Glycine 0 N--CA 1.406 -3.308 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -121.44 100.08 6.83 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 118.843 -1.143 . . . . 0.0 110.194 -178.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 59.21 30.35 20.09 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 122.171 0.986 . . . . 0.0 111.945 176.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.468 ' HB ' ' CB ' ' A' ' 80' ' ' ALA . 3.4 m -97.81 -47.09 12.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 114.482 -1.235 . . . . 0.0 112.163 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.583 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 17.4 mtm-85 76.67 156.33 0.15 Allowed Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 124.388 1.075 . . . . 0.0 111.496 177.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.528 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 10.1 Cg_endo -99.83 174.4 0.37 Allowed 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.445 2.096 . . . . 0.0 115.193 -175.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -69.3 154.36 42.16 Favored 'General case' 0 C--O 1.251 1.142 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 170.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.501 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -60.25 -35.62 75.9 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 120.82 0.343 . . . . 0.0 110.54 179.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.587 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 84.2 m-20 -82.57 -25.73 33.02 Favored 'General case' 0 C--O 1.201 -1.468 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.975 175.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.69 -45.48 78.69 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.813 177.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 20.8 pttm -57.45 -23.36 49.27 Favored 'General case' 0 CA--C 1.571 1.779 0 CA-C-O 120.842 0.353 . . . . 0.0 110.698 177.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.587 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 71.6 mtp180 -84.53 -53.24 5.55 Favored 'General case' 0 N--CA 1.389 -3.506 0 C-N-CA 125.921 1.688 . . . . 0.0 109.201 177.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -49.07 -48.74 43.86 Favored 'General case' 0 C--O 1.186 -2.242 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.793 -178.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.403 ' HB1' HD13 ' A' ' 86' ' ' ILE . . . -48.56 -43.96 36.16 Favored 'General case' 0 CA--C 1.503 -0.83 0 O-C-N 124.284 0.99 . . . . 0.0 111.466 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -82.71 -27.4 31.22 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 114.913 -1.039 . . . . 0.0 112.315 -173.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 35.3 t -88.23 5.09 43.3 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 176.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.55 ' O ' ' HB ' ' A' ' 90' ' ' THR . 20.5 mt-10 -120.96 11.53 11.04 Favored 'General case' 0 CA--C 1.46 -2.497 0 CA-C-N 114.374 -1.285 . . . . 0.0 112.926 -178.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 68.4 mmtt 62.13 22.29 13.02 Favored 'General case' 0 N--CA 1.418 -2.043 0 O-C-N 124.144 0.903 . . . . 0.0 112.83 174.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.1 m -124.4 174.2 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.091 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -121.33 135.38 55.1 Favored 'General case' 0 CA--C 1.49 -1.352 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.917 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.422 HG23 ' HB ' ' A' ' 96' ' ' VAL . 19.3 pt -102.99 123.56 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.135 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 167.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -102.65 120.07 39.92 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.428 HD21 ' H ' ' A' ' 101' ' ' VAL . 2.4 tm? . . . . . 0 N--CA 1.421 -1.914 0 C-N-CA 119.951 -0.699 . . . . 0.0 110.764 -176.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.516 ' OD1' HD11 ' A' ' 74' ' ' ILE . 40.2 m-80 . . . . . 0 CA--C 1.485 -1.539 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 80.9 mt -133.41 160.16 38.2 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.682 0.753 . . . . 0.0 111.121 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.495 HD13 ' CD2' ' A' ' 75' ' ' HIS . 0.5 OUTLIER -124.97 133.4 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.852 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.419 173.215 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 99.4 t -113.34 127.67 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.925 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.846 -176.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.427 ' HZ2' ' CG ' ' A' ' 85' ' ' ASP . 24.4 mmmt -135.2 128.48 32.08 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 124.13 0.972 . . . . 0.0 108.807 -177.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -148.53 168.09 23.66 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.953 -178.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -70.1 -21.93 63.07 Favored 'General case' 0 C--O 1.242 0.699 0 O-C-N 123.946 0.778 . . . . 0.0 111.308 -178.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.4 m -130.13 140.1 49.78 Favored 'Isoleucine or valine' 0 C--O 1.246 0.892 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.594 173.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.637 ' O ' HG23 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -68.56 -6.77 27.34 Favored 'General case' 0 C--O 1.191 -1.978 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -176.825 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.39 -13.27 57.44 Favored Glycine 0 N--CA 1.422 -2.29 0 C-N-CA 118.261 -1.924 . . . . 0.0 112.318 177.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.4 m -81.82 -28.98 32.84 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 176.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 51' ' ' GLN . 15.8 m -70.6 -44.9 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.903 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.674 174.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.594 ' HG2' ' O ' ' A' ' 51' ' ' GLN . 67.8 mm-40 -59.58 -45.48 91.73 Favored 'General case' 0 C--O 1.214 -0.789 0 O-C-N 123.42 0.45 . . . . 0.0 111.391 178.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.07 -42.15 84.9 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 123.348 0.405 . . . . 0.0 111.448 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.434 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 32.2 tp -75.4 -42.31 54.06 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.229 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.509 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 36.0 t -55.99 -45.75 80.33 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.681 0 C-N-CA 123.136 0.574 . . . . 0.0 111.185 176.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.3 -16.84 61.57 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.68 -27.87 13.79 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -80.35 -30.0 37.97 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 113.775 -1.557 . . . . 0.0 110.569 -175.069 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 4.0 pt20 -83.75 -19.25 35.46 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 121.985 -0.447 . . . . 0.0 111.434 177.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt . . . . . 0 C--N 1.32 -0.675 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.344 -177.399 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.3 t . . . . . 0 N--CA 1.427 -1.598 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 26.7 ttpp -154.56 158.13 39.33 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.061 0.458 . . . . 0.0 110.472 -178.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 pp -93.82 156.27 3.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -173.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.516 HD11 ' OD1' ' A' ' 43' ' ' ASN . 26.7 mm -119.74 -32.44 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.464 0.65 . . . . 0.0 110.13 178.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.495 ' CD2' HD13 ' A' ' 45' ' ' ILE . 1.9 t60 -149.67 124.52 9.89 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.471 -168.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -135.96 132.25 36.15 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -155.78 155.66 33.44 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.54 -177.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.452 ' HB ' ' HB3' ' A' ' 51' ' ' GLN . 5.5 p -94.15 94.27 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 CA-C-O 122.823 1.296 . . . . 0.0 110.537 177.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.7 175.09 47.47 Favored Glycine 0 N--CA 1.405 -3.413 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 102' ' ' ARG . . . -82.87 167.98 17.53 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 176.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.4 mp -71.22 120.35 19.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -177.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.436 HG23 ' OD2' ' A' ' 85' ' ' ASP . 13.0 t -119.71 168.89 10.61 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -57.6 -34.94 69.78 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.949 0.5 . . . . 0.0 111.9 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.9 t -62.21 -29.86 70.68 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.046 0.539 . . . . 0.0 110.514 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.436 ' OD2' HG23 ' A' ' 82' ' ' THR . 49.4 m-20 -75.36 -39.41 59.31 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 39.5 mm -63.66 -32.9 58.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.515 -178.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 39.6 m -60.59 -24.05 65.16 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.527 176.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -87.98 -37.07 16.68 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.83 -58.73 6.18 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.947 -176.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.549 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 3.4 t -70.73 -26.56 63.44 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.494 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.18 -59.64 4.18 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.343 0.592 . . . . 0.0 111.901 -178.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.8 t -97.08 4.62 51.24 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.807 -175.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 67.7 32.76 5.27 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.822 0.82 . . . . 0.0 110.299 178.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -94.5 132.9 38.67 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.459 -178.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 36.3 pt -94.83 152.03 3.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 176.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.464 ' HB ' HG23 ' A' ' 118' ' ' ILE . 16.7 t -100.97 123.69 54.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.42 -172.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 7.3 tp -108.44 111.44 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 173.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -103.78 146.34 16.36 Favored Glycine 0 N--CA 1.43 -1.76 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -178.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.432 ' C ' ' H ' ' A' ' 101' ' ' VAL . 90.0 m-85 -121.84 108.98 14.11 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 117.026 0.413 . . . . 0.0 111.121 -175.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.583 ' O ' ' HD3' ' A' ' 102' ' ' ARG . 8.2 t30 67.66 -34.22 0.24 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 126.558 1.943 . . . . 0.0 113.493 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.432 ' H ' ' C ' ' A' ' 99' ' ' PHE . 1.7 m -51.35 -54.72 10.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 117.149 2.277 . . . . 0.0 117.149 -178.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.583 ' HD3' ' O ' ' A' ' 100' ' ' ASN . 1.0 OUTLIER 76.77 170.4 0.11 Allowed Pre-proline 0 N--CA 1.483 1.193 0 C-N-CA 123.958 0.903 . . . . 0.0 110.539 -171.743 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.408 ' HG3' HD11 ' A' ' 118' ' ' ILE . 9.2 Cg_endo -96.03 174.83 0.9 Allowed 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 121.712 1.608 . . . . 0.0 113.009 177.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -82.03 150.44 27.59 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 167.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.534 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -58.88 -30.3 67.65 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.542 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 16.5 m120 -81.08 -33.06 33.65 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 119.966 -0.693 . . . . 0.0 110.036 177.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.34 -42.62 98.96 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.239 177.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 20.9 ptmt -65.32 -26.29 67.99 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.984 178.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.542 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 53.6 mtp180 -75.52 -52.64 10.19 Favored 'General case' 0 N--CA 1.392 -3.353 0 C-N-CA 124.365 1.066 . . . . 0.0 109.027 177.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -53.02 -49.37 66.39 Favored 'General case' 0 C--O 1.195 -1.801 0 CA-C-N 113.947 -1.479 . . . . 0.0 110.091 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -47.04 -48.28 22.21 Favored 'General case' 0 CA--C 1.507 -0.681 0 O-C-N 124.568 1.167 . . . . 0.0 112.449 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.432 ' C ' ' H ' ' A' ' 114' ' ' GLU . 2.8 tm-20 -76.08 -38.79 56.6 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.3 -173.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 26.6 t -76.41 4.23 9.47 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.527 1.156 . . . . 0.0 108.707 178.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.549 ' O ' ' HB ' ' A' ' 90' ' ' THR . 15.2 mt-10 -123.21 14.06 9.69 Favored 'General case' 0 N--CA 1.398 -3.066 0 CA-C-N 114.466 -1.243 . . . . 0.0 113.019 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.528 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 96.7 mttt 66.2 7.54 4.91 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 173.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.5 m -114.25 147.01 18.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 C-N-CA 120.358 -0.537 . . . . 0.0 112.378 -175.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -113.09 128.7 56.56 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.702 -177.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.464 HG23 ' HB ' ' A' ' 96' ' ' VAL . 7.7 pt -97.74 133.82 38.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.079 177.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -118.33 134.77 54.76 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -178.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.408 ' CD1' ' HA ' ' A' ' 102' ' ' ARG . 3.2 mm? . . . . . 0 CA--C 1.505 -0.758 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -174.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.634 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 61.1 m-80 . . . . . 0 N--CA 1.434 -1.233 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.419 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 4.1 pp -151.06 162.49 40.74 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.4 0.619 . . . . 0.0 112.57 177.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.477 HD13 ' CD2' ' A' ' 75' ' ' HIS . 0.2 OUTLIER -118.46 134.58 61.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.209 178.293 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 99.3 t -107.69 126.04 64.09 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.948 -176.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.8 mtpt -138.4 147.17 43.09 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -156.56 167.25 31.01 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -178.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -76.24 -22.83 54.7 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.846 0.832 . . . . 0.0 110.029 177.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 84.6 t -109.28 132.27 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 176.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.78 ' O ' HG21 ' A' ' 54' ' ' VAL . 16.2 tt0 -65.09 -46.2 82.1 Favored 'General case' 0 C--O 1.188 -2.18 0 C-N-CA 120.132 -0.627 . . . . 0.0 111.224 -176.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -73.74 2.65 39.38 Favored Glycine 0 C--N 1.294 -1.77 0 C-N-CA 118.753 -1.689 . . . . 0.0 114.394 -176.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.4 t -83.12 -26.12 31.3 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 176.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.78 HG21 ' O ' ' A' ' 51' ' ' GLN . 5.3 m -80.16 -45.87 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.918 0 CA-C-N 114.549 -1.205 . . . . 0.0 108.642 176.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -56.16 -48.44 76.3 Favored 'General case' 0 C--O 1.245 0.844 0 C-N-CA 124.867 1.267 . . . . 0.0 111.965 -176.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.51 -35.24 80.3 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.234 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.409 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 28.0 tp -76.1 -35.86 59.16 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.407 HG11 HG12 ' A' ' 73' ' ' ILE . 39.4 t -56.69 -43.87 80.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.747 174.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.39 -18.18 65.21 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.903 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.457 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -98.88 -21.4 16.32 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 122.384 1.087 . . . . 0.0 108.782 -177.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.409 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.5 OUTLIER -88.42 -28.96 20.57 Favored 'General case' 0 C--N 1.275 -2.645 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.598 -177.439 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -83.75 -12.65 55.46 Favored 'General case' 0 C--N 1.313 -1.0 0 O-C-N 122.152 -0.342 . . . . 0.0 111.624 176.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 65.0 pttt . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 121.523 0.678 . . . . 0.0 110.137 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.4 t . . . . . 0 N--CA 1.429 -1.488 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -146.28 158.6 43.9 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.067 0.461 . . . . 0.0 110.565 -175.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 1.7 pp -94.03 142.82 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.715 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.412 175.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.412 HD11 ' OD1' ' A' ' 43' ' ' ASN . 34.6 mm -113.72 -27.43 2.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 CA-C-O 121.273 0.559 . . . . 0.0 109.789 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.477 ' CD2' HD13 ' A' ' 45' ' ' ILE . 5.5 t60 -160.95 125.86 3.65 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.782 -171.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.568 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -129.01 130.56 46.79 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -154.76 156.66 36.71 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.383 -178.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.7 p -94.54 97.76 7.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-O 121.947 0.879 . . . . 0.0 108.905 176.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -175.5 170.9 44.01 Favored Glycine 0 N--CA 1.413 -2.839 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' A' ' 102' ' ' ARG . . . -84.74 -176.11 6.08 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 120.838 0.352 . . . . 0.0 110.635 -178.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.49 ' HB ' ' HB3' ' A' ' 103' ' ' PRO . 3.8 mm -87.86 97.9 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.672 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 9.7 t -98.71 147.04 25.27 Favored 'General case' 0 N--CA 1.411 -2.424 0 C-N-CA 119.749 -0.78 . . . . 0.0 109.719 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.31 -39.31 14.44 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 125.111 1.364 . . . . 0.0 112.53 178.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.9 m -78.8 -11.8 60.0 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -174.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -98.34 -23.52 15.58 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -177.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.459 HG23 ' HA ' ' A' ' 111' ' ' ALA . 38.6 mt -66.06 -22.18 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.644 177.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 47.3 t -49.59 -35.49 21.0 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.928 172.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.451 ' O ' HD22 ' A' ' 88' ' ' LEU . 2.0 tm? -70.17 -32.57 70.58 Favored 'General case' 0 C--O 1.25 1.083 0 CA-C-O 120.748 0.309 . . . . 0.0 110.843 179.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.47 -61.68 2.32 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.201 -176.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.589 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 4.8 t -66.02 -25.34 67.02 Favored 'General case' 0 CA--C 1.561 1.375 0 O-C-N 122.012 -0.43 . . . . 0.0 111.783 178.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.24 -55.7 16.98 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.143 0.497 . . . . 0.0 112.176 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 34.3 p -97.01 -4.62 39.4 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.238 0.542 . . . . 0.0 111.072 -176.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.449 ' N ' HD21 ' A' ' 93' ' ' ASN . 0.8 OUTLIER 72.63 33.45 1.36 Allowed 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.805 -178.834 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.634 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -94.34 134.49 36.78 Favored 'General case' 0 N--CA 1.419 -2.018 0 CA-C-N 114.008 -1.451 . . . . 0.0 109.931 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 35.0 pt -94.07 144.4 9.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 176.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.455 ' HA ' HG21 ' A' ' 45' ' ' ILE . 15.6 t -94.95 119.79 43.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 C-N-CA 120.186 -0.605 . . . . 0.0 110.93 -173.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.651 ' HA ' ' O ' ' A' ' 119' ' ' ARG . 24.4 pt -111.91 117.18 54.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-O 121.498 0.666 . . . . 0.0 109.748 174.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -110.9 157.22 15.1 Favored Glycine 0 N--CA 1.437 -1.281 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.825 -176.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.415 ' C ' ' H ' ' A' ' 101' ' ' VAL . 67.8 t80 -132.07 110.82 10.98 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -175.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.446 ' O ' ' HD3' ' A' ' 102' ' ' ARG . 27.5 t-20 70.68 -30.4 0.2 Allowed 'General case' 0 N--CA 1.506 2.354 0 C-N-CA 125.085 1.354 . . . . 0.0 114.029 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.516 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 2.5 m -58.57 -56.55 15.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 N-CA-C 117.765 2.506 . . . . 0.0 117.765 -177.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.541 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 0.6 OUTLIER 75.04 159.26 0.16 Allowed Pre-proline 0 N--CA 1.494 1.738 0 C-N-CA 124.359 1.064 . . . . 0.0 112.003 -174.642 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.49 ' HB3' ' HB ' ' A' ' 81' ' ' ILE . 4.0 Cg_endo -88.75 170.12 5.36 Favored 'Trans proline' 0 CA--C 1.502 -1.095 0 C-N-CA 122.466 2.111 . . . . 0.0 113.261 176.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -87.73 169.45 12.09 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 171.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.42 ' HA ' ' HE3' ' A' ' 108' ' ' LYS . . . -70.98 -11.45 60.98 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 -173.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.512 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 37.0 t30 -104.37 -34.11 8.4 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 176.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.25 -44.34 88.3 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.152 0.501 . . . . 0.0 110.521 175.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.42 ' HE3' ' HA ' ' A' ' 105' ' ' ALA . 18.0 ptpt -59.15 -22.84 61.56 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.032 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 40.4 mtm180 -93.25 -50.38 5.51 Favored 'General case' 0 N--CA 1.38 -3.932 0 C-N-CA 126.108 1.763 . . . . 0.0 109.886 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.15 -45.59 68.48 Favored 'General case' 0 CA--C 1.48 -1.715 0 C-N-CA 125.551 1.541 . . . . 0.0 110.858 -177.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.459 ' HA ' HG23 ' A' ' 86' ' ' ILE . . . -49.48 -48.19 47.94 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 124.505 1.128 . . . . 0.0 111.163 -179.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -78.45 -28.78 46.68 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.461 -174.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 40.2 t -79.29 -3.91 48.25 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 176.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.598 ' O ' ' HB2' ' A' ' 115' ' ' LYS . 27.2 mt-10 -114.08 11.2 17.59 Favored 'General case' 0 CA--C 1.464 -2.329 0 CA-C-N 114.253 -1.34 . . . . 0.0 112.498 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.598 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 55.4 mtpt 68.5 15.04 9.17 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 174.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.9 m -121.28 170.95 10.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -135.48 147.23 48.8 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 176.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 15.0 pt -110.4 140.67 28.46 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.299 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.871 -178.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.651 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 75.2 mtp180 -131.2 123.2 27.97 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -176.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.487 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.292 -1.916 0 O-C-N 121.796 -0.565 . . . . 0.0 112.143 -177.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.2 m120 . . . . . 0 CA--C 1.5 -0.957 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.405 HD12 HD11 ' A' ' 61' ' ' LEU . 56.9 mt -140.8 160.11 40.75 Favored 'General case' 0 C--O 1.246 0.884 0 CA-C-O 121.756 0.788 . . . . 0.0 112.813 177.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.443 HD11 ' O ' ' A' ' 75' ' ' HIS . 0.2 OUTLIER -131.87 133.28 61.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 125.461 1.504 . . . . 0.0 107.259 177.893 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 67.1 t -112.7 138.85 40.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.207 -176.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 60.6 mttp -137.52 160.48 39.01 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 123.71 0.804 . . . . 0.0 109.267 173.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -168.5 171.52 8.91 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -82.08 -37.28 26.61 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 91.8 t -97.51 127.84 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.335 176.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.695 ' O ' HG23 ' A' ' 54' ' ' VAL . 50.1 tt0 -57.43 -45.62 84.46 Favored 'General case' 0 C--O 1.204 -1.295 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -176.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.92 -0.97 61.37 Favored Glycine 0 C--N 1.283 -2.375 0 C-N-CA 118.155 -1.974 . . . . 0.0 113.908 -177.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.1 t -85.87 -18.13 33.67 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 175.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 51' ' ' GLN . 3.7 m -82.37 -46.36 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.949 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 174.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -60.68 -47.18 87.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.309 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.79 -33.95 76.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.585 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.493 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 37.1 tp -76.62 -37.4 56.45 Favored 'General case' 0 C--O 1.209 -1.068 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.407 HG12 HG12 ' A' ' 73' ' ' ILE . 43.5 t -60.09 -41.41 86.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 123.234 0.614 . . . . 0.0 110.954 176.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.73 -25.94 68.15 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.541 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.96 -24.65 19.19 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.493 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -85.12 -30.13 24.27 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.468 -175.585 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -78.45 -13.22 59.94 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.048 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.931 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.099 177.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.469 0.517 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -150.69 157.22 42.71 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 175.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.407 HG12 HG12 ' A' ' 58' ' ' VAL . 1.4 pp -93.61 154.09 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.793 177.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 65.2 mt -112.35 -40.08 3.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-O 121.787 0.803 . . . . 0.0 109.734 177.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.443 ' O ' HD11 ' A' ' 45' ' ' ILE . 2.1 t60 -145.77 137.71 25.29 Favored 'General case' 0 N--CA 1.409 -2.497 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.463 -165.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.25 134.21 52.4 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 47' ' ' LYS . . . -144.27 131.68 20.9 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -178.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.1 p -94.85 93.57 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.969 0 CA-C-O 122.765 1.269 . . . . 0.0 107.699 175.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.95 176.36 48.02 Favored Glycine 0 N--CA 1.397 -3.93 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -176.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 102' ' ' ARG . . . -81.07 175.9 10.27 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.93 105.32 5.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.1 p -104.58 156.51 17.9 Favored 'General case' 0 N--CA 1.403 -2.814 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.26 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.51 -33.16 72.22 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 123.953 0.901 . . . . 0.0 110.482 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.3 m -68.53 -22.42 64.51 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.849 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.444 ' CG ' ' HZ1' ' A' ' 47' ' ' LYS . 4.9 t70 -97.72 -27.55 14.29 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 118.782 -1.167 . . . . 0.0 109.67 -178.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 79.5 mt -59.09 -27.02 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 CA-C-O 121.817 0.818 . . . . 0.0 110.433 174.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.403 ' O ' ' HB2' ' A' ' 91' ' ' ALA . 34.2 m -50.59 -33.76 23.29 Favored 'General case' 0 CA--C 1.561 1.383 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.783 172.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -82.39 -35.31 27.83 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 176.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.81 -58.58 6.73 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.425 -175.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.53 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 9.6 t -78.85 -11.23 59.99 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.773 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 87' ' ' SER . . . -73.21 -49.14 29.57 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.394 -177.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 34.2 m -105.31 -3.63 22.53 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.102 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 71.54 35.61 1.44 Allowed 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 122.103 0.954 . . . . 0.0 110.62 -176.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -95.12 129.52 42.19 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 176.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.7 pt -93.93 144.13 10.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.422 HG13 ' HZ2' ' A' ' 47' ' ' LYS . 16.5 t -102.01 132.33 48.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.766 -173.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 18.7 tt -111.87 137.88 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.782 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 173.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -132.56 146.64 18.39 Favored Glycine 0 N--CA 1.432 -1.587 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.461 ' C ' ' H ' ' A' ' 101' ' ' VAL . 91.9 m-85 -124.14 114.26 19.43 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -174.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 71.5 -36.35 0.36 Allowed 'General case' 0 N--CA 1.505 2.3 0 C-N-CA 124.458 1.103 . . . . 0.0 112.938 178.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.475 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 4.5 m -62.05 -51.23 74.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 124.982 1.313 . . . . 0.0 113.271 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.485 ' O ' ' HB3' ' A' ' 80' ' ' ALA . 23.6 mtm180 68.32 179.03 0.05 OUTLIER Pre-proline 0 CA--C 1.551 1.012 0 O-C-N 123.74 0.65 . . . . 0.0 110.111 178.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -95.36 176.91 0.85 Allowed 'Trans proline' 0 N--CA 1.444 -1.411 0 CA-C-N 121.034 1.405 . . . . 0.0 113.942 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -86.75 155.13 20.46 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 106.274 -1.751 . . . . 0.0 106.274 169.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.523 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -58.02 -30.74 66.36 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 123.074 0.549 . . . . 0.0 112.086 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.588 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 25.2 t30 -82.81 -35.7 26.2 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.91 -44.75 92.0 Favored 'General case' 0 C--O 1.206 -1.212 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.744 178.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 20.1 pttm -59.39 -29.09 67.47 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-O 121.118 0.485 . . . . 0.0 110.001 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.588 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 20.5 mtm180 -74.76 -52.66 10.92 Favored 'General case' 0 N--CA 1.384 -3.754 0 C-N-CA 123.793 0.837 . . . . 0.0 109.059 179.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -53.83 -51.82 62.32 Favored 'General case' 0 C--O 1.194 -1.856 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.067 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -50.7 -48.5 58.65 Favored 'General case' 0 CA--C 1.5 -0.944 0 O-C-N 124.284 0.99 . . . . 0.0 112.143 -176.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -81.23 -25.33 36.74 Favored 'General case' 0 N--CA 1.403 -2.82 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.291 -172.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 46.9 t -87.9 5.8 38.71 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 175.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.57 ' O ' ' HB2' ' A' ' 115' ' ' LYS . 20.5 mt-10 -123.67 17.08 9.55 Favored 'General case' 0 CA--C 1.463 -2.382 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.826 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.57 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 70.5 mmtt 66.14 8.52 5.58 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 173.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.5 m -114.52 125.03 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-O 121.775 0.797 . . . . 0.0 113.044 -176.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -94.18 120.74 34.86 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.288 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.6 pt -93.55 131.81 39.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-O 121.089 0.471 . . . . 0.0 109.947 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -100.39 118.82 37.41 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.119 0.485 . . . . 0.0 109.744 -176.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.46 ' CD1' ' HA ' ' A' ' 102' ' ' ARG . 3.2 mm? . . . . . 0 CA--C 1.474 -1.976 0 CA-C-O 121.264 0.554 . . . . 0.0 111.102 -178.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.51 ' HA ' ' O ' ' A' ' 72' ' ' LYS . 17.7 m120 . . . . . 0 N--CA 1.428 -1.526 0 CA-C-O 120.63 0.252 . . . . 0.0 111.277 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.2 pp -152.39 162.35 41.31 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.919 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.429 HG22 ' HA ' ' A' ' 96' ' ' VAL . 0.1 OUTLIER -117.08 136.36 54.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 123.278 0.631 . . . . 0.0 110.636 178.626 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 85.9 t -102.06 128.07 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.015 -175.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.4 ' O ' ' HA2' ' A' ' 98' ' ' GLY . 27.6 mmmt -134.57 136.54 43.07 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.192 -176.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.16 165.19 29.86 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -88.93 -12.56 41.3 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.606 0.717 . . . . 0.0 109.41 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 88.2 t -108.14 122.73 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 174.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.78 ' O ' HG23 ' A' ' 54' ' ' VAL . 47.8 tt0 -63.27 -40.87 98.6 Favored 'General case' 0 C--O 1.197 -1.681 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.876 -175.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.19 4.88 53.23 Favored Glycine 0 C--N 1.278 -2.66 0 C-N-CA 117.672 -2.204 . . . . 0.0 115.158 -176.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.8 m -87.58 -29.95 20.87 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 172.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 51' ' ' GLN . 12.2 m -76.55 -44.07 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 CA-C-N 114.869 -1.059 . . . . 0.0 109.011 176.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -55.34 -50.63 69.14 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.421 -178.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.42 -42.11 88.24 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.411 -176.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.593 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 32.3 tp -68.4 -41.36 80.6 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.944 -177.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.481 HG13 HG12 ' A' ' 73' ' ' ILE . 39.6 t -57.47 -43.69 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 122.627 0.371 . . . . 0.0 111.04 175.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.34 -23.08 66.9 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.263 -177.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.41 -23.82 16.42 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.593 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -81.7 -37.25 27.65 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.269 -176.048 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -66.58 -21.21 66.14 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.046 0.451 . . . . 0.0 110.897 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt . . . . . 0 C--N 1.313 -1.001 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.943 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.2 t . . . . . 0 N--CA 1.449 -0.509 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 21.6 ttmm -146.75 153.42 40.21 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 121.605 0.717 . . . . 0.0 111.42 -177.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.481 HG12 HG13 ' A' ' 58' ' ' VAL . 1.3 pp -94.97 169.21 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.509 174.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.477 HD12 ' HB3' ' A' ' 43' ' ' ASN . 3.3 mp -135.41 -32.03 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 172.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -151.1 133.45 15.41 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-O 121.234 0.54 . . . . 0.0 110.235 -168.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.414 ' HB3' HG23 ' A' ' 58' ' ' VAL . . . -124.55 141.44 52.09 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 178.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -151.02 135.42 16.96 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.377 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.8 p -93.41 92.01 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 CA-C-O 123.295 1.521 . . . . 0.0 107.906 175.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.8 175.69 47.5 Favored Glycine 0 N--CA 1.41 -3.072 0 N-CA-C 108.653 -1.779 . . . . 0.0 108.653 -177.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 102' ' ' ARG . . . -82.6 -179.19 7.35 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 175.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.5 mp -81.8 118.76 30.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 O-C-N 122.04 -0.412 . . . . 0.0 110.641 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.45 ' O ' HG13 ' A' ' 86' ' ' ILE . 25.7 p -119.81 160.28 22.93 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 178.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -54.07 -50.88 65.77 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.722 0.809 . . . . 0.0 112.501 -173.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.5 m -66.42 -19.38 65.78 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.398 0.618 . . . . 0.0 111.582 -176.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -86.27 -31.43 21.65 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -177.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.454 HD12 ' HB2' ' A' ' 111' ' ' ALA . 29.0 mt -73.11 -24.51 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.863 176.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.423 ' HA ' ' OE2' ' A' ' 114' ' ' GLU . 37.6 m -56.21 -24.6 43.05 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.094 175.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.405 ' O ' HD22 ' A' ' 88' ' ' LEU . 2.3 tm? -76.56 -35.06 58.42 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 175.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.5 -55.54 33.53 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.406 -176.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.572 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 8.9 t -71.81 -24.91 61.81 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.118 179.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.23 -62.03 1.63 Allowed 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.014 0.435 . . . . 0.0 111.937 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 43.3 m -91.75 3.84 54.18 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -177.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 69.52 31.57 3.68 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.733 0.778 . . . . 0.0 109.807 177.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -93.92 139.24 31.15 Favored 'General case' 0 N--CA 1.419 -1.987 0 CA-C-N 114.451 -1.249 . . . . 0.0 109.714 -177.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 45.9 mm -94.73 142.96 12.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 176.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.435 ' HB ' HG21 ' A' ' 118' ' ' ILE . 24.8 t -94.26 118.44 40.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -176.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 119' ' ' ARG . 27.1 pt -115.71 116.28 51.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-O 121.586 0.708 . . . . 0.0 109.644 176.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 47' ' ' LYS . . . -113.22 166.88 12.19 Favored Glycine 0 N--CA 1.428 -1.863 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.892 -177.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -133.17 112.63 11.89 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -177.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 60.52 14.32 4.78 Favored 'General case' 0 N--CA 1.502 2.146 0 C-N-CA 124.713 1.205 . . . . 0.0 113.112 178.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.467 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 1.5 m -96.59 -50.33 11.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 -173.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.571 ' O ' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER 75.49 163.65 0.14 Allowed Pre-proline 0 N--CA 1.479 0.994 0 C-N-CA 124.232 1.013 . . . . 0.0 111.968 -175.302 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -97.21 166.19 0.92 Allowed 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 121.974 1.783 . . . . 0.0 113.179 174.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -71.73 152.55 42.68 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 169.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.491 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -63.73 -25.01 68.0 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 117.912 0.323 . . . . 0.0 111.515 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.516 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 29.9 m-80 -88.62 -26.79 21.72 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.989 -0.684 . . . . 0.0 109.76 177.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.86 -44.34 77.33 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 121.025 0.441 . . . . 0.0 110.3 177.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -62.16 -21.57 65.17 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.922 179.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.516 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 56.2 mtp180 -83.84 -51.3 7.31 Favored 'General case' 0 N--CA 1.39 -3.474 0 C-N-CA 125.129 1.372 . . . . 0.0 109.378 176.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.458 ' O ' ' HG3' ' A' ' 114' ' ' GLU . . . -52.02 -48.23 64.62 Favored 'General case' 0 CA--C 1.489 -1.381 0 CA-C-N 114.403 -1.271 . . . . 0.0 110.642 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.454 ' HB2' HD12 ' A' ' 86' ' ' ILE . . . -51.72 -36.09 45.52 Favored 'General case' 0 CA--C 1.502 -0.885 0 C-N-CA 124.742 1.217 . . . . 0.0 112.17 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -78.78 -38.46 38.43 Favored 'General case' 0 N--CA 1.418 -2.029 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.788 -175.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.8 t -73.02 -9.26 58.54 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 175.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.593 ' O ' ' HB2' ' A' ' 115' ' ' LYS . 28.7 mt-10 -106.4 7.8 31.3 Favored 'General case' 0 CA--C 1.472 -2.056 0 C-N-CA 124.869 1.268 . . . . 0.0 114.009 -177.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.593 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 93.1 mttt 67.31 7.62 5.65 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 172.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.3 m -121.63 141.26 42.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -177.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -100.26 133.31 44.85 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-O 121.403 0.62 . . . . 0.0 109.794 179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.435 HG21 ' HB ' ' A' ' 96' ' ' VAL . 6.1 pt -97.21 139.69 19.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.596 178.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.555 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 64.9 ttt180 -131.85 128.54 38.88 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.41 ' N ' HD12 ' A' ' 120' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.293 -1.859 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.426 ' OD1' ' HB2' ' A' ' 92' ' ' SER . 10.4 m120 . . . . . 0 N--CA 1.42 -1.962 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 49.3 mt -141.69 174.94 10.1 Favored 'General case' 0 C--O 1.249 1.069 0 CA-C-O 121.53 0.681 . . . . 0.0 111.428 178.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.8 tt -136.41 143.33 35.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.963 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 96.6 t -127.89 122.83 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -149.54 121.63 8.29 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.587 179.021 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -131.73 175.66 9.0 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.163 -174.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -81.02 -29.13 35.19 Favored 'General case' 0 C--O 1.246 0.916 0 O-C-N 124.014 0.821 . . . . 0.0 109.815 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 80.7 t -101.88 130.09 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.364 174.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.755 ' O ' HG21 ' A' ' 54' ' ' VAL . 22.6 tm0? -64.72 -40.64 95.67 Favored 'General case' 0 C--O 1.197 -1.68 0 C-N-CA 122.822 0.449 . . . . 0.0 111.984 -174.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.4 2.8 86.6 Favored Glycine 0 C--N 1.29 -2.011 0 C-N-CA 118.114 -1.994 . . . . 0.0 112.988 178.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.2 t -82.59 -28.45 30.86 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 105.677 -1.971 . . . . 0.0 105.677 178.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.755 HG21 ' O ' ' A' ' 51' ' ' GLN . 12.9 m -69.69 -46.96 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.646 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.259 175.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -60.06 -39.54 86.39 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -177.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.91 -36.35 76.81 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 123.604 0.565 . . . . 0.0 110.796 178.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 42.3 tp -85.04 -41.72 15.51 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.714 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 54' ' ' VAL . 47.9 t -55.36 -41.23 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.099 0.96 . . . . 0.0 112.264 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.32 -17.79 64.35 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 120.736 0.303 . . . . 0.0 111.748 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.27 -27.38 14.54 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.25 -28.57 34.7 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.596 -175.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -75.93 -23.46 55.46 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.249 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt . . . . . 0 C--N 1.316 -0.859 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.63 -177.666 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.0 t . . . . . 0 CA--C 1.509 -0.622 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -142.41 155.43 45.12 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.6 pp -94.14 155.08 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.336 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.116 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.466 ' N ' HD12 ' A' ' 74' ' ' ILE . 3.8 mp -123.83 -31.43 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.969 0.89 . . . . 0.0 109.948 178.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -133.21 105.91 7.28 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.996 -170.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -116.33 114.68 24.66 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.059 178.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 47' ' ' LYS . . . -147.82 158.61 44.11 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.709 -177.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.9 p -94.0 101.39 12.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-O 121.859 0.837 . . . . 0.0 109.88 177.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.32 171.89 44.87 Favored Glycine 0 N--CA 1.417 -2.576 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.915 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 102' ' ' ARG . . . -82.24 -152.79 0.11 Allowed 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 174.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.409 ' HB ' ' HA ' ' A' ' 103' ' ' PRO . 2.4 mp -91.41 111.36 23.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 C-N-CA 118.732 -1.187 . . . . 0.0 109.36 176.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.5 p -108.73 165.18 11.74 Favored 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 175.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -60.02 -35.74 75.73 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 121.38 0.609 . . . . 0.0 111.124 -176.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.3 p -69.03 -23.6 64.09 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.12 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -74.28 -41.35 61.35 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 177.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.443 HD11 ' HB1' ' A' ' 111' ' ' ALA . 44.2 mt -66.86 -34.7 71.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-N 114.242 -1.344 . . . . 0.0 111.424 -178.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.484 ' HA ' ' OE2' ' A' ' 114' ' ' GLU . 46.9 m -67.73 -9.09 40.8 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.488 178.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -92.92 -32.67 14.49 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 173.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 93' ' ' ASN . . . -61.11 -53.26 59.33 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.44 -177.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.514 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 9.8 t -74.03 -13.57 60.88 Favored 'General case' 0 CA--C 1.561 1.379 0 CA-C-O 121.136 0.493 . . . . 0.0 110.414 178.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.65 -66.19 0.87 Allowed 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -176.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.426 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 27.1 p -101.51 5.65 41.97 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 120.748 0.309 . . . . 0.0 111.533 -176.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.473 ' HA ' ' O ' ' A' ' 89' ' ' ALA 0.491 0.0 OUTLIER 70.3 57.54 0.27 Allowed 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 127.13 2.172 . . . . 0.0 114.118 -179.462 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -105.3 167.99 9.37 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 113.357 -1.747 . . . . 0.0 108.509 174.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 47.7 mm -124.13 131.57 72.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 176.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.475 ' HB ' HG23 ' A' ' 118' ' ' ILE . 12.0 t -94.11 102.59 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -176.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 13.3 tt -97.93 140.53 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.924 177.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -134.36 146.45 18.44 Favored Glycine 0 N--CA 1.414 -2.772 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 178.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -119.54 109.24 15.47 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -177.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 66.7 t30 71.81 -39.07 0.44 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 126.022 1.729 . . . . 0.0 112.41 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.3 m -45.29 -47.65 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 126.302 1.841 . . . . 0.0 114.986 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.574 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 36.1 mtp180 73.57 170.14 0.11 Allowed Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 123.485 0.714 . . . . 0.0 112.055 179.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.409 ' HA ' ' HB ' ' A' ' 81' ' ' ILE . 9.9 Cg_endo -96.9 168.46 0.95 Allowed 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 121.911 1.741 . . . . 0.0 114.594 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -75.74 153.3 37.12 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 113.215 -1.811 . . . . 0.0 106.769 168.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.487 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -59.15 -35.2 73.1 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.548 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 18.2 m120 -79.58 -27.49 41.15 Favored 'General case' 0 CA--C 1.488 -1.429 0 C-N-CA 119.346 -0.941 . . . . 0.0 110.592 178.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.26 -46.42 77.17 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.766 177.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.487 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 19.9 pttp -59.51 -23.18 62.59 Favored 'General case' 0 CA--C 1.565 1.557 0 CA-C-O 120.965 0.412 . . . . 0.0 111.588 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.548 ' HB2' ' O ' ' A' ' 106' ' ' ASN 0.254 58.4 mtp180 -82.54 -51.2 8.01 Favored 'General case' 0 N--CA 1.393 -3.278 0 C-N-CA 125.821 1.648 . . . . 0.0 109.316 176.928 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.534 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -54.23 -48.5 71.01 Favored 'General case' 0 CA--C 1.471 -2.091 0 C-N-CA 125.914 1.686 . . . . 0.0 110.839 -176.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.443 ' HB1' HD11 ' A' ' 86' ' ' ILE . . . -48.17 -45.59 33.69 Favored 'General case' 0 CA--C 1.504 -0.797 0 O-C-N 124.867 1.354 . . . . 0.0 110.578 -179.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -72.92 -30.27 63.77 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 114.542 -1.208 . . . . 0.0 112.903 -174.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.1 t -92.28 5.27 51.13 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.547 ' O ' ' HB2' ' A' ' 115' ' ' LYS . 7.9 mt-10 -117.9 7.04 12.27 Favored 'General case' 0 N--CA 1.406 -2.662 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -175.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.547 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 29.7 mmmt 68.2 5.74 4.85 Favored 'General case' 0 N--CA 1.42 -1.936 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 174.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.1 m -122.18 145.26 29.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -114.66 143.66 44.68 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 118.726 -1.189 . . . . 0.0 109.761 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.475 HG23 ' HB ' ' A' ' 96' ' ' VAL . 8.7 pt -98.1 131.1 45.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.187 -176.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -98.5 124.83 43.47 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.516 -174.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 CA--C 1.502 -0.865 0 CA-C-O 121.873 0.844 . . . . 0.0 112.867 -178.842 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.593 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 91.3 m-20 . . . . . 0 N--CA 1.416 -2.159 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.3 pp -150.12 164.69 34.94 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.522 HD11 ' CD2' ' A' ' 75' ' ' HIS . 0.3 OUTLIER -119.88 132.88 68.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.368 178.612 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 93.3 t -107.1 126.96 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.058 -177.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 42.5 mtpt -139.23 134.75 33.12 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.211 176.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.78 168.39 23.82 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -178.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -80.2 -18.73 48.77 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.855 0.836 . . . . 0.0 110.421 -178.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 69.4 t -104.76 123.19 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 175.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.79 ' O ' HG22 ' A' ' 54' ' ' VAL . 10.8 tt0 -68.64 -29.78 68.34 Favored 'General case' 0 C--O 1.195 -1.78 0 CA-C-O 121.137 0.494 . . . . 0.0 111.413 -174.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.95 2.59 87.15 Favored Glycine 0 C--N 1.284 -2.36 0 C-N-CA 117.125 -2.464 . . . . 0.0 112.642 177.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.4 t -86.84 -31.07 21.01 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 176.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.79 HG22 ' O ' ' A' ' 51' ' ' GLN . 11.9 m -67.48 -43.4 87.41 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.866 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.423 175.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -66.27 -39.93 89.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.413 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.27 -37.04 79.25 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.747 177.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.511 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 26.6 tp -77.46 -41.68 38.71 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 120.532 -0.467 . . . . 0.0 109.766 177.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.427 HG21 ' O ' ' A' ' 54' ' ' VAL . 32.1 t -53.57 -45.82 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 123.57 0.748 . . . . 0.0 112.079 177.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.34 -26.56 68.51 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.58 -22.83 17.37 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -178.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -82.55 -35.53 27.11 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.47 -175.621 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -67.72 -27.04 66.46 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.112 0.482 . . . . 0.0 110.57 178.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.1 ptpp? . . . . . 0 CA--C 1.538 0.502 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.32 179.12 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.5 t . . . . . 0 N--CA 1.431 -1.416 0 N-CA-C 103.382 -2.822 . . . . 0.0 103.382 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.443 ' HG2' ' N ' ' A' ' 73' ' ' ILE . 87.9 tttt -139.92 161.5 37.44 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.354 0.597 . . . . 0.0 111.142 -176.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.443 ' N ' ' HG2' ' A' ' 72' ' ' LYS . 1.7 pp -93.51 148.52 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.759 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.612 177.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 73.2 mt -119.57 -27.63 2.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-O 121.68 0.753 . . . . 0.0 110.06 176.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.522 ' CD2' HD11 ' A' ' 45' ' ' ILE . 3.0 t60 -154.67 132.28 11.34 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.357 -172.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -134.66 131.03 37.25 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -149.79 156.98 42.75 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.955 -178.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.3 p -93.5 94.42 4.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-O 122.521 1.153 . . . . 0.0 110.295 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.7 176.02 47.79 Favored Glycine 0 N--CA 1.417 -2.572 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 102' ' ' ARG . . . -91.81 -175.38 4.12 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 176.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.433 HG23 HG22 ' A' ' 118' ' ' ILE . 3.2 mp -74.3 111.84 10.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 119.433 -0.907 . . . . 0.0 108.847 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.8 p -117.61 152.97 34.07 Favored 'General case' 0 N--CA 1.42 -1.972 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.702 -178.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -50.33 -41.83 51.85 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.026 0.53 . . . . 0.0 111.588 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.1 m -62.83 -28.12 69.79 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.614 -177.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -86.17 -29.33 23.32 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-O 121.341 0.591 . . . . 0.0 110.94 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.426 HG23 ' HA ' ' A' ' 111' ' ' ALA . 59.2 mt -65.87 -25.72 36.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.699 177.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.413 ' HA ' ' OE1' ' A' ' 114' ' ' GLU . 38.0 m -59.84 -30.7 69.13 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.917 177.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -78.25 -35.78 47.78 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 175.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.05 -58.91 5.39 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.966 -176.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.619 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 9.8 t -71.24 -24.61 62.22 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.478 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.17 -62.67 1.61 Allowed 'General case' 0 C--N 1.342 0.273 0 CA-C-O 120.944 0.402 . . . . 0.0 111.76 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.7 m -96.37 5.44 50.91 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.627 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 65.85 40.88 4.03 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.216 1.006 . . . . 0.0 110.314 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.593 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -94.51 136.45 34.79 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-N 114.206 -1.361 . . . . 0.0 109.081 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.1 mp -93.88 140.23 16.9 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.41 ' HB ' HG21 ' A' ' 118' ' ' ILE . 14.5 t -94.77 117.54 38.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -178.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' A' ' 119' ' ' ARG . 0.2 OUTLIER -112.17 122.86 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 174.3 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -115.37 146.47 18.83 Favored Glycine 0 N--CA 1.426 -1.997 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.159 -177.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -105.6 94.62 5.3 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 118.468 -1.293 . . . . 0.0 109.664 -177.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 63.78 8.64 3.9 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 124.946 1.298 . . . . 0.0 112.866 177.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.424 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 3.6 m -78.89 -49.38 20.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.101 -178.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.541 ' O ' ' HB3' ' A' ' 80' ' ' ALA . 72.7 mtp180 69.59 154.64 0.15 Allowed Pre-proline 0 N--CA 1.477 0.915 0 O-C-N 123.889 0.743 . . . . 0.0 112.82 175.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -91.07 173.69 2.78 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 121.991 1.794 . . . . 0.0 112.47 178.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -89.71 168.28 12.23 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 167.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.576 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -56.58 -28.61 60.63 Favored 'General case' 0 C--O 1.206 -1.203 0 C-N-CA 122.824 0.449 . . . . 0.0 111.041 178.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.655 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 23.1 p30 -72.41 -46.47 55.01 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.21 -34.8 76.92 Favored 'General case' 0 C--N 1.292 -1.922 0 O-C-N 122.096 -0.378 . . . . 0.0 111.563 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 18.1 pttp -63.08 -27.7 69.57 Favored 'General case' 0 CA--C 1.563 1.478 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.318 175.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.655 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 63.5 mtp180 -75.37 -50.28 16.41 Favored 'General case' 0 N--CA 1.405 -2.698 0 C-N-CA 125.212 1.405 . . . . 0.0 109.239 176.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.24 -50.6 66.8 Favored 'General case' 0 C--O 1.201 -1.47 0 CA-C-N 114.118 -1.401 . . . . 0.0 110.269 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.426 ' HA ' HG23 ' A' ' 86' ' ' ILE . . . -49.33 -48.6 46.32 Favored 'General case' 0 CA--C 1.502 -0.886 0 O-C-N 124.587 1.179 . . . . 0.0 111.602 -178.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -79.13 -29.8 43.35 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.864 -173.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 28.7 t -77.19 -6.94 54.92 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 175.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.619 ' O ' ' HB ' ' A' ' 90' ' ' THR . 26.2 mt-10 -114.73 9.32 16.37 Favored 'General case' 0 N--CA 1.411 -2.422 0 CA-C-N 114.471 -1.241 . . . . 0.0 112.912 -177.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 29.2 mmtp 64.46 15.57 9.65 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 174.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.3 m -120.34 131.76 71.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.461 0.648 . . . . 0.0 112.565 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -94.59 130.39 41.06 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.077 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.433 HG22 HG23 ' A' ' 81' ' ' ILE . 15.1 pt -94.85 128.6 45.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.06 179.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.518 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 98.1 mtt180 -122.16 111.69 17.29 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.672 0.749 . . . . 0.0 110.743 -175.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.505 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.286 -2.154 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.148 -177.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 . . . . . 0 C--O 1.237 0.4 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.4 mt -135.23 168.78 18.54 Favored 'General case' 0 C--O 1.248 0.976 0 CA-C-O 121.789 0.804 . . . . 0.0 111.925 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.1 tt -133.18 132.9 58.54 Favored 'Isoleucine or valine' 0 C--O 1.249 1.028 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.198 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.646 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 84.4 t -113.74 131.96 64.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.565 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.97 148.03 36.17 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 178.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.59 158.13 28.51 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 177.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -78.95 -12.33 60.03 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.039 -0.665 . . . . 0.0 110.044 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 99.1 t -109.86 134.12 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 174.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.744 ' O ' HG22 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -69.01 -46.63 67.52 Favored 'General case' 0 C--O 1.202 -1.447 0 C-N-CA 122.431 0.292 . . . . 0.0 110.558 -172.332 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.06 -1.19 67.66 Favored Glycine 0 C--N 1.286 -2.196 0 C-N-CA 118.479 -1.82 . . . . 0.0 114.285 -177.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.7 m -80.17 -29.42 38.74 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 106.282 -1.748 . . . . 0.0 106.282 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.744 HG22 ' O ' ' A' ' 51' ' ' GLN . 5.7 m -72.37 -42.44 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.498 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.354 176.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -54.47 -47.86 72.48 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 124.128 0.893 . . . . 0.0 110.592 178.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.77 -40.03 91.02 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.658 -178.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 34.4 tp -78.94 -36.66 41.33 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.593 -178.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.428 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 43.4 t -59.98 -43.6 92.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 122.727 0.411 . . . . 0.0 110.493 177.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.12 -14.85 62.48 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.61 -13.15 16.64 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.497 0.665 . . . . 0.0 109.294 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.7 -38.67 8.61 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.397 -176.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.428 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 4.1 pt20 -74.11 -5.9 44.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.303 0.573 . . . . 0.0 111.128 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.245 0.856 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.117 177.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.6 t . . . . . 0 N--CA 1.436 -1.145 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -124.27 158.08 33.37 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.52 0.676 . . . . 0.0 111.444 -172.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 pp -93.84 149.76 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.942 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.803 174.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 53.6 mt -120.63 -24.23 2.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-O 121.565 0.698 . . . . 0.0 110.796 178.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -150.41 117.45 5.94 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.63 -172.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.646 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -120.78 129.69 53.7 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 176.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.404 ' O ' HG11 ' A' ' 54' ' ' VAL . . . -145.72 153.53 41.07 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.974 -178.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.402 ' HB ' ' HA ' ' A' ' 51' ' ' GLN . 3.0 p -93.84 93.26 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.704 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 175.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.87 176.49 48.03 Favored Glycine 0 N--CA 1.401 -3.697 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.79 -175.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' A' ' 102' ' ' ARG . . . -90.49 -157.08 0.46 Allowed 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 175.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 103' ' ' PRO . 2.9 mp -83.06 103.74 10.76 Favored 'Isoleucine or valine' 0 C--O 1.254 1.329 0 C-N-CA 118.854 -1.138 . . . . 0.0 108.242 177.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 44.1 p -101.7 159.73 15.07 Favored 'General case' 0 N--CA 1.409 -2.508 0 C-N-CA 119.417 -0.913 . . . . 0.0 108.808 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -60.21 -26.27 66.26 Favored 'General case' 0 CA--C 1.559 1.315 0 CA-C-O 121.466 0.65 . . . . 0.0 109.949 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.6 m -71.97 -22.06 61.5 Favored 'General case' 0 CA--C 1.555 1.146 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.154 178.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -81.48 -33.05 32.18 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-O 121.628 0.728 . . . . 0.0 109.276 178.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.456 HD12 ' HB2' ' A' ' 111' ' ' ALA . 67.8 mt -72.63 -33.13 43.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.25 -178.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.9 p -61.01 -17.29 51.36 Favored 'General case' 0 CA--C 1.557 1.214 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 175.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.474 ' O ' HD21 ' A' ' 88' ' ' LEU . 1.9 tm? -92.22 -33.13 14.8 Favored 'General case' 0 C--O 1.25 1.104 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 174.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.93 -58.94 5.57 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.25 -176.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.47 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 11.2 t -79.29 -4.27 49.95 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-O 121.421 0.629 . . . . 0.0 110.649 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.84 -67.31 0.79 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.039 0.447 . . . . 0.0 112.191 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.4 t -104.85 5.95 33.44 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.391 0.615 . . . . 0.0 109.921 -176.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 74.07 72.12 0.11 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.482 1.113 . . . . 0.0 113.324 178.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -128.33 135.69 49.94 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 173.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.0 tt -94.49 140.79 16.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.474 ' HB ' HG22 ' A' ' 118' ' ' ILE . 49.4 t -94.45 99.45 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.392 0 CA-C-O 121.587 0.708 . . . . 0.0 110.946 -174.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.424 ' HA ' ' O ' ' A' ' 119' ' ' ARG . 42.7 mm -94.11 144.2 10.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 174.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -143.02 158.72 27.28 Favored Glycine 0 C--N 1.293 -1.821 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.06 -179.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.475 ' C ' ' H ' ' A' ' 101' ' ' VAL . 59.1 m-85 -122.38 95.04 4.48 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.243 -177.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . 0.254 95.4 m-20 55.6 -5.09 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 -179.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.475 ' H ' ' C ' ' A' ' 99' ' ' PHE . 1.7 m -62.93 -45.02 99.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 C-N-CA 123.65 0.78 . . . . 0.0 110.159 176.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.601 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 58.9 mtm180 70.88 161.66 0.15 Allowed Pre-proline 0 C--O 1.213 -0.849 0 CA-C-N 114.783 -1.099 . . . . 0.0 113.125 173.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.455 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 11.1 Cg_endo -94.68 170.41 1.61 Allowed 'Trans proline' 0 N--CA 1.441 -1.602 0 C-N-CA 121.479 1.453 . . . . 0.0 114.291 -177.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -74.07 155.35 38.6 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 167.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.561 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -61.67 -36.29 80.44 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.563 0.697 . . . . 0.0 110.193 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.525 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 2.7 t-20 -74.83 -37.76 62.19 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.032 177.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.33 -48.39 81.8 Favored 'General case' 0 C--O 1.214 -0.775 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.48 176.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.561 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 14.8 pttp -59.23 -28.63 66.86 Favored 'General case' 0 CA--C 1.565 1.541 0 CA-C-O 120.982 0.42 . . . . 0.0 111.89 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.55 ' HG3' ' O ' ' A' ' 105' ' ' ALA . 49.3 mtp180 -75.4 -49.59 18.49 Favored 'General case' 0 N--CA 1.386 -3.655 0 C-N-CA 125.5 1.52 . . . . 0.0 109.306 178.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -55.22 -48.01 74.51 Favored 'General case' 0 C--O 1.198 -1.618 0 CA-C-N 113.903 -1.498 . . . . 0.0 110.07 -179.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.456 ' HB2' HD12 ' A' ' 86' ' ' ILE . . . -48.09 -44.07 31.31 Favored 'General case' 0 CA--C 1.496 -1.115 0 O-C-N 124.68 1.237 . . . . 0.0 111.121 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.402 ' C ' ' H ' ' A' ' 114' ' ' GLU . 39.6 mt-10 -75.87 -37.5 58.84 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.748 -174.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 34.0 t -80.41 5.07 16.04 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 122.047 0.927 . . . . 0.0 108.568 178.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.515 ' O ' ' HB2' ' A' ' 115' ' ' LYS . 25.1 mt-10 -121.23 9.76 10.5 Favored 'General case' 0 N--CA 1.404 -2.762 0 CA-C-N 114.442 -1.254 . . . . 0.0 112.839 -178.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.515 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 60.3 mmtt 65.87 10.82 7.19 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 173.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.1 m -115.22 156.42 16.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 C-N-CA 119.831 -0.748 . . . . 0.0 111.744 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -112.57 138.19 49.71 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.329 -177.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.474 HG22 ' HB ' ' A' ' 96' ' ' VAL . 9.9 pt -108.38 113.88 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.628 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 173.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.424 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 50.8 ttp180 -113.31 97.92 6.78 Favored 'General case' 0 N--CA 1.414 -2.27 0 CA-C-O 122.211 1.005 . . . . 0.0 109.719 -175.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.521 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.29 -1.998 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.768 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 17.0 m120 . . . . . 0 CA--C 1.5 -0.944 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 69.87 119.86 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.822 0.849 . . . . 0.0 110.816 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -96.86 118.86 34.21 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.817 -176.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 69.99 96.88 0.07 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.745 1.218 . . . . 0.0 112.032 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -91.91 110.8 22.16 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 176.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -134.54 -144.54 5.06 Favored Glycine 0 N--CA 1.422 -2.238 0 C-N-CA 119.631 -1.271 . . . . 0.0 113.071 -176.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -96.86 138.47 34.36 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -94.79 97.64 10.19 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 176.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.41 61.11 4.24 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 116.32 -0.4 . . . . 0.0 112.4 -177.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 33.8 t -114.08 -31.5 6.33 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.045 0.45 . . . . 0.0 110.343 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.4 m -93.68 11.31 29.44 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.601 0.715 . . . . 0.0 110.814 -178.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -86.93 -12.56 47.29 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.977 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.4 m -105.35 -177.98 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.53 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -75.41 142.45 43.05 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.242 0.544 . . . . 0.0 110.392 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.5 mt -96.77 100.05 11.61 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.158 -172.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 48.2 mm-40 -124.11 -173.31 2.73 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 177.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.22 169.88 12.78 Favored 'General case' 0 C--O 1.246 0.917 0 C-N-CA 120.819 -0.353 . . . . 0.0 111.636 175.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 69.43 30.51 4.09 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -169.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 -65.35 -33.37 75.82 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 113.544 -1.662 . . . . 0.0 110.627 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.0 t -75.91 -42.08 49.99 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.9 p 57.66 145.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 127.157 2.183 . . . . 0.0 112.43 -177.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? 70.86 -65.31 0.34 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.098 0.959 . . . . 0.0 109.508 -177.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 38.0 p -88.77 12.23 15.57 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 122.018 0.914 . . . . 0.0 110.013 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.551 ' HD2' ' O ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -71.8 151.27 43.62 Favored 'General case' 0 C--O 1.247 0.931 0 CA-C-N 114.583 -1.189 . . . . 0.0 111.281 179.185 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.4 p -166.94 144.63 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.0 m -87.71 -61.73 1.65 Allowed 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -133.07 111.01 10.61 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -177.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -117.9 -22.36 7.95 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.356 0.598 . . . . 0.0 111.292 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -82.8 105.89 14.18 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.067 0.461 . . . . 0.0 110.839 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.3 mt -74.01 152.22 40.08 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.389 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -89.07 138.16 31.66 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.346 0.593 . . . . 0.0 111.892 -173.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 33' ' ' GLN . 14.3 tp10 -88.77 -32.22 18.0 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 174.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 32' ' ' GLU . 14.1 mm100 78.68 150.04 0.11 Allowed 'General case' 0 C--N 1.356 0.85 0 C-N-CA 125.006 1.322 . . . . 0.0 111.458 -177.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.5 pp -76.99 159.88 4.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.076 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -161.89 113.4 1.69 Allowed 'General case' 0 C--O 1.247 0.952 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -174.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -83.62 83.05 8.04 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.522 0.677 . . . . 0.0 112.444 -177.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -127.44 17.88 6.13 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 175.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -71.91 -61.34 1.82 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 114.818 -0.691 . . . . 0.0 110.538 -176.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 24.4 mmt -79.5 -24.59 42.18 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.023 -176.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt 71.78 169.2 0.32 Allowed 'General case' 0 C--O 1.24 0.601 0 CA-C-N 113.792 -1.549 . . . . 0.0 110.782 -175.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -108.96 115.5 30.19 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.5 tp -94.14 119.0 32.36 Favored 'General case' 0 N--CA 1.423 -1.799 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.909 -172.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.455 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 89.0 m-20 -109.59 146.73 34.23 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -155.27 165.62 36.1 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-O 121.513 0.673 . . . . 0.0 112.191 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.56 HD12 ' CD2' ' A' ' 75' ' ' HIS . 0.1 OUTLIER -118.43 134.56 61.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 174.591 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 65.5 t -103.84 129.99 55.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.414 -178.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.439 ' HE2' ' HB1' ' A' ' 77' ' ' ALA . 64.4 mttt -141.38 139.27 33.46 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 121.442 0.639 . . . . 0.0 111.149 176.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.72 166.38 33.01 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -82.22 -21.77 36.2 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.996 0.427 . . . . 0.0 110.082 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 94.3 t -99.25 124.09 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 174.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.76 ' O ' HG21 ' A' ' 54' ' ' VAL . 17.3 tt0 -63.77 -40.87 97.74 Favored 'General case' 0 C--O 1.2 -1.546 0 CA-C-O 120.871 0.367 . . . . 0.0 111.56 -174.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.02 5.18 63.27 Favored Glycine 0 C--N 1.278 -2.683 0 C-N-CA 117.639 -2.22 . . . . 0.0 113.647 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.9 t -84.26 -32.28 24.51 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 173.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.76 HG21 ' O ' ' A' ' 51' ' ' GLN . 4.0 m -72.71 -46.8 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.766 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.772 177.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -63.4 -39.48 94.63 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.504 -177.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.42 -37.47 87.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.825 0.345 . . . . 0.0 110.695 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.437 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 31.3 tp -75.08 -42.02 57.6 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.423 HG21 ' HB1' ' A' ' 76' ' ' ALA . 70.3 t -58.78 -42.48 85.57 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.52 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.948 177.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.423 ' O ' ' HE3' ' A' ' 63' ' ' LYS . . . -65.11 -16.87 63.96 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.99 -25.25 14.38 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 122.187 0.994 . . . . 0.0 108.399 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.437 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.6 OUTLIER -83.13 -36.26 24.93 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.168 -176.197 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -71.91 -22.35 61.5 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 122.801 0.44 . . . . 0.0 111.228 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.423 ' HE3' ' O ' ' A' ' 59' ' ' ALA . 19.0 ptpt -90.94 5.1 50.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.201 0.524 . . . . 0.0 110.772 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 31.8 mm -78.25 102.07 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 175.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -132.41 17.84 4.41 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-O 121.473 0.654 . . . . 0.0 109.517 176.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 36.0 m -62.06 137.74 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.436 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -70.92 125.72 27.61 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.41 -177.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.6 -88.71 0.41 Allowed Glycine 0 N--CA 1.432 -1.58 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.564 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.6 t -98.46 109.9 24.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.59 126.99 41.25 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 119.915 -0.714 . . . . 0.0 110.466 177.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 39.5 t -126.47 126.36 68.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -147.98 154.31 40.15 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.365 0.603 . . . . 0.0 110.776 -175.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.413 HG12 HG12 ' A' ' 58' ' ' VAL . 1.6 pp -93.9 147.94 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.68 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.625 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.8 mm -112.5 -22.18 5.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.978 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.56 ' CD2' HD12 ' A' ' 45' ' ' ILE . 5.3 t60 -162.48 149.11 13.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -172.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.423 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -140.41 144.34 36.11 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 178.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.439 ' HB1' ' HE2' ' A' ' 47' ' ' LYS . . . -165.52 149.78 8.49 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 117.904 0.32 . . . . 0.0 110.874 177.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.2 p -94.31 93.67 4.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 122.604 1.192 . . . . 0.0 109.083 177.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -177.09 176.4 48.05 Favored Glycine 0 N--CA 1.408 -3.192 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -177.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' A' ' 102' ' ' ARG . . . -93.11 -175.35 3.83 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 176.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.531 ' O ' ' HA ' ' A' ' 103' ' ' PRO . 3.0 mp -77.83 110.9 14.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.064 -0.655 . . . . 0.0 110.016 -176.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.7 p -110.74 147.81 33.62 Favored 'General case' 0 N--CA 1.408 -2.543 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.187 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -45.7 -44.49 13.59 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 125.125 1.37 . . . . 0.0 112.95 -178.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.9 t -64.15 -33.96 76.96 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 122.556 0.342 . . . . 0.0 111.785 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -78.18 -26.21 47.52 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 121.007 0.432 . . . . 0.0 111.718 -177.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.459 ' CG2' ' HA ' ' A' ' 111' ' ' ALA . 50.8 mt -64.71 -35.48 75.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.952 177.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 57.6 m -61.17 -24.55 66.39 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 175.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -74.96 -37.63 61.9 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 173.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.588 ' HA ' ' O ' ' A' ' 94' ' ' ALA . . . -55.22 -51.23 67.23 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.9 -177.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.479 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 8.9 t -77.14 -15.98 59.33 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 120.596 -0.441 . . . . 0.0 111.099 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.69 -62.13 1.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.062 0.458 . . . . 0.0 111.102 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 68.1 m -91.6 1.3 57.24 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.954 -177.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.2 m120 69.35 23.33 6.22 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.907 0.86 . . . . 0.0 109.38 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.588 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . -94.72 117.2 29.75 Favored 'General case' 0 C--O 1.194 -1.844 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.688 -177.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 44.3 pt -92.38 156.69 3.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 118.378 -1.329 . . . . 0.0 109.782 -177.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.5 t -94.45 116.92 36.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.215 -173.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 6.5 tp -101.08 109.25 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.928 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 173.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -105.9 140.57 15.19 Favored Glycine 0 N--CA 1.414 -2.789 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.047 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -98.68 94.4 6.63 Favored 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 118.238 -1.385 . . . . 0.0 109.281 -176.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 66.8 t30 58.61 14.78 3.27 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 125.489 1.516 . . . . 0.0 111.822 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.465 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 6.5 m -78.91 -49.6 19.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -173.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.65 ' O ' ' HB3' ' A' ' 80' ' ' ALA . 62.6 mtm180 77.87 158.96 0.15 Allowed Pre-proline 0 N--CA 1.482 1.17 0 O-C-N 123.818 0.699 . . . . 0.0 112.756 174.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.531 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 15.4 Cg_endo -100.16 178.79 0.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.546 2.164 . . . . 0.0 114.934 -176.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -73.83 159.91 32.21 Favored 'General case' 0 C--O 1.25 1.084 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 167.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.516 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -67.63 -28.22 67.54 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.079 0.466 . . . . 0.0 109.892 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.638 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 20.0 t-20 -85.9 -36.32 19.99 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.796 176.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.51 -43.81 93.3 Favored 'General case' 0 C--O 1.207 -1.152 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.823 176.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 105' ' ' ALA . 0.0 OUTLIER -57.83 -30.04 65.43 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-O 120.785 0.326 . . . . 0.0 111.602 179.08 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.638 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 91.1 mtt180 -76.29 -52.31 10.24 Favored 'General case' 0 N--CA 1.386 -3.638 0 C-N-CA 125.29 1.436 . . . . 0.0 108.385 178.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -52.73 -45.96 67.21 Favored 'General case' 0 C--O 1.201 -1.484 0 CA-C-N 113.672 -1.603 . . . . 0.0 110.577 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.459 ' HA ' ' CG2' ' A' ' 86' ' ' ILE . . . -47.68 -53.06 16.12 Favored 'General case' 0 CA--C 1.501 -0.936 0 O-C-N 124.749 1.281 . . . . 0.0 110.915 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -78.55 -25.52 45.45 Favored 'General case' 0 C--N 1.271 -2.841 0 CA-C-N 114.558 -1.201 . . . . 0.0 112.529 -173.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 41.6 t -86.39 5.34 35.4 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 177.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.572 ' O ' ' HB2' ' A' ' 115' ' ' LYS . 19.2 mt-10 -123.3 13.11 9.54 Favored 'General case' 0 CA--C 1.462 -2.409 0 CA-C-N 114.612 -1.176 . . . . 0.0 111.737 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.572 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 56.4 mtpt 68.85 12.61 8.7 Favored 'General case' 0 N--CA 1.417 -2.086 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 175.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 3.0 m -126.16 112.49 30.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -93.87 141.07 28.93 Favored 'General case' 0 CA--C 1.498 -1.022 0 C-N-CA 118.29 -1.364 . . . . 0.0 108.352 177.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 6.3 pt -102.06 145.01 12.53 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.601 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.541 -174.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 57.3 mtp180 -122.03 128.48 51.46 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -178.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.499 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -162.45 159.74 25.45 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.621 -177.194 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 66.4 t60 62.08 31.46 17.85 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 122.258 1.027 . . . . 0.0 109.281 172.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -76.42 42.31 0.27 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 114.784 -1.098 . . . . 0.0 112.878 -175.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 56.3 mt -64.59 -55.83 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 175.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 6.0 tp -177.66 119.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.584 174.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -104.75 108.15 19.48 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 104.539 -2.393 . . . . 0.0 104.539 168.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -77.2 78.61 3.73 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 122.129 0.966 . . . . 0.0 112.174 -170.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.4 p -84.67 -10.39 11.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.816 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 59.7 mt -85.06 97.36 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.258 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 68.5 122.6 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.05 1.34 . . . . 0.0 113.414 176.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -86.67 99.44 11.75 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 169.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.456 ' O ' ' HG2' ' A' ' 132' ' ' GLU . 48.3 mm -82.0 82.96 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 CA-C-O 121.503 0.668 . . . . 0.0 111.516 -177.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 131' ' ' ILE . 5.4 mm-40 169.99 137.94 0.02 OUTLIER 'General case' 0 CA--C 1.489 -1.382 0 C-N-CA 130.0 3.32 . . . . 0.0 105.458 174.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 63.8 19.14 11.58 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 122.087 0.946 . . . . 0.0 109.358 -172.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -119.99 148.97 42.89 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-N 114.713 -1.13 . . . . 0.0 108.304 -177.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 44.6 ttm . . . . . 0 C--N 1.286 -2.173 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 -179.096 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 . . . . . 0 CA--C 1.492 -1.276 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -172.76 -43.04 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 69.5 132.79 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.648 1.179 . . . . 0.0 112.768 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 59.18 81.27 0.17 Allowed 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.112 0.965 . . . . 0.0 111.702 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -151.94 -51.55 0.12 Allowed 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.525 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -108.48 91.87 0.7 Allowed Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.3 t -103.67 65.43 0.83 Allowed 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -174.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.4 ' HA ' HG21 ' A' ' 13' ' ' VAL . 31.0 mtt180 -166.99 165.29 15.93 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 124.916 1.286 . . . . 0.0 110.23 174.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 174.66 160.38 22.62 Favored Glycine 0 N--CA 1.428 -1.896 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -176.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.7 m -51.32 97.09 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 125.462 1.505 . . . . 0.0 113.667 -174.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.5 m 57.12 19.11 4.53 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.909 1.284 . . . . 0.0 114.408 174.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -95.93 -15.5 22.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.328 0.585 . . . . 0.0 110.894 178.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.4 HG21 ' HA ' ' A' ' 8' ' ' ARG . 30.1 m -134.04 168.59 23.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 176.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 72.28 21.37 3.85 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.101 0.961 . . . . 0.0 112.185 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.8 mp -73.56 110.0 7.51 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 175.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 -91.7 -47.13 7.53 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.391 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 60.97 -69.76 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.231 1.412 . . . . 0.0 112.358 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 68.51 -59.2 0.46 Allowed 'General case' 0 C--O 1.22 -0.494 0 C-N-CA 125.807 1.643 . . . . 0.0 112.999 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . 0.316 13.7 ptm180 51.4 -77.49 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.522 1.929 . . . . 0.0 115.113 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.436 ' O ' HG21 ' A' ' 21' ' ' VAL . 37.3 p -85.42 -11.44 54.4 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.436 HG21 ' O ' ' A' ' 20' ' ' SER 0.271 5.6 m 67.29 0.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 127.927 2.491 . . . . 0.0 111.425 -176.388 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -89.92 -43.13 10.79 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 35.5 p -80.45 13.01 2.65 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.275 -1.329 . . . . 0.0 112.723 -175.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -78.58 -25.79 45.36 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.372 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.6 p -173.75 -15.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.997 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t 64.1 -147.65 0.29 Allowed 'General case' 0 C--O 1.253 1.247 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 -175.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.9 mt 61.61 41.98 11.62 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 122.044 0.926 . . . . 0.0 109.783 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -83.57 38.3 0.62 Allowed 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.55 -178.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -79.97 -20.55 45.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.82 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 65.9 tp -110.93 86.88 2.41 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -119.3 -12.08 9.46 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.252 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -73.5 153.16 40.44 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.771 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -75.78 134.47 40.42 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.4 mm -59.01 123.85 12.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 176.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -72.46 -29.43 63.67 Favored 'General case' 0 C--N 1.315 -0.917 0 O-C-N 123.439 0.462 . . . . 0.0 111.977 -172.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 74.98 -23.09 0.24 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.791 1.236 . . . . 0.0 113.611 176.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 174.63 -176.95 46.9 Favored Glycine 0 N--CA 1.426 -1.999 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -134.85 145.48 48.34 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 27.0 ttt -144.25 135.66 25.66 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -67.33 -59.04 3.74 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -174.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.55 ' HA ' ' O ' ' A' ' 70' ' ' ARG . 30.4 tt0 -130.62 121.43 25.59 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-O 121.262 0.553 . . . . 0.0 110.223 -174.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -94.95 143.2 26.66 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.047 -0.978 . . . . 0.0 109.207 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.485 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 94.1 m-20 -109.72 128.05 55.02 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -178.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 89.6 mt -135.29 169.65 17.14 Favored 'General case' 0 C--O 1.252 1.194 0 CA-C-O 122.016 0.912 . . . . 0.0 111.894 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -131.61 139.73 49.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 114.259 -1.337 . . . . 0.0 109.944 177.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 93.7 t -117.88 130.67 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-O 121.161 0.505 . . . . 0.0 110.775 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.46 ' HZ2' ' CG ' ' A' ' 85' ' ' ASP . 35.5 mtmm -142.35 144.47 33.2 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.017 173.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -150.48 170.77 18.29 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -82.7 -19.7 37.53 Favored 'General case' 0 C--N 1.313 -1.007 0 O-C-N 124.065 0.853 . . . . 0.0 110.227 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.468 ' HB ' ' OG ' ' A' ' 53' ' ' SER . 95.3 t -110.54 124.26 67.16 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.971 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 173.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.704 ' O ' HG22 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -54.77 -46.61 74.41 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 123.898 0.879 . . . . 0.0 112.61 -176.348 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.19 1.7 79.44 Favored Glycine 0 C--N 1.285 -2.264 0 C-N-CA 118.099 -2.001 . . . . 0.0 114.06 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.468 ' OG ' ' HB ' ' A' ' 50' ' ' VAL . 49.1 m -82.63 -26.78 31.89 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 176.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.704 HG22 ' O ' ' A' ' 51' ' ' GLN . 3.7 m -68.57 -45.08 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.099 0 CA-C-N 114.398 -1.274 . . . . 0.0 107.885 176.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -67.09 -32.33 73.42 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.939 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.56 -34.22 77.32 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.179 0.514 . . . . 0.0 110.29 177.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.4 tp -84.01 -39.13 20.05 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.605 178.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 54' ' ' VAL . 55.6 t -55.44 -45.56 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.033 0.533 . . . . 0.0 112.029 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.19 -15.71 63.38 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.509 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -100.9 -22.16 14.89 Favored 'General case' 0 C--O 1.2 -1.521 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.27 -38.24 17.76 Favored 'General case' 0 N--CA 1.421 -1.919 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.873 -177.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -72.13 -10.02 59.22 Favored 'General case' 0 C--N 1.317 -0.82 0 O-C-N 122.073 -0.392 . . . . 0.0 110.723 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 19.1 pttp -99.25 0.39 43.07 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.527 ' HB ' ' O ' ' A' ' 71' ' ' VAL . 23.1 mm -77.26 83.82 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -140.23 -56.55 0.54 Allowed 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 114.609 -1.178 . . . . 0.0 108.88 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.7 m -90.07 15.11 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.824 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.402 ' HG3' HD13 ' A' ' 64' ' ' ILE . 9.1 mm-40 -98.87 15.37 25.75 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.872 -176.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.43 -68.76 0.29 Allowed Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 22.5 t -117.85 163.6 14.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.55 ' O ' ' HA ' ' A' ' 41' ' ' GLU . 53.9 mtp180 -98.23 113.95 26.05 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.527 ' O ' ' HB ' ' A' ' 64' ' ' ILE . 46.9 t -126.76 124.86 65.84 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 178.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -130.23 155.26 46.56 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-O 121.457 0.646 . . . . 0.0 111.231 -173.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.4 pp -94.74 148.64 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.499 176.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 76.5 mt -113.5 -30.5 2.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-O 121.478 0.656 . . . . 0.0 110.582 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -151.29 133.4 15.2 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.337 -172.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.567 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -134.96 129.49 34.3 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -151.46 159.86 43.99 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 120.53 0.205 . . . . 0.0 110.547 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.2 p -94.08 98.61 8.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-O 121.887 0.851 . . . . 0.0 108.803 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.415 ' O ' ' HB3' ' A' ' 47' ' ' LYS . . . -176.92 175.45 47.66 Favored Glycine 0 N--CA 1.414 -2.779 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.578 ' HB2' ' O ' ' A' ' 102' ' ' ARG . . . -98.41 -170.56 1.97 Allowed 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 174.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.7 mp -84.99 119.04 33.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 C-N-CA 119.725 -0.79 . . . . 0.0 111.374 -176.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.0 p -121.65 162.0 21.48 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.018 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.476 ' CD ' ' H ' ' A' ' 83' ' ' GLU . 2.3 mp0 -53.89 -43.82 69.98 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 124.759 1.223 . . . . 0.0 111.655 -178.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.9 t -68.72 -27.06 65.6 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.28 0.562 . . . . 0.0 110.544 -176.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.46 ' CG ' ' HZ2' ' A' ' 47' ' ' LYS . 9.8 t70 -74.7 -44.26 50.93 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.326 178.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.448 HG23 ' HA ' ' A' ' 111' ' ' ALA . 56.9 mt -60.2 -27.75 40.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.448 177.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.0 t -61.07 -21.58 63.8 Favored 'General case' 0 CA--C 1.563 1.45 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.779 177.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -82.46 -37.35 25.52 Favored 'General case' 0 C--O 1.245 0.863 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 174.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.68 -60.31 3.48 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.555 -176.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.586 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 8.6 t -70.45 -22.2 62.72 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.677 178.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.6 -60.69 2.34 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 20.0 m -97.86 5.23 49.28 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.115 0.484 . . . . 0.0 110.787 -178.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 66.64 37.52 4.36 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.189 0.996 . . . . 0.0 111.203 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -94.86 139.39 31.37 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 114.363 -1.29 . . . . 0.0 108.591 178.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 49.4 mm -94.86 142.23 13.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.486 ' HB ' HG23 ' A' ' 118' ' ' ILE . 36.2 t -94.2 117.29 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.625 0 CA-C-O 121.276 0.56 . . . . 0.0 110.843 -175.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.49 130.92 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.016 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 176.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -136.01 175.38 20.9 Favored Glycine 0 N--CA 1.423 -2.197 0 N-CA-C 108.846 -1.701 . . . . 0.0 108.846 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . 0.288 21.8 p90 -141.66 107.28 5.08 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 119.084 -1.047 . . . . 0.0 113.294 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.2 t30 67.15 9.17 6.73 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 126.069 1.748 . . . . 0.0 111.373 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.431 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 4.9 m -84.12 -48.69 16.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.824 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.578 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 9.1 mtm180 73.07 163.75 0.14 Allowed Pre-proline 0 N--CA 1.485 1.307 0 C-N-CA 124.165 0.986 . . . . 0.0 111.251 176.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -95.25 168.61 1.47 Allowed 'Trans proline' 0 N--CA 1.437 -1.811 0 C-N-CA 121.901 1.734 . . . . 0.0 113.342 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -79.2 161.2 26.56 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 170.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.451 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -63.09 -24.3 67.84 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 122.713 0.405 . . . . 0.0 111.47 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.662 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 68.8 m-20 -85.68 -38.2 18.59 Favored 'General case' 0 C--O 1.206 -1.214 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 176.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.04 -41.51 99.52 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.86 0.362 . . . . 0.0 111.451 -178.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -59.87 -22.06 61.83 Favored 'General case' 0 CA--C 1.559 1.293 0 CA-C-O 121.111 0.481 . . . . 0.0 111.075 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.662 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 38.1 mtm105 -88.46 -51.78 5.54 Favored 'General case' 0 N--CA 1.38 -3.975 0 C-N-CA 125.523 1.529 . . . . 0.0 109.227 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -51.9 -47.01 64.77 Favored 'General case' 0 C--O 1.201 -1.474 0 C-N-CA 125.032 1.333 . . . . 0.0 111.171 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.448 ' HA ' HG23 ' A' ' 86' ' ' ILE . . . -49.42 -43.37 44.58 Favored 'General case' 0 CA--C 1.494 -1.187 0 O-C-N 124.279 0.987 . . . . 0.0 111.078 -179.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -82.89 -23.96 33.36 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-N 114.839 -1.073 . . . . 0.0 113.137 -173.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 38.6 t -89.07 5.89 42.37 Favored 'General case' 0 C--N 1.277 -2.565 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 175.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.586 ' O ' ' HB ' ' A' ' 90' ' ' THR . 23.7 mt-10 -125.27 15.62 8.36 Favored 'General case' 0 N--CA 1.408 -2.533 0 CA-C-N 113.953 -1.476 . . . . 0.0 112.437 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 56.2 mtpt 66.14 3.31 2.64 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 172.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.8 m -114.21 169.03 5.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 121.945 -0.472 . . . . 0.0 111.69 -176.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -130.77 137.71 49.6 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.486 HG23 ' HB ' ' A' ' 96' ' ' VAL . 10.4 pt -107.86 127.35 64.01 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.163 -178.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -129.18 136.96 50.85 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.492 -0.883 . . . . 0.0 113.24 -175.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.411 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -153.8 156.37 37.57 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.341 -179.072 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 68.4 -93.51 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 O-C-N 124.473 1.108 . . . . 0.0 111.867 170.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 46.12 -107.82 0.16 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.976 0.91 . . . . 0.0 112.614 -173.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 47.5 mm 57.98 -79.9 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.857 1.263 . . . . 0.0 111.189 -177.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 10.0 pt -105.22 16.89 5.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-O 121.922 0.867 . . . . 0.0 108.799 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 68.17 -81.14 0.03 OUTLIER 'General case' 0 C--O 1.238 0.483 0 C-N-CA 126.289 1.836 . . . . 0.0 111.253 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -165.98 101.35 0.65 Allowed 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 19.0 m -81.79 142.36 13.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 39.3 mm -70.55 -49.23 54.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.271 -173.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 66.76 -66.36 0.19 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 125.228 1.411 . . . . 0.0 111.627 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -75.57 126.29 30.72 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 124.435 1.094 . . . . 0.0 109.92 -176.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 72.2 mt -82.54 102.57 8.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 175.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -78.73 137.45 37.78 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.633 -176.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 57.15 79.47 0.19 Allowed 'General case' 0 C--O 1.243 0.742 0 C-N-CA 125.393 1.477 . . . . 0.0 113.994 176.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.25 -59.03 1.87 Allowed 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 26.2 mmt . . . . . 0 CA--C 1.495 -1.172 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 176.063 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 . . . . . 0 CA--C 1.497 -1.092 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -81.41 85.1 6.51 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 177.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -97.44 161.28 13.86 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.299 -177.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 64.09 82.42 0.18 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.462 1.105 . . . . 0.0 111.299 -177.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 89.5 mt -93.14 -24.08 18.37 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.721 -176.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.69 55.55 3.79 Favored Glycine 0 C--N 1.314 -0.686 0 C-N-CA 120.792 -0.718 . . . . 0.0 113.757 -176.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.7 p -79.42 -32.28 42.82 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.302 0.572 . . . . 0.0 110.945 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -119.38 -52.65 2.26 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 174.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.38 110.07 0.34 Allowed Glycine 0 N--CA 1.426 -2.01 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 21.7 t -79.48 -40.05 30.69 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.2 m -71.98 -7.1 46.73 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-O 121.105 0.479 . . . . 0.0 111.64 -178.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.1 tpm_? -73.55 -22.44 60.08 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.251 0.548 . . . . 0.0 109.553 175.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.9 t -124.08 -61.73 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.434 -176.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -105.52 86.54 2.43 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.671 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.1 pp -96.21 -22.94 16.95 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.518 0.675 . . . . 0.0 110.006 177.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.444 ' OE1' ' HA ' ' A' ' 16' ' ' GLN . 8.0 mm-40 -133.97 153.98 51.41 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.359 176.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -121.0 -178.69 3.81 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.515 -175.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 67.87 15.23 9.56 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.016 0.926 . . . . 0.0 112.274 172.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -71.16 -40.07 71.51 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 174.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.9 m -112.48 97.33 6.53 Favored 'General case' 0 N--CA 1.414 -2.234 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 174.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.5 p -112.43 97.86 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.026 0 CA-C-O 122.251 1.024 . . . . 0.0 112.522 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -146.35 -63.62 0.31 Allowed 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 173.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 20.2 p -118.91 78.28 1.26 Allowed 'General case' 0 N--CA 1.416 -2.142 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.515 176.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -117.73 154.37 31.81 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.253 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.2 m -96.59 168.38 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 O-C-N 123.421 0.45 . . . . 0.0 109.869 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.5 t 70.61 7.88 6.38 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.123 1.369 . . . . 0.0 111.138 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 60.4 tp -101.95 104.79 15.5 Favored 'General case' 0 N--CA 1.427 -1.625 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 176.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -111.04 179.63 3.99 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -178.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -144.42 -3.22 0.83 Allowed 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 118.027 0.376 . . . . 0.0 111.379 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 64.9 tp -79.18 96.3 5.84 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-O 120.635 0.255 . . . . 0.0 110.849 -178.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 25.7 t80 51.34 52.97 13.71 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.109 1.364 . . . . 0.0 110.356 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.35 121.1 24.71 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -85.46 94.73 9.07 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -171.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.8 pt -91.61 -17.88 7.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 114.517 -1.219 . . . . 0.0 110.105 176.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -125.06 91.37 3.42 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 121.481 0.657 . . . . 0.0 109.46 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -168.85 142.27 2.92 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 -177.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.18 36.78 6.95 Favored Glycine 0 N--CA 1.438 -1.172 0 C-N-CA 120.242 -0.98 . . . . 0.0 110.955 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -106.08 27.55 8.5 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 123.329 1.537 . . . . 0.0 108.651 -176.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.435 ' HE1' ' HA ' ' A' ' 39' ' ' MET . 1.4 mmt -165.26 -173.58 2.9 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 103.013 -2.958 . . . . 0.0 103.013 174.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -80.94 79.87 7.53 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.875 174.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 70' ' ' ARG . 31.0 mt-10 -104.74 104.29 14.06 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.454 -176.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.19 120.97 36.33 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -99.33 128.42 45.44 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -174.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 70.9 mt -131.25 165.61 23.01 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.545 HD11 ' CD2' ' A' ' 75' ' ' HIS . 0.2 OUTLIER -131.65 136.83 56.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-N 112.817 -1.992 . . . . 0.0 107.26 175.753 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 92.1 t -117.31 128.18 74.67 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 176.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.556 ' HE3' ' CG ' ' A' ' 85' ' ' ASP . 12.8 ptmm? -159.43 128.06 5.14 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.44 176.28 9.49 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.894 -171.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -74.68 -32.0 62.08 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 123.948 0.78 . . . . 0.0 109.412 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 86.3 t -94.71 122.04 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.137 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.736 ' O ' HG21 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -61.48 -47.84 83.82 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 124.347 1.059 . . . . 0.0 112.595 -174.776 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.87 5.01 84.06 Favored Glycine 0 C--N 1.278 -2.684 0 C-N-CA 118.049 -2.024 . . . . 0.0 113.003 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.0 t -83.36 -29.09 28.5 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.736 HG21 ' O ' ' A' ' 51' ' ' GLN . 6.0 m -70.87 -45.87 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.397 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.653 176.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -60.24 -40.44 90.24 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.178 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.66 -39.97 95.57 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 123.574 0.546 . . . . 0.0 110.825 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 38.3 tp -75.46 -39.34 58.83 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.177 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 54' ' ' VAL . 54.6 t -57.11 -37.99 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.128 0.571 . . . . 0.0 111.44 178.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.4 -19.14 63.81 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.456 ' O ' HG12 ' A' ' 64' ' ' ILE . . . -98.03 -30.23 12.81 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.17 -36.15 64.05 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.615 -175.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -68.89 -21.23 64.25 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.134 178.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -99.85 6.73 45.3 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 60' ' ' ALA . 34.9 mm -73.17 0.22 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.751 0 CA-C-O 122.371 1.081 . . . . 0.0 110.618 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -65.2 119.0 10.07 Favored 'General case' 0 C--O 1.247 0.924 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.033 175.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.0 m -128.41 -166.58 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 177.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -80.28 114.23 19.03 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 118.067 0.394 . . . . 0.0 110.026 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 94.23 -43.61 2.37 Favored Glycine 0 C--O 1.243 0.7 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.685 177.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.9 t -106.4 132.62 53.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 41' ' ' GLU . 21.2 ptt180 -142.44 111.34 6.34 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-O 122.118 0.961 . . . . 0.0 110.786 176.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.7 t -103.62 131.67 51.68 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -149.43 158.17 43.94 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.141 0.496 . . . . 0.0 110.241 -178.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.42 HG12 HG11 ' A' ' 58' ' ' VAL . 1.5 pp -94.54 144.17 10.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.073 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.5 mp -112.69 -22.73 4.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-O 122.058 0.933 . . . . 0.0 109.438 177.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.545 ' CD2' HD11 ' A' ' 45' ' ' ILE . 2.0 t60 -148.13 139.05 23.17 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -172.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.602 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -140.33 136.69 33.46 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 177.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -163.2 156.93 19.83 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 118.608 0.64 . . . . 0.0 111.426 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.3 p -101.04 94.42 3.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-O 121.774 0.797 . . . . 0.0 109.273 175.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -177.02 173.31 46.2 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 119.365 -1.398 . . . . 0.0 113.304 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 102' ' ' ARG . . . -81.58 170.02 16.36 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 124.159 0.984 . . . . 0.0 108.856 176.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.8 mp -72.82 118.21 17.62 Favored 'Isoleucine or valine' 0 C--O 1.245 0.816 0 CA-C-N 118.505 0.593 . . . . 0.0 110.363 -177.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 70.7 p -118.7 158.58 25.26 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -50.19 -34.22 21.91 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.23 0.612 . . . . 0.0 112.089 176.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.9 m -62.2 -40.28 95.55 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.127 0.489 . . . . 0.0 110.43 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.556 ' CG ' ' HE3' ' A' ' 47' ' ' LYS . 46.5 m-20 -71.88 -38.96 69.91 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.321 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.447 ' CG2' ' HA ' ' A' ' 111' ' ' ALA . 58.8 mt -67.2 -29.75 46.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.977 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 27.8 m -58.08 -35.17 71.0 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.194 174.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -72.44 -34.37 67.73 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.149 177.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.09 -61.96 1.97 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.028 -176.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.577 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 9.2 t -69.5 -21.31 63.69 Favored 'General case' 0 CA--C 1.568 1.655 0 O-C-N 121.583 -0.698 . . . . 0.0 111.054 177.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.89 -52.62 34.38 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 54.1 m -98.78 -2.87 36.93 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.721 178.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.1 m120 68.65 37.32 2.53 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 122.36 1.076 . . . . 0.0 109.376 -176.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.99 155.93 16.53 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 113.99 -1.459 . . . . 0.0 108.401 178.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.4 HG23 ' O ' ' A' ' 117' ' ' ASP . 46.2 mm -111.67 135.06 52.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.483 ' HB ' HG23 ' A' ' 118' ' ' ILE . 19.4 t -93.59 123.62 45.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.218 0.532 . . . . 0.0 109.834 -174.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 35.6 pt -104.55 157.63 5.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.65 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -171.66 172.93 44.88 Favored Glycine 0 N--CA 1.419 -2.449 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 175.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -161.54 133.38 5.63 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 73.28 -41.08 0.49 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.26 1.424 . . . . 0.0 111.872 177.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.6 m -65.59 -51.17 66.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 C-N-CA 124.339 1.055 . . . . 0.0 111.631 176.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.468 ' O ' ' HB3' ' A' ' 80' ' ' ALA . 35.4 mtm180 66.72 178.97 0.05 OUTLIER Pre-proline 0 CA--C 1.566 1.576 0 C-N-CA 123.364 0.666 . . . . 0.0 112.051 174.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.402 ' CD ' ' HB3' ' A' ' 102' ' ' ARG . 21.6 Cg_endo -99.48 176.21 0.35 Allowed 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 122.327 2.018 . . . . 0.0 113.865 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -82.16 156.94 24.21 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 168.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.574 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -61.82 -31.18 71.39 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 120.849 0.357 . . . . 0.0 110.489 178.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.589 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 5.4 m-20 -77.8 -36.31 50.44 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.269 175.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.09 -44.06 97.48 Favored 'General case' 0 C--O 1.211 -0.948 0 O-C-N 121.981 -0.45 . . . . 0.0 111.27 176.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.511 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 14.4 ptmm? -59.83 -29.21 68.1 Favored 'General case' 0 CA--C 1.563 1.445 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.589 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 95.4 mtt180 -73.03 -51.37 18.44 Favored 'General case' 0 N--CA 1.395 -3.179 0 C-N-CA 124.643 1.177 . . . . 0.0 108.997 176.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -52.86 -49.03 66.63 Favored 'General case' 0 C--O 1.194 -1.852 0 CA-C-N 113.7 -1.591 . . . . 0.0 110.226 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.447 ' HA ' ' CG2' ' A' ' 86' ' ' ILE . . . -47.99 -50.76 26.4 Favored 'General case' 0 CA--C 1.483 -1.613 0 O-C-N 124.717 1.26 . . . . 0.0 111.2 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -81.24 -24.77 37.12 Favored 'General case' 0 C--N 1.27 -2.873 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.915 -172.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 38.3 t -87.66 5.45 39.58 Favored 'General case' 0 C--N 1.275 -2.646 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 175.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.577 ' O ' ' HB ' ' A' ' 90' ' ' THR . 24.7 mt-10 -123.35 19.43 9.75 Favored 'General case' 0 CA--C 1.466 -2.255 0 CA-C-N 114.411 -1.268 . . . . 0.0 111.572 177.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.532 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 65.6 mttm 67.0 4.63 3.65 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 173.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.4 m -113.98 163.94 10.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 121.683 -0.635 . . . . 0.0 112.106 -175.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.4 ' O ' HG23 ' A' ' 95' ' ' ILE . 4.0 m-20 -125.89 142.96 51.27 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 177.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.483 HG23 ' HB ' ' A' ' 96' ' ' VAL . 4.8 pt -105.05 138.74 28.56 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.914 178.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -104.64 112.83 26.06 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.519 -175.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.433 ' CD1' ' HA ' ' A' ' 102' ' ' ARG . 3.1 mm? -110.59 134.68 52.19 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.475 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 66.31 75.23 0.33 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.685 174.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 29.0 mmm180 -103.04 10.03 38.27 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.733 -178.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 39.1 pt -110.33 147.92 14.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.522 HD13 ' H ' ' A' ' 124' ' ' ILE . 0.2 OUTLIER -83.67 97.5 4.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-O 122.2 1.0 . . . . 0.0 109.932 175.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -88.06 74.24 8.91 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.791 0.805 . . . . 0.0 110.435 -175.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -141.8 29.93 1.69 Allowed 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.127 177.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 97.9 t 74.17 103.72 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.766 -175.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 27.8 pt -88.11 -1.14 8.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.562 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -80.82 -9.21 59.84 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.061 175.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -82.96 124.91 30.83 Favored 'General case' 0 N--CA 1.416 -2.152 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.655 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.427 ' HB ' ' O ' ' A' ' 134' ' ' ALA . 37.2 pt -81.53 -24.85 10.02 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 69.3 -77.44 0.05 Allowed 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 125.677 1.591 . . . . 0.0 111.548 176.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -144.92 13.7 1.48 Allowed 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.507 0.67 . . . . 0.0 109.92 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.427 ' O ' ' HB ' ' A' ' 131' ' ' ILE . . . -113.4 123.24 49.61 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.211 -176.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 49.0 tpp . . . . . 0 C--N 1.297 -1.678 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 176.451 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 61.4 m-20 . . . . . 0 CA--C 1.507 -0.674 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 62.58 87.55 0.1 Allowed 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.344 1.058 . . . . 0.0 112.48 177.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -98.17 168.56 10.17 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.889 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -60.01 146.46 42.63 Favored 'General case' 0 C--O 1.246 0.911 0 C-N-CA 123.388 0.675 . . . . 0.0 110.168 177.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.3 mt -86.86 -35.21 19.15 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.674 -176.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 178.41 104.25 0.18 Allowed Glycine 0 N--CA 1.428 -1.853 0 C-N-CA 118.663 -1.732 . . . . 0.0 114.773 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.7 m -95.75 97.11 9.44 Favored 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 171.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -70.7 -14.54 62.49 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -172.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 146.73 -72.73 0.31 Allowed Glycine 0 CA--C 1.503 -0.71 0 C-N-CA 118.186 -1.959 . . . . 0.0 114.679 173.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.8 m -62.43 141.15 58.5 Favored 'General case' 0 C--O 1.249 1.059 0 CA-C-O 120.509 0.195 . . . . 0.0 111.29 -176.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.2 m 77.7 -60.11 0.44 Allowed 'General case' 0 C--O 1.249 1.046 0 C-N-CA 125.51 1.524 . . . . 0.0 109.53 -177.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 59.28 -69.22 0.03 OUTLIER 'General case' 0 C--N 1.344 0.348 0 C-N-CA 127.256 2.222 . . . . 0.0 113.192 176.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.6 m -121.26 -13.99 7.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.54 -176.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -124.34 107.65 11.37 Favored 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -91.28 103.23 15.91 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -117.8 81.4 1.66 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 122.268 1.032 . . . . 0.0 109.351 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -98.7 30.44 3.3 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.272 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -80.06 76.07 6.8 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 176.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -87.39 -35.97 18.03 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.118 0.485 . . . . 0.0 110.293 -175.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.9 p -88.8 2.24 53.87 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.419 176.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . 0.306 27.6 m 45.86 51.67 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.725 0 C-N-CA 125.948 1.699 . . . . 0.0 113.235 -177.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.8 tppt? -116.1 158.09 23.73 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.3 p 55.56 18.2 2.63 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 125.326 1.45 . . . . 0.0 113.542 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.415 ' HD2' ' C ' ' A' ' 24' ' ' ARG . 3.1 ppt_? -110.2 6.55 22.74 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.936 -174.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.6 m -79.22 165.09 3.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.015 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.3 t -142.82 -65.56 0.39 Allowed 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.194 -177.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.6 mt -123.47 109.81 14.31 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 120.999 0.428 . . . . 0.0 110.619 -177.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -75.18 -19.91 59.59 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.301 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.8 t70 65.46 -162.64 0.26 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.975 1.71 . . . . 0.0 110.524 176.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 87.2 mt 60.15 37.26 20.9 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.621 1.169 . . . . 0.0 110.469 -178.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -81.6 -41.61 21.27 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.207 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -99.79 153.95 18.72 Favored 'General case' 0 C--O 1.247 0.943 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.009 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -99.74 119.94 38.93 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.0 pt -85.72 158.51 3.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.551 -178.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.2 ptpp? -71.98 116.17 12.07 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.446 175.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -124.64 -48.8 1.78 Allowed 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -177.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.79 47.47 3.72 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.275 -178.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -107.31 -166.4 1.15 Allowed 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 69.24 27.23 5.21 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.938 1.295 . . . . 0.0 108.32 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -77.93 149.28 34.21 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.412 ' HG2' ' HB2' ' A' ' 70' ' ' ARG . 29.8 mt-10 -93.81 149.17 21.46 Favored 'General case' 0 C--N 1.283 -2.293 0 CA-C-O 121.488 0.661 . . . . 0.0 112.072 -169.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -103.29 104.5 14.63 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 114.484 -1.234 . . . . 0.0 108.095 176.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.41 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 92.0 m-20 -99.69 136.15 40.05 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.3 mt -134.42 164.91 26.39 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 122.304 1.05 . . . . 0.0 113.51 -176.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.619 HD12 ' CD2' ' A' ' 75' ' ' HIS . 0.2 OUTLIER -123.01 139.79 48.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.356 175.63 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 66.4 t -112.23 130.02 66.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.342 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -136.93 144.4 43.41 Favored 'General case' 0 CA--C 1.492 -1.277 0 C-N-CA 123.926 0.89 . . . . 0.0 109.951 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.18 165.1 29.95 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 177.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -84.97 -17.08 38.76 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 120.924 0.392 . . . . 0.0 110.699 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 87.3 t -101.69 127.09 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 173.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.724 ' O ' HG21 ' A' ' 54' ' ' VAL . 49.7 tt0 -61.41 -51.69 67.72 Favored 'General case' 0 C--O 1.196 -1.725 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -173.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.51 0.94 53.78 Favored Glycine 0 C--N 1.28 -2.539 0 C-N-CA 118.205 -1.95 . . . . 0.0 113.724 -175.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.4 t -82.88 -24.98 32.95 Favored 'General case' 0 N--CA 1.417 -2.081 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 177.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.724 HG21 ' O ' ' A' ' 51' ' ' GLN . 5.2 m -77.37 -46.45 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.256 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.355 176.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -66.12 -38.61 88.62 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.442 -176.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.85 -38.23 87.44 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.926 0.393 . . . . 0.0 110.548 177.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.469 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 34.9 tp -73.85 -42.25 61.08 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.428 HG21 ' O ' ' A' ' 54' ' ' VAL . 53.5 t -57.0 -41.12 76.77 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 C-N-CA 123.16 0.584 . . . . 0.0 111.335 177.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.05 -24.21 67.62 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.38 -20.35 17.2 Favored 'General case' 0 C--O 1.207 -1.173 0 CA-C-O 121.511 0.672 . . . . 0.0 109.39 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -90.75 -28.1 18.5 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.073 -175.4 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -77.94 -24.06 48.36 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 122.157 -0.34 . . . . 0.0 110.409 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -87.28 2.17 50.98 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.123 -178.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 29.3 mm -81.52 107.04 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 173.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -143.59 119.51 10.62 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.272 -178.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 46.3 t 53.49 92.72 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 C-N-CA 125.195 1.398 . . . . 0.0 114.218 175.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -124.25 21.08 8.84 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 122.63 1.205 . . . . 0.0 107.904 173.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.72 -25.91 26.16 Favored Glycine 0 C--O 1.224 -0.483 0 N-CA-C 107.721 -2.152 . . . . 0.0 107.721 -171.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 41.3 t -121.05 153.92 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.617 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 175.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.412 ' HB2' ' HG2' ' A' ' 41' ' ' GLU . 58.0 mtt-85 -120.93 117.7 28.0 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 178.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 32.8 t -130.3 136.28 58.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.8 ttmp? -167.59 162.71 14.37 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 pp -93.69 150.5 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.606 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.42 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 37.2 mm -115.28 -28.93 2.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 CA-C-O 121.365 0.602 . . . . 0.0 109.666 178.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.619 ' CD2' HD12 ' A' ' 45' ' ' ILE . 3.8 t60 -149.39 140.4 22.92 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -171.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.67 135.15 38.0 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -158.54 141.55 14.72 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.652 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.444 ' HB ' ' HA ' ' A' ' 51' ' ' GLN . 4.5 p -93.86 93.98 4.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-O 122.793 1.282 . . . . 0.0 108.822 175.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.89 175.08 47.51 Favored Glycine 0 N--CA 1.409 -3.103 0 CA-C-N 113.855 -1.521 . . . . 0.0 109.554 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 102' ' ' ARG . . . -83.07 -176.93 6.58 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 177.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.433 HG22 HG22 ' A' ' 118' ' ' ILE . 3.3 mp -78.56 110.91 14.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.5 HG23 ' OD2' ' A' ' 85' ' ' ASP . 14.0 t -113.56 165.56 12.38 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 119.576 -0.849 . . . . 0.0 109.374 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -56.92 -35.06 68.59 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.614 0.765 . . . . 0.0 111.182 -176.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.4 m -67.13 -28.54 68.23 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.523 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.5 ' OD2' HG23 ' A' ' 82' ' ' THR . 17.4 m-20 -77.37 -28.53 52.95 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-O 121.175 0.512 . . . . 0.0 110.408 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.484 ' CG2' ' HA ' ' A' ' 111' ' ' ALA . 46.0 mm -65.54 -33.15 61.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.111 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.9 m -57.01 -39.54 74.93 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.364 177.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -73.94 -39.03 64.06 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.981 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.23 -55.29 22.13 Favored 'General case' 0 C--N 1.316 -0.887 0 O-C-N 123.926 0.766 . . . . 0.0 111.877 -177.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.494 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 10.9 t -77.48 -19.01 56.58 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.419 178.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.79 -66.24 0.58 Allowed 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.057 0.456 . . . . 0.0 111.685 -177.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.6 m -95.41 2.06 54.41 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.409 -177.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.5 m120 62.43 62.92 1.08 Allowed 'General case' 0 CA--C 1.497 -1.079 0 CA-C-O 122.366 1.079 . . . . 0.0 112.332 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -120.24 134.56 55.23 Favored 'General case' 0 N--CA 1.417 -2.092 0 CA-C-N 113.244 -1.798 . . . . 0.0 107.179 176.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 32.2 pt -94.13 141.92 14.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.505 ' HB ' HG21 ' A' ' 118' ' ' ILE . 12.1 t -94.16 116.6 35.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-O 121.192 0.52 . . . . 0.0 110.149 -173.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.513 ' HA ' ' O ' ' A' ' 119' ' ' ARG . 58.0 mt -112.78 125.71 70.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 120' ' ' LEU . . . -132.24 170.25 21.9 Favored Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.441 ' C ' ' H ' ' A' ' 101' ' ' VAL . 66.9 t80 -145.42 117.68 8.42 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -178.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 72.72 -29.34 0.2 Allowed 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 124.78 1.232 . . . . 0.0 113.099 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.447 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 4.6 m -66.34 -48.11 81.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.563 176.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.545 ' O ' ' HB3' ' A' ' 80' ' ' ALA . 59.8 mtm180 66.94 179.37 0.05 OUTLIER Pre-proline 0 CA--C 1.551 1.015 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.878 174.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -98.84 168.72 0.58 Allowed 'Trans proline' 0 N--CA 1.44 -1.663 0 CA-C-N 120.838 1.335 . . . . 0.0 114.568 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -79.48 152.19 30.38 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 113.005 -1.907 . . . . 0.0 106.448 167.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.44 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -61.62 -21.07 64.05 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -176.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.552 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 54.9 t30 -94.47 -28.28 15.55 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.945 -0.702 . . . . 0.0 109.747 177.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.72 -40.8 95.95 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-O 120.965 0.412 . . . . 0.0 110.557 177.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 21.9 ptmt -61.72 -28.5 69.46 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.07 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.552 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 70.7 mtp180 -81.01 -53.09 6.72 Favored 'General case' 0 N--CA 1.385 -3.689 0 C-N-CA 125.918 1.687 . . . . 0.0 109.097 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -52.79 -45.26 67.11 Favored 'General case' 0 C--O 1.196 -1.73 0 CA-C-N 113.85 -1.523 . . . . 0.0 110.457 -178.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.484 ' HA ' ' CG2' ' A' ' 86' ' ' ILE . . . -48.58 -49.28 37.38 Favored 'General case' 0 CA--C 1.49 -1.355 0 O-C-N 124.524 1.14 . . . . 0.0 111.381 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -77.25 -35.2 55.53 Favored 'General case' 0 C--N 1.281 -2.399 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.539 -174.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 35.5 t -79.56 5.47 12.94 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-O 122.374 1.083 . . . . 0.0 108.979 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.494 ' O ' ' HB ' ' A' ' 90' ' ' THR . 19.3 mt-10 -123.75 14.54 9.36 Favored 'General case' 0 CA--C 1.46 -2.504 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.845 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 64.4 mmtt 65.85 17.94 10.98 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 173.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.0 m -120.73 171.41 9.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.362 177.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -137.15 142.35 42.22 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.505 HG21 ' HB ' ' A' ' 96' ' ' VAL . 10.3 pt -107.97 134.52 49.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 121.32 0.581 . . . . 0.0 111.044 -178.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 21.5 mmm180 -113.3 125.04 53.85 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -178.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.548 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 0.0 OUTLIER -147.7 136.65 22.1 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -178.331 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 42.3 t-80 67.25 3.99 3.49 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.506 1.123 . . . . 0.0 112.073 173.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 38.3 mtm-85 63.15 -66.4 0.1 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.862 1.665 . . . . 0.0 110.913 -175.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 65.4 mt -88.92 123.89 41.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 9.3 tp -88.69 153.59 3.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 176.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.44 ' HH ' HG13 ' A' ' 128' ' ' ILE . 41.9 t80 -79.06 72.63 5.6 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 122.221 1.01 . . . . 0.0 110.892 -178.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -96.27 -52.57 3.94 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.249 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 59.6 t -75.92 107.22 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.737 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.44 HG13 ' HH ' ' A' ' 125' ' ' TYR . 14.4 tt -111.79 7.11 8.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.318 -0.994 . . . . 0.0 108.318 -178.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -61.82 110.9 1.67 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.148 -176.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -163.47 -55.83 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.273 0.559 . . . . 0.0 109.886 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.15 87.25 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.286 0 CA-C-O 122.983 1.373 . . . . 0.0 108.569 -176.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -96.81 14.41 25.29 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.236 -1.347 . . . . 0.0 110.101 -175.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -111.35 -167.05 1.13 Allowed 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.601 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 62.48 -161.96 0.29 Allowed 'General case' 0 C--O 1.247 0.93 0 C-N-CA 123.871 0.868 . . . . 0.0 111.266 176.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 23.0 ptt? . . . . . 0 C--N 1.298 -1.659 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.948 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 63.9 t30 . . . . . 0 C--O 1.235 0.317 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -63.91 99.99 0.28 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 58.79 -161.92 0.24 Allowed 'General case' 0 C--O 1.245 0.861 0 O-C-N 124.419 1.074 . . . . 0.0 111.516 173.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -89.92 171.8 9.33 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 91.2 mt -75.27 -59.56 2.69 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.534 -176.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -167.38 55.3 0.23 Allowed Glycine 0 N--CA 1.434 -1.452 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.516 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.9 p -72.41 97.88 2.14 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 122.618 0.367 . . . . 0.0 110.745 -178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -145.81 -163.77 1.81 Allowed 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 121.051 -0.259 . . . . 0.0 110.31 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.54 -119.94 5.44 Favored Glycine 0 N--CA 1.427 -1.935 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -178.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.2 m -58.91 -26.04 63.96 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 124.398 1.079 . . . . 0.0 111.759 -176.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.1 m -63.94 -19.74 65.34 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.714 0.806 . . . . 0.0 112.389 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -125.48 -20.0 4.87 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 119.484 -0.887 . . . . 0.0 112.794 -178.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.7 m -106.46 152.21 8.16 Favored 'Isoleucine or valine' 0 C--O 1.247 0.964 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.772 -178.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.0 t70 69.93 89.2 0.1 Allowed 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 124.522 1.139 . . . . 0.0 110.056 -178.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.1 mt -90.46 156.13 18.42 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.502 -176.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -93.84 -23.63 18.06 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.755 -175.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -62.57 174.96 0.87 Allowed 'General case' 0 C--O 1.212 -0.89 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -176.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -69.82 -1.33 9.06 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.432 0.693 . . . . 0.0 112.345 -176.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -66.65 -31.51 72.23 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 171.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.3 m -151.97 93.1 1.8 Allowed 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 174.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.6 m -58.71 89.34 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -173.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -89.06 -63.57 1.27 Allowed 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.477 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.3 t -131.22 73.2 1.53 Allowed 'General case' 0 N--CA 1.411 -2.413 0 CA-C-O 122.716 1.246 . . . . 0.0 108.171 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.437 ' HA ' ' HE ' ' A' ' 24' ' ' ARG . 3.7 mmp_? -127.39 162.53 26.1 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.195 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.3 t -106.55 122.87 61.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.0 t -109.17 115.43 30.0 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.8 mt -103.85 82.45 1.99 Allowed 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.307 -177.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -97.06 -31.74 12.34 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 174.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -95.57 148.69 22.25 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.372 -1.286 . . . . 0.0 108.589 177.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.7 mp -106.66 141.25 38.23 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.599 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -81.4 115.8 20.92 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 175.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -66.1 103.77 1.03 Allowed 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.761 0.791 . . . . 0.0 109.509 177.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.474 ' OE1' ' HA ' ' A' ' 35' ' ' LYS . 34.3 tt0 -60.62 -34.21 73.92 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 125.812 1.645 . . . . 0.0 112.945 -174.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 59.5 mt 71.57 79.61 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.504 -0.814 0 N-CA-C 103.998 -2.593 . . . . 0.0 103.998 -163.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.474 ' HA ' ' OE1' ' A' ' 33' ' ' GLN 0.293 19.8 pttm -47.31 85.28 0.0 OUTLIER 'General case' 0 C--O 1.239 0.532 0 N-CA-C 116.543 2.053 . . . . 0.0 116.543 -171.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 48.1 tp60 172.7 73.64 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 129.099 2.96 . . . . 0.0 104.55 175.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -110.64 81.9 0.29 Allowed Glycine 0 N--CA 1.419 -2.467 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.384 -177.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 74.54 -69.89 0.17 Allowed 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.262 1.025 . . . . 0.0 111.984 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 50.8 ttm 73.65 -43.3 0.54 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.455 1.502 . . . . 0.0 110.639 -178.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -84.54 86.73 7.26 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 171.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -144.23 171.65 14.01 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 114.517 -1.22 . . . . 0.0 108.599 -174.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 2.8 mm? -98.57 137.47 37.18 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-O 121.088 0.471 . . . . 0.0 109.853 -176.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.538 ' HA ' ' O ' ' A' ' 72' ' ' LYS . 36.5 m-80 -130.69 140.02 50.34 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.206 177.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.8 mt -134.27 163.6 29.26 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.66 0.743 . . . . 0.0 112.012 -177.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.95 135.12 61.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.576 174.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 94.3 t -112.49 123.73 68.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 121.314 0.578 . . . . 0.0 111.401 -176.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -133.51 147.79 51.64 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 124.504 1.122 . . . . 0.0 109.668 176.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.39 161.87 33.19 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -81.65 -9.25 59.71 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 122.283 1.039 . . . . 0.0 109.52 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 96.1 t -114.96 123.73 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 176.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.652 ' O ' HG23 ' A' ' 54' ' ' VAL . 48.2 tt0 -58.24 -49.77 75.93 Favored 'General case' 0 C--O 1.205 -1.259 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -176.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.59 4.0 52.62 Favored Glycine 0 C--N 1.289 -2.059 0 C-N-CA 118.58 -1.772 . . . . 0.0 113.887 -176.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.9 t -86.17 -19.46 30.05 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 176.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 51' ' ' GLN . 4.9 m -81.19 -46.35 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.266 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 174.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -57.43 -50.35 73.3 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.384 -1.28 . . . . 0.0 111.968 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.05 -40.76 81.76 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 123.371 0.42 . . . . 0.0 111.594 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.407 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 36.8 tp -74.34 -43.06 58.24 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.071 -178.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.432 HG13 HG12 ' A' ' 73' ' ' ILE . 54.6 t -59.08 -40.14 80.11 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.595 0 C-N-CA 122.885 0.474 . . . . 0.0 111.071 177.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.62 -12.08 60.89 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.6 -31.72 10.25 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 176.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.407 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -75.71 -28.48 58.6 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 114.235 -1.348 . . . . 0.0 110.923 -175.41 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -83.14 -14.19 54.04 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.682 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.24 5.43 50.07 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.863 -0.735 . . . . 0.0 111.947 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.4 ' HB ' ' O ' ' A' ' 71' ' ' VAL . 31.8 mm -71.57 90.75 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.649 0 CA-C-O 121.407 0.623 . . . . 0.0 111.457 -175.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -121.69 107.37 12.28 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.921 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.7 m -140.65 169.77 15.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 174.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -82.12 125.89 31.39 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 120.948 0.404 . . . . 0.0 111.343 -175.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.2 -38.72 2.74 Favored Glycine 0 C--O 1.246 0.883 0 CA-C-N 116.171 -0.468 . . . . 0.0 113.878 177.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.0 t -107.01 133.6 51.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 53.6 mmm-85 -135.82 137.17 41.28 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 174.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 24.5 t -134.81 119.39 27.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 177.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 24.9 ttpp -139.83 160.37 40.05 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.238 0.542 . . . . 0.0 110.174 -176.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.432 HG12 HG13 ' A' ' 58' ' ' VAL . 1.6 pp -94.89 162.34 2.45 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.003 175.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.45 HD11 ' HB3' ' A' ' 43' ' ' ASN . 1.7 mp -120.52 -33.39 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 174.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -152.38 122.14 6.96 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.341 -166.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -110.81 139.48 46.08 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 176.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -156.42 132.1 9.57 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 120.178 -0.609 . . . . 0.0 111.529 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.414 ' HB ' ' HA ' ' A' ' 51' ' ' GLN . 4.4 p -93.93 93.86 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.887 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 172.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -177.53 175.86 47.77 Favored Glycine 0 N--CA 1.399 -3.814 0 N-CA-C 108.319 -1.912 . . . . 0.0 108.319 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 102' ' ' ARG . . . -86.41 -170.63 3.17 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.163 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.401 ' CD1' HD11 ' A' ' 120' ' ' LEU . 21.2 mt -94.1 105.7 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.007 0 CA-C-O 121.213 0.53 . . . . 0.0 109.6 -173.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.4 t -106.89 162.68 13.6 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -60.79 -35.22 75.9 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 123.109 0.564 . . . . 0.0 111.109 -176.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.7 m -69.83 -10.95 60.35 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.664 -177.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -95.69 -31.66 13.13 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 121.6 0.714 . . . . 0.0 109.796 175.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.486 HD13 ' HB3' ' A' ' 111' ' ' ALA . 59.7 mt -69.8 -25.76 28.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.939 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.0 p -56.75 -37.19 70.7 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.7 175.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -70.86 -36.97 73.05 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 123.278 0.631 . . . . 0.0 110.191 175.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.01 -58.46 6.47 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.222 -175.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.551 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 7.0 t -71.46 -30.12 65.64 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 119.594 -0.842 . . . . 0.0 110.919 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.19 -53.08 62.35 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.061 0.545 . . . . 0.0 112.313 -177.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 31.7 t -101.44 6.91 42.68 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.432 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 9.9 p30 60.11 29.6 19.15 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.791 1.236 . . . . 0.0 111.648 177.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.47 131.64 39.96 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 113.545 -1.661 . . . . 0.0 108.632 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.4 pp -93.87 143.65 11.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.623 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.421 ' HB ' HG21 ' A' ' 118' ' ' ILE . 21.2 t -94.49 113.86 29.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.622 -174.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 119' ' ' ARG . 43.2 mm -112.91 123.41 68.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 175.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -115.08 168.79 12.65 Favored Glycine 0 N--CA 1.423 -2.212 0 C-N-CA 120.231 -0.985 . . . . 0.0 110.666 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -114.84 93.34 4.28 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.111 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 62.7 t30 60.78 10.02 2.49 Favored 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 125.796 1.639 . . . . 0.0 112.583 178.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.506 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 3.8 m -69.87 -47.97 66.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.792 -175.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.512 ' O ' ' HB3' ' A' ' 80' ' ' ALA . 55.9 mtm180 74.8 143.57 0.1 OUTLIER Pre-proline 0 CA--C 1.548 0.873 0 O-C-N 124.251 0.969 . . . . 0.0 111.522 175.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -86.5 169.66 8.14 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 121.753 1.635 . . . . 0.0 114.11 -175.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -77.89 152.16 33.46 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 169.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.479 ' O ' ' HG3' ' A' ' 108' ' ' LYS . . . -60.41 -28.56 68.35 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.479 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 91.3 m-20 -85.3 -29.27 24.69 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.237 177.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.49 -45.71 86.15 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 177.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 105' ' ' ALA . 0.0 OUTLIER -59.95 -29.63 68.54 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.265 179.761 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 62.3 mtt180 -73.1 -52.17 15.27 Favored 'General case' 0 N--CA 1.393 -3.289 0 C-N-CA 124.445 1.098 . . . . 0.0 109.62 178.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.88 -51.23 64.32 Favored 'General case' 0 C--O 1.197 -1.661 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.126 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.486 ' HB3' HD13 ' A' ' 86' ' ' ILE . . . -46.44 -48.77 18.81 Favored 'General case' 0 CA--C 1.494 -1.188 0 O-C-N 124.736 1.272 . . . . 0.0 112.52 -178.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -79.34 -32.34 43.29 Favored 'General case' 0 N--CA 1.407 -2.611 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.396 -171.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 26.0 t -79.58 -1.74 39.25 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.551 ' O ' ' HB ' ' A' ' 90' ' ' THR . 25.9 mt-10 -116.49 14.18 15.53 Favored 'General case' 0 N--CA 1.418 -2.067 0 C-N-CA 125.028 1.331 . . . . 0.0 112.454 -178.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 10.0 mtpm? 66.6 9.5 6.66 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 172.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.7 m -116.8 132.83 65.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-O 121.602 0.715 . . . . 0.0 112.277 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -97.55 127.13 43.26 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.421 HG21 ' HB ' ' A' ' 96' ' ' VAL . 25.9 pt -106.56 128.99 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.018 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.056 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.475 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 12.0 ptt180 -142.21 149.37 39.58 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 121.118 0.485 . . . . 0.0 110.338 -178.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.445 ' N ' HD13 ' A' ' 120' ' ' LEU . 0.0 OUTLIER -151.1 140.75 21.7 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.175 -171.321 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 68.38 -43.5 0.49 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 125.134 1.374 . . . . 0.0 113.794 174.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 69.6 89.28 0.1 Allowed 'General case' 0 CA--C 1.504 -0.826 0 C-N-CA 124.736 1.215 . . . . 0.0 112.096 -178.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 9.8 tp -80.88 99.75 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.746 0 CA-C-N 114.845 -1.07 . . . . 0.0 108.541 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 63.7 mt -71.84 -38.25 64.65 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.556 -176.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -123.66 97.35 5.34 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -84.8 83.37 8.06 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.782 0.801 . . . . 0.0 110.694 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.3 p -159.31 132.01 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 113.926 -1.488 . . . . 0.0 107.315 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.8 tt -166.52 86.39 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-O 121.859 0.838 . . . . 0.0 111.122 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -167.06 69.16 0.1 Allowed 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 122.067 0.936 . . . . 0.0 109.458 175.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -107.69 -3.93 18.7 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-O 122.762 1.267 . . . . 0.0 107.856 174.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.5 pp -141.76 156.62 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.2 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 177.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -76.29 138.99 40.88 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -75.99 19.1 0.23 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -174.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.46 88.9 7.32 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 177.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 91.8 mmm . . . . . 0 C--N 1.298 -1.654 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.837 -176.798 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 10.5 p30 . . . . . 0 CA--C 1.505 -0.75 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -121.18 171.73 8.49 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 120.897 0.379 . . . . 0.0 110.415 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -112.97 137.78 50.83 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 173.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 75.33 155.1 0.16 Allowed 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.327 1.051 . . . . 0.0 110.895 -173.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.9 mp -74.76 -26.74 59.98 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.162 0.506 . . . . 0.0 110.2 -175.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 114.95 -18.23 16.7 Favored Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -177.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.2 p -77.87 92.63 4.27 Favored 'General case' 0 N--CA 1.418 -2.036 0 C-N-CA 123.818 0.847 . . . . 0.0 110.734 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 27.6 ttm-85 -131.1 21.77 4.88 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 123.101 1.429 . . . . 0.0 108.57 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.31 -44.9 2.89 Favored Glycine 0 N--CA 1.435 -1.412 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 173.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.5 m -104.49 107.94 19.13 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 176.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.67 ' HA ' ' OD1' ' A' ' 14' ' ' ASP . 66.7 m 73.53 93.16 0.08 Allowed 'General case' 0 C--O 1.244 0.785 0 CA-C-O 122.829 1.3 . . . . 0.0 112.605 -176.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -126.53 -55.83 1.41 Allowed 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 113.854 -1.521 . . . . 0.0 110.866 -175.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.5 t -116.13 -17.2 8.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.67 ' OD1' ' HA ' ' A' ' 11' ' ' SER . 10.9 p-10 -74.93 71.83 2.07 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 122.911 1.338 . . . . 0.0 109.859 176.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.0 mt -122.19 167.28 13.38 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 113.953 -1.476 . . . . 0.0 107.824 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -106.66 32.54 4.45 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 122.569 1.176 . . . . 0.0 108.517 -177.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -88.06 69.21 9.3 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.584 -1.189 . . . . 0.0 112.429 -178.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -71.48 -43.17 67.09 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 120.563 -0.455 . . . . 0.0 109.884 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 44.55 -92.84 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.475 1.91 . . . . 0.0 115.214 -177.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.4 m -96.9 30.02 2.84 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.798 0.809 . . . . 0.0 108.873 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 24' ' ' ARG 0.395 33.7 m 53.59 69.86 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 126.749 2.02 . . . . 0.0 114.251 -176.243 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -98.97 -39.51 8.52 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.456 175.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.0 p -106.42 18.63 21.69 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 121.794 0.807 . . . . 0.0 109.535 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.473 ' O ' ' HB ' ' A' ' 21' ' ' VAL . 21.8 tpp180 -139.68 120.55 14.47 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.4 m 51.05 170.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 N-CA-C 116.373 1.99 . . . . 0.0 116.373 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.1 m -143.2 15.7 1.88 Allowed 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.516 -1.22 . . . . 0.0 107.806 173.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 77.4 mt -96.58 118.23 32.62 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.785 -177.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -120.22 -5.85 9.92 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.36 0.6 . . . . 0.0 111.229 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -105.46 97.02 6.92 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.9 mp -132.48 16.9 4.42 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -117.11 155.7 28.85 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.172 -174.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -123.26 88.64 2.96 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 175.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -141.46 114.39 8.54 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -178.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 70.8 mt -88.78 -55.99 5.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.654 -178.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -156.37 -52.82 0.08 Allowed 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -172.59 -43.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.802 0.689 . . . . 0.0 109.719 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 133.86 116.11 1.65 Allowed Glycine 0 N--CA 1.434 -1.483 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 -176.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -79.03 73.41 5.58 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.898 0.856 . . . . 0.0 111.655 -175.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 65.0 mtt -120.19 108.16 13.88 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 177.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.0 tptp -145.22 112.93 6.31 Favored 'General case' 0 N--CA 1.426 -1.63 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.629 -178.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -105.42 162.76 13.17 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.999 178.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -106.89 122.1 45.73 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 177.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.427 ' HA ' ' O ' ' A' ' 72' ' ' LYS . 14.8 m120 -120.05 149.12 42.69 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -176.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -154.01 165.25 36.74 Favored 'General case' 0 C--O 1.257 1.453 0 CA-C-O 121.486 0.66 . . . . 0.0 111.375 177.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -116.34 126.57 73.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 CA-C-N 114.638 -1.165 . . . . 0.0 108.986 175.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 73.2 t -95.77 121.08 45.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.696 -176.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.9 mtpm? -134.61 140.98 46.48 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -147.66 175.07 11.18 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -86.33 -13.46 46.5 Favored 'General case' 0 C--N 1.315 -0.934 0 O-C-N 123.813 0.696 . . . . 0.0 109.999 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 79.2 t -120.3 129.56 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 177.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.709 ' O ' HG21 ' A' ' 54' ' ' VAL . 16.1 tt0 -58.7 -48.3 81.59 Favored 'General case' 0 C--O 1.193 -1.904 0 O-C-N 123.291 0.369 . . . . 0.0 111.834 -175.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -73.26 -0.57 53.57 Favored Glycine 0 C--N 1.283 -2.379 0 C-N-CA 118.893 -1.622 . . . . 0.0 114.477 -175.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.3 t -86.48 -20.37 28.19 Favored 'General case' 0 N--CA 1.415 -2.221 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 177.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.709 HG21 ' O ' ' A' ' 51' ' ' GLN . 6.0 m -76.8 -44.22 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.181 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 173.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -63.04 -48.06 80.33 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.215 -1.357 . . . . 0.0 111.321 -177.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.42 -35.23 78.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.583 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.496 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 40.3 tp -78.56 -37.86 41.64 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.239 -178.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.448 HG13 HG12 ' A' ' 73' ' ' ILE . 49.8 t -58.44 -44.66 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 120.625 0.25 . . . . 0.0 110.452 176.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.0 -22.26 66.72 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.676 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.53 -16.01 20.29 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.712 0.768 . . . . 0.0 109.951 -177.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.496 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -97.13 -32.84 11.75 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.25 -175.261 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -73.02 -20.33 61.02 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.028 0.442 . . . . 0.0 110.586 177.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -90.11 -1.04 57.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.194 -177.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 31.8 mm -64.26 129.99 28.75 Favored 'Isoleucine or valine' 0 C--O 1.248 1.022 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.42 ' HB3' ' HG2' ' A' ' 67' ' ' GLU . 12.3 m-20 -65.09 159.07 24.14 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.893 -176.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.0 m -91.36 -9.59 10.18 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 CA-C-O 121.536 0.684 . . . . 0.0 110.266 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.42 ' HG2' ' HB3' ' A' ' 65' ' ' ASP . 11.1 pt-20 -86.6 139.05 31.19 Favored 'General case' 0 C--O 1.254 1.312 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.325 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.2 -79.31 1.73 Allowed Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.95 178.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.0 p -131.73 121.19 47.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 56.0 ttt180 -102.29 101.07 11.3 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 120.234 -0.587 . . . . 0.0 110.273 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.9 t -107.39 136.22 43.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 177.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 57.3 tttp -150.38 154.55 37.97 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.448 HG12 HG13 ' A' ' 58' ' ' VAL . 1.4 pp -93.69 154.45 3.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.635 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 40.3 mm -115.69 -33.32 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-O 121.142 0.496 . . . . 0.0 111.1 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -160.83 134.52 6.83 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -171.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.416 ' HB2' HG23 ' A' ' 58' ' ' VAL . . . -113.51 133.44 55.23 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 176.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -151.94 130.64 12.35 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.307 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.4 p -93.39 93.89 4.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-O 123.2 1.476 . . . . 0.0 110.148 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -177.84 175.49 47.55 Favored Glycine 0 N--CA 1.403 -3.558 0 CA-C-N 113.68 -1.6 . . . . 0.0 109.488 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.489 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -74.11 178.48 5.02 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 174.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 103' ' ' PRO . 3.5 mp -84.27 108.83 16.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 69.6 p -101.04 166.92 10.56 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.512 -0.875 . . . . 0.0 108.992 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -59.53 -33.78 71.82 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.775 0.798 . . . . 0.0 109.508 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.1 m -67.44 -31.44 71.62 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.877 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -73.15 -34.76 66.26 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 121.901 0.858 . . . . 0.0 109.828 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.7 mt -66.55 -26.84 38.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 114.524 -1.216 . . . . 0.0 112.846 -176.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 88.3 p -55.49 -38.32 68.99 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 120.823 0.344 . . . . 0.0 110.507 175.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -73.14 -33.55 65.57 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.028 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.98 -62.16 1.89 Allowed 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.54 -177.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.527 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 4.3 t -70.58 -17.09 62.91 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-O 121.306 0.574 . . . . 0.0 111.129 178.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.82 -55.08 9.33 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 32.6 p -97.53 -8.32 29.38 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 121.017 -0.273 . . . . 0.0 110.767 -176.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . 0.265 0.0 OUTLIER 78.84 30.45 0.35 Allowed 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 127.021 2.128 . . . . 0.0 110.241 -176.799 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -92.6 140.56 29.42 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 113.969 -1.469 . . . . 0.0 110.23 -176.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.4 HG22 ' O ' ' A' ' 117' ' ' ASP . 43.0 mm -94.02 140.44 16.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.528 ' HB ' HG21 ' A' ' 118' ' ' ILE . 11.5 t -95.8 129.5 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -177.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 13.1 tt -127.78 135.99 61.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -137.24 158.23 24.25 Favored Glycine 0 N--CA 1.417 -2.61 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 177.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.412 ' C ' ' H ' ' A' ' 101' ' ' VAL . 91.7 m-85 -117.25 102.7 9.49 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -176.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 59.0 t30 69.75 -31.55 0.21 Allowed 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 124.222 1.009 . . . . 0.0 112.924 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.428 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 1.7 m -49.51 -42.58 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 C-N-CA 124.028 0.931 . . . . 0.0 113.396 177.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.508 ' HA ' ' HG ' ' A' ' 120' ' ' LEU . 49.9 mtp180 69.94 176.44 0.07 OUTLIER Pre-proline 0 CA--C 1.537 0.456 0 O-C-N 123.886 0.741 . . . . 0.0 112.65 175.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.424 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 9.3 Cg_endo -99.25 177.55 0.33 Allowed 'Trans proline' 0 N--CA 1.432 -2.104 0 C-N-CA 121.828 1.685 . . . . 0.0 112.581 178.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -82.84 155.5 24.13 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 168.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.443 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -59.09 -28.84 66.87 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 120.755 0.312 . . . . 0.0 111.642 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.562 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 28.1 m-80 -81.1 -35.39 31.71 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 177.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.4 -42.9 95.85 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 120.799 0.333 . . . . 0.0 110.843 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 17.0 pttp -62.98 -20.69 65.51 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-O 121.089 0.471 . . . . 0.0 110.91 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.562 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 24.8 mtm180 -84.25 -51.68 6.83 Favored 'General case' 0 N--CA 1.392 -3.372 0 C-N-CA 124.593 1.157 . . . . 0.0 109.228 175.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -51.33 -51.52 53.66 Favored 'General case' 0 CA--C 1.477 -1.841 0 C-N-CA 125.34 1.456 . . . . 0.0 110.503 -178.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -49.49 -48.55 47.86 Favored 'General case' 0 CA--C 1.502 -0.877 0 O-C-N 124.842 1.339 . . . . 0.0 112.206 -177.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -78.14 -33.02 50.64 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.384 -172.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 48.0 t -81.44 5.77 16.65 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 176.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.527 ' O ' ' HB ' ' A' ' 90' ' ' THR . 12.3 mt-10 -123.46 12.76 9.41 Favored 'General case' 0 N--CA 1.417 -2.105 0 C-N-CA 124.771 1.228 . . . . 0.0 112.339 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 10.4 mmmm 65.62 10.81 7.01 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 174.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.3 m -115.69 132.97 63.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-O 121.574 0.702 . . . . 0.0 112.492 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.4 ' O ' HG22 ' A' ' 95' ' ' ILE . 28.1 t70 -94.81 126.16 39.94 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.367 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.528 HG21 ' HB ' ' A' ' 96' ' ' VAL . 7.8 pt -94.11 131.86 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-O 121.408 0.623 . . . . 0.0 110.518 178.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 7.0 tpp180 -102.7 115.85 31.41 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.958 -177.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.508 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -155.05 166.91 32.1 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 177.932 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.408 ' O ' ' HB2' ' A' ' 122' ' ' ARG . 40.2 t-80 -93.48 109.87 21.46 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.438 -178.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 121' ' ' HIS . 30.2 ttt180 170.09 113.72 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.766 0 O-C-N 124.93 1.394 . . . . 0.0 109.17 173.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 13.6 tt -118.2 170.96 6.94 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 178.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 9.4 tp -56.15 -23.33 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 CA-C-N 119.006 0.821 . . . . 0.0 110.921 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -83.58 74.84 10.08 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 121.829 0.823 . . . . 0.0 109.081 174.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -137.64 99.51 3.95 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.285 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 25.5 m -69.39 118.51 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.587 177.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 43.8 pt -90.78 127.08 43.45 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 CA-C-O 121.227 0.537 . . . . 0.0 110.77 -177.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -85.7 83.74 7.78 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 175.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -86.38 -32.2 21.08 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.038 -175.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 31.0 pt -126.93 154.06 36.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.279 -176.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -83.14 127.62 33.76 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 174.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -75.73 -11.89 60.08 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -174.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -108.2 149.84 28.03 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.126 0.488 . . . . 0.0 110.888 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 59.1 ttp . . . . . 0 C--N 1.304 -1.4 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.566 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 8.1 p30 . . . . . 0 CA--C 1.51 -0.577 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -87.2 -54.52 4.27 Favored 'General case' 0 C--N 1.316 -0.849 0 O-C-N 123.315 0.384 . . . . 0.0 110.703 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -131.13 -61.64 0.92 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.509 0.671 . . . . 0.0 109.708 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -101.83 164.71 11.58 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.455 -174.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 93.0 mt -87.84 -9.09 54.84 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.339 0.59 . . . . 0.0 109.896 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 102.47 7.4 45.74 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.913 -0.661 . . . . 0.0 113.421 177.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.7 p -99.57 129.3 45.71 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 122.674 -0.309 . . . . 0.0 110.707 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -60.46 -46.3 90.56 Favored 'General case' 0 C--O 1.245 0.857 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.95 77.85 1.95 Allowed Glycine 0 N--CA 1.429 -1.817 0 N-CA-C 108.386 -1.886 . . . . 0.0 108.386 173.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.4 m -64.59 138.76 58.58 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 123.324 0.65 . . . . 0.0 111.5 -175.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.7 m 70.35 35.48 2.01 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.11 0.964 . . . . 0.0 110.772 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -78.98 -17.38 55.51 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.679 0.752 . . . . 0.0 110.281 175.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.1 m -111.36 169.83 3.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 173.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -78.78 133.21 37.1 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 175.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.1 mt -76.38 -16.94 59.6 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -174.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -114.81 116.72 29.06 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 122.184 0.992 . . . . 0.0 111.818 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -120.42 87.02 2.67 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.968 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.573 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 25.0 mp0 -127.45 23.04 6.4 Favored 'General case' 0 CA--C 1.486 -1.506 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.479 ' O ' ' HD2' ' A' ' 19' ' ' ARG . 2.6 tmm_? -66.32 -16.18 63.84 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.411 -177.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.9 m -129.47 26.44 5.36 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 176.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.459 HG13 ' CG ' ' A' ' 24' ' ' ARG . 2.7 p -65.95 -39.25 84.07 Favored 'Isoleucine or valine' 0 C--N 1.357 0.933 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.581 -176.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.4 tptp 172.82 114.69 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 178.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.6 t 47.18 39.75 8.86 Favored 'General case' 0 CA--C 1.567 1.634 0 C-N-CA 125.149 1.38 . . . . 0.0 112.995 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.579 ' HA ' ' HE ' ' A' ' 24' ' ' ARG . 0.9 OUTLIER -95.36 -6.03 41.98 Favored 'General case' 0 C--O 1.24 0.579 0 O-C-N 120.978 -1.076 . . . . 0.0 110.552 -179.537 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.5 t -96.74 -26.49 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 172.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.0 m 60.36 82.57 0.16 Allowed 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.35 1.06 . . . . 0.0 111.899 -176.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.7 mt -130.55 19.44 5.2 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.941 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -70.5 128.06 34.85 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 177.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 76.19 14.86 2.41 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.819 1.248 . . . . 0.0 110.445 -173.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.2 mt 64.7 -83.54 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 126.059 1.744 . . . . 0.0 112.297 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.495 ' CE2' ' HA ' ' A' ' 33' ' ' GLN . 39.5 t80 -163.17 137.61 6.23 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -175.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.93 2.95 56.21 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.199 0.523 . . . . 0.0 111.197 -176.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.495 ' HA ' ' CE2' ' A' ' 31' ' ' PHE . 35.7 tt0 71.86 -79.32 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 125.458 1.503 . . . . 0.0 112.074 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 63.3 mt 40.44 76.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.253 1.277 0 C-N-CA 124.507 1.123 . . . . 0.0 111.964 -178.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.446 ' HZ2' ' HB2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -155.61 121.33 5.0 Favored 'General case' 0 N--CA 1.424 -1.745 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.014 -177.49 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -116.73 112.55 21.34 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 175.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -117.5 -136.67 5.66 Favored Glycine 0 C--N 1.302 -1.322 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.418 -178.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -82.76 147.97 28.11 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 123.108 0.563 . . . . 0.0 109.784 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 22.0 ptp -86.6 111.93 21.1 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.455 177.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -91.46 -21.89 20.7 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.51 -175.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -104.19 104.55 14.48 Favored 'General case' 0 N--CA 1.435 -1.208 0 O-C-N 123.897 0.748 . . . . 0.0 109.949 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.545 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 59.4 tp -97.53 110.3 22.88 Favored 'General case' 0 N--CA 1.409 -2.486 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 175.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.565 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 57.7 m-80 -94.71 152.87 18.11 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -178.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 78.7 mt -138.59 164.57 29.13 Favored 'General case' 0 C--O 1.245 0.849 0 CA-C-O 121.814 0.816 . . . . 0.0 112.35 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.507 HD13 ' O ' ' A' ' 75' ' ' HIS . 0.2 OUTLIER -127.0 135.39 63.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 174.464 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 92.1 t -118.61 127.91 75.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.048 -177.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 41.5 mtpt -144.92 140.89 28.59 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.76 175.18 13.14 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -178.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -84.47 -25.68 28.73 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 122.2 1.0 . . . . 0.0 108.94 177.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 99.0 t -101.61 122.54 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.246 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 174.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.701 ' O ' HG23 ' A' ' 54' ' ' VAL . 17.4 tt0 -62.9 -40.72 98.43 Favored 'General case' 0 C--O 1.192 -1.941 0 CA-C-O 120.602 0.239 . . . . 0.0 111.411 -175.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -73.75 -3.03 62.28 Favored Glycine 0 C--N 1.29 -2.0 0 C-N-CA 118.314 -1.898 . . . . 0.0 114.151 -177.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.4 m -80.72 -24.02 39.08 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 176.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 51' ' ' GLN . 3.3 m -77.14 -47.09 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.767 0 CA-C-N 114.579 -1.191 . . . . 0.0 107.827 176.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -57.13 -48.04 79.64 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.295 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.48 -31.2 72.15 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.333 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.434 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 24.3 tp -79.78 -41.3 26.81 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.239 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 54' ' ' VAL . 53.2 t -53.56 -43.96 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.512 0.725 . . . . 0.0 111.921 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.88 -29.07 70.29 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.44 -13.07 28.39 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 121.325 0.583 . . . . 0.0 110.106 -177.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -96.13 -33.65 11.98 Favored 'General case' 0 N--CA 1.418 -2.064 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.494 -176.174 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -75.52 -14.69 60.42 Favored 'General case' 0 C--N 1.313 -1.002 0 O-C-N 122.066 -0.396 . . . . 0.0 111.59 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -96.76 5.18 51.12 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -178.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.528 ' HB ' ' O ' ' A' ' 71' ' ' VAL . 23.4 mt -78.29 78.93 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -174.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -121.09 -33.15 3.78 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.339 -1.3 . . . . 0.0 108.167 170.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.3 t -72.06 -7.36 9.28 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 CA-C-N 114.408 -1.269 . . . . 0.0 112.059 -172.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -83.59 -9.04 59.17 Favored 'General case' 0 C--N 1.312 -1.048 0 O-C-N 121.689 -0.632 . . . . 0.0 110.849 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.41 13.23 63.8 Favored Glycine 0 CA--C 1.503 -0.7 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.5 p -153.07 149.85 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.974 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -103.27 121.83 43.53 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.624 0.726 . . . . 0.0 110.959 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 46.7 t -130.49 128.88 64.19 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.791 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 177.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 58.8 tttp -153.06 158.5 42.05 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.844 -174.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.423 HG12 HG11 ' A' ' 58' ' ' VAL . 1.2 pp -93.94 152.29 3.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 -177.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.451 HD12 ' OD1' ' A' ' 43' ' ' ASN . 27.7 mm -115.69 -27.26 2.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.839 177.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.507 ' O ' HD13 ' A' ' 45' ' ' ILE . 3.5 t60 -157.69 135.91 11.0 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -169.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -142.48 129.34 20.58 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 47' ' ' LYS . . . -161.91 159.37 26.63 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 120.714 0.293 . . . . 0.0 110.477 -178.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.8 p -94.58 103.46 14.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 175.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -175.88 175.81 47.42 Favored Glycine 0 N--CA 1.425 -2.08 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -177.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.542 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -90.19 178.62 6.12 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 103' ' ' PRO . 3.7 mp -82.38 108.16 15.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 69.5 p -100.42 169.13 9.3 Favored 'General case' 0 N--CA 1.421 -1.885 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -58.83 -28.66 66.25 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.804 0.842 . . . . 0.0 110.254 176.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.0 t -71.58 -37.41 71.02 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.485 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -70.93 -36.05 72.49 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 121.634 0.73 . . . . 0.0 110.225 -177.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.454 HD12 ' HB1' ' A' ' 111' ' ' ALA . 54.3 mt -69.35 -34.6 63.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.426 -177.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 66.5 m -63.99 -19.36 65.11 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 120.471 -0.492 . . . . 0.0 112.152 174.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -79.9 -36.04 37.05 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 173.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.93 -54.18 49.83 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.31 -177.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.534 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 10.1 t -74.52 -12.88 60.59 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.917 178.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.76 -58.7 3.12 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.95 0.405 . . . . 0.0 111.815 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 26.4 m -98.12 5.14 48.92 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.432 -177.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.1 m120 72.43 33.05 1.51 Allowed 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 122.094 0.949 . . . . 0.0 110.041 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.565 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -94.75 170.26 9.57 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 113.938 -1.483 . . . . 0.0 109.71 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 36.6 pt -130.93 148.08 33.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 173.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.423 ' HA ' HG22 ' A' ' 45' ' ' ILE . 3.4 t -100.62 126.79 54.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.973 -175.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.589 ' HA ' ' O ' ' A' ' 119' ' ' ARG . 66.0 mt -112.13 135.78 50.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -132.55 140.16 11.58 Favored Glycine 0 N--CA 1.434 -1.486 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.745 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.418 ' C ' ' H ' ' A' ' 101' ' ' VAL . 97.9 m-85 -107.36 100.12 9.58 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -176.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.2 t30 72.91 -36.19 0.35 Allowed 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 125.332 1.453 . . . . 0.0 111.922 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.418 ' H ' ' C ' ' A' ' 99' ' ' PHE . 3.5 m -50.76 -50.63 22.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 124.698 1.199 . . . . 0.0 112.664 177.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.542 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 76.4 mtp180 67.73 177.21 0.06 OUTLIER Pre-proline 0 CA--C 1.559 1.312 0 O-C-N 123.731 0.644 . . . . 0.0 111.541 176.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 5.3 Cg_endo -94.82 173.58 1.31 Allowed 'Trans proline' 0 CA--C 1.5 -1.183 0 C-N-CA 121.59 1.527 . . . . 0.0 113.985 -177.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -77.48 160.91 28.33 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 113.965 -1.471 . . . . 0.0 107.335 168.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.466 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -67.35 -29.68 69.29 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -176.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 10.3 m-80 -86.72 -35.55 19.17 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.08 -50.42 66.83 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.441 175.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 61.2 pttt -56.97 -24.71 55.16 Favored 'General case' 0 CA--C 1.565 1.527 0 C-N-CA 122.697 0.399 . . . . 0.0 112.075 -178.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.567 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 14.1 mtm180 -86.27 -46.84 9.96 Favored 'General case' 0 N--CA 1.386 -3.628 0 C-N-CA 125.201 1.401 . . . . 0.0 108.93 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.11 -42.39 69.39 Favored 'General case' 0 C--O 1.201 -1.477 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.425 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.454 ' HB1' HD12 ' A' ' 86' ' ' ILE . . . -48.78 -44.86 39.27 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 124.475 1.109 . . . . 0.0 111.406 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -77.82 -32.83 52.46 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 114.874 -1.057 . . . . 0.0 112.277 -175.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 48.3 t -83.13 4.86 24.66 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 176.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.534 ' O ' ' HB ' ' A' ' 90' ' ' THR . 23.2 mt-10 -123.1 12.08 9.57 Favored 'General case' 0 CA--C 1.464 -2.341 0 C-N-CA 124.496 1.118 . . . . 0.0 112.883 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.517 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 26.7 mtpp 66.25 7.99 5.28 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 173.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.1 m -115.41 155.47 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.324 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -174.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -111.99 124.68 52.92 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.457 -178.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 9.3 pt -96.16 133.07 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.626 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.589 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 41.0 ttt85 -119.36 125.32 48.74 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.405 ' HG ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -142.6 168.41 19.8 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.085 -177.596 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.404 ' CE1' ' HB ' ' A' ' 123' ' ' ILE . 9.1 t-160 -96.8 113.46 25.02 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 177.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -75.26 -49.3 19.7 Favored 'General case' 0 C--O 1.216 -0.707 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.404 ' HB ' ' CE1' ' A' ' 121' ' ' HIS 0.291 9.3 tp 49.98 85.04 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.202 0 C-N-CA 125.538 1.535 . . . . 0.0 114.41 178.626 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 15.1 tt -165.45 -27.19 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.984 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 70.08 -74.05 0.09 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.723 1.209 . . . . 0.0 112.38 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -120.0 133.15 55.63 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 28.9 m -82.55 -30.39 9.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 C-N-CA 120.493 -0.483 . . . . 0.0 109.733 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.6 pp -136.43 169.85 19.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 C-N-CA 123.405 0.682 . . . . 0.0 109.92 176.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -140.68 168.62 19.37 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 120.79 0.329 . . . . 0.0 111.593 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -77.86 128.54 34.12 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.838 177.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 64.6 mt 73.17 -58.43 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 125.09 1.356 . . . . 0.0 110.751 -177.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -167.26 -39.97 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 123.743 0.817 . . . . 0.0 110.129 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -164.84 161.11 20.14 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -178.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -86.47 -67.3 0.82 Allowed 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 175.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 87.8 mtp . . . . . 0 C--N 1.316 -0.885 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 174.307 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 8.7 t30 . . . . . 0 CA--C 1.497 -1.08 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -87.82 100.08 12.59 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-O 121.319 0.581 . . . . 0.0 109.735 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -83.41 -38.68 21.61 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -92.12 95.01 9.51 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.735 176.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.7 pp -82.58 -20.84 35.72 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.07 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.73 90.63 1.63 Allowed Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 175.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.5 t -102.32 176.18 5.27 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 120.785 0.326 . . . . 0.0 111.063 -173.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 72.84 -58.73 0.59 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.936 1.694 . . . . 0.0 112.307 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.49 55.88 22.87 Favored Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.3 m -139.29 3.13 2.13 Favored 'General case' 0 C--N 1.314 -0.938 0 O-C-N 122.688 -0.301 . . . . 0.0 111.546 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.7 t -95.5 -5.36 43.06 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 176.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.577 ' O ' HG22 ' A' ' 13' ' ' VAL . 15.1 ptp180 -162.02 164.48 28.23 Favored 'General case' 0 N--CA 1.406 -2.659 0 N-CA-C 104.193 -2.521 . . . . 0.0 104.193 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.577 HG22 ' O ' ' A' ' 12' ' ' ARG . 2.5 t 169.9 109.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 C-N-CA 128.228 2.611 . . . . 0.0 108.046 174.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.7 t70 65.23 77.95 0.29 Allowed 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 122.345 1.069 . . . . 0.0 110.972 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.9 tp -100.22 -50.01 4.09 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.503 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -99.97 159.89 14.74 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.033 -176.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -126.64 133.22 51.05 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.412 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -86.37 -37.23 18.64 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 68.87 -73.11 0.09 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.676 1.59 . . . . 0.0 111.037 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 t -155.8 30.13 0.37 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.5 m 50.68 -169.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 126.447 1.899 . . . . 0.0 111.85 -172.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 87.4 tttt 72.49 -74.41 0.09 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.339 1.056 . . . . 0.0 111.195 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 23.7 p -93.88 21.16 6.87 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.24 0.543 . . . . 0.0 110.852 -178.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -56.53 -39.03 72.7 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.23 177.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.3 m -125.46 -59.6 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.863 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.9 p -171.1 148.67 2.76 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 106.311 -1.736 . . . . 0.0 106.311 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -144.93 117.4 8.54 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -93.22 99.47 12.02 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -76.19 112.75 12.99 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.75 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 49.3 tp -158.26 89.42 0.99 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -118.82 76.72 1.12 Allowed 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.396 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 162.94 149.52 0.01 OUTLIER 'General case' 0 C--O 1.245 0.842 0 C-N-CA 126.791 2.036 . . . . 0.0 106.729 175.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 -135.09 153.58 51.97 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 120.826 0.346 . . . . 0.0 111.928 178.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.6 tp -63.12 135.36 27.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.637 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -96.07 154.38 17.28 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -67.06 -27.7 67.6 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.928 0.87 . . . . 0.0 108.72 176.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.07 -177.48 32.61 Favored Glycine 0 N--CA 1.405 -3.426 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.917 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -83.18 72.02 10.16 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-O 121.417 0.627 . . . . 0.0 109.401 -178.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 14.9 tpt -67.27 -56.03 11.51 Favored 'General case' 0 C--O 1.243 0.742 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 178.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -127.15 122.34 33.9 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-N 114.071 -1.422 . . . . 0.0 107.746 173.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -94.65 142.36 27.53 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 174.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 47.2 tp -93.26 93.2 8.09 Favored 'General case' 0 N--CA 1.395 -3.216 0 N-CA-C 102.761 -3.051 . . . . 0.0 102.761 170.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -106.57 115.97 31.12 Favored 'General case' 0 C--N 1.28 -2.413 0 CA-C-N 113.869 -1.514 . . . . 0.0 107.641 -168.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 93.8 mt -123.36 172.86 8.36 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 122.146 0.974 . . . . 0.0 113.106 -172.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.437 HG22 ' HA ' ' A' ' 96' ' ' VAL . 1.1 tt -122.21 134.99 63.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 114.55 -1.204 . . . . 0.0 110.162 178.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 98.6 t -110.14 120.94 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 CA-C-O 121.496 0.665 . . . . 0.0 110.543 -177.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -140.62 114.61 9.06 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.289 1.036 . . . . 0.0 109.614 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -131.05 167.02 19.78 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.575 -176.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -73.08 -35.59 66.68 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.997 0.903 . . . . 0.0 109.02 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 88.5 t -95.56 124.7 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 176.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.716 ' O ' HG22 ' A' ' 54' ' ' VAL . 24.1 tt0 -62.63 -40.52 97.26 Favored 'General case' 0 C--O 1.194 -1.858 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.071 -177.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -75.67 0.67 60.55 Favored Glycine 0 C--N 1.279 -2.617 0 C-N-CA 118.241 -1.933 . . . . 0.0 114.071 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.4 t -87.53 -22.77 24.66 Favored 'General case' 0 N--CA 1.418 -2.059 0 N-CA-C 106.036 -1.839 . . . . 0.0 106.036 174.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.716 HG22 ' O ' ' A' ' 51' ' ' GLN . 3.9 m -73.0 -43.81 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.847 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 174.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -57.57 -54.87 41.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.222 -1.354 . . . . 0.0 110.636 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.65 -41.05 89.68 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.211 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.504 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 40.3 tp -73.38 -37.92 65.83 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 120.049 -0.661 . . . . 0.0 110.67 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.475 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 39.9 t -59.01 -45.17 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.58 -19.73 64.01 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.661 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.3 -10.91 20.79 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.697 0.76 . . . . 0.0 109.957 -177.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.504 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -105.27 -27.94 11.23 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 114.638 -1.164 . . . . 0.0 110.21 -175.125 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.475 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 4.2 pt20 -84.16 -11.35 56.72 Favored 'General case' 0 C--N 1.315 -0.904 0 O-C-N 121.904 -0.497 . . . . 0.0 111.422 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -86.87 5.36 37.23 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.327 0.584 . . . . 0.0 110.038 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.424 HG22 ' HB ' ' A' ' 71' ' ' VAL . 24.1 mm -83.05 93.45 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.78 0 CA-C-O 121.908 0.861 . . . . 0.0 110.81 -176.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -141.83 -41.14 0.36 Allowed 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.499 -1.228 . . . . 0.0 107.762 174.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.9 t -80.87 87.03 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 172.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 178.49 -31.36 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -170.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.31 -42.1 2.85 Favored Glycine 0 CA--C 1.501 -0.813 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.862 177.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 50.4 t -94.83 143.82 11.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 177.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 -93.74 110.8 22.42 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-O 121.447 0.641 . . . . 0.0 109.898 -178.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.424 ' HB ' HG22 ' A' ' 64' ' ' ILE . 39.0 t -110.9 116.02 51.39 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.698 0 N-CA-C 103.237 -2.875 . . . . 0.0 103.237 171.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -141.04 164.04 31.34 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.661 -171.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.6 pp -100.03 158.35 3.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.714 176.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.3 mt -117.62 -41.57 2.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.999 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -154.56 131.42 10.82 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.626 -169.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -124.99 125.12 43.39 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 124.215 1.006 . . . . 0.0 108.449 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -148.57 145.91 28.04 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.3 p -94.87 94.83 4.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-O 122.754 1.264 . . . . 0.0 110.049 177.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.24 175.09 47.36 Favored Glycine 0 N--CA 1.404 -3.445 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 102' ' ' ARG . . . -89.22 175.47 7.34 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.4 ' CG2' HD11 ' A' ' 86' ' ' ILE . 1.7 mp -72.87 116.95 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 CA-C-O 121.19 0.519 . . . . 0.0 110.151 -177.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.9 t -123.43 155.51 37.3 Favored 'General case' 0 N--CA 1.403 -2.778 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.48 -26.98 68.67 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -173.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.4 t -65.14 -29.0 69.81 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.278 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -82.04 -32.58 30.39 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.542 0.687 . . . . 0.0 109.522 177.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.473 HG22 ' HA ' ' A' ' 111' ' ' ALA . 41.5 mt -68.17 -29.87 45.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.253 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.414 ' HA ' ' OE2' ' A' ' 114' ' ' GLU . 42.6 m -58.8 -24.31 61.67 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 174.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -76.54 -34.45 58.53 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 175.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.42 -57.23 13.21 Favored 'General case' 0 C--O 1.191 -1.984 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.039 -177.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.628 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 1.9 t -66.29 -30.63 71.09 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 120.37 -0.532 . . . . 0.0 112.095 176.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.02 -55.83 25.23 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -177.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 33.7 m -101.34 5.11 42.13 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.972 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 64.36 37.71 8.22 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.828 0.851 . . . . 0.0 109.965 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -93.78 156.47 16.65 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.284 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.1 mp -108.19 136.5 43.5 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 176.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.476 ' HB ' HG21 ' A' ' 118' ' ' ILE . 14.3 t -93.58 103.93 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -176.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 51.4 mt -94.82 112.37 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.824 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -103.18 134.98 12.07 Favored Glycine 0 N--CA 1.414 -2.777 0 N-CA-C 109.984 -1.247 . . . . 0.0 109.984 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.458 ' C ' ' H ' ' A' ' 101' ' ' VAL . 98.4 m-85 -104.15 94.45 5.38 Favored 'General case' 0 C--N 1.281 -2.399 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.237 -173.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 71.69 -22.72 0.19 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 125.626 1.571 . . . . 0.0 112.995 178.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.516 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 2.7 m -54.62 -48.99 70.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 178.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.585 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 37.2 mtp180 72.6 171.14 0.11 Allowed Pre-proline 0 CA--C 1.552 1.048 0 O-C-N 123.863 0.727 . . . . 0.0 111.822 178.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -100.62 -173.17 0.11 Allowed 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.43 2.087 . . . . 0.0 113.504 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -106.75 176.89 5.02 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.275 -1.33 . . . . 0.0 107.444 170.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.514 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -74.2 -12.11 60.48 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 113.701 1.001 . . . . 0.0 113.701 -173.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.512 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 8.8 t30 -101.33 -40.35 7.16 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.07 -46.12 82.74 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 123.355 0.41 . . . . 0.0 110.882 175.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -54.38 -34.56 61.46 Favored 'General case' 0 CA--C 1.562 1.433 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.798 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.514 ' HG3' ' O ' ' A' ' 105' ' ' ALA . 15.7 mtm180 -79.45 -49.77 11.8 Favored 'General case' 0 N--CA 1.386 -3.642 0 C-N-CA 126.118 1.767 . . . . 0.0 109.541 -178.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.55 -43.69 68.64 Favored 'General case' 0 C--O 1.203 -1.355 0 CA-C-N 113.944 -1.48 . . . . 0.0 110.53 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.473 ' HA ' HG22 ' A' ' 86' ' ' ILE . . . -50.56 -47.22 57.88 Favored 'General case' 0 CA--C 1.489 -1.382 0 O-C-N 124.532 1.145 . . . . 0.0 111.356 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -79.23 -30.59 43.28 Favored 'General case' 0 C--N 1.277 -2.583 0 CA-C-N 114.754 -1.112 . . . . 0.0 112.691 -172.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 35.2 t -84.68 4.72 31.21 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-O 122.069 0.937 . . . . 0.0 108.511 176.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.628 ' O ' ' HB ' ' A' ' 90' ' ' THR . 23.3 mt-10 -118.21 17.01 14.02 Favored 'General case' 0 CA--C 1.46 -2.493 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.581 177.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.557 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 47.7 mtmt 66.55 7.83 5.37 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 174.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.3 m -117.62 171.92 5.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.951 -176.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -131.67 143.68 50.46 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.476 HG21 ' HB ' ' A' ' 96' ' ' VAL . 5.6 pt -101.98 138.01 27.78 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.519 179.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 13.6 ttm180 -114.46 111.84 22.05 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -172.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.437 ' CD1' ' HA ' ' A' ' 102' ' ' ARG . 3.1 mm? -111.3 123.14 49.6 Favored 'General case' 0 CA--C 1.478 -1.818 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.067 -174.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 31.5 t-80 68.55 94.57 0.07 Allowed 'General case' 0 CA--C 1.544 0.749 0 O-C-N 124.754 1.284 . . . . 0.0 111.114 175.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 63.89 -173.35 0.17 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.39 1.076 . . . . 0.0 111.923 -176.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 29.6 pt -102.18 -172.78 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 O-C-N 122.017 -0.427 . . . . 0.0 110.802 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 47.0 mm -70.37 -49.37 54.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 CA-C-O 121.162 0.506 . . . . 0.0 109.813 -175.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -81.41 101.75 10.05 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 172.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -74.07 101.09 3.79 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.861 -170.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 60.6 t -103.64 121.72 55.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.873 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.2 mp -88.09 111.56 22.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -79.85 105.54 11.22 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -132.45 107.62 8.61 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.548 0.69 . . . . 0.0 109.835 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 22.7 pt -122.44 -11.15 8.07 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.74 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.81 10.07 12.24 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.75 -1.113 . . . . 0.0 109.657 -177.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -83.07 106.29 14.76 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.906 -175.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -110.06 -13.08 14.45 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.876 0.846 . . . . 0.0 108.955 174.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 89.3 mtp . . . . . 0 C--N 1.31 -1.126 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 -179.001 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 24.7 p30 . . . . . 0 CA--C 1.512 -0.503 0 N-CA-C 110.677 -0.12 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 58.32 -165.06 0.18 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.789 0.436 . . . . 0.0 111.216 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -91.57 114.85 27.49 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 173.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -69.99 120.5 15.8 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.7 pp -139.87 177.72 7.76 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 120.654 0.264 . . . . 0.0 111.329 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -177.71 -45.08 0.07 OUTLIER Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.618 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.0 p -69.51 81.01 0.4 Allowed 'General case' 0 C--O 1.246 0.908 0 CA-C-O 121.63 0.729 . . . . 0.0 112.924 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -117.4 132.58 56.55 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 176.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.33 80.33 1.43 Allowed Glycine 0 N--CA 1.421 -2.304 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 -173.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.0 m -65.27 -30.56 71.44 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.593 0.711 . . . . 0.0 110.612 -177.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 36.8 t -132.12 96.97 4.02 Favored 'General case' 0 N--CA 1.411 -2.421 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -141.32 -159.98 1.03 Allowed 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 37.1 t 66.45 63.5 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 C-N-CA 124.643 1.177 . . . . 0.0 108.249 -174.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.4 t70 72.56 119.65 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 113.509 -1.678 . . . . 0.0 111.875 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.9 mt -84.98 169.88 13.58 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.93 -176.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.54 134.93 45.47 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.676 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.3 -178.08 5.04 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.842 -175.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 76.6 -12.04 1.09 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.543 1.137 . . . . 0.0 112.928 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -50.75 -42.73 57.83 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -176.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.0 t -108.51 4.53 24.26 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.4 t 45.0 69.3 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.538 0 C-N-CA 124.965 1.306 . . . . 0.0 110.524 -171.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.3 tptt -135.04 141.63 46.19 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 103.913 -2.625 . . . . 0.0 103.913 175.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.6 p 61.46 29.16 18.29 Favored 'General case' 0 C--N 1.313 -0.981 0 O-C-N 124.127 0.892 . . . . 0.0 110.326 -176.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 -113.34 22.81 13.87 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.098 -177.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.1 t -75.36 -30.7 22.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.768 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.7 m 60.34 84.34 0.12 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.23 1.012 . . . . 0.0 112.426 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -94.03 75.0 4.11 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -101.75 -22.96 14.28 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.398 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -81.04 -17.44 50.2 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 122.198 0.999 . . . . 0.0 109.055 178.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.7 mp -101.88 139.92 36.87 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 176.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -118.35 144.15 46.1 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -89.5 97.2 11.06 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -120.41 69.12 0.86 Allowed 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.2 mp -97.52 -60.36 2.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.716 -176.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -81.79 94.25 7.0 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.51 -175.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.476 ' O ' ' HD2' ' A' ' 40' ' ' LYS . 60.2 tt0 -96.62 -46.32 6.36 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 173.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -136.92 100.61 0.32 Allowed Glycine 0 N--CA 1.422 -2.29 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.668 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -129.23 96.14 4.23 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 176.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 62.8 mtm 63.41 32.77 14.26 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -175.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.476 ' HD2' ' O ' ' A' ' 36' ' ' GLN . 61.7 tttp -81.01 -43.56 19.41 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.407 -172.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -113.33 99.18 7.6 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.728 -171.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -118.33 130.21 55.89 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 174.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.445 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 40.7 m-80 -127.5 136.25 51.49 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.785 -178.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.1 mt -138.21 167.97 20.71 Favored 'General case' 0 C--O 1.249 1.042 0 CA-C-O 122.212 1.006 . . . . 0.0 112.595 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -130.79 140.11 49.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-N 113.865 -1.516 . . . . 0.0 108.243 176.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.421 ' CG1' ' HA ' ' A' ' 54' ' ' VAL . 95.4 t -111.24 124.48 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.751 0 CA-C-O 121.538 0.685 . . . . 0.0 111.642 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 68.2 mttm -134.92 144.25 47.36 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.354 -1.294 . . . . 0.0 108.573 176.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -163.38 159.73 22.73 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 177.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -69.06 -32.98 72.83 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.584 0.706 . . . . 0.0 111.051 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 76.2 t -91.96 126.08 44.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.689 ' O ' HG21 ' A' ' 54' ' ' VAL . 13.6 tt0 -62.15 -50.21 72.78 Favored 'General case' 0 C--O 1.198 -1.631 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -173.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.65 0.4 56.39 Favored Glycine 0 C--N 1.29 -2.006 0 C-N-CA 118.537 -1.792 . . . . 0.0 114.427 -175.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 43.0 m -82.09 -24.87 34.96 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 175.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.689 HG21 ' O ' ' A' ' 51' ' ' GLN . 4.1 m -74.97 -46.67 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.313 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.194 175.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -63.37 -46.37 86.81 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.989 -177.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.35 -36.78 84.85 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.241 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 34.4 tp -73.26 -39.98 64.98 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.809 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 54' ' ' VAL . 53.3 t -57.95 -40.01 74.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 122.738 0.415 . . . . 0.0 110.912 176.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.88 -6.98 45.67 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.508 ' O ' HG12 ' A' ' 64' ' ' ILE . . . -105.28 -34.9 7.73 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 175.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.401 ' HB3' HG13 ' A' ' 73' ' ' ILE . 0.4 OUTLIER -72.49 -32.43 66.18 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.987 -175.48 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -73.02 -18.07 61.38 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.046 0.451 . . . . 0.0 110.812 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.8 5.76 48.71 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 121.319 0.58 . . . . 0.0 111.199 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.517 ' HB ' ' O ' ' A' ' 71' ' ' VAL . 17.9 mm -92.71 7.18 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-O 122.867 1.318 . . . . 0.0 107.61 175.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -78.92 78.39 5.36 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.337 177.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.6 m -119.98 -176.67 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.631 -175.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -75.46 141.27 43.15 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.607 -178.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 40' ' ' LYS . . . 86.99 -60.95 4.39 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.98 -0.554 . . . . 0.0 113.106 177.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.4 t -126.04 112.19 29.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 -176.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -108.34 117.33 33.87 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 176.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.517 ' O ' ' HB ' ' A' ' 64' ' ' ILE . 44.1 t -115.14 107.28 22.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 174.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -139.94 158.0 44.77 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.604 0.716 . . . . 0.0 111.78 -173.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.401 HG13 ' HB3' ' A' ' 61' ' ' LEU . 1.7 pp -94.42 159.68 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.301 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.6 mp -125.66 -28.49 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.814 175.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -150.41 132.76 15.54 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 120.882 0.372 . . . . 0.0 110.121 -170.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -123.86 140.48 52.94 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 47' ' ' LYS . . . -159.08 140.79 13.39 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.402 ' HB ' ' HA ' ' A' ' 51' ' ' GLN . 3.6 p -94.67 92.93 3.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-O 122.785 1.279 . . . . 0.0 107.552 175.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -177.36 176.2 47.95 Favored Glycine 0 N--CA 1.398 -3.899 0 CA-C-N 114.427 -1.26 . . . . 0.0 110.643 -177.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.632 ' HB2' ' O ' ' A' ' 102' ' ' ARG . . . -83.96 -168.98 2.36 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.514 ' O ' ' HA ' ' A' ' 103' ' ' PRO . 3.3 mp -86.57 108.32 17.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.584 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 18.3 p -101.78 151.15 22.4 Favored 'General case' 0 N--CA 1.414 -2.253 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.111 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -45.59 -53.94 8.38 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.341 1.457 . . . . 0.0 113.618 -177.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.3 t -76.08 -14.43 60.2 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 120.68 0.276 . . . . 0.0 111.516 -174.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -77.57 -35.34 53.19 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.443 HG22 ' HA ' ' A' ' 111' ' ' ALA . 40.7 mt -59.73 -26.62 35.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-N 114.379 -1.282 . . . . 0.0 112.078 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.7 m -58.18 -21.57 47.95 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 175.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -80.22 -35.69 35.86 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 174.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.01 -53.54 55.74 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.577 -176.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.534 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 3.3 t -70.58 -24.7 62.82 Favored 'General case' 0 CA--C 1.557 1.247 0 O-C-N 122.017 -0.427 . . . . 0.0 111.707 177.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.32 -52.57 38.83 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -175.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.6 p -105.26 -2.37 24.14 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 122.05 0.929 . . . . 0.0 109.231 -176.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.405 HD21 ' HA ' ' A' ' 93' ' ' ASN . 1.9 t-20 66.73 41.17 3.02 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.223 -1.808 . . . . 0.0 109.365 -177.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -94.24 130.18 40.59 Favored 'General case' 0 N--CA 1.413 -2.32 0 CA-C-N 113.597 -1.638 . . . . 0.0 106.952 177.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 37.8 pt -93.89 142.66 13.0 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.375 0 C-N-CA 119.112 -1.035 . . . . 0.0 108.996 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.401 ' HB ' HG21 ' A' ' 118' ' ' ILE . 10.6 t -93.53 106.37 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.316 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -175.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.497 ' HA ' ' O ' ' A' ' 119' ' ' ARG . 65.5 mt -101.58 117.6 47.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 177.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 120' ' ' LEU . . . -123.32 176.32 16.67 Favored Glycine 0 C--N 1.289 -2.037 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -178.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.419 ' C ' ' H ' ' A' ' 101' ' ' VAL . 32.8 t80 -148.09 115.93 6.39 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.359 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 8.4 t30 73.91 -27.56 0.19 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 125.586 1.554 . . . . 0.0 113.09 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.427 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 7.8 m -60.92 -53.17 52.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 C-N-CA 124.382 1.073 . . . . 0.0 113.778 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.632 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 61.9 mtp180 73.83 168.47 0.12 Allowed Pre-proline 0 N--CA 1.482 1.132 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 176.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.514 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 9.4 Cg_endo -98.41 176.04 0.45 Allowed 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 122.036 1.824 . . . . 0.0 115.006 -177.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.415 ' HB2' ' H ' ' A' ' 107' ' ' ALA . 65.5 m-20 -67.82 159.43 30.35 Favored 'General case' 0 C--O 1.249 1.067 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 168.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.444 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -66.74 -29.43 69.4 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 176.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.608 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 83.9 m-20 -84.95 -27.22 26.68 Favored 'General case' 0 C--O 1.205 -1.27 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.541 175.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.415 ' H ' ' HB2' ' A' ' 104' ' ' ASP . . . -70.11 -41.46 73.96 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.458 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 13.7 ptmm? -59.75 -21.65 61.01 Favored 'General case' 0 CA--C 1.556 1.174 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.404 178.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 96.1 mtt180 -87.28 -53.8 4.64 Favored 'General case' 0 N--CA 1.384 -3.741 0 C-N-CA 125.44 1.496 . . . . 0.0 109.849 177.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -50.28 -45.27 54.25 Favored 'General case' 0 C--O 1.196 -1.72 0 C-N-CA 124.978 1.311 . . . . 0.0 111.036 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.443 ' HA ' HG22 ' A' ' 86' ' ' ILE . . . -50.49 -46.69 57.2 Favored 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 124.194 0.934 . . . . 0.0 111.886 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -79.75 -29.52 40.55 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.949 -172.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 32.5 t -82.67 3.23 29.87 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.534 ' O ' ' HB ' ' A' ' 90' ' ' THR . 19.1 mt-10 -122.39 11.84 10.05 Favored 'General case' 0 CA--C 1.474 -1.972 0 C-N-CA 124.896 1.278 . . . . 0.0 112.82 -178.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.515 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 56.9 mttp 65.89 12.21 8.22 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 174.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.4 m -120.62 135.28 61.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-O 121.454 0.645 . . . . 0.0 112.557 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -96.51 124.4 40.49 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.455 176.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.401 HG21 ' HB ' ' A' ' 96' ' ' VAL . 9.6 pt -92.91 124.55 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.029 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 176.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.497 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 41.5 mtm180 -123.23 103.61 8.64 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-O 122.207 1.003 . . . . 0.0 111.494 -171.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.531 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -119.0 138.66 52.66 Favored 'General case' 0 N--CA 1.411 -2.387 0 CA-C-N 113.943 -1.481 . . . . 0.0 110.802 -179.384 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 72.21 -49.33 0.69 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.361 1.064 . . . . 0.0 111.347 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -118.71 131.56 56.14 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 123.669 0.788 . . . . 0.0 109.117 176.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 28.0 pt -112.15 128.74 68.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 173.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 11.5 tt -133.64 141.16 45.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -178.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 54.57 59.08 4.35 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.841 0.856 . . . . 0.0 113.037 -176.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -111.41 164.9 12.44 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 177.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . 0.266 11.9 p -80.82 74.84 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-O 122.782 1.277 . . . . 0.0 113.348 -175.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.7 tt -115.58 -40.58 2.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 113.878 -1.51 . . . . 0.0 107.095 172.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -98.26 100.79 12.11 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 105.439 -2.059 . . . . 0.0 105.439 172.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -65.17 -49.1 71.11 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 115.621 1.712 . . . . 0.0 115.621 -169.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 9.3 tp -134.81 129.98 52.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 C-N-CA 118.385 -1.326 . . . . 0.0 113.333 -173.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -95.56 100.58 12.3 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 169.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -97.42 6.26 48.49 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.72 -174.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 70.23 -47.98 0.63 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 125.097 1.359 . . . . 0.0 112.306 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 46.8 tpp . . . . . 0 C--N 1.303 -1.428 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 177.021 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 . . . . . 0 CA--C 1.496 -1.102 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -89.67 82.48 6.31 Favored 'General case' 0 CA--C 1.481 -1.703 0 CA-C-O 121.98 0.895 . . . . 0.0 110.283 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -165.96 83.79 0.31 Allowed 'General case' 0 C--N 1.276 -2.603 0 CA-C-N 113.395 -1.729 . . . . 0.0 109.463 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -149.75 93.7 2.07 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 174.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 pp -80.13 -12.87 59.62 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.835 0.826 . . . . 0.0 110.484 -178.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 176.79 171.93 40.92 Favored Glycine 0 N--CA 1.416 -2.697 0 N-CA-C 108.735 -1.746 . . . . 0.0 108.735 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.9 m -73.88 -31.05 62.96 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 121.588 0.709 . . . . 0.0 109.221 177.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 23.7 tpp180 -73.08 115.14 12.03 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.952 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.94 66.56 3.92 Favored Glycine 0 N--CA 1.438 -1.181 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 176.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.1 t -88.83 -1.04 57.89 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 122.699 0.4 . . . . 0.0 110.552 -175.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.2 t -104.45 0.81 29.32 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -108.99 -12.18 14.89 Favored 'General case' 0 CA--C 1.516 -0.358 0 O-C-N 121.983 -0.448 . . . . 0.0 111.687 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.9 m -128.8 97.34 3.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.079 0.466 . . . . 0.0 109.944 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.5 t70 66.6 98.89 0.05 OUTLIER 'General case' 0 C--O 1.235 0.326 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.538 -176.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.442 ' HG ' ' NE2' ' A' ' 18' ' ' GLN . 4.4 mm? -65.87 148.74 51.3 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.724 -175.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -86.65 137.33 32.56 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 173.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 63.16 -154.65 0.33 Allowed 'General case' 0 C--O 1.243 0.734 0 O-C-N 124.041 0.838 . . . . 0.0 109.418 -173.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.442 ' NE2' ' HG ' ' A' ' 15' ' ' LEU . 14.3 mt-30 66.41 18.58 10.88 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.495 1.118 . . . . 0.0 110.261 179.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -80.08 -25.37 40.06 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.566 0.698 . . . . 0.0 109.381 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.3 t -102.49 0.23 33.33 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 176.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.4 ' O ' ' HG2' ' A' ' 24' ' ' ARG 0.27 10.0 m 58.74 -13.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 C-N-CA 128.151 2.58 . . . . 0.0 116.155 178.039 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 46.9 pttt -64.47 -39.35 93.64 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 178.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.1 p -98.58 89.31 4.35 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-O 121.331 0.586 . . . . 0.0 111.392 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 21' ' ' VAL . 13.1 ptm180 -150.53 136.33 18.28 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.157 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.3 t -133.81 108.01 11.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 177.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.4 m -97.93 -65.42 0.96 Allowed 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.214 0.53 . . . . 0.0 109.96 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -162.55 44.29 0.13 Allowed 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 104.174 -2.528 . . . . 0.0 104.174 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -65.49 117.0 7.36 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 113.514 -1.675 . . . . 0.0 110.247 -178.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -84.16 -2.78 57.44 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.397 0.618 . . . . 0.0 110.028 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.7 mp -89.02 74.31 8.14 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -99.36 -24.14 14.91 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -83.38 74.88 10.03 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.269 177.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -90.26 2.77 55.1 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 122.468 1.128 . . . . 0.0 109.38 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 24.2 pt -122.51 159.5 25.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-N 113.968 -1.469 . . . . 0.0 107.067 178.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -94.45 110.57 22.35 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.875 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -81.08 -36.83 29.91 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.845 -177.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 179.05 95.52 0.1 OUTLIER Glycine 0 N--CA 1.435 -1.418 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.14 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -119.15 140.78 49.58 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 26.2 mmt 68.22 167.54 0.26 Allowed 'General case' 0 C--O 1.246 0.893 0 C-N-CA 125.792 1.637 . . . . 0.0 112.227 -177.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -125.9 -171.57 2.41 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.549 -175.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -94.67 119.54 33.47 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.348 0.594 . . . . 0.0 111.089 -173.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.543 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 2.5 tm? -102.98 113.9 27.75 Favored 'General case' 0 N--CA 1.411 -2.395 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 176.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.527 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 57.5 m-80 -108.51 145.58 34.53 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.419 -175.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 91.4 mt -136.8 160.31 39.23 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-O 122.042 0.925 . . . . 0.0 112.28 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.473 HG23 ' HA ' ' A' ' 96' ' ' VAL . 0.1 OUTLIER -121.14 130.38 74.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 171.434 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 81.4 t -105.19 133.28 49.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.763 -177.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -144.63 134.38 23.6 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -150.9 168.46 24.44 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -80.39 -28.37 37.93 Favored 'General case' 0 C--N 1.316 -0.854 0 O-C-N 123.971 0.794 . . . . 0.0 109.279 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 90.0 t -96.3 124.88 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 174.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.706 ' O ' HG22 ' A' ' 54' ' ' VAL . 16.2 tt0 -64.22 -49.28 72.6 Favored 'General case' 0 C--O 1.19 -2.075 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -173.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.57 1.94 33.79 Favored Glycine 0 C--N 1.292 -1.886 0 C-N-CA 119.278 -1.439 . . . . 0.0 113.648 -177.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.2 t -83.49 -22.19 32.58 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 177.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.706 HG22 ' O ' ' A' ' 51' ' ' GLN . 4.7 m -81.91 -45.8 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.967 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.263 175.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -60.48 -47.49 85.88 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 114.691 -1.141 . . . . 0.0 111.536 -177.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.69 -32.27 73.7 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.087 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.515 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 25.8 tp -76.47 -39.81 52.19 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.882 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 54' ' ' VAL . 24.8 t -53.3 -44.71 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 123.652 0.781 . . . . 0.0 111.573 177.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.84 -21.25 65.2 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.27 -8.52 21.19 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.401 0.62 . . . . 0.0 110.433 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.515 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -97.67 -43.04 7.35 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-N 115.03 -0.987 . . . . 0.0 108.876 -176.879 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -66.06 -20.01 66.03 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.859 0.361 . . . . 0.0 111.414 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -87.71 -0.47 56.95 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.99 -175.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.41 ' HB ' ' HB ' ' A' ' 71' ' ' VAL . 16.3 mt -84.14 93.83 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -140.9 23.62 2.23 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.7 m -97.72 145.5 9.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 114.206 -1.361 . . . . 0.0 112.692 -171.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 63.63 13.4 7.29 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 125.237 1.415 . . . . 0.0 111.995 175.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.59 -9.72 60.67 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.522 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.5 t -93.49 109.04 21.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -177.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 80.5 mtm180 -106.28 111.01 23.42 Favored 'General case' 0 N--CA 1.42 -1.962 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.078 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 41.4 t -114.22 129.72 69.72 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 177.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -140.39 153.6 46.4 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 120.069 -0.653 . . . . 0.0 111.021 -175.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.4 HG12 HG13 ' A' ' 58' ' ' VAL . 1.5 pp -94.32 141.77 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.071 175.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 67.4 mt -111.23 -25.44 3.52 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.472 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.537 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.445 ' O ' HD12 ' A' ' 45' ' ' ILE . 6.1 t60 -161.56 142.86 11.28 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -171.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -146.4 127.32 14.49 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -147.78 153.35 39.11 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.225 -176.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.2 p -94.06 94.57 4.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 122.207 1.003 . . . . 0.0 110.848 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.09 174.43 46.77 Favored Glycine 0 N--CA 1.42 -2.421 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 176.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.53 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -85.58 176.66 8.07 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 173.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.0 mt -79.2 112.55 17.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 122.07 0.148 . . . . 0.0 110.74 -170.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 67.6 p -107.76 165.93 11.07 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.421 ' O ' ' HB ' ' A' ' 86' ' ' ILE . 13.1 pt-20 -66.69 -23.83 66.18 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -174.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.2 t -76.35 -24.82 54.24 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.151 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -70.37 -37.81 74.64 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.493 ' CG2' ' HA ' ' A' ' 111' ' ' ALA . 48.2 mm -56.59 -38.86 59.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 113.868 -1.514 . . . . 0.0 111.35 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.7 m -58.66 -28.37 65.66 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.29 -178.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -76.02 -37.22 58.67 Favored 'General case' 0 C--O 1.251 1.157 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.97 -46.98 87.69 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.135 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.538 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 7.5 t -77.8 -23.06 49.21 Favored 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.138 177.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.04 -67.68 0.43 Allowed 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -176.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 33.5 t -99.01 4.88 47.29 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.283 -175.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 70.76 68.64 0.19 Allowed 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 124.405 1.082 . . . . 0.0 112.189 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -119.86 166.87 12.72 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 113.992 -1.458 . . . . 0.0 108.546 174.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 47.9 mm -121.38 144.49 30.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 174.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.473 ' HA ' HG23 ' A' ' 45' ' ' ILE . 19.9 t -94.63 119.76 43.09 Favored 'Isoleucine or valine' 0 C--O 1.249 1.035 0 CA-C-O 120.974 0.416 . . . . 0.0 110.097 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.1 mp -107.94 111.32 35.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 174.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -99.5 136.39 12.66 Favored Glycine 0 N--CA 1.413 -2.89 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -95.41 93.37 7.19 Favored 'General case' 0 C--N 1.29 -1.996 0 C-N-CA 118.543 -1.263 . . . . 0.0 109.665 -176.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.512 ' OD1' ' HA ' ' A' ' 121' ' ' HIS . 90.9 m-20 54.59 28.91 10.52 Favored 'General case' 0 C--O 1.212 -0.918 0 C-N-CA 123.856 0.862 . . . . 0.0 111.621 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 m -96.58 -46.71 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.984 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -175.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.53 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 63.5 mtm180 75.39 155.09 0.15 Allowed Pre-proline 0 N--CA 1.471 0.583 0 C-N-CA 124.0 0.92 . . . . 0.0 111.455 178.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -89.59 167.73 5.0 Favored 'Trans proline' 0 N--CA 1.432 -2.099 0 C-N-CA 121.475 1.45 . . . . 0.0 115.269 -175.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -75.36 156.66 35.24 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 112.6 -2.091 . . . . 0.0 106.906 170.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.491 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -61.27 -32.72 72.55 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.513 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 77.6 m-20 -87.01 -24.9 24.49 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.63 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.41 -44.03 79.8 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.609 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 17.2 ptpt -57.67 -35.2 70.25 Favored 'General case' 0 CA--C 1.562 1.437 0 O-C-N 123.575 0.547 . . . . 0.0 110.465 177.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.513 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 98.2 mtt180 -72.49 -55.91 6.24 Favored 'General case' 0 N--CA 1.385 -3.686 0 C-N-CA 125.762 1.625 . . . . 0.0 109.402 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -53.82 -47.47 70.86 Favored 'General case' 0 C--O 1.198 -1.626 0 CA-C-N 113.806 -1.543 . . . . 0.0 110.067 -177.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.493 ' HA ' ' CG2' ' A' ' 86' ' ' ILE . . . -48.54 -48.09 38.78 Favored 'General case' 0 CA--C 1.489 -1.386 0 O-C-N 124.618 1.199 . . . . 0.0 111.47 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -77.36 -35.44 54.57 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.872 -174.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 45.4 t -77.61 -3.13 39.3 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 177.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.538 ' O ' ' HB ' ' A' ' 90' ' ' THR . 16.3 mt-10 -113.28 11.94 18.78 Favored 'General case' 0 CA--C 1.468 -2.188 0 C-N-CA 124.388 1.075 . . . . 0.0 112.386 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 55.3 mttp 67.48 11.77 8.55 Favored 'General case' 0 N--CA 1.416 -2.148 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 174.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.7 m -119.85 118.77 58.18 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 121.769 0.795 . . . . 0.0 112.602 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -94.22 124.92 38.55 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.4 pt -94.21 144.29 9.95 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-O 121.182 0.515 . . . . 0.0 111.059 -176.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -126.91 132.59 50.85 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.204 0.526 . . . . 0.0 109.87 -176.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.526 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -160.89 163.82 31.69 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.028 -173.278 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.512 ' HA ' ' OD1' ' A' ' 100' ' ' ASN . 28.3 t-80 71.88 113.63 0.06 Allowed 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.704 1.252 . . . . 0.0 112.727 174.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -81.1 144.58 31.6 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.647 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 25.2 pt -93.52 158.76 2.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.237 -177.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 36.0 mt 67.75 23.94 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.538 0 CA-C-O 122.915 1.341 . . . . 0.0 108.976 -176.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -102.21 -62.96 1.2 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.612 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -86.68 21.91 2.07 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 122.76 1.267 . . . . 0.0 109.647 -178.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.4 p -78.69 -13.91 13.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 176.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.8 mt -99.46 32.78 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 177.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -60.68 -34.91 75.04 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.855 177.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -96.25 117.45 30.8 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 171.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 49.7 mt -66.03 -30.26 49.41 Favored 'Isoleucine or valine' 0 C--O 1.244 0.807 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -170.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -83.44 -1.37 53.37 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -92.21 83.57 5.1 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.88 -22.19 18.78 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.554 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 92.1 mmm . . . . . 0 CA--C 1.499 -0.996 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 176.414 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 . . . . . 0 CA--C 1.505 -0.768 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -101.61 164.39 11.77 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -154.47 74.5 0.95 Allowed 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 176.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -103.45 131.27 50.69 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.144 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.1 mp -105.53 -5.18 20.43 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.497 0.665 . . . . 0.0 109.558 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.83 -89.06 1.39 Allowed Glycine 0 N--CA 1.433 -1.528 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.24 177.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.5 t -165.14 101.4 0.75 Allowed 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 121.942 0.877 . . . . 0.0 110.255 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -142.74 168.43 19.74 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 148.23 129.45 1.86 Allowed Glycine 0 N--CA 1.423 -2.184 0 C-N-CA 119.928 -1.129 . . . . 0.0 112.616 177.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.7 t -98.83 -33.85 10.72 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 177.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.1 t -76.31 -5.88 49.02 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.104 -177.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -82.17 -9.77 59.4 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 174.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.4 t -107.16 -51.86 7.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 176.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -97.58 99.05 10.43 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.6 mp -99.76 -59.44 1.71 Allowed 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.339 0.59 . . . . 0.0 111.309 -178.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -109.92 -46.46 3.47 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.943 -177.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -84.56 140.69 31.23 Favored 'General case' 0 CA--C 1.483 -1.634 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.045 -176.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 67.9 -60.02 0.41 Allowed 'General case' 0 CA--C 1.537 0.451 0 O-C-N 124.821 1.326 . . . . 0.0 112.79 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 56.65 -79.81 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.223 1.809 . . . . 0.0 113.345 -176.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.3 t -135.65 37.11 2.89 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . 0.456 34.1 m 62.03 62.53 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 126.454 1.902 . . . . 0.0 115.357 -178.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -93.55 -68.89 0.78 Allowed 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 171.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.422 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 8.9 p -93.06 86.71 5.48 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.184 178.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.422 ' HB2' ' O ' ' A' ' 23' ' ' THR . 3.0 tpp180 177.57 -28.41 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.637 -177.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 36.0 m -128.05 160.3 38.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 120.833 0.349 . . . . 0.0 111.119 -175.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.8 m -112.71 155.91 23.7 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.368 178.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 57.2 tp -138.26 142.13 39.88 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 177.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -94.18 132.38 38.78 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.154 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -100.42 -37.2 8.94 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 176.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.1 mp -97.32 137.29 36.54 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.13 177.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -128.71 148.05 50.8 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -93.75 128.56 40.04 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.095 0.474 . . . . 0.0 111.947 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -112.37 128.06 56.19 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 60.8 mt -125.87 132.11 71.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -173.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -119.22 173.77 6.74 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-O 121.178 0.513 . . . . 0.0 111.827 177.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -98.08 167.01 11.15 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.876 -177.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 144.14 -20.79 2.11 Favored Glycine 0 N--CA 1.432 -1.604 0 C-N-CA 119.876 -1.154 . . . . 0.0 113.751 176.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -136.89 144.4 43.51 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.284 -176.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 85.3 mmm 79.58 156.84 0.15 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.712 1.605 . . . . 0.0 112.327 176.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? 64.41 27.44 13.6 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.05 0.94 . . . . 0.0 109.885 -173.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -98.46 94.71 6.86 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.103 -176.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -100.23 94.91 6.46 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 176.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -96.84 134.62 39.92 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 114.539 -1.209 . . . . 0.0 109.053 -175.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 95.8 mt -137.19 158.34 44.66 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.613 0.72 . . . . 0.0 112.114 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.492 HD11 ' CD2' ' A' ' 75' ' ' HIS . 0.4 OUTLIER -122.04 132.73 70.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.808 170.509 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 97.7 t -111.05 126.84 68.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.944 -176.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.478 ' O ' ' HA2' ' A' ' 98' ' ' GLY . 74.1 mttt -137.0 147.7 46.43 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.283 -0.872 . . . . 0.0 108.964 173.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.21 170.74 19.81 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 120.827 0.346 . . . . 0.0 110.562 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -72.7 -29.87 63.74 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.438 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 75.8 t -113.32 134.15 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.644 ' O ' HG21 ' A' ' 54' ' ' VAL . 12.4 tt0 -60.36 -52.37 65.55 Favored 'General case' 0 C--O 1.2 -1.514 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -175.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.65 5.15 31.75 Favored Glycine 0 C--N 1.292 -1.875 0 C-N-CA 118.327 -1.892 . . . . 0.0 114.305 -176.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.0 m -88.38 -21.03 24.54 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 174.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.644 HG21 ' O ' ' A' ' 51' ' ' GLN . 3.6 m -76.26 -46.04 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 174.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -67.0 -35.6 80.29 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.475 -1.239 . . . . 0.0 112.079 -176.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.73 -33.65 75.57 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.303 0.573 . . . . 0.0 110.257 176.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 31.3 tp -79.87 -45.99 17.64 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 54' ' ' VAL . 56.1 t -55.88 -44.21 77.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 124.037 0.935 . . . . 0.0 112.264 179.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.66 -20.84 65.23 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -177.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.471 ' O ' HG12 ' A' ' 64' ' ' ILE . . . -98.1 -28.78 13.59 Favored 'General case' 0 C--O 1.202 -1.426 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.71 -33.82 60.35 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 114.023 -1.444 . . . . 0.0 110.265 -176.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -72.64 -20.66 61.23 Favored 'General case' 0 C--N 1.315 -0.908 0 O-C-N 122.061 -0.399 . . . . 0.0 111.159 177.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? -97.19 6.14 48.94 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 179.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.592 ' HB ' ' O ' ' A' ' 71' ' ' VAL . 18.7 mm -83.12 81.07 1.56 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-O 121.81 0.814 . . . . 0.0 109.416 177.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.436 ' O ' ' HG2' ' A' ' 70' ' ' ARG . 3.4 t70 -101.25 -53.48 3.01 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.235 177.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.4 t 62.02 -79.59 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.47 0 C-N-CA 125.046 1.338 . . . . 0.0 111.882 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -176.91 -71.21 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -99.94 -50.87 1.32 Allowed Glycine 0 CA--C 1.492 -1.406 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.86 -176.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.0 t -93.35 109.02 21.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 -176.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.436 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 67.9 mtt180 -114.53 133.85 55.47 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -178.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.592 ' O ' ' HB ' ' A' ' 64' ' ' ILE . 23.0 t -122.91 110.92 27.86 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 178.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -137.5 157.48 46.46 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-O 121.803 0.811 . . . . 0.0 110.589 -174.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 pp -93.83 157.97 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.177 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.413 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 74.3 mt -119.99 -31.04 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.463 177.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.492 ' CD2' HD11 ' A' ' 45' ' ' ILE . 6.4 t60 -151.55 131.97 13.78 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -171.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -139.24 129.31 25.15 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.108 0.963 . . . . 0.0 109.458 -175.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -154.08 157.59 39.21 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.505 -178.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.44 ' HB ' ' HA ' ' A' ' 51' ' ' GLN . 5.1 p -94.49 94.99 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-O 122.132 0.968 . . . . 0.0 108.611 176.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -175.57 175.95 47.33 Favored Glycine 0 N--CA 1.401 -3.698 0 C-N-CA 120.186 -1.006 . . . . 0.0 110.858 -177.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 102' ' ' ARG . . . -87.46 173.12 9.31 Favored 'General case' 0 C--N 1.282 -2.35 0 O-C-N 124.112 0.536 . . . . 0.0 109.721 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.9 mp -75.49 107.76 6.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.65 152.66 22.85 Favored 'General case' 0 N--CA 1.401 -2.91 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.047 -178.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -54.24 -45.39 72.31 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 124.029 0.831 . . . . 0.0 112.547 -174.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.9 p -69.8 -18.71 63.49 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -81.51 -25.37 36.01 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-O 121.603 0.716 . . . . 0.0 110.128 177.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.441 HG22 ' HA ' ' A' ' 111' ' ' ALA . 42.0 mt -72.51 -20.57 19.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.681 178.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.0 m -60.13 -26.8 66.55 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.05 175.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -79.64 -38.58 33.46 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.97 177.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.01 -58.68 6.4 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.338 -176.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.632 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 2.3 t -68.15 -28.22 67.11 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.507 177.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.04 -65.49 0.68 Allowed 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.19 0.519 . . . . 0.0 111.514 -177.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.5 m -93.69 6.0 49.78 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.888 -176.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 67.87 33.0 4.94 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.901 0.858 . . . . 0.0 109.937 177.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.53 153.1 18.05 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.439 -178.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 41.4 mm -107.72 141.21 23.52 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.146 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.466 ' HA ' HG21 ' A' ' 45' ' ' ILE . 10.7 t -94.8 120.47 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 65.8 mt -112.94 120.28 62.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 177.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 47' ' ' LYS . . . -139.83 171.06 24.0 Favored Glycine 0 N--CA 1.427 -1.902 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 178.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.476 ' C ' ' H ' ' A' ' 101' ' ' VAL . 30.4 p90 -158.77 134.57 8.87 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 117.66 0.73 . . . . 0.0 111.324 -178.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 72.84 -23.46 0.21 Allowed 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 125.403 1.481 . . . . 0.0 112.874 178.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.489 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 2.3 m -77.64 -49.71 21.56 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.099 177.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.583 ' O ' ' HB3' ' A' ' 80' ' ' ALA . 53.0 mtm180 72.68 170.82 0.11 Allowed Pre-proline 0 C--N 1.352 0.692 0 O-C-N 124.164 0.915 . . . . 0.0 111.368 177.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -91.99 169.46 2.92 Favored 'Trans proline' 0 N--CA 1.443 -1.455 0 CA-C-N 120.534 1.226 . . . . 0.0 113.718 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -79.0 149.61 32.17 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 169.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.576 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -59.3 -26.53 65.05 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.629 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 16.7 m120 -80.01 -30.7 39.66 Favored 'General case' 0 C--N 1.315 -0.926 0 O-C-N 121.847 -0.533 . . . . 0.0 109.863 177.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.67 -43.05 63.62 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.256 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 21.2 ptmt -59.81 -24.71 64.36 Favored 'General case' 0 CA--C 1.559 1.324 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.735 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.629 ' HB2' ' O ' ' A' ' 106' ' ' ASN 0.287 38.4 mtm180 -77.51 -56.77 4.25 Favored 'General case' 0 N--CA 1.395 -3.176 0 C-N-CA 125.935 1.694 . . . . 0.0 108.217 175.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.46 -47.88 48.02 Favored 'General case' 0 CA--C 1.482 -1.648 0 CA-C-N 113.545 -1.661 . . . . 0.0 111.362 -176.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.441 ' HA ' HG22 ' A' ' 86' ' ' ILE . . . -48.07 -42.76 29.51 Favored 'General case' 0 CA--C 1.505 -0.777 0 O-C-N 124.518 1.136 . . . . 0.0 111.349 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -84.29 -23.7 30.19 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -173.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 30.8 t -85.59 -1.67 57.36 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-O 123.173 1.463 . . . . 0.0 107.254 174.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.632 ' O ' ' HB ' ' A' ' 90' ' ' THR . 35.2 mt-10 -120.56 13.0 11.65 Favored 'General case' 0 N--CA 1.404 -2.754 0 CA-C-N 113.638 -1.619 . . . . 0.0 112.811 -177.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.506 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 92.4 mttt 63.09 13.0 6.42 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 172.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.2 m -119.14 138.53 49.53 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-O 121.875 0.845 . . . . 0.0 112.777 -176.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -99.52 126.57 45.49 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.919 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 6.5 pt -94.05 133.79 33.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.255 0.55 . . . . 0.0 111.369 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -98.39 122.01 41.04 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.652 -177.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.402 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 3.8 mm? -128.68 164.77 22.2 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.617 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -67.35 125.98 27.82 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 106.257 -1.756 . . . . 0.0 106.257 169.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -63.84 140.52 58.88 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 123.906 0.754 . . . . 0.0 112.643 -173.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.9 mp -119.04 121.03 65.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 173.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 63.6 mt -93.2 94.49 4.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 C-N-CA 119.911 -0.716 . . . . 0.0 109.107 178.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 68.96 -82.86 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.416 1.486 . . . . 0.0 110.51 -178.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -149.82 143.92 25.66 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 20.6 m -92.95 168.8 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 176.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 32.4 pt -78.49 85.22 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 122.58 1.181 . . . . 0.0 109.216 173.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -89.63 8.0 33.63 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 113.876 -1.511 . . . . 0.0 109.566 -174.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -69.99 124.57 24.4 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.598 177.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 7.7 tt -73.22 -52.51 21.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -176.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -91.23 70.3 6.14 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 123.08 1.419 . . . . 0.0 112.082 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -115.72 21.17 14.12 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 112.905 -1.952 . . . . 0.0 108.485 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -111.55 81.75 1.5 Allowed 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.244 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 43.9 tpp . . . . . 0 C--N 1.304 -1.395 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 178.631 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 62.9 t30 . . . . . 0 N--CA 1.474 0.77 0 CA-C-O 121.274 0.559 . . . . 0.0 109.896 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.24 -51.58 67.17 Favored 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 124.32 1.048 . . . . 0.0 111.147 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 66.72 157.5 0.12 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.617 1.167 . . . . 0.0 112.882 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -93.1 -55.77 3.21 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.2 mt -150.25 139.18 20.97 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 124.05 0.94 . . . . 0.0 108.928 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.2 -166.74 34.14 Favored Glycine 0 C--N 1.303 -1.273 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.6 p 58.34 172.47 0.06 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.249 1.419 . . . . 0.0 114.096 -178.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 65.44 -81.42 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.66 1.184 . . . . 0.0 112.548 177.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.65 -47.49 86.19 Favored Glycine 0 CA--C 1.501 -0.782 0 N-CA-C 111.969 -0.452 . . . . 0.0 111.969 -175.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.5 p -77.92 2.92 15.92 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.154 0.502 . . . . 0.0 111.816 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.1 m -118.24 11.06 13.05 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 121.133 0.492 . . . . 0.0 110.619 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -128.69 11.33 6.18 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.408 0.623 . . . . 0.0 109.362 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.0 m -77.82 132.03 33.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.847 -173.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 59.86 40.26 19.48 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 114.916 -1.038 . . . . 0.0 113.575 176.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.3 mt -79.01 85.72 4.92 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 172.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -78.08 94.35 4.67 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.444 -177.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -111.88 -170.27 1.62 Allowed 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.209 -177.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.425 ' HA ' ' HG3' ' A' ' 24' ' ' ARG . 9.0 tt0 83.46 -20.17 0.34 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.566 1.546 . . . . 0.0 112.496 178.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -49.44 -43.58 44.86 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 124.253 1.021 . . . . 0.0 112.165 -177.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.5 m -122.09 15.87 10.74 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.029 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.6 m 44.11 23.47 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.824 0 C-N-CA 125.734 1.614 . . . . 0.0 114.174 -176.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.7 tptm -67.55 -53.11 31.16 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 123.944 0.897 . . . . 0.0 110.92 -174.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 20.1 p -103.49 31.53 4.32 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-O 121.356 0.598 . . . . 0.0 110.286 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.586 ' HA ' ' NE ' ' A' ' 24' ' ' ARG . 4.6 mmp_? -99.57 101.21 12.36 Favored 'General case' 0 CA--C 1.485 -1.521 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -174.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.7 t -102.52 94.96 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.343 0 N-CA-C 104.114 -2.55 . . . . 0.0 104.114 167.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.1 m -67.71 -31.04 70.7 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.495 -174.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.448 HD22 HD22 ' A' ' 30' ' ' LEU . 27.3 mt -109.82 82.52 1.61 Allowed 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -73.65 -37.53 65.28 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.756 -175.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -130.08 -75.93 0.54 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.448 HD22 HD22 ' A' ' 27' ' ' LEU . 17.1 tp 51.91 41.55 29.58 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.882 1.273 . . . . 0.0 111.881 177.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -67.88 111.79 4.55 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 67.97 101.56 0.05 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.63 1.172 . . . . 0.0 109.451 -171.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -94.03 140.75 29.34 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 121.721 0.772 . . . . 0.0 112.947 -174.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.2 tp -131.7 -17.86 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 CA-C-N 114.436 -1.256 . . . . 0.0 107.634 170.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 62.5 mttp 72.05 -70.29 0.16 Allowed 'General case' 0 C--N 1.357 0.919 0 C-N-CA 125.647 1.579 . . . . 0.0 110.18 -177.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -144.79 148.81 34.51 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -83.75 61.37 4.75 Favored Glycine 0 C--N 1.312 -0.798 0 N-CA-C 111.886 -0.486 . . . . 0.0 111.886 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -167.08 134.42 2.44 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 123.891 0.877 . . . . 0.0 109.092 -178.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 51.9 ttm -131.93 91.4 2.97 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 174.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -88.19 169.32 11.99 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.343 178.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -94.59 94.23 8.05 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 170.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.451 ' HB2' ' HA ' ' A' ' 71' ' ' VAL . 1.3 pt? -132.17 92.13 3.06 Favored 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -143.48 131.85 22.14 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.659 -168.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 74.7 mt -140.15 155.19 47.07 Favored 'General case' 0 C--O 1.258 1.51 0 O-C-N 123.717 0.636 . . . . 0.0 110.513 174.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.468 HD11 ' CD2' ' A' ' 75' ' ' HIS . 0.4 OUTLIER -120.6 135.07 62.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.03 176.63 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 72.5 t -109.7 126.87 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.869 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.334 -176.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.414 ' O ' ' HA2' ' A' ' 98' ' ' GLY . 23.1 mmtp -142.06 119.35 11.5 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 125.09 1.356 . . . . 0.0 109.858 -179.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -140.18 164.42 30.1 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -178.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.17 -17.08 44.13 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -178.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 86.1 t -105.03 122.59 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.354 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 175.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.738 ' O ' HG23 ' A' ' 54' ' ' VAL . 15.4 tm0? -58.14 -48.88 78.88 Favored 'General case' 0 C--O 1.202 -1.421 0 C-N-CA 122.948 0.499 . . . . 0.0 111.686 -174.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.77 0.8 81.06 Favored Glycine 0 C--N 1.285 -2.273 0 C-N-CA 117.693 -2.194 . . . . 0.0 113.912 -176.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 70.7 m -86.96 -20.86 26.68 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 176.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 51' ' ' GLN . 9.3 m -72.23 -43.23 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.449 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 172.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -62.68 -42.81 99.82 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.968 177.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.04 -35.05 78.95 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.923 0.392 . . . . 0.0 110.676 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.466 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 24.8 tp -76.57 -38.96 54.1 Favored 'General case' 0 C--O 1.208 -1.112 0 C-N-CA 120.456 -0.497 . . . . 0.0 109.711 177.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.423 HG21 ' O ' ' A' ' 54' ' ' VAL . 45.2 t -57.8 -44.49 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 122.746 0.419 . . . . 0.0 110.693 175.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.67 -18.18 64.74 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 123.229 0.612 . . . . 0.0 111.62 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.56 -19.71 15.37 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.153 0.501 . . . . 0.0 109.799 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -88.85 -36.85 15.77 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.034 -175.523 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -65.43 -26.16 67.84 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.011 0.434 . . . . 0.0 110.328 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.47 ' HB2' ' HZ2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -92.59 6.18 48.22 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.027 -179.267 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 31.8 mm -73.07 84.95 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 175.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -160.14 92.32 0.99 Allowed 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.1 t -120.41 -76.48 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -162.62 133.16 4.73 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 114.285 -1.325 . . . . 0.0 107.761 179.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.99 -65.41 3.56 Favored Glycine 0 C--N 1.314 -0.641 0 N-CA-C 111.8 -0.52 . . . . 0.0 111.8 178.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.7 p -94.86 118.05 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 CA-C-O 122.044 0.926 . . . . 0.0 109.841 178.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -137.4 127.39 25.83 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 177.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.451 ' HA ' ' HB2' ' A' ' 42' ' ' LEU . 9.9 t -145.49 156.21 13.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -139.58 160.34 40.09 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 175.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.4 pp -94.43 164.05 2.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.828 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 70.7 mt -120.24 -41.67 2.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 121.523 0.677 . . . . 0.0 110.453 175.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.468 ' CD2' HD11 ' A' ' 45' ' ' ILE . 2.4 t60 -144.17 131.92 21.31 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.909 -168.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.574 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -142.88 134.96 27.18 Favored 'General case' 0 CA--C 1.503 -0.848 0 C-N-CA 124.26 1.024 . . . . 0.0 108.472 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.479 ' O ' HG11 ' A' ' 54' ' ' VAL . . . -160.82 164.86 31.08 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.439 ' HB ' ' HA ' ' A' ' 51' ' ' GLN . 7.1 p -93.34 98.51 8.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-O 122.423 1.106 . . . . 0.0 109.542 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.25 172.93 45.9 Favored Glycine 0 N--CA 1.406 -3.341 0 C-N-CA 120.052 -1.071 . . . . 0.0 110.572 -178.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.615 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -88.68 -166.86 1.7 Allowed 'General case' 0 N--CA 1.412 -2.33 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.6 mp -91.33 120.81 40.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 177.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.9 p -121.23 158.32 28.35 Favored 'General case' 0 C--N 1.317 -0.833 0 O-C-N 123.314 0.384 . . . . 0.0 110.157 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.73 -39.57 77.6 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -176.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.1 m -75.59 -8.74 57.53 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 120.913 0.387 . . . . 0.0 111.544 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -95.51 -30.99 13.55 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.418 ' CG2' ' HA ' ' A' ' 111' ' ' ALA . 31.0 mm -58.18 -31.96 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-N 114.46 -1.245 . . . . 0.0 111.355 174.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 25.8 m -58.53 -31.57 68.05 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.603 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -72.86 -35.23 67.16 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 176.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 94' ' ' ALA . . . -58.03 -52.92 63.54 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.29 -178.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.515 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 3.4 t -71.93 -30.96 65.87 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.995 177.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.76 -63.05 1.43 Allowed 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 40.6 m -97.62 5.26 49.68 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -175.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.1 m120 67.34 28.07 8.0 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.629 0.728 . . . . 0.0 110.88 178.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.436 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . -94.46 129.85 41.07 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 36.2 pt -93.47 150.52 3.91 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.407 ' HA ' HG23 ' A' ' 45' ' ' ILE . 18.3 t -94.11 112.56 27.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-O 121.349 0.595 . . . . 0.0 109.551 -176.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 54.9 mt -98.88 98.1 6.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 47' ' ' LYS . . . -94.78 151.57 20.16 Favored Glycine 0 N--CA 1.427 -1.965 0 C-N-CA 119.998 -1.096 . . . . 0.0 111.852 -176.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.444 ' C ' ' H ' ' A' ' 101' ' ' VAL . 23.8 m-85 -125.22 118.37 25.87 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -176.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 64.8 t30 70.08 -33.22 0.25 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 125.449 1.5 . . . . 0.0 113.018 178.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.444 ' H ' ' C ' ' A' ' 99' ' ' PHE . 0.7 OUTLIER -53.35 -71.74 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 117.739 2.496 . . . . 0.0 117.739 -177.673 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.615 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 0.0 OUTLIER 84.33 164.03 0.11 Allowed Pre-proline 0 N--CA 1.478 0.949 0 C-N-CA 124.573 1.149 . . . . 0.0 111.178 -170.225 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -88.65 171.43 5.08 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 C-N-CA 121.446 1.431 . . . . 0.0 113.509 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -83.33 155.46 23.55 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 113.728 -1.578 . . . . 0.0 107.142 169.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.475 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -60.64 -24.39 65.51 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -178.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.586 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 22.3 m-80 -89.81 -27.8 19.73 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.77 -38.39 70.36 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.163 -178.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -61.79 -27.04 68.47 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.961 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.586 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 62.6 mtp180 -79.38 -55.22 5.23 Favored 'General case' 0 N--CA 1.383 -3.779 0 C-N-CA 125.382 1.473 . . . . 0.0 109.623 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -53.18 -46.54 69.01 Favored 'General case' 0 C--O 1.198 -1.623 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.872 -178.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.418 ' HA ' ' CG2' ' A' ' 86' ' ' ILE . . . -48.53 -48.29 38.49 Favored 'General case' 0 CA--C 1.491 -1.319 0 O-C-N 124.413 1.071 . . . . 0.0 111.918 -178.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -78.7 -33.91 46.51 Favored 'General case' 0 N--CA 1.401 -2.884 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.844 -172.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 32.2 t -77.2 -0.38 24.91 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.515 ' O ' ' HB ' ' A' ' 90' ' ' THR . 21.0 mt-10 -120.23 11.47 11.57 Favored 'General case' 0 N--CA 1.405 -2.684 0 CA-C-N 114.389 -1.278 . . . . 0.0 112.558 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 52.8 mttp 67.68 8.86 6.67 Favored 'General case' 0 N--CA 1.42 -1.955 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 173.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.1 m -112.32 127.1 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.63 0 CA-C-O 121.722 0.773 . . . . 0.0 112.413 -178.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -94.75 122.66 37.6 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.011 -178.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 16.8 pt -106.59 138.44 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.465 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -151.51 147.22 26.56 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.433 ' HG ' ' HG3' ' A' ' 102' ' ' ARG . 2.9 mm? -107.32 162.75 13.62 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -170.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 40.1 t-80 76.16 -57.04 0.57 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 113.53 -1.668 . . . . 0.0 113.015 169.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 52.9 mtt-85 44.29 83.16 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 9.5 tp -101.7 2.04 10.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-O 122.418 1.104 . . . . 0.0 108.502 176.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.1 mm -76.25 90.04 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.277 -178.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 79.7 t80 177.94 -50.25 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -111.57 107.52 16.71 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 106.255 -1.758 . . . . 0.0 106.255 175.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 91.4 t 78.92 103.94 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.508 0 O-C-N 124.619 1.199 . . . . 0.0 108.274 -170.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 70.6 mt 78.96 87.9 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 C-N-CA 124.876 1.27 . . . . 0.0 111.509 -176.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -119.91 -28.52 5.16 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 173.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -83.15 32.89 0.44 Allowed 'General case' 0 C--O 1.242 0.704 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.56 -178.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 9.1 tp -84.99 -12.14 11.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 176.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -122.71 143.28 49.9 Favored 'General case' 0 N--CA 1.425 -1.675 0 CA-C-N 113.987 -1.46 . . . . 0.0 108.318 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -143.69 118.25 9.76 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.67 81.03 8.6 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.333 0.587 . . . . 0.0 109.636 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 24.7 mmt . . . . . 0 C--N 1.305 -1.344 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.219 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 . . . . . 0 N--CA 1.469 0.519 0 CA-C-O 120.774 0.321 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -129.76 137.07 50.33 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -178.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -90.55 80.44 6.02 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.939 0.876 . . . . 0.0 110.743 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -84.1 120.09 25.75 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -83.9 91.35 7.56 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -176.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.17 -179.95 16.23 Favored Glycine 0 C--N 1.301 -1.412 0 N-CA-C 110.091 -1.203 . . . . 0.0 110.091 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.0 t 49.24 -165.53 0.03 OUTLIER 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 125.551 1.54 . . . . 0.0 112.153 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.422 ' HD3' ' C ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -132.58 -49.32 0.9 Allowed 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 176.213 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.04 83.9 0.04 OUTLIER Glycine 0 N--CA 1.421 -2.337 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.2 m -58.78 -61.95 2.23 Favored 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 123.295 0.638 . . . . 0.0 110.08 -177.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.4 m -89.61 63.0 6.08 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 121.479 0.657 . . . . 0.0 112.021 -176.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -155.58 -38.57 0.08 Allowed 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.578 173.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.7 m -89.07 -36.14 8.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 174.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -122.15 116.59 24.46 Favored 'General case' 0 N--CA 1.424 -1.755 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.153 179.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.546 ' O ' ' HG2' ' A' ' 19' ' ' ARG . 5.8 mp -113.98 117.96 32.78 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 174.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -52.51 -34.17 48.37 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.807 0.843 . . . . 0.0 111.187 -175.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -73.32 -53.6 10.42 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.898 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.414 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 34.3 tt0 -63.17 -29.62 70.93 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.782 -175.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.546 ' HG2' ' O ' ' A' ' 15' ' ' LEU . 31.5 mmm180 -65.49 -34.32 78.0 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.083 0.468 . . . . 0.0 111.528 -176.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.3 m -113.55 17.75 18.09 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . 0.266 34.7 m 48.17 16.83 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 C-N-CA 127.213 2.205 . . . . 0.0 115.171 -177.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -73.18 134.77 44.5 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 72.1 p 69.85 -0.73 2.59 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 125.889 1.676 . . . . 0.0 112.362 -175.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -103.29 -60.07 1.61 Allowed 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 174.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.7 t -103.88 93.78 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 107.229 -1.396 . . . . 0.0 107.229 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.3 m -117.17 156.43 27.68 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.321 -176.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.6 pp -112.47 13.76 20.19 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.616 0.722 . . . . 0.0 109.449 177.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.3 t70 65.45 -91.24 0.03 OUTLIER 'General case' 0 C--O 1.242 0.682 0 C-N-CA 125.22 1.408 . . . . 0.0 109.511 -174.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.7 t70 175.5 117.61 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 176.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 pp -137.18 -13.97 1.56 Allowed 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 66.51 -67.44 0.16 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.646 1.178 . . . . 0.0 110.408 -174.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -151.23 -64.03 0.19 Allowed 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 173.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 50.29 81.55 0.06 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.741 1.216 . . . . 0.0 111.791 175.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 24.7 pt -114.12 163.32 11.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-O 120.76 0.314 . . . . 0.0 110.947 -178.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -93.98 -174.75 3.5 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -178.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -138.9 74.07 1.46 Allowed 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 122.151 0.977 . . . . 0.0 109.586 171.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.39 38.94 3.12 Favored Glycine 0 CA--C 1.509 -0.336 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.741 -176.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -84.54 175.83 9.02 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.8 mtt -74.93 -55.01 6.22 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 173.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.8 tttp 61.47 23.87 14.07 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.137 0.975 . . . . 0.0 110.371 174.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -115.73 111.57 20.77 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.214 -178.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 3.0 mm? -115.83 112.05 21.39 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 171.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.433 HD21 ' C ' ' A' ' 42' ' ' LEU . 0.9 OUTLIER -122.21 144.6 48.87 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.226 -172.706 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.436 ' HA ' ' HB1' ' A' ' 94' ' ' ALA . 4.4 pp -158.56 167.21 30.21 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 177.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.408 HG22 ' HA ' ' A' ' 96' ' ' VAL . 0.5 OUTLIER -119.5 137.21 54.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 C-N-CA 123.536 0.734 . . . . 0.0 110.889 179.151 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 65.3 t -109.1 125.35 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.282 -177.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.426 ' O ' ' HA2' ' A' ' 98' ' ' GLY . 14.6 mmmm -138.02 122.42 18.32 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -137.92 169.04 18.48 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -177.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -81.49 -32.2 32.57 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 123.984 0.802 . . . . 0.0 109.099 -177.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 96.2 t -98.08 128.75 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.985 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 174.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.763 ' O ' HG21 ' A' ' 54' ' ' VAL . 16.3 tt0 -62.3 -43.62 98.4 Favored 'General case' 0 C--O 1.191 -1.987 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.305 -175.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -75.19 -0.13 60.56 Favored Glycine 0 C--N 1.291 -1.924 0 C-N-CA 118.388 -1.863 . . . . 0.0 113.268 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.0 t -83.88 -23.36 31.29 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 178.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.763 HG21 ' O ' ' A' ' 51' ' ' GLN . 9.2 m -74.8 -46.54 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.158 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 172.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -56.44 -46.42 80.3 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.328 1.051 . . . . 0.0 112.241 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.88 -43.68 81.5 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.801 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.492 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 27.3 tp -74.14 -45.43 48.84 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.202 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 54' ' ' VAL . 46.6 t -54.05 -43.77 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.128 0.971 . . . . 0.0 112.493 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.42 -28.18 69.8 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.94 -26.9 18.2 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.492 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -76.1 -39.02 56.21 Favored 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 113.962 -1.472 . . . . 0.0 110.37 -176.126 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -69.88 -21.74 63.3 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.822 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.41 ' O ' HG13 ' A' ' 66' ' ' VAL . 7.3 ptpp? -93.55 2.09 56.52 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -178.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.2 mt -82.52 -15.31 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 121.952 0.882 . . . . 0.0 108.967 177.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -57.45 -24.79 57.74 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.294 1.038 . . . . 0.0 112.056 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.41 HG13 ' O ' ' A' ' 63' ' ' LYS . 7.1 p -88.83 -3.73 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.412 0 CA-C-O 121.223 0.535 . . . . 0.0 111.372 -177.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -93.11 172.89 8.02 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.13 -36.1 92.98 Favored Glycine 0 C--O 1.247 0.958 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 176.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.4 t -94.3 103.6 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 105.458 -2.053 . . . . 0.0 105.458 173.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 25.5 mtm180 -94.17 98.5 11.0 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.572 0.701 . . . . 0.0 110.762 -173.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 17.8 t -102.27 137.77 29.0 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -151.15 153.22 34.58 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.415 0.626 . . . . 0.0 110.306 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 pp -94.11 155.86 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.792 176.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.415 ' N ' HD12 ' A' ' 74' ' ' ILE . 3.4 mp -115.79 -41.72 3.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-O 121.438 0.637 . . . . 0.0 109.466 177.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -143.27 122.76 13.17 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.93 -169.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.512 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -131.69 135.57 46.98 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 124.422 1.089 . . . . 0.0 108.496 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.417 ' O ' HG11 ' A' ' 54' ' ' VAL . . . -161.84 163.03 29.57 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 -178.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.6 p -93.51 96.93 6.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 122.405 1.098 . . . . 0.0 109.651 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.81 175.08 47.49 Favored Glycine 0 N--CA 1.406 -3.334 0 N-CA-C 108.332 -1.907 . . . . 0.0 108.332 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.583 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -89.78 -160.72 0.71 Allowed 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 177.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.528 ' O ' ' HA ' ' A' ' 103' ' ' PRO . 33.6 mt -89.12 105.89 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.008 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -176.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 70.6 p -99.43 156.75 16.86 Favored 'General case' 0 N--CA 1.411 -2.411 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -53.14 -32.69 48.93 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 123.473 0.709 . . . . 0.0 109.947 175.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.1 m -67.42 -30.79 70.63 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.048 0.939 . . . . 0.0 111.593 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -71.98 -35.02 69.39 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-O 121.849 0.833 . . . . 0.0 109.055 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.403 HD13 ' HB1' ' A' ' 111' ' ' ALA . 61.2 mt -68.97 -31.65 51.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.749 -178.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.4 m -54.21 -35.13 62.05 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.567 174.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -75.5 -34.84 60.87 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.256 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.71 -56.96 15.19 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.611 -176.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.55 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 5.8 t -71.51 -19.83 62.14 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.822 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.99 -62.62 1.36 Allowed 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.227 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.9 m -95.36 6.5 48.84 Favored 'General case' 0 C--O 1.201 -1.462 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.425 -174.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . 0.272 0.0 OUTLIER 69.89 30.19 3.78 Favored 'General case' 0 N--CA 1.505 2.306 0 C-N-CA 126.213 1.805 . . . . 0.0 111.33 177.033 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.436 ' HB1' ' HA ' ' A' ' 44' ' ' LEU . . . -94.23 162.5 13.83 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 113.186 -1.824 . . . . 0.0 109.183 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.427 HD11 ' H ' ' A' ' 95' ' ' ILE . 0.2 OUTLIER -121.66 156.29 25.83 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 173.414 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.422 ' HB ' HG23 ' A' ' 118' ' ' ILE . 29.3 t -94.41 126.84 46.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -175.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 11.6 tt -125.69 116.08 45.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 175.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 47' ' ' LYS . . . -120.66 161.15 14.91 Favored Glycine 0 N--CA 1.406 -3.308 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -121.44 100.08 6.83 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 118.843 -1.143 . . . . 0.0 110.194 -178.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 59.21 30.35 20.09 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 122.171 0.986 . . . . 0.0 111.945 176.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.468 ' HB ' ' CB ' ' A' ' 80' ' ' ALA . 3.4 m -97.81 -47.09 12.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 114.482 -1.235 . . . . 0.0 112.163 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.583 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 17.4 mtm-85 76.67 156.33 0.15 Allowed Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 124.388 1.075 . . . . 0.0 111.496 177.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.528 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 10.1 Cg_endo -99.83 174.4 0.37 Allowed 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.445 2.096 . . . . 0.0 115.193 -175.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -69.3 154.36 42.16 Favored 'General case' 0 C--O 1.251 1.142 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 170.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.501 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -60.25 -35.62 75.9 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 120.82 0.343 . . . . 0.0 110.54 179.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.587 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 84.2 m-20 -82.57 -25.73 33.02 Favored 'General case' 0 C--O 1.201 -1.468 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.975 175.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.69 -45.48 78.69 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.813 177.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 20.8 pttm -57.45 -23.36 49.27 Favored 'General case' 0 CA--C 1.571 1.779 0 CA-C-O 120.842 0.353 . . . . 0.0 110.698 177.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.587 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 71.6 mtp180 -84.53 -53.24 5.55 Favored 'General case' 0 N--CA 1.389 -3.506 0 C-N-CA 125.921 1.688 . . . . 0.0 109.201 177.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -49.07 -48.74 43.86 Favored 'General case' 0 C--O 1.186 -2.242 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.793 -178.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.403 ' HB1' HD13 ' A' ' 86' ' ' ILE . . . -48.56 -43.96 36.16 Favored 'General case' 0 CA--C 1.503 -0.83 0 O-C-N 124.284 0.99 . . . . 0.0 111.466 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -82.71 -27.4 31.22 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 114.913 -1.039 . . . . 0.0 112.315 -173.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 35.3 t -88.23 5.09 43.3 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 176.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.55 ' O ' ' HB ' ' A' ' 90' ' ' THR . 20.5 mt-10 -120.96 11.53 11.04 Favored 'General case' 0 CA--C 1.46 -2.497 0 CA-C-N 114.374 -1.285 . . . . 0.0 112.926 -178.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 68.4 mmtt 62.13 22.29 13.02 Favored 'General case' 0 N--CA 1.418 -2.043 0 O-C-N 124.144 0.903 . . . . 0.0 112.83 174.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.1 m -124.4 174.2 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.091 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -121.33 135.38 55.1 Favored 'General case' 0 CA--C 1.49 -1.352 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.917 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.422 HG23 ' HB ' ' A' ' 96' ' ' VAL . 19.3 pt -102.99 123.56 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.135 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 167.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -102.65 120.07 39.92 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.437 HD11 ' N ' ' A' ' 121' ' ' HIS . 2.4 tm? -144.23 136.24 26.26 Favored 'General case' 0 N--CA 1.421 -1.914 0 C-N-CA 119.951 -0.699 . . . . 0.0 110.764 -176.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.437 ' N ' HD11 ' A' ' 120' ' ' LEU . 19.5 t-80 68.94 -71.28 0.12 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.645 1.178 . . . . 0.0 113.453 173.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -85.97 81.18 8.61 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 122.534 1.159 . . . . 0.0 111.338 -176.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 54.3 mt -98.01 119.79 46.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 15.0 tt -86.44 -16.76 9.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-O 121.752 0.787 . . . . 0.0 110.147 -178.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.444 ' CG ' ' HA ' ' A' ' 129' ' ' GLU . 95.1 m-85 -92.1 168.91 11.04 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.23 176.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -100.23 -37.7 8.81 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-O 120.935 0.398 . . . . 0.0 110.122 -175.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 34.3 t -113.56 -64.12 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.104 -176.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.511 HG13 ' H ' ' A' ' 129' ' ' GLU . 9.3 pt -140.6 -60.96 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -173.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.511 ' H ' HG13 ' A' ' 128' ' ' ILE . 31.4 tt0 -177.6 39.98 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 -175.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -71.86 98.24 1.97 Allowed 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.723 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.5 pp -77.94 170.14 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 114.659 -1.155 . . . . 0.0 113.447 -173.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -79.54 -84.91 0.09 Allowed 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.551 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 160.5 -21.53 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 125.104 1.362 . . . . 0.0 108.66 -176.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 79.96 -82.24 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 125.64 1.576 . . . . 0.0 108.853 -176.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 C--N 1.307 -1.246 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 175.764 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 . . . . . 0 N--CA 1.468 0.449 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -126.49 149.84 49.1 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 176.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 74.0 t80 60.64 87.19 0.09 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.29 1.036 . . . . 0.0 109.796 -177.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -85.33 77.34 9.98 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 121.733 -0.604 . . . . 0.0 111.469 -176.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 75.7 mt 53.03 -96.77 0.06 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.38 1.072 . . . . 0.0 112.859 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.26 94.81 1.84 Allowed Glycine 0 N--CA 1.437 -1.256 0 N-CA-C 110.546 -1.021 . . . . 0.0 110.546 177.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.0 p -78.95 105.76 10.51 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 123.036 0.534 . . . . 0.0 110.817 -178.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 57.22 79.73 0.18 Allowed 'General case' 0 C--O 1.243 0.75 0 CA-C-O 122.273 1.035 . . . . 0.0 111.59 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.447 ' C ' ' H ' ' A' ' 11' ' ' SER . . . 130.29 -179.61 16.75 Favored Glycine 0 N--CA 1.429 -1.773 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -177.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.0 m 66.33 -24.66 0.1 Allowed 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 124.738 1.215 . . . . 0.0 113.784 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.447 ' H ' ' C ' ' A' ' 9' ' ' GLY . 14.4 p -147.27 20.41 1.22 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.324 0.583 . . . . 0.0 110.411 -178.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -165.99 116.78 1.02 Allowed 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -176.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.6 t 69.14 -62.1 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.895 1.278 . . . . 0.0 110.418 -176.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -99.69 144.2 29.04 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.161 176.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.3 mt -125.39 -45.64 1.8 Allowed 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 174.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -172.13 37.09 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 104.972 -2.233 . . . . 0.0 104.972 176.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -108.71 -162.77 0.83 Allowed 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 113.578 -1.646 . . . . 0.0 110.895 -168.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 69.59 -70.05 0.15 Allowed 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 124.844 1.258 . . . . 0.0 110.935 -178.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 51.29 -81.0 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 125.703 1.601 . . . . 0.0 113.701 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.6 p -109.4 -2.43 17.76 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 122.061 -0.399 . . . . 0.0 111.505 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . 0.34 27.5 m 51.76 -77.06 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 C-N-CA 126.619 1.968 . . . . 0.0 115.859 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.453 ' O ' HG23 ' A' ' 25' ' ' VAL . 53.2 tptt 47.22 -92.89 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.205 1.802 . . . . 0.0 113.267 -176.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 20.9 p -76.46 -15.28 59.95 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.21 0.529 . . . . 0.0 111.35 -177.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -65.53 -20.84 66.5 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 178.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 22' ' ' LYS . 34.0 m -86.87 -41.82 15.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.888 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.7 m -160.89 143.13 12.49 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 124.271 1.028 . . . . 0.0 108.337 177.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.9 mp -101.09 138.09 38.58 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -178.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.6 t70 69.18 175.87 0.28 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.2 1.4 . . . . 0.0 111.909 176.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -94.8 -34.02 12.65 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 123.235 0.614 . . . . 0.0 109.494 177.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.9 mp -105.19 167.05 9.98 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.952 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -104.6 -54.81 2.45 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 64.27 -174.23 0.17 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 175.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.468 ' HA ' ' OE1' ' A' ' 33' ' ' GLN . 10.5 mm-40 72.55 19.36 4.16 Favored 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 125.189 1.396 . . . . 0.0 111.142 -176.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.6 mm -75.11 -38.52 42.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 174.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 67.32 -77.76 0.04 OUTLIER 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 113.387 -1.733 . . . . 0.0 112.268 176.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -139.75 141.21 36.85 Favored 'General case' 0 N--CA 1.413 -2.308 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -175.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.22 -161.43 24.46 Favored Glycine 0 N--CA 1.418 -2.553 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 175.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -82.46 -38.8 23.43 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 4.3 mpp? 51.04 -94.42 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 113.918 -1.492 . . . . 0.0 112.34 -172.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp 61.41 21.27 11.87 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 122.596 1.189 . . . . 0.0 108.776 -174.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.451 ' OE1' ' HB3' ' A' ' 70' ' ' ARG . 3.7 tp10 -140.45 127.51 20.85 Favored 'General case' 0 N--CA 1.409 -2.52 0 CA-C-N 113.239 -1.8 . . . . 0.0 106.714 -173.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 3.6 mm? -94.66 101.46 13.32 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 175.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.516 ' OD1' HD11 ' A' ' 74' ' ' ILE . 40.2 m-80 -94.24 144.65 25.33 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.103 -174.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 80.9 mt -133.41 160.16 38.2 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.682 0.753 . . . . 0.0 111.121 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.495 HD13 ' CD2' ' A' ' 75' ' ' HIS . 0.5 OUTLIER -124.97 133.4 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.852 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.419 173.215 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 99.4 t -113.34 127.67 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.925 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.846 -176.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.427 ' HZ2' ' CG ' ' A' ' 85' ' ' ASP . 24.4 mmmt -135.2 128.48 32.08 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 124.13 0.972 . . . . 0.0 108.807 -177.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -148.53 168.09 23.66 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.953 -178.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -70.1 -21.93 63.07 Favored 'General case' 0 C--O 1.242 0.699 0 O-C-N 123.946 0.778 . . . . 0.0 111.308 -178.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.4 m -130.13 140.1 49.78 Favored 'Isoleucine or valine' 0 C--O 1.246 0.892 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.594 173.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.637 ' O ' HG23 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -68.56 -6.77 27.34 Favored 'General case' 0 C--O 1.191 -1.978 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -176.825 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.39 -13.27 57.44 Favored Glycine 0 N--CA 1.422 -2.29 0 C-N-CA 118.261 -1.924 . . . . 0.0 112.318 177.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.4 m -81.82 -28.98 32.84 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 176.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 51' ' ' GLN . 15.8 m -70.6 -44.9 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.903 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.674 174.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.594 ' HG2' ' O ' ' A' ' 51' ' ' GLN . 67.8 mm-40 -59.58 -45.48 91.73 Favored 'General case' 0 C--O 1.214 -0.789 0 O-C-N 123.42 0.45 . . . . 0.0 111.391 178.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.07 -42.15 84.9 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 123.348 0.405 . . . . 0.0 111.448 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.434 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 32.2 tp -75.4 -42.31 54.06 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.229 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.509 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 36.0 t -55.99 -45.75 80.33 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.681 0 C-N-CA 123.136 0.574 . . . . 0.0 111.185 176.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.3 -16.84 61.57 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.68 -27.87 13.79 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -80.35 -30.0 37.97 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 113.775 -1.557 . . . . 0.0 110.569 -175.069 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 4.0 pt20 -83.75 -19.25 35.46 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 121.985 -0.447 . . . . 0.0 111.434 177.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -96.37 5.93 49.86 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.344 -177.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.8 mm -58.95 103.18 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 121.419 0.628 . . . . 0.0 109.54 177.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -101.69 81.34 2.14 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.869 0.842 . . . . 0.0 110.1 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.2 t -134.79 126.35 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.596 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 176.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -88.14 148.81 24.25 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.864 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.95 -70.43 3.17 Favored Glycine 0 C--N 1.301 -1.366 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.7 t -99.35 93.2 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 176.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.451 ' HB3' ' OE1' ' A' ' 41' ' ' GLU . 29.8 ttm180 -103.28 139.98 38.01 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 28.3 t -120.06 124.89 73.58 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 178.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 26.7 ttpp -154.56 158.13 39.33 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.061 0.458 . . . . 0.0 110.472 -178.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 pp -93.82 156.27 3.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -173.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.516 HD11 ' OD1' ' A' ' 43' ' ' ASN . 26.7 mm -119.74 -32.44 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.464 0.65 . . . . 0.0 110.13 178.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.495 ' CD2' HD13 ' A' ' 45' ' ' ILE . 1.9 t60 -149.67 124.52 9.89 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.471 -168.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -135.96 132.25 36.15 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -155.78 155.66 33.44 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.54 -177.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.452 ' HB ' ' HB3' ' A' ' 51' ' ' GLN . 5.5 p -94.15 94.27 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 CA-C-O 122.823 1.296 . . . . 0.0 110.537 177.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.7 175.09 47.47 Favored Glycine 0 N--CA 1.405 -3.413 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 102' ' ' ARG . . . -82.87 167.98 17.53 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 176.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.4 mp -71.22 120.35 19.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -177.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.436 HG23 ' OD2' ' A' ' 85' ' ' ASP . 13.0 t -119.71 168.89 10.61 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -57.6 -34.94 69.78 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.949 0.5 . . . . 0.0 111.9 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.9 t -62.21 -29.86 70.68 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.046 0.539 . . . . 0.0 110.514 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.436 ' OD2' HG23 ' A' ' 82' ' ' THR . 49.4 m-20 -75.36 -39.41 59.31 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 39.5 mm -63.66 -32.9 58.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.515 -178.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 39.6 m -60.59 -24.05 65.16 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.527 176.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -87.98 -37.07 16.68 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.83 -58.73 6.18 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.947 -176.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.549 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 3.4 t -70.73 -26.56 63.44 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.494 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.18 -59.64 4.18 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.343 0.592 . . . . 0.0 111.901 -178.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.8 t -97.08 4.62 51.24 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.807 -175.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 67.7 32.76 5.27 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.822 0.82 . . . . 0.0 110.299 178.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -94.5 132.9 38.67 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.459 -178.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 36.3 pt -94.83 152.03 3.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 176.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.464 ' HB ' HG23 ' A' ' 118' ' ' ILE . 16.7 t -100.97 123.69 54.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.42 -172.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 7.3 tp -108.44 111.44 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 173.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -103.78 146.34 16.36 Favored Glycine 0 N--CA 1.43 -1.76 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -178.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.432 ' C ' ' H ' ' A' ' 101' ' ' VAL . 90.0 m-85 -121.84 108.98 14.11 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 117.026 0.413 . . . . 0.0 111.121 -175.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.583 ' O ' ' HD3' ' A' ' 102' ' ' ARG . 8.2 t30 67.66 -34.22 0.24 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 126.558 1.943 . . . . 0.0 113.493 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.432 ' H ' ' C ' ' A' ' 99' ' ' PHE . 1.7 m -51.35 -54.72 10.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 117.149 2.277 . . . . 0.0 117.149 -178.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.583 ' HD3' ' O ' ' A' ' 100' ' ' ASN . 1.0 OUTLIER 76.77 170.4 0.11 Allowed Pre-proline 0 N--CA 1.483 1.193 0 C-N-CA 123.958 0.903 . . . . 0.0 110.539 -171.743 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.408 ' HG3' HD11 ' A' ' 118' ' ' ILE . 9.2 Cg_endo -96.03 174.83 0.9 Allowed 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 121.712 1.608 . . . . 0.0 113.009 177.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -82.03 150.44 27.59 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 167.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.534 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -58.88 -30.3 67.65 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.542 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 16.5 m120 -81.08 -33.06 33.65 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 119.966 -0.693 . . . . 0.0 110.036 177.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.34 -42.62 98.96 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.239 177.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 20.9 ptmt -65.32 -26.29 67.99 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.984 178.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.542 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 53.6 mtp180 -75.52 -52.64 10.19 Favored 'General case' 0 N--CA 1.392 -3.353 0 C-N-CA 124.365 1.066 . . . . 0.0 109.027 177.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -53.02 -49.37 66.39 Favored 'General case' 0 C--O 1.195 -1.801 0 CA-C-N 113.947 -1.479 . . . . 0.0 110.091 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -47.04 -48.28 22.21 Favored 'General case' 0 CA--C 1.507 -0.681 0 O-C-N 124.568 1.167 . . . . 0.0 112.449 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.432 ' C ' ' H ' ' A' ' 114' ' ' GLU . 2.8 tm-20 -76.08 -38.79 56.6 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.3 -173.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 26.6 t -76.41 4.23 9.47 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.527 1.156 . . . . 0.0 108.707 178.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.549 ' O ' ' HB ' ' A' ' 90' ' ' THR . 15.2 mt-10 -123.21 14.06 9.69 Favored 'General case' 0 N--CA 1.398 -3.066 0 CA-C-N 114.466 -1.243 . . . . 0.0 113.019 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.528 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 96.7 mttt 66.2 7.54 4.91 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 173.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.5 m -114.25 147.01 18.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 C-N-CA 120.358 -0.537 . . . . 0.0 112.378 -175.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -113.09 128.7 56.56 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.702 -177.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.464 HG23 ' HB ' ' A' ' 96' ' ' VAL . 7.7 pt -97.74 133.82 38.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.079 177.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -118.33 134.77 54.76 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -178.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.408 ' CD1' ' HA ' ' A' ' 102' ' ' ARG . 3.2 mm? -118.06 132.74 56.34 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -174.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 7.2 t60 70.34 -67.84 0.23 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.684 1.594 . . . . 0.0 110.975 173.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 14.3 tpp180 178.23 -61.51 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 7.5 tp -154.4 -46.5 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 C-N-CA 120.336 -0.545 . . . . 0.0 112.117 172.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 38.6 pt -123.02 161.72 24.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.318 -177.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -149.82 91.05 1.75 Allowed 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 123.874 0.87 . . . . 0.0 108.893 178.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -135.09 144.2 47.05 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.131 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.7 p -163.21 142.61 2.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 177.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 57.3 mt 62.63 90.65 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.245 0.862 0 C-N-CA 124.218 1.007 . . . . 0.0 110.11 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -91.61 -21.19 20.95 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.898 0.856 . . . . 0.0 109.129 -175.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -78.76 96.67 5.65 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.951 178.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 61.5 mt -82.55 -45.96 19.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.48 -169.51 2.79 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.577 -179.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 66.35 -165.18 0.23 Allowed 'General case' 0 C--O 1.247 0.963 0 O-C-N 124.016 0.822 . . . . 0.0 111.04 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 73.78 128.89 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.18 1.392 . . . . 0.0 111.21 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 93.2 mmm . . . . . 0 C--N 1.297 -1.687 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.936 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.493 ' O ' HD22 ' A' ' 5' ' ' LEU . 3.3 m-20 . . . . . 0 C--O 1.212 -0.901 0 N-CA-C 110.821 -0.066 . . . . 0.0 110.821 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -71.39 -43.94 65.9 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 178.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -95.64 116.13 28.41 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 170.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 65.38 101.42 0.04 OUTLIER 'General case' 0 C--O 1.244 0.778 0 C-N-CA 124.531 1.132 . . . . 0.0 110.461 -173.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.493 HD22 ' O ' ' A' ' 1' ' ' ASN . 86.9 mt -70.22 102.12 2.03 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.943 -178.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.54 143.54 21.74 Favored Glycine 0 N--CA 1.424 -2.13 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.8 p -89.3 5.35 45.35 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 120.846 0.355 . . . . 0.0 110.689 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 68.82 24.65 6.46 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.464 1.106 . . . . 0.0 111.32 178.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 177.84 -167.24 37.98 Favored Glycine 0 N--CA 1.43 -1.707 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.557 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.8 p -106.39 -163.41 0.92 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.7 t -64.5 106.57 1.17 Allowed 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 175.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -138.69 -45.69 0.49 Allowed 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.296 -177.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 62.1 t -150.34 -42.07 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 103.938 -2.616 . . . . 0.0 103.938 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -73.15 173.62 9.15 Favored 'General case' 0 C--O 1.253 1.239 0 CA-C-N 112.962 -1.926 . . . . 0.0 108.617 174.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.6 mp 66.36 -103.68 0.09 Allowed 'General case' 0 C--N 1.316 -0.864 0 O-C-N 124.18 0.925 . . . . 0.0 110.282 -177.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.516 ' HA ' HH21 ' A' ' 24' ' ' ARG . 40.1 mt-30 60.72 -53.64 0.09 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 126.05 1.74 . . . . 0.0 115.217 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -56.42 137.21 53.31 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -173.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -84.43 -54.32 4.84 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.39 173.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? 62.35 -77.66 0.03 OUTLIER 'General case' 0 C--O 1.216 -0.664 0 C-N-CA 125.808 1.643 . . . . 0.0 112.483 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.7 m -131.0 23.78 4.93 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -178.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . 0.352 7.7 p 47.37 73.38 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.157 0 C-N-CA 125.83 1.652 . . . . 0.0 113.164 -177.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.552 ' HG3' ' H ' ' A' ' 23' ' ' THR . 55.0 pttt -90.97 -70.6 0.67 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.882 178.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.552 ' H ' ' HG3' ' A' ' 22' ' ' LYS . 2.6 p -97.86 8.82 44.07 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 122.313 1.054 . . . . 0.0 110.42 -179.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.516 HH21 ' HA ' ' A' ' 16' ' ' GLN . 25.1 mmt180 -99.34 19.79 14.86 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.406 177.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.7 p -59.44 115.93 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-O 121.7 0.762 . . . . 0.0 109.069 177.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.4 p -117.69 91.81 3.67 Favored 'General case' 0 N--CA 1.41 -2.462 0 CA-C-N 114.909 -1.042 . . . . 0.0 112.092 -174.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.429 ' C ' ' H ' ' A' ' 29' ' ' ASP . 82.1 mt -106.61 91.51 3.72 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 175.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 76.1 -27.92 0.18 Allowed 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 124.698 1.199 . . . . 0.0 111.642 -176.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.429 ' H ' ' C ' ' A' ' 27' ' ' LEU . 25.4 t70 -64.85 104.84 0.9 Allowed 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 124.056 0.942 . . . . 0.0 108.881 175.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 55.9 tp 72.74 -60.86 0.52 Allowed 'General case' 0 C--O 1.244 0.803 0 C-N-CA 125.093 1.357 . . . . 0.0 111.963 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -96.27 127.05 41.93 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 120.613 0.244 . . . . 0.0 110.656 -177.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -141.74 148.02 38.32 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -84.68 -24.83 28.82 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 117.826 0.284 . . . . 0.0 111.096 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 52.8 mt 64.58 -82.34 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.287 1.435 . . . . 0.0 112.468 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -168.72 -76.87 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -177.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . 0.252 2.0 mp0 52.89 -84.54 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.437 0 N-CA-C 115.611 1.708 . . . . 0.0 115.611 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.75 -45.69 2.52 Favored Glycine 0 C--N 1.306 -1.094 0 N-CA-C 106.94 -2.464 . . . . 0.0 106.94 -170.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 61.34 -91.41 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 126.52 1.928 . . . . 0.0 111.792 171.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 54.8 ttm -149.85 12.71 0.78 Allowed 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -86.89 -33.42 19.76 Favored 'General case' 0 C--O 1.211 -0.972 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -101.78 106.92 17.99 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.486 -176.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.655 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 60.2 tp -110.38 104.94 13.77 Favored 'General case' 0 N--CA 1.41 -2.457 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 177.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.634 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 61.1 m-80 -99.83 155.62 17.56 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.419 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 4.1 pp -151.06 162.49 40.74 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.4 0.619 . . . . 0.0 112.57 177.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.477 HD13 ' CD2' ' A' ' 75' ' ' HIS . 0.2 OUTLIER -118.46 134.58 61.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.209 178.293 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 99.3 t -107.69 126.04 64.09 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.948 -176.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.8 mtpt -138.4 147.17 43.09 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -156.56 167.25 31.01 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -178.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -76.24 -22.83 54.7 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.846 0.832 . . . . 0.0 110.029 177.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 84.6 t -109.28 132.27 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 176.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.78 ' O ' HG21 ' A' ' 54' ' ' VAL . 16.2 tt0 -65.09 -46.2 82.1 Favored 'General case' 0 C--O 1.188 -2.18 0 C-N-CA 120.132 -0.627 . . . . 0.0 111.224 -176.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -73.74 2.65 39.38 Favored Glycine 0 C--N 1.294 -1.77 0 C-N-CA 118.753 -1.689 . . . . 0.0 114.394 -176.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.4 t -83.12 -26.12 31.3 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 176.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.78 HG21 ' O ' ' A' ' 51' ' ' GLN . 5.3 m -80.16 -45.87 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.918 0 CA-C-N 114.549 -1.205 . . . . 0.0 108.642 176.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -56.16 -48.44 76.3 Favored 'General case' 0 C--O 1.245 0.844 0 C-N-CA 124.867 1.267 . . . . 0.0 111.965 -176.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.51 -35.24 80.3 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.234 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.409 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 28.0 tp -76.1 -35.86 59.16 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.407 HG11 HG12 ' A' ' 73' ' ' ILE . 39.4 t -56.69 -43.87 80.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.747 174.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.39 -18.18 65.21 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.903 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.457 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -98.88 -21.4 16.32 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 122.384 1.087 . . . . 0.0 108.782 -177.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.409 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.5 OUTLIER -88.42 -28.96 20.57 Favored 'General case' 0 C--N 1.275 -2.645 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.598 -177.439 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -83.75 -12.65 55.46 Favored 'General case' 0 C--N 1.313 -1.0 0 O-C-N 122.152 -0.342 . . . . 0.0 111.624 176.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 65.0 pttt -87.3 2.47 50.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.523 0.678 . . . . 0.0 110.137 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 30.2 mm -79.18 -42.16 23.44 Favored 'Isoleucine or valine' 0 C--O 1.243 0.744 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 58.06 -101.98 0.14 Allowed 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 125.064 1.346 . . . . 0.0 113.481 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.418 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 30.2 t -128.23 -6.6 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.497 -173.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -60.78 108.57 0.87 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.146 0.578 . . . . 0.0 112.474 -173.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.07 -89.89 1.09 Allowed Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.1 t -107.69 145.37 15.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 177.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.418 ' HG2' ' HA ' ' A' ' 66' ' ' VAL . 16.2 mtp180 -93.76 93.06 7.77 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.655 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 13.4 t -104.88 124.24 59.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -177.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -146.28 158.6 43.9 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.067 0.461 . . . . 0.0 110.565 -175.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 1.7 pp -94.03 142.82 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.715 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.412 175.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.412 HD11 ' OD1' ' A' ' 43' ' ' ASN . 34.6 mm -113.72 -27.43 2.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 CA-C-O 121.273 0.559 . . . . 0.0 109.789 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.477 ' CD2' HD13 ' A' ' 45' ' ' ILE . 5.5 t60 -160.95 125.86 3.65 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.782 -171.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.568 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -129.01 130.56 46.79 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -154.76 156.66 36.71 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.383 -178.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.7 p -94.54 97.76 7.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-O 121.947 0.879 . . . . 0.0 108.905 176.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -175.5 170.9 44.01 Favored Glycine 0 N--CA 1.413 -2.839 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' A' ' 102' ' ' ARG . . . -84.74 -176.11 6.08 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 120.838 0.352 . . . . 0.0 110.635 -178.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.49 ' HB ' ' HB3' ' A' ' 103' ' ' PRO . 3.8 mm -87.86 97.9 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.672 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 9.7 t -98.71 147.04 25.27 Favored 'General case' 0 N--CA 1.411 -2.424 0 C-N-CA 119.749 -0.78 . . . . 0.0 109.719 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.31 -39.31 14.44 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 125.111 1.364 . . . . 0.0 112.53 178.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.9 m -78.8 -11.8 60.0 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -174.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -98.34 -23.52 15.58 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -177.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.459 HG23 ' HA ' ' A' ' 111' ' ' ALA . 38.6 mt -66.06 -22.18 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.644 177.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 47.3 t -49.59 -35.49 21.0 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.928 172.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.451 ' O ' HD22 ' A' ' 88' ' ' LEU . 2.0 tm? -70.17 -32.57 70.58 Favored 'General case' 0 C--O 1.25 1.083 0 CA-C-O 120.748 0.309 . . . . 0.0 110.843 179.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.47 -61.68 2.32 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.201 -176.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.589 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 4.8 t -66.02 -25.34 67.02 Favored 'General case' 0 CA--C 1.561 1.375 0 O-C-N 122.012 -0.43 . . . . 0.0 111.783 178.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.24 -55.7 16.98 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.143 0.497 . . . . 0.0 112.176 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 34.3 p -97.01 -4.62 39.4 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.238 0.542 . . . . 0.0 111.072 -176.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.449 ' N ' HD21 ' A' ' 93' ' ' ASN . 0.8 OUTLIER 72.63 33.45 1.36 Allowed 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.805 -178.834 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.634 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -94.34 134.49 36.78 Favored 'General case' 0 N--CA 1.419 -2.018 0 CA-C-N 114.008 -1.451 . . . . 0.0 109.931 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 35.0 pt -94.07 144.4 9.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 176.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.455 ' HA ' HG21 ' A' ' 45' ' ' ILE . 15.6 t -94.95 119.79 43.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 C-N-CA 120.186 -0.605 . . . . 0.0 110.93 -173.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.651 ' HA ' ' O ' ' A' ' 119' ' ' ARG . 24.4 pt -111.91 117.18 54.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-O 121.498 0.666 . . . . 0.0 109.748 174.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -110.9 157.22 15.1 Favored Glycine 0 N--CA 1.437 -1.281 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.825 -176.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.415 ' C ' ' H ' ' A' ' 101' ' ' VAL . 67.8 t80 -132.07 110.82 10.98 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -175.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.446 ' O ' ' HD3' ' A' ' 102' ' ' ARG . 27.5 t-20 70.68 -30.4 0.2 Allowed 'General case' 0 N--CA 1.506 2.354 0 C-N-CA 125.085 1.354 . . . . 0.0 114.029 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.516 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 2.5 m -58.57 -56.55 15.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 N-CA-C 117.765 2.506 . . . . 0.0 117.765 -177.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.541 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 0.6 OUTLIER 75.04 159.26 0.16 Allowed Pre-proline 0 N--CA 1.494 1.738 0 C-N-CA 124.359 1.064 . . . . 0.0 112.003 -174.642 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.49 ' HB3' ' HB ' ' A' ' 81' ' ' ILE . 4.0 Cg_endo -88.75 170.12 5.36 Favored 'Trans proline' 0 CA--C 1.502 -1.095 0 C-N-CA 122.466 2.111 . . . . 0.0 113.261 176.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -87.73 169.45 12.09 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 171.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.42 ' HA ' ' HE3' ' A' ' 108' ' ' LYS . . . -70.98 -11.45 60.98 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 -173.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.512 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 37.0 t30 -104.37 -34.11 8.4 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 176.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.25 -44.34 88.3 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.152 0.501 . . . . 0.0 110.521 175.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.42 ' HE3' ' HA ' ' A' ' 105' ' ' ALA . 18.0 ptpt -59.15 -22.84 61.56 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.032 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 40.4 mtm180 -93.25 -50.38 5.51 Favored 'General case' 0 N--CA 1.38 -3.932 0 C-N-CA 126.108 1.763 . . . . 0.0 109.886 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.15 -45.59 68.48 Favored 'General case' 0 CA--C 1.48 -1.715 0 C-N-CA 125.551 1.541 . . . . 0.0 110.858 -177.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.459 ' HA ' HG23 ' A' ' 86' ' ' ILE . . . -49.48 -48.19 47.94 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 124.505 1.128 . . . . 0.0 111.163 -179.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -78.45 -28.78 46.68 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.461 -174.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 40.2 t -79.29 -3.91 48.25 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 176.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.598 ' O ' ' HB2' ' A' ' 115' ' ' LYS . 27.2 mt-10 -114.08 11.2 17.59 Favored 'General case' 0 CA--C 1.464 -2.329 0 CA-C-N 114.253 -1.34 . . . . 0.0 112.498 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.598 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 55.4 mtpt 68.5 15.04 9.17 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 174.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.9 m -121.28 170.95 10.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -135.48 147.23 48.8 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 176.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 15.0 pt -110.4 140.67 28.46 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.299 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.871 -178.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.651 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 75.2 mtp180 -131.2 123.2 27.97 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -176.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.487 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -146.54 172.13 14.03 Favored 'General case' 0 C--N 1.292 -1.916 0 O-C-N 121.796 -0.565 . . . . 0.0 112.143 -177.495 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 70.72 23.34 4.59 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 122.087 0.946 . . . . 0.0 110.723 174.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -61.96 -11.98 16.05 Favored 'General case' 0 CA--C 1.562 1.423 0 CA-C-N 114.892 -1.049 . . . . 0.0 113.304 -175.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 13.0 tt -74.25 1.25 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.417 0 CA-C-O 122.29 1.043 . . . . 0.0 110.844 -179.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 10.2 tp -73.47 -15.74 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 173.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -73.29 126.06 29.24 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 174.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -138.31 -179.74 5.97 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.5 p -79.72 -17.69 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 176.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.462 HD11 ' O ' ' A' ' 128' ' ' ILE . 2.8 pp -77.94 122.96 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 CA-C-O 121.979 0.895 . . . . 0.0 110.771 175.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -126.32 -72.37 0.65 Allowed 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.548 -176.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -96.69 -30.31 13.3 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 73.1 mt -86.14 112.8 23.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.289 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 59.51 83.02 0.14 Allowed 'General case' 0 CA--C 1.537 0.48 0 O-C-N 124.345 1.028 . . . . 0.0 112.623 176.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -72.03 157.76 37.22 Favored 'General case' 0 C--O 1.245 0.858 0 CA-C-N 114.564 -1.198 . . . . 0.0 112.149 -177.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -99.02 -11.45 21.5 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.618 -177.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 53.7 ttm . . . . . 0 C--N 1.306 -1.312 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.4 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 . . . . . 0 CA--C 1.5 -0.963 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 57.49 92.16 0.03 OUTLIER 'General case' 0 C--O 1.246 0.891 0 O-C-N 124.2 0.938 . . . . 0.0 111.924 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -70.47 -29.55 66.13 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.047 -175.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.93 -177.66 3.46 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 177.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -78.13 -10.82 59.8 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -171.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 106.82 115.83 4.06 Favored Glycine 0 N--CA 1.42 -2.412 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -175.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.67 73.82 7.62 Favored 'General case' 0 N--CA 1.42 -1.956 0 CA-C-O 122.716 1.246 . . . . 0.0 112.748 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -85.9 5.16 34.2 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.051 176.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.435 ' O ' ' HG2' ' A' ' 12' ' ' ARG . . . -156.49 129.83 2.54 Favored Glycine 0 N--CA 1.408 -3.172 0 N-CA-C 107.408 -2.277 . . . . 0.0 107.408 175.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 21.3 t -87.36 -11.15 50.2 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 122.075 0.94 . . . . 0.0 108.874 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.1 p -83.62 19.74 1.56 Allowed 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.926 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.435 ' HG2' ' O ' ' A' ' 9' ' ' GLY . 13.9 ptm180 -121.4 10.95 10.62 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.158 0.504 . . . . 0.0 109.93 177.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 51.7 t -92.04 99.4 9.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -178.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 70.97 106.42 0.06 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.781 1.233 . . . . 0.0 111.436 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.4 mp -107.6 132.84 52.85 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 73.35 130.25 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 O-C-N 124.596 1.185 . . . . 0.0 111.972 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.02 107.11 8.0 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -177.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.441 ' O ' ' HB ' ' A' ' 21' ' ' VAL . 9.7 tt0 -87.97 -6.45 58.0 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 123.284 0.634 . . . . 0.0 112.644 -175.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -78.3 -24.59 46.62 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 173.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.4 m -98.16 63.29 1.57 Allowed 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 168.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.441 ' HB ' ' O ' ' A' ' 18' ' ' GLN . 9.5 p -68.37 1.58 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.125 0 CA-C-N 114.195 -1.366 . . . . 0.0 114.174 -169.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -54.29 -43.98 71.55 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.003 0.43 . . . . 0.0 111.078 176.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.4 p -99.03 14.9 27.58 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.846 0.832 . . . . 0.0 111.682 -178.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.531 ' HA ' ' NE ' ' A' ' 24' ' ' ARG . 4.2 mmp_? -116.63 8.01 13.73 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.674 174.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 63.9 t 70.96 104.22 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-N 113.991 -1.459 . . . . 0.0 112.498 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.4 t -158.68 165.82 33.47 Favored 'General case' 0 N--CA 1.421 -1.895 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 177.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -124.73 -177.92 3.98 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -133.57 153.61 51.52 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 176.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -77.42 130.34 36.93 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.077 0.465 . . . . 0.0 111.544 -172.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.7 tp -99.99 153.85 18.86 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.221 -175.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -107.81 138.54 43.87 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 177.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.57 113.11 24.88 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.06 176.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -96.12 88.08 4.73 Favored 'General case' 0 C--N 1.288 -2.086 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.052 178.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.2 tp -107.2 91.16 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.226 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -85.09 90.07 7.77 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -115.3 169.31 9.23 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.973 -176.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.48 127.67 5.54 Favored Glycine 0 N--CA 1.434 -1.454 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.032 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -137.24 99.66 4.04 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 67.3 mtt -111.27 6.58 20.64 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.765 -177.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -78.47 96.1 5.31 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.649 -178.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -98.89 117.77 34.15 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -137.39 92.73 2.73 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-O 121.524 0.678 . . . . 0.0 109.683 -176.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -147.1 143.25 28.16 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -177.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.405 HD12 HD11 ' A' ' 61' ' ' LEU . 56.9 mt -140.8 160.11 40.75 Favored 'General case' 0 C--O 1.246 0.884 0 CA-C-O 121.756 0.788 . . . . 0.0 112.813 177.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.443 HD11 ' O ' ' A' ' 75' ' ' HIS . 0.2 OUTLIER -131.87 133.28 61.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 125.461 1.504 . . . . 0.0 107.259 177.893 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 67.1 t -112.7 138.85 40.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.207 -176.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 60.6 mttp -137.52 160.48 39.01 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 123.71 0.804 . . . . 0.0 109.267 173.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -168.5 171.52 8.91 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -82.08 -37.28 26.61 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 91.8 t -97.51 127.84 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.335 176.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.695 ' O ' HG23 ' A' ' 54' ' ' VAL . 50.1 tt0 -57.43 -45.62 84.46 Favored 'General case' 0 C--O 1.204 -1.295 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -176.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.92 -0.97 61.37 Favored Glycine 0 C--N 1.283 -2.375 0 C-N-CA 118.155 -1.974 . . . . 0.0 113.908 -177.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.1 t -85.87 -18.13 33.67 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 175.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 51' ' ' GLN . 3.7 m -82.37 -46.36 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.949 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 174.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -60.68 -47.18 87.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.309 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.79 -33.95 76.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.585 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.493 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 37.1 tp -76.62 -37.4 56.45 Favored 'General case' 0 C--O 1.209 -1.068 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.407 HG12 HG12 ' A' ' 73' ' ' ILE . 43.5 t -60.09 -41.41 86.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 123.234 0.614 . . . . 0.0 110.954 176.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.73 -25.94 68.15 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.541 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.96 -24.65 19.19 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.493 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -85.12 -30.13 24.27 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.468 -175.585 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -78.45 -13.22 59.94 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.048 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.74 5.47 51.3 Favored 'General case' 0 C--O 1.247 0.931 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.099 177.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.419 HG23 ' HA ' ' A' ' 70' ' ' ARG . 35.3 mm -74.74 75.2 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 122.701 1.238 . . . . 0.0 109.84 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -146.2 -47.8 0.2 Allowed 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 177.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.4 m -91.28 83.7 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 CA-C-N 114.376 -1.284 . . . . 0.0 107.607 168.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -169.24 -171.66 1.34 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 104.14 -2.541 . . . . 0.0 104.14 -174.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -76.66 -34.58 43.48 Favored Glycine 0 N--CA 1.44 -1.095 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 178.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 9.0 p -120.53 163.41 18.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 177.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.419 ' HA ' HG23 ' A' ' 64' ' ' ILE . 3.9 ptm180 -125.13 130.99 53.32 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 176.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 t -154.18 172.42 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 -177.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -150.69 157.22 42.71 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 175.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.407 HG12 HG12 ' A' ' 58' ' ' VAL . 1.4 pp -93.61 154.09 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.793 177.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 65.2 mt -112.35 -40.08 3.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-O 121.787 0.803 . . . . 0.0 109.734 177.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.443 ' O ' HD11 ' A' ' 45' ' ' ILE . 2.1 t60 -145.77 137.71 25.29 Favored 'General case' 0 N--CA 1.409 -2.497 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.463 -165.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.25 134.21 52.4 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 47' ' ' LYS . . . -144.27 131.68 20.9 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -178.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.1 p -94.85 93.57 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.969 0 CA-C-O 122.765 1.269 . . . . 0.0 107.699 175.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.95 176.36 48.02 Favored Glycine 0 N--CA 1.397 -3.93 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -176.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 102' ' ' ARG . . . -81.07 175.9 10.27 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.93 105.32 5.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.1 p -104.58 156.51 17.9 Favored 'General case' 0 N--CA 1.403 -2.814 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.26 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.51 -33.16 72.22 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 123.953 0.901 . . . . 0.0 110.482 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.3 m -68.53 -22.42 64.51 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.849 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.444 ' CG ' ' HZ1' ' A' ' 47' ' ' LYS . 4.9 t70 -97.72 -27.55 14.29 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 118.782 -1.167 . . . . 0.0 109.67 -178.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 79.5 mt -59.09 -27.02 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 CA-C-O 121.817 0.818 . . . . 0.0 110.433 174.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.403 ' O ' ' HB2' ' A' ' 91' ' ' ALA . 34.2 m -50.59 -33.76 23.29 Favored 'General case' 0 CA--C 1.561 1.383 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.783 172.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -82.39 -35.31 27.83 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 176.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.81 -58.58 6.73 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.425 -175.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.53 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 9.6 t -78.85 -11.23 59.99 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.773 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 87' ' ' SER . . . -73.21 -49.14 29.57 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.394 -177.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 34.2 m -105.31 -3.63 22.53 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.102 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 71.54 35.61 1.44 Allowed 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 122.103 0.954 . . . . 0.0 110.62 -176.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -95.12 129.52 42.19 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 176.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.7 pt -93.93 144.13 10.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.422 HG13 ' HZ2' ' A' ' 47' ' ' LYS . 16.5 t -102.01 132.33 48.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.766 -173.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 18.7 tt -111.87 137.88 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.782 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 173.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -132.56 146.64 18.39 Favored Glycine 0 N--CA 1.432 -1.587 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.461 ' C ' ' H ' ' A' ' 101' ' ' VAL . 91.9 m-85 -124.14 114.26 19.43 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -174.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 71.5 -36.35 0.36 Allowed 'General case' 0 N--CA 1.505 2.3 0 C-N-CA 124.458 1.103 . . . . 0.0 112.938 178.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.475 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 4.5 m -62.05 -51.23 74.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 124.982 1.313 . . . . 0.0 113.271 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.485 ' O ' ' HB3' ' A' ' 80' ' ' ALA . 23.6 mtm180 68.32 179.03 0.05 OUTLIER Pre-proline 0 CA--C 1.551 1.012 0 O-C-N 123.74 0.65 . . . . 0.0 110.111 178.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -95.36 176.91 0.85 Allowed 'Trans proline' 0 N--CA 1.444 -1.411 0 CA-C-N 121.034 1.405 . . . . 0.0 113.942 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -86.75 155.13 20.46 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 106.274 -1.751 . . . . 0.0 106.274 169.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.523 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -58.02 -30.74 66.36 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 123.074 0.549 . . . . 0.0 112.086 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.588 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 25.2 t30 -82.81 -35.7 26.2 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.91 -44.75 92.0 Favored 'General case' 0 C--O 1.206 -1.212 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.744 178.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 20.1 pttm -59.39 -29.09 67.47 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-O 121.118 0.485 . . . . 0.0 110.001 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.588 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 20.5 mtm180 -74.76 -52.66 10.92 Favored 'General case' 0 N--CA 1.384 -3.754 0 C-N-CA 123.793 0.837 . . . . 0.0 109.059 179.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -53.83 -51.82 62.32 Favored 'General case' 0 C--O 1.194 -1.856 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.067 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -50.7 -48.5 58.65 Favored 'General case' 0 CA--C 1.5 -0.944 0 O-C-N 124.284 0.99 . . . . 0.0 112.143 -176.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -81.23 -25.33 36.74 Favored 'General case' 0 N--CA 1.403 -2.82 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.291 -172.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 46.9 t -87.9 5.8 38.71 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 175.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.57 ' O ' ' HB2' ' A' ' 115' ' ' LYS . 20.5 mt-10 -123.67 17.08 9.55 Favored 'General case' 0 CA--C 1.463 -2.382 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.826 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.57 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 70.5 mmtt 66.14 8.52 5.58 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 173.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.5 m -114.52 125.03 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-O 121.775 0.797 . . . . 0.0 113.044 -176.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -94.18 120.74 34.86 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.288 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.6 pt -93.55 131.81 39.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-O 121.089 0.471 . . . . 0.0 109.947 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -100.39 118.82 37.41 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.119 0.485 . . . . 0.0 109.744 -176.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.46 ' CD1' ' HA ' ' A' ' 102' ' ' ARG . 3.2 mm? -114.87 172.64 6.92 Favored 'General case' 0 CA--C 1.474 -1.976 0 CA-C-O 121.264 0.554 . . . . 0.0 111.102 -178.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 35.4 t-80 -77.56 104.56 8.17 Favored 'General case' 0 N--CA 1.413 -2.315 0 CA-C-N 114.531 -1.213 . . . . 0.0 108.899 174.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.409 ' C ' ' H ' ' A' ' 124' ' ' ILE . 2.4 ptp180 -95.69 -169.91 2.04 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.516 179.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 50.3 mm 79.9 -38.96 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 124.921 1.288 . . . . 0.0 108.907 -174.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.409 ' H ' ' C ' ' A' ' 122' ' ' ARG . 67.0 mt 69.41 -51.89 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 125.904 1.681 . . . . 0.0 114.46 171.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -78.94 -1.42 35.2 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 122.579 0.352 . . . . 0.0 111.387 -176.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 72.62 -79.18 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.076 1.35 . . . . 0.0 108.51 -175.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 45.2 t -143.15 81.42 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 175.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 63.4 mt -140.92 82.97 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 174.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 55.21 88.01 0.04 OUTLIER 'General case' 0 C--O 1.242 0.678 0 C-N-CA 125.184 1.394 . . . . 0.0 112.139 -177.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -57.12 118.11 4.7 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.873 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . 0.259 1.7 pp -62.03 92.46 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -176.59 168.4 2.65 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 103.312 -2.848 . . . . 0.0 103.312 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -97.61 2.62 50.12 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 118.689 0.677 . . . . 0.0 110.355 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 66.82 97.18 0.05 Allowed 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.897 1.279 . . . . 0.0 111.154 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 CA--C 1.509 -0.632 0 C-N-CA 124.552 1.141 . . . . 0.0 110.549 178.574 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 . . . . . 0 CA--C 1.493 -1.234 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 71.94 154.31 0.14 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.46 1.504 . . . . 0.0 112.649 178.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -137.54 178.04 7.41 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -79.24 78.01 5.74 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 122.745 1.26 . . . . 0.0 111.737 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.6 mt -121.81 13.29 10.69 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 176.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.19 87.92 1.57 Allowed Glycine 0 N--CA 1.419 -2.467 0 CA-C-N 114.502 -1.226 . . . . 0.0 112.339 -174.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -90.41 116.8 28.63 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 175.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -132.54 122.21 24.47 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -177.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.516 ' O ' ' HG2' ' A' ' 12' ' ' ARG . . . -94.11 51.64 2.19 Favored Glycine 0 N--CA 1.434 -1.483 0 C-N-CA 121.125 -0.56 . . . . 0.0 113.089 -174.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.7 m -65.39 -39.0 91.7 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.785 0.802 . . . . 0.0 109.663 177.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.2 p -81.39 15.63 1.95 Allowed 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 114.557 -1.201 . . . . 0.0 113.964 -173.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.516 ' HG2' ' O ' ' A' ' 9' ' ' GLY . 19.3 ptt180 -99.15 -7.03 27.2 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 122.146 0.974 . . . . 0.0 108.438 174.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.1 t -94.99 137.58 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 176.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.5 t70 67.25 77.43 0.27 Allowed 'General case' 0 C--N 1.32 -0.693 0 O-C-N 124.698 1.249 . . . . 0.0 109.521 -176.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.3 mt -106.18 79.99 1.46 Allowed 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.747 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -88.27 -36.08 16.91 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -158.09 -83.37 0.05 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.985 174.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 63.75 -44.9 0.26 Allowed 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -40.37 -58.55 1.51 Allowed 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 -171.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.486 ' C ' ' H ' ' A' ' 22' ' ' LYS . 48.3 p -89.5 0.83 56.61 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.662 -0.648 . . . . 0.0 111.847 -176.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . 0.312 35.8 m 55.86 -6.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 C-N-CA 127.567 2.347 . . . . 0.0 115.236 -175.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.486 ' H ' ' C ' ' A' ' 20' ' ' SER . 62.8 tttp -54.2 -65.23 0.61 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.724 1.61 . . . . 0.0 111.274 -177.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.8 p -86.31 1.32 51.45 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.852 0.834 . . . . 0.0 111.487 -177.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.3 tpm_? -84.02 -42.33 16.3 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.621 179.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.0 t -97.0 -44.0 12.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.147 -177.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.4 m -127.63 170.63 12.45 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.202 -175.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.5 mp -121.55 117.82 27.72 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 174.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -79.99 66.23 5.41 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -177.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -173.16 107.02 0.15 Allowed 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 176.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -66.28 136.61 56.08 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.706 -178.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -73.8 126.09 29.6 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.402 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -86.36 123.53 31.7 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.313 0.578 . . . . 0.0 109.622 -177.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -96.12 -25.71 15.76 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.883 -178.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 68.1 mt -125.62 104.89 13.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.577 -176.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -138.77 105.61 5.4 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 176.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -94.29 133.75 37.5 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -99.03 179.07 31.05 Favored Glycine 0 C--N 1.308 -1.018 0 C-N-CA 120.361 -0.924 . . . . 0.0 112.28 -178.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -93.2 126.23 38.21 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 51.0 ttm -109.21 125.35 52.14 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.375 -177.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -77.8 152.88 33.27 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.053 -176.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -115.31 117.51 30.65 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 169.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -93.76 114.33 26.58 Favored 'General case' 0 N--CA 1.42 -1.937 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 -177.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.51 ' HA ' ' O ' ' A' ' 72' ' ' LYS . 17.7 m120 -105.39 149.51 26.04 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.277 -176.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.2 pp -152.39 162.35 41.31 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.919 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.429 HG22 ' HA ' ' A' ' 96' ' ' VAL . 0.1 OUTLIER -117.08 136.36 54.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 123.278 0.631 . . . . 0.0 110.636 178.626 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 85.9 t -102.06 128.07 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.015 -175.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.4 ' O ' ' HA2' ' A' ' 98' ' ' GLY . 27.6 mmmt -134.57 136.54 43.07 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.192 -176.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.16 165.19 29.86 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -88.93 -12.56 41.3 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.606 0.717 . . . . 0.0 109.41 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 88.2 t -108.14 122.73 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 174.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.78 ' O ' HG23 ' A' ' 54' ' ' VAL . 47.8 tt0 -63.27 -40.87 98.6 Favored 'General case' 0 C--O 1.197 -1.681 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.876 -175.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.19 4.88 53.23 Favored Glycine 0 C--N 1.278 -2.66 0 C-N-CA 117.672 -2.204 . . . . 0.0 115.158 -176.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.8 m -87.58 -29.95 20.87 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 172.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 51' ' ' GLN . 12.2 m -76.55 -44.07 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 CA-C-N 114.869 -1.059 . . . . 0.0 109.011 176.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -55.34 -50.63 69.14 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.421 -178.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.42 -42.11 88.24 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.411 -176.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.593 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 32.3 tp -68.4 -41.36 80.6 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.944 -177.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.481 HG13 HG12 ' A' ' 73' ' ' ILE . 39.6 t -57.47 -43.69 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 122.627 0.371 . . . . 0.0 111.04 175.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.34 -23.08 66.9 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.263 -177.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.41 -23.82 16.42 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.593 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -81.7 -37.25 27.65 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.269 -176.048 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -66.58 -21.21 66.14 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.046 0.451 . . . . 0.0 110.897 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -97.94 6.24 47.94 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 20.6 mm -74.74 79.28 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.651 0 CA-C-O 122.015 0.912 . . . . 0.0 110.566 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -136.22 10.72 3.27 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 176.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.5 p -72.79 -10.48 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 CA-C-N 113.906 -1.497 . . . . 0.0 112.514 -173.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -138.14 -170.07 2.71 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.78 -0.575 . . . . 0.0 110.263 -177.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -76.19 -19.38 78.54 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 121.505 -0.379 . . . . 0.0 112.169 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.2 t -95.07 118.9 42.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 176.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -95.11 124.37 39.11 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -177.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.2 t -124.58 135.78 62.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 21.6 ttmm -146.75 153.42 40.21 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 121.605 0.717 . . . . 0.0 111.42 -177.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.481 HG12 HG13 ' A' ' 58' ' ' VAL . 1.3 pp -94.97 169.21 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.509 174.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.477 HD12 ' HB3' ' A' ' 43' ' ' ASN . 3.3 mp -135.41 -32.03 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 172.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -151.1 133.45 15.41 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-O 121.234 0.54 . . . . 0.0 110.235 -168.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.414 ' HB3' HG23 ' A' ' 58' ' ' VAL . . . -124.55 141.44 52.09 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 178.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -151.02 135.42 16.96 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.377 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.8 p -93.41 92.01 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 CA-C-O 123.295 1.521 . . . . 0.0 107.906 175.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.8 175.69 47.5 Favored Glycine 0 N--CA 1.41 -3.072 0 N-CA-C 108.653 -1.779 . . . . 0.0 108.653 -177.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 102' ' ' ARG . . . -82.6 -179.19 7.35 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 175.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.5 mp -81.8 118.76 30.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 O-C-N 122.04 -0.412 . . . . 0.0 110.641 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.45 ' O ' HG13 ' A' ' 86' ' ' ILE . 25.7 p -119.81 160.28 22.93 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 178.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -54.07 -50.88 65.77 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.722 0.809 . . . . 0.0 112.501 -173.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.5 m -66.42 -19.38 65.78 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.398 0.618 . . . . 0.0 111.582 -176.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -86.27 -31.43 21.65 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -177.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.454 HD12 ' HB2' ' A' ' 111' ' ' ALA . 29.0 mt -73.11 -24.51 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.863 176.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.423 ' HA ' ' OE2' ' A' ' 114' ' ' GLU . 37.6 m -56.21 -24.6 43.05 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.094 175.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.405 ' O ' HD22 ' A' ' 88' ' ' LEU . 2.3 tm? -76.56 -35.06 58.42 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 175.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.5 -55.54 33.53 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.406 -176.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.572 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 8.9 t -71.81 -24.91 61.81 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.118 179.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.23 -62.03 1.63 Allowed 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.014 0.435 . . . . 0.0 111.937 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 43.3 m -91.75 3.84 54.18 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -177.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 69.52 31.57 3.68 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.733 0.778 . . . . 0.0 109.807 177.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -93.92 139.24 31.15 Favored 'General case' 0 N--CA 1.419 -1.987 0 CA-C-N 114.451 -1.249 . . . . 0.0 109.714 -177.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 45.9 mm -94.73 142.96 12.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 176.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.435 ' HB ' HG21 ' A' ' 118' ' ' ILE . 24.8 t -94.26 118.44 40.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -176.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 119' ' ' ARG . 27.1 pt -115.71 116.28 51.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-O 121.586 0.708 . . . . 0.0 109.644 176.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 47' ' ' LYS . . . -113.22 166.88 12.19 Favored Glycine 0 N--CA 1.428 -1.863 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.892 -177.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -133.17 112.63 11.89 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -177.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 60.52 14.32 4.78 Favored 'General case' 0 N--CA 1.502 2.146 0 C-N-CA 124.713 1.205 . . . . 0.0 113.112 178.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.467 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 1.5 m -96.59 -50.33 11.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 -173.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.571 ' O ' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER 75.49 163.65 0.14 Allowed Pre-proline 0 N--CA 1.479 0.994 0 C-N-CA 124.232 1.013 . . . . 0.0 111.968 -175.302 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -97.21 166.19 0.92 Allowed 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 121.974 1.783 . . . . 0.0 113.179 174.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -71.73 152.55 42.68 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 169.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.491 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -63.73 -25.01 68.0 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 117.912 0.323 . . . . 0.0 111.515 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.516 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 29.9 m-80 -88.62 -26.79 21.72 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.989 -0.684 . . . . 0.0 109.76 177.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.86 -44.34 77.33 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 121.025 0.441 . . . . 0.0 110.3 177.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -62.16 -21.57 65.17 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.922 179.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.516 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 56.2 mtp180 -83.84 -51.3 7.31 Favored 'General case' 0 N--CA 1.39 -3.474 0 C-N-CA 125.129 1.372 . . . . 0.0 109.378 176.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.458 ' O ' ' HG3' ' A' ' 114' ' ' GLU . . . -52.02 -48.23 64.62 Favored 'General case' 0 CA--C 1.489 -1.381 0 CA-C-N 114.403 -1.271 . . . . 0.0 110.642 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.454 ' HB2' HD12 ' A' ' 86' ' ' ILE . . . -51.72 -36.09 45.52 Favored 'General case' 0 CA--C 1.502 -0.885 0 C-N-CA 124.742 1.217 . . . . 0.0 112.17 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -78.78 -38.46 38.43 Favored 'General case' 0 N--CA 1.418 -2.029 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.788 -175.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.8 t -73.02 -9.26 58.54 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 175.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.593 ' O ' ' HB2' ' A' ' 115' ' ' LYS . 28.7 mt-10 -106.4 7.8 31.3 Favored 'General case' 0 CA--C 1.472 -2.056 0 C-N-CA 124.869 1.268 . . . . 0.0 114.009 -177.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.593 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 93.1 mttt 67.31 7.62 5.65 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 172.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.3 m -121.63 141.26 42.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -177.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -100.26 133.31 44.85 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-O 121.403 0.62 . . . . 0.0 109.794 179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.435 HG21 ' HB ' ' A' ' 96' ' ' VAL . 6.1 pt -97.21 139.69 19.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.596 178.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.555 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 64.9 ttt180 -131.85 128.54 38.88 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.41 ' N ' HD12 ' A' ' 120' ' ' LEU . 0.0 OUTLIER -143.52 138.06 28.92 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.239 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 49.1 t60 61.36 81.4 0.19 Allowed 'General case' 0 C--O 1.243 0.737 0 O-C-N 124.469 1.105 . . . . 0.0 110.01 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.85 93.2 3.15 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.9 tp -91.04 93.52 4.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 15.0 tt -67.52 -29.8 46.68 Favored 'Isoleucine or valine' 0 C--O 1.245 0.868 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.359 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 53.7 t80 69.38 158.49 0.17 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.791 1.236 . . . . 0.0 111.342 176.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 72.49 -58.82 0.58 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.858 1.263 . . . . 0.0 113.139 178.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.9 m -95.06 24.56 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 121.971 0.891 . . . . 0.0 109.778 178.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 10.4 tp -84.6 -10.73 11.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.675 -176.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -90.72 -59.26 2.22 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -112.14 98.36 7.28 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 176.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.5 mp -73.22 -40.33 57.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 174.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -122.01 128.46 51.45 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 113.77 -1.559 . . . . 0.0 107.316 173.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -80.01 -65.24 1.03 Allowed 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.099 0.476 . . . . 0.0 110.092 -177.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -137.09 -33.26 0.76 Allowed 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 14.2 tpt . . . . . 0 C--N 1.307 -1.252 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 178.396 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 . . . . . 0 CA--C 1.503 -0.853 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -99.86 -17.31 17.69 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 119.163 -1.015 . . . . 0.0 111.239 175.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -82.49 131.82 35.21 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 176.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 67.75 25.88 7.92 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.437 1.095 . . . . 0.0 109.082 -173.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 89.4 mt 70.18 177.84 0.26 Allowed 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.808 1.243 . . . . 0.0 111.364 -178.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.563 ' HA2' ' NH2' ' A' ' 12' ' ' ARG . . . 137.59 -80.33 0.29 Allowed Glycine 0 CA--C 1.49 -1.484 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 -175.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.0 m -59.34 -37.4 77.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.83 0.824 . . . . 0.0 108.869 172.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -85.64 116.12 23.73 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 174.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 139.28 -72.3 0.43 Allowed Glycine 0 N--CA 1.423 -2.201 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -178.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 29.2 m 58.5 -81.63 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.433 1.093 . . . . 0.0 113.242 178.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.9 t -81.14 91.67 6.17 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 176.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.596 ' O ' HG22 ' A' ' 13' ' ' VAL . 26.9 ptt180 -156.81 135.56 11.66 Favored 'General case' 0 N--CA 1.424 -1.755 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.588 -177.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 12' ' ' ARG . 37.2 t 158.86 82.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 130.413 3.485 . . . . 0.0 106.261 169.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -150.88 96.22 2.31 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 113.74 -1.573 . . . . 0.0 107.707 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -156.41 108.3 2.51 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.85 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.42 ' HA ' ' NH1' ' A' ' 24' ' ' ARG . 15.7 mm100 -69.3 -68.07 0.43 Allowed 'General case' 0 N--CA 1.424 -1.775 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.392 178.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 58.57 -78.41 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.799 0 O-C-N 125.417 1.698 . . . . 0.0 112.03 177.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 65.72 -81.29 0.03 OUTLIER 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 124.574 1.15 . . . . 0.0 109.524 -177.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 50.68 -77.48 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.62 1.568 . . . . 0.0 113.15 -177.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.0 p -103.47 -6.08 22.18 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 122.205 -0.309 . . . . 0.0 111.327 178.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.6 m 55.83 21.12 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 C-N-CA 126.827 2.051 . . . . 0.0 113.148 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -67.34 -17.96 64.96 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -176.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 23.0 p -121.75 11.49 10.47 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.42 ' NH1' ' HA ' ' A' ' 16' ' ' GLN . 19.7 mtp180 -120.15 144.58 47.59 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.4 m -61.36 110.38 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.867 0.841 . . . . 0.0 111.169 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.5 m -92.32 -41.44 10.37 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.2 -176.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 82.1 mt -118.17 137.04 53.25 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.102 -177.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -82.35 -49.29 10.17 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.238 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -63.3 -34.17 77.12 Favored 'General case' 0 CA--C 1.495 -1.167 0 O-C-N 123.815 0.697 . . . . 0.0 112.559 -178.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 56.6 tp -79.95 109.03 14.0 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -95.89 170.85 9.01 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.725 -178.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -81.21 -29.25 34.59 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -104.11 123.71 47.76 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.506 -1.224 . . . . 0.0 110.92 -175.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.6 pp -101.51 174.17 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.308 176.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.447 ' HD3' ' N ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -153.47 98.53 2.25 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.349 0.595 . . . . 0.0 110.712 -178.575 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -116.48 -46.22 2.78 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.9 0.857 . . . . 0.0 109.606 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 160.59 73.66 0.02 OUTLIER Glycine 0 N--CA 1.427 -1.957 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 -177.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -87.68 -0.33 56.74 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.045 0.45 . . . . 0.0 111.379 -174.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -86.33 142.11 28.73 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.578 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -86.0 -15.93 39.89 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 70' ' ' ARG . 7.3 mt-10 -95.7 95.3 8.24 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 114.26 -1.336 . . . . 0.0 110.072 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.416 ' HB3' HG21 ' A' ' 71' ' ' VAL . 56.7 tp -94.22 155.64 16.94 Favored 'General case' 0 N--CA 1.411 -2.388 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.039 -177.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.426 ' OD1' ' HB2' ' A' ' 92' ' ' SER . 10.4 m120 -122.82 147.91 45.99 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.358 -177.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 49.3 mt -141.69 174.94 10.1 Favored 'General case' 0 C--O 1.249 1.069 0 CA-C-O 121.53 0.681 . . . . 0.0 111.428 178.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.8 tt -136.41 143.33 35.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.963 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 96.6 t -127.89 122.83 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -149.54 121.63 8.29 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.587 179.021 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -131.73 175.66 9.0 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.163 -174.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -81.02 -29.13 35.19 Favored 'General case' 0 C--O 1.246 0.916 0 O-C-N 124.014 0.821 . . . . 0.0 109.815 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 80.7 t -101.88 130.09 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.364 174.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.755 ' O ' HG21 ' A' ' 54' ' ' VAL . 22.6 tm0? -64.72 -40.64 95.67 Favored 'General case' 0 C--O 1.197 -1.68 0 C-N-CA 122.822 0.449 . . . . 0.0 111.984 -174.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.4 2.8 86.6 Favored Glycine 0 C--N 1.29 -2.011 0 C-N-CA 118.114 -1.994 . . . . 0.0 112.988 178.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.2 t -82.59 -28.45 30.86 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 105.677 -1.971 . . . . 0.0 105.677 178.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.755 HG21 ' O ' ' A' ' 51' ' ' GLN . 12.9 m -69.69 -46.96 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.646 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.259 175.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -60.06 -39.54 86.39 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -177.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.91 -36.35 76.81 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 123.604 0.565 . . . . 0.0 110.796 178.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 42.3 tp -85.04 -41.72 15.51 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.714 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 54' ' ' VAL . 47.9 t -55.36 -41.23 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.099 0.96 . . . . 0.0 112.264 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.32 -17.79 64.35 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 120.736 0.303 . . . . 0.0 111.748 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.27 -27.38 14.54 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.25 -28.57 34.7 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.596 -175.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -75.93 -23.46 55.46 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.249 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -94.15 6.1 49.64 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.63 -177.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 34.3 mm -70.0 93.01 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-O 121.939 0.876 . . . . 0.0 111.959 -177.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -126.3 -22.31 4.05 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.427 -1.261 . . . . 0.0 108.793 171.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.1 m -65.34 172.77 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.251 1.181 0 CA-C-N 114.325 -1.307 . . . . 0.0 112.234 -177.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 74.24 -59.9 0.54 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.352 1.461 . . . . 0.0 109.065 -177.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 150.86 33.11 0.04 OUTLIER Glycine 0 N--CA 1.433 -1.563 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.3 p -147.59 142.9 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.527 ' O ' ' HA ' ' A' ' 41' ' ' GLU . 14.3 tpt180 -107.61 102.17 11.43 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 -178.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.416 HG21 ' HB3' ' A' ' 42' ' ' LEU . 20.0 t -118.87 137.44 52.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -178.021 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -142.41 155.43 45.12 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.6 pp -94.14 155.08 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.336 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.116 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.466 ' N ' HD12 ' A' ' 74' ' ' ILE . 3.8 mp -123.83 -31.43 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.969 0.89 . . . . 0.0 109.948 178.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -133.21 105.91 7.28 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.996 -170.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -116.33 114.68 24.66 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.059 178.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 47' ' ' LYS . . . -147.82 158.61 44.11 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.709 -177.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.9 p -94.0 101.39 12.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-O 121.859 0.837 . . . . 0.0 109.88 177.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.32 171.89 44.87 Favored Glycine 0 N--CA 1.417 -2.576 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.915 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 102' ' ' ARG . . . -82.24 -152.79 0.11 Allowed 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 174.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.409 ' HB ' ' HA ' ' A' ' 103' ' ' PRO . 2.4 mp -91.41 111.36 23.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 C-N-CA 118.732 -1.187 . . . . 0.0 109.36 176.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.5 p -108.73 165.18 11.74 Favored 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 175.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -60.02 -35.74 75.73 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 121.38 0.609 . . . . 0.0 111.124 -176.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.3 p -69.03 -23.6 64.09 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.12 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -74.28 -41.35 61.35 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 177.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.443 HD11 ' HB1' ' A' ' 111' ' ' ALA . 44.2 mt -66.86 -34.7 71.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-N 114.242 -1.344 . . . . 0.0 111.424 -178.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.484 ' HA ' ' OE2' ' A' ' 114' ' ' GLU . 46.9 m -67.73 -9.09 40.8 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.488 178.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -92.92 -32.67 14.49 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 173.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 93' ' ' ASN . . . -61.11 -53.26 59.33 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.44 -177.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.514 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 9.8 t -74.03 -13.57 60.88 Favored 'General case' 0 CA--C 1.561 1.379 0 CA-C-O 121.136 0.493 . . . . 0.0 110.414 178.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.65 -66.19 0.87 Allowed 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -176.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.426 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 27.1 p -101.51 5.65 41.97 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 120.748 0.309 . . . . 0.0 111.533 -176.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.473 ' HA ' ' O ' ' A' ' 89' ' ' ALA 0.491 0.0 OUTLIER 70.3 57.54 0.27 Allowed 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 127.13 2.172 . . . . 0.0 114.118 -179.462 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -105.3 167.99 9.37 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 113.357 -1.747 . . . . 0.0 108.509 174.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 47.7 mm -124.13 131.57 72.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 176.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.475 ' HB ' HG23 ' A' ' 118' ' ' ILE . 12.0 t -94.11 102.59 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -176.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 13.3 tt -97.93 140.53 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.924 177.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -134.36 146.45 18.44 Favored Glycine 0 N--CA 1.414 -2.772 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 178.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -119.54 109.24 15.47 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -177.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 66.7 t30 71.81 -39.07 0.44 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 126.022 1.729 . . . . 0.0 112.41 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.3 m -45.29 -47.65 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 126.302 1.841 . . . . 0.0 114.986 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.574 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 36.1 mtp180 73.57 170.14 0.11 Allowed Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 123.485 0.714 . . . . 0.0 112.055 179.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.409 ' HA ' ' HB ' ' A' ' 81' ' ' ILE . 9.9 Cg_endo -96.9 168.46 0.95 Allowed 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 121.911 1.741 . . . . 0.0 114.594 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -75.74 153.3 37.12 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 113.215 -1.811 . . . . 0.0 106.769 168.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.487 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -59.15 -35.2 73.1 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.548 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 18.2 m120 -79.58 -27.49 41.15 Favored 'General case' 0 CA--C 1.488 -1.429 0 C-N-CA 119.346 -0.941 . . . . 0.0 110.592 178.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.26 -46.42 77.17 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.766 177.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.487 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 19.9 pttp -59.51 -23.18 62.59 Favored 'General case' 0 CA--C 1.565 1.557 0 CA-C-O 120.965 0.412 . . . . 0.0 111.588 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.548 ' HB2' ' O ' ' A' ' 106' ' ' ASN 0.254 58.4 mtp180 -82.54 -51.2 8.01 Favored 'General case' 0 N--CA 1.393 -3.278 0 C-N-CA 125.821 1.648 . . . . 0.0 109.316 176.928 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.534 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -54.23 -48.5 71.01 Favored 'General case' 0 CA--C 1.471 -2.091 0 C-N-CA 125.914 1.686 . . . . 0.0 110.839 -176.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.443 ' HB1' HD11 ' A' ' 86' ' ' ILE . . . -48.17 -45.59 33.69 Favored 'General case' 0 CA--C 1.504 -0.797 0 O-C-N 124.867 1.354 . . . . 0.0 110.578 -179.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -72.92 -30.27 63.77 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 114.542 -1.208 . . . . 0.0 112.903 -174.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.1 t -92.28 5.27 51.13 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.547 ' O ' ' HB2' ' A' ' 115' ' ' LYS . 7.9 mt-10 -117.9 7.04 12.27 Favored 'General case' 0 N--CA 1.406 -2.662 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -175.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.547 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 29.7 mmmt 68.2 5.74 4.85 Favored 'General case' 0 N--CA 1.42 -1.936 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 174.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.1 m -122.18 145.26 29.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -114.66 143.66 44.68 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 118.726 -1.189 . . . . 0.0 109.761 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.475 HG23 ' HB ' ' A' ' 96' ' ' VAL . 8.7 pt -98.1 131.1 45.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.187 -176.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -98.5 124.83 43.47 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.516 -174.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -123.01 175.26 6.69 Favored 'General case' 0 CA--C 1.502 -0.865 0 CA-C-O 121.873 0.844 . . . . 0.0 112.867 -178.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.437 ' O ' HG12 ' A' ' 123' ' ' ILE . 47.4 t-80 -69.84 155.0 41.21 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.509 -1.678 . . . . 0.0 108.041 174.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.6 ttp180 -52.23 115.85 1.93 Allowed 'General case' 0 C--O 1.246 0.897 0 C-N-CA 123.628 0.771 . . . . 0.0 110.62 176.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.437 HG12 ' O ' ' A' ' 121' ' ' HIS . 47.9 mm -119.35 108.65 24.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 28.3 pt -69.02 132.53 32.97 Favored 'Isoleucine or valine' 0 C--O 1.268 2.065 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.676 178.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.409 ' CE2' ' HG2' ' A' ' 129' ' ' GLU . 0.9 OUTLIER 67.47 -159.01 0.22 Allowed 'General case' 0 CA--C 1.557 1.227 0 O-C-N 124.728 1.267 . . . . 0.0 107.665 -179.483 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 29.2 p30 -140.34 172.33 12.88 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 28.8 m -106.09 18.42 5.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -175.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 32.9 pt -127.82 23.1 2.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-O 121.709 0.766 . . . . 0.0 109.402 -178.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.409 ' HG2' ' CE2' ' A' ' 125' ' ' TYR . 0.4 OUTLIER -79.24 -4.77 52.27 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -169.49 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.04 -18.45 24.56 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.074 178.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 66.2 mt 63.19 88.31 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.048 -177.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -77.92 -56.55 4.4 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 177.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -122.42 -59.48 1.63 Allowed 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.295 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 62.8 118.93 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.092 1.357 . . . . 0.0 112.851 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.294 -1.805 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.564 -178.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.9 p30 . . . . . 0 N--CA 1.464 0.264 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -107.64 111.15 23.23 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -178.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -110.86 -26.44 9.33 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-N 113.925 -1.489 . . . . 0.0 107.048 173.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -89.26 -23.52 22.3 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.6 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 89.6 mt 66.57 31.55 7.81 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.099 0.959 . . . . 0.0 109.661 177.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -139.52 -112.7 1.04 Allowed Glycine 0 N--CA 1.424 -2.146 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -177.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.5 m 71.01 -38.16 0.41 Allowed 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 125.0 1.32 . . . . 0.0 113.915 176.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 51.9 mtm180 -53.41 -54.45 36.68 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 123.958 0.903 . . . . 0.0 112.271 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -117.64 44.47 1.43 Allowed Glycine 0 N--CA 1.435 -1.404 0 C-N-CA 121.225 -0.512 . . . . 0.0 112.986 -177.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 38.0 m -68.8 -51.65 38.66 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.206 0.527 . . . . 0.0 110.315 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.4 m -96.3 41.96 1.1 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.798 0.839 . . . . 0.0 110.074 -177.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -66.38 -18.48 65.38 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -173.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 19.4 m -94.84 2.87 9.4 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.893 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.5 t70 70.38 99.12 0.06 Allowed 'General case' 0 CA--C 1.5 -0.945 0 C-N-CA 124.423 1.089 . . . . 0.0 110.588 -176.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.6 mt -80.52 107.44 13.32 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -106.34 -19.76 13.6 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.987 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -60.42 109.07 0.91 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.624 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 69.26 11.84 8.26 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.945 1.298 . . . . 0.0 110.306 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -101.52 -36.32 8.84 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.0 p -73.79 -33.31 64.17 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.171 178.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . 0.317 20.7 m 58.39 -16.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 127.659 2.383 . . . . 0.0 116.819 177.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.5 ptpp? -54.17 -36.06 62.96 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.146 0.498 . . . . 0.0 112.045 178.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.5 p -100.6 22.85 11.2 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 123.619 0.768 . . . . 0.0 110.858 -178.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -128.98 -42.2 1.4 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.307 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.6 m -77.9 -13.63 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.151 0.501 . . . . 0.0 111.233 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.0 p -93.06 168.5 11.08 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.3 tt -122.35 -63.71 1.26 Allowed 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -96.09 172.66 7.85 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -178.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -71.24 -57.22 4.69 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 123.068 0.547 . . . . 0.0 109.969 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 47.0 tp 64.32 9.25 4.74 Favored 'General case' 0 CA--C 1.562 1.438 0 C-N-CA 124.591 1.156 . . . . 0.0 113.637 177.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -88.87 -12.84 40.69 Favored 'General case' 0 C--N 1.318 -0.768 0 O-C-N 120.824 -1.172 . . . . 0.0 111.898 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.12 143.76 49.49 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 121.247 -0.181 . . . . 0.0 110.862 176.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.4 tp60 -166.86 -61.68 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -178.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 59.8 mt -99.08 131.22 46.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.4 mttm 79.5 80.2 0.05 Allowed 'General case' 0 CA--C 1.501 -0.904 0 C-N-CA 125.198 1.399 . . . . 0.0 110.816 -176.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -76.76 -39.96 49.94 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 113.585 -1.643 . . . . 0.0 108.303 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.21 -170.61 42.82 Favored Glycine 0 N--CA 1.415 -2.718 0 N-CA-C 107.55 -2.22 . . . . 0.0 107.55 -179.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -85.64 -69.27 0.67 Allowed 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 117.778 0.789 . . . . 0.0 109.303 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 53.49 78.33 0.15 Allowed 'General case' 0 C--O 1.24 0.565 0 CA-C-N 114.156 -1.383 . . . . 0.0 108.034 -174.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -73.87 146.76 43.84 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.479 -175.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.518 ' HB3' ' ND2' ' A' ' 43' ' ' ASN . 58.8 mm-40 -94.16 105.59 17.58 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.644 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 3.7 mm? -94.02 94.15 8.26 Favored 'General case' 0 CA--C 1.486 -1.518 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 176.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.593 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 91.3 m-20 -124.46 146.87 48.68 Favored 'General case' 0 C--N 1.28 -2.455 0 CA-C-N 113.294 -1.775 . . . . 0.0 107.317 -174.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.3 pp -150.12 164.69 34.94 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.522 HD11 ' CD2' ' A' ' 75' ' ' HIS . 0.3 OUTLIER -119.88 132.88 68.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.368 178.612 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 93.3 t -107.1 126.96 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.058 -177.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 42.5 mtpt -139.23 134.75 33.12 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.211 176.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.78 168.39 23.82 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -178.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -80.2 -18.73 48.77 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.855 0.836 . . . . 0.0 110.421 -178.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 69.4 t -104.76 123.19 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 175.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.79 ' O ' HG22 ' A' ' 54' ' ' VAL . 10.8 tt0 -68.64 -29.78 68.34 Favored 'General case' 0 C--O 1.195 -1.78 0 CA-C-O 121.137 0.494 . . . . 0.0 111.413 -174.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.95 2.59 87.15 Favored Glycine 0 C--N 1.284 -2.36 0 C-N-CA 117.125 -2.464 . . . . 0.0 112.642 177.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.4 t -86.84 -31.07 21.01 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 176.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.79 HG22 ' O ' ' A' ' 51' ' ' GLN . 11.9 m -67.48 -43.4 87.41 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.866 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.423 175.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -66.27 -39.93 89.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.413 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.27 -37.04 79.25 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.747 177.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.511 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 26.6 tp -77.46 -41.68 38.71 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 120.532 -0.467 . . . . 0.0 109.766 177.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.427 HG21 ' O ' ' A' ' 54' ' ' VAL . 32.1 t -53.57 -45.82 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 123.57 0.748 . . . . 0.0 112.079 177.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.34 -26.56 68.51 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.58 -22.83 17.37 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -178.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -82.55 -35.53 27.11 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.47 -175.621 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -67.72 -27.04 66.46 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.112 0.482 . . . . 0.0 110.57 178.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.1 ptpp? -88.68 5.59 42.46 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.32 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.428 ' HB ' ' O ' ' A' ' 71' ' ' VAL . 39.7 mm -76.71 -23.3 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 178.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -69.14 105.27 2.41 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-O 121.475 0.655 . . . . 0.0 110.112 176.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 31.5 m -127.53 -173.07 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 176.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.8 102.17 11.42 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 121.414 0.625 . . . . 0.0 110.801 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 118.21 -42.1 1.89 Allowed Glycine 0 C--N 1.314 -0.646 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.496 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.6 t -115.69 134.05 60.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.421 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -152.56 125.65 8.57 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 120.697 0.284 . . . . 0.0 110.943 -179.73 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.428 ' O ' ' HB ' ' A' ' 64' ' ' ILE . 34.5 t -142.6 129.65 18.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 103.382 -2.822 . . . . 0.0 103.382 171.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.443 ' HG2' ' N ' ' A' ' 73' ' ' ILE . 87.9 tttt -139.92 161.5 37.44 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.354 0.597 . . . . 0.0 111.142 -176.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.443 ' N ' ' HG2' ' A' ' 72' ' ' LYS . 1.7 pp -93.51 148.52 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.759 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.612 177.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 73.2 mt -119.57 -27.63 2.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-O 121.68 0.753 . . . . 0.0 110.06 176.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.522 ' CD2' HD11 ' A' ' 45' ' ' ILE . 3.0 t60 -154.67 132.28 11.34 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.357 -172.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -134.66 131.03 37.25 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -149.79 156.98 42.75 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.955 -178.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.3 p -93.5 94.42 4.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-O 122.521 1.153 . . . . 0.0 110.295 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.7 176.02 47.79 Favored Glycine 0 N--CA 1.417 -2.572 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 102' ' ' ARG . . . -91.81 -175.38 4.12 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 176.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.433 HG23 HG22 ' A' ' 118' ' ' ILE . 3.2 mp -74.3 111.84 10.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 119.433 -0.907 . . . . 0.0 108.847 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.8 p -117.61 152.97 34.07 Favored 'General case' 0 N--CA 1.42 -1.972 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.702 -178.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -50.33 -41.83 51.85 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.026 0.53 . . . . 0.0 111.588 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.1 m -62.83 -28.12 69.79 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.614 -177.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -86.17 -29.33 23.32 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-O 121.341 0.591 . . . . 0.0 110.94 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.426 HG23 ' HA ' ' A' ' 111' ' ' ALA . 59.2 mt -65.87 -25.72 36.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.699 177.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.413 ' HA ' ' OE1' ' A' ' 114' ' ' GLU . 38.0 m -59.84 -30.7 69.13 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.917 177.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -78.25 -35.78 47.78 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 175.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.05 -58.91 5.39 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.966 -176.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.619 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 9.8 t -71.24 -24.61 62.22 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.478 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.17 -62.67 1.61 Allowed 'General case' 0 C--N 1.342 0.273 0 CA-C-O 120.944 0.402 . . . . 0.0 111.76 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.7 m -96.37 5.44 50.91 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.627 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 65.85 40.88 4.03 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.216 1.006 . . . . 0.0 110.314 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.593 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -94.51 136.45 34.79 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-N 114.206 -1.361 . . . . 0.0 109.081 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.1 mp -93.88 140.23 16.9 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.41 ' HB ' HG21 ' A' ' 118' ' ' ILE . 14.5 t -94.77 117.54 38.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -178.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' A' ' 119' ' ' ARG . 0.2 OUTLIER -112.17 122.86 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 174.3 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -115.37 146.47 18.83 Favored Glycine 0 N--CA 1.426 -1.997 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.159 -177.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -105.6 94.62 5.3 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 118.468 -1.293 . . . . 0.0 109.664 -177.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 63.78 8.64 3.9 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 124.946 1.298 . . . . 0.0 112.866 177.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.424 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 3.6 m -78.89 -49.38 20.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.101 -178.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.541 ' O ' ' HB3' ' A' ' 80' ' ' ALA . 72.7 mtp180 69.59 154.64 0.15 Allowed Pre-proline 0 N--CA 1.477 0.915 0 O-C-N 123.889 0.743 . . . . 0.0 112.82 175.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -91.07 173.69 2.78 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 121.991 1.794 . . . . 0.0 112.47 178.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -89.71 168.28 12.23 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 167.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.576 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -56.58 -28.61 60.63 Favored 'General case' 0 C--O 1.206 -1.203 0 C-N-CA 122.824 0.449 . . . . 0.0 111.041 178.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.655 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 23.1 p30 -72.41 -46.47 55.01 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.21 -34.8 76.92 Favored 'General case' 0 C--N 1.292 -1.922 0 O-C-N 122.096 -0.378 . . . . 0.0 111.563 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 18.1 pttp -63.08 -27.7 69.57 Favored 'General case' 0 CA--C 1.563 1.478 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.318 175.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.655 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 63.5 mtp180 -75.37 -50.28 16.41 Favored 'General case' 0 N--CA 1.405 -2.698 0 C-N-CA 125.212 1.405 . . . . 0.0 109.239 176.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.24 -50.6 66.8 Favored 'General case' 0 C--O 1.201 -1.47 0 CA-C-N 114.118 -1.401 . . . . 0.0 110.269 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.426 ' HA ' HG23 ' A' ' 86' ' ' ILE . . . -49.33 -48.6 46.32 Favored 'General case' 0 CA--C 1.502 -0.886 0 O-C-N 124.587 1.179 . . . . 0.0 111.602 -178.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -79.13 -29.8 43.35 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.864 -173.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 28.7 t -77.19 -6.94 54.92 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 175.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.619 ' O ' ' HB ' ' A' ' 90' ' ' THR . 26.2 mt-10 -114.73 9.32 16.37 Favored 'General case' 0 N--CA 1.411 -2.422 0 CA-C-N 114.471 -1.241 . . . . 0.0 112.912 -177.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 29.2 mmtp 64.46 15.57 9.65 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 174.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.3 m -120.34 131.76 71.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.461 0.648 . . . . 0.0 112.565 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -94.59 130.39 41.06 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.077 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.433 HG22 HG23 ' A' ' 81' ' ' ILE . 15.1 pt -94.85 128.6 45.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.06 179.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.518 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 98.1 mtt180 -122.16 111.69 17.29 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.672 0.749 . . . . 0.0 110.743 -175.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.505 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -129.65 148.43 51.54 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.148 -177.786 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 29.8 t60 67.62 -74.68 0.07 Allowed 'General case' 0 N--CA 1.477 0.913 0 O-C-N 124.303 1.002 . . . . 0.0 111.158 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -91.29 90.29 7.67 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 122.231 1.015 . . . . 0.0 111.075 -175.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 44.5 mm -85.32 -26.94 6.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 40.9 pt -126.53 163.8 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 CA-C-N 114.083 -1.417 . . . . 0.0 107.249 177.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -86.62 107.78 18.32 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 176.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -75.15 98.8 3.79 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.533 0.682 . . . . 0.0 112.294 -176.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 46.4 t -94.16 -53.19 8.69 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 172.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 55.6 mt 56.78 75.39 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-N 113.079 -1.873 . . . . 0.0 112.444 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.5 17.1 5.92 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 122.877 1.322 . . . . 0.0 107.915 174.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -119.35 10.16 11.85 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 112.743 -2.026 . . . . 0.0 109.476 -176.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 72.3 mt 71.09 123.42 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 124.677 1.191 . . . . 0.0 112.364 -175.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -103.6 126.54 50.81 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 172.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -125.76 113.28 17.09 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -172.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -135.39 -80.49 0.43 Allowed 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 172.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 54.4 mtm . . . . . 0 CA--C 1.496 -1.098 0 C-N-CA 126.466 1.906 . . . . 0.0 107.009 172.636 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 N--CA 1.476 0.837 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -142.04 60.96 1.46 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -172.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -93.16 -19.97 20.94 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 115.03 -0.987 . . . . 0.0 109.207 177.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -106.65 127.96 53.78 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.737 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.522 ' HG ' ' NE2' ' A' ' 18' ' ' GLN . 2.9 mm? -119.83 -77.56 0.58 Allowed 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 177.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.3 126.28 11.36 Favored Glycine 0 N--CA 1.434 -1.44 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -178.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.4 m -71.94 -24.38 61.61 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 121.639 0.733 . . . . 0.0 109.851 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -79.05 98.5 6.51 Favored 'General case' 0 C--O 1.245 0.859 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 173.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 139.31 167.18 10.88 Favored Glycine 0 N--CA 1.411 -2.968 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.2 m -158.28 22.16 0.24 Allowed 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 -178.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.1 m 64.15 36.39 9.62 Favored 'General case' 0 C--N 1.351 0.634 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -170.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -103.09 -54.26 2.65 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.857 -178.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.13 4.34 2.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -114.2 109.68 18.78 Favored 'General case' 0 N--CA 1.417 -2.085 0 CA-C-N 113.496 -1.684 . . . . 0.0 110.424 -173.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.6 mp -101.67 97.96 8.31 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 177.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 72.8 mm-40 -105.02 150.15 25.19 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -178.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -149.96 101.87 3.07 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -179.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.522 ' NE2' ' HG ' ' A' ' 5' ' ' LEU 0.295 41.8 mt-30 -130.52 52.76 2.0 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-O 122.367 1.079 . . . . 0.0 112.573 175.075 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -106.18 -48.35 3.61 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 170.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.9 p -111.23 7.1 21.04 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.317 -1.311 . . . . 0.0 109.478 175.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.7 m 47.29 35.34 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 126.507 1.923 . . . . 0.0 114.038 177.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -112.97 152.29 29.57 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 70.9 p 62.76 11.35 4.85 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.804 1.242 . . . . 0.0 112.417 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -72.2 -23.37 61.24 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.956 -176.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.9 t -89.68 -53.1 9.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 176.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.6 t 72.85 -56.14 0.66 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.037 1.335 . . . . 0.0 112.063 177.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 79.7 mt 62.36 66.33 0.8 Allowed 'General case' 0 CA--C 1.503 -0.844 0 C-N-CA 123.989 0.916 . . . . 0.0 111.545 -176.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -85.33 -27.78 25.69 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 174.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -117.29 141.1 48.73 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 173.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.3 tp -125.98 10.13 7.56 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.967 -172.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 62.59 83.05 0.16 Allowed 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.425 0.631 . . . . 0.0 109.811 -171.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -50.19 -45.13 53.29 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.297 -1.32 . . . . 0.0 114.189 -177.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -112.66 161.86 16.36 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.032 -177.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.3 pt -82.04 131.96 32.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.128 0.49 . . . . 0.0 110.623 -178.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -85.43 -37.89 19.27 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.348 0.594 . . . . 0.0 109.669 178.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -111.13 136.88 49.52 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.65 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -115.95 175.6 15.95 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 178.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -90.09 176.14 6.89 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 86.7 mtp -73.77 134.15 43.39 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.45 -178.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -90.15 -56.81 3.07 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.776 -175.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.77 124.3 48.05 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.439 -178.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.404 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 3.9 mm? -122.47 99.08 6.22 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 169.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -107.77 140.94 40.08 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -171.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.4 mt -135.23 168.78 18.54 Favored 'General case' 0 C--O 1.248 0.976 0 CA-C-O 121.789 0.804 . . . . 0.0 111.925 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.1 tt -133.18 132.9 58.54 Favored 'Isoleucine or valine' 0 C--O 1.249 1.028 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.198 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.646 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 84.4 t -113.74 131.96 64.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.565 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.97 148.03 36.17 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 178.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.59 158.13 28.51 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 177.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -78.95 -12.33 60.03 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.039 -0.665 . . . . 0.0 110.044 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 99.1 t -109.86 134.12 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 174.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.744 ' O ' HG22 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -69.01 -46.63 67.52 Favored 'General case' 0 C--O 1.202 -1.447 0 C-N-CA 122.431 0.292 . . . . 0.0 110.558 -172.332 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.06 -1.19 67.66 Favored Glycine 0 C--N 1.286 -2.196 0 C-N-CA 118.479 -1.82 . . . . 0.0 114.285 -177.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.7 m -80.17 -29.42 38.74 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 106.282 -1.748 . . . . 0.0 106.282 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.744 HG22 ' O ' ' A' ' 51' ' ' GLN . 5.7 m -72.37 -42.44 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.498 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.354 176.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -54.47 -47.86 72.48 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 124.128 0.893 . . . . 0.0 110.592 178.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.77 -40.03 91.02 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.658 -178.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 34.4 tp -78.94 -36.66 41.33 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.593 -178.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.428 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 43.4 t -59.98 -43.6 92.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 122.727 0.411 . . . . 0.0 110.493 177.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.12 -14.85 62.48 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.61 -13.15 16.64 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.497 0.665 . . . . 0.0 109.294 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.7 -38.67 8.61 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.397 -176.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.428 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 4.1 pt20 -74.11 -5.9 44.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.303 0.573 . . . . 0.0 111.128 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.22 -5.34 50.17 Favored 'General case' 0 C--O 1.245 0.856 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.117 177.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.6 mm -86.69 77.5 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -131.5 -67.29 0.7 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.215 -174.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.7 m -89.53 -4.37 10.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.68 0.752 . . . . 0.0 109.992 177.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -90.31 86.52 6.51 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.345 -178.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 76.78 -74.26 1.81 Allowed Glycine 0 CA--C 1.525 0.682 0 CA-C-N 115.395 -0.82 . . . . 0.0 113.801 178.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 43.8 t -135.59 156.36 38.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -175.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -93.94 107.24 19.16 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.138 0.494 . . . . 0.0 110.044 176.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 43.6 t -117.04 113.36 42.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 175.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -124.27 158.08 33.37 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.52 0.676 . . . . 0.0 111.444 -172.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 pp -93.84 149.76 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.942 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.803 174.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 53.6 mt -120.63 -24.23 2.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-O 121.565 0.698 . . . . 0.0 110.796 178.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -150.41 117.45 5.94 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.63 -172.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.646 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -120.78 129.69 53.7 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 176.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.404 ' O ' HG11 ' A' ' 54' ' ' VAL . . . -145.72 153.53 41.07 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.974 -178.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.402 ' HB ' ' HA ' ' A' ' 51' ' ' GLN . 3.0 p -93.84 93.26 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.704 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 175.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.87 176.49 48.03 Favored Glycine 0 N--CA 1.401 -3.697 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.79 -175.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' A' ' 102' ' ' ARG . . . -90.49 -157.08 0.46 Allowed 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 175.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 103' ' ' PRO . 2.9 mp -83.06 103.74 10.76 Favored 'Isoleucine or valine' 0 C--O 1.254 1.329 0 C-N-CA 118.854 -1.138 . . . . 0.0 108.242 177.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 44.1 p -101.7 159.73 15.07 Favored 'General case' 0 N--CA 1.409 -2.508 0 C-N-CA 119.417 -0.913 . . . . 0.0 108.808 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -60.21 -26.27 66.26 Favored 'General case' 0 CA--C 1.559 1.315 0 CA-C-O 121.466 0.65 . . . . 0.0 109.949 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.6 m -71.97 -22.06 61.5 Favored 'General case' 0 CA--C 1.555 1.146 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.154 178.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -81.48 -33.05 32.18 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-O 121.628 0.728 . . . . 0.0 109.276 178.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.456 HD12 ' HB2' ' A' ' 111' ' ' ALA . 67.8 mt -72.63 -33.13 43.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.25 -178.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.9 p -61.01 -17.29 51.36 Favored 'General case' 0 CA--C 1.557 1.214 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 175.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.474 ' O ' HD21 ' A' ' 88' ' ' LEU . 1.9 tm? -92.22 -33.13 14.8 Favored 'General case' 0 C--O 1.25 1.104 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 174.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.93 -58.94 5.57 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.25 -176.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.47 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 11.2 t -79.29 -4.27 49.95 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-O 121.421 0.629 . . . . 0.0 110.649 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.84 -67.31 0.79 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.039 0.447 . . . . 0.0 112.191 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.4 t -104.85 5.95 33.44 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.391 0.615 . . . . 0.0 109.921 -176.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 74.07 72.12 0.11 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.482 1.113 . . . . 0.0 113.324 178.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -128.33 135.69 49.94 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 173.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.0 tt -94.49 140.79 16.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.474 ' HB ' HG22 ' A' ' 118' ' ' ILE . 49.4 t -94.45 99.45 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.392 0 CA-C-O 121.587 0.708 . . . . 0.0 110.946 -174.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.424 ' HA ' ' O ' ' A' ' 119' ' ' ARG . 42.7 mm -94.11 144.2 10.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 174.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -143.02 158.72 27.28 Favored Glycine 0 C--N 1.293 -1.821 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.06 -179.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.475 ' C ' ' H ' ' A' ' 101' ' ' VAL . 59.1 m-85 -122.38 95.04 4.48 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.243 -177.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . 0.254 95.4 m-20 55.6 -5.09 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 -179.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.475 ' H ' ' C ' ' A' ' 99' ' ' PHE . 1.7 m -62.93 -45.02 99.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 C-N-CA 123.65 0.78 . . . . 0.0 110.159 176.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.601 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 58.9 mtm180 70.88 161.66 0.15 Allowed Pre-proline 0 C--O 1.213 -0.849 0 CA-C-N 114.783 -1.099 . . . . 0.0 113.125 173.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.455 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 11.1 Cg_endo -94.68 170.41 1.61 Allowed 'Trans proline' 0 N--CA 1.441 -1.602 0 C-N-CA 121.479 1.453 . . . . 0.0 114.291 -177.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -74.07 155.35 38.6 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 167.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.561 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -61.67 -36.29 80.44 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.563 0.697 . . . . 0.0 110.193 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.525 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 2.7 t-20 -74.83 -37.76 62.19 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.032 177.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.33 -48.39 81.8 Favored 'General case' 0 C--O 1.214 -0.775 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.48 176.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.561 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 14.8 pttp -59.23 -28.63 66.86 Favored 'General case' 0 CA--C 1.565 1.541 0 CA-C-O 120.982 0.42 . . . . 0.0 111.89 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.55 ' HG3' ' O ' ' A' ' 105' ' ' ALA . 49.3 mtp180 -75.4 -49.59 18.49 Favored 'General case' 0 N--CA 1.386 -3.655 0 C-N-CA 125.5 1.52 . . . . 0.0 109.306 178.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -55.22 -48.01 74.51 Favored 'General case' 0 C--O 1.198 -1.618 0 CA-C-N 113.903 -1.498 . . . . 0.0 110.07 -179.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.456 ' HB2' HD12 ' A' ' 86' ' ' ILE . . . -48.09 -44.07 31.31 Favored 'General case' 0 CA--C 1.496 -1.115 0 O-C-N 124.68 1.237 . . . . 0.0 111.121 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.402 ' C ' ' H ' ' A' ' 114' ' ' GLU . 39.6 mt-10 -75.87 -37.5 58.84 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.748 -174.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 34.0 t -80.41 5.07 16.04 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 122.047 0.927 . . . . 0.0 108.568 178.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.515 ' O ' ' HB2' ' A' ' 115' ' ' LYS . 25.1 mt-10 -121.23 9.76 10.5 Favored 'General case' 0 N--CA 1.404 -2.762 0 CA-C-N 114.442 -1.254 . . . . 0.0 112.839 -178.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.515 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 60.3 mmtt 65.87 10.82 7.19 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 173.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.1 m -115.22 156.42 16.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 C-N-CA 119.831 -0.748 . . . . 0.0 111.744 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -112.57 138.19 49.71 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.329 -177.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.474 HG22 ' HB ' ' A' ' 96' ' ' VAL . 9.9 pt -108.38 113.88 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.628 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 173.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.424 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 50.8 ttp180 -113.31 97.92 6.78 Favored 'General case' 0 N--CA 1.414 -2.27 0 CA-C-O 122.211 1.005 . . . . 0.0 109.719 -175.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.521 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -116.62 142.35 47.0 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.768 -179.46 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 67.86 19.72 9.47 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 59.14 -92.0 0.03 OUTLIER 'General case' 0 C--N 1.345 0.38 0 C-N-CA 125.938 1.695 . . . . 0.0 112.03 -176.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 64.8 mt -136.63 -82.28 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.432 HG23 ' H ' ' A' ' 126' ' ' ASN . 35.6 mm 61.27 -77.49 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 124.658 1.183 . . . . 0.0 111.128 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 57.24 20.15 5.51 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.432 ' H ' HG23 ' A' ' 124' ' ' ILE . 5.6 t30 -87.6 59.51 5.49 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 122.207 1.003 . . . . 0.0 109.009 177.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 28.5 m -127.36 -0.12 3.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 113.098 -1.865 . . . . 0.0 106.807 172.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.1 mp -94.5 113.08 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 174.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -77.19 -13.07 60.0 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.185 -176.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 68.24 96.31 0.06 Allowed 'General case' 0 CA--C 1.513 -0.481 0 C-N-CA 125.316 1.447 . . . . 0.0 110.618 176.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 65.9 mt 72.07 104.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 124.894 1.278 . . . . 0.0 109.84 -176.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -76.94 83.45 3.48 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.479 0.657 . . . . 0.0 110.026 177.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -153.14 108.87 3.29 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.611 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.59 -24.76 31.37 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 176.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 20.1 mmt . . . . . 0 C--N 1.307 -1.258 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 -179.729 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.47 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 89.0 m-20 . . . . . 0 CA--C 1.504 -0.826 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -155.27 165.62 36.1 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-O 121.513 0.673 . . . . 0.0 112.191 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.57 HD13 ' CD2' ' A' ' 75' ' ' HIS . 0.1 OUTLIER -118.43 134.56 61.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 174.591 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 65.5 t -103.84 129.99 55.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.414 -178.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.472 ' HE2' ' HB3' ' A' ' 77' ' ' ALA . 64.4 mttt -141.38 139.27 33.46 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 121.442 0.639 . . . . 0.0 111.149 176.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.72 166.38 33.01 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -82.22 -21.77 36.2 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.996 0.427 . . . . 0.0 110.082 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 94.3 t -99.25 124.09 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 174.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.771 ' O ' HG22 ' A' ' 54' ' ' VAL . 17.3 tt0 -63.77 -40.87 97.74 Favored 'General case' 0 C--O 1.2 -1.546 0 CA-C-O 120.871 0.367 . . . . 0.0 111.56 -174.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.02 5.18 63.27 Favored Glycine 0 C--N 1.278 -2.683 0 C-N-CA 117.639 -2.22 . . . . 0.0 113.647 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.9 t -84.26 -32.28 24.51 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 173.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.771 HG22 ' O ' ' A' ' 51' ' ' GLN . 4.0 m -72.71 -46.8 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.766 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.772 177.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -63.4 -39.48 94.63 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.504 -177.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.42 -37.47 87.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.825 0.345 . . . . 0.0 110.695 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.41 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 31.3 tp -75.08 -42.02 57.6 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.507 HG21 ' HB2' ' A' ' 76' ' ' ALA . 70.3 t -58.78 -42.48 85.57 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.52 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.948 177.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.433 ' O ' ' HE3' ' A' ' 63' ' ' LYS . . . -65.11 -16.87 63.96 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.99 -25.25 14.38 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 122.187 0.994 . . . . 0.0 108.399 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.431 ' HB3' HG13 ' A' ' 73' ' ' ILE . 0.6 OUTLIER -83.13 -36.26 24.93 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.168 -176.197 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -71.91 -22.35 61.5 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 122.801 0.44 . . . . 0.0 111.228 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.433 ' HE3' ' O ' ' A' ' 59' ' ' ALA . 19.0 ptpt . . . . . 0 C--N 1.329 -0.283 0 CA-C-O 121.201 0.524 . . . . 0.0 110.772 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 39.5 t . . . . . 0 N--CA 1.439 -0.995 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -147.98 154.31 40.15 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.365 0.603 . . . . 0.0 110.776 -175.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.431 HG13 ' HB3' ' A' ' 61' ' ' LEU . 1.6 pp -93.9 147.94 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.68 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.625 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.8 mm -112.5 -22.18 5.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.978 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.57 ' CD2' HD13 ' A' ' 45' ' ' ILE . 5.3 t60 -162.48 149.11 13.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -172.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.507 ' HB2' HG21 ' A' ' 58' ' ' VAL . . . -140.41 144.34 36.11 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 178.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.472 ' HB3' ' HE2' ' A' ' 47' ' ' LYS . . . -165.52 149.78 8.49 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 117.904 0.32 . . . . 0.0 110.874 177.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.2 p -94.31 93.67 4.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 122.604 1.192 . . . . 0.0 109.083 177.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -177.09 176.4 48.05 Favored Glycine 0 N--CA 1.408 -3.192 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -177.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.661 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -93.11 -175.35 3.83 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 176.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 103' ' ' PRO . 3.0 mp -77.83 110.9 14.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.064 -0.655 . . . . 0.0 110.016 -176.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.7 p -110.74 147.81 33.62 Favored 'General case' 0 N--CA 1.408 -2.543 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.187 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -45.7 -44.49 13.59 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 125.125 1.37 . . . . 0.0 112.95 -178.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.9 t -64.15 -33.96 76.96 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 122.556 0.342 . . . . 0.0 111.785 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -78.18 -26.21 47.52 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 121.007 0.432 . . . . 0.0 111.718 -177.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.536 HG21 ' HA ' ' A' ' 111' ' ' ALA . 50.8 mt -64.71 -35.48 75.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.952 177.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 57.6 m -61.17 -24.55 66.39 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 175.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -74.96 -37.63 61.9 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 173.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.606 ' HA ' ' O ' ' A' ' 94' ' ' ALA . . . -55.22 -51.23 67.23 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.9 -177.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.417 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 8.9 t -77.14 -15.98 59.33 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 120.596 -0.441 . . . . 0.0 111.099 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.69 -62.13 1.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.062 0.458 . . . . 0.0 111.102 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 68.1 m -91.6 1.3 57.24 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.954 -177.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 69.35 23.33 6.22 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.907 0.86 . . . . 0.0 109.38 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.606 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . -94.72 117.2 29.75 Favored 'General case' 0 C--O 1.194 -1.844 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.688 -177.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 44.3 pt -92.38 156.69 3.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 118.378 -1.329 . . . . 0.0 109.782 -177.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.439 HG11 HG13 ' A' ' 81' ' ' ILE . 10.5 t -94.45 116.92 36.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.215 -173.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 6.5 tp -101.08 109.25 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.928 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 173.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -105.9 140.57 15.19 Favored Glycine 0 N--CA 1.414 -2.789 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.047 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -98.68 94.4 6.63 Favored 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 118.238 -1.385 . . . . 0.0 109.281 -176.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 66.8 t30 58.61 14.78 3.27 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 125.489 1.516 . . . . 0.0 111.822 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.508 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 6.5 m -78.91 -49.6 19.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -173.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.661 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 62.6 mtm180 77.87 158.96 0.15 Allowed Pre-proline 0 N--CA 1.482 1.17 0 O-C-N 123.818 0.699 . . . . 0.0 112.756 174.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.478 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 15.4 Cg_endo -100.16 178.79 0.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.546 2.164 . . . . 0.0 114.934 -176.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.494 ' HB2' ' H ' ' A' ' 107' ' ' ALA . 11.4 m-20 -73.83 159.91 32.21 Favored 'General case' 0 C--O 1.25 1.084 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 167.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.505 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -67.63 -28.22 67.54 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.079 0.466 . . . . 0.0 109.892 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.621 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 20.0 t-20 -85.9 -36.32 19.99 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.796 176.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.494 ' H ' ' HB2' ' A' ' 104' ' ' ASP . . . -59.51 -43.81 93.3 Favored 'General case' 0 C--O 1.207 -1.152 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.823 176.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 105' ' ' ALA . 0.0 OUTLIER -57.83 -30.04 65.43 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-O 120.785 0.326 . . . . 0.0 111.602 179.08 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.621 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 91.1 mtt180 -76.29 -52.31 10.24 Favored 'General case' 0 N--CA 1.386 -3.638 0 C-N-CA 125.29 1.436 . . . . 0.0 108.385 178.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -52.73 -45.96 67.21 Favored 'General case' 0 C--O 1.201 -1.484 0 CA-C-N 113.672 -1.603 . . . . 0.0 110.577 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.536 ' HA ' HG21 ' A' ' 86' ' ' ILE . . . -47.68 -53.06 16.12 Favored 'General case' 0 CA--C 1.501 -0.936 0 O-C-N 124.749 1.281 . . . . 0.0 110.915 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -78.55 -25.52 45.45 Favored 'General case' 0 C--N 1.271 -2.841 0 CA-C-N 114.558 -1.201 . . . . 0.0 112.529 -173.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 41.6 t -86.39 5.34 35.4 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 177.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.518 ' O ' ' HB2' ' A' ' 115' ' ' LYS . 19.2 mt-10 -123.3 13.11 9.54 Favored 'General case' 0 CA--C 1.462 -2.409 0 CA-C-N 114.612 -1.176 . . . . 0.0 111.737 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.518 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 56.4 mtpt 68.85 12.61 8.7 Favored 'General case' 0 N--CA 1.417 -2.086 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 175.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.434 ' O ' ' HB1' ' A' ' 111' ' ' ALA . 3.0 m -126.16 112.49 30.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -93.87 141.07 28.93 Favored 'General case' 0 CA--C 1.498 -1.022 0 C-N-CA 118.29 -1.364 . . . . 0.0 108.352 177.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.421 HG12 ' H ' ' A' ' 118' ' ' ILE . 6.3 pt -102.06 145.01 12.53 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.601 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.541 -174.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 57.3 mtp180 -122.03 128.48 51.46 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -178.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.448 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.309 -1.165 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.621 -177.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.502 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 94.1 m-20 . . . . . 0 CA--C 1.503 -0.843 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 89.6 mt -135.29 169.65 17.14 Favored 'General case' 0 C--O 1.252 1.194 0 CA-C-O 122.016 0.912 . . . . 0.0 111.894 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.573 HG23 ' HA ' ' A' ' 96' ' ' VAL . 0.8 OUTLIER -131.61 139.73 49.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 114.259 -1.337 . . . . 0.0 109.944 177.938 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 93.7 t -117.88 130.67 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-O 121.161 0.505 . . . . 0.0 110.775 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 79' ' ' GLY . 35.5 mtmm -142.35 144.47 33.2 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.017 173.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -150.48 170.77 18.29 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -82.7 -19.7 37.53 Favored 'General case' 0 C--N 1.313 -1.007 0 O-C-N 124.065 0.853 . . . . 0.0 110.227 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.472 ' HB ' ' OG ' ' A' ' 53' ' ' SER . 95.3 t -110.54 124.26 67.16 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.971 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 173.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.714 ' O ' HG22 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -54.77 -46.61 74.41 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 123.898 0.879 . . . . 0.0 112.61 -176.348 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.19 1.7 79.44 Favored Glycine 0 C--N 1.285 -2.264 0 C-N-CA 118.099 -2.001 . . . . 0.0 114.06 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.472 ' OG ' ' HB ' ' A' ' 50' ' ' VAL . 49.1 m -82.63 -26.78 31.89 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 176.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.714 HG22 ' O ' ' A' ' 51' ' ' GLN . 3.7 m -68.57 -45.08 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.099 0 CA-C-N 114.398 -1.274 . . . . 0.0 107.885 176.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -67.09 -32.33 73.42 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.939 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.56 -34.22 77.32 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.179 0.514 . . . . 0.0 110.29 177.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.4 tp -84.01 -39.13 20.05 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.605 178.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 54' ' ' VAL . 55.6 t -55.44 -45.56 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.033 0.533 . . . . 0.0 112.029 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.19 -15.71 63.38 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.541 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -100.9 -22.16 14.89 Favored 'General case' 0 C--O 1.2 -1.521 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.27 -38.24 17.76 Favored 'General case' 0 N--CA 1.421 -1.919 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.873 -177.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -72.13 -10.02 59.22 Favored 'General case' 0 C--N 1.317 -0.82 0 O-C-N 122.073 -0.392 . . . . 0.0 110.723 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.541 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 19.1 pttp . . . . . 0 C--O 1.243 0.745 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.9 t . . . . . 0 CA--C 1.499 -1.019 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -130.23 155.26 46.56 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-O 121.457 0.646 . . . . 0.0 111.231 -173.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.4 pp -94.74 148.64 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.499 176.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 76.5 mt -113.5 -30.5 2.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-O 121.478 0.656 . . . . 0.0 110.582 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 12.8 t-160 -151.29 133.4 15.2 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.337 -172.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -134.96 129.49 34.3 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -151.46 159.86 43.99 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 120.53 0.205 . . . . 0.0 110.547 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.4 ' HB ' ' HA ' ' A' ' 51' ' ' GLN . 6.2 p -94.08 98.61 8.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-O 121.887 0.851 . . . . 0.0 108.803 176.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' A' ' 47' ' ' LYS . . . -176.92 175.45 47.66 Favored Glycine 0 N--CA 1.414 -2.779 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.59 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -98.41 -170.56 1.97 Allowed 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 174.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.569 HG21 HG21 ' A' ' 118' ' ' ILE . 3.7 mp -84.99 119.04 33.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 C-N-CA 119.725 -0.79 . . . . 0.0 111.374 -176.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.0 p -121.65 162.0 21.48 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.018 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.539 ' CD ' ' H ' ' A' ' 83' ' ' GLU . 2.3 mp0 -53.89 -43.82 69.98 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 124.759 1.223 . . . . 0.0 111.655 -178.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.9 t -68.72 -27.06 65.6 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.28 0.562 . . . . 0.0 110.544 -176.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -74.7 -44.26 50.93 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.326 178.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.584 HG21 ' HA ' ' A' ' 111' ' ' ALA . 56.9 mt -60.2 -27.75 40.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.448 177.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.0 t -61.07 -21.58 63.8 Favored 'General case' 0 CA--C 1.563 1.45 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.779 177.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -82.46 -37.35 25.52 Favored 'General case' 0 C--O 1.245 0.863 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 174.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.68 -60.31 3.48 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.555 -176.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.563 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 8.6 t -70.45 -22.2 62.72 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.677 178.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.6 -60.69 2.34 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 20.0 m -97.86 5.23 49.28 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.115 0.484 . . . . 0.0 110.787 -178.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 66.64 37.52 4.36 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.189 0.996 . . . . 0.0 111.203 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.502 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -94.86 139.39 31.37 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 114.363 -1.29 . . . . 0.0 108.591 178.155 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 49.4 mm -94.86 142.23 13.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.623 ' HB ' HG22 ' A' ' 118' ' ' ILE . 36.2 t -94.2 117.29 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.625 0 CA-C-O 121.276 0.56 . . . . 0.0 110.843 -175.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.49 130.92 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.016 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 176.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -136.01 175.38 20.9 Favored Glycine 0 N--CA 1.423 -2.197 0 N-CA-C 108.846 -1.701 . . . . 0.0 108.846 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . 0.288 21.8 p90 -141.66 107.28 5.08 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 119.084 -1.047 . . . . 0.0 113.294 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.2 t30 67.15 9.17 6.73 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 126.069 1.748 . . . . 0.0 111.373 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.495 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 4.9 m -84.12 -48.69 16.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.824 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.59 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 9.1 mtm180 73.07 163.75 0.14 Allowed Pre-proline 0 N--CA 1.485 1.307 0 C-N-CA 124.165 0.986 . . . . 0.0 111.251 176.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -95.25 168.61 1.47 Allowed 'Trans proline' 0 N--CA 1.437 -1.811 0 C-N-CA 121.901 1.734 . . . . 0.0 113.342 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -79.2 161.2 26.56 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 170.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.423 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -63.09 -24.3 67.84 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 122.713 0.405 . . . . 0.0 111.47 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.634 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 68.8 m-20 -85.68 -38.2 18.59 Favored 'General case' 0 C--O 1.206 -1.214 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 176.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.04 -41.51 99.52 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.86 0.362 . . . . 0.0 111.451 -178.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -59.87 -22.06 61.83 Favored 'General case' 0 CA--C 1.559 1.293 0 CA-C-O 121.111 0.481 . . . . 0.0 111.075 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.634 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 38.1 mtm105 -88.46 -51.78 5.54 Favored 'General case' 0 N--CA 1.38 -3.975 0 C-N-CA 125.523 1.529 . . . . 0.0 109.227 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -51.9 -47.01 64.77 Favored 'General case' 0 C--O 1.201 -1.474 0 C-N-CA 125.032 1.333 . . . . 0.0 111.171 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.584 ' HA ' HG21 ' A' ' 86' ' ' ILE . . . -49.42 -43.37 44.58 Favored 'General case' 0 CA--C 1.494 -1.187 0 O-C-N 124.279 0.987 . . . . 0.0 111.078 -179.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -82.89 -23.96 33.36 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-N 114.839 -1.073 . . . . 0.0 113.137 -173.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 38.6 t -89.07 5.89 42.37 Favored 'General case' 0 C--N 1.277 -2.565 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 175.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.563 ' O ' ' HB ' ' A' ' 90' ' ' THR . 23.7 mt-10 -125.27 15.62 8.36 Favored 'General case' 0 N--CA 1.408 -2.533 0 CA-C-N 113.953 -1.476 . . . . 0.0 112.437 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 56.2 mtpt 66.14 3.31 2.64 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 172.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.8 m -114.21 169.03 5.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 121.945 -0.472 . . . . 0.0 111.69 -176.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -130.77 137.71 49.6 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.623 HG22 ' HB ' ' A' ' 96' ' ' VAL . 10.4 pt -107.86 127.35 64.01 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.163 -178.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -129.18 136.96 50.85 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.492 -0.883 . . . . 0.0 113.24 -175.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.436 -1.144 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.341 -179.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 . . . . . 0 CA--C 1.504 -0.813 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 70.9 mt -131.25 165.61 23.01 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.535 HD13 ' CD2' ' A' ' 75' ' ' HIS . 0.2 OUTLIER -131.65 136.83 56.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-N 112.817 -1.992 . . . . 0.0 107.26 175.753 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.601 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 92.1 t -117.31 128.18 74.67 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 176.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.57 ' HE3' ' CG ' ' A' ' 85' ' ' ASP . 12.8 ptmm? -159.43 128.06 5.14 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.44 176.28 9.49 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.894 -171.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -74.68 -32.0 62.08 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 123.948 0.78 . . . . 0.0 109.412 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 86.3 t -94.71 122.04 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.137 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.745 ' O ' HG22 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -61.48 -47.84 83.82 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 124.347 1.059 . . . . 0.0 112.595 -174.776 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.87 5.01 84.06 Favored Glycine 0 C--N 1.278 -2.684 0 C-N-CA 118.049 -2.024 . . . . 0.0 113.003 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.0 t -83.36 -29.09 28.5 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.745 HG22 ' O ' ' A' ' 51' ' ' GLN . 6.0 m -70.87 -45.87 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.397 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.653 176.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -60.24 -40.44 90.24 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.178 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.66 -39.97 95.57 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 123.574 0.546 . . . . 0.0 110.825 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 38.3 tp -75.46 -39.34 58.83 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.177 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 54' ' ' VAL . 54.6 t -57.11 -37.99 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.128 0.571 . . . . 0.0 111.44 178.019 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.4 -19.14 63.81 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.03 -30.23 12.81 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.17 -36.15 64.05 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.615 -175.083 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -68.89 -21.23 64.25 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.134 178.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt . . . . . 0 CA--C 1.548 0.904 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 179.959 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.7 t . . . . . 0 N--CA 1.428 -1.551 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -149.43 158.17 43.94 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.141 0.496 . . . . 0.0 110.241 -178.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.445 HG12 HG13 ' A' ' 58' ' ' VAL . 1.5 pp -94.54 144.17 10.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.073 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.401 ' N ' HD12 ' A' ' 74' ' ' ILE . 3.5 mp -112.69 -22.73 4.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-O 122.058 0.933 . . . . 0.0 109.438 177.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.535 ' CD2' HD13 ' A' ' 45' ' ' ILE . 2.0 t60 -148.13 139.05 23.17 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -172.026 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.601 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -140.33 136.69 33.46 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 177.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -163.2 156.93 19.83 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 118.608 0.64 . . . . 0.0 111.426 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.3 p -101.04 94.42 3.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-O 121.774 0.797 . . . . 0.0 109.273 175.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -177.02 173.31 46.2 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 119.365 -1.398 . . . . 0.0 113.304 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.476 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -81.58 170.02 16.36 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 124.159 0.984 . . . . 0.0 108.856 176.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.43 HD13 HD11 ' A' ' 120' ' ' LEU . 1.8 mp -72.82 118.21 17.62 Favored 'Isoleucine or valine' 0 C--O 1.245 0.816 0 CA-C-N 118.505 0.593 . . . . 0.0 110.363 -177.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 70.7 p -118.7 158.58 25.26 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -50.19 -34.22 21.91 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.23 0.612 . . . . 0.0 112.089 176.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.9 m -62.2 -40.28 95.55 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.127 0.489 . . . . 0.0 110.43 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.57 ' CG ' ' HE3' ' A' ' 47' ' ' LYS . 46.5 m-20 -71.88 -38.96 69.91 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.321 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.6 HD13 ' HB2' ' A' ' 111' ' ' ALA . 58.8 mt -67.2 -29.75 46.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.977 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 27.8 m -58.08 -35.17 71.0 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.194 174.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -72.44 -34.37 67.73 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.149 177.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.414 ' HB3' HG21 ' A' ' 116' ' ' VAL . . . -55.09 -61.96 1.97 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.028 -176.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.573 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 9.2 t -69.5 -21.31 63.69 Favored 'General case' 0 CA--C 1.568 1.655 0 O-C-N 121.583 -0.698 . . . . 0.0 111.054 177.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.89 -52.62 34.38 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 54.1 m -98.78 -2.87 36.93 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.721 178.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 68.65 37.32 2.53 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 122.36 1.076 . . . . 0.0 109.376 -176.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.99 155.93 16.53 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 113.99 -1.459 . . . . 0.0 108.401 178.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 117' ' ' ASP . 46.2 mm -111.67 135.06 52.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.662 ' HB ' HG22 ' A' ' 118' ' ' ILE . 19.4 t -93.59 123.62 45.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.218 0.532 . . . . 0.0 109.834 -174.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 35.6 pt -104.55 157.63 5.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.65 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -171.66 172.93 44.88 Favored Glycine 0 N--CA 1.419 -2.449 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 175.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -161.54 133.38 5.63 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 73.28 -41.08 0.49 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.26 1.424 . . . . 0.0 111.872 177.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.6 m -65.59 -51.17 66.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 C-N-CA 124.339 1.055 . . . . 0.0 111.631 176.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.476 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 35.4 mtm180 66.72 178.97 0.05 OUTLIER Pre-proline 0 CA--C 1.566 1.576 0 C-N-CA 123.364 0.666 . . . . 0.0 112.051 174.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.452 ' HG3' HD12 ' A' ' 118' ' ' ILE . 21.6 Cg_endo -99.48 176.21 0.35 Allowed 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 122.327 2.018 . . . . 0.0 113.865 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -82.16 156.94 24.21 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 168.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.545 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -61.82 -31.18 71.39 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 120.849 0.357 . . . . 0.0 110.489 178.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.579 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 5.4 m-20 -77.8 -36.31 50.44 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.269 175.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.09 -44.06 97.48 Favored 'General case' 0 C--O 1.211 -0.948 0 O-C-N 121.981 -0.45 . . . . 0.0 111.27 176.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.53 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 14.4 ptmm? -59.83 -29.21 68.1 Favored 'General case' 0 CA--C 1.563 1.445 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.579 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 95.4 mtt180 -73.03 -51.37 18.44 Favored 'General case' 0 N--CA 1.395 -3.179 0 C-N-CA 124.643 1.177 . . . . 0.0 108.997 176.083 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -52.86 -49.03 66.63 Favored 'General case' 0 C--O 1.194 -1.852 0 CA-C-N 113.7 -1.591 . . . . 0.0 110.226 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.6 ' HB2' HD13 ' A' ' 86' ' ' ILE . . . -47.99 -50.76 26.4 Favored 'General case' 0 CA--C 1.483 -1.613 0 O-C-N 124.717 1.26 . . . . 0.0 111.2 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -81.24 -24.77 37.12 Favored 'General case' 0 C--N 1.27 -2.873 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.915 -172.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 38.3 t -87.66 5.45 39.58 Favored 'General case' 0 C--N 1.275 -2.646 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 175.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.573 ' O ' ' HB ' ' A' ' 90' ' ' THR . 24.7 mt-10 -123.35 19.43 9.75 Favored 'General case' 0 CA--C 1.466 -2.255 0 CA-C-N 114.411 -1.268 . . . . 0.0 111.572 177.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 65.6 mttm 67.0 4.63 3.65 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 173.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.414 HG21 ' HB3' ' A' ' 89' ' ' ALA . 5.4 m -113.98 163.94 10.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 121.683 -0.635 . . . . 0.0 112.106 -175.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.41 ' O ' HG23 ' A' ' 95' ' ' ILE . 4.0 m-20 -125.89 142.96 51.27 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 177.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.662 HG22 ' HB ' ' A' ' 96' ' ' VAL . 4.8 pt -105.05 138.74 28.56 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.914 178.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -104.64 112.83 26.06 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.519 -175.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.43 HD11 HD13 ' A' ' 81' ' ' ILE . 3.1 mm? . . . . . 0 C--N 1.299 -1.601 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.475 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.432 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 92.0 m-20 . . . . . 0 N--CA 1.441 -0.899 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.3 mt -134.42 164.91 26.39 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 122.304 1.05 . . . . 0.0 113.51 -176.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.631 HD13 ' CD2' ' A' ' 75' ' ' HIS . 0.2 OUTLIER -123.01 139.79 48.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.356 175.63 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 66.4 t -112.23 130.02 66.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.342 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -136.93 144.4 43.41 Favored 'General case' 0 CA--C 1.492 -1.277 0 C-N-CA 123.926 0.89 . . . . 0.0 109.951 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.18 165.1 29.95 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 177.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -84.97 -17.08 38.76 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 120.924 0.392 . . . . 0.0 110.699 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 87.3 t -101.69 127.09 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 173.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.719 ' O ' HG22 ' A' ' 54' ' ' VAL . 49.7 tt0 -61.41 -51.69 67.72 Favored 'General case' 0 C--O 1.196 -1.725 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -173.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.51 0.94 53.78 Favored Glycine 0 C--N 1.28 -2.539 0 C-N-CA 118.205 -1.95 . . . . 0.0 113.724 -175.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.4 t -82.88 -24.98 32.95 Favored 'General case' 0 N--CA 1.417 -2.081 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 177.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.719 HG22 ' O ' ' A' ' 51' ' ' GLN . 5.2 m -77.37 -46.45 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.256 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.355 176.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -66.12 -38.61 88.62 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.442 -176.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.85 -38.23 87.44 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.926 0.393 . . . . 0.0 110.548 177.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.479 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 34.9 tp -73.85 -42.25 61.08 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.48 HG21 ' HB2' ' A' ' 76' ' ' ALA . 53.5 t -57.0 -41.12 76.77 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 C-N-CA 123.16 0.584 . . . . 0.0 111.335 177.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.05 -24.21 67.62 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.38 -20.35 17.2 Favored 'General case' 0 C--O 1.207 -1.173 0 CA-C-O 121.511 0.672 . . . . 0.0 109.39 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -90.75 -28.1 18.5 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.073 -175.4 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -77.94 -24.06 48.36 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 122.157 -0.34 . . . . 0.0 110.409 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt . . . . . 0 C--N 1.322 -0.628 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.123 -178.481 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 32.8 t . . . . . 0 N--CA 1.442 -0.841 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.8 ttmp? -167.59 162.71 14.37 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.41 HG13 ' HB3' ' A' ' 61' ' ' LEU . 1.5 pp -93.69 150.5 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.606 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.42 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 37.2 mm -115.28 -28.93 2.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 CA-C-O 121.365 0.602 . . . . 0.0 109.666 178.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.631 ' CD2' HD13 ' A' ' 45' ' ' ILE . 3.8 t60 -149.39 140.4 22.92 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -171.091 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.48 ' HB2' HG21 ' A' ' 58' ' ' VAL . . . -136.67 135.15 38.0 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 177.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -158.54 141.55 14.72 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.652 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.476 ' HB ' ' HA ' ' A' ' 51' ' ' GLN . 4.5 p -93.86 93.98 4.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-O 122.793 1.282 . . . . 0.0 108.822 175.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.89 175.08 47.51 Favored Glycine 0 N--CA 1.409 -3.103 0 CA-C-N 113.855 -1.521 . . . . 0.0 109.554 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.555 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -83.07 -176.93 6.58 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 177.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.531 HG21 HG21 ' A' ' 118' ' ' ILE . 3.3 mp -78.56 110.91 14.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.066 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.512 HG22 ' OD2' ' A' ' 85' ' ' ASP . 14.0 t -113.56 165.56 12.38 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 119.576 -0.849 . . . . 0.0 109.374 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -56.92 -35.06 68.59 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.614 0.765 . . . . 0.0 111.182 -176.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.4 m -67.13 -28.54 68.23 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.523 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.512 ' OD2' HG22 ' A' ' 82' ' ' THR . 17.4 m-20 -77.37 -28.53 52.95 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-O 121.175 0.512 . . . . 0.0 110.408 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.518 ' CG2' ' HA ' ' A' ' 111' ' ' ALA . 46.0 mm -65.54 -33.15 61.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.111 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.9 m -57.01 -39.54 74.93 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.364 177.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -73.94 -39.03 64.06 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.981 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.23 -55.29 22.13 Favored 'General case' 0 C--N 1.316 -0.887 0 O-C-N 123.926 0.766 . . . . 0.0 111.877 -177.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.454 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 10.9 t -77.48 -19.01 56.58 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.419 178.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.79 -66.24 0.58 Allowed 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.057 0.456 . . . . 0.0 111.685 -177.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.6 m -95.41 2.06 54.41 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.409 -177.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 62.43 62.92 1.08 Allowed 'General case' 0 CA--C 1.497 -1.079 0 CA-C-O 122.366 1.079 . . . . 0.0 112.332 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -120.24 134.56 55.23 Favored 'General case' 0 N--CA 1.417 -2.092 0 CA-C-N 113.244 -1.798 . . . . 0.0 107.179 176.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 32.2 pt -94.13 141.92 14.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.525 ' HB ' HG22 ' A' ' 118' ' ' ILE . 12.1 t -94.16 116.6 35.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-O 121.192 0.52 . . . . 0.0 110.149 -173.041 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 119' ' ' ARG . 58.0 mt -112.78 125.71 70.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 120' ' ' LEU . . . -132.24 170.25 21.9 Favored Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -145.42 117.68 8.42 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 72.72 -29.34 0.2 Allowed 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 124.78 1.232 . . . . 0.0 113.099 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.485 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 4.6 m -66.34 -48.11 81.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.563 176.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.555 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 59.8 mtm180 66.94 179.37 0.05 OUTLIER Pre-proline 0 CA--C 1.551 1.015 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.878 174.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.452 ' HG3' HD12 ' A' ' 118' ' ' ILE . 9.5 Cg_endo -98.84 168.72 0.58 Allowed 'Trans proline' 0 N--CA 1.44 -1.663 0 CA-C-N 120.838 1.335 . . . . 0.0 114.568 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -79.48 152.19 30.38 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 113.005 -1.907 . . . . 0.0 106.448 167.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.432 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -61.62 -21.07 64.05 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -176.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.534 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 54.9 t30 -94.47 -28.28 15.55 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.945 -0.702 . . . . 0.0 109.747 177.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.72 -40.8 95.95 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-O 120.965 0.412 . . . . 0.0 110.557 177.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 21.9 ptmt -61.72 -28.5 69.46 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.07 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.534 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 70.7 mtp180 -81.01 -53.09 6.72 Favored 'General case' 0 N--CA 1.385 -3.689 0 C-N-CA 125.918 1.687 . . . . 0.0 109.097 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -52.79 -45.26 67.11 Favored 'General case' 0 C--O 1.196 -1.73 0 CA-C-N 113.85 -1.523 . . . . 0.0 110.457 -178.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.518 ' HA ' ' CG2' ' A' ' 86' ' ' ILE . . . -48.58 -49.28 37.38 Favored 'General case' 0 CA--C 1.49 -1.355 0 O-C-N 124.524 1.14 . . . . 0.0 111.381 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -77.25 -35.2 55.53 Favored 'General case' 0 C--N 1.281 -2.399 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.539 -174.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 35.5 t -79.56 5.47 12.94 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-O 122.374 1.083 . . . . 0.0 108.979 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.454 ' O ' ' HB ' ' A' ' 90' ' ' THR . 19.3 mt-10 -123.75 14.54 9.36 Favored 'General case' 0 CA--C 1.46 -2.504 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.845 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 64.4 mmtt 65.85 17.94 10.98 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 173.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.0 m -120.73 171.41 9.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.362 177.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -137.15 142.35 42.22 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.531 HG21 HG21 ' A' ' 81' ' ' ILE . 10.3 pt -107.97 134.52 49.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 121.32 0.581 . . . . 0.0 111.044 -178.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.507 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 21.5 mmm180 -113.3 125.04 53.85 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -178.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.564 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.717 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -178.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.78 ' HB3' HD11 ' A' ' 74' ' ' ILE . 36.5 m-80 . . . . . 0 N--CA 1.433 -1.319 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.8 mt -134.27 163.6 29.26 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.66 0.743 . . . . 0.0 112.012 -177.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.426 HG21 HG22 ' A' ' 96' ' ' VAL . 0.8 OUTLIER -119.95 135.12 61.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.576 174.108 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.422 ' CG1' ' HA ' ' A' ' 54' ' ' VAL . 94.3 t -112.49 123.73 68.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 121.314 0.578 . . . . 0.0 111.401 -176.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -133.51 147.79 51.64 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 124.504 1.122 . . . . 0.0 109.668 176.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.39 161.87 33.19 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -81.65 -9.25 59.71 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 122.283 1.039 . . . . 0.0 109.52 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 96.1 t -114.96 123.73 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 176.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.671 ' O ' HG22 ' A' ' 54' ' ' VAL . 48.2 tt0 -58.24 -49.77 75.93 Favored 'General case' 0 C--O 1.205 -1.259 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -176.014 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.59 4.0 52.62 Favored Glycine 0 C--N 1.289 -2.059 0 C-N-CA 118.58 -1.772 . . . . 0.0 113.887 -176.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.9 t -86.17 -19.46 30.05 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 176.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.671 HG22 ' O ' ' A' ' 51' ' ' GLN . 4.9 m -81.19 -46.35 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.266 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 174.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -57.43 -50.35 73.3 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.384 -1.28 . . . . 0.0 111.968 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.05 -40.76 81.76 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 123.371 0.42 . . . . 0.0 111.594 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.403 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 36.8 tp -74.34 -43.06 58.24 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.071 -178.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.537 HG21 ' HB2' ' A' ' 76' ' ' ALA . 54.6 t -59.08 -40.14 80.11 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.595 0 C-N-CA 122.885 0.474 . . . . 0.0 111.071 177.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.62 -12.08 60.89 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.6 -31.72 10.25 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 176.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -75.71 -28.48 58.6 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 114.235 -1.348 . . . . 0.0 110.923 -175.41 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -83.14 -14.19 54.04 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.682 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.486 0 C-N-CA 119.863 -0.735 . . . . 0.0 111.947 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.5 t . . . . . 0 N--CA 1.441 -0.888 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 24.9 ttpp -139.83 160.37 40.05 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.238 0.542 . . . . 0.0 110.174 -176.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.458 HG12 HG13 ' A' ' 58' ' ' VAL . 1.6 pp -94.89 162.34 2.45 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.003 175.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.78 HD11 ' HB3' ' A' ' 43' ' ' ASN . 1.7 mp -120.52 -33.39 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 174.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -152.38 122.14 6.96 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.341 -166.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.537 ' HB2' HG21 ' A' ' 58' ' ' VAL . . . -110.81 139.48 46.08 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 176.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -156.42 132.1 9.57 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 120.178 -0.609 . . . . 0.0 111.529 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.421 ' HB ' ' HA ' ' A' ' 51' ' ' GLN . 4.4 p -93.93 93.86 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.887 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 172.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -177.53 175.86 47.77 Favored Glycine 0 N--CA 1.399 -3.814 0 N-CA-C 108.319 -1.912 . . . . 0.0 108.319 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.606 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . . . -86.41 -170.63 3.17 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.163 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.417 ' CD1' HD12 ' A' ' 120' ' ' LEU . 21.2 mt -94.1 105.7 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.007 0 CA-C-O 121.213 0.53 . . . . 0.0 109.6 -173.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.4 t -106.89 162.68 13.6 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.412 ' HG3' ' CB ' ' A' ' 110' ' ' ALA . 39.3 tt0 -60.79 -35.22 75.9 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 123.109 0.564 . . . . 0.0 111.109 -176.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.7 m -69.83 -10.95 60.35 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.664 -177.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -95.69 -31.66 13.13 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 121.6 0.714 . . . . 0.0 109.796 175.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.641 HD13 ' HB2' ' A' ' 111' ' ' ALA . 59.7 mt -69.8 -25.76 28.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.939 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.0 p -56.75 -37.19 70.7 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.7 175.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.459 HD11 HD13 ' A' ' 74' ' ' ILE . 1.9 tm? -70.86 -36.97 73.05 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 123.278 0.631 . . . . 0.0 110.191 175.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.01 -58.46 6.47 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.222 -175.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.536 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 7.0 t -71.46 -30.12 65.64 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 119.594 -0.842 . . . . 0.0 110.919 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.19 -53.08 62.35 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.061 0.545 . . . . 0.0 112.313 -177.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 31.7 t -101.44 6.91 42.68 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.432 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 9.9 p30 60.11 29.6 19.15 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.791 1.236 . . . . 0.0 111.648 177.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.47 131.64 39.96 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 113.545 -1.661 . . . . 0.0 108.632 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.4 pp -93.87 143.65 11.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.623 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.503 ' HB ' HG22 ' A' ' 118' ' ' ILE . 21.2 t -94.49 113.86 29.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.622 -174.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.456 ' HA ' ' O ' ' A' ' 119' ' ' ARG . 43.2 mm -112.91 123.41 68.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 175.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -115.08 168.79 12.65 Favored Glycine 0 N--CA 1.423 -2.212 0 C-N-CA 120.231 -0.985 . . . . 0.0 110.666 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -114.84 93.34 4.28 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.111 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 62.7 t30 60.78 10.02 2.49 Favored 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 125.796 1.639 . . . . 0.0 112.583 178.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.606 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 3.8 m -69.87 -47.97 66.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.792 -175.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.537 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 55.9 mtm180 74.8 143.57 0.1 OUTLIER Pre-proline 0 CA--C 1.548 0.873 0 O-C-N 124.251 0.969 . . . . 0.0 111.522 175.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 102' ' ' ARG . 6.4 Cg_endo -86.5 169.66 8.14 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 121.753 1.635 . . . . 0.0 114.11 -175.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -77.89 152.16 33.46 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 169.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.491 ' O ' ' HG3' ' A' ' 108' ' ' LYS . . . -60.41 -28.56 68.35 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.483 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 91.3 m-20 -85.3 -29.27 24.69 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.237 177.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.49 -45.71 86.15 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 177.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' A' ' 105' ' ' ALA . 0.0 OUTLIER -59.95 -29.63 68.54 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.265 179.761 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 62.3 mtt180 -73.1 -52.17 15.27 Favored 'General case' 0 N--CA 1.393 -3.289 0 C-N-CA 124.445 1.098 . . . . 0.0 109.62 178.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.412 ' CB ' ' HG3' ' A' ' 83' ' ' GLU . . . -53.88 -51.23 64.32 Favored 'General case' 0 C--O 1.197 -1.661 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.126 -178.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.641 ' HB2' HD13 ' A' ' 86' ' ' ILE . . . -46.44 -48.77 18.81 Favored 'General case' 0 CA--C 1.494 -1.188 0 O-C-N 124.736 1.272 . . . . 0.0 112.52 -178.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -79.34 -32.34 43.29 Favored 'General case' 0 N--CA 1.407 -2.611 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.396 -171.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 26.0 t -79.58 -1.74 39.25 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.536 ' O ' ' HB ' ' A' ' 90' ' ' THR . 25.9 mt-10 -116.49 14.18 15.53 Favored 'General case' 0 N--CA 1.418 -2.067 0 C-N-CA 125.028 1.331 . . . . 0.0 112.454 -178.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 10.0 mtpm? 66.6 9.5 6.66 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 172.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.7 m -116.8 132.83 65.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-O 121.602 0.715 . . . . 0.0 112.277 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -97.55 127.13 43.26 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.503 HG22 ' HB ' ' A' ' 96' ' ' VAL . 25.9 pt -106.56 128.99 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.018 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.056 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.456 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 12.0 ptt180 -142.21 149.37 39.58 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 121.118 0.485 . . . . 0.0 110.338 -178.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.521 ' HG ' ' H ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.59 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.175 -171.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.436 ' HA ' ' O ' ' A' ' 72' ' ' LYS . 14.8 m120 . . . . . 0 CA--C 1.498 -1.046 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.421 HD21 HD11 ' A' ' 61' ' ' LEU . 2.4 pt? -154.01 165.25 36.74 Favored 'General case' 0 C--O 1.257 1.453 0 CA-C-O 121.486 0.66 . . . . 0.0 111.375 177.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.612 HG23 ' HA ' ' A' ' 96' ' ' VAL . 0.6 OUTLIER -116.34 126.57 73.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 CA-C-N 114.638 -1.165 . . . . 0.0 108.986 175.105 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.417 HG12 ' HA ' ' A' ' 54' ' ' VAL . 73.2 t -95.77 121.08 45.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.696 -176.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 3.9 mtpm? -134.61 140.98 46.48 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -147.66 175.07 11.18 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -86.33 -13.46 46.5 Favored 'General case' 0 C--N 1.315 -0.934 0 O-C-N 123.813 0.696 . . . . 0.0 109.999 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 79.2 t -120.3 129.56 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 177.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.725 ' O ' HG22 ' A' ' 54' ' ' VAL . 16.1 tt0 -58.7 -48.3 81.59 Favored 'General case' 0 C--O 1.193 -1.904 0 O-C-N 123.291 0.369 . . . . 0.0 111.834 -175.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -73.26 -0.57 53.57 Favored Glycine 0 C--N 1.283 -2.379 0 C-N-CA 118.893 -1.622 . . . . 0.0 114.477 -175.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.3 t -86.48 -20.37 28.19 Favored 'General case' 0 N--CA 1.415 -2.221 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 177.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.725 HG22 ' O ' ' A' ' 51' ' ' GLN . 6.0 m -76.8 -44.22 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.181 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 173.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -63.04 -48.06 80.33 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.215 -1.357 . . . . 0.0 111.321 -177.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.42 -35.23 78.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.583 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.506 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 40.3 tp -78.56 -37.86 41.64 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.239 -178.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.506 HG21 ' HB2' ' A' ' 76' ' ' ALA . 49.8 t -58.44 -44.66 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 120.625 0.25 . . . . 0.0 110.452 176.191 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.0 -22.26 66.72 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.676 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.53 -16.01 20.29 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.712 0.768 . . . . 0.0 109.951 -177.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.506 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -97.13 -32.84 11.75 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.25 -175.261 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -73.02 -20.33 61.02 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.028 0.442 . . . . 0.0 110.586 177.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt . . . . . 0 C--N 1.326 -0.449 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.194 -177.55 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.44 -0.951 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 57.3 tttp -150.38 154.55 37.97 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.474 HG12 HG13 ' A' ' 58' ' ' VAL . 1.4 pp -93.69 154.45 3.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.635 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 40.3 mm -115.69 -33.32 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-O 121.142 0.496 . . . . 0.0 111.1 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -160.83 134.52 6.83 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -171.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.506 ' HB2' HG21 ' A' ' 58' ' ' VAL . . . -113.51 133.44 55.23 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 176.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 47' ' ' LYS . . . -151.94 130.64 12.35 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.307 -177.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.4 p -93.39 93.89 4.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-O 123.2 1.476 . . . . 0.0 110.148 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -177.84 175.49 47.55 Favored Glycine 0 N--CA 1.403 -3.558 0 CA-C-N 113.68 -1.6 . . . . 0.0 109.488 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.498 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -74.11 178.48 5.02 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 174.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.426 HG21 HG21 ' A' ' 118' ' ' ILE . 3.5 mp -84.27 108.83 16.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 69.6 p -101.04 166.92 10.56 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.512 -0.875 . . . . 0.0 108.992 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -59.53 -33.78 71.82 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.775 0.798 . . . . 0.0 109.508 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.1 m -67.44 -31.44 71.62 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.877 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -73.15 -34.76 66.26 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 121.901 0.858 . . . . 0.0 109.828 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.502 HD13 ' HB2' ' A' ' 111' ' ' ALA . 70.7 mt -66.55 -26.84 38.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 114.524 -1.216 . . . . 0.0 112.846 -176.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 88.3 p -55.49 -38.32 68.99 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 120.823 0.344 . . . . 0.0 110.507 175.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -73.14 -33.55 65.57 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.028 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.98 -62.16 1.89 Allowed 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.54 -177.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 4.3 t -70.58 -17.09 62.91 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-O 121.306 0.574 . . . . 0.0 111.129 178.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.82 -55.08 9.33 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 32.6 p -97.53 -8.32 29.38 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 121.017 -0.273 . . . . 0.0 110.767 -176.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . 0.265 0.0 OUTLIER 78.84 30.45 0.35 Allowed 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 127.021 2.128 . . . . 0.0 110.241 -176.799 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -92.6 140.56 29.42 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 113.969 -1.469 . . . . 0.0 110.23 -176.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.411 HG23 ' O ' ' A' ' 117' ' ' ASP . 43.0 mm -94.02 140.44 16.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.612 ' HA ' HG23 ' A' ' 45' ' ' ILE . 11.5 t -95.8 129.5 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -177.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 13.1 tt -127.78 135.99 61.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -137.24 158.23 24.25 Favored Glycine 0 N--CA 1.417 -2.61 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 177.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -117.25 102.7 9.49 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -176.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 59.0 t30 69.75 -31.55 0.21 Allowed 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 124.222 1.009 . . . . 0.0 112.924 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.457 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 1.7 m -49.51 -42.58 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 C-N-CA 124.028 0.931 . . . . 0.0 113.396 177.119 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.598 ' HA ' ' HG ' ' A' ' 120' ' ' LEU . 49.9 mtp180 69.94 176.44 0.07 OUTLIER Pre-proline 0 CA--C 1.537 0.456 0 O-C-N 123.886 0.741 . . . . 0.0 112.65 175.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.476 ' HG3' HD12 ' A' ' 118' ' ' ILE . 9.3 Cg_endo -99.25 177.55 0.33 Allowed 'Trans proline' 0 N--CA 1.432 -2.104 0 C-N-CA 121.828 1.685 . . . . 0.0 112.581 178.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -82.84 155.5 24.13 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 168.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.457 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -59.09 -28.84 66.87 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 120.755 0.312 . . . . 0.0 111.642 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.572 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 28.1 m-80 -81.1 -35.39 31.71 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 177.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.4 -42.9 95.85 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 120.799 0.333 . . . . 0.0 110.843 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 17.0 pttp -62.98 -20.69 65.51 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-O 121.089 0.471 . . . . 0.0 110.91 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.572 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 24.8 mtm180 -84.25 -51.68 6.83 Favored 'General case' 0 N--CA 1.392 -3.372 0 C-N-CA 124.593 1.157 . . . . 0.0 109.228 175.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -51.33 -51.52 53.66 Favored 'General case' 0 CA--C 1.477 -1.841 0 C-N-CA 125.34 1.456 . . . . 0.0 110.503 -178.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.502 ' HB2' HD13 ' A' ' 86' ' ' ILE . . . -49.49 -48.55 47.86 Favored 'General case' 0 CA--C 1.502 -0.877 0 O-C-N 124.842 1.339 . . . . 0.0 112.206 -177.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -78.14 -33.02 50.64 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.384 -172.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 48.0 t -81.44 5.77 16.65 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 176.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.512 ' O ' ' HB ' ' A' ' 90' ' ' THR . 12.3 mt-10 -123.46 12.76 9.41 Favored 'General case' 0 N--CA 1.417 -2.105 0 C-N-CA 124.771 1.228 . . . . 0.0 112.339 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 10.4 mmmm 65.62 10.81 7.01 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 174.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.3 m -115.69 132.97 63.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-O 121.574 0.702 . . . . 0.0 112.492 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.411 ' O ' HG23 ' A' ' 95' ' ' ILE . 28.1 t70 -94.81 126.16 39.94 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.367 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.574 HG22 ' HB ' ' A' ' 96' ' ' VAL . 7.8 pt -94.11 131.86 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-O 121.408 0.623 . . . . 0.0 110.518 178.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 7.0 tpp180 -102.7 115.85 31.41 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.958 -177.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.598 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.307 -1.239 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 177.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.558 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 57.7 m-80 . . . . . 0 N--CA 1.432 -1.358 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.404 HD12 HD11 ' A' ' 61' ' ' LEU . 78.7 mt -138.59 164.57 29.13 Favored 'General case' 0 C--O 1.245 0.849 0 CA-C-O 121.814 0.816 . . . . 0.0 112.35 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.506 HD12 ' O ' ' A' ' 75' ' ' HIS . 0.2 OUTLIER -127.0 135.39 63.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 174.464 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.444 ' CG1' ' HA ' ' A' ' 54' ' ' VAL . 92.1 t -118.61 127.91 75.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.048 -177.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 41.5 mtpt -144.92 140.89 28.59 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.76 175.18 13.14 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -178.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -84.47 -25.68 28.73 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 122.2 1.0 . . . . 0.0 108.94 177.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 99.0 t -101.61 122.54 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.246 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 174.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.709 ' O ' HG22 ' A' ' 54' ' ' VAL . 17.4 tt0 -62.9 -40.72 98.43 Favored 'General case' 0 C--O 1.192 -1.941 0 CA-C-O 120.602 0.239 . . . . 0.0 111.411 -175.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -73.75 -3.03 62.28 Favored Glycine 0 C--N 1.29 -2.0 0 C-N-CA 118.314 -1.898 . . . . 0.0 114.151 -177.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.4 m -80.72 -24.02 39.08 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 176.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.709 HG22 ' O ' ' A' ' 51' ' ' GLN . 3.3 m -77.14 -47.09 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.767 0 CA-C-N 114.579 -1.191 . . . . 0.0 107.827 176.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -57.13 -48.04 79.64 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.295 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.48 -31.2 72.15 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.333 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.442 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 24.3 tp -79.78 -41.3 26.81 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.239 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 54' ' ' VAL . 53.2 t -53.56 -43.96 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.512 0.725 . . . . 0.0 111.921 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.88 -29.07 70.29 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.44 -13.07 28.39 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 121.325 0.583 . . . . 0.0 110.106 -177.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -96.13 -33.65 11.98 Favored 'General case' 0 N--CA 1.418 -2.064 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.494 -176.174 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -75.52 -14.69 60.42 Favored 'General case' 0 C--N 1.313 -1.002 0 O-C-N 122.066 -0.396 . . . . 0.0 111.59 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt . . . . . 0 C--N 1.308 -1.238 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -178.157 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.7 t . . . . . 0 N--CA 1.423 -1.817 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 58.8 tttp -153.06 158.5 42.05 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.844 -174.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.441 HG12 HG13 ' A' ' 58' ' ' VAL . 1.2 pp -93.94 152.29 3.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 -177.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.454 HD11 ' OD1' ' A' ' 43' ' ' ASN . 27.7 mm -115.69 -27.26 2.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.839 177.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.506 ' O ' HD12 ' A' ' 45' ' ' ILE . 18.0 t-160 -157.69 135.91 11.0 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -169.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -142.48 129.34 20.58 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.426 ' O ' ' HA ' ' A' ' 47' ' ' LYS . . . -161.91 159.37 26.63 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 120.714 0.293 . . . . 0.0 110.477 -178.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.8 p -94.58 103.46 14.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 175.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -175.88 175.81 47.42 Favored Glycine 0 N--CA 1.425 -2.08 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -177.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.546 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -90.19 178.62 6.12 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.448 HG21 HG21 ' A' ' 118' ' ' ILE . 3.7 mp -82.38 108.16 15.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 69.5 p -100.42 169.13 9.3 Favored 'General case' 0 N--CA 1.421 -1.885 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -58.83 -28.66 66.25 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.804 0.842 . . . . 0.0 110.254 176.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.0 t -71.58 -37.41 71.02 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.485 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -70.93 -36.05 72.49 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 121.634 0.73 . . . . 0.0 110.225 -177.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.55 HG21 ' HA ' ' A' ' 111' ' ' ALA . 54.3 mt -69.35 -34.6 63.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.426 -177.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 66.5 m -63.99 -19.36 65.11 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 120.471 -0.492 . . . . 0.0 112.152 174.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.41 HD21 HG21 ' A' ' 74' ' ' ILE . 2.2 tm? -79.9 -36.04 37.05 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 173.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.93 -54.18 49.83 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.31 -177.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.508 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 10.1 t -74.52 -12.88 60.59 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.917 178.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.76 -58.7 3.12 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.95 0.405 . . . . 0.0 111.815 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 26.4 m -98.12 5.14 48.92 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.432 -177.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 72.43 33.05 1.51 Allowed 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 122.094 0.949 . . . . 0.0 110.041 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -94.75 170.26 9.57 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 113.938 -1.483 . . . . 0.0 109.71 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 36.6 pt -130.93 148.08 33.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 173.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.474 ' HA ' HG23 ' A' ' 45' ' ' ILE . 3.4 t -100.62 126.79 54.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.973 -175.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.593 ' HA ' ' O ' ' A' ' 119' ' ' ARG . 66.0 mt -112.13 135.78 50.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.223 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.448 ' HA3' HD11 ' A' ' 81' ' ' ILE . . . -132.55 140.16 11.58 Favored Glycine 0 N--CA 1.434 -1.486 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.745 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -107.36 100.12 9.58 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -176.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.2 t30 72.91 -36.19 0.35 Allowed 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 125.332 1.453 . . . . 0.0 111.922 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.403 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 3.5 m -50.76 -50.63 22.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 124.698 1.199 . . . . 0.0 112.664 177.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.546 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 76.4 mtp180 67.73 177.21 0.06 OUTLIER Pre-proline 0 CA--C 1.559 1.312 0 O-C-N 123.731 0.644 . . . . 0.0 111.541 176.002 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.47 ' HG3' HD12 ' A' ' 118' ' ' ILE . 5.3 Cg_endo -94.82 173.58 1.31 Allowed 'Trans proline' 0 CA--C 1.5 -1.183 0 C-N-CA 121.59 1.527 . . . . 0.0 113.985 -177.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -77.48 160.91 28.33 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 113.965 -1.471 . . . . 0.0 107.335 168.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.486 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -67.35 -29.68 69.29 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -176.313 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.521 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 10.3 m-80 -86.72 -35.55 19.17 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.08 -50.42 66.83 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.441 175.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 61.2 pttt -56.97 -24.71 55.16 Favored 'General case' 0 CA--C 1.565 1.527 0 C-N-CA 122.697 0.399 . . . . 0.0 112.075 -178.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.521 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 14.1 mtm180 -86.27 -46.84 9.96 Favored 'General case' 0 N--CA 1.386 -3.628 0 C-N-CA 125.201 1.401 . . . . 0.0 108.93 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.11 -42.39 69.39 Favored 'General case' 0 C--O 1.201 -1.477 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.425 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.55 ' HA ' HG21 ' A' ' 86' ' ' ILE . . . -48.78 -44.86 39.27 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 124.475 1.109 . . . . 0.0 111.406 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -77.82 -32.83 52.46 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 114.874 -1.057 . . . . 0.0 112.277 -175.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 48.3 t -83.13 4.86 24.66 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 176.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.508 ' O ' ' HB ' ' A' ' 90' ' ' THR . 23.2 mt-10 -123.1 12.08 9.57 Favored 'General case' 0 CA--C 1.464 -2.341 0 C-N-CA 124.496 1.118 . . . . 0.0 112.883 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 26.7 mtpp 66.25 7.99 5.28 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 173.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.1 m -115.41 155.47 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.324 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -174.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -111.99 124.68 52.92 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.457 -178.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.47 HD12 ' HG3' ' A' ' 103' ' ' PRO . 9.3 pt -96.16 133.07 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.626 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.024 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.593 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 41.0 ttt85 -119.36 125.32 48.74 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.458 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.285 -2.209 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.085 -177.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 72' ' ' LYS . 18.2 t30 . . . . . 0 N--CA 1.419 -1.994 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 93.8 mt -123.36 172.86 8.36 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 122.146 0.974 . . . . 0.0 113.106 -172.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.658 HG23 ' HA ' ' A' ' 96' ' ' VAL . 1.1 tt -122.21 134.99 63.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 114.55 -1.204 . . . . 0.0 110.162 178.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 98.6 t -110.14 120.94 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 CA-C-O 121.496 0.665 . . . . 0.0 110.543 -177.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 28.1 mtpp -140.62 114.61 9.06 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.289 1.036 . . . . 0.0 109.614 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -131.05 167.02 19.78 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.575 -176.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -73.08 -35.59 66.68 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.997 0.903 . . . . 0.0 109.02 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 88.5 t -95.56 124.7 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 176.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.734 ' O ' HG22 ' A' ' 54' ' ' VAL . 24.1 tt0 -62.63 -40.52 97.26 Favored 'General case' 0 C--O 1.194 -1.858 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.071 -177.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -75.67 0.67 60.55 Favored Glycine 0 C--N 1.279 -2.617 0 C-N-CA 118.241 -1.933 . . . . 0.0 114.071 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.4 t -87.53 -22.77 24.66 Favored 'General case' 0 N--CA 1.418 -2.059 0 N-CA-C 106.036 -1.839 . . . . 0.0 106.036 174.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.734 HG22 ' O ' ' A' ' 51' ' ' GLN . 3.9 m -73.0 -43.81 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.847 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 174.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -57.57 -54.87 41.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.222 -1.354 . . . . 0.0 110.636 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.65 -41.05 89.68 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.211 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.5 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 40.3 tp -73.38 -37.92 65.83 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 120.049 -0.661 . . . . 0.0 110.67 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.468 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 39.9 t -59.01 -45.17 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.58 -19.73 64.01 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.661 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.3 -10.91 20.79 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.697 0.76 . . . . 0.0 109.957 -177.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.5 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -105.27 -27.94 11.23 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 114.638 -1.164 . . . . 0.0 110.21 -175.125 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 12.9 pt20 -84.16 -11.35 56.72 Favored 'General case' 0 C--N 1.315 -0.904 0 O-C-N 121.904 -0.497 . . . . 0.0 111.422 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt . . . . . 0 C--N 1.317 -0.809 0 CA-C-O 121.327 0.584 . . . . 0.0 110.038 179.906 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 39.0 t . . . . . 0 N--CA 1.417 -2.109 0 N-CA-C 103.237 -2.875 . . . . 0.0 103.237 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 4.5 ttpm? -141.04 164.04 31.34 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.661 -171.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.407 HG23 ' HG ' ' A' ' 61' ' ' LEU . 1.6 pp -100.03 158.35 3.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.714 176.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.3 mt -117.62 -41.57 2.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.999 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -154.56 131.42 10.82 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.626 -169.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -124.99 125.12 43.39 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 124.215 1.006 . . . . 0.0 108.449 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 47' ' ' LYS . . . -148.57 145.91 28.04 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.3 p -94.87 94.83 4.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-O 122.754 1.264 . . . . 0.0 110.049 177.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.24 175.09 47.36 Favored Glycine 0 N--CA 1.404 -3.445 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.597 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -89.22 175.47 7.34 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.416 ' CG2' HD11 ' A' ' 86' ' ' ILE . 1.7 mp -72.87 116.95 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 CA-C-O 121.19 0.519 . . . . 0.0 110.151 -177.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.9 t -123.43 155.51 37.3 Favored 'General case' 0 N--CA 1.403 -2.778 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.48 -26.98 68.67 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -173.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.4 t -65.14 -29.0 69.81 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.278 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -82.04 -32.58 30.39 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.542 0.687 . . . . 0.0 109.522 177.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.637 HD13 ' HB2' ' A' ' 111' ' ' ALA . 41.5 mt -68.17 -29.87 45.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.253 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.407 ' HA ' ' OE2' ' A' ' 114' ' ' GLU . 42.6 m -58.8 -24.31 61.67 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 174.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -76.54 -34.45 58.53 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 175.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.407 ' HB3' HG21 ' A' ' 116' ' ' VAL . . . -56.42 -57.23 13.21 Favored 'General case' 0 C--O 1.191 -1.984 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.039 -177.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.626 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 1.9 t -66.29 -30.63 71.09 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 120.37 -0.532 . . . . 0.0 112.095 176.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.02 -55.83 25.23 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -177.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 33.7 m -101.34 5.11 42.13 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.972 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 64.36 37.71 8.22 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.828 0.851 . . . . 0.0 109.965 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -93.78 156.47 16.65 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.284 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.1 mp -108.19 136.5 43.5 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 176.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.658 ' HA ' HG23 ' A' ' 45' ' ' ILE . 14.3 t -93.58 103.93 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -176.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 51.4 mt -94.82 112.37 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.824 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -103.18 134.98 12.07 Favored Glycine 0 N--CA 1.414 -2.777 0 N-CA-C 109.984 -1.247 . . . . 0.0 109.984 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.414 ' C ' ' H ' ' A' ' 101' ' ' VAL . 98.4 m-85 -104.15 94.45 5.38 Favored 'General case' 0 C--N 1.281 -2.399 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.237 -173.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 71.69 -22.72 0.19 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 125.626 1.571 . . . . 0.0 112.995 178.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.574 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 2.7 m -54.62 -48.99 70.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 178.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.597 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 37.2 mtp180 72.6 171.14 0.11 Allowed Pre-proline 0 CA--C 1.552 1.048 0 O-C-N 123.863 0.727 . . . . 0.0 111.822 178.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.451 ' HG3' HD12 ' A' ' 118' ' ' ILE . 13.7 Cg_endo -100.62 -173.17 0.11 Allowed 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.43 2.087 . . . . 0.0 113.504 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -106.75 176.89 5.02 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.275 -1.33 . . . . 0.0 107.444 170.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.505 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -74.2 -12.11 60.48 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 113.701 1.001 . . . . 0.0 113.701 -173.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.474 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 8.8 t30 -101.33 -40.35 7.16 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.07 -46.12 82.74 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 123.355 0.41 . . . . 0.0 110.882 175.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -54.38 -34.56 61.46 Favored 'General case' 0 CA--C 1.562 1.433 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.798 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.505 ' HG3' ' O ' ' A' ' 105' ' ' ALA . 15.7 mtm180 -79.45 -49.77 11.8 Favored 'General case' 0 N--CA 1.386 -3.642 0 C-N-CA 126.118 1.767 . . . . 0.0 109.541 -178.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.55 -43.69 68.64 Favored 'General case' 0 C--O 1.203 -1.355 0 CA-C-N 113.944 -1.48 . . . . 0.0 110.53 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.637 ' HB2' HD13 ' A' ' 86' ' ' ILE . . . -50.56 -47.22 57.88 Favored 'General case' 0 CA--C 1.489 -1.382 0 O-C-N 124.532 1.145 . . . . 0.0 111.356 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -79.23 -30.59 43.28 Favored 'General case' 0 C--N 1.277 -2.583 0 CA-C-N 114.754 -1.112 . . . . 0.0 112.691 -172.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 35.2 t -84.68 4.72 31.21 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-O 122.069 0.937 . . . . 0.0 108.511 176.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.626 ' O ' ' HB ' ' A' ' 90' ' ' THR . 23.3 mt-10 -118.21 17.01 14.02 Favored 'General case' 0 CA--C 1.46 -2.493 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.581 177.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 47.7 mtmt 66.55 7.83 5.37 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 174.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.407 HG21 ' HB3' ' A' ' 89' ' ' ALA . 11.3 m -117.62 171.92 5.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.951 -176.154 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -131.67 143.68 50.46 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.525 HG22 ' HB ' ' A' ' 96' ' ' VAL . 5.6 pt -101.98 138.01 27.78 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.519 179.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 13.6 ttm180 -114.46 111.84 22.05 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -172.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.401 ' CD1' ' HA ' ' A' ' 102' ' ' ARG . 3.1 mm? . . . . . 0 CA--C 1.478 -1.818 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.067 -174.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.462 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 40.7 m-80 . . . . . 0 CA--C 1.494 -1.179 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.1 mt -138.21 167.97 20.71 Favored 'General case' 0 C--O 1.249 1.042 0 CA-C-O 122.212 1.006 . . . . 0.0 112.595 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.456 HG21 HG22 ' A' ' 96' ' ' VAL . 0.6 OUTLIER -130.79 140.11 49.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-N 113.865 -1.516 . . . . 0.0 108.243 176.214 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.449 ' CG1' ' HA ' ' A' ' 54' ' ' VAL . 95.4 t -111.24 124.48 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.751 0 CA-C-O 121.538 0.685 . . . . 0.0 111.642 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 68.2 mttm -134.92 144.25 47.36 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.354 -1.294 . . . . 0.0 108.573 176.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -163.38 159.73 22.73 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 177.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -69.06 -32.98 72.83 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.584 0.706 . . . . 0.0 111.051 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 76.2 t -91.96 126.08 44.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.696 ' O ' HG22 ' A' ' 54' ' ' VAL . 13.6 tt0 -62.15 -50.21 72.78 Favored 'General case' 0 C--O 1.198 -1.631 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -173.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.65 0.4 56.39 Favored Glycine 0 C--N 1.29 -2.006 0 C-N-CA 118.537 -1.792 . . . . 0.0 114.427 -175.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 43.0 m -82.09 -24.87 34.96 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 175.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.696 HG22 ' O ' ' A' ' 51' ' ' GLN . 4.1 m -74.97 -46.67 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.313 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.194 175.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -63.37 -46.37 86.81 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.989 -177.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.35 -36.78 84.85 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.241 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 34.4 tp -73.26 -39.98 64.98 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.809 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.49 HG21 ' HB2' ' A' ' 76' ' ' ALA . 53.3 t -57.95 -40.01 74.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 122.738 0.415 . . . . 0.0 110.912 176.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.88 -6.98 45.67 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -105.28 -34.9 7.73 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.436 ' HB3' HG13 ' A' ' 73' ' ' ILE . 0.4 OUTLIER -72.49 -32.43 66.18 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.987 -175.48 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -73.02 -18.07 61.38 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.046 0.451 . . . . 0.0 110.812 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.444 -0.76 0 CA-C-O 121.319 0.58 . . . . 0.0 111.199 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.1 t . . . . . 0 N--CA 1.438 -1.03 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -139.94 158.0 44.77 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.604 0.716 . . . . 0.0 111.78 -173.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.436 HG13 ' HB3' ' A' ' 61' ' ' LEU . 1.7 pp -94.42 159.68 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.301 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.6 mp -125.66 -28.49 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.814 175.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.409 ' CD2' HD12 ' A' ' 45' ' ' ILE . 3.7 t60 -150.41 132.76 15.54 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 120.882 0.372 . . . . 0.0 110.121 -170.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.49 ' HB2' HG21 ' A' ' 58' ' ' VAL . . . -123.86 140.48 52.94 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 47' ' ' LYS . . . -159.08 140.79 13.39 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.427 ' HB ' ' HA ' ' A' ' 51' ' ' GLN . 3.6 p -94.67 92.93 3.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-O 122.785 1.279 . . . . 0.0 107.552 175.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -177.36 176.2 47.95 Favored Glycine 0 N--CA 1.398 -3.899 0 CA-C-N 114.427 -1.26 . . . . 0.0 110.643 -177.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.64 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -83.96 -168.98 2.36 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 103' ' ' PRO . 3.3 mp -86.57 108.32 17.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.584 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 18.3 p -101.78 151.15 22.4 Favored 'General case' 0 N--CA 1.414 -2.253 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.111 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -45.59 -53.94 8.38 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.341 1.457 . . . . 0.0 113.618 -177.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.3 t -76.08 -14.43 60.2 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 120.68 0.276 . . . . 0.0 111.516 -174.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -77.57 -35.34 53.19 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.548 HD13 ' HB2' ' A' ' 111' ' ' ALA . 40.7 mt -59.73 -26.62 35.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-N 114.379 -1.282 . . . . 0.0 112.078 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.7 m -58.18 -21.57 47.95 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 175.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -80.22 -35.69 35.86 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 174.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.01 -53.54 55.74 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.577 -176.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.51 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 3.3 t -70.58 -24.7 62.82 Favored 'General case' 0 CA--C 1.557 1.247 0 O-C-N 122.017 -0.427 . . . . 0.0 111.707 177.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.32 -52.57 38.83 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -175.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.6 p -105.26 -2.37 24.14 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 122.05 0.929 . . . . 0.0 109.231 -176.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 52.7 t30 66.73 41.17 3.02 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.223 -1.808 . . . . 0.0 109.365 -177.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -94.24 130.18 40.59 Favored 'General case' 0 N--CA 1.413 -2.32 0 CA-C-N 113.597 -1.638 . . . . 0.0 106.952 177.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 37.8 pt -93.89 142.66 13.0 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.375 0 C-N-CA 119.112 -1.035 . . . . 0.0 108.996 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.484 ' HB ' HG22 ' A' ' 118' ' ' ILE . 10.6 t -93.53 106.37 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.316 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -175.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.498 ' HA ' ' O ' ' A' ' 119' ' ' ARG . 65.5 mt -101.58 117.6 47.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 177.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 120' ' ' LEU . . . -123.32 176.32 16.67 Favored Glycine 0 C--N 1.289 -2.037 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -178.349 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -148.09 115.93 6.39 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.359 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 8.4 t30 73.91 -27.56 0.19 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 125.586 1.554 . . . . 0.0 113.09 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.456 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 7.8 m -60.92 -53.17 52.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 C-N-CA 124.382 1.073 . . . . 0.0 113.778 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.64 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 61.9 mtp180 73.83 168.47 0.12 Allowed Pre-proline 0 N--CA 1.482 1.132 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 176.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 9.4 Cg_endo -98.41 176.04 0.45 Allowed 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 122.036 1.824 . . . . 0.0 115.006 -177.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.529 ' HB2' ' H ' ' A' ' 107' ' ' ALA . 65.5 m-20 -67.82 159.43 30.35 Favored 'General case' 0 C--O 1.249 1.067 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 168.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.459 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -66.74 -29.43 69.4 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 176.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.592 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 83.9 m-20 -84.95 -27.22 26.68 Favored 'General case' 0 C--O 1.205 -1.27 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.541 175.009 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.529 ' H ' ' HB2' ' A' ' 104' ' ' ASP . . . -70.11 -41.46 73.96 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.458 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 13.7 ptmm? -59.75 -21.65 61.01 Favored 'General case' 0 CA--C 1.556 1.174 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.404 178.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.592 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 96.1 mtt180 -87.28 -53.8 4.64 Favored 'General case' 0 N--CA 1.384 -3.741 0 C-N-CA 125.44 1.496 . . . . 0.0 109.849 177.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -50.28 -45.27 54.25 Favored 'General case' 0 C--O 1.196 -1.72 0 C-N-CA 124.978 1.311 . . . . 0.0 111.036 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.548 ' HB2' HD13 ' A' ' 86' ' ' ILE . . . -50.49 -46.69 57.2 Favored 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 124.194 0.934 . . . . 0.0 111.886 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -79.75 -29.52 40.55 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.949 -172.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 32.5 t -82.67 3.23 29.87 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.51 ' O ' ' HB ' ' A' ' 90' ' ' THR . 19.1 mt-10 -122.39 11.84 10.05 Favored 'General case' 0 CA--C 1.474 -1.972 0 C-N-CA 124.896 1.278 . . . . 0.0 112.82 -178.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 56.9 mttp 65.89 12.21 8.22 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 174.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.4 m -120.62 135.28 61.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-O 121.454 0.645 . . . . 0.0 112.557 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -96.51 124.4 40.49 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.455 176.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.484 HG22 ' HB ' ' A' ' 96' ' ' VAL . 9.6 pt -92.91 124.55 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.029 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 176.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 41.5 mtm180 -123.23 103.61 8.64 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-O 122.207 1.003 . . . . 0.0 111.494 -171.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.532 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.411 -2.387 0 CA-C-N 113.943 -1.481 . . . . 0.0 110.802 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.548 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 57.5 m-80 . . . . . 0 CA--C 1.493 -1.228 0 CA-C-O 120.441 0.162 . . . . 0.0 111.419 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 91.4 mt -136.8 160.31 39.23 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-O 122.042 0.925 . . . . 0.0 112.28 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.549 HG23 ' HA ' ' A' ' 96' ' ' VAL . 0.1 OUTLIER -121.14 130.38 74.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 171.434 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 81.4 t -105.19 133.28 49.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.763 -177.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -144.63 134.38 23.6 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -150.9 168.46 24.44 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -80.39 -28.37 37.93 Favored 'General case' 0 C--N 1.316 -0.854 0 O-C-N 123.971 0.794 . . . . 0.0 109.279 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 90.0 t -96.3 124.88 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 174.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.715 ' O ' HG22 ' A' ' 54' ' ' VAL . 16.2 tt0 -64.22 -49.28 72.6 Favored 'General case' 0 C--O 1.19 -2.075 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -173.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.57 1.94 33.79 Favored Glycine 0 C--N 1.292 -1.886 0 C-N-CA 119.278 -1.439 . . . . 0.0 113.648 -177.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.2 t -83.49 -22.19 32.58 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 177.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.715 HG22 ' O ' ' A' ' 51' ' ' GLN . 4.7 m -81.91 -45.8 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.967 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.263 175.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -60.48 -47.49 85.88 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 114.691 -1.141 . . . . 0.0 111.536 -177.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.69 -32.27 73.7 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.087 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.524 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 25.8 tp -76.47 -39.81 52.19 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.882 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.411 HG13 HG12 ' A' ' 73' ' ' ILE . 24.8 t -53.3 -44.71 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 123.652 0.781 . . . . 0.0 111.573 177.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.84 -21.25 65.2 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.27 -8.52 21.19 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.401 0.62 . . . . 0.0 110.433 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.524 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -97.67 -43.04 7.35 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-N 115.03 -0.987 . . . . 0.0 108.876 -176.879 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -66.06 -20.01 66.03 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.859 0.361 . . . . 0.0 111.414 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.3 pttp . . . . . 0 N--CA 1.439 -0.983 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.99 -175.155 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 41.4 t . . . . . 0 N--CA 1.424 -1.763 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -140.39 153.6 46.4 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 120.069 -0.653 . . . . 0.0 111.021 -175.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.411 HG12 HG13 ' A' ' 58' ' ' VAL . 1.5 pp -94.32 141.77 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.071 175.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.403 ' CD1' ' HB3' ' A' ' 43' ' ' ASN . 67.4 mt -111.23 -25.44 3.52 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.472 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.537 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.451 ' O ' HD12 ' A' ' 45' ' ' ILE . 13.2 t-160 -161.56 142.86 11.28 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -171.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -146.4 127.32 14.49 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -147.78 153.35 39.11 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.225 -176.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.2 p -94.06 94.57 4.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 122.207 1.003 . . . . 0.0 110.848 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.09 174.43 46.77 Favored Glycine 0 N--CA 1.42 -2.421 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 176.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.541 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -85.58 176.66 8.07 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 173.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.0 mt -79.2 112.55 17.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 122.07 0.148 . . . . 0.0 110.74 -170.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 67.6 p -107.76 165.93 11.07 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.434 ' O ' ' HB ' ' A' ' 86' ' ' ILE . 13.1 pt-20 -66.69 -23.83 66.18 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -174.008 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.2 t -76.35 -24.82 54.24 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.151 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -70.37 -37.81 74.64 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.532 ' CG2' ' HA ' ' A' ' 111' ' ' ALA . 48.2 mm -56.59 -38.86 59.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 113.868 -1.514 . . . . 0.0 111.35 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.7 m -58.66 -28.37 65.66 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.29 -178.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -76.02 -37.22 58.67 Favored 'General case' 0 C--O 1.251 1.157 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.97 -46.98 87.69 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.135 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.496 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 7.5 t -77.8 -23.06 49.21 Favored 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.138 177.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.04 -67.68 0.43 Allowed 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -176.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 33.5 t -99.01 4.88 47.29 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.283 -175.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 70.76 68.64 0.19 Allowed 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 124.405 1.082 . . . . 0.0 112.189 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -119.86 166.87 12.72 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 113.992 -1.458 . . . . 0.0 108.546 174.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 47.9 mm -121.38 144.49 30.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 174.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.549 ' HA ' HG23 ' A' ' 45' ' ' ILE . 19.9 t -94.63 119.76 43.09 Favored 'Isoleucine or valine' 0 C--O 1.249 1.035 0 CA-C-O 120.974 0.416 . . . . 0.0 110.097 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.1 mp -107.94 111.32 35.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 174.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -99.5 136.39 12.66 Favored Glycine 0 N--CA 1.413 -2.89 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -95.41 93.37 7.19 Favored 'General case' 0 C--N 1.29 -1.996 0 C-N-CA 118.543 -1.263 . . . . 0.0 109.665 -176.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 54.59 28.91 10.52 Favored 'General case' 0 C--O 1.212 -0.918 0 C-N-CA 123.856 0.862 . . . . 0.0 111.621 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 m -96.58 -46.71 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.984 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -175.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.541 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 63.5 mtm180 75.39 155.09 0.15 Allowed Pre-proline 0 N--CA 1.471 0.583 0 C-N-CA 124.0 0.92 . . . . 0.0 111.455 178.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -89.59 167.73 5.0 Favored 'Trans proline' 0 N--CA 1.432 -2.099 0 C-N-CA 121.475 1.45 . . . . 0.0 115.269 -175.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -75.36 156.66 35.24 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 112.6 -2.091 . . . . 0.0 106.906 170.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.507 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -61.27 -32.72 72.55 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.499 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 77.6 m-20 -87.01 -24.9 24.49 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.63 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.41 -44.03 79.8 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.609 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 17.2 ptpt -57.67 -35.2 70.25 Favored 'General case' 0 CA--C 1.562 1.437 0 O-C-N 123.575 0.547 . . . . 0.0 110.465 177.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.499 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 98.2 mtt180 -72.49 -55.91 6.24 Favored 'General case' 0 N--CA 1.385 -3.686 0 C-N-CA 125.762 1.625 . . . . 0.0 109.402 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -53.82 -47.47 70.86 Favored 'General case' 0 C--O 1.198 -1.626 0 CA-C-N 113.806 -1.543 . . . . 0.0 110.067 -177.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.532 ' HA ' ' CG2' ' A' ' 86' ' ' ILE . . . -48.54 -48.09 38.78 Favored 'General case' 0 CA--C 1.489 -1.386 0 O-C-N 124.618 1.199 . . . . 0.0 111.47 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -77.36 -35.44 54.57 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.872 -174.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 45.4 t -77.61 -3.13 39.3 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 177.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.496 ' O ' ' HB ' ' A' ' 90' ' ' THR . 16.3 mt-10 -113.28 11.94 18.78 Favored 'General case' 0 CA--C 1.468 -2.188 0 C-N-CA 124.388 1.075 . . . . 0.0 112.386 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 55.3 mttp 67.48 11.77 8.55 Favored 'General case' 0 N--CA 1.416 -2.148 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 174.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.7 m -119.85 118.77 58.18 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 121.769 0.795 . . . . 0.0 112.602 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -94.22 124.92 38.55 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.514 HG22 ' HB ' ' A' ' 96' ' ' VAL . 8.4 pt -94.21 144.29 9.95 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-O 121.182 0.515 . . . . 0.0 111.059 -176.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -126.91 132.59 50.85 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.204 0.526 . . . . 0.0 109.87 -176.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.502 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.3 -1.574 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.028 -173.278 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 . . . . . 0 N--CA 1.439 -0.979 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 95.8 mt -137.19 158.34 44.66 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.613 0.72 . . . . 0.0 112.114 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.706 HG23 ' HA ' ' A' ' 96' ' ' VAL . 0.4 OUTLIER -122.04 132.73 70.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.808 170.509 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 97.7 t -111.05 126.84 68.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.944 -176.151 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.491 ' O ' ' HA2' ' A' ' 98' ' ' GLY . 74.1 mttt -137.0 147.7 46.43 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.283 -0.872 . . . . 0.0 108.964 173.484 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.21 170.74 19.81 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 120.827 0.346 . . . . 0.0 110.562 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -72.7 -29.87 63.74 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.438 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 75.8 t -113.32 134.15 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.645 ' O ' HG22 ' A' ' 54' ' ' VAL . 12.4 tt0 -60.36 -52.37 65.55 Favored 'General case' 0 C--O 1.2 -1.514 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -175.36 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.65 5.15 31.75 Favored Glycine 0 C--N 1.292 -1.875 0 C-N-CA 118.327 -1.892 . . . . 0.0 114.305 -176.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.0 m -88.38 -21.03 24.54 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 174.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.645 HG22 ' O ' ' A' ' 51' ' ' GLN . 3.6 m -76.26 -46.04 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 174.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -67.0 -35.6 80.29 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.475 -1.239 . . . . 0.0 112.079 -176.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.73 -33.65 75.57 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.303 0.573 . . . . 0.0 110.257 176.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 31.3 tp -79.87 -45.99 17.64 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 54' ' ' VAL . 56.1 t -55.88 -44.21 77.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 124.037 0.935 . . . . 0.0 112.264 179.049 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.66 -20.84 65.23 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -177.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.1 -28.78 13.59 Favored 'General case' 0 C--O 1.202 -1.426 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.71 -33.82 60.35 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 114.023 -1.444 . . . . 0.0 110.265 -176.031 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -72.64 -20.66 61.23 Favored 'General case' 0 C--N 1.315 -0.908 0 O-C-N 122.061 -0.399 . . . . 0.0 111.159 177.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? . . . . . 0 C--N 1.318 -0.761 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 179.109 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.432 -1.354 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -137.5 157.48 46.46 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-O 121.803 0.811 . . . . 0.0 110.589 -174.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 pp -93.83 157.97 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.177 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.413 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 74.3 mt -119.99 -31.04 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.463 177.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.499 ' CD2' HD12 ' A' ' 45' ' ' ILE . 6.4 t60 -151.55 131.97 13.78 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -171.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -139.24 129.31 25.15 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.108 0.963 . . . . 0.0 109.458 -175.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -154.08 157.59 39.21 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.505 -178.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.491 ' HB ' ' HA ' ' A' ' 51' ' ' GLN . 5.1 p -94.49 94.99 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-O 122.132 0.968 . . . . 0.0 108.611 176.493 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -175.57 175.95 47.33 Favored Glycine 0 N--CA 1.401 -3.698 0 C-N-CA 120.186 -1.006 . . . . 0.0 110.858 -177.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.584 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -87.46 173.12 9.31 Favored 'General case' 0 C--N 1.282 -2.35 0 O-C-N 124.112 0.536 . . . . 0.0 109.721 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.526 HD13 HD11 ' A' ' 120' ' ' LEU . 1.9 mp -75.49 107.76 6.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.65 152.66 22.85 Favored 'General case' 0 N--CA 1.401 -2.91 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.047 -178.231 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.432 ' HG3' ' HB2' ' A' ' 110' ' ' ALA . 41.7 tt0 -54.24 -45.39 72.31 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 124.029 0.831 . . . . 0.0 112.547 -174.022 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.9 p -69.8 -18.71 63.49 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -81.51 -25.37 36.01 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-O 121.603 0.716 . . . . 0.0 110.128 177.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.556 HG21 ' HA ' ' A' ' 111' ' ' ALA . 42.0 mt -72.51 -20.57 19.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.681 178.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.0 m -60.13 -26.8 66.55 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.05 175.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -79.64 -38.58 33.46 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.97 177.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.01 -58.68 6.4 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.338 -176.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.613 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 2.3 t -68.15 -28.22 67.11 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.507 177.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.04 -65.49 0.68 Allowed 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.19 0.519 . . . . 0.0 111.514 -177.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.5 m -93.69 6.0 49.78 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.888 -176.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 67.87 33.0 4.94 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.901 0.858 . . . . 0.0 109.937 177.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.53 153.1 18.05 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.439 -178.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 41.4 mm -107.72 141.21 23.52 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.146 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.706 ' HA ' HG23 ' A' ' 45' ' ' ILE . 10.7 t -94.8 120.47 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 65.8 mt -112.94 120.28 62.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 177.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 47' ' ' LYS . . . -139.83 171.06 24.0 Favored Glycine 0 N--CA 1.427 -1.902 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 178.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.444 ' C ' ' H ' ' A' ' 101' ' ' VAL . 30.4 p90 -158.77 134.57 8.87 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 117.66 0.73 . . . . 0.0 111.324 -178.231 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 72.84 -23.46 0.21 Allowed 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 125.403 1.481 . . . . 0.0 112.874 178.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.511 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 2.3 m -77.64 -49.71 21.56 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.099 177.162 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.584 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 53.0 mtm180 72.68 170.82 0.11 Allowed Pre-proline 0 C--N 1.352 0.692 0 O-C-N 124.164 0.915 . . . . 0.0 111.368 177.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -91.99 169.46 2.92 Favored 'Trans proline' 0 N--CA 1.443 -1.455 0 CA-C-N 120.534 1.226 . . . . 0.0 113.718 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -79.0 149.61 32.17 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 169.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.573 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -59.3 -26.53 65.05 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.625 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 27.7 m-80 -80.01 -30.7 39.66 Favored 'General case' 0 C--N 1.315 -0.926 0 O-C-N 121.847 -0.533 . . . . 0.0 109.863 177.023 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.67 -43.05 63.62 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.256 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 21.2 ptmt -59.81 -24.71 64.36 Favored 'General case' 0 CA--C 1.559 1.324 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.735 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.625 ' HB2' ' O ' ' A' ' 106' ' ' ASN 0.287 38.4 mtm180 -77.51 -56.77 4.25 Favored 'General case' 0 N--CA 1.395 -3.176 0 C-N-CA 125.935 1.694 . . . . 0.0 108.217 175.946 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.432 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . . . -49.46 -47.88 48.02 Favored 'General case' 0 CA--C 1.482 -1.648 0 CA-C-N 113.545 -1.661 . . . . 0.0 111.362 -176.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.556 ' HA ' HG21 ' A' ' 86' ' ' ILE . . . -48.07 -42.76 29.51 Favored 'General case' 0 CA--C 1.505 -0.777 0 O-C-N 124.518 1.136 . . . . 0.0 111.349 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -84.29 -23.7 30.19 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -173.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 30.8 t -85.59 -1.67 57.36 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-O 123.173 1.463 . . . . 0.0 107.254 174.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.613 ' O ' ' HB ' ' A' ' 90' ' ' THR . 35.2 mt-10 -120.56 13.0 11.65 Favored 'General case' 0 N--CA 1.404 -2.754 0 CA-C-N 113.638 -1.619 . . . . 0.0 112.811 -177.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 92.4 mttt 63.09 13.0 6.42 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 172.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.2 m -119.14 138.53 49.53 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-O 121.875 0.845 . . . . 0.0 112.777 -176.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -99.52 126.57 45.49 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.919 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.445 HG22 ' HB ' ' A' ' 96' ' ' VAL . 6.5 pt -94.05 133.79 33.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.255 0.55 . . . . 0.0 111.369 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -98.39 122.01 41.04 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.652 -177.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.526 HD11 HD13 ' A' ' 81' ' ' ILE . 3.8 mm? . . . . . 0 C--N 1.307 -1.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.617 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 . . . . . 0 CA--C 1.486 -1.504 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 74.7 mt -140.15 155.19 47.07 Favored 'General case' 0 C--O 1.258 1.51 0 O-C-N 123.717 0.636 . . . . 0.0 110.513 174.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.503 HG23 ' HA ' ' A' ' 96' ' ' VAL . 0.4 OUTLIER -120.6 135.07 62.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.03 176.63 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 72.5 t -109.7 126.87 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.869 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.334 -176.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.426 ' O ' ' HA2' ' A' ' 98' ' ' GLY . 23.1 mmtp -142.06 119.35 11.5 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 125.09 1.356 . . . . 0.0 109.858 -179.048 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -140.18 164.42 30.1 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -178.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.17 -17.08 44.13 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -178.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 86.1 t -105.03 122.59 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.354 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 175.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.751 ' O ' HG22 ' A' ' 54' ' ' VAL . 15.4 tm0? -58.14 -48.88 78.88 Favored 'General case' 0 C--O 1.202 -1.421 0 C-N-CA 122.948 0.499 . . . . 0.0 111.686 -174.035 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.77 0.8 81.06 Favored Glycine 0 C--N 1.285 -2.273 0 C-N-CA 117.693 -2.194 . . . . 0.0 113.912 -176.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 70.7 m -86.96 -20.86 26.68 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 176.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.751 HG22 ' O ' ' A' ' 51' ' ' GLN . 9.3 m -72.23 -43.23 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.449 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 172.289 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -62.68 -42.81 99.82 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.968 177.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.04 -35.05 78.95 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.923 0.392 . . . . 0.0 110.676 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.473 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 24.8 tp -76.57 -38.96 54.1 Favored 'General case' 0 C--O 1.208 -1.112 0 C-N-CA 120.456 -0.497 . . . . 0.0 109.711 177.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 54' ' ' VAL . 45.2 t -57.8 -44.49 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 122.746 0.419 . . . . 0.0 110.693 175.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.67 -18.18 64.74 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 123.229 0.612 . . . . 0.0 111.62 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.56 -19.71 15.37 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.153 0.501 . . . . 0.0 109.799 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -88.85 -36.85 15.77 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.034 -175.523 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -65.43 -26.16 67.84 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.011 0.434 . . . . 0.0 110.328 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.879 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.027 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.9 t . . . . . 0 N--CA 1.471 0.589 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -139.58 160.34 40.09 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 175.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.425 HG23 ' HG ' ' A' ' 61' ' ' LEU . 1.4 pp -94.43 164.05 2.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.828 178.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 70.7 mt -120.24 -41.67 2.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 121.523 0.677 . . . . 0.0 110.453 175.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.471 ' CD2' HD12 ' A' ' 45' ' ' ILE . 2.4 t60 -144.17 131.92 21.31 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.909 -168.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -142.88 134.96 27.18 Favored 'General case' 0 CA--C 1.503 -0.848 0 C-N-CA 124.26 1.024 . . . . 0.0 108.472 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.484 ' O ' HG11 ' A' ' 54' ' ' VAL . . . -160.82 164.86 31.08 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.481 ' HB ' ' HA ' ' A' ' 51' ' ' GLN . 7.1 p -93.34 98.51 8.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-O 122.423 1.106 . . . . 0.0 109.542 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.25 172.93 45.9 Favored Glycine 0 N--CA 1.406 -3.341 0 C-N-CA 120.052 -1.071 . . . . 0.0 110.572 -178.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.619 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -88.68 -166.86 1.7 Allowed 'General case' 0 N--CA 1.412 -2.33 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.489 HG13 HG11 ' A' ' 96' ' ' VAL . 2.6 mp -91.33 120.81 40.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 177.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.403 ' HA ' ' HB2' ' A' ' 107' ' ' ALA . 10.9 p -121.23 158.32 28.35 Favored 'General case' 0 C--N 1.317 -0.833 0 O-C-N 123.314 0.384 . . . . 0.0 110.157 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.73 -39.57 77.6 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -176.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.1 m -75.59 -8.74 57.53 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 120.913 0.387 . . . . 0.0 111.544 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -95.51 -30.99 13.55 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.502 HG21 ' HA ' ' A' ' 111' ' ' ALA . 31.0 mm -58.18 -31.96 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-N 114.46 -1.245 . . . . 0.0 111.355 174.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 25.8 m -58.53 -31.57 68.05 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.603 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -72.86 -35.23 67.16 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 176.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 94' ' ' ALA . . . -58.03 -52.92 63.54 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.29 -178.173 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.486 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 3.4 t -71.93 -30.96 65.87 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.995 177.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.76 -63.05 1.43 Allowed 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 40.6 m -97.62 5.26 49.68 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -175.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 67.34 28.07 8.0 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.629 0.728 . . . . 0.0 110.88 178.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . -94.46 129.85 41.07 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 36.2 pt -93.47 150.52 3.91 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.503 ' HA ' HG23 ' A' ' 45' ' ' ILE . 18.3 t -94.11 112.56 27.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-O 121.349 0.595 . . . . 0.0 109.551 -176.097 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 54.9 mt -98.88 98.1 6.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 47' ' ' LYS . . . -94.78 151.57 20.16 Favored Glycine 0 N--CA 1.427 -1.965 0 C-N-CA 119.998 -1.096 . . . . 0.0 111.852 -176.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.405 ' C ' ' H ' ' A' ' 101' ' ' VAL . 23.8 m-85 -125.22 118.37 25.87 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -176.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 64.8 t30 70.08 -33.22 0.25 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 125.449 1.5 . . . . 0.0 113.018 178.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 0.7 OUTLIER -53.35 -71.74 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 117.739 2.496 . . . . 0.0 117.739 -177.673 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.619 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 0.0 OUTLIER 84.33 164.03 0.11 Allowed Pre-proline 0 N--CA 1.478 0.949 0 C-N-CA 124.573 1.149 . . . . 0.0 111.178 -170.225 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.409 ' HD3' HD21 ' A' ' 120' ' ' LEU . 2.1 Cg_endo -88.65 171.43 5.08 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 C-N-CA 121.446 1.431 . . . . 0.0 113.509 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -83.33 155.46 23.55 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 113.728 -1.578 . . . . 0.0 107.142 169.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.448 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -60.64 -24.39 65.51 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -178.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.588 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 22.3 m-80 -89.81 -27.8 19.73 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.403 ' HB2' ' HA ' ' A' ' 82' ' ' THR . . . -71.77 -38.39 70.36 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.163 -178.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -61.79 -27.04 68.47 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.961 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.588 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 62.6 mtp180 -79.38 -55.22 5.23 Favored 'General case' 0 N--CA 1.383 -3.779 0 C-N-CA 125.382 1.473 . . . . 0.0 109.623 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.18 -46.54 69.01 Favored 'General case' 0 C--O 1.198 -1.623 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.872 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.502 ' HA ' HG21 ' A' ' 86' ' ' ILE . . . -48.53 -48.29 38.49 Favored 'General case' 0 CA--C 1.491 -1.319 0 O-C-N 124.413 1.071 . . . . 0.0 111.918 -178.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -78.7 -33.91 46.51 Favored 'General case' 0 N--CA 1.401 -2.884 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.844 -172.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 32.2 t -77.2 -0.38 24.91 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.486 ' O ' ' HB ' ' A' ' 90' ' ' THR . 21.0 mt-10 -120.23 11.47 11.57 Favored 'General case' 0 N--CA 1.405 -2.684 0 CA-C-N 114.389 -1.278 . . . . 0.0 112.558 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 52.8 mttp 67.68 8.86 6.67 Favored 'General case' 0 N--CA 1.42 -1.955 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 173.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.1 m -112.32 127.1 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.63 0 CA-C-O 121.722 0.773 . . . . 0.0 112.413 -178.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -94.75 122.66 37.6 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.011 -178.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 16.8 pt -106.59 138.44 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.465 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -151.51 147.22 26.56 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.466 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 2.9 mm? . . . . . 0 C--N 1.292 -1.906 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -170.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.427 ' HB3' HD11 ' A' ' 74' ' ' ILE . 0.9 OUTLIER . . . . . 0 CA--C 1.502 -0.879 0 N-CA-C 111.226 0.084 . . . . 0.0 111.226 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.49 ' HA ' ' HB1' ' A' ' 94' ' ' ALA . 4.4 pp -158.56 167.21 30.21 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 177.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.66 HG23 ' HA ' ' A' ' 96' ' ' VAL . 0.5 OUTLIER -119.5 137.21 54.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 C-N-CA 123.536 0.734 . . . . 0.0 110.889 179.151 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 65.3 t -109.1 125.35 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.282 -177.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.502 ' HE3' ' HB3' ' A' ' 77' ' ' ALA . 14.6 mmmm -138.02 122.42 18.32 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -137.92 169.04 18.48 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -177.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -81.49 -32.2 32.57 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 123.984 0.802 . . . . 0.0 109.099 -177.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.445 ' HB ' ' HB2' ' A' ' 53' ' ' SER . 96.2 t -98.08 128.75 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.985 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 174.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.771 ' O ' HG22 ' A' ' 54' ' ' VAL . 16.3 tt0 -62.3 -43.62 98.4 Favored 'General case' 0 C--O 1.191 -1.987 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.305 -175.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -75.19 -0.13 60.56 Favored Glycine 0 C--N 1.291 -1.924 0 C-N-CA 118.388 -1.863 . . . . 0.0 113.268 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.445 ' HB2' ' HB ' ' A' ' 50' ' ' VAL . 34.0 t -83.88 -23.36 31.29 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 178.387 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.771 HG22 ' O ' ' A' ' 51' ' ' GLN . 9.2 m -74.8 -46.54 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.158 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 172.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -56.44 -46.42 80.3 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.328 1.051 . . . . 0.0 112.241 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.88 -43.68 81.5 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.801 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.489 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 27.3 tp -74.14 -45.43 48.84 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.202 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 54' ' ' VAL . 46.6 t -54.05 -43.77 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.128 0.971 . . . . 0.0 112.493 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.42 -28.18 69.8 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.94 -26.9 18.2 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -76.1 -39.02 56.21 Favored 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 113.962 -1.472 . . . . 0.0 110.37 -176.126 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -69.88 -21.74 63.3 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.822 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? . . . . . 0 N--CA 1.444 -0.771 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -178.295 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.8 t . . . . . 0 N--CA 1.425 -1.719 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -151.15 153.22 34.58 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.415 0.626 . . . . 0.0 110.306 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 pp -94.11 155.86 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.792 176.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.427 HD11 ' HB3' ' A' ' 43' ' ' ASN . 3.4 mp -115.79 -41.72 3.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-O 121.438 0.637 . . . . 0.0 109.466 177.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -143.27 122.76 13.17 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.93 -169.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -131.69 135.57 46.98 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 124.422 1.089 . . . . 0.0 108.496 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.502 ' HB3' ' HE3' ' A' ' 47' ' ' LYS . . . -161.84 163.03 29.57 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 -178.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.6 p -93.51 96.93 6.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 122.405 1.098 . . . . 0.0 109.651 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.81 175.08 47.49 Favored Glycine 0 N--CA 1.406 -3.334 0 N-CA-C 108.332 -1.907 . . . . 0.0 108.332 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.605 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -89.78 -160.72 0.71 Allowed 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 177.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.495 ' O ' ' HA ' ' A' ' 103' ' ' PRO . 33.6 mt -89.12 105.89 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.008 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -176.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 70.6 p -99.43 156.75 16.86 Favored 'General case' 0 N--CA 1.411 -2.411 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -53.14 -32.69 48.93 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 123.473 0.709 . . . . 0.0 109.947 175.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.1 m -67.42 -30.79 70.63 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.048 0.939 . . . . 0.0 111.593 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -71.98 -35.02 69.39 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-O 121.849 0.833 . . . . 0.0 109.055 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.517 HD13 ' HB2' ' A' ' 111' ' ' ALA . 61.2 mt -68.97 -31.65 51.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.749 -178.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.4 m -54.21 -35.13 62.05 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.567 174.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -75.5 -34.84 60.87 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.256 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.71 -56.96 15.19 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.611 -176.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.523 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 5.8 t -71.51 -19.83 62.14 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.822 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.99 -62.62 1.36 Allowed 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.227 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.9 m -95.36 6.5 48.84 Favored 'General case' 0 C--O 1.201 -1.462 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.425 -174.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . 0.272 0.0 OUTLIER 69.89 30.19 3.78 Favored 'General case' 0 N--CA 1.505 2.306 0 C-N-CA 126.213 1.805 . . . . 0.0 111.33 177.033 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.49 ' HB1' ' HA ' ' A' ' 44' ' ' LEU . . . -94.23 162.5 13.83 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 113.186 -1.824 . . . . 0.0 109.183 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.496 HD13 ' H ' ' A' ' 95' ' ' ILE . 0.2 OUTLIER -121.66 156.29 25.83 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 173.414 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.66 ' HA ' HG23 ' A' ' 45' ' ' ILE . 29.3 t -94.41 126.84 46.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -175.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 11.6 tt -125.69 116.08 45.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 175.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 47' ' ' LYS . . . -120.66 161.15 14.91 Favored Glycine 0 N--CA 1.406 -3.308 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.001 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -121.44 100.08 6.83 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 118.843 -1.143 . . . . 0.0 110.194 -178.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 59.21 30.35 20.09 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 122.171 0.986 . . . . 0.0 111.945 176.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.503 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 3.4 m -97.81 -47.09 12.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 114.482 -1.235 . . . . 0.0 112.163 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.605 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 17.4 mtm-85 76.67 156.33 0.15 Allowed Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 124.388 1.075 . . . . 0.0 111.496 177.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 10.1 Cg_endo -99.83 174.4 0.37 Allowed 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.445 2.096 . . . . 0.0 115.193 -175.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.409 ' HB2' ' H ' ' A' ' 107' ' ' ALA . 43.6 m-20 -69.3 154.36 42.16 Favored 'General case' 0 C--O 1.251 1.142 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 170.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.513 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -60.25 -35.62 75.9 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 120.82 0.343 . . . . 0.0 110.54 179.14 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.576 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 84.2 m-20 -82.57 -25.73 33.02 Favored 'General case' 0 C--O 1.201 -1.468 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.975 175.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.409 ' H ' ' HB2' ' A' ' 104' ' ' ASP . . . -66.69 -45.48 78.69 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.813 177.145 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 20.8 pttm -57.45 -23.36 49.27 Favored 'General case' 0 CA--C 1.571 1.779 0 CA-C-O 120.842 0.353 . . . . 0.0 110.698 177.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.576 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 71.6 mtp180 -84.53 -53.24 5.55 Favored 'General case' 0 N--CA 1.389 -3.506 0 C-N-CA 125.921 1.688 . . . . 0.0 109.201 177.276 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.07 -48.74 43.86 Favored 'General case' 0 C--O 1.186 -2.242 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.793 -178.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.517 ' HB2' HD13 ' A' ' 86' ' ' ILE . . . -48.56 -43.96 36.16 Favored 'General case' 0 CA--C 1.503 -0.83 0 O-C-N 124.284 0.99 . . . . 0.0 111.466 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -82.71 -27.4 31.22 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 114.913 -1.039 . . . . 0.0 112.315 -173.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 35.3 t -88.23 5.09 43.3 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 176.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.523 ' O ' ' HB ' ' A' ' 90' ' ' THR . 20.5 mt-10 -120.96 11.53 11.04 Favored 'General case' 0 CA--C 1.46 -2.497 0 CA-C-N 114.374 -1.285 . . . . 0.0 112.926 -178.314 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 68.4 mmtt 62.13 22.29 13.02 Favored 'General case' 0 N--CA 1.418 -2.043 0 O-C-N 124.144 0.903 . . . . 0.0 112.83 174.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.1 m -124.4 174.2 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.091 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -121.33 135.38 55.1 Favored 'General case' 0 CA--C 1.49 -1.352 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.917 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.464 HG22 ' HB ' ' A' ' 96' ' ' VAL . 19.3 pt -102.99 123.56 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.135 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 167.015 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -102.65 120.07 39.92 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.503 HD21 ' H ' ' A' ' 101' ' ' VAL . 2.4 tm? . . . . . 0 N--CA 1.421 -1.914 0 C-N-CA 119.951 -0.699 . . . . 0.0 110.764 -176.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.522 ' OD1' HD11 ' A' ' 74' ' ' ILE . 40.2 m-80 . . . . . 0 CA--C 1.485 -1.539 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.435 HD12 HD11 ' A' ' 61' ' ' LEU . 80.9 mt -133.41 160.16 38.2 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.682 0.753 . . . . 0.0 111.121 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.529 HG23 ' HA ' ' A' ' 96' ' ' VAL . 0.5 OUTLIER -124.97 133.4 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.852 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.419 173.215 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.589 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 99.4 t -113.34 127.67 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.925 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.846 -176.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -135.2 128.48 32.08 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 124.13 0.972 . . . . 0.0 108.807 -177.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -148.53 168.09 23.66 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.953 -178.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -70.1 -21.93 63.07 Favored 'General case' 0 C--O 1.242 0.699 0 O-C-N 123.946 0.778 . . . . 0.0 111.308 -178.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.4 m -130.13 140.1 49.78 Favored 'Isoleucine or valine' 0 C--O 1.246 0.892 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.594 173.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.617 ' O ' HG22 ' A' ' 54' ' ' VAL . 3.8 pp0? -68.56 -6.77 27.34 Favored 'General case' 0 C--O 1.191 -1.978 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -176.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.39 -13.27 57.44 Favored Glycine 0 N--CA 1.422 -2.29 0 C-N-CA 118.261 -1.924 . . . . 0.0 112.318 177.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.4 m -81.82 -28.98 32.84 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 176.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.617 HG22 ' O ' ' A' ' 51' ' ' GLN . 15.8 m -70.6 -44.9 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.903 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.674 174.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.611 ' HG2' ' O ' ' A' ' 51' ' ' GLN . 67.8 mm-40 -59.58 -45.48 91.73 Favored 'General case' 0 C--O 1.214 -0.789 0 O-C-N 123.42 0.45 . . . . 0.0 111.391 178.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.07 -42.15 84.9 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 123.348 0.405 . . . . 0.0 111.448 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.432 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 32.2 tp -75.4 -42.31 54.06 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.229 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.508 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 36.0 t -55.99 -45.75 80.33 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.681 0 C-N-CA 123.136 0.574 . . . . 0.0 111.185 176.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.3 -16.84 61.57 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.68 -27.87 13.79 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.083 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.435 HD11 HD12 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -80.35 -30.0 37.97 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 113.775 -1.557 . . . . 0.0 110.569 -175.069 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 12.6 pt20 -83.75 -19.25 35.46 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 121.985 -0.447 . . . . 0.0 111.434 177.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt . . . . . 0 C--N 1.32 -0.675 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.344 -177.399 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.3 t . . . . . 0 N--CA 1.427 -1.598 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 26.7 ttpp -154.56 158.13 39.33 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.061 0.458 . . . . 0.0 110.472 -178.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 pp -93.82 156.27 3.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -173.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.522 HD11 ' OD1' ' A' ' 43' ' ' ASN . 26.7 mm -119.74 -32.44 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.464 0.65 . . . . 0.0 110.13 178.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.497 ' CD2' HD12 ' A' ' 45' ' ' ILE . 1.9 t60 -149.67 124.52 9.89 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.471 -168.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.589 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -135.96 132.25 36.15 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.318 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -155.78 155.66 33.44 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.54 -177.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.523 ' HB ' ' HB3' ' A' ' 51' ' ' GLN . 5.5 p -94.15 94.27 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 CA-C-O 122.823 1.296 . . . . 0.0 110.537 177.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.7 175.09 47.47 Favored Glycine 0 N--CA 1.405 -3.413 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.493 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . . . -82.87 167.98 17.53 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 176.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.491 HG21 HG21 ' A' ' 118' ' ' ILE . 2.4 mp -71.22 120.35 19.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -177.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.448 HG22 ' OD2' ' A' ' 85' ' ' ASP . 13.0 t -119.71 168.89 10.61 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -57.6 -34.94 69.78 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.949 0.5 . . . . 0.0 111.9 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.9 t -62.21 -29.86 70.68 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.046 0.539 . . . . 0.0 110.514 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.448 ' OD2' HG22 ' A' ' 82' ' ' THR . 49.4 m-20 -75.36 -39.41 59.31 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.259 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.414 ' CG2' ' HA ' ' A' ' 111' ' ' ALA . 39.5 mm -63.66 -32.9 58.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.515 -178.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 39.6 m -60.59 -24.05 65.16 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.527 176.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.428 HD21 HG21 ' A' ' 74' ' ' ILE . 2.4 tm? -87.98 -37.07 16.68 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.83 -58.73 6.18 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.947 -176.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.536 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 3.4 t -70.73 -26.56 63.44 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.494 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.18 -59.64 4.18 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.343 0.592 . . . . 0.0 111.901 -178.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.8 t -97.08 4.62 51.24 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.807 -175.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 67.7 32.76 5.27 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.822 0.82 . . . . 0.0 110.299 178.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -94.5 132.9 38.67 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.459 -178.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 36.3 pt -94.83 152.03 3.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 176.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.558 ' HB ' HG22 ' A' ' 118' ' ' ILE . 16.7 t -100.97 123.69 54.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.42 -172.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 7.3 tp -108.44 111.44 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 173.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -103.78 146.34 16.36 Favored Glycine 0 N--CA 1.43 -1.76 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -178.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.4 ' C ' ' H ' ' A' ' 101' ' ' VAL . 90.0 m-85 -121.84 108.98 14.11 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 117.026 0.413 . . . . 0.0 111.121 -175.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.603 ' O ' ' HD3' ' A' ' 102' ' ' ARG . 8.2 t30 67.66 -34.22 0.24 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 126.558 1.943 . . . . 0.0 113.493 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.493 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 1.7 m -51.35 -54.72 10.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 117.149 2.277 . . . . 0.0 117.149 -178.282 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.603 ' HD3' ' O ' ' A' ' 100' ' ' ASN . 1.0 OUTLIER 76.77 170.4 0.11 Allowed Pre-proline 0 N--CA 1.483 1.193 0 C-N-CA 123.958 0.903 . . . . 0.0 110.539 -171.743 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.516 ' HG3' HD12 ' A' ' 118' ' ' ILE . 9.2 Cg_endo -96.03 174.83 0.9 Allowed 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 121.712 1.608 . . . . 0.0 113.009 177.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -82.03 150.44 27.59 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 167.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.52 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -58.88 -30.3 67.65 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.143 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.539 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 16.5 m120 -81.08 -33.06 33.65 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 119.966 -0.693 . . . . 0.0 110.036 177.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.34 -42.62 98.96 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.239 177.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 20.9 ptmt -65.32 -26.29 67.99 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.984 178.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.539 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 53.6 mtp180 -75.52 -52.64 10.19 Favored 'General case' 0 N--CA 1.392 -3.353 0 C-N-CA 124.365 1.066 . . . . 0.0 109.027 177.044 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -53.02 -49.37 66.39 Favored 'General case' 0 C--O 1.195 -1.801 0 CA-C-N 113.947 -1.479 . . . . 0.0 110.091 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.414 ' HA ' ' CG2' ' A' ' 86' ' ' ILE . . . -47.04 -48.28 22.21 Favored 'General case' 0 CA--C 1.507 -0.681 0 O-C-N 124.568 1.167 . . . . 0.0 112.449 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.418 ' C ' ' H ' ' A' ' 114' ' ' GLU . 2.8 tm-20 -76.08 -38.79 56.6 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.3 -173.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 26.6 t -76.41 4.23 9.47 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.527 1.156 . . . . 0.0 108.707 178.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.536 ' O ' ' HB ' ' A' ' 90' ' ' THR . 15.2 mt-10 -123.21 14.06 9.69 Favored 'General case' 0 N--CA 1.398 -3.066 0 CA-C-N 114.466 -1.243 . . . . 0.0 113.019 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 96.7 mttt 66.2 7.54 4.91 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 173.029 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.5 m -114.25 147.01 18.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 C-N-CA 120.358 -0.537 . . . . 0.0 112.378 -175.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -113.09 128.7 56.56 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.702 -177.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.558 HG22 ' HB ' ' A' ' 96' ' ' VAL . 7.7 pt -97.74 133.82 38.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.079 177.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -118.33 134.77 54.76 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -178.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 0 CA--C 1.505 -0.758 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -174.228 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.651 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 61.1 m-80 . . . . . 0 N--CA 1.434 -1.233 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 4.1 pp -151.06 162.49 40.74 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.4 0.619 . . . . 0.0 112.57 177.307 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.615 HG23 ' HA ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -118.46 134.58 61.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.209 178.293 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 99.3 t -107.69 126.04 64.09 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.948 -176.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.8 mtpt -138.4 147.17 43.09 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.407 ' CB ' ' HB3' ' A' ' 99' ' ' PHE . . . -156.56 167.25 31.01 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -178.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -76.24 -22.83 54.7 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.846 0.832 . . . . 0.0 110.029 177.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 84.6 t -109.28 132.27 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 176.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.776 ' O ' HG22 ' A' ' 54' ' ' VAL . 16.2 tt0 -65.09 -46.2 82.1 Favored 'General case' 0 C--O 1.188 -2.18 0 C-N-CA 120.132 -0.627 . . . . 0.0 111.224 -176.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -73.74 2.65 39.38 Favored Glycine 0 C--N 1.294 -1.77 0 C-N-CA 118.753 -1.689 . . . . 0.0 114.394 -176.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.4 t -83.12 -26.12 31.3 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 176.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.776 HG22 ' O ' ' A' ' 51' ' ' GLN . 5.3 m -80.16 -45.87 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.918 0 CA-C-N 114.549 -1.205 . . . . 0.0 108.642 176.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -56.16 -48.44 76.3 Favored 'General case' 0 C--O 1.245 0.844 0 C-N-CA 124.867 1.267 . . . . 0.0 111.965 -176.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.51 -35.24 80.3 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.234 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 28.0 tp -76.1 -35.86 59.16 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.428 HG13 HG12 ' A' ' 73' ' ' ILE . 39.4 t -56.69 -43.87 80.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.747 174.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.39 -18.18 65.21 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.903 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.488 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -98.88 -21.4 16.32 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 122.384 1.087 . . . . 0.0 108.782 -177.347 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.42 -28.96 20.57 Favored 'General case' 0 C--N 1.275 -2.645 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.598 -177.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -83.75 -12.65 55.46 Favored 'General case' 0 C--N 1.313 -1.0 0 O-C-N 122.152 -0.342 . . . . 0.0 111.624 176.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 65.0 pttt . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 121.523 0.678 . . . . 0.0 110.137 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.4 t . . . . . 0 N--CA 1.429 -1.488 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -146.28 158.6 43.9 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.067 0.461 . . . . 0.0 110.565 -175.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.428 HG12 HG13 ' A' ' 58' ' ' VAL . 1.7 pp -94.03 142.82 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.715 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.412 175.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.423 HD11 ' OD1' ' A' ' 43' ' ' ASN . 34.6 mm -113.72 -27.43 2.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 CA-C-O 121.273 0.559 . . . . 0.0 109.789 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.504 ' CD2' HD12 ' A' ' 45' ' ' ILE . 5.5 t60 -160.95 125.86 3.65 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.782 -171.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.572 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -129.01 130.56 46.79 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -154.76 156.66 36.71 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.383 -178.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.7 p -94.54 97.76 7.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-O 121.947 0.879 . . . . 0.0 108.905 176.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -175.5 170.9 44.01 Favored Glycine 0 N--CA 1.413 -2.839 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.666 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . . . -84.74 -176.11 6.08 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 120.838 0.352 . . . . 0.0 110.635 -178.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.521 ' HB ' ' HB3' ' A' ' 103' ' ' PRO . 3.8 mm -87.86 97.9 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.672 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 9.7 t -98.71 147.04 25.27 Favored 'General case' 0 N--CA 1.411 -2.424 0 C-N-CA 119.749 -0.78 . . . . 0.0 109.719 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.463 ' N ' ' HB2' ' A' ' 107' ' ' ALA . 0.0 OUTLIER -47.31 -39.31 14.44 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 125.111 1.364 . . . . 0.0 112.53 178.915 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.9 m -78.8 -11.8 60.0 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -174.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -98.34 -23.52 15.58 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -177.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.559 HD13 ' HB2' ' A' ' 111' ' ' ALA . 38.6 mt -66.06 -22.18 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.644 177.176 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 47.3 t -49.59 -35.49 21.0 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.928 172.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.434 ' O ' HD22 ' A' ' 88' ' ' LEU . 2.0 tm? -70.17 -32.57 70.58 Favored 'General case' 0 C--O 1.25 1.083 0 CA-C-O 120.748 0.309 . . . . 0.0 110.843 179.052 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.47 -61.68 2.32 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.201 -176.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.563 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 4.8 t -66.02 -25.34 67.02 Favored 'General case' 0 CA--C 1.561 1.375 0 O-C-N 122.012 -0.43 . . . . 0.0 111.783 178.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.24 -55.7 16.98 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.143 0.497 . . . . 0.0 112.176 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 34.3 p -97.01 -4.62 39.4 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.238 0.542 . . . . 0.0 111.072 -176.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 72.63 33.45 1.36 Allowed 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.805 -178.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.651 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -94.34 134.49 36.78 Favored 'General case' 0 N--CA 1.419 -2.018 0 CA-C-N 114.008 -1.451 . . . . 0.0 109.931 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 35.0 pt -94.07 144.4 9.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 176.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.615 ' HA ' HG23 ' A' ' 45' ' ' ILE . 15.6 t -94.95 119.79 43.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 C-N-CA 120.186 -0.605 . . . . 0.0 110.93 -173.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.637 ' HA ' ' O ' ' A' ' 119' ' ' ARG . 24.4 pt -111.91 117.18 54.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-O 121.498 0.666 . . . . 0.0 109.748 174.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -110.9 157.22 15.1 Favored Glycine 0 N--CA 1.437 -1.281 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.825 -176.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.407 ' HB3' ' CB ' ' A' ' 48' ' ' ALA . 67.8 t80 -132.07 110.82 10.98 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -175.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.495 ' O ' ' HD3' ' A' ' 102' ' ' ARG . 27.5 t-20 70.68 -30.4 0.2 Allowed 'General case' 0 N--CA 1.506 2.354 0 C-N-CA 125.085 1.354 . . . . 0.0 114.029 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.666 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 2.5 m -58.57 -56.55 15.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 N-CA-C 117.765 2.506 . . . . 0.0 117.765 -177.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.533 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 0.6 OUTLIER 75.04 159.26 0.16 Allowed Pre-proline 0 N--CA 1.494 1.738 0 C-N-CA 124.359 1.064 . . . . 0.0 112.003 -174.642 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.521 ' HB3' ' HB ' ' A' ' 81' ' ' ILE . 4.0 Cg_endo -88.75 170.12 5.36 Favored 'Trans proline' 0 CA--C 1.502 -1.095 0 C-N-CA 122.466 2.111 . . . . 0.0 113.261 176.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -87.73 169.45 12.09 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 171.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.448 ' HA ' ' HE3' ' A' ' 108' ' ' LYS . . . -70.98 -11.45 60.98 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 -173.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.502 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 37.0 t30 -104.37 -34.11 8.4 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 176.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.463 ' HB2' ' N ' ' A' ' 83' ' ' GLU . . . -58.25 -44.34 88.3 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.152 0.501 . . . . 0.0 110.521 175.257 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.448 ' HE3' ' HA ' ' A' ' 105' ' ' ALA . 18.0 ptpt -59.15 -22.84 61.56 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.032 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.502 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 40.4 mtm180 -93.25 -50.38 5.51 Favored 'General case' 0 N--CA 1.38 -3.932 0 C-N-CA 126.108 1.763 . . . . 0.0 109.886 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.15 -45.59 68.48 Favored 'General case' 0 CA--C 1.48 -1.715 0 C-N-CA 125.551 1.541 . . . . 0.0 110.858 -177.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.559 ' HB2' HD13 ' A' ' 86' ' ' ILE . . . -49.48 -48.19 47.94 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 124.505 1.128 . . . . 0.0 111.163 -179.004 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -78.45 -28.78 46.68 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.461 -174.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 40.2 t -79.29 -3.91 48.25 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 176.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.563 ' O ' ' HB ' ' A' ' 90' ' ' THR . 27.2 mt-10 -114.08 11.2 17.59 Favored 'General case' 0 CA--C 1.464 -2.329 0 CA-C-N 114.253 -1.34 . . . . 0.0 112.498 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 55.4 mtpt 68.5 15.04 9.17 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 174.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.9 m -121.28 170.95 10.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -135.48 147.23 48.8 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 176.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.447 HG22 ' HB ' ' A' ' 96' ' ' VAL . 15.0 pt -110.4 140.67 28.46 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.299 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.871 -178.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.637 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 75.2 mtp180 -131.2 123.2 27.97 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -176.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.481 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.292 -1.916 0 O-C-N 121.796 -0.565 . . . . 0.0 112.143 -177.495 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.2 m120 . . . . . 0 CA--C 1.5 -0.957 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.47 HD12 HD11 ' A' ' 61' ' ' LEU . 56.9 mt -140.8 160.11 40.75 Favored 'General case' 0 C--O 1.246 0.884 0 CA-C-O 121.756 0.788 . . . . 0.0 112.813 177.131 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.469 HD12 ' O ' ' A' ' 75' ' ' HIS . 0.2 OUTLIER -131.87 133.28 61.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 125.461 1.504 . . . . 0.0 107.259 177.893 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.406 HG13 HD23 ' A' ' 57' ' ' LEU . 67.1 t -112.7 138.85 40.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.207 -176.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 60.6 mttp -137.52 160.48 39.01 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 123.71 0.804 . . . . 0.0 109.267 173.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -168.5 171.52 8.91 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -82.08 -37.28 26.61 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 91.8 t -97.51 127.84 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.335 176.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.698 ' O ' HG22 ' A' ' 54' ' ' VAL . 50.1 tt0 -57.43 -45.62 84.46 Favored 'General case' 0 C--O 1.204 -1.295 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -176.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.92 -0.97 61.37 Favored Glycine 0 C--N 1.283 -2.375 0 C-N-CA 118.155 -1.974 . . . . 0.0 113.908 -177.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.1 t -85.87 -18.13 33.67 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 175.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.698 HG22 ' O ' ' A' ' 51' ' ' GLN . 3.7 m -82.37 -46.36 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.949 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 174.34 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -60.68 -47.18 87.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.309 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.79 -33.95 76.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.585 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.496 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 37.1 tp -76.62 -37.4 56.45 Favored 'General case' 0 C--O 1.209 -1.068 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.526 HG21 ' HB2' ' A' ' 76' ' ' ALA . 43.5 t -60.09 -41.41 86.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 123.234 0.614 . . . . 0.0 110.954 176.344 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.73 -25.94 68.15 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.541 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.96 -24.65 19.19 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.496 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -85.12 -30.13 24.27 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.468 -175.585 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -78.45 -13.22 59.94 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.048 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.931 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.099 177.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.44 HG12 ' H ' ' A' ' 72' ' ' LYS . 3.5 t . . . . . 0 N--CA 1.469 0.517 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.44 ' H ' HG12 ' A' ' 71' ' ' VAL . 88.0 tttt -150.69 157.22 42.71 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 175.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.409 HG12 HG13 ' A' ' 58' ' ' VAL . 1.4 pp -93.61 154.09 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.793 177.224 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 65.2 mt -112.35 -40.08 3.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-O 121.787 0.803 . . . . 0.0 109.734 177.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.469 ' O ' HD12 ' A' ' 45' ' ' ILE . 2.1 t60 -145.77 137.71 25.29 Favored 'General case' 0 N--CA 1.409 -2.497 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.463 -165.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.526 ' HB2' HG21 ' A' ' 58' ' ' VAL . . . -125.25 134.21 52.4 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 177.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 47' ' ' LYS . . . -144.27 131.68 20.9 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -178.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.1 p -94.85 93.57 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.969 0 CA-C-O 122.765 1.269 . . . . 0.0 107.699 175.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.95 176.36 48.02 Favored Glycine 0 N--CA 1.397 -3.93 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -176.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.536 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . . . -81.07 175.9 10.27 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.371 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.458 HD13 HD11 ' A' ' 120' ' ' LEU . 1.7 mp -76.93 105.32 5.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.1 p -104.58 156.51 17.9 Favored 'General case' 0 N--CA 1.403 -2.814 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.26 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.51 -33.16 72.22 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 123.953 0.901 . . . . 0.0 110.482 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.3 m -68.53 -22.42 64.51 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.849 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -97.72 -27.55 14.29 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 118.782 -1.167 . . . . 0.0 109.67 -178.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.543 HD13 ' HB2' ' A' ' 111' ' ' ALA . 79.5 mt -59.09 -27.02 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 CA-C-O 121.817 0.818 . . . . 0.0 110.433 174.29 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 34.2 m -50.59 -33.76 23.29 Favored 'General case' 0 CA--C 1.561 1.383 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.783 172.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -82.39 -35.31 27.83 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 176.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.81 -58.58 6.73 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.425 -175.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.457 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 9.6 t -78.85 -11.23 59.99 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.773 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.21 -49.14 29.57 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.394 -177.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 34.2 m -105.31 -3.63 22.53 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.102 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 71.54 35.61 1.44 Allowed 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 122.103 0.954 . . . . 0.0 110.62 -176.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -95.12 129.52 42.19 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 176.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.7 pt -93.93 144.13 10.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.487 ' HB ' HG22 ' A' ' 118' ' ' ILE . 16.5 t -102.01 132.33 48.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.766 -173.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 18.7 tt -111.87 137.88 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.782 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 173.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -132.56 146.64 18.39 Favored Glycine 0 N--CA 1.432 -1.587 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.412 ' C ' ' H ' ' A' ' 101' ' ' VAL . 91.9 m-85 -124.14 114.26 19.43 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -174.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 71.5 -36.35 0.36 Allowed 'General case' 0 N--CA 1.505 2.3 0 C-N-CA 124.458 1.103 . . . . 0.0 112.938 178.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.536 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 4.5 m -62.05 -51.23 74.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 124.982 1.313 . . . . 0.0 113.271 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.493 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 23.6 mtm180 68.32 179.03 0.05 OUTLIER Pre-proline 0 CA--C 1.551 1.012 0 O-C-N 123.74 0.65 . . . . 0.0 110.111 178.055 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -95.36 176.91 0.85 Allowed 'Trans proline' 0 N--CA 1.444 -1.411 0 CA-C-N 121.034 1.405 . . . . 0.0 113.942 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -86.75 155.13 20.46 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 106.274 -1.751 . . . . 0.0 106.274 169.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.531 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -58.02 -30.74 66.36 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 123.074 0.549 . . . . 0.0 112.086 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.572 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 25.2 t30 -82.81 -35.7 26.2 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.292 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.91 -44.75 92.0 Favored 'General case' 0 C--O 1.206 -1.212 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.744 178.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 20.1 pttm -59.39 -29.09 67.47 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-O 121.118 0.485 . . . . 0.0 110.001 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.572 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 20.5 mtm180 -74.76 -52.66 10.92 Favored 'General case' 0 N--CA 1.384 -3.754 0 C-N-CA 123.793 0.837 . . . . 0.0 109.059 179.109 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.83 -51.82 62.32 Favored 'General case' 0 C--O 1.194 -1.856 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.067 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.543 ' HB2' HD13 ' A' ' 86' ' ' ILE . . . -50.7 -48.5 58.65 Favored 'General case' 0 CA--C 1.5 -0.944 0 O-C-N 124.284 0.99 . . . . 0.0 112.143 -176.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -81.23 -25.33 36.74 Favored 'General case' 0 N--CA 1.403 -2.82 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.291 -172.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 46.9 t -87.9 5.8 38.71 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 175.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.465 ' O ' ' HB2' ' A' ' 115' ' ' LYS . 20.5 mt-10 -123.67 17.08 9.55 Favored 'General case' 0 CA--C 1.463 -2.382 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.826 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 70.5 mmtt 66.14 8.52 5.58 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 173.222 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.5 m -114.52 125.03 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-O 121.775 0.797 . . . . 0.0 113.044 -176.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -94.18 120.74 34.86 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.288 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.487 HG22 ' HB ' ' A' ' 96' ' ' VAL . 8.6 pt -93.55 131.81 39.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-O 121.089 0.471 . . . . 0.0 109.947 179.015 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -100.39 118.82 37.41 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.119 0.485 . . . . 0.0 109.744 -176.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.458 HD11 HD13 ' A' ' 81' ' ' ILE . 3.2 mm? . . . . . 0 CA--C 1.474 -1.976 0 CA-C-O 121.264 0.554 . . . . 0.0 111.102 -178.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.757 ' HB3' HD11 ' A' ' 74' ' ' ILE . 17.7 m120 . . . . . 0 N--CA 1.428 -1.526 0 CA-C-O 120.63 0.252 . . . . 0.0 111.277 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.2 pp -152.39 162.35 41.31 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.919 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.613 HG23 ' HA ' ' A' ' 96' ' ' VAL . 0.1 OUTLIER -117.08 136.36 54.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 123.278 0.631 . . . . 0.0 110.636 178.626 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.411 ' CG1' ' HA ' ' A' ' 54' ' ' VAL . 85.9 t -102.06 128.07 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.015 -175.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.415 ' HB2' ' HA2' ' A' ' 98' ' ' GLY . 27.6 mmmt -134.57 136.54 43.07 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.192 -176.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.16 165.19 29.86 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -88.93 -12.56 41.3 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.606 0.717 . . . . 0.0 109.41 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 88.2 t -108.14 122.73 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 174.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.75 ' O ' HG22 ' A' ' 54' ' ' VAL . 47.8 tt0 -63.27 -40.87 98.6 Favored 'General case' 0 C--O 1.197 -1.681 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.876 -175.116 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.19 4.88 53.23 Favored Glycine 0 C--N 1.278 -2.66 0 C-N-CA 117.672 -2.204 . . . . 0.0 115.158 -176.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.8 m -87.58 -29.95 20.87 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 172.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.75 HG22 ' O ' ' A' ' 51' ' ' GLN . 12.2 m -76.55 -44.07 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 CA-C-N 114.869 -1.059 . . . . 0.0 109.011 176.286 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -55.34 -50.63 69.14 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.421 -178.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.42 -42.11 88.24 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.411 -176.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.598 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 32.3 tp -68.4 -41.36 80.6 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.944 -177.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.513 HG13 HG12 ' A' ' 73' ' ' ILE . 39.6 t -57.47 -43.69 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 122.627 0.371 . . . . 0.0 111.04 175.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.413 ' O ' ' HE3' ' A' ' 63' ' ' LYS . . . -65.34 -23.08 66.9 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.263 -177.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.41 -23.82 16.42 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.598 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -81.7 -37.25 27.65 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.269 -176.048 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -66.58 -21.21 66.14 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.046 0.451 . . . . 0.0 110.897 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.413 ' HE3' ' O ' ' A' ' 59' ' ' ALA . 18.3 ptpt . . . . . 0 C--N 1.313 -1.001 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.2 t . . . . . 0 N--CA 1.449 -0.509 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 21.6 ttmm -146.75 153.42 40.21 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 121.605 0.717 . . . . 0.0 111.42 -177.079 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.513 HG12 HG13 ' A' ' 58' ' ' VAL . 1.3 pp -94.97 169.21 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.509 174.278 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.757 HD11 ' HB3' ' A' ' 43' ' ' ASN . 3.3 mp -135.41 -32.03 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 172.063 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -151.1 133.45 15.41 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-O 121.234 0.54 . . . . 0.0 110.235 -168.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.5 ' HB2' HG21 ' A' ' 58' ' ' VAL . . . -124.55 141.44 52.09 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 178.452 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -151.02 135.42 16.96 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.377 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.8 p -93.41 92.01 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 CA-C-O 123.295 1.521 . . . . 0.0 107.906 175.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.8 175.69 47.5 Favored Glycine 0 N--CA 1.41 -3.072 0 N-CA-C 108.653 -1.779 . . . . 0.0 108.653 -177.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.621 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . . . -82.6 -179.19 7.35 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 175.242 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.422 ' CG2' HD11 ' A' ' 86' ' ' ILE . 3.5 mp -81.8 118.76 30.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 O-C-N 122.04 -0.412 . . . . 0.0 110.641 -178.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.458 ' O ' HG13 ' A' ' 86' ' ' ILE . 25.7 p -119.81 160.28 22.93 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 178.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.43 ' HG3' ' HA ' ' A' ' 107' ' ' ALA . 1.6 mp0 -54.07 -50.88 65.77 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.722 0.809 . . . . 0.0 112.501 -173.193 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.5 m -66.42 -19.38 65.78 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.398 0.618 . . . . 0.0 111.582 -176.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -86.27 -31.43 21.65 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -177.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.777 HD13 ' HB2' ' A' ' 111' ' ' ALA . 29.0 mt -73.11 -24.51 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.863 176.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.406 ' HA ' ' OE2' ' A' ' 114' ' ' GLU . 37.6 m -56.21 -24.6 43.05 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.094 175.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -76.56 -35.06 58.42 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 175.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.418 ' HB3' HG21 ' A' ' 116' ' ' VAL . . . -57.5 -55.54 33.53 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.406 -176.289 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.525 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 8.9 t -71.81 -24.91 61.81 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.118 179.206 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.23 -62.03 1.63 Allowed 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.014 0.435 . . . . 0.0 111.937 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 43.3 m -91.75 3.84 54.18 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -177.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 69.52 31.57 3.68 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.733 0.778 . . . . 0.0 109.807 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -93.92 139.24 31.15 Favored 'General case' 0 N--CA 1.419 -1.987 0 CA-C-N 114.451 -1.249 . . . . 0.0 109.714 -177.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 45.9 mm -94.73 142.96 12.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 176.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.613 ' HA ' HG23 ' A' ' 45' ' ' ILE . 24.8 t -94.26 118.44 40.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -176.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.534 ' HA ' ' O ' ' A' ' 119' ' ' ARG . 27.1 pt -115.71 116.28 51.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-O 121.586 0.708 . . . . 0.0 109.644 176.071 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.415 ' HA2' ' HB2' ' A' ' 47' ' ' LYS . . . -113.22 166.88 12.19 Favored Glycine 0 N--CA 1.428 -1.863 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.892 -177.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -133.17 112.63 11.89 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -177.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 60.52 14.32 4.78 Favored 'General case' 0 N--CA 1.502 2.146 0 C-N-CA 124.713 1.205 . . . . 0.0 113.112 178.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.621 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 1.5 m -96.59 -50.33 11.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 -173.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.576 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 0.0 OUTLIER 75.49 163.65 0.14 Allowed Pre-proline 0 N--CA 1.479 0.994 0 C-N-CA 124.232 1.013 . . . . 0.0 111.968 -175.302 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -97.21 166.19 0.92 Allowed 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 121.974 1.783 . . . . 0.0 113.179 174.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -71.73 152.55 42.68 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 169.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.447 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -63.73 -25.01 68.0 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 117.912 0.323 . . . . 0.0 111.515 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.539 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 29.9 m-80 -88.62 -26.79 21.72 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.989 -0.684 . . . . 0.0 109.76 177.339 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.43 ' HA ' ' HG3' ' A' ' 83' ' ' GLU . . . -67.86 -44.34 77.33 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 121.025 0.441 . . . . 0.0 110.3 177.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.403 ' HE3' ' HA ' ' A' ' 105' ' ' ALA . 17.6 ptpt -62.16 -21.57 65.17 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.922 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.539 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 56.2 mtp180 -83.84 -51.3 7.31 Favored 'General case' 0 N--CA 1.39 -3.474 0 C-N-CA 125.129 1.372 . . . . 0.0 109.378 176.223 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -52.02 -48.23 64.62 Favored 'General case' 0 CA--C 1.489 -1.381 0 CA-C-N 114.403 -1.271 . . . . 0.0 110.642 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.777 ' HB2' HD13 ' A' ' 86' ' ' ILE . . . -51.72 -36.09 45.52 Favored 'General case' 0 CA--C 1.502 -0.885 0 C-N-CA 124.742 1.217 . . . . 0.0 112.17 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -78.78 -38.46 38.43 Favored 'General case' 0 N--CA 1.418 -2.029 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.788 -175.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.8 t -73.02 -9.26 58.54 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 175.112 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.525 ' O ' ' HB ' ' A' ' 90' ' ' THR . 28.7 mt-10 -106.4 7.8 31.3 Favored 'General case' 0 CA--C 1.472 -2.056 0 C-N-CA 124.869 1.268 . . . . 0.0 114.009 -177.039 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 93.1 mttt 67.31 7.62 5.65 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 172.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.418 HG21 ' HB3' ' A' ' 89' ' ' ALA . 4.3 m -121.63 141.26 42.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -177.353 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -100.26 133.31 44.85 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-O 121.403 0.62 . . . . 0.0 109.794 179.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.475 HG22 ' HB ' ' A' ' 96' ' ' VAL . 6.1 pt -97.21 139.69 19.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.596 178.135 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.534 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 64.9 ttt180 -131.85 128.54 38.88 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.406 ' N ' HD13 ' A' ' 120' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.293 -1.859 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.239 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.432 ' HB3' ' CD1' ' A' ' 74' ' ' ILE . 10.4 m120 . . . . . 0 N--CA 1.42 -1.962 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 49.3 mt -141.69 174.94 10.1 Favored 'General case' 0 C--O 1.249 1.069 0 CA-C-O 121.53 0.681 . . . . 0.0 111.428 178.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.8 tt -136.41 143.33 35.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.963 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.517 HG23 HG21 ' A' ' 73' ' ' ILE . 96.6 t -127.89 122.83 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -149.54 121.63 8.29 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.587 179.021 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -131.73 175.66 9.0 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.163 -174.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -81.02 -29.13 35.19 Favored 'General case' 0 C--O 1.246 0.916 0 O-C-N 124.014 0.821 . . . . 0.0 109.815 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 80.7 t -101.88 130.09 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.364 174.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.756 ' O ' HG22 ' A' ' 54' ' ' VAL . 22.6 tm0? -64.72 -40.64 95.67 Favored 'General case' 0 C--O 1.197 -1.68 0 C-N-CA 122.822 0.449 . . . . 0.0 111.984 -174.101 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.4 2.8 86.6 Favored Glycine 0 C--N 1.29 -2.011 0 C-N-CA 118.114 -1.994 . . . . 0.0 112.988 178.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.2 t -82.59 -28.45 30.86 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 105.677 -1.971 . . . . 0.0 105.677 178.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.756 HG22 ' O ' ' A' ' 51' ' ' GLN . 12.9 m -69.69 -46.96 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.646 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.259 175.149 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -60.06 -39.54 86.39 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -177.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.91 -36.35 76.81 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 123.604 0.565 . . . . 0.0 110.796 178.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 42.3 tp -85.04 -41.72 15.51 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.714 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 54' ' ' VAL . 47.9 t -55.36 -41.23 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.099 0.96 . . . . 0.0 112.264 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.32 -17.79 64.35 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 120.736 0.303 . . . . 0.0 111.748 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.27 -27.38 14.54 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.25 -28.57 34.7 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.596 -175.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -75.93 -23.46 55.46 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.249 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt . . . . . 0 C--N 1.316 -0.859 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.63 -177.666 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.0 t . . . . . 0 CA--C 1.509 -0.622 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -142.41 155.43 45.12 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.517 HG21 HG23 ' A' ' 46' ' ' VAL . 1.6 pp -94.14 155.08 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.336 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.116 178.521 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.45 ' N ' HD12 ' A' ' 74' ' ' ILE . 3.8 mp -123.83 -31.43 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.969 0.89 . . . . 0.0 109.948 178.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -133.21 105.91 7.28 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.996 -170.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -116.33 114.68 24.66 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.059 178.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.516 ' O ' ' HA ' ' A' ' 47' ' ' LYS . . . -147.82 158.61 44.11 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.709 -177.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.9 p -94.0 101.39 12.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-O 121.859 0.837 . . . . 0.0 109.88 177.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.32 171.89 44.87 Favored Glycine 0 N--CA 1.417 -2.576 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.915 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.575 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -82.24 -152.79 0.11 Allowed 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 174.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.465 HD13 HD11 ' A' ' 120' ' ' LEU . 2.4 mp -91.41 111.36 23.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 C-N-CA 118.732 -1.187 . . . . 0.0 109.36 176.022 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.5 p -108.73 165.18 11.74 Favored 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 175.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -60.02 -35.74 75.73 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 121.38 0.609 . . . . 0.0 111.124 -176.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.3 p -69.03 -23.6 64.09 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.12 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -74.28 -41.35 61.35 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 177.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.533 HD13 ' HB2' ' A' ' 111' ' ' ALA . 44.2 mt -66.86 -34.7 71.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-N 114.242 -1.344 . . . . 0.0 111.424 -178.412 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.454 ' HA ' ' OE2' ' A' ' 114' ' ' GLU . 46.9 m -67.73 -9.09 40.8 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.488 178.139 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -92.92 -32.67 14.49 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 173.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.11 -53.26 59.33 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.44 -177.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 9.8 t -74.03 -13.57 60.88 Favored 'General case' 0 CA--C 1.561 1.379 0 CA-C-O 121.136 0.493 . . . . 0.0 110.414 178.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.65 -66.19 0.87 Allowed 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -176.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.429 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 27.1 p -101.51 5.65 41.97 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 120.748 0.309 . . . . 0.0 111.533 -176.334 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . 0.491 0.0 OUTLIER 70.3 57.54 0.27 Allowed 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 127.13 2.172 . . . . 0.0 114.118 -179.462 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -105.3 167.99 9.37 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 113.357 -1.747 . . . . 0.0 108.509 174.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 47.7 mm -124.13 131.57 72.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 176.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.599 ' HB ' HG22 ' A' ' 118' ' ' ILE . 12.0 t -94.11 102.59 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -176.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 13.3 tt -97.93 140.53 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.924 177.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.461 ' HA3' HD11 ' A' ' 81' ' ' ILE . . . -134.36 146.45 18.44 Favored Glycine 0 N--CA 1.414 -2.772 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 178.105 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -119.54 109.24 15.47 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -177.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 66.7 t30 71.81 -39.07 0.44 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 126.022 1.729 . . . . 0.0 112.41 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.3 m -45.29 -47.65 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 126.302 1.841 . . . . 0.0 114.986 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.575 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 36.1 mtp180 73.57 170.14 0.11 Allowed Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 123.485 0.714 . . . . 0.0 112.055 179.062 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -96.9 168.46 0.95 Allowed 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 121.911 1.741 . . . . 0.0 114.594 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -75.74 153.3 37.12 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 113.215 -1.811 . . . . 0.0 106.769 168.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.509 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -59.15 -35.2 73.1 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.32 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.549 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 18.2 m120 -79.58 -27.49 41.15 Favored 'General case' 0 CA--C 1.488 -1.429 0 C-N-CA 119.346 -0.941 . . . . 0.0 110.592 178.352 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.26 -46.42 77.17 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.766 177.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 19.9 pttp -59.51 -23.18 62.59 Favored 'General case' 0 CA--C 1.565 1.557 0 CA-C-O 120.965 0.412 . . . . 0.0 111.588 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.549 ' HB2' ' O ' ' A' ' 106' ' ' ASN 0.254 58.4 mtp180 -82.54 -51.2 8.01 Favored 'General case' 0 N--CA 1.393 -3.278 0 C-N-CA 125.821 1.648 . . . . 0.0 109.316 176.928 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.532 ' HB1' ' OE1' ' A' ' 114' ' ' GLU . . . -54.23 -48.5 71.01 Favored 'General case' 0 CA--C 1.471 -2.091 0 C-N-CA 125.914 1.686 . . . . 0.0 110.839 -176.173 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.533 ' HB2' HD13 ' A' ' 86' ' ' ILE . . . -48.17 -45.59 33.69 Favored 'General case' 0 CA--C 1.504 -0.797 0 O-C-N 124.867 1.354 . . . . 0.0 110.578 -179.373 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -72.92 -30.27 63.77 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 114.542 -1.208 . . . . 0.0 112.903 -174.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.1 t -92.28 5.27 51.13 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.532 ' OE1' ' HB1' ' A' ' 110' ' ' ALA . 7.9 mt-10 -117.9 7.04 12.27 Favored 'General case' 0 N--CA 1.406 -2.662 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -175.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 29.7 mmmt 68.2 5.74 4.85 Favored 'General case' 0 N--CA 1.42 -1.936 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 174.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.1 m -122.18 145.26 29.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -114.66 143.66 44.68 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 118.726 -1.189 . . . . 0.0 109.761 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.599 HG22 ' HB ' ' A' ' 96' ' ' VAL . 8.7 pt -98.1 131.1 45.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.187 -176.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -98.5 124.83 43.47 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.516 -174.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.465 HD11 HD13 ' A' ' 81' ' ' ILE . 3.5 mm? . . . . . 0 CA--C 1.502 -0.865 0 CA-C-O 121.873 0.844 . . . . 0.0 112.867 -178.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.61 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 91.3 m-20 . . . . . 0 N--CA 1.416 -2.159 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.3 pp -150.12 164.69 34.94 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.549 HG23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -119.88 132.88 68.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.368 178.612 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 93.3 t -107.1 126.96 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.058 -177.445 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 42.5 mtpt -139.23 134.75 33.12 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.211 176.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.78 168.39 23.82 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -178.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -80.2 -18.73 48.77 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.855 0.836 . . . . 0.0 110.421 -178.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 69.4 t -104.76 123.19 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 175.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.792 ' O ' HG22 ' A' ' 54' ' ' VAL . 10.8 tt0 -68.64 -29.78 68.34 Favored 'General case' 0 C--O 1.195 -1.78 0 CA-C-O 121.137 0.494 . . . . 0.0 111.413 -174.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.95 2.59 87.15 Favored Glycine 0 C--N 1.284 -2.36 0 C-N-CA 117.125 -2.464 . . . . 0.0 112.642 177.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.4 t -86.84 -31.07 21.01 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 176.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.792 HG22 ' O ' ' A' ' 51' ' ' GLN . 11.9 m -67.48 -43.4 87.41 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.866 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.423 175.258 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -66.27 -39.93 89.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.413 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.27 -37.04 79.25 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.747 177.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.513 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 26.6 tp -77.46 -41.68 38.71 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 120.532 -0.467 . . . . 0.0 109.766 177.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 54' ' ' VAL . 32.1 t -53.57 -45.82 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 123.57 0.748 . . . . 0.0 112.079 177.311 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.34 -26.56 68.51 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.58 -22.83 17.37 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -178.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.513 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -82.55 -35.53 27.11 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.47 -175.621 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -67.72 -27.04 66.46 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.112 0.482 . . . . 0.0 110.57 178.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.1 ptpp? . . . . . 0 CA--C 1.538 0.502 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.32 179.12 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.5 t . . . . . 0 N--CA 1.431 -1.416 0 N-CA-C 103.382 -2.822 . . . . 0.0 103.382 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.462 ' HG2' ' N ' ' A' ' 73' ' ' ILE . 87.9 tttt -139.92 161.5 37.44 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.354 0.597 . . . . 0.0 111.142 -176.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.462 ' N ' ' HG2' ' A' ' 72' ' ' LYS . 1.7 pp -93.51 148.52 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.759 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.612 177.117 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 73.2 mt -119.57 -27.63 2.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-O 121.68 0.753 . . . . 0.0 110.06 176.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.534 ' CD2' HD12 ' A' ' 45' ' ' ILE . 3.0 t60 -154.67 132.28 11.34 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.357 -172.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -134.66 131.03 37.25 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.404 ' O ' HG11 ' A' ' 54' ' ' VAL . . . -149.79 156.98 42.75 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.955 -178.197 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.3 p -93.5 94.42 4.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-O 122.521 1.153 . . . . 0.0 110.295 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.7 176.02 47.79 Favored Glycine 0 N--CA 1.417 -2.572 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.549 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -91.81 -175.38 4.12 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 176.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.494 HG21 HG21 ' A' ' 118' ' ' ILE . 3.2 mp -74.3 111.84 10.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 119.433 -0.907 . . . . 0.0 108.847 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.8 p -117.61 152.97 34.07 Favored 'General case' 0 N--CA 1.42 -1.972 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.702 -178.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -50.33 -41.83 51.85 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.026 0.53 . . . . 0.0 111.588 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.1 m -62.83 -28.12 69.79 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.614 -177.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -86.17 -29.33 23.32 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-O 121.341 0.591 . . . . 0.0 110.94 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.52 HG21 ' HA ' ' A' ' 111' ' ' ALA . 59.2 mt -65.87 -25.72 36.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.699 177.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 38.0 m -59.84 -30.7 69.13 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.917 177.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -78.25 -35.78 47.78 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 175.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.05 -58.91 5.39 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.966 -176.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.564 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 9.8 t -71.24 -24.61 62.22 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.478 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.17 -62.67 1.61 Allowed 'General case' 0 C--N 1.342 0.273 0 CA-C-O 120.944 0.402 . . . . 0.0 111.76 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.7 m -96.37 5.44 50.91 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.627 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 65.85 40.88 4.03 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.216 1.006 . . . . 0.0 110.314 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.61 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -94.51 136.45 34.79 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-N 114.206 -1.361 . . . . 0.0 109.081 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.1 mp -93.88 140.23 16.9 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.549 ' HA ' HG23 ' A' ' 45' ' ' ILE . 14.5 t -94.77 117.54 38.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -178.134 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.54 ' HA ' ' O ' ' A' ' 119' ' ' ARG . 0.2 OUTLIER -112.17 122.86 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 174.3 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -115.37 146.47 18.83 Favored Glycine 0 N--CA 1.426 -1.997 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.159 -177.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -105.6 94.62 5.3 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 118.468 -1.293 . . . . 0.0 109.664 -177.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 63.78 8.64 3.9 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 124.946 1.298 . . . . 0.0 112.866 177.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.471 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 3.6 m -78.89 -49.38 20.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.101 -178.201 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.549 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 72.7 mtp180 69.59 154.64 0.15 Allowed Pre-proline 0 N--CA 1.477 0.915 0 O-C-N 123.889 0.743 . . . . 0.0 112.82 175.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -91.07 173.69 2.78 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 121.991 1.794 . . . . 0.0 112.47 178.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -89.71 168.28 12.23 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 167.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.543 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -56.58 -28.61 60.63 Favored 'General case' 0 C--O 1.206 -1.203 0 C-N-CA 122.824 0.449 . . . . 0.0 111.041 178.625 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.644 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 23.1 p30 -72.41 -46.47 55.01 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.21 -34.8 76.92 Favored 'General case' 0 C--N 1.292 -1.922 0 O-C-N 122.096 -0.378 . . . . 0.0 111.563 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 18.1 pttp -63.08 -27.7 69.57 Favored 'General case' 0 CA--C 1.563 1.478 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.318 175.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.644 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 63.5 mtp180 -75.37 -50.28 16.41 Favored 'General case' 0 N--CA 1.405 -2.698 0 C-N-CA 125.212 1.405 . . . . 0.0 109.239 176.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.24 -50.6 66.8 Favored 'General case' 0 C--O 1.201 -1.47 0 CA-C-N 114.118 -1.401 . . . . 0.0 110.269 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.52 ' HA ' HG21 ' A' ' 86' ' ' ILE . . . -49.33 -48.6 46.32 Favored 'General case' 0 CA--C 1.502 -0.886 0 O-C-N 124.587 1.179 . . . . 0.0 111.602 -178.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -79.13 -29.8 43.35 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.864 -173.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 28.7 t -77.19 -6.94 54.92 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 175.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.564 ' O ' ' HB ' ' A' ' 90' ' ' THR . 26.2 mt-10 -114.73 9.32 16.37 Favored 'General case' 0 N--CA 1.411 -2.422 0 CA-C-N 114.471 -1.241 . . . . 0.0 112.912 -177.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 29.2 mmtp 64.46 15.57 9.65 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 174.286 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.3 m -120.34 131.76 71.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.461 0.648 . . . . 0.0 112.565 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -94.59 130.39 41.06 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.077 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.494 HG21 HG21 ' A' ' 81' ' ' ILE . 15.1 pt -94.85 128.6 45.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.06 179.394 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.54 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 98.1 mtt180 -122.16 111.69 17.29 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.672 0.749 . . . . 0.0 110.743 -175.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.509 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.286 -2.154 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.148 -177.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 . . . . . 0 C--O 1.237 0.4 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.4 mt -135.23 168.78 18.54 Favored 'General case' 0 C--O 1.248 0.976 0 CA-C-O 121.789 0.804 . . . . 0.0 111.925 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.472 HG12 ' CE ' ' A' ' 47' ' ' LYS . 1.1 tt -133.18 132.9 58.54 Favored 'Isoleucine or valine' 0 C--O 1.249 1.028 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.198 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.647 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 84.4 t -113.74 131.96 64.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.565 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.472 ' CE ' HG12 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -142.97 148.03 36.17 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 178.444 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.59 158.13 28.51 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 177.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -78.95 -12.33 60.03 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.039 -0.665 . . . . 0.0 110.044 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 99.1 t -109.86 134.12 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 174.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.738 ' O ' HG22 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -69.01 -46.63 67.52 Favored 'General case' 0 C--O 1.202 -1.447 0 C-N-CA 122.431 0.292 . . . . 0.0 110.558 -172.332 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.06 -1.19 67.66 Favored Glycine 0 C--N 1.286 -2.196 0 C-N-CA 118.479 -1.82 . . . . 0.0 114.285 -177.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.7 m -80.17 -29.42 38.74 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 106.282 -1.748 . . . . 0.0 106.282 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.738 HG22 ' O ' ' A' ' 51' ' ' GLN . 5.7 m -72.37 -42.44 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.498 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.354 176.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -54.47 -47.86 72.48 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 124.128 0.893 . . . . 0.0 110.592 178.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.77 -40.03 91.02 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.658 -178.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 34.4 tp -78.94 -36.66 41.33 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.593 -178.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.425 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 43.4 t -59.98 -43.6 92.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 122.727 0.411 . . . . 0.0 110.493 177.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.12 -14.85 62.48 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.61 -13.15 16.64 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.497 0.665 . . . . 0.0 109.294 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.419 ' HG ' HG23 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -99.7 -38.67 8.61 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.397 -176.148 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 12.9 pt20 -74.11 -5.9 44.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.303 0.573 . . . . 0.0 111.128 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.245 0.856 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.117 177.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.6 t . . . . . 0 N--CA 1.436 -1.145 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -124.27 158.08 33.37 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.52 0.676 . . . . 0.0 111.444 -172.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.419 HG23 ' HG ' ' A' ' 61' ' ' LEU . 1.5 pp -93.84 149.76 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.942 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.803 174.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 53.6 mt -120.63 -24.23 2.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-O 121.565 0.698 . . . . 0.0 110.796 178.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -150.41 117.45 5.94 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.63 -172.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.647 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -120.78 129.69 53.7 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 176.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.41 ' O ' HG11 ' A' ' 54' ' ' VAL . . . -145.72 153.53 41.07 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.974 -178.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.444 ' HB ' ' HA ' ' A' ' 51' ' ' GLN . 3.0 p -93.84 93.26 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.704 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 175.044 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.87 176.49 48.03 Favored Glycine 0 N--CA 1.401 -3.697 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.79 -175.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.598 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -90.49 -157.08 0.46 Allowed 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 175.234 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.509 HG21 HG21 ' A' ' 118' ' ' ILE . 2.9 mp -83.06 103.74 10.76 Favored 'Isoleucine or valine' 0 C--O 1.254 1.329 0 C-N-CA 118.854 -1.138 . . . . 0.0 108.242 177.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 44.1 p -101.7 159.73 15.07 Favored 'General case' 0 N--CA 1.409 -2.508 0 C-N-CA 119.417 -0.913 . . . . 0.0 108.808 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -60.21 -26.27 66.26 Favored 'General case' 0 CA--C 1.559 1.315 0 CA-C-O 121.466 0.65 . . . . 0.0 109.949 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.6 m -71.97 -22.06 61.5 Favored 'General case' 0 CA--C 1.555 1.146 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.154 178.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -81.48 -33.05 32.18 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-O 121.628 0.728 . . . . 0.0 109.276 178.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.563 HD13 ' HB2' ' A' ' 111' ' ' ALA . 67.8 mt -72.63 -33.13 43.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.25 -178.216 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.9 p -61.01 -17.29 51.36 Favored 'General case' 0 CA--C 1.557 1.214 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 175.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.451 ' O ' HD22 ' A' ' 88' ' ' LEU . 1.9 tm? -92.22 -33.13 14.8 Favored 'General case' 0 C--O 1.25 1.104 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 174.554 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.93 -58.94 5.57 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.25 -176.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.405 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 11.2 t -79.29 -4.27 49.95 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-O 121.421 0.629 . . . . 0.0 110.649 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.84 -67.31 0.79 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.039 0.447 . . . . 0.0 112.191 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.4 t -104.85 5.95 33.44 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.391 0.615 . . . . 0.0 109.921 -176.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 74.07 72.12 0.11 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.482 1.113 . . . . 0.0 113.324 178.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -128.33 135.69 49.94 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 173.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.0 tt -94.49 140.79 16.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.793 ' HB ' HG22 ' A' ' 118' ' ' ILE . 49.4 t -94.45 99.45 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.392 0 CA-C-O 121.587 0.708 . . . . 0.0 110.946 -174.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 119' ' ' ARG . 42.7 mm -94.11 144.2 10.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 174.34 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.426 ' HA3' HD11 ' A' ' 81' ' ' ILE . . . -143.02 158.72 27.28 Favored Glycine 0 C--N 1.293 -1.821 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.06 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -122.38 95.04 4.48 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.243 -177.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . 0.254 95.4 m-20 55.6 -5.09 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 -179.159 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.448 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 1.7 m -62.93 -45.02 99.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 C-N-CA 123.65 0.78 . . . . 0.0 110.159 176.065 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.598 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 58.9 mtm180 70.88 161.66 0.15 Allowed Pre-proline 0 C--O 1.213 -0.849 0 CA-C-N 114.783 -1.099 . . . . 0.0 113.125 173.357 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.472 ' HG3' HD12 ' A' ' 118' ' ' ILE . 11.1 Cg_endo -94.68 170.41 1.61 Allowed 'Trans proline' 0 N--CA 1.441 -1.602 0 C-N-CA 121.479 1.453 . . . . 0.0 114.291 -177.064 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -74.07 155.35 38.6 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 167.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.576 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -61.67 -36.29 80.44 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.563 0.697 . . . . 0.0 110.193 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.511 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 2.7 t-20 -74.83 -37.76 62.19 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.032 177.491 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.33 -48.39 81.8 Favored 'General case' 0 C--O 1.214 -0.775 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.48 176.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.576 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 14.8 pttp -59.23 -28.63 66.86 Favored 'General case' 0 CA--C 1.565 1.541 0 CA-C-O 120.982 0.42 . . . . 0.0 111.89 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.511 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 49.3 mtp180 -75.4 -49.59 18.49 Favored 'General case' 0 N--CA 1.386 -3.655 0 C-N-CA 125.5 1.52 . . . . 0.0 109.306 178.37 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -55.22 -48.01 74.51 Favored 'General case' 0 C--O 1.198 -1.618 0 CA-C-N 113.903 -1.498 . . . . 0.0 110.07 -179.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.563 ' HB2' HD13 ' A' ' 86' ' ' ILE . . . -48.09 -44.07 31.31 Favored 'General case' 0 CA--C 1.496 -1.115 0 O-C-N 124.68 1.237 . . . . 0.0 111.121 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -75.87 -37.5 58.84 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.748 -174.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 34.0 t -80.41 5.07 16.04 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 122.047 0.927 . . . . 0.0 108.568 178.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' ' 115' ' ' LYS . 25.1 mt-10 -121.23 9.76 10.5 Favored 'General case' 0 N--CA 1.404 -2.762 0 CA-C-N 114.442 -1.254 . . . . 0.0 112.839 -178.228 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 60.3 mmtt 65.87 10.82 7.19 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 173.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.1 m -115.22 156.42 16.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 C-N-CA 119.831 -0.748 . . . . 0.0 111.744 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -112.57 138.19 49.71 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.329 -177.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.793 HG22 ' HB ' ' A' ' 96' ' ' VAL . 9.9 pt -108.38 113.88 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.628 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 173.203 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.417 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 50.8 ttp180 -113.31 97.92 6.78 Favored 'General case' 0 N--CA 1.414 -2.27 0 CA-C-O 122.211 1.005 . . . . 0.0 109.719 -175.007 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.524 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.29 -1.998 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.768 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 17.0 m120 . . . . . 0 CA--C 1.5 -0.944 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 69.87 119.86 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.822 0.849 . . . . 0.0 110.816 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -96.86 118.86 34.21 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.817 -176.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 69.99 96.88 0.07 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.745 1.218 . . . . 0.0 112.032 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -91.91 110.8 22.16 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 176.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -134.54 -144.54 5.06 Favored Glycine 0 N--CA 1.422 -2.238 0 C-N-CA 119.631 -1.271 . . . . 0.0 113.071 -176.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -96.86 138.47 34.36 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -94.79 97.64 10.19 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 176.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.41 61.11 4.24 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 116.32 -0.4 . . . . 0.0 112.4 -177.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 33.8 t -114.08 -31.5 6.33 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.045 0.45 . . . . 0.0 110.343 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.4 m -93.68 11.31 29.44 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.601 0.715 . . . . 0.0 110.814 -178.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -86.93 -12.56 47.29 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.977 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.4 m -105.35 -177.98 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.53 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -75.41 142.45 43.05 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.242 0.544 . . . . 0.0 110.392 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.5 mt -96.77 100.05 11.61 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.158 -172.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 48.2 mm-40 -124.11 -173.31 2.73 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 177.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.22 169.88 12.78 Favored 'General case' 0 C--O 1.246 0.917 0 C-N-CA 120.819 -0.353 . . . . 0.0 111.636 175.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 69.43 30.51 4.09 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -169.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 -65.35 -33.37 75.82 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 113.544 -1.662 . . . . 0.0 110.627 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.4 ' O ' HG12 ' A' ' 21' ' ' VAL . 33.0 t -75.91 -42.08 49.99 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' ' 20' ' ' SER . 2.9 p 57.66 145.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 127.157 2.183 . . . . 0.0 112.43 -177.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.421 ' HD2' HG23 ' A' ' 23' ' ' THR . 9.7 tmtt? 70.86 -65.31 0.34 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.098 0.959 . . . . 0.0 109.508 -177.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.421 HG23 ' HD2' ' A' ' 22' ' ' LYS . 38.0 p -88.77 12.23 15.57 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 122.018 0.914 . . . . 0.0 110.013 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.562 ' HD2' ' O ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -71.8 151.27 43.62 Favored 'General case' 0 C--O 1.247 0.931 0 CA-C-N 114.583 -1.189 . . . . 0.0 111.281 179.185 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.483 HG21 ' HB2' ' A' ' 28' ' ' ASP . 14.4 p -166.94 144.63 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.0 m -87.71 -61.73 1.65 Allowed 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -133.07 111.01 10.61 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -177.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.483 ' HB2' HG21 ' A' ' 25' ' ' VAL . 31.8 t70 -117.9 -22.36 7.95 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.356 0.598 . . . . 0.0 111.292 -178.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -82.8 105.89 14.18 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.067 0.461 . . . . 0.0 110.839 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.3 mt -74.01 152.22 40.08 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.389 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -89.07 138.16 31.66 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.346 0.593 . . . . 0.0 111.892 -173.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 33' ' ' GLN . 14.3 tp10 -88.77 -32.22 18.0 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 174.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' A' ' 32' ' ' GLU . 85.8 mm-40 78.68 150.04 0.11 Allowed 'General case' 0 C--N 1.356 0.85 0 C-N-CA 125.006 1.322 . . . . 0.0 111.458 -177.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.5 pp -76.99 159.88 4.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.076 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -161.89 113.4 1.69 Allowed 'General case' 0 C--O 1.247 0.952 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -174.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -83.62 83.05 8.04 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.522 0.677 . . . . 0.0 112.444 -177.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -127.44 17.88 6.13 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 175.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -71.91 -61.34 1.82 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 114.818 -0.691 . . . . 0.0 110.538 -176.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 24.4 mmt -79.5 -24.59 42.18 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.023 -176.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt 71.78 169.2 0.32 Allowed 'General case' 0 C--O 1.24 0.601 0 CA-C-N 113.792 -1.549 . . . . 0.0 110.782 -175.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -108.96 115.5 30.19 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.5 tp -94.14 119.0 32.36 Favored 'General case' 0 N--CA 1.423 -1.799 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.909 -172.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.47 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 89.0 m-20 -109.59 146.73 34.23 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -155.27 165.62 36.1 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-O 121.513 0.673 . . . . 0.0 112.191 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.57 HD13 ' CD2' ' A' ' 75' ' ' HIS . 0.1 OUTLIER -118.43 134.56 61.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 174.591 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 65.5 t -103.84 129.99 55.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.414 -178.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.472 ' HE2' ' HB3' ' A' ' 77' ' ' ALA . 64.4 mttt -141.38 139.27 33.46 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 121.442 0.639 . . . . 0.0 111.149 176.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.72 166.38 33.01 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -82.22 -21.77 36.2 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.996 0.427 . . . . 0.0 110.082 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 94.3 t -99.25 124.09 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 174.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.771 ' O ' HG22 ' A' ' 54' ' ' VAL . 17.3 tt0 -63.77 -40.87 97.74 Favored 'General case' 0 C--O 1.2 -1.546 0 CA-C-O 120.871 0.367 . . . . 0.0 111.56 -174.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.02 5.18 63.27 Favored Glycine 0 C--N 1.278 -2.683 0 C-N-CA 117.639 -2.22 . . . . 0.0 113.647 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.9 t -84.26 -32.28 24.51 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 173.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.771 HG22 ' O ' ' A' ' 51' ' ' GLN . 4.0 m -72.71 -46.8 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.766 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.772 177.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -63.4 -39.48 94.63 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.504 -177.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.42 -37.47 87.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.825 0.345 . . . . 0.0 110.695 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.41 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 31.3 tp -75.08 -42.02 57.6 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.507 HG21 ' HB2' ' A' ' 76' ' ' ALA . 70.3 t -58.78 -42.48 85.57 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.52 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.948 177.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.433 ' O ' ' HE3' ' A' ' 63' ' ' LYS . . . -65.11 -16.87 63.96 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.99 -25.25 14.38 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 122.187 0.994 . . . . 0.0 108.399 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.431 ' HB3' HG13 ' A' ' 73' ' ' ILE . 0.6 OUTLIER -83.13 -36.26 24.93 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.168 -176.197 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -71.91 -22.35 61.5 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 122.801 0.44 . . . . 0.0 111.228 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.433 ' HE3' ' O ' ' A' ' 59' ' ' ALA . 19.0 ptpt -90.94 5.1 50.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.201 0.524 . . . . 0.0 110.772 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 31.8 mm -78.25 102.07 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 175.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -132.41 17.84 4.41 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-O 121.473 0.654 . . . . 0.0 109.517 176.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 36.0 m -62.06 137.74 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.436 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -70.92 125.72 27.61 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.41 -177.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.6 -88.71 0.41 Allowed Glycine 0 N--CA 1.432 -1.58 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.564 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.6 t -98.46 109.9 24.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.59 126.99 41.25 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 119.915 -0.714 . . . . 0.0 110.466 177.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 39.5 t -126.47 126.36 68.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -147.98 154.31 40.15 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.365 0.603 . . . . 0.0 110.776 -175.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.431 HG13 ' HB3' ' A' ' 61' ' ' LEU . 1.6 pp -93.9 147.94 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.68 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.625 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.8 mm -112.5 -22.18 5.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.978 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.57 ' CD2' HD13 ' A' ' 45' ' ' ILE . 5.3 t60 -162.48 149.11 13.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -172.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.507 ' HB2' HG21 ' A' ' 58' ' ' VAL . . . -140.41 144.34 36.11 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 178.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.472 ' HB3' ' HE2' ' A' ' 47' ' ' LYS . . . -165.52 149.78 8.49 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 117.904 0.32 . . . . 0.0 110.874 177.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.2 p -94.31 93.67 4.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 122.604 1.192 . . . . 0.0 109.083 177.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -177.09 176.4 48.05 Favored Glycine 0 N--CA 1.408 -3.192 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -177.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.661 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -93.11 -175.35 3.83 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 176.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 103' ' ' PRO . 3.0 mp -77.83 110.9 14.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.064 -0.655 . . . . 0.0 110.016 -176.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.7 p -110.74 147.81 33.62 Favored 'General case' 0 N--CA 1.408 -2.543 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.187 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -45.7 -44.49 13.59 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 125.125 1.37 . . . . 0.0 112.95 -178.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.9 t -64.15 -33.96 76.96 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 122.556 0.342 . . . . 0.0 111.785 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -78.18 -26.21 47.52 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 121.007 0.432 . . . . 0.0 111.718 -177.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.536 HG21 ' HA ' ' A' ' 111' ' ' ALA . 50.8 mt -64.71 -35.48 75.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.952 177.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 57.6 m -61.17 -24.55 66.39 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 175.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -74.96 -37.63 61.9 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 173.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.606 ' HA ' ' O ' ' A' ' 94' ' ' ALA . . . -55.22 -51.23 67.23 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.9 -177.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.417 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 8.9 t -77.14 -15.98 59.33 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 120.596 -0.441 . . . . 0.0 111.099 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.69 -62.13 1.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.062 0.458 . . . . 0.0 111.102 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 68.1 m -91.6 1.3 57.24 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.954 -177.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 69.35 23.33 6.22 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.907 0.86 . . . . 0.0 109.38 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.606 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . -94.72 117.2 29.75 Favored 'General case' 0 C--O 1.194 -1.844 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.688 -177.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 44.3 pt -92.38 156.69 3.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 118.378 -1.329 . . . . 0.0 109.782 -177.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.439 HG11 HG13 ' A' ' 81' ' ' ILE . 10.5 t -94.45 116.92 36.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.215 -173.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 6.5 tp -101.08 109.25 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.928 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 173.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -105.9 140.57 15.19 Favored Glycine 0 N--CA 1.414 -2.789 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.047 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -98.68 94.4 6.63 Favored 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 118.238 -1.385 . . . . 0.0 109.281 -176.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 66.8 t30 58.61 14.78 3.27 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 125.489 1.516 . . . . 0.0 111.822 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.508 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 6.5 m -78.91 -49.6 19.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -173.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.661 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 62.6 mtm180 77.87 158.96 0.15 Allowed Pre-proline 0 N--CA 1.482 1.17 0 O-C-N 123.818 0.699 . . . . 0.0 112.756 174.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.478 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 15.4 Cg_endo -100.16 178.79 0.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.546 2.164 . . . . 0.0 114.934 -176.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.494 ' HB2' ' H ' ' A' ' 107' ' ' ALA . 11.4 m-20 -73.83 159.91 32.21 Favored 'General case' 0 C--O 1.25 1.084 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 167.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.505 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -67.63 -28.22 67.54 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.079 0.466 . . . . 0.0 109.892 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.621 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 20.0 t-20 -85.9 -36.32 19.99 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.796 176.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.494 ' H ' ' HB2' ' A' ' 104' ' ' ASP . . . -59.51 -43.81 93.3 Favored 'General case' 0 C--O 1.207 -1.152 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.823 176.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 105' ' ' ALA . 0.0 OUTLIER -57.83 -30.04 65.43 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-O 120.785 0.326 . . . . 0.0 111.602 179.08 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.621 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 91.1 mtt180 -76.29 -52.31 10.24 Favored 'General case' 0 N--CA 1.386 -3.638 0 C-N-CA 125.29 1.436 . . . . 0.0 108.385 178.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -52.73 -45.96 67.21 Favored 'General case' 0 C--O 1.201 -1.484 0 CA-C-N 113.672 -1.603 . . . . 0.0 110.577 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.536 ' HA ' HG21 ' A' ' 86' ' ' ILE . . . -47.68 -53.06 16.12 Favored 'General case' 0 CA--C 1.501 -0.936 0 O-C-N 124.749 1.281 . . . . 0.0 110.915 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -78.55 -25.52 45.45 Favored 'General case' 0 C--N 1.271 -2.841 0 CA-C-N 114.558 -1.201 . . . . 0.0 112.529 -173.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 41.6 t -86.39 5.34 35.4 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 177.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.518 ' O ' ' HB2' ' A' ' 115' ' ' LYS . 19.2 mt-10 -123.3 13.11 9.54 Favored 'General case' 0 CA--C 1.462 -2.409 0 CA-C-N 114.612 -1.176 . . . . 0.0 111.737 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.518 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 56.4 mtpt 68.85 12.61 8.7 Favored 'General case' 0 N--CA 1.417 -2.086 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 175.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.434 ' O ' ' HB1' ' A' ' 111' ' ' ALA . 3.0 m -126.16 112.49 30.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -93.87 141.07 28.93 Favored 'General case' 0 CA--C 1.498 -1.022 0 C-N-CA 118.29 -1.364 . . . . 0.0 108.352 177.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.421 HG12 ' H ' ' A' ' 118' ' ' ILE . 6.3 pt -102.06 145.01 12.53 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.601 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.541 -174.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 57.3 mtp180 -122.03 128.48 51.46 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -178.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.448 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -162.45 159.74 25.45 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.621 -177.194 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 66.4 t60 62.08 31.46 17.85 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 122.258 1.027 . . . . 0.0 109.281 172.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -76.42 42.31 0.27 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 114.784 -1.098 . . . . 0.0 112.878 -175.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 56.3 mt -64.59 -55.83 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 175.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 6.0 tp -177.66 119.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.584 174.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -104.75 108.15 19.48 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 104.539 -2.393 . . . . 0.0 104.539 168.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -77.2 78.61 3.73 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 122.129 0.966 . . . . 0.0 112.174 -170.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.4 p -84.67 -10.39 11.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.816 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 59.7 mt -85.06 97.36 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.258 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 68.5 122.6 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.05 1.34 . . . . 0.0 113.414 176.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -86.67 99.44 11.75 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 169.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.457 ' O ' ' HG2' ' A' ' 132' ' ' GLU . 48.3 mm -82.0 82.96 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 CA-C-O 121.503 0.668 . . . . 0.0 111.516 -177.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 131' ' ' ILE . 5.4 mm-40 169.99 137.94 0.02 OUTLIER 'General case' 0 CA--C 1.489 -1.382 0 C-N-CA 130.0 3.32 . . . . 0.0 105.458 174.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 63.8 19.14 11.58 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 122.087 0.946 . . . . 0.0 109.358 -172.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -119.99 148.97 42.89 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-N 114.713 -1.13 . . . . 0.0 108.304 -177.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 44.6 ttm . . . . . 0 C--N 1.286 -2.173 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 -179.096 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 . . . . . 0 CA--C 1.492 -1.276 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -172.76 -43.04 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 69.5 132.79 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.648 1.179 . . . . 0.0 112.768 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 59.18 81.27 0.17 Allowed 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.112 0.965 . . . . 0.0 111.702 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -151.94 -51.55 0.12 Allowed 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.525 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -108.48 91.87 0.7 Allowed Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.3 t -103.67 65.43 0.83 Allowed 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -174.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.503 ' HA ' HG21 ' A' ' 13' ' ' VAL . 31.0 mtt180 -166.99 165.29 15.93 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 124.916 1.286 . . . . 0.0 110.23 174.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 174.66 160.38 22.62 Favored Glycine 0 N--CA 1.428 -1.896 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -176.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.7 m -51.32 97.09 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 125.462 1.505 . . . . 0.0 113.667 -174.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.5 m 57.12 19.11 4.53 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.909 1.284 . . . . 0.0 114.408 174.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -95.93 -15.5 22.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.328 0.585 . . . . 0.0 110.894 178.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.503 HG21 ' HA ' ' A' ' 8' ' ' ARG . 30.1 m -134.04 168.59 23.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 176.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 72.28 21.37 3.85 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.101 0.961 . . . . 0.0 112.185 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.8 mp -73.56 110.0 7.51 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 175.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 -91.7 -47.13 7.53 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.391 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 60.97 -69.76 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.231 1.412 . . . . 0.0 112.358 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 68.51 -59.2 0.46 Allowed 'General case' 0 C--O 1.22 -0.494 0 C-N-CA 125.807 1.643 . . . . 0.0 112.999 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . 0.316 13.7 ptm180 51.4 -77.49 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.522 1.929 . . . . 0.0 115.113 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.442 ' O ' HG22 ' A' ' 21' ' ' VAL . 37.3 p -85.42 -11.44 54.4 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.091 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.442 HG22 ' O ' ' A' ' 20' ' ' SER 0.271 5.6 m 67.29 0.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 127.927 2.491 . . . . 0.0 111.425 -176.388 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -89.92 -43.13 10.79 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 35.5 p -80.45 13.01 2.65 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.275 -1.329 . . . . 0.0 112.723 -175.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -78.58 -25.79 45.36 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.372 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.6 p -173.75 -15.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.997 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t 64.1 -147.65 0.29 Allowed 'General case' 0 C--O 1.253 1.247 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 -175.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.9 mt 61.61 41.98 11.62 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 122.044 0.926 . . . . 0.0 109.783 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -83.57 38.3 0.62 Allowed 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.55 -178.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -79.97 -20.55 45.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.82 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 65.9 tp -110.93 86.88 2.41 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -119.3 -12.08 9.46 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.252 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -73.5 153.16 40.44 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.771 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -75.78 134.47 40.42 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.4 mm -59.01 123.85 12.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 176.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -72.46 -29.43 63.67 Favored 'General case' 0 C--N 1.315 -0.917 0 O-C-N 123.439 0.462 . . . . 0.0 111.977 -172.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 74.98 -23.09 0.24 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.791 1.236 . . . . 0.0 113.611 176.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 174.63 -176.95 46.9 Favored Glycine 0 N--CA 1.426 -1.999 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -134.85 145.48 48.34 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 27.0 ttt -144.25 135.66 25.66 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -67.33 -59.04 3.74 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -174.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' A' ' 70' ' ' ARG . 30.4 tt0 -130.62 121.43 25.59 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-O 121.262 0.553 . . . . 0.0 110.223 -174.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -94.95 143.2 26.66 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.047 -0.978 . . . . 0.0 109.207 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.502 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 94.1 m-20 -109.72 128.05 55.02 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -178.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 89.6 mt -135.29 169.65 17.14 Favored 'General case' 0 C--O 1.252 1.194 0 CA-C-O 122.016 0.912 . . . . 0.0 111.894 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.573 HG23 ' HA ' ' A' ' 96' ' ' VAL . 0.8 OUTLIER -131.61 139.73 49.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 114.259 -1.337 . . . . 0.0 109.944 177.938 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 93.7 t -117.88 130.67 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-O 121.161 0.505 . . . . 0.0 110.775 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 79' ' ' GLY . 35.5 mtmm -142.35 144.47 33.2 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.017 173.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -150.48 170.77 18.29 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -82.7 -19.7 37.53 Favored 'General case' 0 C--N 1.313 -1.007 0 O-C-N 124.065 0.853 . . . . 0.0 110.227 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.472 ' HB ' ' OG ' ' A' ' 53' ' ' SER . 95.3 t -110.54 124.26 67.16 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.971 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 173.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.714 ' O ' HG22 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -54.77 -46.61 74.41 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 123.898 0.879 . . . . 0.0 112.61 -176.348 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.19 1.7 79.44 Favored Glycine 0 C--N 1.285 -2.264 0 C-N-CA 118.099 -2.001 . . . . 0.0 114.06 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.472 ' OG ' ' HB ' ' A' ' 50' ' ' VAL . 49.1 m -82.63 -26.78 31.89 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 176.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.714 HG22 ' O ' ' A' ' 51' ' ' GLN . 3.7 m -68.57 -45.08 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.099 0 CA-C-N 114.398 -1.274 . . . . 0.0 107.885 176.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -67.09 -32.33 73.42 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.939 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.56 -34.22 77.32 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.179 0.514 . . . . 0.0 110.29 177.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.4 tp -84.01 -39.13 20.05 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.605 178.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 54' ' ' VAL . 55.6 t -55.44 -45.56 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.033 0.533 . . . . 0.0 112.029 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.19 -15.71 63.38 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.541 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -100.9 -22.16 14.89 Favored 'General case' 0 C--O 1.2 -1.521 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.27 -38.24 17.76 Favored 'General case' 0 N--CA 1.421 -1.919 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.873 -177.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -72.13 -10.02 59.22 Favored 'General case' 0 C--N 1.317 -0.82 0 O-C-N 122.073 -0.392 . . . . 0.0 110.723 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.541 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 19.1 pttp -99.25 0.39 43.07 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.537 ' HB ' ' O ' ' A' ' 71' ' ' VAL . 23.1 mm -77.26 83.82 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -140.23 -56.55 0.54 Allowed 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 114.609 -1.178 . . . . 0.0 108.88 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.7 m -90.07 15.11 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.824 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.477 ' HG3' HD13 ' A' ' 64' ' ' ILE . 9.1 mm-40 -98.87 15.37 25.75 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.872 -176.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.43 -68.76 0.29 Allowed Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 22.5 t -117.85 163.6 14.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.564 ' O ' ' HA ' ' A' ' 41' ' ' GLU . 53.9 mtp180 -98.23 113.95 26.05 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.537 ' O ' ' HB ' ' A' ' 64' ' ' ILE . 46.9 t -126.76 124.86 65.84 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 178.148 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -130.23 155.26 46.56 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-O 121.457 0.646 . . . . 0.0 111.231 -173.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.4 pp -94.74 148.64 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.499 176.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 76.5 mt -113.5 -30.5 2.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-O 121.478 0.656 . . . . 0.0 110.582 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 12.8 t-160 -151.29 133.4 15.2 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.337 -172.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -134.96 129.49 34.3 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -151.46 159.86 43.99 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 120.53 0.205 . . . . 0.0 110.547 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.4 ' HB ' ' HA ' ' A' ' 51' ' ' GLN . 6.2 p -94.08 98.61 8.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-O 121.887 0.851 . . . . 0.0 108.803 176.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' A' ' 47' ' ' LYS . . . -176.92 175.45 47.66 Favored Glycine 0 N--CA 1.414 -2.779 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.59 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -98.41 -170.56 1.97 Allowed 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 174.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.569 HG21 HG21 ' A' ' 118' ' ' ILE . 3.7 mp -84.99 119.04 33.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 C-N-CA 119.725 -0.79 . . . . 0.0 111.374 -176.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.0 p -121.65 162.0 21.48 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.018 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.539 ' CD ' ' H ' ' A' ' 83' ' ' GLU . 2.3 mp0 -53.89 -43.82 69.98 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 124.759 1.223 . . . . 0.0 111.655 -178.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.9 t -68.72 -27.06 65.6 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.28 0.562 . . . . 0.0 110.544 -176.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -74.7 -44.26 50.93 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.326 178.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.584 HG21 ' HA ' ' A' ' 111' ' ' ALA . 56.9 mt -60.2 -27.75 40.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.448 177.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.0 t -61.07 -21.58 63.8 Favored 'General case' 0 CA--C 1.563 1.45 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.779 177.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -82.46 -37.35 25.52 Favored 'General case' 0 C--O 1.245 0.863 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 174.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.68 -60.31 3.48 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.555 -176.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.563 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 8.6 t -70.45 -22.2 62.72 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.677 178.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.6 -60.69 2.34 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 20.0 m -97.86 5.23 49.28 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.115 0.484 . . . . 0.0 110.787 -178.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 66.64 37.52 4.36 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.189 0.996 . . . . 0.0 111.203 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.502 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -94.86 139.39 31.37 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 114.363 -1.29 . . . . 0.0 108.591 178.155 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 49.4 mm -94.86 142.23 13.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.623 ' HB ' HG22 ' A' ' 118' ' ' ILE . 36.2 t -94.2 117.29 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.625 0 CA-C-O 121.276 0.56 . . . . 0.0 110.843 -175.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.49 130.92 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.016 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 176.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -136.01 175.38 20.9 Favored Glycine 0 N--CA 1.423 -2.197 0 N-CA-C 108.846 -1.701 . . . . 0.0 108.846 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . 0.288 21.8 p90 -141.66 107.28 5.08 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 119.084 -1.047 . . . . 0.0 113.294 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.2 t30 67.15 9.17 6.73 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 126.069 1.748 . . . . 0.0 111.373 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.495 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 4.9 m -84.12 -48.69 16.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.824 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.59 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 9.1 mtm180 73.07 163.75 0.14 Allowed Pre-proline 0 N--CA 1.485 1.307 0 C-N-CA 124.165 0.986 . . . . 0.0 111.251 176.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -95.25 168.61 1.47 Allowed 'Trans proline' 0 N--CA 1.437 -1.811 0 C-N-CA 121.901 1.734 . . . . 0.0 113.342 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -79.2 161.2 26.56 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 170.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.423 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -63.09 -24.3 67.84 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 122.713 0.405 . . . . 0.0 111.47 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.634 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 68.8 m-20 -85.68 -38.2 18.59 Favored 'General case' 0 C--O 1.206 -1.214 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 176.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.04 -41.51 99.52 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.86 0.362 . . . . 0.0 111.451 -178.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -59.87 -22.06 61.83 Favored 'General case' 0 CA--C 1.559 1.293 0 CA-C-O 121.111 0.481 . . . . 0.0 111.075 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.634 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 38.1 mtm105 -88.46 -51.78 5.54 Favored 'General case' 0 N--CA 1.38 -3.975 0 C-N-CA 125.523 1.529 . . . . 0.0 109.227 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -51.9 -47.01 64.77 Favored 'General case' 0 C--O 1.201 -1.474 0 C-N-CA 125.032 1.333 . . . . 0.0 111.171 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.584 ' HA ' HG21 ' A' ' 86' ' ' ILE . . . -49.42 -43.37 44.58 Favored 'General case' 0 CA--C 1.494 -1.187 0 O-C-N 124.279 0.987 . . . . 0.0 111.078 -179.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -82.89 -23.96 33.36 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-N 114.839 -1.073 . . . . 0.0 113.137 -173.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 38.6 t -89.07 5.89 42.37 Favored 'General case' 0 C--N 1.277 -2.565 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 175.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.563 ' O ' ' HB ' ' A' ' 90' ' ' THR . 23.7 mt-10 -125.27 15.62 8.36 Favored 'General case' 0 N--CA 1.408 -2.533 0 CA-C-N 113.953 -1.476 . . . . 0.0 112.437 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 56.2 mtpt 66.14 3.31 2.64 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 172.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.8 m -114.21 169.03 5.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 121.945 -0.472 . . . . 0.0 111.69 -176.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -130.77 137.71 49.6 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.623 HG22 ' HB ' ' A' ' 96' ' ' VAL . 10.4 pt -107.86 127.35 64.01 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.163 -178.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -129.18 136.96 50.85 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.492 -0.883 . . . . 0.0 113.24 -175.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.8 156.37 37.57 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.341 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.4 ' O ' HG12 ' A' ' 123' ' ' ILE . 57.5 t-80 68.4 -93.51 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 O-C-N 124.473 1.108 . . . . 0.0 111.867 170.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 46.12 -107.82 0.16 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.976 0.91 . . . . 0.0 112.614 -173.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 121' ' ' HIS . 47.5 mm 57.98 -79.9 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.857 1.263 . . . . 0.0 111.189 -177.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 10.0 pt -105.22 16.89 5.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-O 121.922 0.867 . . . . 0.0 108.799 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 68.17 -81.14 0.03 OUTLIER 'General case' 0 C--O 1.238 0.483 0 C-N-CA 126.289 1.836 . . . . 0.0 111.253 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -165.98 101.35 0.65 Allowed 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 19.0 m -81.79 142.36 13.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 39.3 mm -70.55 -49.23 54.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.271 -173.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 66.76 -66.36 0.19 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 125.228 1.411 . . . . 0.0 111.627 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -75.57 126.29 30.72 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 124.435 1.094 . . . . 0.0 109.92 -176.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 72.2 mt -82.54 102.57 8.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 175.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -78.73 137.45 37.78 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.633 -176.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 57.15 79.47 0.19 Allowed 'General case' 0 C--O 1.243 0.742 0 C-N-CA 125.393 1.477 . . . . 0.0 113.994 176.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.25 -59.03 1.87 Allowed 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 26.2 mmt . . . . . 0 CA--C 1.495 -1.172 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 176.063 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 . . . . . 0 CA--C 1.497 -1.092 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -81.41 85.1 6.51 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 177.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -97.44 161.28 13.86 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.299 -177.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 64.09 82.42 0.18 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.462 1.105 . . . . 0.0 111.299 -177.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 89.5 mt -93.14 -24.08 18.37 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.721 -176.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.69 55.55 3.79 Favored Glycine 0 C--N 1.314 -0.686 0 C-N-CA 120.792 -0.718 . . . . 0.0 113.757 -176.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.7 p -79.42 -32.28 42.82 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.302 0.572 . . . . 0.0 110.945 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -119.38 -52.65 2.26 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 174.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.38 110.07 0.34 Allowed Glycine 0 N--CA 1.426 -2.01 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 21.7 t -79.48 -40.05 30.69 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.2 m -71.98 -7.1 46.73 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-O 121.105 0.479 . . . . 0.0 111.64 -178.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.1 tpm_? -73.55 -22.44 60.08 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.251 0.548 . . . . 0.0 109.553 175.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.9 t -124.08 -61.73 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.434 -176.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -105.52 86.54 2.43 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.671 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.1 pp -96.21 -22.94 16.95 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.518 0.675 . . . . 0.0 110.006 177.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.478 ' HA ' ' OE1' ' A' ' 16' ' ' GLN . 8.0 mm-40 -133.97 153.98 51.41 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.359 176.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -121.0 -178.69 3.81 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.515 -175.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 67.87 15.23 9.56 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.016 0.926 . . . . 0.0 112.274 172.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -71.16 -40.07 71.51 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 174.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.9 m -112.48 97.33 6.53 Favored 'General case' 0 N--CA 1.414 -2.234 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 174.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.5 p -112.43 97.86 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.026 0 CA-C-O 122.251 1.024 . . . . 0.0 112.522 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -146.35 -63.62 0.31 Allowed 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 173.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 20.2 p -118.91 78.28 1.26 Allowed 'General case' 0 N--CA 1.416 -2.142 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.515 176.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -117.73 154.37 31.81 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.253 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.2 m -96.59 168.38 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 O-C-N 123.421 0.45 . . . . 0.0 109.869 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.5 t 70.61 7.88 6.38 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.123 1.369 . . . . 0.0 111.138 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 60.4 tp -101.95 104.79 15.5 Favored 'General case' 0 N--CA 1.427 -1.625 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 176.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -111.04 179.63 3.99 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -178.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -144.42 -3.22 0.83 Allowed 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 118.027 0.376 . . . . 0.0 111.379 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 64.9 tp -79.18 96.3 5.84 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-O 120.635 0.255 . . . . 0.0 110.849 -178.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 25.7 t80 51.34 52.97 13.71 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.109 1.364 . . . . 0.0 110.356 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.35 121.1 24.71 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -85.46 94.73 9.07 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -171.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.8 pt -91.61 -17.88 7.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 114.517 -1.219 . . . . 0.0 110.105 176.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -125.06 91.37 3.42 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 121.481 0.657 . . . . 0.0 109.46 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -168.85 142.27 2.92 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 -177.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.18 36.78 6.95 Favored Glycine 0 N--CA 1.438 -1.172 0 C-N-CA 120.242 -0.98 . . . . 0.0 110.955 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -106.08 27.55 8.5 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 123.329 1.537 . . . . 0.0 108.651 -176.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.415 ' HA ' ' CE ' ' A' ' 39' ' ' MET . 1.4 mmt -165.26 -173.58 2.9 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 103.013 -2.958 . . . . 0.0 103.013 174.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -80.94 79.87 7.53 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.875 174.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 70' ' ' ARG . 31.0 mt-10 -104.74 104.29 14.06 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.454 -176.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.19 120.97 36.33 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -99.33 128.42 45.44 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -174.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 70.9 mt -131.25 165.61 23.01 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.535 HD13 ' CD2' ' A' ' 75' ' ' HIS . 0.2 OUTLIER -131.65 136.83 56.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-N 112.817 -1.992 . . . . 0.0 107.26 175.753 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.601 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 92.1 t -117.31 128.18 74.67 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 176.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.57 ' HE3' ' CG ' ' A' ' 85' ' ' ASP . 12.8 ptmm? -159.43 128.06 5.14 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.44 176.28 9.49 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.894 -171.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -74.68 -32.0 62.08 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 123.948 0.78 . . . . 0.0 109.412 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 86.3 t -94.71 122.04 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.137 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.745 ' O ' HG22 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -61.48 -47.84 83.82 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 124.347 1.059 . . . . 0.0 112.595 -174.776 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.87 5.01 84.06 Favored Glycine 0 C--N 1.278 -2.684 0 C-N-CA 118.049 -2.024 . . . . 0.0 113.003 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.0 t -83.36 -29.09 28.5 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.745 HG22 ' O ' ' A' ' 51' ' ' GLN . 6.0 m -70.87 -45.87 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.397 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.653 176.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -60.24 -40.44 90.24 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.178 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.66 -39.97 95.57 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 123.574 0.546 . . . . 0.0 110.825 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 38.3 tp -75.46 -39.34 58.83 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.177 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 54' ' ' VAL . 54.6 t -57.11 -37.99 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.128 0.571 . . . . 0.0 111.44 178.019 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.4 -19.14 63.81 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.452 ' O ' HG12 ' A' ' 64' ' ' ILE . . . -98.03 -30.23 12.81 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.441 ' HA ' HG12 ' A' ' 64' ' ' ILE . 0.2 OUTLIER -74.17 -36.15 64.05 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.615 -175.083 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -68.89 -21.23 64.25 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.134 178.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -99.85 6.73 45.3 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 60' ' ' ALA . 34.9 mm -73.17 0.22 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.751 0 CA-C-O 122.371 1.081 . . . . 0.0 110.618 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -65.2 119.0 10.07 Favored 'General case' 0 C--O 1.247 0.924 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.033 175.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.0 m -128.41 -166.58 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 177.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -80.28 114.23 19.03 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 118.067 0.394 . . . . 0.0 110.026 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 94.23 -43.61 2.37 Favored Glycine 0 C--O 1.243 0.7 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.685 177.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.9 t -106.4 132.62 53.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.483 ' O ' ' HA ' ' A' ' 41' ' ' GLU . 21.2 ptt180 -142.44 111.34 6.34 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-O 122.118 0.961 . . . . 0.0 110.786 176.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.7 t -103.62 131.67 51.68 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -149.43 158.17 43.94 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.141 0.496 . . . . 0.0 110.241 -178.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.445 HG12 HG13 ' A' ' 58' ' ' VAL . 1.5 pp -94.54 144.17 10.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.073 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.401 ' N ' HD12 ' A' ' 74' ' ' ILE . 3.5 mp -112.69 -22.73 4.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-O 122.058 0.933 . . . . 0.0 109.438 177.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.535 ' CD2' HD13 ' A' ' 45' ' ' ILE . 2.0 t60 -148.13 139.05 23.17 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -172.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.601 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -140.33 136.69 33.46 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 177.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -163.2 156.93 19.83 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 118.608 0.64 . . . . 0.0 111.426 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.3 p -101.04 94.42 3.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-O 121.774 0.797 . . . . 0.0 109.273 175.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -177.02 173.31 46.2 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 119.365 -1.398 . . . . 0.0 113.304 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.476 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -81.58 170.02 16.36 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 124.159 0.984 . . . . 0.0 108.856 176.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.43 HD13 HD11 ' A' ' 120' ' ' LEU . 1.8 mp -72.82 118.21 17.62 Favored 'Isoleucine or valine' 0 C--O 1.245 0.816 0 CA-C-N 118.505 0.593 . . . . 0.0 110.363 -177.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 70.7 p -118.7 158.58 25.26 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -50.19 -34.22 21.91 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.23 0.612 . . . . 0.0 112.089 176.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.9 m -62.2 -40.28 95.55 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.127 0.489 . . . . 0.0 110.43 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.57 ' CG ' ' HE3' ' A' ' 47' ' ' LYS . 46.5 m-20 -71.88 -38.96 69.91 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.321 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.6 HD13 ' HB2' ' A' ' 111' ' ' ALA . 58.8 mt -67.2 -29.75 46.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.977 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 27.8 m -58.08 -35.17 71.0 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.194 174.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -72.44 -34.37 67.73 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.149 177.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.414 ' HB3' HG21 ' A' ' 116' ' ' VAL . . . -55.09 -61.96 1.97 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.028 -176.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.573 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 9.2 t -69.5 -21.31 63.69 Favored 'General case' 0 CA--C 1.568 1.655 0 O-C-N 121.583 -0.698 . . . . 0.0 111.054 177.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.89 -52.62 34.38 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 54.1 m -98.78 -2.87 36.93 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.721 178.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 68.65 37.32 2.53 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 122.36 1.076 . . . . 0.0 109.376 -176.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.99 155.93 16.53 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 113.99 -1.459 . . . . 0.0 108.401 178.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 117' ' ' ASP . 46.2 mm -111.67 135.06 52.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.662 ' HB ' HG22 ' A' ' 118' ' ' ILE . 19.4 t -93.59 123.62 45.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.218 0.532 . . . . 0.0 109.834 -174.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 35.6 pt -104.55 157.63 5.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.65 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -171.66 172.93 44.88 Favored Glycine 0 N--CA 1.419 -2.449 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 175.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -161.54 133.38 5.63 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 73.28 -41.08 0.49 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.26 1.424 . . . . 0.0 111.872 177.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.6 m -65.59 -51.17 66.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 C-N-CA 124.339 1.055 . . . . 0.0 111.631 176.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.476 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 35.4 mtm180 66.72 178.97 0.05 OUTLIER Pre-proline 0 CA--C 1.566 1.576 0 C-N-CA 123.364 0.666 . . . . 0.0 112.051 174.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.452 ' HG3' HD12 ' A' ' 118' ' ' ILE . 21.6 Cg_endo -99.48 176.21 0.35 Allowed 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 122.327 2.018 . . . . 0.0 113.865 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -82.16 156.94 24.21 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 168.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.545 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -61.82 -31.18 71.39 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 120.849 0.357 . . . . 0.0 110.489 178.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.579 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 5.4 m-20 -77.8 -36.31 50.44 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.269 175.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.09 -44.06 97.48 Favored 'General case' 0 C--O 1.211 -0.948 0 O-C-N 121.981 -0.45 . . . . 0.0 111.27 176.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.53 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 14.4 ptmm? -59.83 -29.21 68.1 Favored 'General case' 0 CA--C 1.563 1.445 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.579 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 95.4 mtt180 -73.03 -51.37 18.44 Favored 'General case' 0 N--CA 1.395 -3.179 0 C-N-CA 124.643 1.177 . . . . 0.0 108.997 176.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -52.86 -49.03 66.63 Favored 'General case' 0 C--O 1.194 -1.852 0 CA-C-N 113.7 -1.591 . . . . 0.0 110.226 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.6 ' HB2' HD13 ' A' ' 86' ' ' ILE . . . -47.99 -50.76 26.4 Favored 'General case' 0 CA--C 1.483 -1.613 0 O-C-N 124.717 1.26 . . . . 0.0 111.2 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -81.24 -24.77 37.12 Favored 'General case' 0 C--N 1.27 -2.873 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.915 -172.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 38.3 t -87.66 5.45 39.58 Favored 'General case' 0 C--N 1.275 -2.646 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 175.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.573 ' O ' ' HB ' ' A' ' 90' ' ' THR . 24.7 mt-10 -123.35 19.43 9.75 Favored 'General case' 0 CA--C 1.466 -2.255 0 CA-C-N 114.411 -1.268 . . . . 0.0 111.572 177.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 65.6 mttm 67.0 4.63 3.65 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 173.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.414 HG21 ' HB3' ' A' ' 89' ' ' ALA . 5.4 m -113.98 163.94 10.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 121.683 -0.635 . . . . 0.0 112.106 -175.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.41 ' O ' HG23 ' A' ' 95' ' ' ILE . 4.0 m-20 -125.89 142.96 51.27 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 177.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.662 HG22 ' HB ' ' A' ' 96' ' ' VAL . 4.8 pt -105.05 138.74 28.56 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.914 178.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -104.64 112.83 26.06 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.519 -175.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.43 HD11 HD13 ' A' ' 81' ' ' ILE . 3.1 mm? -110.59 134.68 52.19 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.475 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 66.31 75.23 0.33 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.685 174.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 29.0 mmm180 -103.04 10.03 38.27 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.733 -178.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 39.1 pt -110.33 147.92 14.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.704 HD13 ' H ' ' A' ' 124' ' ' ILE . 0.2 OUTLIER -83.67 97.5 4.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-O 122.2 1.0 . . . . 0.0 109.932 175.865 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -88.06 74.24 8.91 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.791 0.805 . . . . 0.0 110.435 -175.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -141.8 29.93 1.69 Allowed 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.127 177.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 97.9 t 74.17 103.72 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.766 -175.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 27.8 pt -88.11 -1.14 8.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.562 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -80.82 -9.21 59.84 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.061 175.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -82.96 124.91 30.83 Favored 'General case' 0 N--CA 1.416 -2.152 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.655 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.439 ' HB ' ' O ' ' A' ' 134' ' ' ALA . 37.2 pt -81.53 -24.85 10.02 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 69.3 -77.44 0.05 Allowed 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 125.677 1.591 . . . . 0.0 111.548 176.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -144.92 13.7 1.48 Allowed 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.507 0.67 . . . . 0.0 109.92 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.439 ' O ' ' HB ' ' A' ' 131' ' ' ILE . . . -113.4 123.24 49.61 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.211 -176.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 49.0 tpp . . . . . 0 C--N 1.297 -1.678 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 176.451 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 61.4 m-20 . . . . . 0 CA--C 1.507 -0.674 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 62.58 87.55 0.1 Allowed 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.344 1.058 . . . . 0.0 112.48 177.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -98.17 168.56 10.17 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.889 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -60.01 146.46 42.63 Favored 'General case' 0 C--O 1.246 0.911 0 C-N-CA 123.388 0.675 . . . . 0.0 110.168 177.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.3 mt -86.86 -35.21 19.15 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.674 -176.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 178.41 104.25 0.18 Allowed Glycine 0 N--CA 1.428 -1.853 0 C-N-CA 118.663 -1.732 . . . . 0.0 114.773 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.7 m -95.75 97.11 9.44 Favored 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 171.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -70.7 -14.54 62.49 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -172.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 146.73 -72.73 0.31 Allowed Glycine 0 CA--C 1.503 -0.71 0 C-N-CA 118.186 -1.959 . . . . 0.0 114.679 173.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.8 m -62.43 141.15 58.5 Favored 'General case' 0 C--O 1.249 1.059 0 CA-C-O 120.509 0.195 . . . . 0.0 111.29 -176.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.2 m 77.7 -60.11 0.44 Allowed 'General case' 0 C--O 1.249 1.046 0 C-N-CA 125.51 1.524 . . . . 0.0 109.53 -177.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.403 ' HG2' HG13 ' A' ' 13' ' ' VAL . 73.4 ttt180 59.28 -69.22 0.03 OUTLIER 'General case' 0 C--N 1.344 0.348 0 C-N-CA 127.256 2.222 . . . . 0.0 113.192 176.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.403 HG13 ' HG2' ' A' ' 12' ' ' ARG . 14.6 m -121.26 -13.99 7.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.54 -176.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -124.34 107.65 11.37 Favored 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -91.28 103.23 15.91 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -117.8 81.4 1.66 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 122.268 1.032 . . . . 0.0 109.351 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -98.7 30.44 3.3 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.272 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -80.06 76.07 6.8 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 176.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -87.39 -35.97 18.03 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.118 0.485 . . . . 0.0 110.293 -175.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.9 p -88.8 2.24 53.87 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.419 176.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . 0.306 27.6 m 45.86 51.67 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.725 0 C-N-CA 125.948 1.699 . . . . 0.0 113.235 -177.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.8 tppt? -116.1 158.09 23.73 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.3 p 55.56 18.2 2.63 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 125.326 1.45 . . . . 0.0 113.542 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.416 ' C ' ' HD2' ' A' ' 24' ' ' ARG . 3.1 ppt_? -110.2 6.55 22.74 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.936 -174.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.6 m -79.22 165.09 3.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.015 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.3 t -142.82 -65.56 0.39 Allowed 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.194 -177.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.6 mt -123.47 109.81 14.31 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 120.999 0.428 . . . . 0.0 110.619 -177.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -75.18 -19.91 59.59 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.301 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.8 t70 65.46 -162.64 0.26 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.975 1.71 . . . . 0.0 110.524 176.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 87.2 mt 60.15 37.26 20.9 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.621 1.169 . . . . 0.0 110.469 -178.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -81.6 -41.61 21.27 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.207 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -99.79 153.95 18.72 Favored 'General case' 0 C--O 1.247 0.943 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.009 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -99.74 119.94 38.93 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.0 pt -85.72 158.51 3.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.551 -178.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.2 ptpp? -71.98 116.17 12.07 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.446 175.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -124.64 -48.8 1.78 Allowed 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -177.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.79 47.47 3.72 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.275 -178.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -107.31 -166.4 1.15 Allowed 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 69.24 27.23 5.21 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.938 1.295 . . . . 0.0 108.32 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -77.93 149.28 34.21 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.471 ' HG2' ' HB2' ' A' ' 70' ' ' ARG . 29.8 mt-10 -93.81 149.17 21.46 Favored 'General case' 0 C--N 1.283 -2.293 0 CA-C-O 121.488 0.661 . . . . 0.0 112.072 -169.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -103.29 104.5 14.63 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 114.484 -1.234 . . . . 0.0 108.095 176.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.432 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 92.0 m-20 -99.69 136.15 40.05 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.3 mt -134.42 164.91 26.39 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 122.304 1.05 . . . . 0.0 113.51 -176.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.631 HD13 ' CD2' ' A' ' 75' ' ' HIS . 0.2 OUTLIER -123.01 139.79 48.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.356 175.63 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 66.4 t -112.23 130.02 66.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.342 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -136.93 144.4 43.41 Favored 'General case' 0 CA--C 1.492 -1.277 0 C-N-CA 123.926 0.89 . . . . 0.0 109.951 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.18 165.1 29.95 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 177.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -84.97 -17.08 38.76 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 120.924 0.392 . . . . 0.0 110.699 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 87.3 t -101.69 127.09 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 173.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.719 ' O ' HG22 ' A' ' 54' ' ' VAL . 49.7 tt0 -61.41 -51.69 67.72 Favored 'General case' 0 C--O 1.196 -1.725 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -173.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.51 0.94 53.78 Favored Glycine 0 C--N 1.28 -2.539 0 C-N-CA 118.205 -1.95 . . . . 0.0 113.724 -175.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.4 t -82.88 -24.98 32.95 Favored 'General case' 0 N--CA 1.417 -2.081 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 177.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.719 HG22 ' O ' ' A' ' 51' ' ' GLN . 5.2 m -77.37 -46.45 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.256 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.355 176.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -66.12 -38.61 88.62 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.442 -176.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.85 -38.23 87.44 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.926 0.393 . . . . 0.0 110.548 177.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.479 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 34.9 tp -73.85 -42.25 61.08 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.48 HG21 ' HB2' ' A' ' 76' ' ' ALA . 53.5 t -57.0 -41.12 76.77 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 C-N-CA 123.16 0.584 . . . . 0.0 111.335 177.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.05 -24.21 67.62 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.38 -20.35 17.2 Favored 'General case' 0 C--O 1.207 -1.173 0 CA-C-O 121.511 0.672 . . . . 0.0 109.39 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -90.75 -28.1 18.5 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.073 -175.4 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -77.94 -24.06 48.36 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 122.157 -0.34 . . . . 0.0 110.409 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -87.28 2.17 50.98 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.123 -178.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 29.3 mm -81.52 107.04 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 173.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -143.59 119.51 10.62 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.272 -178.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 46.3 t 53.49 92.72 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 C-N-CA 125.195 1.398 . . . . 0.0 114.218 175.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -124.25 21.08 8.84 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 122.63 1.205 . . . . 0.0 107.904 173.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.72 -25.91 26.16 Favored Glycine 0 C--O 1.224 -0.483 0 N-CA-C 107.721 -2.152 . . . . 0.0 107.721 -171.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 41.3 t -121.05 153.92 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.617 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 175.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.471 ' HB2' ' HG2' ' A' ' 41' ' ' GLU . 58.0 mtt-85 -120.93 117.7 28.0 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 178.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 32.8 t -130.3 136.28 58.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.8 ttmp? -167.59 162.71 14.37 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.41 HG13 ' HB3' ' A' ' 61' ' ' LEU . 1.5 pp -93.69 150.5 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.606 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.42 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 37.2 mm -115.28 -28.93 2.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 CA-C-O 121.365 0.602 . . . . 0.0 109.666 178.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.631 ' CD2' HD13 ' A' ' 45' ' ' ILE . 3.8 t60 -149.39 140.4 22.92 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -171.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.48 ' HB2' HG21 ' A' ' 58' ' ' VAL . . . -136.67 135.15 38.0 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 177.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -158.54 141.55 14.72 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.652 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.476 ' HB ' ' HA ' ' A' ' 51' ' ' GLN . 4.5 p -93.86 93.98 4.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-O 122.793 1.282 . . . . 0.0 108.822 175.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.89 175.08 47.51 Favored Glycine 0 N--CA 1.409 -3.103 0 CA-C-N 113.855 -1.521 . . . . 0.0 109.554 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.555 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -83.07 -176.93 6.58 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 177.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.531 HG21 HG21 ' A' ' 118' ' ' ILE . 3.3 mp -78.56 110.91 14.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.512 HG22 ' OD2' ' A' ' 85' ' ' ASP . 14.0 t -113.56 165.56 12.38 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 119.576 -0.849 . . . . 0.0 109.374 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -56.92 -35.06 68.59 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.614 0.765 . . . . 0.0 111.182 -176.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.4 m -67.13 -28.54 68.23 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.523 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.512 ' OD2' HG22 ' A' ' 82' ' ' THR . 17.4 m-20 -77.37 -28.53 52.95 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-O 121.175 0.512 . . . . 0.0 110.408 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.518 ' CG2' ' HA ' ' A' ' 111' ' ' ALA . 46.0 mm -65.54 -33.15 61.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.111 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.9 m -57.01 -39.54 74.93 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.364 177.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -73.94 -39.03 64.06 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.981 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.23 -55.29 22.13 Favored 'General case' 0 C--N 1.316 -0.887 0 O-C-N 123.926 0.766 . . . . 0.0 111.877 -177.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.454 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 10.9 t -77.48 -19.01 56.58 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.419 178.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.79 -66.24 0.58 Allowed 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.057 0.456 . . . . 0.0 111.685 -177.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.6 m -95.41 2.06 54.41 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.409 -177.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 62.43 62.92 1.08 Allowed 'General case' 0 CA--C 1.497 -1.079 0 CA-C-O 122.366 1.079 . . . . 0.0 112.332 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -120.24 134.56 55.23 Favored 'General case' 0 N--CA 1.417 -2.092 0 CA-C-N 113.244 -1.798 . . . . 0.0 107.179 176.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 32.2 pt -94.13 141.92 14.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.525 ' HB ' HG22 ' A' ' 118' ' ' ILE . 12.1 t -94.16 116.6 35.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-O 121.192 0.52 . . . . 0.0 110.149 -173.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 119' ' ' ARG . 58.0 mt -112.78 125.71 70.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 120' ' ' LEU . . . -132.24 170.25 21.9 Favored Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -145.42 117.68 8.42 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 72.72 -29.34 0.2 Allowed 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 124.78 1.232 . . . . 0.0 113.099 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.485 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 4.6 m -66.34 -48.11 81.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.563 176.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.555 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 59.8 mtm180 66.94 179.37 0.05 OUTLIER Pre-proline 0 CA--C 1.551 1.015 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.878 174.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.452 ' HG3' HD12 ' A' ' 118' ' ' ILE . 9.5 Cg_endo -98.84 168.72 0.58 Allowed 'Trans proline' 0 N--CA 1.44 -1.663 0 CA-C-N 120.838 1.335 . . . . 0.0 114.568 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -79.48 152.19 30.38 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 113.005 -1.907 . . . . 0.0 106.448 167.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.432 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -61.62 -21.07 64.05 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -176.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.534 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 54.9 t30 -94.47 -28.28 15.55 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.945 -0.702 . . . . 0.0 109.747 177.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.72 -40.8 95.95 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-O 120.965 0.412 . . . . 0.0 110.557 177.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 21.9 ptmt -61.72 -28.5 69.46 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.07 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.534 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 70.7 mtp180 -81.01 -53.09 6.72 Favored 'General case' 0 N--CA 1.385 -3.689 0 C-N-CA 125.918 1.687 . . . . 0.0 109.097 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -52.79 -45.26 67.11 Favored 'General case' 0 C--O 1.196 -1.73 0 CA-C-N 113.85 -1.523 . . . . 0.0 110.457 -178.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.518 ' HA ' ' CG2' ' A' ' 86' ' ' ILE . . . -48.58 -49.28 37.38 Favored 'General case' 0 CA--C 1.49 -1.355 0 O-C-N 124.524 1.14 . . . . 0.0 111.381 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -77.25 -35.2 55.53 Favored 'General case' 0 C--N 1.281 -2.399 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.539 -174.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 35.5 t -79.56 5.47 12.94 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-O 122.374 1.083 . . . . 0.0 108.979 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.454 ' O ' ' HB ' ' A' ' 90' ' ' THR . 19.3 mt-10 -123.75 14.54 9.36 Favored 'General case' 0 CA--C 1.46 -2.504 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.845 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 64.4 mmtt 65.85 17.94 10.98 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 173.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.0 m -120.73 171.41 9.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.362 177.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -137.15 142.35 42.22 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.531 HG21 HG21 ' A' ' 81' ' ' ILE . 10.3 pt -107.97 134.52 49.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 121.32 0.581 . . . . 0.0 111.044 -178.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.507 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 21.5 mmm180 -113.3 125.04 53.85 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -178.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.564 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 0.0 OUTLIER -147.7 136.65 22.1 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -178.331 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 42.3 t-80 67.25 3.99 3.49 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.506 1.123 . . . . 0.0 112.073 173.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 38.3 mtm-85 63.15 -66.4 0.1 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.862 1.665 . . . . 0.0 110.913 -175.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 65.4 mt -88.92 123.89 41.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 9.3 tp -88.69 153.59 3.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 176.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -79.06 72.63 5.6 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 122.221 1.01 . . . . 0.0 110.892 -178.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -96.27 -52.57 3.94 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.249 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 59.6 t -75.92 107.22 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.737 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 14.4 tt -111.79 7.11 8.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.318 -0.994 . . . . 0.0 108.318 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -61.82 110.9 1.67 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.148 -176.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -163.47 -55.83 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.273 0.559 . . . . 0.0 109.886 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.15 87.25 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.286 0 CA-C-O 122.983 1.373 . . . . 0.0 108.569 -176.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -96.81 14.41 25.29 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.236 -1.347 . . . . 0.0 110.101 -175.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -111.35 -167.05 1.13 Allowed 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.601 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 62.48 -161.96 0.29 Allowed 'General case' 0 C--O 1.247 0.93 0 C-N-CA 123.871 0.868 . . . . 0.0 111.266 176.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 23.0 ptt? . . . . . 0 C--N 1.298 -1.659 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.948 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 63.9 t30 . . . . . 0 C--O 1.235 0.317 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -63.91 99.99 0.28 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 58.79 -161.92 0.24 Allowed 'General case' 0 C--O 1.245 0.861 0 O-C-N 124.419 1.074 . . . . 0.0 111.516 173.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -89.92 171.8 9.33 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 91.2 mt -75.27 -59.56 2.69 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.534 -176.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -167.38 55.3 0.23 Allowed Glycine 0 N--CA 1.434 -1.452 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.516 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.9 p -72.41 97.88 2.14 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 122.618 0.367 . . . . 0.0 110.745 -178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -145.81 -163.77 1.81 Allowed 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 121.051 -0.259 . . . . 0.0 110.31 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.54 -119.94 5.44 Favored Glycine 0 N--CA 1.427 -1.935 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -178.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.2 m -58.91 -26.04 63.96 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 124.398 1.079 . . . . 0.0 111.759 -176.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.1 m -63.94 -19.74 65.34 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.714 0.806 . . . . 0.0 112.389 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -125.48 -20.0 4.87 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 119.484 -0.887 . . . . 0.0 112.794 -178.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.7 m -106.46 152.21 8.16 Favored 'Isoleucine or valine' 0 C--O 1.247 0.964 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.772 -178.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.0 t70 69.93 89.2 0.1 Allowed 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 124.522 1.139 . . . . 0.0 110.056 -178.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.1 mt -90.46 156.13 18.42 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.502 -176.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -93.84 -23.63 18.06 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.755 -175.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.434 ' HA ' ' HD2' ' A' ' 24' ' ' ARG . 3.6 mm-40 -62.57 174.96 0.87 Allowed 'General case' 0 C--O 1.212 -0.89 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -176.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -69.82 -1.33 9.06 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.432 0.693 . . . . 0.0 112.345 -176.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -66.65 -31.51 72.23 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 171.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.3 m -151.97 93.1 1.8 Allowed 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 174.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.6 m -58.71 89.34 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -173.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -89.06 -63.57 1.27 Allowed 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.477 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.3 t -131.22 73.2 1.53 Allowed 'General case' 0 N--CA 1.411 -2.413 0 CA-C-O 122.716 1.246 . . . . 0.0 108.171 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.456 ' NE ' ' HA ' ' A' ' 24' ' ' ARG . 3.7 mmp_? -127.39 162.53 26.1 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.195 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.3 t -106.55 122.87 61.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.0 t -109.17 115.43 30.0 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.8 mt -103.85 82.45 1.99 Allowed 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.307 -177.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -97.06 -31.74 12.34 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 174.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -95.57 148.69 22.25 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.372 -1.286 . . . . 0.0 108.589 177.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.7 mp -106.66 141.25 38.23 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.599 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -81.4 115.8 20.92 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 175.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -66.1 103.77 1.03 Allowed 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.761 0.791 . . . . 0.0 109.509 177.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.474 ' OE1' ' HA ' ' A' ' 35' ' ' LYS . 34.3 tt0 -60.62 -34.21 73.92 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 125.812 1.645 . . . . 0.0 112.945 -174.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 59.5 mt 71.57 79.61 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.504 -0.814 0 N-CA-C 103.998 -2.593 . . . . 0.0 103.998 -163.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.474 ' HA ' ' OE1' ' A' ' 33' ' ' GLN 0.293 19.8 pttm -47.31 85.28 0.0 OUTLIER 'General case' 0 C--O 1.239 0.532 0 N-CA-C 116.543 2.053 . . . . 0.0 116.543 -171.932 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 48.1 tp60 172.7 73.64 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 129.099 2.96 . . . . 0.0 104.55 175.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -110.64 81.9 0.29 Allowed Glycine 0 N--CA 1.419 -2.467 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.384 -177.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 74.54 -69.89 0.17 Allowed 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.262 1.025 . . . . 0.0 111.984 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 50.8 ttm 73.65 -43.3 0.54 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.455 1.502 . . . . 0.0 110.639 -178.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -84.54 86.73 7.26 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 171.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -144.23 171.65 14.01 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 114.517 -1.22 . . . . 0.0 108.599 -174.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -98.57 137.47 37.18 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-O 121.088 0.471 . . . . 0.0 109.853 -176.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.78 ' HB3' HD11 ' A' ' 74' ' ' ILE . 36.5 m-80 -130.69 140.02 50.34 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.206 177.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.8 mt -134.27 163.6 29.26 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.66 0.743 . . . . 0.0 112.012 -177.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.426 HG21 HG22 ' A' ' 96' ' ' VAL . 0.8 OUTLIER -119.95 135.12 61.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.576 174.108 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.422 ' CG1' ' HA ' ' A' ' 54' ' ' VAL . 94.3 t -112.49 123.73 68.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 121.314 0.578 . . . . 0.0 111.401 -176.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -133.51 147.79 51.64 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 124.504 1.122 . . . . 0.0 109.668 176.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.39 161.87 33.19 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -81.65 -9.25 59.71 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 122.283 1.039 . . . . 0.0 109.52 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 96.1 t -114.96 123.73 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 176.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.671 ' O ' HG22 ' A' ' 54' ' ' VAL . 48.2 tt0 -58.24 -49.77 75.93 Favored 'General case' 0 C--O 1.205 -1.259 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -176.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.59 4.0 52.62 Favored Glycine 0 C--N 1.289 -2.059 0 C-N-CA 118.58 -1.772 . . . . 0.0 113.887 -176.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.9 t -86.17 -19.46 30.05 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 176.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.671 HG22 ' O ' ' A' ' 51' ' ' GLN . 4.9 m -81.19 -46.35 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.266 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 174.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -57.43 -50.35 73.3 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.384 -1.28 . . . . 0.0 111.968 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.05 -40.76 81.76 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 123.371 0.42 . . . . 0.0 111.594 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.403 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 36.8 tp -74.34 -43.06 58.24 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.071 -178.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.537 HG21 ' HB2' ' A' ' 76' ' ' ALA . 54.6 t -59.08 -40.14 80.11 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.595 0 C-N-CA 122.885 0.474 . . . . 0.0 111.071 177.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.62 -12.08 60.89 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.6 -31.72 10.25 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 176.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -75.71 -28.48 58.6 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 114.235 -1.348 . . . . 0.0 110.923 -175.41 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -83.14 -14.19 54.04 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.682 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.24 5.43 50.07 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.863 -0.735 . . . . 0.0 111.947 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.413 ' HB ' ' O ' ' A' ' 71' ' ' VAL . 31.8 mm -71.57 90.75 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.649 0 CA-C-O 121.407 0.623 . . . . 0.0 111.457 -175.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -121.69 107.37 12.28 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.921 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.7 m -140.65 169.77 15.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 174.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -82.12 125.89 31.39 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 120.948 0.404 . . . . 0.0 111.343 -175.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.2 -38.72 2.74 Favored Glycine 0 C--O 1.246 0.883 0 CA-C-N 116.171 -0.468 . . . . 0.0 113.878 177.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.0 t -107.01 133.6 51.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 53.6 mmm-85 -135.82 137.17 41.28 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 174.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.413 ' O ' ' HB ' ' A' ' 64' ' ' ILE . 24.5 t -134.81 119.39 27.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 177.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 24.9 ttpp -139.83 160.37 40.05 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.238 0.542 . . . . 0.0 110.174 -176.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.458 HG12 HG13 ' A' ' 58' ' ' VAL . 1.6 pp -94.89 162.34 2.45 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.003 175.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.78 HD11 ' HB3' ' A' ' 43' ' ' ASN . 1.7 mp -120.52 -33.39 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 174.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -152.38 122.14 6.96 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.341 -166.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.537 ' HB2' HG21 ' A' ' 58' ' ' VAL . . . -110.81 139.48 46.08 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 176.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -156.42 132.1 9.57 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 120.178 -0.609 . . . . 0.0 111.529 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.421 ' HB ' ' HA ' ' A' ' 51' ' ' GLN . 4.4 p -93.93 93.86 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.887 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 172.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -177.53 175.86 47.77 Favored Glycine 0 N--CA 1.399 -3.814 0 N-CA-C 108.319 -1.912 . . . . 0.0 108.319 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.606 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . . . -86.41 -170.63 3.17 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.163 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.417 ' CD1' HD12 ' A' ' 120' ' ' LEU . 21.2 mt -94.1 105.7 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.007 0 CA-C-O 121.213 0.53 . . . . 0.0 109.6 -173.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.4 t -106.89 162.68 13.6 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.412 ' HG3' ' CB ' ' A' ' 110' ' ' ALA . 39.3 tt0 -60.79 -35.22 75.9 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 123.109 0.564 . . . . 0.0 111.109 -176.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.7 m -69.83 -10.95 60.35 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.664 -177.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -95.69 -31.66 13.13 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 121.6 0.714 . . . . 0.0 109.796 175.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.641 HD13 ' HB2' ' A' ' 111' ' ' ALA . 59.7 mt -69.8 -25.76 28.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.939 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.0 p -56.75 -37.19 70.7 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.7 175.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.459 HD11 HD13 ' A' ' 74' ' ' ILE . 1.9 tm? -70.86 -36.97 73.05 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 123.278 0.631 . . . . 0.0 110.191 175.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.01 -58.46 6.47 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.222 -175.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.536 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 7.0 t -71.46 -30.12 65.64 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 119.594 -0.842 . . . . 0.0 110.919 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.19 -53.08 62.35 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.061 0.545 . . . . 0.0 112.313 -177.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 31.7 t -101.44 6.91 42.68 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.432 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 9.9 p30 60.11 29.6 19.15 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.791 1.236 . . . . 0.0 111.648 177.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.47 131.64 39.96 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 113.545 -1.661 . . . . 0.0 108.632 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.4 pp -93.87 143.65 11.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.623 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.503 ' HB ' HG22 ' A' ' 118' ' ' ILE . 21.2 t -94.49 113.86 29.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.622 -174.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.456 ' HA ' ' O ' ' A' ' 119' ' ' ARG . 43.2 mm -112.91 123.41 68.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 175.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -115.08 168.79 12.65 Favored Glycine 0 N--CA 1.423 -2.212 0 C-N-CA 120.231 -0.985 . . . . 0.0 110.666 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -114.84 93.34 4.28 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.111 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 62.7 t30 60.78 10.02 2.49 Favored 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 125.796 1.639 . . . . 0.0 112.583 178.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.606 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 3.8 m -69.87 -47.97 66.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.792 -175.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.537 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 55.9 mtm180 74.8 143.57 0.1 OUTLIER Pre-proline 0 CA--C 1.548 0.873 0 O-C-N 124.251 0.969 . . . . 0.0 111.522 175.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 102' ' ' ARG . 6.4 Cg_endo -86.5 169.66 8.14 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 121.753 1.635 . . . . 0.0 114.11 -175.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -77.89 152.16 33.46 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 169.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.491 ' O ' ' HG3' ' A' ' 108' ' ' LYS . . . -60.41 -28.56 68.35 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.483 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 91.3 m-20 -85.3 -29.27 24.69 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.237 177.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.49 -45.71 86.15 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 177.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' A' ' 105' ' ' ALA . 0.0 OUTLIER -59.95 -29.63 68.54 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.265 179.761 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 62.3 mtt180 -73.1 -52.17 15.27 Favored 'General case' 0 N--CA 1.393 -3.289 0 C-N-CA 124.445 1.098 . . . . 0.0 109.62 178.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.412 ' CB ' ' HG3' ' A' ' 83' ' ' GLU . . . -53.88 -51.23 64.32 Favored 'General case' 0 C--O 1.197 -1.661 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.126 -178.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.641 ' HB2' HD13 ' A' ' 86' ' ' ILE . . . -46.44 -48.77 18.81 Favored 'General case' 0 CA--C 1.494 -1.188 0 O-C-N 124.736 1.272 . . . . 0.0 112.52 -178.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -79.34 -32.34 43.29 Favored 'General case' 0 N--CA 1.407 -2.611 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.396 -171.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 26.0 t -79.58 -1.74 39.25 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.536 ' O ' ' HB ' ' A' ' 90' ' ' THR . 25.9 mt-10 -116.49 14.18 15.53 Favored 'General case' 0 N--CA 1.418 -2.067 0 C-N-CA 125.028 1.331 . . . . 0.0 112.454 -178.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 10.0 mtpm? 66.6 9.5 6.66 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 172.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.7 m -116.8 132.83 65.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-O 121.602 0.715 . . . . 0.0 112.277 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -97.55 127.13 43.26 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.503 HG22 ' HB ' ' A' ' 96' ' ' VAL . 25.9 pt -106.56 128.99 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.018 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.056 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.456 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 12.0 ptt180 -142.21 149.37 39.58 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 121.118 0.485 . . . . 0.0 110.338 -178.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.521 ' HG ' ' H ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -151.1 140.75 21.7 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.175 -171.321 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 68.38 -43.5 0.49 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 125.134 1.374 . . . . 0.0 113.794 174.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 69.6 89.28 0.1 Allowed 'General case' 0 CA--C 1.504 -0.826 0 C-N-CA 124.736 1.215 . . . . 0.0 112.096 -178.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 9.8 tp -80.88 99.75 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.746 0 CA-C-N 114.845 -1.07 . . . . 0.0 108.541 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 63.7 mt -71.84 -38.25 64.65 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.556 -176.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -123.66 97.35 5.34 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -84.8 83.37 8.06 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.782 0.801 . . . . 0.0 110.694 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.3 p -159.31 132.01 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 113.926 -1.488 . . . . 0.0 107.315 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.8 tt -166.52 86.39 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-O 121.859 0.838 . . . . 0.0 111.122 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -167.06 69.16 0.1 Allowed 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 122.067 0.936 . . . . 0.0 109.458 175.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -107.69 -3.93 18.7 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-O 122.762 1.267 . . . . 0.0 107.856 174.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.5 pp -141.76 156.62 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.2 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 177.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -76.29 138.99 40.88 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -75.99 19.1 0.23 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -174.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.46 88.9 7.32 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 177.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 91.8 mmm . . . . . 0 C--N 1.298 -1.654 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.837 -176.798 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 10.5 p30 . . . . . 0 CA--C 1.505 -0.75 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -121.18 171.73 8.49 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 120.897 0.379 . . . . 0.0 110.415 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -112.97 137.78 50.83 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 173.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 75.33 155.1 0.16 Allowed 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.327 1.051 . . . . 0.0 110.895 -173.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.9 mp -74.76 -26.74 59.98 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.162 0.506 . . . . 0.0 110.2 -175.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 114.95 -18.23 16.7 Favored Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -177.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.2 p -77.87 92.63 4.27 Favored 'General case' 0 N--CA 1.418 -2.036 0 C-N-CA 123.818 0.847 . . . . 0.0 110.734 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 27.6 ttm-85 -131.1 21.77 4.88 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 123.101 1.429 . . . . 0.0 108.57 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.31 -44.9 2.89 Favored Glycine 0 N--CA 1.435 -1.412 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 173.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.5 m -104.49 107.94 19.13 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 176.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.654 ' HA ' ' OD1' ' A' ' 14' ' ' ASP . 66.7 m 73.53 93.16 0.08 Allowed 'General case' 0 C--O 1.244 0.785 0 CA-C-O 122.829 1.3 . . . . 0.0 112.605 -176.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -126.53 -55.83 1.41 Allowed 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 113.854 -1.521 . . . . 0.0 110.866 -175.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.5 t -116.13 -17.2 8.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.654 ' OD1' ' HA ' ' A' ' 11' ' ' SER . 10.9 p-10 -74.93 71.83 2.07 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 122.911 1.338 . . . . 0.0 109.859 176.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.0 mt -122.19 167.28 13.38 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 113.953 -1.476 . . . . 0.0 107.824 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -106.66 32.54 4.45 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 122.569 1.176 . . . . 0.0 108.517 -177.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -88.06 69.21 9.3 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.584 -1.189 . . . . 0.0 112.429 -178.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -71.48 -43.17 67.09 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 120.563 -0.455 . . . . 0.0 109.884 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 44.55 -92.84 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.475 1.91 . . . . 0.0 115.214 -177.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.4 m -96.9 30.02 2.84 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.798 0.809 . . . . 0.0 108.873 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.488 ' HB ' ' O ' ' A' ' 24' ' ' ARG 0.395 33.7 m 53.59 69.86 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 126.749 2.02 . . . . 0.0 114.251 -176.243 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -98.97 -39.51 8.52 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.456 175.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.0 p -106.42 18.63 21.69 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 121.794 0.807 . . . . 0.0 109.535 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.488 ' O ' ' HB ' ' A' ' 21' ' ' VAL . 21.8 tpp180 -139.68 120.55 14.47 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.4 m 51.05 170.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 N-CA-C 116.373 1.99 . . . . 0.0 116.373 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.1 m -143.2 15.7 1.88 Allowed 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.516 -1.22 . . . . 0.0 107.806 173.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 77.4 mt -96.58 118.23 32.62 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.785 -177.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -120.22 -5.85 9.92 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.36 0.6 . . . . 0.0 111.229 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -105.46 97.02 6.92 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.9 mp -132.48 16.9 4.42 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -117.11 155.7 28.85 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.172 -174.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -123.26 88.64 2.96 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 175.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -141.46 114.39 8.54 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -178.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 70.8 mt -88.78 -55.99 5.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.654 -178.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -156.37 -52.82 0.08 Allowed 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -172.59 -43.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.802 0.689 . . . . 0.0 109.719 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 133.86 116.11 1.65 Allowed Glycine 0 N--CA 1.434 -1.483 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 -176.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -79.03 73.41 5.58 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.898 0.856 . . . . 0.0 111.655 -175.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 65.0 mtt -120.19 108.16 13.88 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 177.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.0 tptp -145.22 112.93 6.31 Favored 'General case' 0 N--CA 1.426 -1.63 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.629 -178.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -105.42 162.76 13.17 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.999 178.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -106.89 122.1 45.73 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 177.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.436 ' HA ' ' O ' ' A' ' 72' ' ' LYS . 14.8 m120 -120.05 149.12 42.69 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -176.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.421 HD21 HD11 ' A' ' 61' ' ' LEU . 2.4 pt? -154.01 165.25 36.74 Favored 'General case' 0 C--O 1.257 1.453 0 CA-C-O 121.486 0.66 . . . . 0.0 111.375 177.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.612 HG23 ' HA ' ' A' ' 96' ' ' VAL . 0.6 OUTLIER -116.34 126.57 73.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 CA-C-N 114.638 -1.165 . . . . 0.0 108.986 175.105 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.417 HG12 ' HA ' ' A' ' 54' ' ' VAL . 73.2 t -95.77 121.08 45.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.696 -176.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 3.9 mtpm? -134.61 140.98 46.48 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -147.66 175.07 11.18 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -86.33 -13.46 46.5 Favored 'General case' 0 C--N 1.315 -0.934 0 O-C-N 123.813 0.696 . . . . 0.0 109.999 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 79.2 t -120.3 129.56 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 177.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.725 ' O ' HG22 ' A' ' 54' ' ' VAL . 16.1 tt0 -58.7 -48.3 81.59 Favored 'General case' 0 C--O 1.193 -1.904 0 O-C-N 123.291 0.369 . . . . 0.0 111.834 -175.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -73.26 -0.57 53.57 Favored Glycine 0 C--N 1.283 -2.379 0 C-N-CA 118.893 -1.622 . . . . 0.0 114.477 -175.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.3 t -86.48 -20.37 28.19 Favored 'General case' 0 N--CA 1.415 -2.221 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 177.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.725 HG22 ' O ' ' A' ' 51' ' ' GLN . 6.0 m -76.8 -44.22 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.181 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 173.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -63.04 -48.06 80.33 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.215 -1.357 . . . . 0.0 111.321 -177.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.42 -35.23 78.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.583 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.506 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 40.3 tp -78.56 -37.86 41.64 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.239 -178.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.506 HG21 ' HB2' ' A' ' 76' ' ' ALA . 49.8 t -58.44 -44.66 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 120.625 0.25 . . . . 0.0 110.452 176.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.0 -22.26 66.72 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.676 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.53 -16.01 20.29 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.712 0.768 . . . . 0.0 109.951 -177.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.506 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -97.13 -32.84 11.75 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.25 -175.261 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -73.02 -20.33 61.02 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.028 0.442 . . . . 0.0 110.586 177.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -90.11 -1.04 57.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.194 -177.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 31.8 mm -64.26 129.99 28.75 Favored 'Isoleucine or valine' 0 C--O 1.248 1.022 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.471 ' HB3' ' HG2' ' A' ' 67' ' ' GLU . 12.3 m-20 -65.09 159.07 24.14 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.893 -176.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.0 m -91.36 -9.59 10.18 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 CA-C-O 121.536 0.684 . . . . 0.0 110.266 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.471 ' HG2' ' HB3' ' A' ' 65' ' ' ASP . 11.1 pt-20 -86.6 139.05 31.19 Favored 'General case' 0 C--O 1.254 1.312 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.325 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.2 -79.31 1.73 Allowed Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.95 178.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.0 p -131.73 121.19 47.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 56.0 ttt180 -102.29 101.07 11.3 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 120.234 -0.587 . . . . 0.0 110.273 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.9 t -107.39 136.22 43.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 177.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 57.3 tttp -150.38 154.55 37.97 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.474 HG12 HG13 ' A' ' 58' ' ' VAL . 1.4 pp -93.69 154.45 3.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.635 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 40.3 mm -115.69 -33.32 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-O 121.142 0.496 . . . . 0.0 111.1 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -160.83 134.52 6.83 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -171.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.506 ' HB2' HG21 ' A' ' 58' ' ' VAL . . . -113.51 133.44 55.23 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 176.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 47' ' ' LYS . . . -151.94 130.64 12.35 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.307 -177.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.4 p -93.39 93.89 4.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-O 123.2 1.476 . . . . 0.0 110.148 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -177.84 175.49 47.55 Favored Glycine 0 N--CA 1.403 -3.558 0 CA-C-N 113.68 -1.6 . . . . 0.0 109.488 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.498 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -74.11 178.48 5.02 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 174.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.426 HG21 HG21 ' A' ' 118' ' ' ILE . 3.5 mp -84.27 108.83 16.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 69.6 p -101.04 166.92 10.56 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.512 -0.875 . . . . 0.0 108.992 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -59.53 -33.78 71.82 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.775 0.798 . . . . 0.0 109.508 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.1 m -67.44 -31.44 71.62 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.877 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -73.15 -34.76 66.26 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 121.901 0.858 . . . . 0.0 109.828 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.502 HD13 ' HB2' ' A' ' 111' ' ' ALA . 70.7 mt -66.55 -26.84 38.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 114.524 -1.216 . . . . 0.0 112.846 -176.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 88.3 p -55.49 -38.32 68.99 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 120.823 0.344 . . . . 0.0 110.507 175.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -73.14 -33.55 65.57 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.028 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.98 -62.16 1.89 Allowed 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.54 -177.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 4.3 t -70.58 -17.09 62.91 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-O 121.306 0.574 . . . . 0.0 111.129 178.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.82 -55.08 9.33 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 32.6 p -97.53 -8.32 29.38 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 121.017 -0.273 . . . . 0.0 110.767 -176.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . 0.265 0.0 OUTLIER 78.84 30.45 0.35 Allowed 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 127.021 2.128 . . . . 0.0 110.241 -176.799 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -92.6 140.56 29.42 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 113.969 -1.469 . . . . 0.0 110.23 -176.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.411 HG23 ' O ' ' A' ' 117' ' ' ASP . 43.0 mm -94.02 140.44 16.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.612 ' HA ' HG23 ' A' ' 45' ' ' ILE . 11.5 t -95.8 129.5 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -177.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 13.1 tt -127.78 135.99 61.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -137.24 158.23 24.25 Favored Glycine 0 N--CA 1.417 -2.61 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 177.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -117.25 102.7 9.49 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -176.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 59.0 t30 69.75 -31.55 0.21 Allowed 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 124.222 1.009 . . . . 0.0 112.924 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.457 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 1.7 m -49.51 -42.58 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 C-N-CA 124.028 0.931 . . . . 0.0 113.396 177.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.598 ' HA ' ' HG ' ' A' ' 120' ' ' LEU . 49.9 mtp180 69.94 176.44 0.07 OUTLIER Pre-proline 0 CA--C 1.537 0.456 0 O-C-N 123.886 0.741 . . . . 0.0 112.65 175.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.476 ' HG3' HD12 ' A' ' 118' ' ' ILE . 9.3 Cg_endo -99.25 177.55 0.33 Allowed 'Trans proline' 0 N--CA 1.432 -2.104 0 C-N-CA 121.828 1.685 . . . . 0.0 112.581 178.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -82.84 155.5 24.13 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 168.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.457 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -59.09 -28.84 66.87 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 120.755 0.312 . . . . 0.0 111.642 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.572 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 28.1 m-80 -81.1 -35.39 31.71 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 177.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.4 -42.9 95.85 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 120.799 0.333 . . . . 0.0 110.843 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 17.0 pttp -62.98 -20.69 65.51 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-O 121.089 0.471 . . . . 0.0 110.91 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.572 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 24.8 mtm180 -84.25 -51.68 6.83 Favored 'General case' 0 N--CA 1.392 -3.372 0 C-N-CA 124.593 1.157 . . . . 0.0 109.228 175.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -51.33 -51.52 53.66 Favored 'General case' 0 CA--C 1.477 -1.841 0 C-N-CA 125.34 1.456 . . . . 0.0 110.503 -178.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.502 ' HB2' HD13 ' A' ' 86' ' ' ILE . . . -49.49 -48.55 47.86 Favored 'General case' 0 CA--C 1.502 -0.877 0 O-C-N 124.842 1.339 . . . . 0.0 112.206 -177.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -78.14 -33.02 50.64 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.384 -172.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 48.0 t -81.44 5.77 16.65 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 176.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.512 ' O ' ' HB ' ' A' ' 90' ' ' THR . 12.3 mt-10 -123.46 12.76 9.41 Favored 'General case' 0 N--CA 1.417 -2.105 0 C-N-CA 124.771 1.228 . . . . 0.0 112.339 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 10.4 mmmm 65.62 10.81 7.01 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 174.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.3 m -115.69 132.97 63.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-O 121.574 0.702 . . . . 0.0 112.492 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.411 ' O ' HG23 ' A' ' 95' ' ' ILE . 28.1 t70 -94.81 126.16 39.94 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.367 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.574 HG22 ' HB ' ' A' ' 96' ' ' VAL . 7.8 pt -94.11 131.86 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-O 121.408 0.623 . . . . 0.0 110.518 178.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 7.0 tpp180 -102.7 115.85 31.41 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.958 -177.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.598 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -155.05 166.91 32.1 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 177.932 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.408 ' O ' ' HB2' ' A' ' 122' ' ' ARG . 40.2 t-80 -93.48 109.87 21.46 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.438 -178.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 121' ' ' HIS . 30.2 ttt180 170.09 113.72 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.766 0 O-C-N 124.93 1.394 . . . . 0.0 109.17 173.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 13.6 tt -118.2 170.96 6.94 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 178.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 9.4 tp -56.15 -23.33 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 CA-C-N 119.006 0.821 . . . . 0.0 110.921 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -83.58 74.84 10.08 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 121.829 0.823 . . . . 0.0 109.081 174.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -137.64 99.51 3.95 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.285 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 25.5 m -69.39 118.51 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.587 177.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 43.8 pt -90.78 127.08 43.45 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 CA-C-O 121.227 0.537 . . . . 0.0 110.77 -177.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -85.7 83.74 7.78 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 175.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -86.38 -32.2 21.08 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.038 -175.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 31.0 pt -126.93 154.06 36.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.279 -176.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -83.14 127.62 33.76 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 174.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -75.73 -11.89 60.08 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -174.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -108.2 149.84 28.03 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.126 0.488 . . . . 0.0 110.888 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 59.1 ttp . . . . . 0 C--N 1.304 -1.4 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.566 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 8.1 p30 . . . . . 0 CA--C 1.51 -0.577 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -87.2 -54.52 4.27 Favored 'General case' 0 C--N 1.316 -0.849 0 O-C-N 123.315 0.384 . . . . 0.0 110.703 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -131.13 -61.64 0.92 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.509 0.671 . . . . 0.0 109.708 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -101.83 164.71 11.58 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.455 -174.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 93.0 mt -87.84 -9.09 54.84 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.339 0.59 . . . . 0.0 109.896 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 102.47 7.4 45.74 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.913 -0.661 . . . . 0.0 113.421 177.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.7 p -99.57 129.3 45.71 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 122.674 -0.309 . . . . 0.0 110.707 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -60.46 -46.3 90.56 Favored 'General case' 0 C--O 1.245 0.857 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.95 77.85 1.95 Allowed Glycine 0 N--CA 1.429 -1.817 0 N-CA-C 108.386 -1.886 . . . . 0.0 108.386 173.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.4 m -64.59 138.76 58.58 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 123.324 0.65 . . . . 0.0 111.5 -175.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.7 m 70.35 35.48 2.01 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.11 0.964 . . . . 0.0 110.772 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.411 ' HE ' ' HB3' ' A' ' 12' ' ' ARG . 7.1 ptp180 -78.98 -17.38 55.51 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.679 0.752 . . . . 0.0 110.281 175.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.1 m -111.36 169.83 3.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 173.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -78.78 133.21 37.1 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 175.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.1 mt -76.38 -16.94 59.6 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -174.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -114.81 116.72 29.06 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 122.184 0.992 . . . . 0.0 111.818 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -120.42 87.02 2.67 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.968 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.564 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 25.0 mp0 -127.45 23.04 6.4 Favored 'General case' 0 CA--C 1.486 -1.506 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.477 ' HD2' ' O ' ' A' ' 19' ' ' ARG . 2.6 tmm_? -66.32 -16.18 63.84 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.411 -177.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.9 m -129.47 26.44 5.36 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 176.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.549 HG12 ' HG3' ' A' ' 24' ' ' ARG . 2.7 p -65.95 -39.25 84.07 Favored 'Isoleucine or valine' 0 C--N 1.357 0.933 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.581 -176.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.4 tptp 172.82 114.69 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 178.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.6 t 47.18 39.75 8.86 Favored 'General case' 0 CA--C 1.567 1.634 0 C-N-CA 125.149 1.38 . . . . 0.0 112.995 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.613 ' HE ' ' HA ' ' A' ' 24' ' ' ARG . 0.9 OUTLIER -95.36 -6.03 41.98 Favored 'General case' 0 C--O 1.24 0.579 0 O-C-N 120.978 -1.076 . . . . 0.0 110.552 -179.537 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.5 t -96.74 -26.49 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 172.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.0 m 60.36 82.57 0.16 Allowed 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.35 1.06 . . . . 0.0 111.899 -176.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.7 mt -130.55 19.44 5.2 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.941 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -70.5 128.06 34.85 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 177.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 76.19 14.86 2.41 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.819 1.248 . . . . 0.0 110.445 -173.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.2 mt 64.7 -83.54 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 126.059 1.744 . . . . 0.0 112.297 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.474 ' CE2' ' HA ' ' A' ' 33' ' ' GLN . 39.5 t80 -163.17 137.61 6.23 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -175.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.464 ' CD ' ' H ' ' A' ' 32' ' ' GLU . 0.2 OUTLIER -91.93 2.95 56.21 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.199 0.523 . . . . 0.0 111.197 -176.375 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.474 ' HA ' ' CE2' ' A' ' 31' ' ' PHE . 35.7 tt0 71.86 -79.32 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 125.458 1.503 . . . . 0.0 112.074 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 63.3 mt 40.44 76.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.253 1.277 0 C-N-CA 124.507 1.123 . . . . 0.0 111.964 -178.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.61 121.33 5.0 Favored 'General case' 0 N--CA 1.424 -1.745 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.014 -177.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -116.73 112.55 21.34 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 175.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -117.5 -136.67 5.66 Favored Glycine 0 C--N 1.302 -1.322 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.418 -178.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -82.76 147.97 28.11 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 123.108 0.563 . . . . 0.0 109.784 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 22.0 ptp -86.6 111.93 21.1 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.455 177.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -91.46 -21.89 20.7 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.51 -175.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -104.19 104.55 14.48 Favored 'General case' 0 N--CA 1.435 -1.208 0 O-C-N 123.897 0.748 . . . . 0.0 109.949 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.564 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 59.4 tp -97.53 110.3 22.88 Favored 'General case' 0 N--CA 1.409 -2.486 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 175.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.558 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 57.7 m-80 -94.71 152.87 18.11 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -178.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.404 HD12 HD11 ' A' ' 61' ' ' LEU . 78.7 mt -138.59 164.57 29.13 Favored 'General case' 0 C--O 1.245 0.849 0 CA-C-O 121.814 0.816 . . . . 0.0 112.35 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.506 HD12 ' O ' ' A' ' 75' ' ' HIS . 0.2 OUTLIER -127.0 135.39 63.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 174.464 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.444 ' CG1' ' HA ' ' A' ' 54' ' ' VAL . 92.1 t -118.61 127.91 75.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.048 -177.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 41.5 mtpt -144.92 140.89 28.59 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.76 175.18 13.14 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -178.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -84.47 -25.68 28.73 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 122.2 1.0 . . . . 0.0 108.94 177.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 99.0 t -101.61 122.54 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.246 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 174.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.709 ' O ' HG22 ' A' ' 54' ' ' VAL . 17.4 tt0 -62.9 -40.72 98.43 Favored 'General case' 0 C--O 1.192 -1.941 0 CA-C-O 120.602 0.239 . . . . 0.0 111.411 -175.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -73.75 -3.03 62.28 Favored Glycine 0 C--N 1.29 -2.0 0 C-N-CA 118.314 -1.898 . . . . 0.0 114.151 -177.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.4 m -80.72 -24.02 39.08 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 176.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.709 HG22 ' O ' ' A' ' 51' ' ' GLN . 3.3 m -77.14 -47.09 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.767 0 CA-C-N 114.579 -1.191 . . . . 0.0 107.827 176.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -57.13 -48.04 79.64 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.295 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.48 -31.2 72.15 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.333 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.442 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 24.3 tp -79.78 -41.3 26.81 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.239 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 54' ' ' VAL . 53.2 t -53.56 -43.96 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.512 0.725 . . . . 0.0 111.921 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.88 -29.07 70.29 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.44 -13.07 28.39 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 121.325 0.583 . . . . 0.0 110.106 -177.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -96.13 -33.65 11.98 Favored 'General case' 0 N--CA 1.418 -2.064 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.494 -176.174 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -75.52 -14.69 60.42 Favored 'General case' 0 C--N 1.313 -1.002 0 O-C-N 122.066 -0.396 . . . . 0.0 111.59 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -96.76 5.18 51.12 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -178.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.533 ' HB ' ' O ' ' A' ' 71' ' ' VAL . 23.4 mt -78.29 78.93 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -174.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -121.09 -33.15 3.78 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.339 -1.3 . . . . 0.0 108.167 170.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.3 t -72.06 -7.36 9.28 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 CA-C-N 114.408 -1.269 . . . . 0.0 112.059 -172.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -83.59 -9.04 59.17 Favored 'General case' 0 C--N 1.312 -1.048 0 O-C-N 121.689 -0.632 . . . . 0.0 110.849 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.41 13.23 63.8 Favored Glycine 0 CA--C 1.503 -0.7 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.5 p -153.07 149.85 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.974 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 64' ' ' ILE . 62.9 mtt180 -103.27 121.83 43.53 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.624 0.726 . . . . 0.0 110.959 -178.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 46.7 t -130.49 128.88 64.19 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.791 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 177.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 58.8 tttp -153.06 158.5 42.05 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.844 -174.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.441 HG12 HG13 ' A' ' 58' ' ' VAL . 1.2 pp -93.94 152.29 3.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 -177.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.454 HD11 ' OD1' ' A' ' 43' ' ' ASN . 27.7 mm -115.69 -27.26 2.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.839 177.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.506 ' O ' HD12 ' A' ' 45' ' ' ILE . 18.0 t-160 -157.69 135.91 11.0 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -169.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -142.48 129.34 20.58 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.426 ' O ' ' HA ' ' A' ' 47' ' ' LYS . . . -161.91 159.37 26.63 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 120.714 0.293 . . . . 0.0 110.477 -178.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.8 p -94.58 103.46 14.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 175.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -175.88 175.81 47.42 Favored Glycine 0 N--CA 1.425 -2.08 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -177.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.546 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -90.19 178.62 6.12 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.448 HG21 HG21 ' A' ' 118' ' ' ILE . 3.7 mp -82.38 108.16 15.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 69.5 p -100.42 169.13 9.3 Favored 'General case' 0 N--CA 1.421 -1.885 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -58.83 -28.66 66.25 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.804 0.842 . . . . 0.0 110.254 176.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.0 t -71.58 -37.41 71.02 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.485 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -70.93 -36.05 72.49 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 121.634 0.73 . . . . 0.0 110.225 -177.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.55 HG21 ' HA ' ' A' ' 111' ' ' ALA . 54.3 mt -69.35 -34.6 63.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.426 -177.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 66.5 m -63.99 -19.36 65.11 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 120.471 -0.492 . . . . 0.0 112.152 174.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.41 HD21 HG21 ' A' ' 74' ' ' ILE . 2.2 tm? -79.9 -36.04 37.05 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 173.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.93 -54.18 49.83 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.31 -177.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.508 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 10.1 t -74.52 -12.88 60.59 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.917 178.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.76 -58.7 3.12 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.95 0.405 . . . . 0.0 111.815 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 26.4 m -98.12 5.14 48.92 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.432 -177.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 72.43 33.05 1.51 Allowed 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 122.094 0.949 . . . . 0.0 110.041 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -94.75 170.26 9.57 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 113.938 -1.483 . . . . 0.0 109.71 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 36.6 pt -130.93 148.08 33.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 173.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.474 ' HA ' HG23 ' A' ' 45' ' ' ILE . 3.4 t -100.62 126.79 54.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.973 -175.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.593 ' HA ' ' O ' ' A' ' 119' ' ' ARG . 66.0 mt -112.13 135.78 50.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.448 ' HA3' HD11 ' A' ' 81' ' ' ILE . . . -132.55 140.16 11.58 Favored Glycine 0 N--CA 1.434 -1.486 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.745 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -107.36 100.12 9.58 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -176.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.2 t30 72.91 -36.19 0.35 Allowed 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 125.332 1.453 . . . . 0.0 111.922 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.403 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 3.5 m -50.76 -50.63 22.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 124.698 1.199 . . . . 0.0 112.664 177.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.546 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 76.4 mtp180 67.73 177.21 0.06 OUTLIER Pre-proline 0 CA--C 1.559 1.312 0 O-C-N 123.731 0.644 . . . . 0.0 111.541 176.002 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.47 ' HG3' HD12 ' A' ' 118' ' ' ILE . 5.3 Cg_endo -94.82 173.58 1.31 Allowed 'Trans proline' 0 CA--C 1.5 -1.183 0 C-N-CA 121.59 1.527 . . . . 0.0 113.985 -177.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -77.48 160.91 28.33 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 113.965 -1.471 . . . . 0.0 107.335 168.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.486 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -67.35 -29.68 69.29 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -176.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.521 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 10.3 m-80 -86.72 -35.55 19.17 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.08 -50.42 66.83 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.441 175.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 61.2 pttt -56.97 -24.71 55.16 Favored 'General case' 0 CA--C 1.565 1.527 0 C-N-CA 122.697 0.399 . . . . 0.0 112.075 -178.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.521 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 14.1 mtm180 -86.27 -46.84 9.96 Favored 'General case' 0 N--CA 1.386 -3.628 0 C-N-CA 125.201 1.401 . . . . 0.0 108.93 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.11 -42.39 69.39 Favored 'General case' 0 C--O 1.201 -1.477 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.425 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.55 ' HA ' HG21 ' A' ' 86' ' ' ILE . . . -48.78 -44.86 39.27 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 124.475 1.109 . . . . 0.0 111.406 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -77.82 -32.83 52.46 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 114.874 -1.057 . . . . 0.0 112.277 -175.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 48.3 t -83.13 4.86 24.66 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 176.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.508 ' O ' ' HB ' ' A' ' 90' ' ' THR . 23.2 mt-10 -123.1 12.08 9.57 Favored 'General case' 0 CA--C 1.464 -2.341 0 C-N-CA 124.496 1.118 . . . . 0.0 112.883 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 26.7 mtpp 66.25 7.99 5.28 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 173.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.1 m -115.41 155.47 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.324 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -174.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -111.99 124.68 52.92 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.457 -178.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.47 HD12 ' HG3' ' A' ' 103' ' ' PRO . 9.3 pt -96.16 133.07 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.626 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.024 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.593 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 41.0 ttt85 -119.36 125.32 48.74 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.458 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -142.6 168.41 19.8 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.085 -177.596 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -96.8 113.46 25.02 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -75.26 -49.3 19.7 Favored 'General case' 0 C--O 1.216 -0.707 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . 0.291 9.3 tp 49.98 85.04 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.202 0 C-N-CA 125.538 1.535 . . . . 0.0 114.41 178.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 15.1 tt -165.45 -27.19 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.984 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 70.08 -74.05 0.09 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.723 1.209 . . . . 0.0 112.38 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -120.0 133.15 55.63 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 28.9 m -82.55 -30.39 9.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 C-N-CA 120.493 -0.483 . . . . 0.0 109.733 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.6 pp -136.43 169.85 19.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 C-N-CA 123.405 0.682 . . . . 0.0 109.92 176.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -140.68 168.62 19.37 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 120.79 0.329 . . . . 0.0 111.593 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -77.86 128.54 34.12 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.838 177.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 64.6 mt 73.17 -58.43 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 125.09 1.356 . . . . 0.0 110.751 -177.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -167.26 -39.97 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 123.743 0.817 . . . . 0.0 110.129 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -164.84 161.11 20.14 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -178.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -86.47 -67.3 0.82 Allowed 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 175.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 87.8 mtp . . . . . 0 C--N 1.316 -0.885 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 174.307 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 8.7 t30 . . . . . 0 CA--C 1.497 -1.08 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -87.82 100.08 12.59 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-O 121.319 0.581 . . . . 0.0 109.735 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -83.41 -38.68 21.61 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -92.12 95.01 9.51 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.735 176.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.7 pp -82.58 -20.84 35.72 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.07 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.73 90.63 1.63 Allowed Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 175.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.5 t -102.32 176.18 5.27 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 120.785 0.326 . . . . 0.0 111.063 -173.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 72.84 -58.73 0.59 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.936 1.694 . . . . 0.0 112.307 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.49 55.88 22.87 Favored Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.3 m -139.29 3.13 2.13 Favored 'General case' 0 C--N 1.314 -0.938 0 O-C-N 122.688 -0.301 . . . . 0.0 111.546 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.7 t -95.5 -5.36 43.06 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 176.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.583 ' O ' HG23 ' A' ' 13' ' ' VAL . 15.1 ptp180 -162.02 164.48 28.23 Favored 'General case' 0 N--CA 1.406 -2.659 0 N-CA-C 104.193 -2.521 . . . . 0.0 104.193 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 12' ' ' ARG . 2.5 t 169.9 109.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 C-N-CA 128.228 2.611 . . . . 0.0 108.046 174.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.7 t70 65.23 77.95 0.29 Allowed 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 122.345 1.069 . . . . 0.0 110.972 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.9 tp -100.22 -50.01 4.09 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.503 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -99.97 159.89 14.74 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.033 -176.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -126.64 133.22 51.05 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.412 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -86.37 -37.23 18.64 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 68.87 -73.11 0.09 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.676 1.59 . . . . 0.0 111.037 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 t -155.8 30.13 0.37 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.5 m 50.68 -169.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 126.447 1.899 . . . . 0.0 111.85 -172.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 87.4 tttt 72.49 -74.41 0.09 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.339 1.056 . . . . 0.0 111.195 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 23.7 p -93.88 21.16 6.87 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.24 0.543 . . . . 0.0 110.852 -178.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -56.53 -39.03 72.7 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.23 177.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.3 m -125.46 -59.6 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.863 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.9 p -171.1 148.67 2.76 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 106.311 -1.736 . . . . 0.0 106.311 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -144.93 117.4 8.54 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -93.22 99.47 12.02 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -76.19 112.75 12.99 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.75 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 49.3 tp -158.26 89.42 0.99 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.402 ' O ' ' HB2' ' A' ' 32' ' ' GLU . 71.4 t80 -118.82 76.72 1.12 Allowed 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.396 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 31' ' ' PHE . 8.5 tp10 162.94 149.52 0.01 OUTLIER 'General case' 0 C--O 1.245 0.842 0 C-N-CA 126.791 2.036 . . . . 0.0 106.729 175.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 -135.09 153.58 51.97 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 120.826 0.346 . . . . 0.0 111.928 178.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.6 tp -63.12 135.36 27.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.637 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -96.07 154.38 17.28 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -67.06 -27.7 67.6 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.928 0.87 . . . . 0.0 108.72 176.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.07 -177.48 32.61 Favored Glycine 0 N--CA 1.405 -3.426 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.917 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -83.18 72.02 10.16 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-O 121.417 0.627 . . . . 0.0 109.401 -178.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 14.9 tpt -67.27 -56.03 11.51 Favored 'General case' 0 C--O 1.243 0.742 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 178.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -127.15 122.34 33.9 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-N 114.071 -1.422 . . . . 0.0 107.746 173.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -94.65 142.36 27.53 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 174.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 47.2 tp -93.26 93.2 8.09 Favored 'General case' 0 N--CA 1.395 -3.216 0 N-CA-C 102.761 -3.051 . . . . 0.0 102.761 170.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 72' ' ' LYS . 18.2 t30 -106.57 115.97 31.12 Favored 'General case' 0 C--N 1.28 -2.413 0 CA-C-N 113.869 -1.514 . . . . 0.0 107.641 -168.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 93.8 mt -123.36 172.86 8.36 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 122.146 0.974 . . . . 0.0 113.106 -172.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.658 HG23 ' HA ' ' A' ' 96' ' ' VAL . 1.1 tt -122.21 134.99 63.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 114.55 -1.204 . . . . 0.0 110.162 178.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 98.6 t -110.14 120.94 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 CA-C-O 121.496 0.665 . . . . 0.0 110.543 -177.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 28.1 mtpp -140.62 114.61 9.06 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.289 1.036 . . . . 0.0 109.614 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -131.05 167.02 19.78 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.575 -176.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -73.08 -35.59 66.68 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.997 0.903 . . . . 0.0 109.02 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 88.5 t -95.56 124.7 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 176.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.734 ' O ' HG22 ' A' ' 54' ' ' VAL . 24.1 tt0 -62.63 -40.52 97.26 Favored 'General case' 0 C--O 1.194 -1.858 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.071 -177.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -75.67 0.67 60.55 Favored Glycine 0 C--N 1.279 -2.617 0 C-N-CA 118.241 -1.933 . . . . 0.0 114.071 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.4 t -87.53 -22.77 24.66 Favored 'General case' 0 N--CA 1.418 -2.059 0 N-CA-C 106.036 -1.839 . . . . 0.0 106.036 174.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.734 HG22 ' O ' ' A' ' 51' ' ' GLN . 3.9 m -73.0 -43.81 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.847 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 174.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -57.57 -54.87 41.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.222 -1.354 . . . . 0.0 110.636 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.65 -41.05 89.68 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.211 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.5 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 40.3 tp -73.38 -37.92 65.83 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 120.049 -0.661 . . . . 0.0 110.67 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.468 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 39.9 t -59.01 -45.17 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.58 -19.73 64.01 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.661 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.3 -10.91 20.79 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.697 0.76 . . . . 0.0 109.957 -177.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.5 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -105.27 -27.94 11.23 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 114.638 -1.164 . . . . 0.0 110.21 -175.125 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 12.9 pt20 -84.16 -11.35 56.72 Favored 'General case' 0 C--N 1.315 -0.904 0 O-C-N 121.904 -0.497 . . . . 0.0 111.422 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -86.87 5.36 37.23 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.327 0.584 . . . . 0.0 110.038 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.461 HG21 ' HB ' ' A' ' 71' ' ' VAL . 24.1 mm -83.05 93.45 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.78 0 CA-C-O 121.908 0.861 . . . . 0.0 110.81 -176.026 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -141.83 -41.14 0.36 Allowed 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.499 -1.228 . . . . 0.0 107.762 174.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.9 t -80.87 87.03 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 172.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 178.49 -31.36 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -170.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.31 -42.1 2.85 Favored Glycine 0 CA--C 1.501 -0.813 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.862 177.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 50.4 t -94.83 143.82 11.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 177.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 -93.74 110.8 22.42 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-O 121.447 0.641 . . . . 0.0 109.898 -178.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.461 ' HB ' HG21 ' A' ' 64' ' ' ILE . 39.0 t -110.9 116.02 51.39 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.698 0 N-CA-C 103.237 -2.875 . . . . 0.0 103.237 171.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 4.5 ttpm? -141.04 164.04 31.34 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.661 -171.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.407 HG23 ' HG ' ' A' ' 61' ' ' LEU . 1.6 pp -100.03 158.35 3.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.714 176.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.3 mt -117.62 -41.57 2.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.999 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -154.56 131.42 10.82 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.626 -169.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -124.99 125.12 43.39 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 124.215 1.006 . . . . 0.0 108.449 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 47' ' ' LYS . . . -148.57 145.91 28.04 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.3 p -94.87 94.83 4.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-O 122.754 1.264 . . . . 0.0 110.049 177.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.24 175.09 47.36 Favored Glycine 0 N--CA 1.404 -3.445 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.597 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -89.22 175.47 7.34 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.416 ' CG2' HD11 ' A' ' 86' ' ' ILE . 1.7 mp -72.87 116.95 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 CA-C-O 121.19 0.519 . . . . 0.0 110.151 -177.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.9 t -123.43 155.51 37.3 Favored 'General case' 0 N--CA 1.403 -2.778 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.48 -26.98 68.67 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -173.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.4 t -65.14 -29.0 69.81 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.278 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -82.04 -32.58 30.39 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.542 0.687 . . . . 0.0 109.522 177.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.637 HD13 ' HB2' ' A' ' 111' ' ' ALA . 41.5 mt -68.17 -29.87 45.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.253 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.407 ' HA ' ' OE2' ' A' ' 114' ' ' GLU . 42.6 m -58.8 -24.31 61.67 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 174.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -76.54 -34.45 58.53 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 175.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.407 ' HB3' HG21 ' A' ' 116' ' ' VAL . . . -56.42 -57.23 13.21 Favored 'General case' 0 C--O 1.191 -1.984 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.039 -177.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.626 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 1.9 t -66.29 -30.63 71.09 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 120.37 -0.532 . . . . 0.0 112.095 176.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.02 -55.83 25.23 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -177.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 33.7 m -101.34 5.11 42.13 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.972 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 64.36 37.71 8.22 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.828 0.851 . . . . 0.0 109.965 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -93.78 156.47 16.65 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.284 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.1 mp -108.19 136.5 43.5 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 176.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.658 ' HA ' HG23 ' A' ' 45' ' ' ILE . 14.3 t -93.58 103.93 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -176.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 51.4 mt -94.82 112.37 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.824 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -103.18 134.98 12.07 Favored Glycine 0 N--CA 1.414 -2.777 0 N-CA-C 109.984 -1.247 . . . . 0.0 109.984 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.414 ' C ' ' H ' ' A' ' 101' ' ' VAL . 98.4 m-85 -104.15 94.45 5.38 Favored 'General case' 0 C--N 1.281 -2.399 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.237 -173.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 71.69 -22.72 0.19 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 125.626 1.571 . . . . 0.0 112.995 178.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.574 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 2.7 m -54.62 -48.99 70.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 178.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.597 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 37.2 mtp180 72.6 171.14 0.11 Allowed Pre-proline 0 CA--C 1.552 1.048 0 O-C-N 123.863 0.727 . . . . 0.0 111.822 178.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.451 ' HG3' HD12 ' A' ' 118' ' ' ILE . 13.7 Cg_endo -100.62 -173.17 0.11 Allowed 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.43 2.087 . . . . 0.0 113.504 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -106.75 176.89 5.02 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.275 -1.33 . . . . 0.0 107.444 170.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.505 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -74.2 -12.11 60.48 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 113.701 1.001 . . . . 0.0 113.701 -173.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.474 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 8.8 t30 -101.33 -40.35 7.16 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.07 -46.12 82.74 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 123.355 0.41 . . . . 0.0 110.882 175.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -54.38 -34.56 61.46 Favored 'General case' 0 CA--C 1.562 1.433 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.798 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.505 ' HG3' ' O ' ' A' ' 105' ' ' ALA . 15.7 mtm180 -79.45 -49.77 11.8 Favored 'General case' 0 N--CA 1.386 -3.642 0 C-N-CA 126.118 1.767 . . . . 0.0 109.541 -178.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.55 -43.69 68.64 Favored 'General case' 0 C--O 1.203 -1.355 0 CA-C-N 113.944 -1.48 . . . . 0.0 110.53 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.637 ' HB2' HD13 ' A' ' 86' ' ' ILE . . . -50.56 -47.22 57.88 Favored 'General case' 0 CA--C 1.489 -1.382 0 O-C-N 124.532 1.145 . . . . 0.0 111.356 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -79.23 -30.59 43.28 Favored 'General case' 0 C--N 1.277 -2.583 0 CA-C-N 114.754 -1.112 . . . . 0.0 112.691 -172.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 35.2 t -84.68 4.72 31.21 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-O 122.069 0.937 . . . . 0.0 108.511 176.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.626 ' O ' ' HB ' ' A' ' 90' ' ' THR . 23.3 mt-10 -118.21 17.01 14.02 Favored 'General case' 0 CA--C 1.46 -2.493 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.581 177.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 47.7 mtmt 66.55 7.83 5.37 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 174.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.407 HG21 ' HB3' ' A' ' 89' ' ' ALA . 11.3 m -117.62 171.92 5.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.951 -176.154 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -131.67 143.68 50.46 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.525 HG22 ' HB ' ' A' ' 96' ' ' VAL . 5.6 pt -101.98 138.01 27.78 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.519 179.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 13.6 ttm180 -114.46 111.84 22.05 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -172.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.401 ' CD1' ' HA ' ' A' ' 102' ' ' ARG . 3.1 mm? -111.3 123.14 49.6 Favored 'General case' 0 CA--C 1.478 -1.818 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.067 -174.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 31.5 t-80 68.55 94.57 0.07 Allowed 'General case' 0 CA--C 1.544 0.749 0 O-C-N 124.754 1.284 . . . . 0.0 111.114 175.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 63.89 -173.35 0.17 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.39 1.076 . . . . 0.0 111.923 -176.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 29.6 pt -102.18 -172.78 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 O-C-N 122.017 -0.427 . . . . 0.0 110.802 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 47.0 mm -70.37 -49.37 54.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 CA-C-O 121.162 0.506 . . . . 0.0 109.813 -175.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -81.41 101.75 10.05 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 172.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -74.07 101.09 3.79 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.861 -170.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 60.6 t -103.64 121.72 55.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.873 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.2 mp -88.09 111.56 22.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -79.85 105.54 11.22 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -132.45 107.62 8.61 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.548 0.69 . . . . 0.0 109.835 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 22.7 pt -122.44 -11.15 8.07 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.74 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.81 10.07 12.24 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.75 -1.113 . . . . 0.0 109.657 -177.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -83.07 106.29 14.76 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.906 -175.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -110.06 -13.08 14.45 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.876 0.846 . . . . 0.0 108.955 174.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 89.3 mtp . . . . . 0 C--N 1.31 -1.126 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 -179.001 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.512 -0.503 0 N-CA-C 110.677 -0.12 . . . . 0.0 110.677 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 58.32 -165.06 0.18 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.789 0.436 . . . . 0.0 111.216 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -91.57 114.85 27.49 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 173.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -69.99 120.5 15.8 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.7 pp -139.87 177.72 7.76 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 120.654 0.264 . . . . 0.0 111.329 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -177.71 -45.08 0.07 OUTLIER Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.618 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.0 p -69.51 81.01 0.4 Allowed 'General case' 0 C--O 1.246 0.908 0 CA-C-O 121.63 0.729 . . . . 0.0 112.924 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 8' ' ' ARG . 36.4 mmt180 -117.4 132.58 56.55 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 176.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.33 80.33 1.43 Allowed Glycine 0 N--CA 1.421 -2.304 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 -173.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.0 m -65.27 -30.56 71.44 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.593 0.711 . . . . 0.0 110.612 -177.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 36.8 t -132.12 96.97 4.02 Favored 'General case' 0 N--CA 1.411 -2.421 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -141.32 -159.98 1.03 Allowed 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 37.1 t 66.45 63.5 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 C-N-CA 124.643 1.177 . . . . 0.0 108.249 -174.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.4 t70 72.56 119.65 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 113.509 -1.678 . . . . 0.0 111.875 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.9 mt -84.98 169.88 13.58 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.93 -176.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.54 134.93 45.47 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.676 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.3 -178.08 5.04 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.842 -175.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.437 ' HA ' ' HG3' ' A' ' 24' ' ' ARG . 49.0 tt0 76.6 -12.04 1.09 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.543 1.137 . . . . 0.0 112.928 177.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -50.75 -42.73 57.83 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -176.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.0 t -108.51 4.53 24.26 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.4 t 45.0 69.3 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.538 0 C-N-CA 124.965 1.306 . . . . 0.0 110.524 -171.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.3 tptt -135.04 141.63 46.19 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 103.913 -2.625 . . . . 0.0 103.913 175.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.6 p 61.46 29.16 18.29 Favored 'General case' 0 C--N 1.313 -0.981 0 O-C-N 124.127 0.892 . . . . 0.0 110.326 -176.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.437 ' HG3' ' HA ' ' A' ' 18' ' ' GLN . 24.5 mmm180 -113.34 22.81 13.87 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.098 -177.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.1 t -75.36 -30.7 22.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.768 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.7 m 60.34 84.34 0.12 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.23 1.012 . . . . 0.0 112.426 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -94.03 75.0 4.11 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -101.75 -22.96 14.28 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.398 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -81.04 -17.44 50.2 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 122.198 0.999 . . . . 0.0 109.055 178.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.7 mp -101.88 139.92 36.87 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 176.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -118.35 144.15 46.1 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -89.5 97.2 11.06 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -120.41 69.12 0.86 Allowed 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.2 mp -97.52 -60.36 2.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.716 -176.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -81.79 94.25 7.0 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.51 -175.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.483 ' O ' ' HD2' ' A' ' 40' ' ' LYS . 60.2 tt0 -96.62 -46.32 6.36 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 173.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -136.92 100.61 0.32 Allowed Glycine 0 N--CA 1.422 -2.29 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.668 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -129.23 96.14 4.23 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 176.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 62.8 mtm 63.41 32.77 14.26 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -175.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.483 ' HD2' ' O ' ' A' ' 36' ' ' GLN . 61.7 tttp -81.01 -43.56 19.41 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.407 -172.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -113.33 99.18 7.6 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.728 -171.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -118.33 130.21 55.89 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 174.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.462 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 40.7 m-80 -127.5 136.25 51.49 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.785 -178.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.1 mt -138.21 167.97 20.71 Favored 'General case' 0 C--O 1.249 1.042 0 CA-C-O 122.212 1.006 . . . . 0.0 112.595 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.456 HG21 HG22 ' A' ' 96' ' ' VAL . 0.6 OUTLIER -130.79 140.11 49.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-N 113.865 -1.516 . . . . 0.0 108.243 176.214 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.449 ' CG1' ' HA ' ' A' ' 54' ' ' VAL . 95.4 t -111.24 124.48 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.751 0 CA-C-O 121.538 0.685 . . . . 0.0 111.642 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 68.2 mttm -134.92 144.25 47.36 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.354 -1.294 . . . . 0.0 108.573 176.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -163.38 159.73 22.73 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 177.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -69.06 -32.98 72.83 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.584 0.706 . . . . 0.0 111.051 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 76.2 t -91.96 126.08 44.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.696 ' O ' HG22 ' A' ' 54' ' ' VAL . 13.6 tt0 -62.15 -50.21 72.78 Favored 'General case' 0 C--O 1.198 -1.631 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -173.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.65 0.4 56.39 Favored Glycine 0 C--N 1.29 -2.006 0 C-N-CA 118.537 -1.792 . . . . 0.0 114.427 -175.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 43.0 m -82.09 -24.87 34.96 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 175.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.696 HG22 ' O ' ' A' ' 51' ' ' GLN . 4.1 m -74.97 -46.67 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.313 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.194 175.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -63.37 -46.37 86.81 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.989 -177.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.35 -36.78 84.85 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.241 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 34.4 tp -73.26 -39.98 64.98 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.809 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.49 HG21 ' HB2' ' A' ' 76' ' ' ALA . 53.3 t -57.95 -40.01 74.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 122.738 0.415 . . . . 0.0 110.912 176.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.88 -6.98 45.67 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.52 ' O ' HG12 ' A' ' 64' ' ' ILE . . . -105.28 -34.9 7.73 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 175.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.436 ' HB3' HG13 ' A' ' 73' ' ' ILE . 0.4 OUTLIER -72.49 -32.43 66.18 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.987 -175.48 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -73.02 -18.07 61.38 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.046 0.451 . . . . 0.0 110.812 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.8 5.76 48.71 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 121.319 0.58 . . . . 0.0 111.199 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.52 HG12 ' O ' ' A' ' 60' ' ' ALA . 17.9 mm -92.71 7.18 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-O 122.867 1.318 . . . . 0.0 107.61 175.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -78.92 78.39 5.36 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.337 177.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.6 m -119.98 -176.67 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.631 -175.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -75.46 141.27 43.15 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.607 -178.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 86.99 -60.95 4.39 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.98 -0.554 . . . . 0.0 113.106 177.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.4 t -126.04 112.19 29.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 -176.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -108.34 117.33 33.87 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 176.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.518 ' O ' ' HB ' ' A' ' 64' ' ' ILE . 44.1 t -115.14 107.28 22.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 174.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -139.94 158.0 44.77 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.604 0.716 . . . . 0.0 111.78 -173.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.436 HG13 ' HB3' ' A' ' 61' ' ' LEU . 1.7 pp -94.42 159.68 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.301 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.6 mp -125.66 -28.49 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.814 175.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.409 ' CD2' HD12 ' A' ' 45' ' ' ILE . 3.7 t60 -150.41 132.76 15.54 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 120.882 0.372 . . . . 0.0 110.121 -170.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.49 ' HB2' HG21 ' A' ' 58' ' ' VAL . . . -123.86 140.48 52.94 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 47' ' ' LYS . . . -159.08 140.79 13.39 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.427 ' HB ' ' HA ' ' A' ' 51' ' ' GLN . 3.6 p -94.67 92.93 3.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-O 122.785 1.279 . . . . 0.0 107.552 175.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -177.36 176.2 47.95 Favored Glycine 0 N--CA 1.398 -3.899 0 CA-C-N 114.427 -1.26 . . . . 0.0 110.643 -177.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.64 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -83.96 -168.98 2.36 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 103' ' ' PRO . 3.3 mp -86.57 108.32 17.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.584 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 18.3 p -101.78 151.15 22.4 Favored 'General case' 0 N--CA 1.414 -2.253 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.111 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -45.59 -53.94 8.38 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.341 1.457 . . . . 0.0 113.618 -177.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.3 t -76.08 -14.43 60.2 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 120.68 0.276 . . . . 0.0 111.516 -174.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -77.57 -35.34 53.19 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.548 HD13 ' HB2' ' A' ' 111' ' ' ALA . 40.7 mt -59.73 -26.62 35.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-N 114.379 -1.282 . . . . 0.0 112.078 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.7 m -58.18 -21.57 47.95 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 175.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -80.22 -35.69 35.86 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 174.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.01 -53.54 55.74 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.577 -176.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.51 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 3.3 t -70.58 -24.7 62.82 Favored 'General case' 0 CA--C 1.557 1.247 0 O-C-N 122.017 -0.427 . . . . 0.0 111.707 177.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.32 -52.57 38.83 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -175.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.6 p -105.26 -2.37 24.14 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 122.05 0.929 . . . . 0.0 109.231 -176.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 52.7 t30 66.73 41.17 3.02 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.223 -1.808 . . . . 0.0 109.365 -177.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -94.24 130.18 40.59 Favored 'General case' 0 N--CA 1.413 -2.32 0 CA-C-N 113.597 -1.638 . . . . 0.0 106.952 177.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 37.8 pt -93.89 142.66 13.0 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.375 0 C-N-CA 119.112 -1.035 . . . . 0.0 108.996 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.484 ' HB ' HG22 ' A' ' 118' ' ' ILE . 10.6 t -93.53 106.37 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.316 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -175.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.498 ' HA ' ' O ' ' A' ' 119' ' ' ARG . 65.5 mt -101.58 117.6 47.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 177.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 120' ' ' LEU . . . -123.32 176.32 16.67 Favored Glycine 0 C--N 1.289 -2.037 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -178.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -148.09 115.93 6.39 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.359 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 8.4 t30 73.91 -27.56 0.19 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 125.586 1.554 . . . . 0.0 113.09 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.456 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 7.8 m -60.92 -53.17 52.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 C-N-CA 124.382 1.073 . . . . 0.0 113.778 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.64 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 61.9 mtp180 73.83 168.47 0.12 Allowed Pre-proline 0 N--CA 1.482 1.132 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 176.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 9.4 Cg_endo -98.41 176.04 0.45 Allowed 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 122.036 1.824 . . . . 0.0 115.006 -177.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.529 ' HB2' ' H ' ' A' ' 107' ' ' ALA . 65.5 m-20 -67.82 159.43 30.35 Favored 'General case' 0 C--O 1.249 1.067 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 168.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.459 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -66.74 -29.43 69.4 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 176.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.592 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 83.9 m-20 -84.95 -27.22 26.68 Favored 'General case' 0 C--O 1.205 -1.27 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.541 175.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.529 ' H ' ' HB2' ' A' ' 104' ' ' ASP . . . -70.11 -41.46 73.96 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.458 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 13.7 ptmm? -59.75 -21.65 61.01 Favored 'General case' 0 CA--C 1.556 1.174 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.404 178.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.592 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 96.1 mtt180 -87.28 -53.8 4.64 Favored 'General case' 0 N--CA 1.384 -3.741 0 C-N-CA 125.44 1.496 . . . . 0.0 109.849 177.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -50.28 -45.27 54.25 Favored 'General case' 0 C--O 1.196 -1.72 0 C-N-CA 124.978 1.311 . . . . 0.0 111.036 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.548 ' HB2' HD13 ' A' ' 86' ' ' ILE . . . -50.49 -46.69 57.2 Favored 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 124.194 0.934 . . . . 0.0 111.886 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -79.75 -29.52 40.55 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.949 -172.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 32.5 t -82.67 3.23 29.87 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.51 ' O ' ' HB ' ' A' ' 90' ' ' THR . 19.1 mt-10 -122.39 11.84 10.05 Favored 'General case' 0 CA--C 1.474 -1.972 0 C-N-CA 124.896 1.278 . . . . 0.0 112.82 -178.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 56.9 mttp 65.89 12.21 8.22 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 174.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.4 m -120.62 135.28 61.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-O 121.454 0.645 . . . . 0.0 112.557 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -96.51 124.4 40.49 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.455 176.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.484 HG22 ' HB ' ' A' ' 96' ' ' VAL . 9.6 pt -92.91 124.55 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.029 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 176.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 41.5 mtm180 -123.23 103.61 8.64 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-O 122.207 1.003 . . . . 0.0 111.494 -171.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.532 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -119.0 138.66 52.66 Favored 'General case' 0 N--CA 1.411 -2.387 0 CA-C-N 113.943 -1.481 . . . . 0.0 110.802 -179.384 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 72.21 -49.33 0.69 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.361 1.064 . . . . 0.0 111.347 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -118.71 131.56 56.14 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 123.669 0.788 . . . . 0.0 109.117 176.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 28.0 pt -112.15 128.74 68.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 173.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 11.5 tt -133.64 141.16 45.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -178.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 54.57 59.08 4.35 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.841 0.856 . . . . 0.0 113.037 -176.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -111.41 164.9 12.44 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 177.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . 0.266 11.9 p -80.82 74.84 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-O 122.782 1.277 . . . . 0.0 113.348 -175.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.7 tt -115.58 -40.58 2.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 113.878 -1.51 . . . . 0.0 107.095 172.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -98.26 100.79 12.11 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 105.439 -2.059 . . . . 0.0 105.439 172.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -65.17 -49.1 71.11 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 115.621 1.712 . . . . 0.0 115.621 -169.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 9.3 tp -134.81 129.98 52.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 C-N-CA 118.385 -1.326 . . . . 0.0 113.333 -173.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -95.56 100.58 12.3 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 169.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -97.42 6.26 48.49 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.72 -174.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 70.23 -47.98 0.63 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 125.097 1.359 . . . . 0.0 112.306 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 46.8 tpp . . . . . 0 C--N 1.303 -1.428 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 177.021 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 . . . . . 0 CA--C 1.496 -1.102 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -89.67 82.48 6.31 Favored 'General case' 0 CA--C 1.481 -1.703 0 CA-C-O 121.98 0.895 . . . . 0.0 110.283 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -165.96 83.79 0.31 Allowed 'General case' 0 C--N 1.276 -2.603 0 CA-C-N 113.395 -1.729 . . . . 0.0 109.463 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -149.75 93.7 2.07 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 174.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 pp -80.13 -12.87 59.62 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.835 0.826 . . . . 0.0 110.484 -178.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 176.79 171.93 40.92 Favored Glycine 0 N--CA 1.416 -2.697 0 N-CA-C 108.735 -1.746 . . . . 0.0 108.735 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.9 m -73.88 -31.05 62.96 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 121.588 0.709 . . . . 0.0 109.221 177.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 23.7 tpp180 -73.08 115.14 12.03 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.952 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.94 66.56 3.92 Favored Glycine 0 N--CA 1.438 -1.181 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 176.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.1 t -88.83 -1.04 57.89 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 122.699 0.4 . . . . 0.0 110.552 -175.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.2 t -104.45 0.81 29.32 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -108.99 -12.18 14.89 Favored 'General case' 0 CA--C 1.516 -0.358 0 O-C-N 121.983 -0.448 . . . . 0.0 111.687 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.9 m -128.8 97.34 3.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.079 0.466 . . . . 0.0 109.944 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.5 t70 66.6 98.89 0.05 OUTLIER 'General case' 0 C--O 1.235 0.326 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.538 -176.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -65.87 148.74 51.3 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.724 -175.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -86.65 137.33 32.56 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 173.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 63.16 -154.65 0.33 Allowed 'General case' 0 C--O 1.243 0.734 0 O-C-N 124.041 0.838 . . . . 0.0 109.418 -173.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 66.41 18.58 10.88 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.495 1.118 . . . . 0.0 110.261 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -80.08 -25.37 40.06 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.566 0.698 . . . . 0.0 109.381 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.3 t -102.49 0.23 33.33 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 176.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.401 ' O ' ' HG2' ' A' ' 24' ' ' ARG 0.27 10.0 m 58.74 -13.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 C-N-CA 128.151 2.58 . . . . 0.0 116.155 178.039 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 46.9 pttt -64.47 -39.35 93.64 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 178.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.1 p -98.58 89.31 4.35 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-O 121.331 0.586 . . . . 0.0 111.392 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 21' ' ' VAL . 13.1 ptm180 -150.53 136.33 18.28 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.157 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.3 t -133.81 108.01 11.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 177.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.4 m -97.93 -65.42 0.96 Allowed 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.214 0.53 . . . . 0.0 109.96 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -162.55 44.29 0.13 Allowed 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 104.174 -2.528 . . . . 0.0 104.174 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -65.49 117.0 7.36 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 113.514 -1.675 . . . . 0.0 110.247 -178.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -84.16 -2.78 57.44 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.397 0.618 . . . . 0.0 110.028 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.7 mp -89.02 74.31 8.14 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -99.36 -24.14 14.91 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -83.38 74.88 10.03 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.269 177.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -90.26 2.77 55.1 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 122.468 1.128 . . . . 0.0 109.38 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 24.2 pt -122.51 159.5 25.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-N 113.968 -1.469 . . . . 0.0 107.067 178.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -94.45 110.57 22.35 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.875 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -81.08 -36.83 29.91 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.845 -177.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 179.05 95.52 0.1 OUTLIER Glycine 0 N--CA 1.435 -1.418 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.14 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -119.15 140.78 49.58 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 26.2 mmt 68.22 167.54 0.26 Allowed 'General case' 0 C--O 1.246 0.893 0 C-N-CA 125.792 1.637 . . . . 0.0 112.227 -177.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -125.9 -171.57 2.41 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.549 -175.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -94.67 119.54 33.47 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.348 0.594 . . . . 0.0 111.089 -173.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.57 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 2.5 tm? -102.98 113.9 27.75 Favored 'General case' 0 N--CA 1.411 -2.395 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 176.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.548 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 57.5 m-80 -108.51 145.58 34.53 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.419 -175.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 91.4 mt -136.8 160.31 39.23 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-O 122.042 0.925 . . . . 0.0 112.28 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.549 HG23 ' HA ' ' A' ' 96' ' ' VAL . 0.1 OUTLIER -121.14 130.38 74.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 171.434 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 81.4 t -105.19 133.28 49.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.763 -177.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -144.63 134.38 23.6 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -150.9 168.46 24.44 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -80.39 -28.37 37.93 Favored 'General case' 0 C--N 1.316 -0.854 0 O-C-N 123.971 0.794 . . . . 0.0 109.279 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 90.0 t -96.3 124.88 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 174.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.715 ' O ' HG22 ' A' ' 54' ' ' VAL . 16.2 tt0 -64.22 -49.28 72.6 Favored 'General case' 0 C--O 1.19 -2.075 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -173.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.57 1.94 33.79 Favored Glycine 0 C--N 1.292 -1.886 0 C-N-CA 119.278 -1.439 . . . . 0.0 113.648 -177.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.2 t -83.49 -22.19 32.58 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 177.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.715 HG22 ' O ' ' A' ' 51' ' ' GLN . 4.7 m -81.91 -45.8 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.967 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.263 175.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -60.48 -47.49 85.88 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 114.691 -1.141 . . . . 0.0 111.536 -177.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.69 -32.27 73.7 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.087 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.524 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 25.8 tp -76.47 -39.81 52.19 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.882 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.411 HG13 HG12 ' A' ' 73' ' ' ILE . 24.8 t -53.3 -44.71 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 123.652 0.781 . . . . 0.0 111.573 177.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.84 -21.25 65.2 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.27 -8.52 21.19 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.401 0.62 . . . . 0.0 110.433 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.524 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -97.67 -43.04 7.35 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-N 115.03 -0.987 . . . . 0.0 108.876 -176.879 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -66.06 -20.01 66.03 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.859 0.361 . . . . 0.0 111.414 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -87.71 -0.47 56.95 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.99 -175.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.464 ' HB ' ' HB ' ' A' ' 71' ' ' VAL . 16.3 mt -84.14 93.83 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -140.9 23.62 2.23 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.7 m -97.72 145.5 9.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 114.206 -1.361 . . . . 0.0 112.692 -171.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 63.63 13.4 7.29 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 125.237 1.415 . . . . 0.0 111.995 175.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.59 -9.72 60.67 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.522 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.5 t -93.49 109.04 21.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -177.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 80.5 mtm180 -106.28 111.01 23.42 Favored 'General case' 0 N--CA 1.42 -1.962 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.078 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.57 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 41.4 t -114.22 129.72 69.72 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 177.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -140.39 153.6 46.4 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 120.069 -0.653 . . . . 0.0 111.021 -175.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.411 HG12 HG13 ' A' ' 58' ' ' VAL . 1.5 pp -94.32 141.77 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.071 175.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.403 ' CD1' ' HB3' ' A' ' 43' ' ' ASN . 67.4 mt -111.23 -25.44 3.52 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.472 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.537 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.451 ' O ' HD12 ' A' ' 45' ' ' ILE . 13.2 t-160 -161.56 142.86 11.28 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -171.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -146.4 127.32 14.49 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -147.78 153.35 39.11 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.225 -176.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.2 p -94.06 94.57 4.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 122.207 1.003 . . . . 0.0 110.848 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.09 174.43 46.77 Favored Glycine 0 N--CA 1.42 -2.421 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 176.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.541 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -85.58 176.66 8.07 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 173.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.0 mt -79.2 112.55 17.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 122.07 0.148 . . . . 0.0 110.74 -170.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 67.6 p -107.76 165.93 11.07 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.434 ' O ' ' HB ' ' A' ' 86' ' ' ILE . 13.1 pt-20 -66.69 -23.83 66.18 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -174.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.2 t -76.35 -24.82 54.24 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.151 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -70.37 -37.81 74.64 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.532 ' CG2' ' HA ' ' A' ' 111' ' ' ALA . 48.2 mm -56.59 -38.86 59.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 113.868 -1.514 . . . . 0.0 111.35 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.7 m -58.66 -28.37 65.66 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.29 -178.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -76.02 -37.22 58.67 Favored 'General case' 0 C--O 1.251 1.157 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.97 -46.98 87.69 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.135 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.496 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 7.5 t -77.8 -23.06 49.21 Favored 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.138 177.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.04 -67.68 0.43 Allowed 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -176.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 33.5 t -99.01 4.88 47.29 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.283 -175.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 70.76 68.64 0.19 Allowed 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 124.405 1.082 . . . . 0.0 112.189 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -119.86 166.87 12.72 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 113.992 -1.458 . . . . 0.0 108.546 174.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 47.9 mm -121.38 144.49 30.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 174.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.549 ' HA ' HG23 ' A' ' 45' ' ' ILE . 19.9 t -94.63 119.76 43.09 Favored 'Isoleucine or valine' 0 C--O 1.249 1.035 0 CA-C-O 120.974 0.416 . . . . 0.0 110.097 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.1 mp -107.94 111.32 35.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 174.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -99.5 136.39 12.66 Favored Glycine 0 N--CA 1.413 -2.89 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -95.41 93.37 7.19 Favored 'General case' 0 C--N 1.29 -1.996 0 C-N-CA 118.543 -1.263 . . . . 0.0 109.665 -176.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.53 ' OD1' ' HA ' ' A' ' 121' ' ' HIS . 90.9 m-20 54.59 28.91 10.52 Favored 'General case' 0 C--O 1.212 -0.918 0 C-N-CA 123.856 0.862 . . . . 0.0 111.621 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 m -96.58 -46.71 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.984 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -175.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.541 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 63.5 mtm180 75.39 155.09 0.15 Allowed Pre-proline 0 N--CA 1.471 0.583 0 C-N-CA 124.0 0.92 . . . . 0.0 111.455 178.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -89.59 167.73 5.0 Favored 'Trans proline' 0 N--CA 1.432 -2.099 0 C-N-CA 121.475 1.45 . . . . 0.0 115.269 -175.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -75.36 156.66 35.24 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 112.6 -2.091 . . . . 0.0 106.906 170.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.507 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -61.27 -32.72 72.55 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.499 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 77.6 m-20 -87.01 -24.9 24.49 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.63 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.41 -44.03 79.8 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.609 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 17.2 ptpt -57.67 -35.2 70.25 Favored 'General case' 0 CA--C 1.562 1.437 0 O-C-N 123.575 0.547 . . . . 0.0 110.465 177.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.499 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 98.2 mtt180 -72.49 -55.91 6.24 Favored 'General case' 0 N--CA 1.385 -3.686 0 C-N-CA 125.762 1.625 . . . . 0.0 109.402 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -53.82 -47.47 70.86 Favored 'General case' 0 C--O 1.198 -1.626 0 CA-C-N 113.806 -1.543 . . . . 0.0 110.067 -177.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.532 ' HA ' ' CG2' ' A' ' 86' ' ' ILE . . . -48.54 -48.09 38.78 Favored 'General case' 0 CA--C 1.489 -1.386 0 O-C-N 124.618 1.199 . . . . 0.0 111.47 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -77.36 -35.44 54.57 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.872 -174.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 45.4 t -77.61 -3.13 39.3 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 177.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.496 ' O ' ' HB ' ' A' ' 90' ' ' THR . 16.3 mt-10 -113.28 11.94 18.78 Favored 'General case' 0 CA--C 1.468 -2.188 0 C-N-CA 124.388 1.075 . . . . 0.0 112.386 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 55.3 mttp 67.48 11.77 8.55 Favored 'General case' 0 N--CA 1.416 -2.148 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 174.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.7 m -119.85 118.77 58.18 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 121.769 0.795 . . . . 0.0 112.602 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -94.22 124.92 38.55 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.514 HG22 ' HB ' ' A' ' 96' ' ' VAL . 8.4 pt -94.21 144.29 9.95 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-O 121.182 0.515 . . . . 0.0 111.059 -176.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -126.91 132.59 50.85 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.204 0.526 . . . . 0.0 109.87 -176.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.502 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -160.89 163.82 31.69 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.028 -173.278 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.53 ' HA ' ' OD1' ' A' ' 100' ' ' ASN . 28.3 t-80 71.88 113.63 0.06 Allowed 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.704 1.252 . . . . 0.0 112.727 174.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -81.1 144.58 31.6 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.647 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 25.2 pt -93.52 158.76 2.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.237 -177.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 36.0 mt 67.75 23.94 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.538 0 CA-C-O 122.915 1.341 . . . . 0.0 108.976 -176.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -102.21 -62.96 1.2 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.612 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -86.68 21.91 2.07 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 122.76 1.267 . . . . 0.0 109.647 -178.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.4 p -78.69 -13.91 13.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 176.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.8 mt -99.46 32.78 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 177.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -60.68 -34.91 75.04 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.855 177.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -96.25 117.45 30.8 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 171.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 49.7 mt -66.03 -30.26 49.41 Favored 'Isoleucine or valine' 0 C--O 1.244 0.807 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -170.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -83.44 -1.37 53.37 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -92.21 83.57 5.1 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.88 -22.19 18.78 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.554 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 92.1 mmm . . . . . 0 CA--C 1.499 -0.996 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 176.414 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 . . . . . 0 CA--C 1.505 -0.768 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -101.61 164.39 11.77 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -154.47 74.5 0.95 Allowed 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 176.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -103.45 131.27 50.69 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.144 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.1 mp -105.53 -5.18 20.43 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.497 0.665 . . . . 0.0 109.558 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.83 -89.06 1.39 Allowed Glycine 0 N--CA 1.433 -1.528 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.24 177.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.5 t -165.14 101.4 0.75 Allowed 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 121.942 0.877 . . . . 0.0 110.255 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -142.74 168.43 19.74 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 148.23 129.45 1.86 Allowed Glycine 0 N--CA 1.423 -2.184 0 C-N-CA 119.928 -1.129 . . . . 0.0 112.616 177.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.7 t -98.83 -33.85 10.72 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 177.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.1 t -76.31 -5.88 49.02 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.104 -177.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -82.17 -9.77 59.4 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 174.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.4 t -107.16 -51.86 7.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 176.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -97.58 99.05 10.43 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.6 mp -99.76 -59.44 1.71 Allowed 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.339 0.59 . . . . 0.0 111.309 -178.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -109.92 -46.46 3.47 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.943 -177.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -84.56 140.69 31.23 Favored 'General case' 0 CA--C 1.483 -1.634 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.045 -176.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.401 ' OE1' ' HG2' ' A' ' 24' ' ' ARG . 28.5 tt0 67.9 -60.02 0.41 Allowed 'General case' 0 CA--C 1.537 0.451 0 O-C-N 124.821 1.326 . . . . 0.0 112.79 178.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 56.65 -79.81 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.223 1.809 . . . . 0.0 113.345 -176.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.3 t -135.65 37.11 2.89 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . 0.456 34.1 m 62.03 62.53 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 126.454 1.902 . . . . 0.0 115.357 -178.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -93.55 -68.89 0.78 Allowed 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 171.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.428 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 8.9 p -93.06 86.71 5.48 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.184 178.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.428 ' HB2' ' O ' ' A' ' 23' ' ' THR . 3.0 tpp180 177.57 -28.41 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.637 -177.211 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 36.0 m -128.05 160.3 38.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 120.833 0.349 . . . . 0.0 111.119 -175.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.8 m -112.71 155.91 23.7 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.368 178.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 57.2 tp -138.26 142.13 39.88 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 177.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -94.18 132.38 38.78 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.154 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -100.42 -37.2 8.94 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 176.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.1 mp -97.32 137.29 36.54 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.13 177.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -128.71 148.05 50.8 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -93.75 128.56 40.04 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.095 0.474 . . . . 0.0 111.947 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -112.37 128.06 56.19 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 60.8 mt -125.87 132.11 71.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -173.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -119.22 173.77 6.74 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-O 121.178 0.513 . . . . 0.0 111.827 177.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -98.08 167.01 11.15 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.876 -177.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 144.14 -20.79 2.11 Favored Glycine 0 N--CA 1.432 -1.604 0 C-N-CA 119.876 -1.154 . . . . 0.0 113.751 176.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -136.89 144.4 43.51 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.284 -176.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 85.3 mmm 79.58 156.84 0.15 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.712 1.605 . . . . 0.0 112.327 176.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? 64.41 27.44 13.6 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.05 0.94 . . . . 0.0 109.885 -173.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -98.46 94.71 6.86 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.103 -176.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -100.23 94.91 6.46 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 176.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -96.84 134.62 39.92 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 114.539 -1.209 . . . . 0.0 109.053 -175.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 95.8 mt -137.19 158.34 44.66 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.613 0.72 . . . . 0.0 112.114 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.706 HG23 ' HA ' ' A' ' 96' ' ' VAL . 0.4 OUTLIER -122.04 132.73 70.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.808 170.509 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 97.7 t -111.05 126.84 68.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.944 -176.151 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.491 ' O ' ' HA2' ' A' ' 98' ' ' GLY . 74.1 mttt -137.0 147.7 46.43 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.283 -0.872 . . . . 0.0 108.964 173.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.21 170.74 19.81 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 120.827 0.346 . . . . 0.0 110.562 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -72.7 -29.87 63.74 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.438 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 75.8 t -113.32 134.15 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.645 ' O ' HG22 ' A' ' 54' ' ' VAL . 12.4 tt0 -60.36 -52.37 65.55 Favored 'General case' 0 C--O 1.2 -1.514 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -175.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.65 5.15 31.75 Favored Glycine 0 C--N 1.292 -1.875 0 C-N-CA 118.327 -1.892 . . . . 0.0 114.305 -176.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.0 m -88.38 -21.03 24.54 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 174.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.645 HG22 ' O ' ' A' ' 51' ' ' GLN . 3.6 m -76.26 -46.04 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 174.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -67.0 -35.6 80.29 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.475 -1.239 . . . . 0.0 112.079 -176.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.73 -33.65 75.57 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.303 0.573 . . . . 0.0 110.257 176.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 31.3 tp -79.87 -45.99 17.64 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 54' ' ' VAL . 56.1 t -55.88 -44.21 77.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 124.037 0.935 . . . . 0.0 112.264 179.049 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.66 -20.84 65.23 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -177.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.47 ' O ' HG12 ' A' ' 64' ' ' ILE . . . -98.1 -28.78 13.59 Favored 'General case' 0 C--O 1.202 -1.426 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.71 -33.82 60.35 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 114.023 -1.444 . . . . 0.0 110.265 -176.031 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -72.64 -20.66 61.23 Favored 'General case' 0 C--N 1.315 -0.908 0 O-C-N 122.061 -0.399 . . . . 0.0 111.159 177.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? -97.19 6.14 48.94 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 179.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.603 ' HB ' ' O ' ' A' ' 71' ' ' VAL . 18.7 mm -83.12 81.07 1.56 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-O 121.81 0.814 . . . . 0.0 109.416 177.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.447 ' O ' ' HG2' ' A' ' 70' ' ' ARG . 3.4 t70 -101.25 -53.48 3.01 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.235 177.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.4 t 62.02 -79.59 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.47 0 C-N-CA 125.046 1.338 . . . . 0.0 111.882 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -176.91 -71.21 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -99.94 -50.87 1.32 Allowed Glycine 0 CA--C 1.492 -1.406 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.86 -176.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.0 t -93.35 109.02 21.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 -176.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.447 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 67.9 mtt180 -114.53 133.85 55.47 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -178.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.603 ' O ' ' HB ' ' A' ' 64' ' ' ILE . 23.0 t -122.91 110.92 27.86 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 178.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -137.5 157.48 46.46 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-O 121.803 0.811 . . . . 0.0 110.589 -174.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 pp -93.83 157.97 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.177 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.413 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 74.3 mt -119.99 -31.04 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.463 177.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.499 ' CD2' HD12 ' A' ' 45' ' ' ILE . 6.4 t60 -151.55 131.97 13.78 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -171.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -139.24 129.31 25.15 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.108 0.963 . . . . 0.0 109.458 -175.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -154.08 157.59 39.21 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.505 -178.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.491 ' HB ' ' HA ' ' A' ' 51' ' ' GLN . 5.1 p -94.49 94.99 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-O 122.132 0.968 . . . . 0.0 108.611 176.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -175.57 175.95 47.33 Favored Glycine 0 N--CA 1.401 -3.698 0 C-N-CA 120.186 -1.006 . . . . 0.0 110.858 -177.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.584 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -87.46 173.12 9.31 Favored 'General case' 0 C--N 1.282 -2.35 0 O-C-N 124.112 0.536 . . . . 0.0 109.721 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.526 HD13 HD11 ' A' ' 120' ' ' LEU . 1.9 mp -75.49 107.76 6.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.65 152.66 22.85 Favored 'General case' 0 N--CA 1.401 -2.91 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.047 -178.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.432 ' HG3' ' HB2' ' A' ' 110' ' ' ALA . 41.7 tt0 -54.24 -45.39 72.31 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 124.029 0.831 . . . . 0.0 112.547 -174.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.9 p -69.8 -18.71 63.49 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -81.51 -25.37 36.01 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-O 121.603 0.716 . . . . 0.0 110.128 177.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.556 HG21 ' HA ' ' A' ' 111' ' ' ALA . 42.0 mt -72.51 -20.57 19.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.681 178.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.0 m -60.13 -26.8 66.55 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.05 175.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -79.64 -38.58 33.46 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.97 177.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.01 -58.68 6.4 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.338 -176.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.613 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 2.3 t -68.15 -28.22 67.11 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.507 177.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.04 -65.49 0.68 Allowed 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.19 0.519 . . . . 0.0 111.514 -177.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.5 m -93.69 6.0 49.78 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.888 -176.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 67.87 33.0 4.94 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.901 0.858 . . . . 0.0 109.937 177.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.53 153.1 18.05 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.439 -178.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 41.4 mm -107.72 141.21 23.52 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.146 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.706 ' HA ' HG23 ' A' ' 45' ' ' ILE . 10.7 t -94.8 120.47 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 65.8 mt -112.94 120.28 62.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 177.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 47' ' ' LYS . . . -139.83 171.06 24.0 Favored Glycine 0 N--CA 1.427 -1.902 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 178.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.444 ' C ' ' H ' ' A' ' 101' ' ' VAL . 30.4 p90 -158.77 134.57 8.87 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 117.66 0.73 . . . . 0.0 111.324 -178.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 72.84 -23.46 0.21 Allowed 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 125.403 1.481 . . . . 0.0 112.874 178.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.511 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 2.3 m -77.64 -49.71 21.56 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.099 177.162 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.584 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 53.0 mtm180 72.68 170.82 0.11 Allowed Pre-proline 0 C--N 1.352 0.692 0 O-C-N 124.164 0.915 . . . . 0.0 111.368 177.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -91.99 169.46 2.92 Favored 'Trans proline' 0 N--CA 1.443 -1.455 0 CA-C-N 120.534 1.226 . . . . 0.0 113.718 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -79.0 149.61 32.17 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 169.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.573 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -59.3 -26.53 65.05 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.625 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 27.7 m-80 -80.01 -30.7 39.66 Favored 'General case' 0 C--N 1.315 -0.926 0 O-C-N 121.847 -0.533 . . . . 0.0 109.863 177.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.67 -43.05 63.62 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.256 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 21.2 ptmt -59.81 -24.71 64.36 Favored 'General case' 0 CA--C 1.559 1.324 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.735 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.625 ' HB2' ' O ' ' A' ' 106' ' ' ASN 0.287 38.4 mtm180 -77.51 -56.77 4.25 Favored 'General case' 0 N--CA 1.395 -3.176 0 C-N-CA 125.935 1.694 . . . . 0.0 108.217 175.946 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.432 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . . . -49.46 -47.88 48.02 Favored 'General case' 0 CA--C 1.482 -1.648 0 CA-C-N 113.545 -1.661 . . . . 0.0 111.362 -176.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.556 ' HA ' HG21 ' A' ' 86' ' ' ILE . . . -48.07 -42.76 29.51 Favored 'General case' 0 CA--C 1.505 -0.777 0 O-C-N 124.518 1.136 . . . . 0.0 111.349 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -84.29 -23.7 30.19 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -173.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 30.8 t -85.59 -1.67 57.36 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-O 123.173 1.463 . . . . 0.0 107.254 174.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.613 ' O ' ' HB ' ' A' ' 90' ' ' THR . 35.2 mt-10 -120.56 13.0 11.65 Favored 'General case' 0 N--CA 1.404 -2.754 0 CA-C-N 113.638 -1.619 . . . . 0.0 112.811 -177.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 92.4 mttt 63.09 13.0 6.42 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 172.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.2 m -119.14 138.53 49.53 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-O 121.875 0.845 . . . . 0.0 112.777 -176.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -99.52 126.57 45.49 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.919 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.445 HG22 ' HB ' ' A' ' 96' ' ' VAL . 6.5 pt -94.05 133.79 33.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.255 0.55 . . . . 0.0 111.369 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -98.39 122.01 41.04 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.652 -177.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.526 HD11 HD13 ' A' ' 81' ' ' ILE . 3.8 mm? -128.68 164.77 22.2 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.617 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -67.35 125.98 27.82 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 106.257 -1.756 . . . . 0.0 106.257 169.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -63.84 140.52 58.88 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 123.906 0.754 . . . . 0.0 112.643 -173.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.9 mp -119.04 121.03 65.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 173.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 63.6 mt -93.2 94.49 4.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 C-N-CA 119.911 -0.716 . . . . 0.0 109.107 178.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 68.96 -82.86 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.416 1.486 . . . . 0.0 110.51 -178.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -149.82 143.92 25.66 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 20.6 m -92.95 168.8 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 176.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 32.4 pt -78.49 85.22 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 122.58 1.181 . . . . 0.0 109.216 173.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -89.63 8.0 33.63 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 113.876 -1.511 . . . . 0.0 109.566 -174.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -69.99 124.57 24.4 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.598 177.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 7.7 tt -73.22 -52.51 21.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -176.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -91.23 70.3 6.14 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 123.08 1.419 . . . . 0.0 112.082 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -115.72 21.17 14.12 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 112.905 -1.952 . . . . 0.0 108.485 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -111.55 81.75 1.5 Allowed 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.244 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 43.9 tpp . . . . . 0 C--N 1.304 -1.395 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 178.631 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 62.9 t30 . . . . . 0 N--CA 1.474 0.77 0 CA-C-O 121.274 0.559 . . . . 0.0 109.896 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.24 -51.58 67.17 Favored 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 124.32 1.048 . . . . 0.0 111.147 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 66.72 157.5 0.12 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.617 1.167 . . . . 0.0 112.882 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -93.1 -55.77 3.21 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.2 mt -150.25 139.18 20.97 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 124.05 0.94 . . . . 0.0 108.928 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.2 -166.74 34.14 Favored Glycine 0 C--N 1.303 -1.273 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.6 p 58.34 172.47 0.06 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.249 1.419 . . . . 0.0 114.096 -178.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 65.44 -81.42 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.66 1.184 . . . . 0.0 112.548 177.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.65 -47.49 86.19 Favored Glycine 0 CA--C 1.501 -0.782 0 N-CA-C 111.969 -0.452 . . . . 0.0 111.969 -175.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.5 p -77.92 2.92 15.92 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.154 0.502 . . . . 0.0 111.816 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.1 m -118.24 11.06 13.05 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 121.133 0.492 . . . . 0.0 110.619 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -128.69 11.33 6.18 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.408 0.623 . . . . 0.0 109.362 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.0 m -77.82 132.03 33.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.847 -173.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 59.86 40.26 19.48 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 114.916 -1.038 . . . . 0.0 113.575 176.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.3 mt -79.01 85.72 4.92 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 172.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -78.08 94.35 4.67 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.444 -177.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -111.88 -170.27 1.62 Allowed 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.209 -177.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.513 ' HA ' ' HG3' ' A' ' 24' ' ' ARG . 52.0 tt0 83.46 -20.17 0.34 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.566 1.546 . . . . 0.0 112.496 178.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -49.44 -43.58 44.86 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 124.253 1.021 . . . . 0.0 112.165 -177.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.5 m -122.09 15.87 10.74 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.029 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.6 m 44.11 23.47 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.824 0 C-N-CA 125.734 1.614 . . . . 0.0 114.174 -176.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.7 tptm -67.55 -53.11 31.16 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 123.944 0.897 . . . . 0.0 110.92 -174.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 20.1 p -103.49 31.53 4.32 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-O 121.356 0.598 . . . . 0.0 110.286 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.592 ' NE ' ' HA ' ' A' ' 24' ' ' ARG . 4.6 mmp_? -99.57 101.21 12.36 Favored 'General case' 0 CA--C 1.485 -1.521 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -174.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.7 t -102.52 94.96 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.343 0 N-CA-C 104.114 -2.55 . . . . 0.0 104.114 167.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.1 m -67.71 -31.04 70.7 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.495 -174.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.543 HD22 HD22 ' A' ' 30' ' ' LEU . 27.3 mt -109.82 82.52 1.61 Allowed 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -73.65 -37.53 65.28 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.756 -175.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -130.08 -75.93 0.54 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.543 HD22 HD22 ' A' ' 27' ' ' LEU . 17.1 tp 51.91 41.55 29.58 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.882 1.273 . . . . 0.0 111.881 177.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -67.88 111.79 4.55 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 67.97 101.56 0.05 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.63 1.172 . . . . 0.0 109.451 -171.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -94.03 140.75 29.34 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 121.721 0.772 . . . . 0.0 112.947 -174.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.2 tp -131.7 -17.86 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 CA-C-N 114.436 -1.256 . . . . 0.0 107.634 170.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 62.5 mttp 72.05 -70.29 0.16 Allowed 'General case' 0 C--N 1.357 0.919 0 C-N-CA 125.647 1.579 . . . . 0.0 110.18 -177.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -144.79 148.81 34.51 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -83.75 61.37 4.75 Favored Glycine 0 C--N 1.312 -0.798 0 N-CA-C 111.886 -0.486 . . . . 0.0 111.886 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -167.08 134.42 2.44 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 123.891 0.877 . . . . 0.0 109.092 -178.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 51.9 ttm -131.93 91.4 2.97 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 174.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -88.19 169.32 11.99 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.343 178.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -94.59 94.23 8.05 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 170.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.522 ' HB2' ' HA ' ' A' ' 71' ' ' VAL . 1.3 pt? -132.17 92.13 3.06 Favored 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -143.48 131.85 22.14 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.659 -168.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 74.7 mt -140.15 155.19 47.07 Favored 'General case' 0 C--O 1.258 1.51 0 O-C-N 123.717 0.636 . . . . 0.0 110.513 174.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.503 HG23 ' HA ' ' A' ' 96' ' ' VAL . 0.4 OUTLIER -120.6 135.07 62.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.03 176.63 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 72.5 t -109.7 126.87 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.869 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.334 -176.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.426 ' O ' ' HA2' ' A' ' 98' ' ' GLY . 23.1 mmtp -142.06 119.35 11.5 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 125.09 1.356 . . . . 0.0 109.858 -179.048 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -140.18 164.42 30.1 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -178.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.17 -17.08 44.13 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -178.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 86.1 t -105.03 122.59 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.354 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 175.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.751 ' O ' HG22 ' A' ' 54' ' ' VAL . 15.4 tm0? -58.14 -48.88 78.88 Favored 'General case' 0 C--O 1.202 -1.421 0 C-N-CA 122.948 0.499 . . . . 0.0 111.686 -174.035 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.77 0.8 81.06 Favored Glycine 0 C--N 1.285 -2.273 0 C-N-CA 117.693 -2.194 . . . . 0.0 113.912 -176.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 70.7 m -86.96 -20.86 26.68 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 176.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.751 HG22 ' O ' ' A' ' 51' ' ' GLN . 9.3 m -72.23 -43.23 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.449 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 172.289 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -62.68 -42.81 99.82 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.968 177.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.04 -35.05 78.95 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.923 0.392 . . . . 0.0 110.676 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.473 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 24.8 tp -76.57 -38.96 54.1 Favored 'General case' 0 C--O 1.208 -1.112 0 C-N-CA 120.456 -0.497 . . . . 0.0 109.711 177.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 54' ' ' VAL . 45.2 t -57.8 -44.49 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 122.746 0.419 . . . . 0.0 110.693 175.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.67 -18.18 64.74 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 123.229 0.612 . . . . 0.0 111.62 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.56 -19.71 15.37 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.153 0.501 . . . . 0.0 109.799 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.477 ' HA ' HG12 ' A' ' 64' ' ' ILE . 0.2 OUTLIER -88.85 -36.85 15.77 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.034 -175.523 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -65.43 -26.16 67.84 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.011 0.434 . . . . 0.0 110.328 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.59 6.18 48.22 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.027 -179.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.477 HG12 ' HA ' ' A' ' 61' ' ' LEU . 31.8 mm -73.07 84.95 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 175.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -160.14 92.32 0.99 Allowed 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.404 HG12 ' HG2' ' A' ' 67' ' ' GLU . 24.1 t -120.41 -76.48 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.404 ' HG2' HG12 ' A' ' 66' ' ' VAL . 9.3 pt-20 -162.62 133.16 4.73 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 114.285 -1.325 . . . . 0.0 107.761 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.99 -65.41 3.56 Favored Glycine 0 C--N 1.314 -0.641 0 N-CA-C 111.8 -0.52 . . . . 0.0 111.8 178.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.7 p -94.86 118.05 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 CA-C-O 122.044 0.926 . . . . 0.0 109.841 178.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -137.4 127.39 25.83 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 177.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.522 ' HA ' ' HB2' ' A' ' 42' ' ' LEU . 9.9 t -145.49 156.21 13.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -139.58 160.34 40.09 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 175.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.425 HG23 ' HG ' ' A' ' 61' ' ' LEU . 1.4 pp -94.43 164.05 2.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.828 178.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 70.7 mt -120.24 -41.67 2.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 121.523 0.677 . . . . 0.0 110.453 175.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.471 ' CD2' HD12 ' A' ' 45' ' ' ILE . 2.4 t60 -144.17 131.92 21.31 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.909 -168.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -142.88 134.96 27.18 Favored 'General case' 0 CA--C 1.503 -0.848 0 C-N-CA 124.26 1.024 . . . . 0.0 108.472 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.484 ' O ' HG11 ' A' ' 54' ' ' VAL . . . -160.82 164.86 31.08 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.481 ' HB ' ' HA ' ' A' ' 51' ' ' GLN . 7.1 p -93.34 98.51 8.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-O 122.423 1.106 . . . . 0.0 109.542 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.25 172.93 45.9 Favored Glycine 0 N--CA 1.406 -3.341 0 C-N-CA 120.052 -1.071 . . . . 0.0 110.572 -178.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.619 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -88.68 -166.86 1.7 Allowed 'General case' 0 N--CA 1.412 -2.33 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.489 HG13 HG11 ' A' ' 96' ' ' VAL . 2.6 mp -91.33 120.81 40.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 177.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.403 ' HA ' ' HB2' ' A' ' 107' ' ' ALA . 10.9 p -121.23 158.32 28.35 Favored 'General case' 0 C--N 1.317 -0.833 0 O-C-N 123.314 0.384 . . . . 0.0 110.157 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.73 -39.57 77.6 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -176.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.1 m -75.59 -8.74 57.53 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 120.913 0.387 . . . . 0.0 111.544 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -95.51 -30.99 13.55 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.502 HG21 ' HA ' ' A' ' 111' ' ' ALA . 31.0 mm -58.18 -31.96 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-N 114.46 -1.245 . . . . 0.0 111.355 174.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 25.8 m -58.53 -31.57 68.05 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.603 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -72.86 -35.23 67.16 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 176.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 94' ' ' ALA . . . -58.03 -52.92 63.54 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.29 -178.173 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.486 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 3.4 t -71.93 -30.96 65.87 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.995 177.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.76 -63.05 1.43 Allowed 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 40.6 m -97.62 5.26 49.68 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -175.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 67.34 28.07 8.0 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.629 0.728 . . . . 0.0 110.88 178.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . -94.46 129.85 41.07 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 36.2 pt -93.47 150.52 3.91 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.503 ' HA ' HG23 ' A' ' 45' ' ' ILE . 18.3 t -94.11 112.56 27.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-O 121.349 0.595 . . . . 0.0 109.551 -176.097 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 54.9 mt -98.88 98.1 6.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 47' ' ' LYS . . . -94.78 151.57 20.16 Favored Glycine 0 N--CA 1.427 -1.965 0 C-N-CA 119.998 -1.096 . . . . 0.0 111.852 -176.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.405 ' C ' ' H ' ' A' ' 101' ' ' VAL . 23.8 m-85 -125.22 118.37 25.87 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -176.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 64.8 t30 70.08 -33.22 0.25 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 125.449 1.5 . . . . 0.0 113.018 178.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 0.7 OUTLIER -53.35 -71.74 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 117.739 2.496 . . . . 0.0 117.739 -177.673 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.619 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 0.0 OUTLIER 84.33 164.03 0.11 Allowed Pre-proline 0 N--CA 1.478 0.949 0 C-N-CA 124.573 1.149 . . . . 0.0 111.178 -170.225 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.409 ' HD3' HD21 ' A' ' 120' ' ' LEU . 2.1 Cg_endo -88.65 171.43 5.08 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 C-N-CA 121.446 1.431 . . . . 0.0 113.509 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -83.33 155.46 23.55 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 113.728 -1.578 . . . . 0.0 107.142 169.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.448 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -60.64 -24.39 65.51 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -178.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.588 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 22.3 m-80 -89.81 -27.8 19.73 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.403 ' HB2' ' HA ' ' A' ' 82' ' ' THR . . . -71.77 -38.39 70.36 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.163 -178.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -61.79 -27.04 68.47 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.961 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.588 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 62.6 mtp180 -79.38 -55.22 5.23 Favored 'General case' 0 N--CA 1.383 -3.779 0 C-N-CA 125.382 1.473 . . . . 0.0 109.623 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.18 -46.54 69.01 Favored 'General case' 0 C--O 1.198 -1.623 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.872 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.502 ' HA ' HG21 ' A' ' 86' ' ' ILE . . . -48.53 -48.29 38.49 Favored 'General case' 0 CA--C 1.491 -1.319 0 O-C-N 124.413 1.071 . . . . 0.0 111.918 -178.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -78.7 -33.91 46.51 Favored 'General case' 0 N--CA 1.401 -2.884 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.844 -172.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 32.2 t -77.2 -0.38 24.91 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.486 ' O ' ' HB ' ' A' ' 90' ' ' THR . 21.0 mt-10 -120.23 11.47 11.57 Favored 'General case' 0 N--CA 1.405 -2.684 0 CA-C-N 114.389 -1.278 . . . . 0.0 112.558 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 52.8 mttp 67.68 8.86 6.67 Favored 'General case' 0 N--CA 1.42 -1.955 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 173.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.1 m -112.32 127.1 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.63 0 CA-C-O 121.722 0.773 . . . . 0.0 112.413 -178.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -94.75 122.66 37.6 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.011 -178.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 16.8 pt -106.59 138.44 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.465 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -151.51 147.22 26.56 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.466 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 2.9 mm? -107.32 162.75 13.62 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -170.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 40.1 t-80 76.16 -57.04 0.57 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 113.53 -1.668 . . . . 0.0 113.015 169.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 52.9 mtt-85 44.29 83.16 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 9.5 tp -101.7 2.04 10.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-O 122.418 1.104 . . . . 0.0 108.502 176.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.1 mm -76.25 90.04 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.277 -178.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 79.7 t80 177.94 -50.25 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -111.57 107.52 16.71 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 106.255 -1.758 . . . . 0.0 106.255 175.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 91.4 t 78.92 103.94 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.508 0 O-C-N 124.619 1.199 . . . . 0.0 108.274 -170.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 70.6 mt 78.96 87.9 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 C-N-CA 124.876 1.27 . . . . 0.0 111.509 -176.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -119.91 -28.52 5.16 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 173.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -83.15 32.89 0.44 Allowed 'General case' 0 C--O 1.242 0.704 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.56 -178.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 9.1 tp -84.99 -12.14 11.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 176.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -122.71 143.28 49.9 Favored 'General case' 0 N--CA 1.425 -1.675 0 CA-C-N 113.987 -1.46 . . . . 0.0 108.318 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -143.69 118.25 9.76 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.67 81.03 8.6 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.333 0.587 . . . . 0.0 109.636 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 24.7 mmt . . . . . 0 C--N 1.305 -1.344 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.219 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 . . . . . 0 N--CA 1.469 0.519 0 CA-C-O 120.774 0.321 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -129.76 137.07 50.33 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -178.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -90.55 80.44 6.02 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.939 0.876 . . . . 0.0 110.743 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -84.1 120.09 25.75 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -83.9 91.35 7.56 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -176.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.17 -179.95 16.23 Favored Glycine 0 C--N 1.301 -1.412 0 N-CA-C 110.091 -1.203 . . . . 0.0 110.091 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.0 t 49.24 -165.53 0.03 OUTLIER 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 125.551 1.54 . . . . 0.0 112.153 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.418 ' C ' ' HD3' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -132.58 -49.32 0.9 Allowed 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 176.213 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.04 83.9 0.04 OUTLIER Glycine 0 N--CA 1.421 -2.337 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.2 m -58.78 -61.95 2.23 Favored 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 123.295 0.638 . . . . 0.0 110.08 -177.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.4 m -89.61 63.0 6.08 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 121.479 0.657 . . . . 0.0 112.021 -176.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -155.58 -38.57 0.08 Allowed 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.578 173.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.7 m -89.07 -36.14 8.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 174.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -122.15 116.59 24.46 Favored 'General case' 0 N--CA 1.424 -1.755 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.153 179.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.554 ' O ' ' HG2' ' A' ' 19' ' ' ARG . 5.8 mp -113.98 117.96 32.78 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 174.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -52.51 -34.17 48.37 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.807 0.843 . . . . 0.0 111.187 -175.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -73.32 -53.6 10.42 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.898 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.484 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 34.3 tt0 -63.17 -29.62 70.93 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.782 -175.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.554 ' HG2' ' O ' ' A' ' 15' ' ' LEU . 31.5 mmm180 -65.49 -34.32 78.0 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.083 0.468 . . . . 0.0 111.528 -176.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.3 m -113.55 17.75 18.09 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . 0.266 34.7 m 48.17 16.83 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 C-N-CA 127.213 2.205 . . . . 0.0 115.171 -177.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -73.18 134.77 44.5 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 72.1 p 69.85 -0.73 2.59 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 125.889 1.676 . . . . 0.0 112.362 -175.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -103.29 -60.07 1.61 Allowed 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 174.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.7 t -103.88 93.78 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 107.229 -1.396 . . . . 0.0 107.229 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.3 m -117.17 156.43 27.68 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.321 -176.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.6 pp -112.47 13.76 20.19 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.616 0.722 . . . . 0.0 109.449 177.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.3 t70 65.45 -91.24 0.03 OUTLIER 'General case' 0 C--O 1.242 0.682 0 C-N-CA 125.22 1.408 . . . . 0.0 109.511 -174.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.7 t70 175.5 117.61 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 176.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 pp -137.18 -13.97 1.56 Allowed 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 66.51 -67.44 0.16 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.646 1.178 . . . . 0.0 110.408 -174.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -151.23 -64.03 0.19 Allowed 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 173.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 50.29 81.55 0.06 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.741 1.216 . . . . 0.0 111.791 175.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 24.7 pt -114.12 163.32 11.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-O 120.76 0.314 . . . . 0.0 110.947 -178.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -93.98 -174.75 3.5 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -178.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -138.9 74.07 1.46 Allowed 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 122.151 0.977 . . . . 0.0 109.586 171.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.39 38.94 3.12 Favored Glycine 0 CA--C 1.509 -0.336 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.741 -176.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -84.54 175.83 9.02 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.8 mtt -74.93 -55.01 6.22 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 173.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.8 tttp 61.47 23.87 14.07 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.137 0.975 . . . . 0.0 110.371 174.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -115.73 111.57 20.77 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.214 -178.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 3.0 mm? -115.83 112.05 21.39 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 171.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.427 ' HB3' HD11 ' A' ' 74' ' ' ILE . 7.1 m-20 -122.21 144.6 48.87 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.226 -172.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.49 ' HA ' ' HB1' ' A' ' 94' ' ' ALA . 4.4 pp -158.56 167.21 30.21 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 177.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.66 HG23 ' HA ' ' A' ' 96' ' ' VAL . 0.5 OUTLIER -119.5 137.21 54.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 C-N-CA 123.536 0.734 . . . . 0.0 110.889 179.151 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 65.3 t -109.1 125.35 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.282 -177.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.502 ' HE3' ' HB3' ' A' ' 77' ' ' ALA . 14.6 mmmm -138.02 122.42 18.32 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -137.92 169.04 18.48 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -177.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -81.49 -32.2 32.57 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 123.984 0.802 . . . . 0.0 109.099 -177.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.445 ' HB ' ' HB2' ' A' ' 53' ' ' SER . 96.2 t -98.08 128.75 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.985 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 174.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.771 ' O ' HG22 ' A' ' 54' ' ' VAL . 16.3 tt0 -62.3 -43.62 98.4 Favored 'General case' 0 C--O 1.191 -1.987 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.305 -175.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -75.19 -0.13 60.56 Favored Glycine 0 C--N 1.291 -1.924 0 C-N-CA 118.388 -1.863 . . . . 0.0 113.268 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.445 ' HB2' ' HB ' ' A' ' 50' ' ' VAL . 34.0 t -83.88 -23.36 31.29 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 178.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.771 HG22 ' O ' ' A' ' 51' ' ' GLN . 9.2 m -74.8 -46.54 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.158 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 172.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -56.44 -46.42 80.3 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.328 1.051 . . . . 0.0 112.241 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.88 -43.68 81.5 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.801 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.489 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 27.3 tp -74.14 -45.43 48.84 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.202 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 54' ' ' VAL . 46.6 t -54.05 -43.77 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.128 0.971 . . . . 0.0 112.493 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.42 -28.18 69.8 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.94 -26.9 18.2 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -76.1 -39.02 56.21 Favored 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 113.962 -1.472 . . . . 0.0 110.37 -176.126 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -69.88 -21.74 63.3 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.822 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.421 ' O ' HG12 ' A' ' 66' ' ' VAL . 7.3 ptpp? -93.55 2.09 56.52 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -178.295 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.2 mt -82.52 -15.31 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 121.952 0.882 . . . . 0.0 108.967 177.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -57.45 -24.79 57.74 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.294 1.038 . . . . 0.0 112.056 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.421 HG12 ' O ' ' A' ' 63' ' ' LYS . 7.1 p -88.83 -3.73 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.412 0 CA-C-O 121.223 0.535 . . . . 0.0 111.372 -177.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -93.11 172.89 8.02 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.13 -36.1 92.98 Favored Glycine 0 C--O 1.247 0.958 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 176.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.4 t -94.3 103.6 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 105.458 -2.053 . . . . 0.0 105.458 173.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 25.5 mtm180 -94.17 98.5 11.0 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.572 0.701 . . . . 0.0 110.762 -173.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 17.8 t -102.27 137.77 29.0 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -151.15 153.22 34.58 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.415 0.626 . . . . 0.0 110.306 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 pp -94.11 155.86 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.792 176.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.427 HD11 ' HB3' ' A' ' 43' ' ' ASN . 3.4 mp -115.79 -41.72 3.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-O 121.438 0.637 . . . . 0.0 109.466 177.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -143.27 122.76 13.17 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.93 -169.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -131.69 135.57 46.98 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 124.422 1.089 . . . . 0.0 108.496 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.502 ' HB3' ' HE3' ' A' ' 47' ' ' LYS . . . -161.84 163.03 29.57 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 -178.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.6 p -93.51 96.93 6.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 122.405 1.098 . . . . 0.0 109.651 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.81 175.08 47.49 Favored Glycine 0 N--CA 1.406 -3.334 0 N-CA-C 108.332 -1.907 . . . . 0.0 108.332 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.605 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -89.78 -160.72 0.71 Allowed 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 177.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.495 ' O ' ' HA ' ' A' ' 103' ' ' PRO . 33.6 mt -89.12 105.89 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.008 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -176.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 70.6 p -99.43 156.75 16.86 Favored 'General case' 0 N--CA 1.411 -2.411 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -53.14 -32.69 48.93 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 123.473 0.709 . . . . 0.0 109.947 175.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.1 m -67.42 -30.79 70.63 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.048 0.939 . . . . 0.0 111.593 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -71.98 -35.02 69.39 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-O 121.849 0.833 . . . . 0.0 109.055 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.517 HD13 ' HB2' ' A' ' 111' ' ' ALA . 61.2 mt -68.97 -31.65 51.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.749 -178.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.4 m -54.21 -35.13 62.05 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.567 174.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -75.5 -34.84 60.87 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.256 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.71 -56.96 15.19 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.611 -176.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.523 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 5.8 t -71.51 -19.83 62.14 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.822 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.99 -62.62 1.36 Allowed 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.227 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.9 m -95.36 6.5 48.84 Favored 'General case' 0 C--O 1.201 -1.462 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.425 -174.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . 0.272 0.0 OUTLIER 69.89 30.19 3.78 Favored 'General case' 0 N--CA 1.505 2.306 0 C-N-CA 126.213 1.805 . . . . 0.0 111.33 177.033 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.49 ' HB1' ' HA ' ' A' ' 44' ' ' LEU . . . -94.23 162.5 13.83 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 113.186 -1.824 . . . . 0.0 109.183 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.496 HD13 ' H ' ' A' ' 95' ' ' ILE . 0.2 OUTLIER -121.66 156.29 25.83 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 173.414 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.66 ' HA ' HG23 ' A' ' 45' ' ' ILE . 29.3 t -94.41 126.84 46.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -175.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 11.6 tt -125.69 116.08 45.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 175.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 47' ' ' LYS . . . -120.66 161.15 14.91 Favored Glycine 0 N--CA 1.406 -3.308 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.001 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -121.44 100.08 6.83 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 118.843 -1.143 . . . . 0.0 110.194 -178.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 59.21 30.35 20.09 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 122.171 0.986 . . . . 0.0 111.945 176.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.503 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 3.4 m -97.81 -47.09 12.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 114.482 -1.235 . . . . 0.0 112.163 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.605 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 17.4 mtm-85 76.67 156.33 0.15 Allowed Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 124.388 1.075 . . . . 0.0 111.496 177.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 10.1 Cg_endo -99.83 174.4 0.37 Allowed 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.445 2.096 . . . . 0.0 115.193 -175.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.409 ' HB2' ' H ' ' A' ' 107' ' ' ALA . 43.6 m-20 -69.3 154.36 42.16 Favored 'General case' 0 C--O 1.251 1.142 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 170.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.513 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -60.25 -35.62 75.9 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 120.82 0.343 . . . . 0.0 110.54 179.14 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.576 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 84.2 m-20 -82.57 -25.73 33.02 Favored 'General case' 0 C--O 1.201 -1.468 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.975 175.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.409 ' H ' ' HB2' ' A' ' 104' ' ' ASP . . . -66.69 -45.48 78.69 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.813 177.145 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 20.8 pttm -57.45 -23.36 49.27 Favored 'General case' 0 CA--C 1.571 1.779 0 CA-C-O 120.842 0.353 . . . . 0.0 110.698 177.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.576 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 71.6 mtp180 -84.53 -53.24 5.55 Favored 'General case' 0 N--CA 1.389 -3.506 0 C-N-CA 125.921 1.688 . . . . 0.0 109.201 177.276 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.07 -48.74 43.86 Favored 'General case' 0 C--O 1.186 -2.242 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.793 -178.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.517 ' HB2' HD13 ' A' ' 86' ' ' ILE . . . -48.56 -43.96 36.16 Favored 'General case' 0 CA--C 1.503 -0.83 0 O-C-N 124.284 0.99 . . . . 0.0 111.466 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -82.71 -27.4 31.22 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 114.913 -1.039 . . . . 0.0 112.315 -173.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 35.3 t -88.23 5.09 43.3 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 176.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.523 ' O ' ' HB ' ' A' ' 90' ' ' THR . 20.5 mt-10 -120.96 11.53 11.04 Favored 'General case' 0 CA--C 1.46 -2.497 0 CA-C-N 114.374 -1.285 . . . . 0.0 112.926 -178.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 68.4 mmtt 62.13 22.29 13.02 Favored 'General case' 0 N--CA 1.418 -2.043 0 O-C-N 124.144 0.903 . . . . 0.0 112.83 174.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.1 m -124.4 174.2 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.091 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -121.33 135.38 55.1 Favored 'General case' 0 CA--C 1.49 -1.352 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.917 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.464 HG22 ' HB ' ' A' ' 96' ' ' VAL . 19.3 pt -102.99 123.56 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.135 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 167.015 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -102.65 120.07 39.92 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.503 HD21 ' H ' ' A' ' 101' ' ' VAL . 2.4 tm? -144.23 136.24 26.26 Favored 'General case' 0 N--CA 1.421 -1.914 0 C-N-CA 119.951 -0.699 . . . . 0.0 110.764 -176.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.434 ' N ' HD13 ' A' ' 120' ' ' LEU . 19.5 t-80 68.94 -71.28 0.12 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.645 1.178 . . . . 0.0 113.453 173.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -85.97 81.18 8.61 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 122.534 1.159 . . . . 0.0 111.338 -176.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 54.3 mt -98.01 119.79 46.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 15.0 tt -86.44 -16.76 9.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-O 121.752 0.787 . . . . 0.0 110.147 -178.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.416 ' CG ' ' HA ' ' A' ' 129' ' ' GLU . 95.1 m-85 -92.1 168.91 11.04 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.23 176.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -100.23 -37.7 8.81 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-O 120.935 0.398 . . . . 0.0 110.122 -175.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 34.3 t -113.56 -64.12 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.104 -176.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.566 HG13 ' H ' ' A' ' 129' ' ' GLU . 9.3 pt -140.6 -60.96 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -173.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.566 ' H ' HG13 ' A' ' 128' ' ' ILE . 31.4 tt0 -177.6 39.98 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 -175.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -71.86 98.24 1.97 Allowed 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.723 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.5 pp -77.94 170.14 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 114.659 -1.155 . . . . 0.0 113.447 -173.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -79.54 -84.91 0.09 Allowed 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.551 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 160.5 -21.53 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 125.104 1.362 . . . . 0.0 108.66 -176.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 79.96 -82.24 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 125.64 1.576 . . . . 0.0 108.853 -176.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 C--N 1.307 -1.246 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 175.764 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 . . . . . 0 N--CA 1.468 0.449 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -126.49 149.84 49.1 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 176.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 74.0 t80 60.64 87.19 0.09 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.29 1.036 . . . . 0.0 109.796 -177.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -85.33 77.34 9.98 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 121.733 -0.604 . . . . 0.0 111.469 -176.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 75.7 mt 53.03 -96.77 0.06 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.38 1.072 . . . . 0.0 112.859 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.26 94.81 1.84 Allowed Glycine 0 N--CA 1.437 -1.256 0 N-CA-C 110.546 -1.021 . . . . 0.0 110.546 177.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.0 p -78.95 105.76 10.51 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 123.036 0.534 . . . . 0.0 110.817 -178.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 57.22 79.73 0.18 Allowed 'General case' 0 C--O 1.243 0.75 0 CA-C-O 122.273 1.035 . . . . 0.0 111.59 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.41 ' C ' ' H ' ' A' ' 11' ' ' SER . . . 130.29 -179.61 16.75 Favored Glycine 0 N--CA 1.429 -1.773 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -177.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.0 m 66.33 -24.66 0.1 Allowed 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 124.738 1.215 . . . . 0.0 113.784 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.41 ' H ' ' C ' ' A' ' 9' ' ' GLY . 14.4 p -147.27 20.41 1.22 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.324 0.583 . . . . 0.0 110.411 -178.221 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -165.99 116.78 1.02 Allowed 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -176.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.6 t 69.14 -62.1 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.895 1.278 . . . . 0.0 110.418 -176.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -99.69 144.2 29.04 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.161 176.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.3 mt -125.39 -45.64 1.8 Allowed 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 174.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -172.13 37.09 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 104.972 -2.233 . . . . 0.0 104.972 176.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -108.71 -162.77 0.83 Allowed 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 113.578 -1.646 . . . . 0.0 110.895 -168.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 69.59 -70.05 0.15 Allowed 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 124.844 1.258 . . . . 0.0 110.935 -178.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 51.29 -81.0 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 125.703 1.601 . . . . 0.0 113.701 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.6 p -109.4 -2.43 17.76 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 122.061 -0.399 . . . . 0.0 111.505 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.47 HG23 ' H ' ' A' ' 22' ' ' LYS 0.34 27.5 m 51.76 -77.06 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 C-N-CA 126.619 1.968 . . . . 0.0 115.859 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.47 ' H ' HG23 ' A' ' 21' ' ' VAL . 53.2 tptt 47.22 -92.89 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.205 1.802 . . . . 0.0 113.267 -176.138 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 20.9 p -76.46 -15.28 59.95 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.21 0.529 . . . . 0.0 111.35 -177.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -65.53 -20.84 66.5 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 178.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 22' ' ' LYS . 34.0 m -86.87 -41.82 15.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.888 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.7 m -160.89 143.13 12.49 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 124.271 1.028 . . . . 0.0 108.337 177.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.9 mp -101.09 138.09 38.58 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -178.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.6 t70 69.18 175.87 0.28 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.2 1.4 . . . . 0.0 111.909 176.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -94.8 -34.02 12.65 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 123.235 0.614 . . . . 0.0 109.494 177.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.9 mp -105.19 167.05 9.98 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.952 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -104.6 -54.81 2.45 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 64.27 -174.23 0.17 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 175.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.53 ' HA ' ' OE1' ' A' ' 33' ' ' GLN . 10.5 mm-40 72.55 19.36 4.16 Favored 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 125.189 1.396 . . . . 0.0 111.142 -176.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.6 mm -75.11 -38.52 42.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 174.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 67.32 -77.76 0.04 OUTLIER 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 113.387 -1.733 . . . . 0.0 112.268 176.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -139.75 141.21 36.85 Favored 'General case' 0 N--CA 1.413 -2.308 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -175.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.22 -161.43 24.46 Favored Glycine 0 N--CA 1.418 -2.553 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 175.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -82.46 -38.8 23.43 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 4.3 mpp? 51.04 -94.42 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 113.918 -1.492 . . . . 0.0 112.34 -172.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp 61.41 21.27 11.87 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 122.596 1.189 . . . . 0.0 108.776 -174.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.453 ' OE1' ' HB3' ' A' ' 70' ' ' ARG . 3.7 tp10 -140.45 127.51 20.85 Favored 'General case' 0 N--CA 1.409 -2.52 0 CA-C-N 113.239 -1.8 . . . . 0.0 106.714 -173.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 3.6 mm? -94.66 101.46 13.32 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 175.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.522 ' OD1' HD11 ' A' ' 74' ' ' ILE . 40.2 m-80 -94.24 144.65 25.33 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.103 -174.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.435 HD12 HD11 ' A' ' 61' ' ' LEU . 80.9 mt -133.41 160.16 38.2 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.682 0.753 . . . . 0.0 111.121 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.529 HG23 ' HA ' ' A' ' 96' ' ' VAL . 0.5 OUTLIER -124.97 133.4 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.852 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.419 173.215 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.589 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 99.4 t -113.34 127.67 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.925 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.846 -176.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -135.2 128.48 32.08 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 124.13 0.972 . . . . 0.0 108.807 -177.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -148.53 168.09 23.66 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.953 -178.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -70.1 -21.93 63.07 Favored 'General case' 0 C--O 1.242 0.699 0 O-C-N 123.946 0.778 . . . . 0.0 111.308 -178.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.4 m -130.13 140.1 49.78 Favored 'Isoleucine or valine' 0 C--O 1.246 0.892 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.594 173.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.617 ' O ' HG22 ' A' ' 54' ' ' VAL . 3.8 pp0? -68.56 -6.77 27.34 Favored 'General case' 0 C--O 1.191 -1.978 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -176.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.39 -13.27 57.44 Favored Glycine 0 N--CA 1.422 -2.29 0 C-N-CA 118.261 -1.924 . . . . 0.0 112.318 177.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.4 m -81.82 -28.98 32.84 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 176.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.617 HG22 ' O ' ' A' ' 51' ' ' GLN . 15.8 m -70.6 -44.9 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.903 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.674 174.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.611 ' HG2' ' O ' ' A' ' 51' ' ' GLN . 67.8 mm-40 -59.58 -45.48 91.73 Favored 'General case' 0 C--O 1.214 -0.789 0 O-C-N 123.42 0.45 . . . . 0.0 111.391 178.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.07 -42.15 84.9 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 123.348 0.405 . . . . 0.0 111.448 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.432 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 32.2 tp -75.4 -42.31 54.06 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.229 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.508 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 36.0 t -55.99 -45.75 80.33 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.681 0 C-N-CA 123.136 0.574 . . . . 0.0 111.185 176.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.3 -16.84 61.57 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.68 -27.87 13.79 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.435 HD11 HD12 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -80.35 -30.0 37.97 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 113.775 -1.557 . . . . 0.0 110.569 -175.069 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 12.6 pt20 -83.75 -19.25 35.46 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 121.985 -0.447 . . . . 0.0 111.434 177.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -96.37 5.93 49.86 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.344 -177.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.8 mm -58.95 103.18 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 121.419 0.628 . . . . 0.0 109.54 177.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -101.69 81.34 2.14 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.869 0.842 . . . . 0.0 110.1 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.2 t -134.79 126.35 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.596 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 176.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -88.14 148.81 24.25 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.864 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.95 -70.43 3.17 Favored Glycine 0 C--N 1.301 -1.366 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.7 t -99.35 93.2 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 176.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.453 ' HB3' ' OE1' ' A' ' 41' ' ' GLU . 29.8 ttm180 -103.28 139.98 38.01 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 28.3 t -120.06 124.89 73.58 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 178.01 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 26.7 ttpp -154.56 158.13 39.33 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.061 0.458 . . . . 0.0 110.472 -178.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 pp -93.82 156.27 3.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -173.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.522 HD11 ' OD1' ' A' ' 43' ' ' ASN . 26.7 mm -119.74 -32.44 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.464 0.65 . . . . 0.0 110.13 178.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.497 ' CD2' HD12 ' A' ' 45' ' ' ILE . 1.9 t60 -149.67 124.52 9.89 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.471 -168.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.589 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -135.96 132.25 36.15 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -155.78 155.66 33.44 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.54 -177.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.523 ' HB ' ' HB3' ' A' ' 51' ' ' GLN . 5.5 p -94.15 94.27 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 CA-C-O 122.823 1.296 . . . . 0.0 110.537 177.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.7 175.09 47.47 Favored Glycine 0 N--CA 1.405 -3.413 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.493 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . . . -82.87 167.98 17.53 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 176.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.491 HG21 HG21 ' A' ' 118' ' ' ILE . 2.4 mp -71.22 120.35 19.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -177.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.448 HG22 ' OD2' ' A' ' 85' ' ' ASP . 13.0 t -119.71 168.89 10.61 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -57.6 -34.94 69.78 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.949 0.5 . . . . 0.0 111.9 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.9 t -62.21 -29.86 70.68 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.046 0.539 . . . . 0.0 110.514 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.448 ' OD2' HG22 ' A' ' 82' ' ' THR . 49.4 m-20 -75.36 -39.41 59.31 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.414 ' CG2' ' HA ' ' A' ' 111' ' ' ALA . 39.5 mm -63.66 -32.9 58.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.515 -178.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 39.6 m -60.59 -24.05 65.16 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.527 176.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.428 HD21 HG21 ' A' ' 74' ' ' ILE . 2.4 tm? -87.98 -37.07 16.68 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.83 -58.73 6.18 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.947 -176.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.536 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 3.4 t -70.73 -26.56 63.44 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.494 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.18 -59.64 4.18 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.343 0.592 . . . . 0.0 111.901 -178.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.8 t -97.08 4.62 51.24 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.807 -175.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 67.7 32.76 5.27 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.822 0.82 . . . . 0.0 110.299 178.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -94.5 132.9 38.67 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.459 -178.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 36.3 pt -94.83 152.03 3.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 176.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.558 ' HB ' HG22 ' A' ' 118' ' ' ILE . 16.7 t -100.97 123.69 54.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.42 -172.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 7.3 tp -108.44 111.44 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 173.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -103.78 146.34 16.36 Favored Glycine 0 N--CA 1.43 -1.76 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -178.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.4 ' C ' ' H ' ' A' ' 101' ' ' VAL . 90.0 m-85 -121.84 108.98 14.11 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 117.026 0.413 . . . . 0.0 111.121 -175.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.603 ' O ' ' HD3' ' A' ' 102' ' ' ARG . 8.2 t30 67.66 -34.22 0.24 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 126.558 1.943 . . . . 0.0 113.493 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.493 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 1.7 m -51.35 -54.72 10.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 117.149 2.277 . . . . 0.0 117.149 -178.282 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.603 ' HD3' ' O ' ' A' ' 100' ' ' ASN . 1.0 OUTLIER 76.77 170.4 0.11 Allowed Pre-proline 0 N--CA 1.483 1.193 0 C-N-CA 123.958 0.903 . . . . 0.0 110.539 -171.743 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.516 ' HG3' HD12 ' A' ' 118' ' ' ILE . 9.2 Cg_endo -96.03 174.83 0.9 Allowed 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 121.712 1.608 . . . . 0.0 113.009 177.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -82.03 150.44 27.59 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 167.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.52 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -58.88 -30.3 67.65 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.143 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.539 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 16.5 m120 -81.08 -33.06 33.65 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 119.966 -0.693 . . . . 0.0 110.036 177.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.34 -42.62 98.96 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.239 177.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 20.9 ptmt -65.32 -26.29 67.99 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.984 178.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.539 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 53.6 mtp180 -75.52 -52.64 10.19 Favored 'General case' 0 N--CA 1.392 -3.353 0 C-N-CA 124.365 1.066 . . . . 0.0 109.027 177.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -53.02 -49.37 66.39 Favored 'General case' 0 C--O 1.195 -1.801 0 CA-C-N 113.947 -1.479 . . . . 0.0 110.091 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.414 ' HA ' ' CG2' ' A' ' 86' ' ' ILE . . . -47.04 -48.28 22.21 Favored 'General case' 0 CA--C 1.507 -0.681 0 O-C-N 124.568 1.167 . . . . 0.0 112.449 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.418 ' C ' ' H ' ' A' ' 114' ' ' GLU . 2.8 tm-20 -76.08 -38.79 56.6 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.3 -173.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 26.6 t -76.41 4.23 9.47 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.527 1.156 . . . . 0.0 108.707 178.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.536 ' O ' ' HB ' ' A' ' 90' ' ' THR . 15.2 mt-10 -123.21 14.06 9.69 Favored 'General case' 0 N--CA 1.398 -3.066 0 CA-C-N 114.466 -1.243 . . . . 0.0 113.019 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 96.7 mttt 66.2 7.54 4.91 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 173.029 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.5 m -114.25 147.01 18.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 C-N-CA 120.358 -0.537 . . . . 0.0 112.378 -175.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -113.09 128.7 56.56 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.702 -177.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.558 HG22 ' HB ' ' A' ' 96' ' ' VAL . 7.7 pt -97.74 133.82 38.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.079 177.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -118.33 134.77 54.76 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -178.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -118.06 132.74 56.34 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -174.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 7.2 t60 70.34 -67.84 0.23 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.684 1.594 . . . . 0.0 110.975 173.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 14.3 tpp180 178.23 -61.51 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 7.5 tp -154.4 -46.5 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 C-N-CA 120.336 -0.545 . . . . 0.0 112.117 172.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 38.6 pt -123.02 161.72 24.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.318 -177.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -149.82 91.05 1.75 Allowed 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 123.874 0.87 . . . . 0.0 108.893 178.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -135.09 144.2 47.05 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.131 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.7 p -163.21 142.61 2.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 177.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 57.3 mt 62.63 90.65 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.245 0.862 0 C-N-CA 124.218 1.007 . . . . 0.0 110.11 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -91.61 -21.19 20.95 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.898 0.856 . . . . 0.0 109.129 -175.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -78.76 96.67 5.65 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.951 178.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 61.5 mt -82.55 -45.96 19.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.48 -169.51 2.79 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.577 -179.123 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 66.35 -165.18 0.23 Allowed 'General case' 0 C--O 1.247 0.963 0 O-C-N 124.016 0.822 . . . . 0.0 111.04 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 73.78 128.89 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.18 1.392 . . . . 0.0 111.21 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 93.2 mmm . . . . . 0 C--N 1.297 -1.687 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.936 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.499 ' O ' HD23 ' A' ' 5' ' ' LEU . 3.3 m-20 . . . . . 0 C--O 1.212 -0.901 0 N-CA-C 110.821 -0.066 . . . . 0.0 110.821 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -71.39 -43.94 65.9 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 178.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -95.64 116.13 28.41 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 170.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 65.38 101.42 0.04 OUTLIER 'General case' 0 C--O 1.244 0.778 0 C-N-CA 124.531 1.132 . . . . 0.0 110.461 -173.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.499 HD23 ' O ' ' A' ' 1' ' ' ASN . 86.9 mt -70.22 102.12 2.03 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.943 -178.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.54 143.54 21.74 Favored Glycine 0 N--CA 1.424 -2.13 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.8 p -89.3 5.35 45.35 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 120.846 0.355 . . . . 0.0 110.689 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 68.82 24.65 6.46 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.464 1.106 . . . . 0.0 111.32 178.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 177.84 -167.24 37.98 Favored Glycine 0 N--CA 1.43 -1.707 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.557 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.8 p -106.39 -163.41 0.92 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.7 t -64.5 106.57 1.17 Allowed 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 175.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -138.69 -45.69 0.49 Allowed 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.296 -177.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 62.1 t -150.34 -42.07 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 103.938 -2.616 . . . . 0.0 103.938 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -73.15 173.62 9.15 Favored 'General case' 0 C--O 1.253 1.239 0 CA-C-N 112.962 -1.926 . . . . 0.0 108.617 174.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.6 mp 66.36 -103.68 0.09 Allowed 'General case' 0 C--N 1.316 -0.864 0 O-C-N 124.18 0.925 . . . . 0.0 110.282 -177.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.566 ' HA ' HH21 ' A' ' 24' ' ' ARG . 40.1 mt-30 60.72 -53.64 0.09 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 126.05 1.74 . . . . 0.0 115.217 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -56.42 137.21 53.31 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -173.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -84.43 -54.32 4.84 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.39 173.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? 62.35 -77.66 0.03 OUTLIER 'General case' 0 C--O 1.216 -0.664 0 C-N-CA 125.808 1.643 . . . . 0.0 112.483 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.7 m -131.0 23.78 4.93 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -178.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . 0.352 7.7 p 47.37 73.38 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.157 0 C-N-CA 125.83 1.652 . . . . 0.0 113.164 -177.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.584 ' HG3' ' H ' ' A' ' 23' ' ' THR . 55.0 pttt -90.97 -70.6 0.67 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.882 178.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.584 ' H ' ' HG3' ' A' ' 22' ' ' LYS . 2.6 p -97.86 8.82 44.07 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 122.313 1.054 . . . . 0.0 110.42 -179.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.566 HH21 ' HA ' ' A' ' 16' ' ' GLN . 25.1 mmt180 -99.34 19.79 14.86 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.406 177.083 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.7 p -59.44 115.93 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-O 121.7 0.762 . . . . 0.0 109.069 177.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.4 p -117.69 91.81 3.67 Favored 'General case' 0 N--CA 1.41 -2.462 0 CA-C-N 114.909 -1.042 . . . . 0.0 112.092 -174.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 82.1 mt -106.61 91.51 3.72 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 175.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 76.1 -27.92 0.18 Allowed 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 124.698 1.199 . . . . 0.0 111.642 -176.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -64.85 104.84 0.9 Allowed 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 124.056 0.942 . . . . 0.0 108.881 175.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 55.9 tp 72.74 -60.86 0.52 Allowed 'General case' 0 C--O 1.244 0.803 0 C-N-CA 125.093 1.357 . . . . 0.0 111.963 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -96.27 127.05 41.93 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 120.613 0.244 . . . . 0.0 110.656 -177.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.404 ' HG2' ' H ' ' A' ' 34' ' ' ILE . 46.6 tt0 -141.74 148.02 38.32 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -84.68 -24.83 28.82 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 117.826 0.284 . . . . 0.0 111.096 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.404 ' H ' ' HG2' ' A' ' 32' ' ' GLU . 52.8 mt 64.58 -82.34 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.287 1.435 . . . . 0.0 112.468 177.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -168.72 -76.87 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -177.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . 0.252 2.0 mp0 52.89 -84.54 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.437 0 N-CA-C 115.611 1.708 . . . . 0.0 115.611 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.75 -45.69 2.52 Favored Glycine 0 C--N 1.306 -1.094 0 N-CA-C 106.94 -2.464 . . . . 0.0 106.94 -170.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 61.34 -91.41 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 126.52 1.928 . . . . 0.0 111.792 171.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 54.8 ttm -149.85 12.71 0.78 Allowed 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -86.89 -33.42 19.76 Favored 'General case' 0 C--O 1.211 -0.972 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -101.78 106.92 17.99 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.486 -176.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 60.2 tp -110.38 104.94 13.77 Favored 'General case' 0 N--CA 1.41 -2.457 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 177.127 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.651 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 61.1 m-80 -99.83 155.62 17.56 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 4.1 pp -151.06 162.49 40.74 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.4 0.619 . . . . 0.0 112.57 177.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.615 HG23 ' HA ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -118.46 134.58 61.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.209 178.293 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 99.3 t -107.69 126.04 64.09 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.948 -176.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.8 mtpt -138.4 147.17 43.09 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.407 ' CB ' ' HB3' ' A' ' 99' ' ' PHE . . . -156.56 167.25 31.01 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -178.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -76.24 -22.83 54.7 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.846 0.832 . . . . 0.0 110.029 177.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 84.6 t -109.28 132.27 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 176.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.776 ' O ' HG22 ' A' ' 54' ' ' VAL . 16.2 tt0 -65.09 -46.2 82.1 Favored 'General case' 0 C--O 1.188 -2.18 0 C-N-CA 120.132 -0.627 . . . . 0.0 111.224 -176.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -73.74 2.65 39.38 Favored Glycine 0 C--N 1.294 -1.77 0 C-N-CA 118.753 -1.689 . . . . 0.0 114.394 -176.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.4 t -83.12 -26.12 31.3 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 176.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.776 HG22 ' O ' ' A' ' 51' ' ' GLN . 5.3 m -80.16 -45.87 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.918 0 CA-C-N 114.549 -1.205 . . . . 0.0 108.642 176.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -56.16 -48.44 76.3 Favored 'General case' 0 C--O 1.245 0.844 0 C-N-CA 124.867 1.267 . . . . 0.0 111.965 -176.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.51 -35.24 80.3 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.234 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 28.0 tp -76.1 -35.86 59.16 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.428 HG13 HG12 ' A' ' 73' ' ' ILE . 39.4 t -56.69 -43.87 80.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.747 174.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.39 -18.18 65.21 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.903 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.488 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -98.88 -21.4 16.32 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 122.384 1.087 . . . . 0.0 108.782 -177.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.42 -28.96 20.57 Favored 'General case' 0 C--N 1.275 -2.645 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.598 -177.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -83.75 -12.65 55.46 Favored 'General case' 0 C--N 1.313 -1.0 0 O-C-N 122.152 -0.342 . . . . 0.0 111.624 176.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 65.0 pttt -87.3 2.47 50.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.523 0.678 . . . . 0.0 110.137 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 30.2 mm -79.18 -42.16 23.44 Favored 'Isoleucine or valine' 0 C--O 1.243 0.744 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 58.06 -101.98 0.14 Allowed 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 125.064 1.346 . . . . 0.0 113.481 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.457 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 30.2 t -128.23 -6.6 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.497 -173.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -60.78 108.57 0.87 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.146 0.578 . . . . 0.0 112.474 -173.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.07 -89.89 1.09 Allowed Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.1 t -107.69 145.37 15.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 177.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.457 ' HG2' ' HA ' ' A' ' 66' ' ' VAL . 16.2 mtp180 -93.76 93.06 7.77 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.656 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 13.4 t -104.88 124.24 59.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -177.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -146.28 158.6 43.9 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.067 0.461 . . . . 0.0 110.565 -175.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.428 HG12 HG13 ' A' ' 58' ' ' VAL . 1.7 pp -94.03 142.82 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.715 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.412 175.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.423 HD11 ' OD1' ' A' ' 43' ' ' ASN . 34.6 mm -113.72 -27.43 2.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 CA-C-O 121.273 0.559 . . . . 0.0 109.789 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.504 ' CD2' HD12 ' A' ' 45' ' ' ILE . 5.5 t60 -160.95 125.86 3.65 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.782 -171.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.572 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -129.01 130.56 46.79 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -154.76 156.66 36.71 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.383 -178.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.7 p -94.54 97.76 7.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-O 121.947 0.879 . . . . 0.0 108.905 176.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -175.5 170.9 44.01 Favored Glycine 0 N--CA 1.413 -2.839 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.666 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . . . -84.74 -176.11 6.08 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 120.838 0.352 . . . . 0.0 110.635 -178.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.521 ' HB ' ' HB3' ' A' ' 103' ' ' PRO . 3.8 mm -87.86 97.9 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.672 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 9.7 t -98.71 147.04 25.27 Favored 'General case' 0 N--CA 1.411 -2.424 0 C-N-CA 119.749 -0.78 . . . . 0.0 109.719 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.463 ' N ' ' HB2' ' A' ' 107' ' ' ALA . 0.0 OUTLIER -47.31 -39.31 14.44 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 125.111 1.364 . . . . 0.0 112.53 178.915 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.9 m -78.8 -11.8 60.0 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -174.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -98.34 -23.52 15.58 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -177.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.559 HD13 ' HB2' ' A' ' 111' ' ' ALA . 38.6 mt -66.06 -22.18 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.644 177.176 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 47.3 t -49.59 -35.49 21.0 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.928 172.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.434 ' O ' HD22 ' A' ' 88' ' ' LEU . 2.0 tm? -70.17 -32.57 70.58 Favored 'General case' 0 C--O 1.25 1.083 0 CA-C-O 120.748 0.309 . . . . 0.0 110.843 179.052 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.47 -61.68 2.32 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.201 -176.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.563 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 4.8 t -66.02 -25.34 67.02 Favored 'General case' 0 CA--C 1.561 1.375 0 O-C-N 122.012 -0.43 . . . . 0.0 111.783 178.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.24 -55.7 16.98 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.143 0.497 . . . . 0.0 112.176 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 34.3 p -97.01 -4.62 39.4 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.238 0.542 . . . . 0.0 111.072 -176.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 72.63 33.45 1.36 Allowed 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.805 -178.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.651 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -94.34 134.49 36.78 Favored 'General case' 0 N--CA 1.419 -2.018 0 CA-C-N 114.008 -1.451 . . . . 0.0 109.931 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 35.0 pt -94.07 144.4 9.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 176.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.615 ' HA ' HG23 ' A' ' 45' ' ' ILE . 15.6 t -94.95 119.79 43.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 C-N-CA 120.186 -0.605 . . . . 0.0 110.93 -173.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.637 ' HA ' ' O ' ' A' ' 119' ' ' ARG . 24.4 pt -111.91 117.18 54.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-O 121.498 0.666 . . . . 0.0 109.748 174.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -110.9 157.22 15.1 Favored Glycine 0 N--CA 1.437 -1.281 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.825 -176.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.407 ' HB3' ' CB ' ' A' ' 48' ' ' ALA . 67.8 t80 -132.07 110.82 10.98 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -175.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.495 ' O ' ' HD3' ' A' ' 102' ' ' ARG . 27.5 t-20 70.68 -30.4 0.2 Allowed 'General case' 0 N--CA 1.506 2.354 0 C-N-CA 125.085 1.354 . . . . 0.0 114.029 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.666 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 2.5 m -58.57 -56.55 15.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 N-CA-C 117.765 2.506 . . . . 0.0 117.765 -177.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.533 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 0.6 OUTLIER 75.04 159.26 0.16 Allowed Pre-proline 0 N--CA 1.494 1.738 0 C-N-CA 124.359 1.064 . . . . 0.0 112.003 -174.642 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.521 ' HB3' ' HB ' ' A' ' 81' ' ' ILE . 4.0 Cg_endo -88.75 170.12 5.36 Favored 'Trans proline' 0 CA--C 1.502 -1.095 0 C-N-CA 122.466 2.111 . . . . 0.0 113.261 176.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -87.73 169.45 12.09 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 171.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.448 ' HA ' ' HE3' ' A' ' 108' ' ' LYS . . . -70.98 -11.45 60.98 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 -173.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.502 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 37.0 t30 -104.37 -34.11 8.4 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 176.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.463 ' HB2' ' N ' ' A' ' 83' ' ' GLU . . . -58.25 -44.34 88.3 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.152 0.501 . . . . 0.0 110.521 175.257 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.448 ' HE3' ' HA ' ' A' ' 105' ' ' ALA . 18.0 ptpt -59.15 -22.84 61.56 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.032 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.502 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 40.4 mtm180 -93.25 -50.38 5.51 Favored 'General case' 0 N--CA 1.38 -3.932 0 C-N-CA 126.108 1.763 . . . . 0.0 109.886 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.15 -45.59 68.48 Favored 'General case' 0 CA--C 1.48 -1.715 0 C-N-CA 125.551 1.541 . . . . 0.0 110.858 -177.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.559 ' HB2' HD13 ' A' ' 86' ' ' ILE . . . -49.48 -48.19 47.94 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 124.505 1.128 . . . . 0.0 111.163 -179.004 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -78.45 -28.78 46.68 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.461 -174.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 40.2 t -79.29 -3.91 48.25 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 176.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.563 ' O ' ' HB ' ' A' ' 90' ' ' THR . 27.2 mt-10 -114.08 11.2 17.59 Favored 'General case' 0 CA--C 1.464 -2.329 0 CA-C-N 114.253 -1.34 . . . . 0.0 112.498 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 55.4 mtpt 68.5 15.04 9.17 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 174.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.9 m -121.28 170.95 10.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -135.48 147.23 48.8 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 176.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.447 HG22 ' HB ' ' A' ' 96' ' ' VAL . 15.0 pt -110.4 140.67 28.46 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.299 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.871 -178.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.637 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 75.2 mtp180 -131.2 123.2 27.97 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -176.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.481 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -146.54 172.13 14.03 Favored 'General case' 0 C--N 1.292 -1.916 0 O-C-N 121.796 -0.565 . . . . 0.0 112.143 -177.495 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 70.72 23.34 4.59 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 122.087 0.946 . . . . 0.0 110.723 174.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -61.96 -11.98 16.05 Favored 'General case' 0 CA--C 1.562 1.423 0 CA-C-N 114.892 -1.049 . . . . 0.0 113.304 -175.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 13.0 tt -74.25 1.25 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.417 0 CA-C-O 122.29 1.043 . . . . 0.0 110.844 -179.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 10.2 tp -73.47 -15.74 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 173.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -73.29 126.06 29.24 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 174.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -138.31 -179.74 5.97 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.5 p -79.72 -17.69 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 176.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.47 ' O ' HD12 ' A' ' 128' ' ' ILE . 2.8 pp -77.94 122.96 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 CA-C-O 121.979 0.895 . . . . 0.0 110.771 175.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -126.32 -72.37 0.65 Allowed 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.548 -176.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -96.69 -30.31 13.3 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 73.1 mt -86.14 112.8 23.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.289 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 59.51 83.02 0.14 Allowed 'General case' 0 CA--C 1.537 0.48 0 O-C-N 124.345 1.028 . . . . 0.0 112.623 176.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -72.03 157.76 37.22 Favored 'General case' 0 C--O 1.245 0.858 0 CA-C-N 114.564 -1.198 . . . . 0.0 112.149 -177.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -99.02 -11.45 21.5 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.618 -177.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 53.7 ttm . . . . . 0 C--N 1.306 -1.312 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.4 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 . . . . . 0 CA--C 1.5 -0.963 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 57.49 92.16 0.03 OUTLIER 'General case' 0 C--O 1.246 0.891 0 O-C-N 124.2 0.938 . . . . 0.0 111.924 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -70.47 -29.55 66.13 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.047 -175.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.93 -177.66 3.46 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 177.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -78.13 -10.82 59.8 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -171.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 106.82 115.83 4.06 Favored Glycine 0 N--CA 1.42 -2.412 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -175.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.67 73.82 7.62 Favored 'General case' 0 N--CA 1.42 -1.956 0 CA-C-O 122.716 1.246 . . . . 0.0 112.748 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -85.9 5.16 34.2 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.051 176.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.45 ' O ' ' HG2' ' A' ' 12' ' ' ARG . . . -156.49 129.83 2.54 Favored Glycine 0 N--CA 1.408 -3.172 0 N-CA-C 107.408 -2.277 . . . . 0.0 107.408 175.173 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 21.3 t -87.36 -11.15 50.2 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 122.075 0.94 . . . . 0.0 108.874 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.1 p -83.62 19.74 1.56 Allowed 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.926 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 9' ' ' GLY . 13.9 ptm180 -121.4 10.95 10.62 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.158 0.504 . . . . 0.0 109.93 177.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 51.7 t -92.04 99.4 9.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -178.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 70.97 106.42 0.06 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.781 1.233 . . . . 0.0 111.436 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.4 mp -107.6 132.84 52.85 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 73.35 130.25 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 O-C-N 124.596 1.185 . . . . 0.0 111.972 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.02 107.11 8.0 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -177.068 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.441 ' O ' ' HB ' ' A' ' 21' ' ' VAL . 60.9 tt0 -87.97 -6.45 58.0 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 123.284 0.634 . . . . 0.0 112.644 -175.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -78.3 -24.59 46.62 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 173.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.4 m -98.16 63.29 1.57 Allowed 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 168.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.441 ' HB ' ' O ' ' A' ' 18' ' ' GLN . 9.5 p -68.37 1.58 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.125 0 CA-C-N 114.195 -1.366 . . . . 0.0 114.174 -169.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -54.29 -43.98 71.55 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.003 0.43 . . . . 0.0 111.078 176.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.4 p -99.03 14.9 27.58 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.846 0.832 . . . . 0.0 111.682 -178.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.569 ' NE ' ' HA ' ' A' ' 24' ' ' ARG . 4.2 mmp_? -116.63 8.01 13.73 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.674 174.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 63.9 t 70.96 104.22 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-N 113.991 -1.459 . . . . 0.0 112.498 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.4 t -158.68 165.82 33.47 Favored 'General case' 0 N--CA 1.421 -1.895 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 177.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -124.73 -177.92 3.98 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -133.57 153.61 51.52 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 176.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -77.42 130.34 36.93 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.077 0.465 . . . . 0.0 111.544 -172.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.7 tp -99.99 153.85 18.86 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.221 -175.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -107.81 138.54 43.87 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 177.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.57 113.11 24.88 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.06 176.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -96.12 88.08 4.73 Favored 'General case' 0 C--N 1.288 -2.086 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.052 178.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.2 tp -107.2 91.16 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.226 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -85.09 90.07 7.77 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -115.3 169.31 9.23 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.973 -176.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.48 127.67 5.54 Favored Glycine 0 N--CA 1.434 -1.454 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.032 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -137.24 99.66 4.04 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 67.3 mtt -111.27 6.58 20.64 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.765 -177.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -78.47 96.1 5.31 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.649 -178.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -98.89 117.77 34.15 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.425 HD23 ' H ' ' A' ' 42' ' ' LEU . 1.5 pt? -137.39 92.73 2.73 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-O 121.524 0.678 . . . . 0.0 109.683 -176.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -147.1 143.25 28.16 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -177.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.47 HD12 HD11 ' A' ' 61' ' ' LEU . 56.9 mt -140.8 160.11 40.75 Favored 'General case' 0 C--O 1.246 0.884 0 CA-C-O 121.756 0.788 . . . . 0.0 112.813 177.131 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.469 HD12 ' O ' ' A' ' 75' ' ' HIS . 0.2 OUTLIER -131.87 133.28 61.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 125.461 1.504 . . . . 0.0 107.259 177.893 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.406 HG13 HD23 ' A' ' 57' ' ' LEU . 67.1 t -112.7 138.85 40.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.207 -176.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 60.6 mttp -137.52 160.48 39.01 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 123.71 0.804 . . . . 0.0 109.267 173.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -168.5 171.52 8.91 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -82.08 -37.28 26.61 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 91.8 t -97.51 127.84 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.335 176.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.698 ' O ' HG22 ' A' ' 54' ' ' VAL . 50.1 tt0 -57.43 -45.62 84.46 Favored 'General case' 0 C--O 1.204 -1.295 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -176.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.92 -0.97 61.37 Favored Glycine 0 C--N 1.283 -2.375 0 C-N-CA 118.155 -1.974 . . . . 0.0 113.908 -177.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.1 t -85.87 -18.13 33.67 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 175.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.698 HG22 ' O ' ' A' ' 51' ' ' GLN . 3.7 m -82.37 -46.36 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.949 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 174.34 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -60.68 -47.18 87.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.309 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.79 -33.95 76.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.585 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.496 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 37.1 tp -76.62 -37.4 56.45 Favored 'General case' 0 C--O 1.209 -1.068 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.526 HG21 ' HB2' ' A' ' 76' ' ' ALA . 43.5 t -60.09 -41.41 86.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 123.234 0.614 . . . . 0.0 110.954 176.344 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.73 -25.94 68.15 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.541 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.96 -24.65 19.19 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.496 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -85.12 -30.13 24.27 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.468 -175.585 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -78.45 -13.22 59.94 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.048 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.74 5.47 51.3 Favored 'General case' 0 C--O 1.247 0.931 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.099 177.127 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.438 HG12 ' HA ' ' A' ' 61' ' ' LEU . 35.3 mm -74.74 75.2 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 122.701 1.238 . . . . 0.0 109.84 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -146.2 -47.8 0.2 Allowed 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 177.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.4 m -91.28 83.7 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 CA-C-N 114.376 -1.284 . . . . 0.0 107.607 168.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -169.24 -171.66 1.34 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 104.14 -2.541 . . . . 0.0 104.14 -174.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -76.66 -34.58 43.48 Favored Glycine 0 N--CA 1.44 -1.095 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 178.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 9.0 p -120.53 163.41 18.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 177.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.425 ' HA ' HG22 ' A' ' 64' ' ' ILE . 3.9 ptm180 -125.13 130.99 53.32 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 176.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.44 HG12 ' H ' ' A' ' 72' ' ' LYS . 3.5 t -154.18 172.42 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 -177.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.44 ' H ' HG12 ' A' ' 71' ' ' VAL . 88.0 tttt -150.69 157.22 42.71 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 175.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.409 HG12 HG13 ' A' ' 58' ' ' VAL . 1.4 pp -93.61 154.09 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.793 177.224 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 65.2 mt -112.35 -40.08 3.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-O 121.787 0.803 . . . . 0.0 109.734 177.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.469 ' O ' HD12 ' A' ' 45' ' ' ILE . 2.1 t60 -145.77 137.71 25.29 Favored 'General case' 0 N--CA 1.409 -2.497 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.463 -165.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.526 ' HB2' HG21 ' A' ' 58' ' ' VAL . . . -125.25 134.21 52.4 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 177.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 47' ' ' LYS . . . -144.27 131.68 20.9 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -178.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.1 p -94.85 93.57 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.969 0 CA-C-O 122.765 1.269 . . . . 0.0 107.699 175.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.95 176.36 48.02 Favored Glycine 0 N--CA 1.397 -3.93 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -176.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.536 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . . . -81.07 175.9 10.27 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.458 HD13 HD11 ' A' ' 120' ' ' LEU . 1.7 mp -76.93 105.32 5.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.1 p -104.58 156.51 17.9 Favored 'General case' 0 N--CA 1.403 -2.814 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.26 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.51 -33.16 72.22 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 123.953 0.901 . . . . 0.0 110.482 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.3 m -68.53 -22.42 64.51 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.849 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -97.72 -27.55 14.29 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 118.782 -1.167 . . . . 0.0 109.67 -178.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.543 HD13 ' HB2' ' A' ' 111' ' ' ALA . 79.5 mt -59.09 -27.02 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 CA-C-O 121.817 0.818 . . . . 0.0 110.433 174.29 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 34.2 m -50.59 -33.76 23.29 Favored 'General case' 0 CA--C 1.561 1.383 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.783 172.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -82.39 -35.31 27.83 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 176.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.81 -58.58 6.73 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.425 -175.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.457 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 9.6 t -78.85 -11.23 59.99 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.773 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.21 -49.14 29.57 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.394 -177.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 34.2 m -105.31 -3.63 22.53 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.102 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 71.54 35.61 1.44 Allowed 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 122.103 0.954 . . . . 0.0 110.62 -176.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -95.12 129.52 42.19 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 176.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.7 pt -93.93 144.13 10.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.487 ' HB ' HG22 ' A' ' 118' ' ' ILE . 16.5 t -102.01 132.33 48.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.766 -173.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 18.7 tt -111.87 137.88 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.782 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 173.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -132.56 146.64 18.39 Favored Glycine 0 N--CA 1.432 -1.587 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.412 ' C ' ' H ' ' A' ' 101' ' ' VAL . 91.9 m-85 -124.14 114.26 19.43 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -174.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 71.5 -36.35 0.36 Allowed 'General case' 0 N--CA 1.505 2.3 0 C-N-CA 124.458 1.103 . . . . 0.0 112.938 178.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.536 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 4.5 m -62.05 -51.23 74.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 124.982 1.313 . . . . 0.0 113.271 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.493 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 23.6 mtm180 68.32 179.03 0.05 OUTLIER Pre-proline 0 CA--C 1.551 1.012 0 O-C-N 123.74 0.65 . . . . 0.0 110.111 178.055 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -95.36 176.91 0.85 Allowed 'Trans proline' 0 N--CA 1.444 -1.411 0 CA-C-N 121.034 1.405 . . . . 0.0 113.942 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -86.75 155.13 20.46 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 106.274 -1.751 . . . . 0.0 106.274 169.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.531 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -58.02 -30.74 66.36 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 123.074 0.549 . . . . 0.0 112.086 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.572 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 25.2 t30 -82.81 -35.7 26.2 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.91 -44.75 92.0 Favored 'General case' 0 C--O 1.206 -1.212 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.744 178.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 20.1 pttm -59.39 -29.09 67.47 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-O 121.118 0.485 . . . . 0.0 110.001 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.572 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 20.5 mtm180 -74.76 -52.66 10.92 Favored 'General case' 0 N--CA 1.384 -3.754 0 C-N-CA 123.793 0.837 . . . . 0.0 109.059 179.109 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.83 -51.82 62.32 Favored 'General case' 0 C--O 1.194 -1.856 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.067 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.543 ' HB2' HD13 ' A' ' 86' ' ' ILE . . . -50.7 -48.5 58.65 Favored 'General case' 0 CA--C 1.5 -0.944 0 O-C-N 124.284 0.99 . . . . 0.0 112.143 -176.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -81.23 -25.33 36.74 Favored 'General case' 0 N--CA 1.403 -2.82 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.291 -172.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 46.9 t -87.9 5.8 38.71 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 175.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.465 ' O ' ' HB2' ' A' ' 115' ' ' LYS . 20.5 mt-10 -123.67 17.08 9.55 Favored 'General case' 0 CA--C 1.463 -2.382 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.826 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 70.5 mmtt 66.14 8.52 5.58 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 173.222 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.5 m -114.52 125.03 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-O 121.775 0.797 . . . . 0.0 113.044 -176.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -94.18 120.74 34.86 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.288 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.487 HG22 ' HB ' ' A' ' 96' ' ' VAL . 8.6 pt -93.55 131.81 39.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-O 121.089 0.471 . . . . 0.0 109.947 179.015 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -100.39 118.82 37.41 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.119 0.485 . . . . 0.0 109.744 -176.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.458 HD11 HD13 ' A' ' 81' ' ' ILE . 3.2 mm? -114.87 172.64 6.92 Favored 'General case' 0 CA--C 1.474 -1.976 0 CA-C-O 121.264 0.554 . . . . 0.0 111.102 -178.085 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 35.4 t-80 -77.56 104.56 8.17 Favored 'General case' 0 N--CA 1.413 -2.315 0 CA-C-N 114.531 -1.213 . . . . 0.0 108.899 174.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -95.69 -169.91 2.04 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.516 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 50.3 mm 79.9 -38.96 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 124.921 1.288 . . . . 0.0 108.907 -174.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 67.0 mt 69.41 -51.89 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 125.904 1.681 . . . . 0.0 114.46 171.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.402 ' HB3' ' HB ' ' A' ' 128' ' ' ILE . 63.4 m-85 -78.94 -1.42 35.2 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 122.579 0.352 . . . . 0.0 111.387 -176.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 72.62 -79.18 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.076 1.35 . . . . 0.0 108.51 -175.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 45.2 t -143.15 81.42 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 175.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.402 ' HB ' ' HB3' ' A' ' 125' ' ' TYR . 63.4 mt -140.92 82.97 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 174.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 55.21 88.01 0.04 OUTLIER 'General case' 0 C--O 1.242 0.678 0 C-N-CA 125.184 1.394 . . . . 0.0 112.139 -177.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -57.12 118.11 4.7 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.873 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . 0.259 1.7 pp -62.03 92.46 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -176.59 168.4 2.65 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 103.312 -2.848 . . . . 0.0 103.312 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -97.61 2.62 50.12 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 118.689 0.677 . . . . 0.0 110.355 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 66.82 97.18 0.05 Allowed 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.897 1.279 . . . . 0.0 111.154 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 CA--C 1.509 -0.632 0 C-N-CA 124.552 1.141 . . . . 0.0 110.549 178.574 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 . . . . . 0 CA--C 1.493 -1.234 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 71.94 154.31 0.14 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.46 1.504 . . . . 0.0 112.649 178.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -137.54 178.04 7.41 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -79.24 78.01 5.74 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 122.745 1.26 . . . . 0.0 111.737 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.6 mt -121.81 13.29 10.69 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 176.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.19 87.92 1.57 Allowed Glycine 0 N--CA 1.419 -2.467 0 CA-C-N 114.502 -1.226 . . . . 0.0 112.339 -174.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -90.41 116.8 28.63 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 175.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -132.54 122.21 24.47 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -177.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.522 ' O ' ' HG2' ' A' ' 12' ' ' ARG . . . -94.11 51.64 2.19 Favored Glycine 0 N--CA 1.434 -1.483 0 C-N-CA 121.125 -0.56 . . . . 0.0 113.089 -174.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.7 m -65.39 -39.0 91.7 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.785 0.802 . . . . 0.0 109.663 177.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.2 p -81.39 15.63 1.95 Allowed 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 114.557 -1.201 . . . . 0.0 113.964 -173.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.522 ' HG2' ' O ' ' A' ' 9' ' ' GLY . 19.3 ptt180 -99.15 -7.03 27.2 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 122.146 0.974 . . . . 0.0 108.438 174.145 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.1 t -94.99 137.58 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 176.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.5 t70 67.25 77.43 0.27 Allowed 'General case' 0 C--N 1.32 -0.693 0 O-C-N 124.698 1.249 . . . . 0.0 109.521 -176.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.3 mt -106.18 79.99 1.46 Allowed 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.747 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -88.27 -36.08 16.91 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -158.09 -83.37 0.05 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.985 174.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 63.75 -44.9 0.26 Allowed 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -40.37 -58.55 1.51 Allowed 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 -171.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.453 ' C ' ' H ' ' A' ' 22' ' ' LYS . 48.3 p -89.5 0.83 56.61 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.662 -0.648 . . . . 0.0 111.847 -176.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . 0.312 35.8 m 55.86 -6.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 C-N-CA 127.567 2.347 . . . . 0.0 115.236 -175.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.453 ' H ' ' C ' ' A' ' 20' ' ' SER . 62.8 tttp -54.2 -65.23 0.61 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.724 1.61 . . . . 0.0 111.274 -177.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.8 p -86.31 1.32 51.45 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.852 0.834 . . . . 0.0 111.487 -177.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.3 tpm_? -84.02 -42.33 16.3 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.621 179.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.0 t -97.0 -44.0 12.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.147 -177.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.4 m -127.63 170.63 12.45 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.202 -175.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.5 mp -121.55 117.82 27.72 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 174.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -79.99 66.23 5.41 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -177.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -173.16 107.02 0.15 Allowed 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 176.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.426 ' H ' HD23 ' A' ' 30' ' ' LEU . 2.4 pt? -66.28 136.61 56.08 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.706 -178.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -73.8 126.09 29.6 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.402 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -86.36 123.53 31.7 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.313 0.578 . . . . 0.0 109.622 -177.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -96.12 -25.71 15.76 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.883 -178.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 68.1 mt -125.62 104.89 13.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.577 -176.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -138.77 105.61 5.4 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 176.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -94.29 133.75 37.5 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -99.03 179.07 31.05 Favored Glycine 0 C--N 1.308 -1.018 0 C-N-CA 120.361 -0.924 . . . . 0.0 112.28 -178.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -93.2 126.23 38.21 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 51.0 ttm -109.21 125.35 52.14 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.375 -177.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -77.8 152.88 33.27 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.053 -176.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -115.31 117.51 30.65 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 169.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -93.76 114.33 26.58 Favored 'General case' 0 N--CA 1.42 -1.937 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 -177.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.757 ' HB3' HD11 ' A' ' 74' ' ' ILE . 17.7 m120 -105.39 149.51 26.04 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.277 -176.066 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.2 pp -152.39 162.35 41.31 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.919 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.613 HG23 ' HA ' ' A' ' 96' ' ' VAL . 0.1 OUTLIER -117.08 136.36 54.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 123.278 0.631 . . . . 0.0 110.636 178.626 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.411 ' CG1' ' HA ' ' A' ' 54' ' ' VAL . 85.9 t -102.06 128.07 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.015 -175.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.415 ' HB2' ' HA2' ' A' ' 98' ' ' GLY . 27.6 mmmt -134.57 136.54 43.07 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.192 -176.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.16 165.19 29.86 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -88.93 -12.56 41.3 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.606 0.717 . . . . 0.0 109.41 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 88.2 t -108.14 122.73 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 174.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.75 ' O ' HG22 ' A' ' 54' ' ' VAL . 47.8 tt0 -63.27 -40.87 98.6 Favored 'General case' 0 C--O 1.197 -1.681 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.876 -175.116 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.19 4.88 53.23 Favored Glycine 0 C--N 1.278 -2.66 0 C-N-CA 117.672 -2.204 . . . . 0.0 115.158 -176.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.8 m -87.58 -29.95 20.87 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 172.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.75 HG22 ' O ' ' A' ' 51' ' ' GLN . 12.2 m -76.55 -44.07 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 CA-C-N 114.869 -1.059 . . . . 0.0 109.011 176.286 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -55.34 -50.63 69.14 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.421 -178.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.42 -42.11 88.24 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.411 -176.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.598 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 32.3 tp -68.4 -41.36 80.6 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.944 -177.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.513 HG13 HG12 ' A' ' 73' ' ' ILE . 39.6 t -57.47 -43.69 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 122.627 0.371 . . . . 0.0 111.04 175.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.413 ' O ' ' HE3' ' A' ' 63' ' ' LYS . . . -65.34 -23.08 66.9 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.263 -177.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.41 -23.82 16.42 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.598 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -81.7 -37.25 27.65 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.269 -176.048 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -66.58 -21.21 66.14 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.046 0.451 . . . . 0.0 110.897 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.413 ' HE3' ' O ' ' A' ' 59' ' ' ALA . 18.3 ptpt -97.94 6.24 47.94 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 20.6 mm -74.74 79.28 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.651 0 CA-C-O 122.015 0.912 . . . . 0.0 110.566 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -136.22 10.72 3.27 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 176.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.5 p -72.79 -10.48 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 CA-C-N 113.906 -1.497 . . . . 0.0 112.514 -173.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -138.14 -170.07 2.71 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.78 -0.575 . . . . 0.0 110.263 -177.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -76.19 -19.38 78.54 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 121.505 -0.379 . . . . 0.0 112.169 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.2 t -95.07 118.9 42.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 176.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -95.11 124.37 39.11 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -177.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.2 t -124.58 135.78 62.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 21.6 ttmm -146.75 153.42 40.21 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 121.605 0.717 . . . . 0.0 111.42 -177.079 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.513 HG12 HG13 ' A' ' 58' ' ' VAL . 1.3 pp -94.97 169.21 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.509 174.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.757 HD11 ' HB3' ' A' ' 43' ' ' ASN . 3.3 mp -135.41 -32.03 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 172.063 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -151.1 133.45 15.41 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-O 121.234 0.54 . . . . 0.0 110.235 -168.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.5 ' HB2' HG21 ' A' ' 58' ' ' VAL . . . -124.55 141.44 52.09 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 178.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -151.02 135.42 16.96 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.377 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.8 p -93.41 92.01 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 CA-C-O 123.295 1.521 . . . . 0.0 107.906 175.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.8 175.69 47.5 Favored Glycine 0 N--CA 1.41 -3.072 0 N-CA-C 108.653 -1.779 . . . . 0.0 108.653 -177.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.621 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . . . -82.6 -179.19 7.35 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 175.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.422 ' CG2' HD11 ' A' ' 86' ' ' ILE . 3.5 mp -81.8 118.76 30.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 O-C-N 122.04 -0.412 . . . . 0.0 110.641 -178.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.458 ' O ' HG13 ' A' ' 86' ' ' ILE . 25.7 p -119.81 160.28 22.93 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 178.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.43 ' HG3' ' HA ' ' A' ' 107' ' ' ALA . 1.6 mp0 -54.07 -50.88 65.77 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.722 0.809 . . . . 0.0 112.501 -173.193 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.5 m -66.42 -19.38 65.78 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.398 0.618 . . . . 0.0 111.582 -176.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -86.27 -31.43 21.65 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -177.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.777 HD13 ' HB2' ' A' ' 111' ' ' ALA . 29.0 mt -73.11 -24.51 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.863 176.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.406 ' HA ' ' OE2' ' A' ' 114' ' ' GLU . 37.6 m -56.21 -24.6 43.05 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.094 175.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -76.56 -35.06 58.42 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 175.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.418 ' HB3' HG21 ' A' ' 116' ' ' VAL . . . -57.5 -55.54 33.53 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.406 -176.289 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.525 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 8.9 t -71.81 -24.91 61.81 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.118 179.206 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.23 -62.03 1.63 Allowed 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.014 0.435 . . . . 0.0 111.937 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 43.3 m -91.75 3.84 54.18 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -177.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 69.52 31.57 3.68 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.733 0.778 . . . . 0.0 109.807 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -93.92 139.24 31.15 Favored 'General case' 0 N--CA 1.419 -1.987 0 CA-C-N 114.451 -1.249 . . . . 0.0 109.714 -177.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 45.9 mm -94.73 142.96 12.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 176.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.613 ' HA ' HG23 ' A' ' 45' ' ' ILE . 24.8 t -94.26 118.44 40.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -176.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.534 ' HA ' ' O ' ' A' ' 119' ' ' ARG . 27.1 pt -115.71 116.28 51.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-O 121.586 0.708 . . . . 0.0 109.644 176.071 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.415 ' HA2' ' HB2' ' A' ' 47' ' ' LYS . . . -113.22 166.88 12.19 Favored Glycine 0 N--CA 1.428 -1.863 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.892 -177.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -133.17 112.63 11.89 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -177.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.404 ' H ' ' HB2' ' A' ' 121' ' ' HIS . 80.5 m-20 60.52 14.32 4.78 Favored 'General case' 0 N--CA 1.502 2.146 0 C-N-CA 124.713 1.205 . . . . 0.0 113.112 178.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.621 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 1.5 m -96.59 -50.33 11.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 -173.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.576 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 0.0 OUTLIER 75.49 163.65 0.14 Allowed Pre-proline 0 N--CA 1.479 0.994 0 C-N-CA 124.232 1.013 . . . . 0.0 111.968 -175.302 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -97.21 166.19 0.92 Allowed 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 121.974 1.783 . . . . 0.0 113.179 174.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -71.73 152.55 42.68 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 169.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.447 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -63.73 -25.01 68.0 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 117.912 0.323 . . . . 0.0 111.515 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.539 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 29.9 m-80 -88.62 -26.79 21.72 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.989 -0.684 . . . . 0.0 109.76 177.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.43 ' HA ' ' HG3' ' A' ' 83' ' ' GLU . . . -67.86 -44.34 77.33 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 121.025 0.441 . . . . 0.0 110.3 177.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.403 ' HE3' ' HA ' ' A' ' 105' ' ' ALA . 17.6 ptpt -62.16 -21.57 65.17 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.922 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.539 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 56.2 mtp180 -83.84 -51.3 7.31 Favored 'General case' 0 N--CA 1.39 -3.474 0 C-N-CA 125.129 1.372 . . . . 0.0 109.378 176.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -52.02 -48.23 64.62 Favored 'General case' 0 CA--C 1.489 -1.381 0 CA-C-N 114.403 -1.271 . . . . 0.0 110.642 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.777 ' HB2' HD13 ' A' ' 86' ' ' ILE . . . -51.72 -36.09 45.52 Favored 'General case' 0 CA--C 1.502 -0.885 0 C-N-CA 124.742 1.217 . . . . 0.0 112.17 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -78.78 -38.46 38.43 Favored 'General case' 0 N--CA 1.418 -2.029 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.788 -175.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.8 t -73.02 -9.26 58.54 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 175.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.525 ' O ' ' HB ' ' A' ' 90' ' ' THR . 28.7 mt-10 -106.4 7.8 31.3 Favored 'General case' 0 CA--C 1.472 -2.056 0 C-N-CA 124.869 1.268 . . . . 0.0 114.009 -177.039 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 93.1 mttt 67.31 7.62 5.65 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 172.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.418 HG21 ' HB3' ' A' ' 89' ' ' ALA . 4.3 m -121.63 141.26 42.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -177.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -100.26 133.31 44.85 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-O 121.403 0.62 . . . . 0.0 109.794 179.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.475 HG22 ' HB ' ' A' ' 96' ' ' VAL . 6.1 pt -97.21 139.69 19.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.596 178.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.534 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 64.9 ttt180 -131.85 128.54 38.88 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.406 ' N ' HD13 ' A' ' 120' ' ' LEU . 0.0 OUTLIER -143.52 138.06 28.92 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.239 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.404 ' HB2' ' H ' ' A' ' 100' ' ' ASN . 49.1 t60 61.36 81.4 0.19 Allowed 'General case' 0 C--O 1.243 0.737 0 O-C-N 124.469 1.105 . . . . 0.0 110.01 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.85 93.2 3.15 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.9 tp -91.04 93.52 4.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 15.0 tt -67.52 -29.8 46.68 Favored 'Isoleucine or valine' 0 C--O 1.245 0.868 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.359 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 53.7 t80 69.38 158.49 0.17 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.791 1.236 . . . . 0.0 111.342 176.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 72.49 -58.82 0.58 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.858 1.263 . . . . 0.0 113.139 178.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.9 m -95.06 24.56 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 121.971 0.891 . . . . 0.0 109.778 178.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 10.4 tp -84.6 -10.73 11.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.675 -176.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -90.72 -59.26 2.22 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -112.14 98.36 7.28 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 176.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.5 mp -73.22 -40.33 57.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 174.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -122.01 128.46 51.45 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 113.77 -1.559 . . . . 0.0 107.316 173.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -80.01 -65.24 1.03 Allowed 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.099 0.476 . . . . 0.0 110.092 -177.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -137.09 -33.26 0.76 Allowed 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 14.2 tpt . . . . . 0 C--N 1.307 -1.252 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 178.396 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 . . . . . 0 CA--C 1.503 -0.853 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -99.86 -17.31 17.69 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 119.163 -1.015 . . . . 0.0 111.239 175.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -82.49 131.82 35.21 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 176.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 67.75 25.88 7.92 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.437 1.095 . . . . 0.0 109.082 -173.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 89.4 mt 70.18 177.84 0.26 Allowed 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.808 1.243 . . . . 0.0 111.364 -178.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.568 ' HA2' ' NH2' ' A' ' 12' ' ' ARG . . . 137.59 -80.33 0.29 Allowed Glycine 0 CA--C 1.49 -1.484 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 -175.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.0 m -59.34 -37.4 77.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.83 0.824 . . . . 0.0 108.869 172.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -85.64 116.12 23.73 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 174.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 139.28 -72.3 0.43 Allowed Glycine 0 N--CA 1.423 -2.201 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -178.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 29.2 m 58.5 -81.63 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.433 1.093 . . . . 0.0 113.242 178.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.9 t -81.14 91.67 6.17 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 176.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.603 ' O ' HG23 ' A' ' 13' ' ' VAL . 26.9 ptt180 -156.81 135.56 11.66 Favored 'General case' 0 N--CA 1.424 -1.755 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.588 -177.13 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 12' ' ' ARG . 37.2 t 158.86 82.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 130.413 3.485 . . . . 0.0 106.261 169.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -150.88 96.22 2.31 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 113.74 -1.573 . . . . 0.0 107.707 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -156.41 108.3 2.51 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.85 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.427 ' HA ' ' NH1' ' A' ' 24' ' ' ARG . 15.7 mm100 -69.3 -68.07 0.43 Allowed 'General case' 0 N--CA 1.424 -1.775 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.392 178.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 58.57 -78.41 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.799 0 O-C-N 125.417 1.698 . . . . 0.0 112.03 177.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 65.72 -81.29 0.03 OUTLIER 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 124.574 1.15 . . . . 0.0 109.524 -177.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 50.68 -77.48 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.62 1.568 . . . . 0.0 113.15 -177.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.0 p -103.47 -6.08 22.18 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 122.205 -0.309 . . . . 0.0 111.327 178.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.6 m 55.83 21.12 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 C-N-CA 126.827 2.051 . . . . 0.0 113.148 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -67.34 -17.96 64.96 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -176.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 23.0 p -121.75 11.49 10.47 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.427 ' NH1' ' HA ' ' A' ' 16' ' ' GLN . 19.7 mtp180 -120.15 144.58 47.59 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.032 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.4 m -61.36 110.38 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.867 0.841 . . . . 0.0 111.169 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.5 m -92.32 -41.44 10.37 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.2 -176.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 82.1 mt -118.17 137.04 53.25 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.102 -177.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -82.35 -49.29 10.17 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.238 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -63.3 -34.17 77.12 Favored 'General case' 0 CA--C 1.495 -1.167 0 O-C-N 123.815 0.697 . . . . 0.0 112.559 -178.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 56.6 tp -79.95 109.03 14.0 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -95.89 170.85 9.01 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.725 -178.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -81.21 -29.25 34.59 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -104.11 123.71 47.76 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.506 -1.224 . . . . 0.0 110.92 -175.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.6 pp -101.51 174.17 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.308 176.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.456 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -153.47 98.53 2.25 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.349 0.595 . . . . 0.0 110.712 -178.575 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -116.48 -46.22 2.78 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.9 0.857 . . . . 0.0 109.606 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 160.59 73.66 0.02 OUTLIER Glycine 0 N--CA 1.427 -1.957 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 -177.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -87.68 -0.33 56.74 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.045 0.45 . . . . 0.0 111.379 -174.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -86.33 142.11 28.73 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.578 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -86.0 -15.93 39.89 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 70' ' ' ARG . 7.3 mt-10 -95.7 95.3 8.24 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 114.26 -1.336 . . . . 0.0 110.072 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.46 ' HB3' HG22 ' A' ' 71' ' ' VAL . 56.7 tp -94.22 155.64 16.94 Favored 'General case' 0 N--CA 1.411 -2.388 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.039 -177.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.432 ' HB3' ' CD1' ' A' ' 74' ' ' ILE . 10.4 m120 -122.82 147.91 45.99 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.358 -177.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 49.3 mt -141.69 174.94 10.1 Favored 'General case' 0 C--O 1.249 1.069 0 CA-C-O 121.53 0.681 . . . . 0.0 111.428 178.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.8 tt -136.41 143.33 35.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.963 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.517 HG23 HG21 ' A' ' 73' ' ' ILE . 96.6 t -127.89 122.83 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -149.54 121.63 8.29 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.587 179.021 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -131.73 175.66 9.0 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.163 -174.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -81.02 -29.13 35.19 Favored 'General case' 0 C--O 1.246 0.916 0 O-C-N 124.014 0.821 . . . . 0.0 109.815 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 80.7 t -101.88 130.09 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.364 174.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.756 ' O ' HG22 ' A' ' 54' ' ' VAL . 22.6 tm0? -64.72 -40.64 95.67 Favored 'General case' 0 C--O 1.197 -1.68 0 C-N-CA 122.822 0.449 . . . . 0.0 111.984 -174.101 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.4 2.8 86.6 Favored Glycine 0 C--N 1.29 -2.011 0 C-N-CA 118.114 -1.994 . . . . 0.0 112.988 178.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.2 t -82.59 -28.45 30.86 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 105.677 -1.971 . . . . 0.0 105.677 178.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.756 HG22 ' O ' ' A' ' 51' ' ' GLN . 12.9 m -69.69 -46.96 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.646 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.259 175.149 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -60.06 -39.54 86.39 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -177.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.91 -36.35 76.81 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 123.604 0.565 . . . . 0.0 110.796 178.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 42.3 tp -85.04 -41.72 15.51 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.714 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 54' ' ' VAL . 47.9 t -55.36 -41.23 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.099 0.96 . . . . 0.0 112.264 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.32 -17.79 64.35 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 120.736 0.303 . . . . 0.0 111.748 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.27 -27.38 14.54 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.25 -28.57 34.7 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.596 -175.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -75.93 -23.46 55.46 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.249 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -94.15 6.1 49.64 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.63 -177.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 34.3 mm -70.0 93.01 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-O 121.939 0.876 . . . . 0.0 111.959 -177.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -126.3 -22.31 4.05 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.427 -1.261 . . . . 0.0 108.793 171.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.1 m -65.34 172.77 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.251 1.181 0 CA-C-N 114.325 -1.307 . . . . 0.0 112.234 -177.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 74.24 -59.9 0.54 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.352 1.461 . . . . 0.0 109.065 -177.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 150.86 33.11 0.04 OUTLIER Glycine 0 N--CA 1.433 -1.563 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.3 p -147.59 142.9 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.543 ' O ' ' HA ' ' A' ' 41' ' ' GLU . 14.3 tpt180 -107.61 102.17 11.43 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 -178.08 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.46 HG22 ' HB3' ' A' ' 42' ' ' LEU . 20.0 t -118.87 137.44 52.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -178.021 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -142.41 155.43 45.12 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.517 HG21 HG23 ' A' ' 46' ' ' VAL . 1.6 pp -94.14 155.08 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.336 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.116 178.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.45 ' N ' HD12 ' A' ' 74' ' ' ILE . 3.8 mp -123.83 -31.43 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.969 0.89 . . . . 0.0 109.948 178.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -133.21 105.91 7.28 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.996 -170.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -116.33 114.68 24.66 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.059 178.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.516 ' O ' ' HA ' ' A' ' 47' ' ' LYS . . . -147.82 158.61 44.11 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.709 -177.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.9 p -94.0 101.39 12.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-O 121.859 0.837 . . . . 0.0 109.88 177.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.32 171.89 44.87 Favored Glycine 0 N--CA 1.417 -2.576 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.915 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.575 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -82.24 -152.79 0.11 Allowed 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 174.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.465 HD13 HD11 ' A' ' 120' ' ' LEU . 2.4 mp -91.41 111.36 23.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 C-N-CA 118.732 -1.187 . . . . 0.0 109.36 176.022 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.5 p -108.73 165.18 11.74 Favored 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 175.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -60.02 -35.74 75.73 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 121.38 0.609 . . . . 0.0 111.124 -176.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.3 p -69.03 -23.6 64.09 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.12 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -74.28 -41.35 61.35 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 177.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.533 HD13 ' HB2' ' A' ' 111' ' ' ALA . 44.2 mt -66.86 -34.7 71.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-N 114.242 -1.344 . . . . 0.0 111.424 -178.412 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.454 ' HA ' ' OE2' ' A' ' 114' ' ' GLU . 46.9 m -67.73 -9.09 40.8 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.488 178.139 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -92.92 -32.67 14.49 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 173.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.11 -53.26 59.33 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.44 -177.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 9.8 t -74.03 -13.57 60.88 Favored 'General case' 0 CA--C 1.561 1.379 0 CA-C-O 121.136 0.493 . . . . 0.0 110.414 178.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.65 -66.19 0.87 Allowed 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -176.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.429 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 27.1 p -101.51 5.65 41.97 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 120.748 0.309 . . . . 0.0 111.533 -176.334 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . 0.491 0.0 OUTLIER 70.3 57.54 0.27 Allowed 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 127.13 2.172 . . . . 0.0 114.118 -179.462 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -105.3 167.99 9.37 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 113.357 -1.747 . . . . 0.0 108.509 174.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 47.7 mm -124.13 131.57 72.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 176.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.599 ' HB ' HG22 ' A' ' 118' ' ' ILE . 12.0 t -94.11 102.59 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -176.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 13.3 tt -97.93 140.53 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.924 177.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.461 ' HA3' HD11 ' A' ' 81' ' ' ILE . . . -134.36 146.45 18.44 Favored Glycine 0 N--CA 1.414 -2.772 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 178.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -119.54 109.24 15.47 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -177.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 66.7 t30 71.81 -39.07 0.44 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 126.022 1.729 . . . . 0.0 112.41 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.3 m -45.29 -47.65 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 126.302 1.841 . . . . 0.0 114.986 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.575 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 36.1 mtp180 73.57 170.14 0.11 Allowed Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 123.485 0.714 . . . . 0.0 112.055 179.062 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -96.9 168.46 0.95 Allowed 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 121.911 1.741 . . . . 0.0 114.594 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -75.74 153.3 37.12 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 113.215 -1.811 . . . . 0.0 106.769 168.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.509 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -59.15 -35.2 73.1 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.32 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.549 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 18.2 m120 -79.58 -27.49 41.15 Favored 'General case' 0 CA--C 1.488 -1.429 0 C-N-CA 119.346 -0.941 . . . . 0.0 110.592 178.352 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.26 -46.42 77.17 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.766 177.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 19.9 pttp -59.51 -23.18 62.59 Favored 'General case' 0 CA--C 1.565 1.557 0 CA-C-O 120.965 0.412 . . . . 0.0 111.588 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.549 ' HB2' ' O ' ' A' ' 106' ' ' ASN 0.254 58.4 mtp180 -82.54 -51.2 8.01 Favored 'General case' 0 N--CA 1.393 -3.278 0 C-N-CA 125.821 1.648 . . . . 0.0 109.316 176.928 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.532 ' HB1' ' OE1' ' A' ' 114' ' ' GLU . . . -54.23 -48.5 71.01 Favored 'General case' 0 CA--C 1.471 -2.091 0 C-N-CA 125.914 1.686 . . . . 0.0 110.839 -176.173 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.533 ' HB2' HD13 ' A' ' 86' ' ' ILE . . . -48.17 -45.59 33.69 Favored 'General case' 0 CA--C 1.504 -0.797 0 O-C-N 124.867 1.354 . . . . 0.0 110.578 -179.373 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -72.92 -30.27 63.77 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 114.542 -1.208 . . . . 0.0 112.903 -174.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.1 t -92.28 5.27 51.13 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.532 ' OE1' ' HB1' ' A' ' 110' ' ' ALA . 7.9 mt-10 -117.9 7.04 12.27 Favored 'General case' 0 N--CA 1.406 -2.662 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -175.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 29.7 mmmt 68.2 5.74 4.85 Favored 'General case' 0 N--CA 1.42 -1.936 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 174.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.1 m -122.18 145.26 29.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -114.66 143.66 44.68 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 118.726 -1.189 . . . . 0.0 109.761 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.599 HG22 ' HB ' ' A' ' 96' ' ' VAL . 8.7 pt -98.1 131.1 45.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.187 -176.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -98.5 124.83 43.47 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.516 -174.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.465 HD11 HD13 ' A' ' 81' ' ' ILE . 3.5 mm? -123.01 175.26 6.69 Favored 'General case' 0 CA--C 1.502 -0.865 0 CA-C-O 121.873 0.844 . . . . 0.0 112.867 -178.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.44 ' O ' HG12 ' A' ' 123' ' ' ILE . 47.4 t-80 -69.84 155.0 41.21 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.509 -1.678 . . . . 0.0 108.041 174.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.6 ttp180 -52.23 115.85 1.93 Allowed 'General case' 0 C--O 1.246 0.897 0 C-N-CA 123.628 0.771 . . . . 0.0 110.62 176.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 121' ' ' HIS . 47.9 mm -119.35 108.65 24.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.436 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 28.3 pt -69.02 132.53 32.97 Favored 'Isoleucine or valine' 0 C--O 1.268 2.065 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.676 178.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 67.47 -159.01 0.22 Allowed 'General case' 0 CA--C 1.557 1.227 0 O-C-N 124.728 1.267 . . . . 0.0 107.665 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 29.2 p30 -140.34 172.33 12.88 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 28.8 m -106.09 18.42 5.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -175.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 32.9 pt -127.82 23.1 2.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-O 121.709 0.766 . . . . 0.0 109.402 -178.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.24 -4.77 52.27 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -169.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.04 -18.45 24.56 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.074 178.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 66.2 mt 63.19 88.31 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.048 -177.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -77.92 -56.55 4.4 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 177.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -122.42 -59.48 1.63 Allowed 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.295 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 62.8 118.93 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.092 1.357 . . . . 0.0 112.851 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.294 -1.805 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.564 -178.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.9 p30 . . . . . 0 N--CA 1.464 0.264 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -107.64 111.15 23.23 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -178.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -110.86 -26.44 9.33 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-N 113.925 -1.489 . . . . 0.0 107.048 173.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -89.26 -23.52 22.3 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.6 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 89.6 mt 66.57 31.55 7.81 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.099 0.959 . . . . 0.0 109.661 177.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -139.52 -112.7 1.04 Allowed Glycine 0 N--CA 1.424 -2.146 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -177.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.5 m 71.01 -38.16 0.41 Allowed 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 125.0 1.32 . . . . 0.0 113.915 176.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 51.9 mtm180 -53.41 -54.45 36.68 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 123.958 0.903 . . . . 0.0 112.271 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -117.64 44.47 1.43 Allowed Glycine 0 N--CA 1.435 -1.404 0 C-N-CA 121.225 -0.512 . . . . 0.0 112.986 -177.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 38.0 m -68.8 -51.65 38.66 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.206 0.527 . . . . 0.0 110.315 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.4 m -96.3 41.96 1.1 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.798 0.839 . . . . 0.0 110.074 -177.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -66.38 -18.48 65.38 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -173.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 19.4 m -94.84 2.87 9.4 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.893 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.5 t70 70.38 99.12 0.06 Allowed 'General case' 0 CA--C 1.5 -0.945 0 C-N-CA 124.423 1.089 . . . . 0.0 110.588 -176.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.6 mt -80.52 107.44 13.32 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -106.34 -19.76 13.6 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.987 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -60.42 109.07 0.91 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.624 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.41 ' HA ' ' HG3' ' A' ' 24' ' ' ARG . 44.3 tt0 69.26 11.84 8.26 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.945 1.298 . . . . 0.0 110.306 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -101.52 -36.32 8.84 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.0 p -73.79 -33.31 64.17 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.171 178.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . 0.317 20.7 m 58.39 -16.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 127.659 2.383 . . . . 0.0 116.819 177.059 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.5 ptpp? -54.17 -36.06 62.96 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.146 0.498 . . . . 0.0 112.045 178.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.5 p -100.6 22.85 11.2 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 123.619 0.768 . . . . 0.0 110.858 -178.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.41 ' HG3' ' HA ' ' A' ' 18' ' ' GLN . 3.0 mmp_? -128.98 -42.2 1.4 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.307 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.6 m -77.9 -13.63 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.151 0.501 . . . . 0.0 111.233 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.0 p -93.06 168.5 11.08 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.3 tt -122.35 -63.71 1.26 Allowed 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -96.09 172.66 7.85 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -178.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -71.24 -57.22 4.69 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 123.068 0.547 . . . . 0.0 109.969 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 47.0 tp 64.32 9.25 4.74 Favored 'General case' 0 CA--C 1.562 1.438 0 C-N-CA 124.591 1.156 . . . . 0.0 113.637 177.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -88.87 -12.84 40.69 Favored 'General case' 0 C--N 1.318 -0.768 0 O-C-N 120.824 -1.172 . . . . 0.0 111.898 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.12 143.76 49.49 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 121.247 -0.181 . . . . 0.0 110.862 176.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.4 tp60 -166.86 -61.68 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -178.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 59.8 mt -99.08 131.22 46.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.4 mttm 79.5 80.2 0.05 Allowed 'General case' 0 CA--C 1.501 -0.904 0 C-N-CA 125.198 1.399 . . . . 0.0 110.816 -176.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -76.76 -39.96 49.94 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 113.585 -1.643 . . . . 0.0 108.303 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.21 -170.61 42.82 Favored Glycine 0 N--CA 1.415 -2.718 0 N-CA-C 107.55 -2.22 . . . . 0.0 107.55 -179.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -85.64 -69.27 0.67 Allowed 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 117.778 0.789 . . . . 0.0 109.303 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 53.49 78.33 0.15 Allowed 'General case' 0 C--O 1.24 0.565 0 CA-C-N 114.156 -1.383 . . . . 0.0 108.034 -174.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -73.87 146.76 43.84 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.479 -175.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.53 ' HB3' ' ND2' ' A' ' 43' ' ' ASN . 58.8 mm-40 -94.16 105.59 17.58 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.644 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.435 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 3.7 mm? -94.02 94.15 8.26 Favored 'General case' 0 CA--C 1.486 -1.518 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 176.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.61 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 91.3 m-20 -124.46 146.87 48.68 Favored 'General case' 0 C--N 1.28 -2.455 0 CA-C-N 113.294 -1.775 . . . . 0.0 107.317 -174.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.3 pp -150.12 164.69 34.94 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.549 HG23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -119.88 132.88 68.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.368 178.612 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 93.3 t -107.1 126.96 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.058 -177.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 42.5 mtpt -139.23 134.75 33.12 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.211 176.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.78 168.39 23.82 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -178.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -80.2 -18.73 48.77 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.855 0.836 . . . . 0.0 110.421 -178.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 69.4 t -104.76 123.19 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 175.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.792 ' O ' HG22 ' A' ' 54' ' ' VAL . 10.8 tt0 -68.64 -29.78 68.34 Favored 'General case' 0 C--O 1.195 -1.78 0 CA-C-O 121.137 0.494 . . . . 0.0 111.413 -174.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.95 2.59 87.15 Favored Glycine 0 C--N 1.284 -2.36 0 C-N-CA 117.125 -2.464 . . . . 0.0 112.642 177.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.4 t -86.84 -31.07 21.01 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 176.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.792 HG22 ' O ' ' A' ' 51' ' ' GLN . 11.9 m -67.48 -43.4 87.41 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.866 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.423 175.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -66.27 -39.93 89.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.413 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.27 -37.04 79.25 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.747 177.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.513 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 26.6 tp -77.46 -41.68 38.71 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 120.532 -0.467 . . . . 0.0 109.766 177.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 54' ' ' VAL . 32.1 t -53.57 -45.82 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 123.57 0.748 . . . . 0.0 112.079 177.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.34 -26.56 68.51 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.58 -22.83 17.37 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -178.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.513 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -82.55 -35.53 27.11 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.47 -175.621 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -67.72 -27.04 66.46 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.112 0.482 . . . . 0.0 110.57 178.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.1 ptpp? -88.68 5.59 42.46 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.32 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.438 ' HB ' ' O ' ' A' ' 71' ' ' VAL . 39.7 mm -76.71 -23.3 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 178.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -69.14 105.27 2.41 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-O 121.475 0.655 . . . . 0.0 110.112 176.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 31.5 m -127.53 -173.07 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 176.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.8 102.17 11.42 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 121.414 0.625 . . . . 0.0 110.801 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 118.21 -42.1 1.89 Allowed Glycine 0 C--N 1.314 -0.646 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.496 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.6 t -115.69 134.05 60.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.435 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -152.56 125.65 8.57 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 120.697 0.284 . . . . 0.0 110.943 -179.73 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.438 ' O ' ' HB ' ' A' ' 64' ' ' ILE . 34.5 t -142.6 129.65 18.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 103.382 -2.822 . . . . 0.0 103.382 171.159 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.462 ' HG2' ' N ' ' A' ' 73' ' ' ILE . 87.9 tttt -139.92 161.5 37.44 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.354 0.597 . . . . 0.0 111.142 -176.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.462 ' N ' ' HG2' ' A' ' 72' ' ' LYS . 1.7 pp -93.51 148.52 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.759 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.612 177.117 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 73.2 mt -119.57 -27.63 2.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-O 121.68 0.753 . . . . 0.0 110.06 176.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.534 ' CD2' HD12 ' A' ' 45' ' ' ILE . 3.0 t60 -154.67 132.28 11.34 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.357 -172.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -134.66 131.03 37.25 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.404 ' O ' HG11 ' A' ' 54' ' ' VAL . . . -149.79 156.98 42.75 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.955 -178.197 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.3 p -93.5 94.42 4.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-O 122.521 1.153 . . . . 0.0 110.295 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.7 176.02 47.79 Favored Glycine 0 N--CA 1.417 -2.572 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.549 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -91.81 -175.38 4.12 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 176.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.494 HG21 HG21 ' A' ' 118' ' ' ILE . 3.2 mp -74.3 111.84 10.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 119.433 -0.907 . . . . 0.0 108.847 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.8 p -117.61 152.97 34.07 Favored 'General case' 0 N--CA 1.42 -1.972 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.702 -178.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -50.33 -41.83 51.85 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.026 0.53 . . . . 0.0 111.588 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.1 m -62.83 -28.12 69.79 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.614 -177.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -86.17 -29.33 23.32 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-O 121.341 0.591 . . . . 0.0 110.94 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.52 HG21 ' HA ' ' A' ' 111' ' ' ALA . 59.2 mt -65.87 -25.72 36.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.699 177.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 38.0 m -59.84 -30.7 69.13 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.917 177.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -78.25 -35.78 47.78 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 175.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.05 -58.91 5.39 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.966 -176.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.564 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 9.8 t -71.24 -24.61 62.22 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.478 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.17 -62.67 1.61 Allowed 'General case' 0 C--N 1.342 0.273 0 CA-C-O 120.944 0.402 . . . . 0.0 111.76 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.7 m -96.37 5.44 50.91 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.627 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 65.85 40.88 4.03 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.216 1.006 . . . . 0.0 110.314 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.61 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -94.51 136.45 34.79 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-N 114.206 -1.361 . . . . 0.0 109.081 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.1 mp -93.88 140.23 16.9 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.549 ' HA ' HG23 ' A' ' 45' ' ' ILE . 14.5 t -94.77 117.54 38.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -178.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.54 ' HA ' ' O ' ' A' ' 119' ' ' ARG . 0.2 OUTLIER -112.17 122.86 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 174.3 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -115.37 146.47 18.83 Favored Glycine 0 N--CA 1.426 -1.997 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.159 -177.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -105.6 94.62 5.3 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 118.468 -1.293 . . . . 0.0 109.664 -177.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 63.78 8.64 3.9 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 124.946 1.298 . . . . 0.0 112.866 177.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.471 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 3.6 m -78.89 -49.38 20.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.101 -178.201 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.549 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 72.7 mtp180 69.59 154.64 0.15 Allowed Pre-proline 0 N--CA 1.477 0.915 0 O-C-N 123.889 0.743 . . . . 0.0 112.82 175.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -91.07 173.69 2.78 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 121.991 1.794 . . . . 0.0 112.47 178.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -89.71 168.28 12.23 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 167.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.543 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -56.58 -28.61 60.63 Favored 'General case' 0 C--O 1.206 -1.203 0 C-N-CA 122.824 0.449 . . . . 0.0 111.041 178.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.644 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 23.1 p30 -72.41 -46.47 55.01 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.21 -34.8 76.92 Favored 'General case' 0 C--N 1.292 -1.922 0 O-C-N 122.096 -0.378 . . . . 0.0 111.563 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 18.1 pttp -63.08 -27.7 69.57 Favored 'General case' 0 CA--C 1.563 1.478 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.318 175.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.644 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 63.5 mtp180 -75.37 -50.28 16.41 Favored 'General case' 0 N--CA 1.405 -2.698 0 C-N-CA 125.212 1.405 . . . . 0.0 109.239 176.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.24 -50.6 66.8 Favored 'General case' 0 C--O 1.201 -1.47 0 CA-C-N 114.118 -1.401 . . . . 0.0 110.269 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.52 ' HA ' HG21 ' A' ' 86' ' ' ILE . . . -49.33 -48.6 46.32 Favored 'General case' 0 CA--C 1.502 -0.886 0 O-C-N 124.587 1.179 . . . . 0.0 111.602 -178.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -79.13 -29.8 43.35 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.864 -173.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 28.7 t -77.19 -6.94 54.92 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 175.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.564 ' O ' ' HB ' ' A' ' 90' ' ' THR . 26.2 mt-10 -114.73 9.32 16.37 Favored 'General case' 0 N--CA 1.411 -2.422 0 CA-C-N 114.471 -1.241 . . . . 0.0 112.912 -177.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 29.2 mmtp 64.46 15.57 9.65 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 174.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.3 m -120.34 131.76 71.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.461 0.648 . . . . 0.0 112.565 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -94.59 130.39 41.06 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.077 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.494 HG21 HG21 ' A' ' 81' ' ' ILE . 15.1 pt -94.85 128.6 45.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.06 179.394 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.54 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 98.1 mtt180 -122.16 111.69 17.29 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.672 0.749 . . . . 0.0 110.743 -175.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.509 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -129.65 148.43 51.54 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.148 -177.786 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 29.8 t60 67.62 -74.68 0.07 Allowed 'General case' 0 N--CA 1.477 0.913 0 O-C-N 124.303 1.002 . . . . 0.0 111.158 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -91.29 90.29 7.67 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 122.231 1.015 . . . . 0.0 111.075 -175.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 44.5 mm -85.32 -26.94 6.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 40.9 pt -126.53 163.8 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 CA-C-N 114.083 -1.417 . . . . 0.0 107.249 177.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -86.62 107.78 18.32 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 176.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -75.15 98.8 3.79 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.533 0.682 . . . . 0.0 112.294 -176.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 46.4 t -94.16 -53.19 8.69 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 172.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 55.6 mt 56.78 75.39 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-N 113.079 -1.873 . . . . 0.0 112.444 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.5 17.1 5.92 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 122.877 1.322 . . . . 0.0 107.915 174.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -119.35 10.16 11.85 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 112.743 -2.026 . . . . 0.0 109.476 -176.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 72.3 mt 71.09 123.42 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 124.677 1.191 . . . . 0.0 112.364 -175.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -103.6 126.54 50.81 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 172.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -125.76 113.28 17.09 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -172.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -135.39 -80.49 0.43 Allowed 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 172.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 54.4 mtm . . . . . 0 CA--C 1.496 -1.098 0 C-N-CA 126.466 1.906 . . . . 0.0 107.009 172.636 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 N--CA 1.476 0.837 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -142.04 60.96 1.46 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -172.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -93.16 -19.97 20.94 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 115.03 -0.987 . . . . 0.0 109.207 177.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -106.65 127.96 53.78 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.737 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.544 ' HG ' ' NE2' ' A' ' 18' ' ' GLN . 2.9 mm? -119.83 -77.56 0.58 Allowed 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 177.462 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.3 126.28 11.36 Favored Glycine 0 N--CA 1.434 -1.44 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -178.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.4 m -71.94 -24.38 61.61 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 121.639 0.733 . . . . 0.0 109.851 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -79.05 98.5 6.51 Favored 'General case' 0 C--O 1.245 0.859 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 173.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 139.31 167.18 10.88 Favored Glycine 0 N--CA 1.411 -2.968 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.2 m -158.28 22.16 0.24 Allowed 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 -178.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.1 m 64.15 36.39 9.62 Favored 'General case' 0 C--N 1.351 0.634 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -170.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -103.09 -54.26 2.65 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.857 -178.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.13 4.34 2.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -114.2 109.68 18.78 Favored 'General case' 0 N--CA 1.417 -2.085 0 CA-C-N 113.496 -1.684 . . . . 0.0 110.424 -173.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.6 mp -101.67 97.96 8.31 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 177.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -105.02 150.15 25.19 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -178.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -149.96 101.87 3.07 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -179.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.544 ' NE2' ' HG ' ' A' ' 5' ' ' LEU 0.295 41.8 mt-30 -130.52 52.76 2.0 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-O 122.367 1.079 . . . . 0.0 112.573 175.075 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -106.18 -48.35 3.61 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 170.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.9 p -111.23 7.1 21.04 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.317 -1.311 . . . . 0.0 109.478 175.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.7 m 47.29 35.34 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 126.507 1.923 . . . . 0.0 114.038 177.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -112.97 152.29 29.57 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 70.9 p 62.76 11.35 4.85 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.804 1.242 . . . . 0.0 112.417 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -72.2 -23.37 61.24 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.956 -176.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.9 t -89.68 -53.1 9.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 176.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.6 t 72.85 -56.14 0.66 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.037 1.335 . . . . 0.0 112.063 177.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 79.7 mt 62.36 66.33 0.8 Allowed 'General case' 0 CA--C 1.503 -0.844 0 C-N-CA 123.989 0.916 . . . . 0.0 111.545 -176.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -85.33 -27.78 25.69 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 174.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -117.29 141.1 48.73 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 173.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.3 tp -125.98 10.13 7.56 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.967 -172.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 62.59 83.05 0.16 Allowed 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.425 0.631 . . . . 0.0 109.811 -171.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -50.19 -45.13 53.29 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.297 -1.32 . . . . 0.0 114.189 -177.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -112.66 161.86 16.36 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.032 -177.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.3 pt -82.04 131.96 32.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.128 0.49 . . . . 0.0 110.623 -178.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -85.43 -37.89 19.27 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.348 0.594 . . . . 0.0 109.669 178.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -111.13 136.88 49.52 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.65 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -115.95 175.6 15.95 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 178.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -90.09 176.14 6.89 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 86.7 mtp -73.77 134.15 43.39 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.45 -178.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -90.15 -56.81 3.07 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.776 -175.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.77 124.3 48.05 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.439 -178.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -122.47 99.08 6.22 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 169.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -107.77 140.94 40.08 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -171.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.4 mt -135.23 168.78 18.54 Favored 'General case' 0 C--O 1.248 0.976 0 CA-C-O 121.789 0.804 . . . . 0.0 111.925 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.472 HG12 ' CE ' ' A' ' 47' ' ' LYS . 1.1 tt -133.18 132.9 58.54 Favored 'Isoleucine or valine' 0 C--O 1.249 1.028 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.198 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.647 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 84.4 t -113.74 131.96 64.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.565 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.472 ' CE ' HG12 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -142.97 148.03 36.17 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 178.444 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.59 158.13 28.51 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 177.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -78.95 -12.33 60.03 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.039 -0.665 . . . . 0.0 110.044 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 99.1 t -109.86 134.12 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 174.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.738 ' O ' HG22 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -69.01 -46.63 67.52 Favored 'General case' 0 C--O 1.202 -1.447 0 C-N-CA 122.431 0.292 . . . . 0.0 110.558 -172.332 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.06 -1.19 67.66 Favored Glycine 0 C--N 1.286 -2.196 0 C-N-CA 118.479 -1.82 . . . . 0.0 114.285 -177.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.7 m -80.17 -29.42 38.74 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 106.282 -1.748 . . . . 0.0 106.282 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.738 HG22 ' O ' ' A' ' 51' ' ' GLN . 5.7 m -72.37 -42.44 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.498 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.354 176.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -54.47 -47.86 72.48 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 124.128 0.893 . . . . 0.0 110.592 178.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.77 -40.03 91.02 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.658 -178.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 34.4 tp -78.94 -36.66 41.33 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.593 -178.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.425 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 43.4 t -59.98 -43.6 92.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 122.727 0.411 . . . . 0.0 110.493 177.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.12 -14.85 62.48 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.61 -13.15 16.64 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.497 0.665 . . . . 0.0 109.294 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.419 ' HG ' HG23 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -99.7 -38.67 8.61 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.397 -176.148 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 12.9 pt20 -74.11 -5.9 44.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.303 0.573 . . . . 0.0 111.128 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.22 -5.34 50.17 Favored 'General case' 0 C--O 1.245 0.856 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.117 177.024 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.6 mm -86.69 77.5 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -131.5 -67.29 0.7 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.215 -174.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.7 m -89.53 -4.37 10.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.68 0.752 . . . . 0.0 109.992 177.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -90.31 86.52 6.51 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.345 -178.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 76.78 -74.26 1.81 Allowed Glycine 0 CA--C 1.525 0.682 0 CA-C-N 115.395 -0.82 . . . . 0.0 113.801 178.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 43.8 t -135.59 156.36 38.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -175.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -93.94 107.24 19.16 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.138 0.494 . . . . 0.0 110.044 176.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.6 t -117.04 113.36 42.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 175.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -124.27 158.08 33.37 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.52 0.676 . . . . 0.0 111.444 -172.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.419 HG23 ' HG ' ' A' ' 61' ' ' LEU . 1.5 pp -93.84 149.76 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.942 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.803 174.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 53.6 mt -120.63 -24.23 2.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-O 121.565 0.698 . . . . 0.0 110.796 178.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -150.41 117.45 5.94 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.63 -172.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.647 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -120.78 129.69 53.7 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 176.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.41 ' O ' HG11 ' A' ' 54' ' ' VAL . . . -145.72 153.53 41.07 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.974 -178.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.444 ' HB ' ' HA ' ' A' ' 51' ' ' GLN . 3.0 p -93.84 93.26 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.704 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 175.044 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.87 176.49 48.03 Favored Glycine 0 N--CA 1.401 -3.697 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.79 -175.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.598 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -90.49 -157.08 0.46 Allowed 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 175.234 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.509 HG21 HG21 ' A' ' 118' ' ' ILE . 2.9 mp -83.06 103.74 10.76 Favored 'Isoleucine or valine' 0 C--O 1.254 1.329 0 C-N-CA 118.854 -1.138 . . . . 0.0 108.242 177.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 44.1 p -101.7 159.73 15.07 Favored 'General case' 0 N--CA 1.409 -2.508 0 C-N-CA 119.417 -0.913 . . . . 0.0 108.808 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -60.21 -26.27 66.26 Favored 'General case' 0 CA--C 1.559 1.315 0 CA-C-O 121.466 0.65 . . . . 0.0 109.949 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.6 m -71.97 -22.06 61.5 Favored 'General case' 0 CA--C 1.555 1.146 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.154 178.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -81.48 -33.05 32.18 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-O 121.628 0.728 . . . . 0.0 109.276 178.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.563 HD13 ' HB2' ' A' ' 111' ' ' ALA . 67.8 mt -72.63 -33.13 43.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.25 -178.216 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.9 p -61.01 -17.29 51.36 Favored 'General case' 0 CA--C 1.557 1.214 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 175.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.451 ' O ' HD22 ' A' ' 88' ' ' LEU . 1.9 tm? -92.22 -33.13 14.8 Favored 'General case' 0 C--O 1.25 1.104 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 174.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.93 -58.94 5.57 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.25 -176.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.405 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 11.2 t -79.29 -4.27 49.95 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-O 121.421 0.629 . . . . 0.0 110.649 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.84 -67.31 0.79 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.039 0.447 . . . . 0.0 112.191 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.4 t -104.85 5.95 33.44 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.391 0.615 . . . . 0.0 109.921 -176.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 74.07 72.12 0.11 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.482 1.113 . . . . 0.0 113.324 178.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -128.33 135.69 49.94 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 173.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.0 tt -94.49 140.79 16.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.793 ' HB ' HG22 ' A' ' 118' ' ' ILE . 49.4 t -94.45 99.45 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.392 0 CA-C-O 121.587 0.708 . . . . 0.0 110.946 -174.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 119' ' ' ARG . 42.7 mm -94.11 144.2 10.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 174.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.426 ' HA3' HD11 ' A' ' 81' ' ' ILE . . . -143.02 158.72 27.28 Favored Glycine 0 C--N 1.293 -1.821 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.06 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -122.38 95.04 4.48 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.243 -177.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . 0.254 95.4 m-20 55.6 -5.09 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 -179.159 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.448 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 1.7 m -62.93 -45.02 99.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 C-N-CA 123.65 0.78 . . . . 0.0 110.159 176.065 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.598 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 58.9 mtm180 70.88 161.66 0.15 Allowed Pre-proline 0 C--O 1.213 -0.849 0 CA-C-N 114.783 -1.099 . . . . 0.0 113.125 173.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.472 ' HG3' HD12 ' A' ' 118' ' ' ILE . 11.1 Cg_endo -94.68 170.41 1.61 Allowed 'Trans proline' 0 N--CA 1.441 -1.602 0 C-N-CA 121.479 1.453 . . . . 0.0 114.291 -177.064 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -74.07 155.35 38.6 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 167.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.576 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -61.67 -36.29 80.44 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.563 0.697 . . . . 0.0 110.193 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.511 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 2.7 t-20 -74.83 -37.76 62.19 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.032 177.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.33 -48.39 81.8 Favored 'General case' 0 C--O 1.214 -0.775 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.48 176.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.576 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 14.8 pttp -59.23 -28.63 66.86 Favored 'General case' 0 CA--C 1.565 1.541 0 CA-C-O 120.982 0.42 . . . . 0.0 111.89 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.511 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 49.3 mtp180 -75.4 -49.59 18.49 Favored 'General case' 0 N--CA 1.386 -3.655 0 C-N-CA 125.5 1.52 . . . . 0.0 109.306 178.37 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -55.22 -48.01 74.51 Favored 'General case' 0 C--O 1.198 -1.618 0 CA-C-N 113.903 -1.498 . . . . 0.0 110.07 -179.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.563 ' HB2' HD13 ' A' ' 86' ' ' ILE . . . -48.09 -44.07 31.31 Favored 'General case' 0 CA--C 1.496 -1.115 0 O-C-N 124.68 1.237 . . . . 0.0 111.121 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -75.87 -37.5 58.84 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.748 -174.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 34.0 t -80.41 5.07 16.04 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 122.047 0.927 . . . . 0.0 108.568 178.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' ' 115' ' ' LYS . 25.1 mt-10 -121.23 9.76 10.5 Favored 'General case' 0 N--CA 1.404 -2.762 0 CA-C-N 114.442 -1.254 . . . . 0.0 112.839 -178.228 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 60.3 mmtt 65.87 10.82 7.19 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 173.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.1 m -115.22 156.42 16.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 C-N-CA 119.831 -0.748 . . . . 0.0 111.744 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -112.57 138.19 49.71 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.329 -177.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.793 HG22 ' HB ' ' A' ' 96' ' ' VAL . 9.9 pt -108.38 113.88 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.628 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 173.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.417 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 50.8 ttp180 -113.31 97.92 6.78 Favored 'General case' 0 N--CA 1.414 -2.27 0 CA-C-O 122.211 1.005 . . . . 0.0 109.719 -175.007 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.524 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -116.62 142.35 47.0 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.768 -179.46 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 67.86 19.72 9.47 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 59.14 -92.0 0.03 OUTLIER 'General case' 0 C--N 1.345 0.38 0 C-N-CA 125.938 1.695 . . . . 0.0 112.03 -176.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 64.8 mt -136.63 -82.28 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.515 HG22 ' H ' ' A' ' 126' ' ' ASN . 35.6 mm 61.27 -77.49 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 124.658 1.183 . . . . 0.0 111.128 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 57.24 20.15 5.51 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.515 ' H ' HG22 ' A' ' 124' ' ' ILE . 5.6 t30 -87.6 59.51 5.49 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 122.207 1.003 . . . . 0.0 109.009 177.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 28.5 m -127.36 -0.12 3.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 113.098 -1.865 . . . . 0.0 106.807 172.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.1 mp -94.5 113.08 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 174.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -77.19 -13.07 60.0 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.185 -176.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 68.24 96.31 0.06 Allowed 'General case' 0 CA--C 1.513 -0.481 0 C-N-CA 125.316 1.447 . . . . 0.0 110.618 176.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 65.9 mt 72.07 104.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 124.894 1.278 . . . . 0.0 109.84 -176.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -76.94 83.45 3.48 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.479 0.657 . . . . 0.0 110.026 177.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -153.14 108.87 3.29 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.611 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.59 -24.76 31.37 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 176.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 20.1 mmt . . . . . 0 C--N 1.307 -1.258 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 -179.729 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.47 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 89.0 m-20 . . . . . 0 CA--C 1.504 -0.826 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -155.27 165.62 36.1 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-O 121.513 0.673 . . . . 0.0 112.191 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.57 HD13 ' CD2' ' A' ' 75' ' ' HIS . 0.1 OUTLIER -118.43 134.56 61.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 174.591 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 65.5 t -103.84 129.99 55.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.414 -178.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.472 ' HE2' ' HB3' ' A' ' 77' ' ' ALA . 64.4 mttt -141.38 139.27 33.46 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 121.442 0.639 . . . . 0.0 111.149 176.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.72 166.38 33.01 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -82.22 -21.77 36.2 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.996 0.427 . . . . 0.0 110.082 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 94.3 t -99.25 124.09 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 174.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.771 ' O ' HG22 ' A' ' 54' ' ' VAL . 17.3 tt0 -63.77 -40.87 97.74 Favored 'General case' 0 C--O 1.2 -1.546 0 CA-C-O 120.871 0.367 . . . . 0.0 111.56 -174.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.02 5.18 63.27 Favored Glycine 0 C--N 1.278 -2.683 0 C-N-CA 117.639 -2.22 . . . . 0.0 113.647 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.9 t -84.26 -32.28 24.51 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 173.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.771 HG22 ' O ' ' A' ' 51' ' ' GLN . 4.0 m -72.71 -46.8 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.766 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.772 177.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -63.4 -39.48 94.63 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.504 -177.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.42 -37.47 87.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.825 0.345 . . . . 0.0 110.695 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.41 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 31.3 tp -75.08 -42.02 57.6 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.507 HG21 ' HB2' ' A' ' 76' ' ' ALA . 70.3 t -58.78 -42.48 85.57 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.52 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.948 177.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.433 ' O ' ' HE3' ' A' ' 63' ' ' LYS . . . -65.11 -16.87 63.96 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.99 -25.25 14.38 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 122.187 0.994 . . . . 0.0 108.399 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.431 ' HB3' HG13 ' A' ' 73' ' ' ILE . 0.6 OUTLIER -83.13 -36.26 24.93 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.168 -176.197 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -71.91 -22.35 61.5 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 122.801 0.44 . . . . 0.0 111.228 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.433 ' HE3' ' O ' ' A' ' 59' ' ' ALA . 19.0 ptpt . . . . . 0 C--N 1.329 -0.283 0 CA-C-O 121.201 0.524 . . . . 0.0 110.772 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 39.5 t . . . . . 0 N--CA 1.439 -0.995 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -147.98 154.31 40.15 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.365 0.603 . . . . 0.0 110.776 -175.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.431 HG13 ' HB3' ' A' ' 61' ' ' LEU . 1.6 pp -93.9 147.94 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.68 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.625 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.8 mm -112.5 -22.18 5.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.978 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.57 ' CD2' HD13 ' A' ' 45' ' ' ILE . 5.3 t60 -162.48 149.11 13.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -172.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.507 ' HB2' HG21 ' A' ' 58' ' ' VAL . . . -140.41 144.34 36.11 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 178.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.472 ' HB3' ' HE2' ' A' ' 47' ' ' LYS . . . -165.52 149.78 8.49 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 117.904 0.32 . . . . 0.0 110.874 177.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.2 p -94.31 93.67 4.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 122.604 1.192 . . . . 0.0 109.083 177.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -177.09 176.4 48.05 Favored Glycine 0 N--CA 1.408 -3.192 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -177.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.661 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -93.11 -175.35 3.83 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 176.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 103' ' ' PRO . 3.0 mp -77.83 110.9 14.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.064 -0.655 . . . . 0.0 110.016 -176.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.7 p -110.74 147.81 33.62 Favored 'General case' 0 N--CA 1.408 -2.543 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.187 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -45.7 -44.49 13.59 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 125.125 1.37 . . . . 0.0 112.95 -178.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.9 t -64.15 -33.96 76.96 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 122.556 0.342 . . . . 0.0 111.785 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -78.18 -26.21 47.52 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 121.007 0.432 . . . . 0.0 111.718 -177.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.536 HG21 ' HA ' ' A' ' 111' ' ' ALA . 50.8 mt -64.71 -35.48 75.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.952 177.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 57.6 m -61.17 -24.55 66.39 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 175.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -74.96 -37.63 61.9 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 173.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.606 ' HA ' ' O ' ' A' ' 94' ' ' ALA . . . -55.22 -51.23 67.23 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.9 -177.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.417 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 8.9 t -77.14 -15.98 59.33 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 120.596 -0.441 . . . . 0.0 111.099 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.69 -62.13 1.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.062 0.458 . . . . 0.0 111.102 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 68.1 m -91.6 1.3 57.24 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.954 -177.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.2 m120 69.35 23.33 6.22 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.907 0.86 . . . . 0.0 109.38 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.606 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . -94.72 117.2 29.75 Favored 'General case' 0 C--O 1.194 -1.844 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.688 -177.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 44.3 pt -92.38 156.69 3.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 118.378 -1.329 . . . . 0.0 109.782 -177.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.439 HG11 HG13 ' A' ' 81' ' ' ILE . 10.5 t -94.45 116.92 36.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.215 -173.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 6.5 tp -101.08 109.25 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.928 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 173.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -105.9 140.57 15.19 Favored Glycine 0 N--CA 1.414 -2.789 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.047 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -98.68 94.4 6.63 Favored 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 118.238 -1.385 . . . . 0.0 109.281 -176.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 66.8 t30 58.61 14.78 3.27 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 125.489 1.516 . . . . 0.0 111.822 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.508 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 6.5 m -78.91 -49.6 19.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -173.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.661 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 62.6 mtm180 77.87 158.96 0.15 Allowed Pre-proline 0 N--CA 1.482 1.17 0 O-C-N 123.818 0.699 . . . . 0.0 112.756 174.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.478 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 15.4 Cg_endo -100.16 178.79 0.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.546 2.164 . . . . 0.0 114.934 -176.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.494 ' HB2' ' H ' ' A' ' 107' ' ' ALA . 11.4 m-20 -73.83 159.91 32.21 Favored 'General case' 0 C--O 1.25 1.084 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 167.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.505 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -67.63 -28.22 67.54 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.079 0.466 . . . . 0.0 109.892 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.621 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 20.0 t-20 -85.9 -36.32 19.99 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.796 176.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.494 ' H ' ' HB2' ' A' ' 104' ' ' ASP . . . -59.51 -43.81 93.3 Favored 'General case' 0 C--O 1.207 -1.152 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.823 176.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 105' ' ' ALA . 0.0 OUTLIER -57.83 -30.04 65.43 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-O 120.785 0.326 . . . . 0.0 111.602 179.08 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.621 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 91.1 mtt180 -76.29 -52.31 10.24 Favored 'General case' 0 N--CA 1.386 -3.638 0 C-N-CA 125.29 1.436 . . . . 0.0 108.385 178.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -52.73 -45.96 67.21 Favored 'General case' 0 C--O 1.201 -1.484 0 CA-C-N 113.672 -1.603 . . . . 0.0 110.577 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.536 ' HA ' HG21 ' A' ' 86' ' ' ILE . . . -47.68 -53.06 16.12 Favored 'General case' 0 CA--C 1.501 -0.936 0 O-C-N 124.749 1.281 . . . . 0.0 110.915 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -78.55 -25.52 45.45 Favored 'General case' 0 C--N 1.271 -2.841 0 CA-C-N 114.558 -1.201 . . . . 0.0 112.529 -173.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 41.6 t -86.39 5.34 35.4 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 177.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.518 ' O ' ' HB2' ' A' ' 115' ' ' LYS . 19.2 mt-10 -123.3 13.11 9.54 Favored 'General case' 0 CA--C 1.462 -2.409 0 CA-C-N 114.612 -1.176 . . . . 0.0 111.737 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.518 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 56.4 mtpt 68.85 12.61 8.7 Favored 'General case' 0 N--CA 1.417 -2.086 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 175.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.434 ' O ' ' HB1' ' A' ' 111' ' ' ALA . 3.0 m -126.16 112.49 30.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -93.87 141.07 28.93 Favored 'General case' 0 CA--C 1.498 -1.022 0 C-N-CA 118.29 -1.364 . . . . 0.0 108.352 177.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.421 ' H ' HG12 ' A' ' 118' ' ' ILE . 6.3 pt -102.06 145.01 12.53 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.601 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.541 -174.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 57.3 mtp180 -122.03 128.48 51.46 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -178.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.448 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.309 -1.165 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.621 -177.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.502 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 94.1 m-20 . . . . . 0 CA--C 1.503 -0.843 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 89.6 mt -135.29 169.65 17.14 Favored 'General case' 0 C--O 1.252 1.194 0 CA-C-O 122.016 0.912 . . . . 0.0 111.894 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.573 HG23 ' HA ' ' A' ' 96' ' ' VAL . 0.8 OUTLIER -131.61 139.73 49.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 114.259 -1.337 . . . . 0.0 109.944 177.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 93.7 t -117.88 130.67 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-O 121.161 0.505 . . . . 0.0 110.775 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 79' ' ' GLY . 35.5 mtmm -142.35 144.47 33.2 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.017 173.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -150.48 170.77 18.29 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -82.7 -19.7 37.53 Favored 'General case' 0 C--N 1.313 -1.007 0 O-C-N 124.065 0.853 . . . . 0.0 110.227 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.472 ' HB ' ' OG ' ' A' ' 53' ' ' SER . 95.3 t -110.54 124.26 67.16 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.971 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 173.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.714 ' O ' HG22 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -54.77 -46.61 74.41 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 123.898 0.879 . . . . 0.0 112.61 -176.348 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.19 1.7 79.44 Favored Glycine 0 C--N 1.285 -2.264 0 C-N-CA 118.099 -2.001 . . . . 0.0 114.06 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.472 ' OG ' ' HB ' ' A' ' 50' ' ' VAL . 49.1 m -82.63 -26.78 31.89 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 176.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.714 HG22 ' O ' ' A' ' 51' ' ' GLN . 3.7 m -68.57 -45.08 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.099 0 CA-C-N 114.398 -1.274 . . . . 0.0 107.885 176.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -67.09 -32.33 73.42 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.939 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.56 -34.22 77.32 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.179 0.514 . . . . 0.0 110.29 177.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.4 tp -84.01 -39.13 20.05 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.605 178.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 54' ' ' VAL . 55.6 t -55.44 -45.56 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.033 0.533 . . . . 0.0 112.029 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.19 -15.71 63.38 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.541 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -100.9 -22.16 14.89 Favored 'General case' 0 C--O 1.2 -1.521 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.27 -38.24 17.76 Favored 'General case' 0 N--CA 1.421 -1.919 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.873 -177.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -72.13 -10.02 59.22 Favored 'General case' 0 C--N 1.317 -0.82 0 O-C-N 122.073 -0.392 . . . . 0.0 110.723 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.541 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 19.1 pttp . . . . . 0 C--O 1.243 0.745 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.9 t . . . . . 0 CA--C 1.499 -1.019 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -130.23 155.26 46.56 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-O 121.457 0.646 . . . . 0.0 111.231 -173.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.4 pp -94.74 148.64 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.499 176.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 76.5 mt -113.5 -30.5 2.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-O 121.478 0.656 . . . . 0.0 110.582 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -151.29 133.4 15.2 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.337 -172.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -134.96 129.49 34.3 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -151.46 159.86 43.99 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 120.53 0.205 . . . . 0.0 110.547 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.4 ' HB ' ' HA ' ' A' ' 51' ' ' GLN . 6.2 p -94.08 98.61 8.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-O 121.887 0.851 . . . . 0.0 108.803 176.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' A' ' 47' ' ' LYS . . . -176.92 175.45 47.66 Favored Glycine 0 N--CA 1.414 -2.779 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.59 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -98.41 -170.56 1.97 Allowed 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 174.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.569 HG21 HG21 ' A' ' 118' ' ' ILE . 3.7 mp -84.99 119.04 33.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 C-N-CA 119.725 -0.79 . . . . 0.0 111.374 -176.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.0 p -121.65 162.0 21.48 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.018 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.539 ' CD ' ' H ' ' A' ' 83' ' ' GLU . 2.3 mp0 -53.89 -43.82 69.98 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 124.759 1.223 . . . . 0.0 111.655 -178.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.9 t -68.72 -27.06 65.6 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.28 0.562 . . . . 0.0 110.544 -176.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -74.7 -44.26 50.93 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.326 178.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.584 HG21 ' HA ' ' A' ' 111' ' ' ALA . 56.9 mt -60.2 -27.75 40.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.448 177.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.0 t -61.07 -21.58 63.8 Favored 'General case' 0 CA--C 1.563 1.45 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.779 177.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -82.46 -37.35 25.52 Favored 'General case' 0 C--O 1.245 0.863 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 174.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.68 -60.31 3.48 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.555 -176.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.563 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 8.6 t -70.45 -22.2 62.72 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.677 178.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.6 -60.69 2.34 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 20.0 m -97.86 5.23 49.28 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.115 0.484 . . . . 0.0 110.787 -178.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 66.64 37.52 4.36 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.189 0.996 . . . . 0.0 111.203 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.502 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -94.86 139.39 31.37 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 114.363 -1.29 . . . . 0.0 108.591 178.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 49.4 mm -94.86 142.23 13.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.623 ' HB ' HG22 ' A' ' 118' ' ' ILE . 36.2 t -94.2 117.29 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.625 0 CA-C-O 121.276 0.56 . . . . 0.0 110.843 -175.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.49 130.92 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.016 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 176.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -136.01 175.38 20.9 Favored Glycine 0 N--CA 1.423 -2.197 0 N-CA-C 108.846 -1.701 . . . . 0.0 108.846 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . 0.288 21.8 p90 -141.66 107.28 5.08 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 119.084 -1.047 . . . . 0.0 113.294 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.2 t30 67.15 9.17 6.73 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 126.069 1.748 . . . . 0.0 111.373 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.495 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 4.9 m -84.12 -48.69 16.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.824 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.59 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 9.1 mtm180 73.07 163.75 0.14 Allowed Pre-proline 0 N--CA 1.485 1.307 0 C-N-CA 124.165 0.986 . . . . 0.0 111.251 176.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -95.25 168.61 1.47 Allowed 'Trans proline' 0 N--CA 1.437 -1.811 0 C-N-CA 121.901 1.734 . . . . 0.0 113.342 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -79.2 161.2 26.56 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 170.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.423 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -63.09 -24.3 67.84 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 122.713 0.405 . . . . 0.0 111.47 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.634 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 68.8 m-20 -85.68 -38.2 18.59 Favored 'General case' 0 C--O 1.206 -1.214 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 176.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.04 -41.51 99.52 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.86 0.362 . . . . 0.0 111.451 -178.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -59.87 -22.06 61.83 Favored 'General case' 0 CA--C 1.559 1.293 0 CA-C-O 121.111 0.481 . . . . 0.0 111.075 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.634 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 38.1 mtm105 -88.46 -51.78 5.54 Favored 'General case' 0 N--CA 1.38 -3.975 0 C-N-CA 125.523 1.529 . . . . 0.0 109.227 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -51.9 -47.01 64.77 Favored 'General case' 0 C--O 1.201 -1.474 0 C-N-CA 125.032 1.333 . . . . 0.0 111.171 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.584 ' HA ' HG21 ' A' ' 86' ' ' ILE . . . -49.42 -43.37 44.58 Favored 'General case' 0 CA--C 1.494 -1.187 0 O-C-N 124.279 0.987 . . . . 0.0 111.078 -179.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -82.89 -23.96 33.36 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-N 114.839 -1.073 . . . . 0.0 113.137 -173.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 38.6 t -89.07 5.89 42.37 Favored 'General case' 0 C--N 1.277 -2.565 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 175.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.563 ' O ' ' HB ' ' A' ' 90' ' ' THR . 23.7 mt-10 -125.27 15.62 8.36 Favored 'General case' 0 N--CA 1.408 -2.533 0 CA-C-N 113.953 -1.476 . . . . 0.0 112.437 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 56.2 mtpt 66.14 3.31 2.64 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 172.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.8 m -114.21 169.03 5.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 121.945 -0.472 . . . . 0.0 111.69 -176.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -130.77 137.71 49.6 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.623 HG22 ' HB ' ' A' ' 96' ' ' VAL . 10.4 pt -107.86 127.35 64.01 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.163 -178.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -129.18 136.96 50.85 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.492 -0.883 . . . . 0.0 113.24 -175.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.436 -1.144 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.341 -179.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 . . . . . 0 CA--C 1.504 -0.813 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 70.9 mt -131.25 165.61 23.01 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.535 HD13 ' CD2' ' A' ' 75' ' ' HIS . 0.2 OUTLIER -131.65 136.83 56.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-N 112.817 -1.992 . . . . 0.0 107.26 175.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.601 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 92.1 t -117.31 128.18 74.67 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 176.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.57 ' HE3' ' CG ' ' A' ' 85' ' ' ASP . 12.8 ptmm? -159.43 128.06 5.14 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.44 176.28 9.49 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.894 -171.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -74.68 -32.0 62.08 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 123.948 0.78 . . . . 0.0 109.412 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 86.3 t -94.71 122.04 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.137 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.745 ' O ' HG22 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -61.48 -47.84 83.82 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 124.347 1.059 . . . . 0.0 112.595 -174.776 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.87 5.01 84.06 Favored Glycine 0 C--N 1.278 -2.684 0 C-N-CA 118.049 -2.024 . . . . 0.0 113.003 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.0 t -83.36 -29.09 28.5 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.745 HG22 ' O ' ' A' ' 51' ' ' GLN . 6.0 m -70.87 -45.87 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.397 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.653 176.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -60.24 -40.44 90.24 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.178 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.66 -39.97 95.57 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 123.574 0.546 . . . . 0.0 110.825 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 38.3 tp -75.46 -39.34 58.83 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.177 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 54' ' ' VAL . 54.6 t -57.11 -37.99 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.128 0.571 . . . . 0.0 111.44 178.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.415 ' HA ' ' NE2' ' A' ' 62' ' ' GLN . . . -69.4 -19.14 63.81 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.03 -30.23 12.81 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.17 -36.15 64.05 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.615 -175.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.415 ' NE2' ' HA ' ' A' ' 59' ' ' ALA . 10.8 pt20 -68.89 -21.23 64.25 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.134 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt . . . . . 0 CA--C 1.548 0.904 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 179.959 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.7 t . . . . . 0 N--CA 1.428 -1.551 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -149.43 158.17 43.94 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.141 0.496 . . . . 0.0 110.241 -178.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.445 HG12 HG13 ' A' ' 58' ' ' VAL . 1.5 pp -94.54 144.17 10.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.073 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.401 ' N ' HD12 ' A' ' 74' ' ' ILE . 3.5 mp -112.69 -22.73 4.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-O 122.058 0.933 . . . . 0.0 109.438 177.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.535 ' CD2' HD13 ' A' ' 45' ' ' ILE . 2.0 t60 -148.13 139.05 23.17 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -172.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.601 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -140.33 136.69 33.46 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 177.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -163.2 156.93 19.83 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 118.608 0.64 . . . . 0.0 111.426 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.3 p -101.04 94.42 3.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-O 121.774 0.797 . . . . 0.0 109.273 175.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -177.02 173.31 46.2 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 119.365 -1.398 . . . . 0.0 113.304 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.476 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -81.58 170.02 16.36 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 124.159 0.984 . . . . 0.0 108.856 176.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.43 HD13 HD11 ' A' ' 120' ' ' LEU . 1.8 mp -72.82 118.21 17.62 Favored 'Isoleucine or valine' 0 C--O 1.245 0.816 0 CA-C-N 118.505 0.593 . . . . 0.0 110.363 -177.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 70.7 p -118.7 158.58 25.26 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -50.19 -34.22 21.91 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.23 0.612 . . . . 0.0 112.089 176.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.9 m -62.2 -40.28 95.55 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.127 0.489 . . . . 0.0 110.43 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.57 ' CG ' ' HE3' ' A' ' 47' ' ' LYS . 46.5 m-20 -71.88 -38.96 69.91 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.321 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.6 HD13 ' HB2' ' A' ' 111' ' ' ALA . 58.8 mt -67.2 -29.75 46.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.977 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 27.8 m -58.08 -35.17 71.0 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.194 174.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -72.44 -34.37 67.73 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.149 177.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.414 ' HB3' HG21 ' A' ' 116' ' ' VAL . . . -55.09 -61.96 1.97 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.028 -176.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.573 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 9.2 t -69.5 -21.31 63.69 Favored 'General case' 0 CA--C 1.568 1.655 0 O-C-N 121.583 -0.698 . . . . 0.0 111.054 177.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.89 -52.62 34.38 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 54.1 m -98.78 -2.87 36.93 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.721 178.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.1 m120 68.65 37.32 2.53 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 122.36 1.076 . . . . 0.0 109.376 -176.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.99 155.93 16.53 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 113.99 -1.459 . . . . 0.0 108.401 178.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 117' ' ' ASP . 46.2 mm -111.67 135.06 52.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.662 ' HB ' HG22 ' A' ' 118' ' ' ILE . 19.4 t -93.59 123.62 45.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.218 0.532 . . . . 0.0 109.834 -174.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 35.6 pt -104.55 157.63 5.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.65 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -171.66 172.93 44.88 Favored Glycine 0 N--CA 1.419 -2.449 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 175.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -161.54 133.38 5.63 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 73.28 -41.08 0.49 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.26 1.424 . . . . 0.0 111.872 177.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.6 m -65.59 -51.17 66.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 C-N-CA 124.339 1.055 . . . . 0.0 111.631 176.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.476 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 35.4 mtm180 66.72 178.97 0.05 OUTLIER Pre-proline 0 CA--C 1.566 1.576 0 C-N-CA 123.364 0.666 . . . . 0.0 112.051 174.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.452 ' HG3' HD12 ' A' ' 118' ' ' ILE . 21.6 Cg_endo -99.48 176.21 0.35 Allowed 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 122.327 2.018 . . . . 0.0 113.865 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -82.16 156.94 24.21 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 168.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.545 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -61.82 -31.18 71.39 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 120.849 0.357 . . . . 0.0 110.489 178.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.579 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 5.4 m-20 -77.8 -36.31 50.44 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.269 175.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.09 -44.06 97.48 Favored 'General case' 0 C--O 1.211 -0.948 0 O-C-N 121.981 -0.45 . . . . 0.0 111.27 176.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.53 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 14.4 ptmm? -59.83 -29.21 68.1 Favored 'General case' 0 CA--C 1.563 1.445 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.579 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 95.4 mtt180 -73.03 -51.37 18.44 Favored 'General case' 0 N--CA 1.395 -3.179 0 C-N-CA 124.643 1.177 . . . . 0.0 108.997 176.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -52.86 -49.03 66.63 Favored 'General case' 0 C--O 1.194 -1.852 0 CA-C-N 113.7 -1.591 . . . . 0.0 110.226 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.6 ' HB2' HD13 ' A' ' 86' ' ' ILE . . . -47.99 -50.76 26.4 Favored 'General case' 0 CA--C 1.483 -1.613 0 O-C-N 124.717 1.26 . . . . 0.0 111.2 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -81.24 -24.77 37.12 Favored 'General case' 0 C--N 1.27 -2.873 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.915 -172.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 38.3 t -87.66 5.45 39.58 Favored 'General case' 0 C--N 1.275 -2.646 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 175.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.573 ' O ' ' HB ' ' A' ' 90' ' ' THR . 24.7 mt-10 -123.35 19.43 9.75 Favored 'General case' 0 CA--C 1.466 -2.255 0 CA-C-N 114.411 -1.268 . . . . 0.0 111.572 177.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 65.6 mttm 67.0 4.63 3.65 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 173.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.414 HG21 ' HB3' ' A' ' 89' ' ' ALA . 5.4 m -113.98 163.94 10.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 121.683 -0.635 . . . . 0.0 112.106 -175.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.41 ' O ' HG23 ' A' ' 95' ' ' ILE . 4.0 m-20 -125.89 142.96 51.27 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 177.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.662 HG22 ' HB ' ' A' ' 96' ' ' VAL . 4.8 pt -105.05 138.74 28.56 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.914 178.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -104.64 112.83 26.06 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.519 -175.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.43 HD11 HD13 ' A' ' 81' ' ' ILE . 3.1 mm? . . . . . 0 C--N 1.299 -1.601 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.475 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.432 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 92.0 m-20 . . . . . 0 N--CA 1.441 -0.899 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.3 mt -134.42 164.91 26.39 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 122.304 1.05 . . . . 0.0 113.51 -176.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.631 HD13 ' CD2' ' A' ' 75' ' ' HIS . 0.2 OUTLIER -123.01 139.79 48.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.356 175.63 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 66.4 t -112.23 130.02 66.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.342 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -136.93 144.4 43.41 Favored 'General case' 0 CA--C 1.492 -1.277 0 C-N-CA 123.926 0.89 . . . . 0.0 109.951 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.18 165.1 29.95 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 177.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -84.97 -17.08 38.76 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 120.924 0.392 . . . . 0.0 110.699 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 87.3 t -101.69 127.09 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 173.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.719 ' O ' HG22 ' A' ' 54' ' ' VAL . 49.7 tt0 -61.41 -51.69 67.72 Favored 'General case' 0 C--O 1.196 -1.725 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -173.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.51 0.94 53.78 Favored Glycine 0 C--N 1.28 -2.539 0 C-N-CA 118.205 -1.95 . . . . 0.0 113.724 -175.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.4 t -82.88 -24.98 32.95 Favored 'General case' 0 N--CA 1.417 -2.081 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 177.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.719 HG22 ' O ' ' A' ' 51' ' ' GLN . 5.2 m -77.37 -46.45 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.256 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.355 176.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -66.12 -38.61 88.62 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.442 -176.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.85 -38.23 87.44 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.926 0.393 . . . . 0.0 110.548 177.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.479 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 34.9 tp -73.85 -42.25 61.08 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.48 HG21 ' HB2' ' A' ' 76' ' ' ALA . 53.5 t -57.0 -41.12 76.77 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 C-N-CA 123.16 0.584 . . . . 0.0 111.335 177.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.05 -24.21 67.62 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.38 -20.35 17.2 Favored 'General case' 0 C--O 1.207 -1.173 0 CA-C-O 121.511 0.672 . . . . 0.0 109.39 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -90.75 -28.1 18.5 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.073 -175.4 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -77.94 -24.06 48.36 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 122.157 -0.34 . . . . 0.0 110.409 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt . . . . . 0 C--N 1.322 -0.628 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.123 -178.481 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 32.8 t . . . . . 0 N--CA 1.442 -0.841 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.8 ttmp? -167.59 162.71 14.37 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.41 HG13 ' HB3' ' A' ' 61' ' ' LEU . 1.5 pp -93.69 150.5 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.606 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.42 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 37.2 mm -115.28 -28.93 2.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 CA-C-O 121.365 0.602 . . . . 0.0 109.666 178.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.631 ' CD2' HD13 ' A' ' 45' ' ' ILE . 3.8 t60 -149.39 140.4 22.92 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -171.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.48 ' HB2' HG21 ' A' ' 58' ' ' VAL . . . -136.67 135.15 38.0 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 177.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -158.54 141.55 14.72 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.652 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.476 ' HB ' ' HA ' ' A' ' 51' ' ' GLN . 4.5 p -93.86 93.98 4.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-O 122.793 1.282 . . . . 0.0 108.822 175.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.89 175.08 47.51 Favored Glycine 0 N--CA 1.409 -3.103 0 CA-C-N 113.855 -1.521 . . . . 0.0 109.554 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.555 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -83.07 -176.93 6.58 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 177.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.531 HG21 HG21 ' A' ' 118' ' ' ILE . 3.3 mp -78.56 110.91 14.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.512 HG22 ' OD2' ' A' ' 85' ' ' ASP . 14.0 t -113.56 165.56 12.38 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 119.576 -0.849 . . . . 0.0 109.374 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -56.92 -35.06 68.59 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.614 0.765 . . . . 0.0 111.182 -176.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.4 m -67.13 -28.54 68.23 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.523 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.512 ' OD2' HG22 ' A' ' 82' ' ' THR . 17.4 m-20 -77.37 -28.53 52.95 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-O 121.175 0.512 . . . . 0.0 110.408 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.518 ' CG2' ' HA ' ' A' ' 111' ' ' ALA . 46.0 mm -65.54 -33.15 61.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.111 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.9 m -57.01 -39.54 74.93 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.364 177.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -73.94 -39.03 64.06 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.981 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.23 -55.29 22.13 Favored 'General case' 0 C--N 1.316 -0.887 0 O-C-N 123.926 0.766 . . . . 0.0 111.877 -177.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.454 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 10.9 t -77.48 -19.01 56.58 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.419 178.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.79 -66.24 0.58 Allowed 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.057 0.456 . . . . 0.0 111.685 -177.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.6 m -95.41 2.06 54.41 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.409 -177.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.441 HD22 ' HA ' ' A' ' 93' ' ' ASN . 10.5 m120 62.43 62.92 1.08 Allowed 'General case' 0 CA--C 1.497 -1.079 0 CA-C-O 122.366 1.079 . . . . 0.0 112.332 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -120.24 134.56 55.23 Favored 'General case' 0 N--CA 1.417 -2.092 0 CA-C-N 113.244 -1.798 . . . . 0.0 107.179 176.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 32.2 pt -94.13 141.92 14.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.525 ' HB ' HG22 ' A' ' 118' ' ' ILE . 12.1 t -94.16 116.6 35.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-O 121.192 0.52 . . . . 0.0 110.149 -173.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 119' ' ' ARG . 58.0 mt -112.78 125.71 70.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 120' ' ' LEU . . . -132.24 170.25 21.9 Favored Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -145.42 117.68 8.42 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 72.72 -29.34 0.2 Allowed 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 124.78 1.232 . . . . 0.0 113.099 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.485 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 4.6 m -66.34 -48.11 81.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.563 176.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.555 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 59.8 mtm180 66.94 179.37 0.05 OUTLIER Pre-proline 0 CA--C 1.551 1.015 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.878 174.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.452 ' HG3' HD12 ' A' ' 118' ' ' ILE . 9.5 Cg_endo -98.84 168.72 0.58 Allowed 'Trans proline' 0 N--CA 1.44 -1.663 0 CA-C-N 120.838 1.335 . . . . 0.0 114.568 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -79.48 152.19 30.38 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 113.005 -1.907 . . . . 0.0 106.448 167.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.432 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -61.62 -21.07 64.05 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -176.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.534 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 54.9 t30 -94.47 -28.28 15.55 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.945 -0.702 . . . . 0.0 109.747 177.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.72 -40.8 95.95 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-O 120.965 0.412 . . . . 0.0 110.557 177.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 21.9 ptmt -61.72 -28.5 69.46 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.07 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.534 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 70.7 mtp180 -81.01 -53.09 6.72 Favored 'General case' 0 N--CA 1.385 -3.689 0 C-N-CA 125.918 1.687 . . . . 0.0 109.097 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -52.79 -45.26 67.11 Favored 'General case' 0 C--O 1.196 -1.73 0 CA-C-N 113.85 -1.523 . . . . 0.0 110.457 -178.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.518 ' HA ' ' CG2' ' A' ' 86' ' ' ILE . . . -48.58 -49.28 37.38 Favored 'General case' 0 CA--C 1.49 -1.355 0 O-C-N 124.524 1.14 . . . . 0.0 111.381 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -77.25 -35.2 55.53 Favored 'General case' 0 C--N 1.281 -2.399 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.539 -174.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 35.5 t -79.56 5.47 12.94 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-O 122.374 1.083 . . . . 0.0 108.979 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.454 ' O ' ' HB ' ' A' ' 90' ' ' THR . 19.3 mt-10 -123.75 14.54 9.36 Favored 'General case' 0 CA--C 1.46 -2.504 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.845 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 64.4 mmtt 65.85 17.94 10.98 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 173.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.0 m -120.73 171.41 9.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.362 177.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -137.15 142.35 42.22 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.531 HG21 HG21 ' A' ' 81' ' ' ILE . 10.3 pt -107.97 134.52 49.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 121.32 0.581 . . . . 0.0 111.044 -178.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.507 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 21.5 mmm180 -113.3 125.04 53.85 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -178.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.564 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.717 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -178.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.78 ' HB3' HD11 ' A' ' 74' ' ' ILE . 36.5 m-80 . . . . . 0 N--CA 1.433 -1.319 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.8 mt -134.27 163.6 29.26 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.66 0.743 . . . . 0.0 112.012 -177.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.426 HG21 HG22 ' A' ' 96' ' ' VAL . 0.8 OUTLIER -119.95 135.12 61.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.576 174.108 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.422 ' CG1' ' HA ' ' A' ' 54' ' ' VAL . 94.3 t -112.49 123.73 68.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 121.314 0.578 . . . . 0.0 111.401 -176.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -133.51 147.79 51.64 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 124.504 1.122 . . . . 0.0 109.668 176.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.39 161.87 33.19 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -81.65 -9.25 59.71 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 122.283 1.039 . . . . 0.0 109.52 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 96.1 t -114.96 123.73 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 176.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.671 ' O ' HG22 ' A' ' 54' ' ' VAL . 48.2 tt0 -58.24 -49.77 75.93 Favored 'General case' 0 C--O 1.205 -1.259 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -176.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.59 4.0 52.62 Favored Glycine 0 C--N 1.289 -2.059 0 C-N-CA 118.58 -1.772 . . . . 0.0 113.887 -176.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.9 t -86.17 -19.46 30.05 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 176.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.671 HG22 ' O ' ' A' ' 51' ' ' GLN . 4.9 m -81.19 -46.35 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.266 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 174.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -57.43 -50.35 73.3 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.384 -1.28 . . . . 0.0 111.968 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.05 -40.76 81.76 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 123.371 0.42 . . . . 0.0 111.594 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.403 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 36.8 tp -74.34 -43.06 58.24 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.071 -178.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.537 HG21 ' HB2' ' A' ' 76' ' ' ALA . 54.6 t -59.08 -40.14 80.11 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.595 0 C-N-CA 122.885 0.474 . . . . 0.0 111.071 177.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.62 -12.08 60.89 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.6 -31.72 10.25 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 176.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -75.71 -28.48 58.6 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 114.235 -1.348 . . . . 0.0 110.923 -175.41 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -83.14 -14.19 54.04 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.682 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.486 0 C-N-CA 119.863 -0.735 . . . . 0.0 111.947 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.5 t . . . . . 0 N--CA 1.441 -0.888 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 24.9 ttpp -139.83 160.37 40.05 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.238 0.542 . . . . 0.0 110.174 -176.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.458 HG12 HG13 ' A' ' 58' ' ' VAL . 1.6 pp -94.89 162.34 2.45 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.003 175.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.78 HD11 ' HB3' ' A' ' 43' ' ' ASN . 1.7 mp -120.52 -33.39 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 174.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -152.38 122.14 6.96 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.341 -166.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.537 ' HB2' HG21 ' A' ' 58' ' ' VAL . . . -110.81 139.48 46.08 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 176.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -156.42 132.1 9.57 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 120.178 -0.609 . . . . 0.0 111.529 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.421 ' HB ' ' HA ' ' A' ' 51' ' ' GLN . 4.4 p -93.93 93.86 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.887 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 172.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -177.53 175.86 47.77 Favored Glycine 0 N--CA 1.399 -3.814 0 N-CA-C 108.319 -1.912 . . . . 0.0 108.319 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.606 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . . . -86.41 -170.63 3.17 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.163 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.417 ' CD1' HD12 ' A' ' 120' ' ' LEU . 21.2 mt -94.1 105.7 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.007 0 CA-C-O 121.213 0.53 . . . . 0.0 109.6 -173.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.4 t -106.89 162.68 13.6 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.412 ' HG3' ' CB ' ' A' ' 110' ' ' ALA . 39.3 tt0 -60.79 -35.22 75.9 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 123.109 0.564 . . . . 0.0 111.109 -176.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.7 m -69.83 -10.95 60.35 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.664 -177.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -95.69 -31.66 13.13 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 121.6 0.714 . . . . 0.0 109.796 175.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.641 HD13 ' HB2' ' A' ' 111' ' ' ALA . 59.7 mt -69.8 -25.76 28.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.939 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.0 p -56.75 -37.19 70.7 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.7 175.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.459 HD11 HD13 ' A' ' 74' ' ' ILE . 1.9 tm? -70.86 -36.97 73.05 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 123.278 0.631 . . . . 0.0 110.191 175.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.01 -58.46 6.47 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.222 -175.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.536 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 7.0 t -71.46 -30.12 65.64 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 119.594 -0.842 . . . . 0.0 110.919 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.19 -53.08 62.35 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.061 0.545 . . . . 0.0 112.313 -177.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 31.7 t -101.44 6.91 42.68 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.432 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 9.9 p30 60.11 29.6 19.15 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.791 1.236 . . . . 0.0 111.648 177.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.47 131.64 39.96 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 113.545 -1.661 . . . . 0.0 108.632 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.4 pp -93.87 143.65 11.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.623 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.503 ' HB ' HG22 ' A' ' 118' ' ' ILE . 21.2 t -94.49 113.86 29.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.622 -174.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.456 ' HA ' ' O ' ' A' ' 119' ' ' ARG . 43.2 mm -112.91 123.41 68.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 175.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -115.08 168.79 12.65 Favored Glycine 0 N--CA 1.423 -2.212 0 C-N-CA 120.231 -0.985 . . . . 0.0 110.666 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -114.84 93.34 4.28 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.111 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 62.7 t30 60.78 10.02 2.49 Favored 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 125.796 1.639 . . . . 0.0 112.583 178.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.606 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 3.8 m -69.87 -47.97 66.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.792 -175.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.537 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 55.9 mtm180 74.8 143.57 0.1 OUTLIER Pre-proline 0 CA--C 1.548 0.873 0 O-C-N 124.251 0.969 . . . . 0.0 111.522 175.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 102' ' ' ARG . 6.4 Cg_endo -86.5 169.66 8.14 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 121.753 1.635 . . . . 0.0 114.11 -175.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -77.89 152.16 33.46 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 169.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.491 ' O ' ' HG3' ' A' ' 108' ' ' LYS . . . -60.41 -28.56 68.35 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.483 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 91.3 m-20 -85.3 -29.27 24.69 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.237 177.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.49 -45.71 86.15 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 177.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' A' ' 105' ' ' ALA . 0.0 OUTLIER -59.95 -29.63 68.54 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.265 179.761 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 62.3 mtt180 -73.1 -52.17 15.27 Favored 'General case' 0 N--CA 1.393 -3.289 0 C-N-CA 124.445 1.098 . . . . 0.0 109.62 178.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.412 ' CB ' ' HG3' ' A' ' 83' ' ' GLU . . . -53.88 -51.23 64.32 Favored 'General case' 0 C--O 1.197 -1.661 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.126 -178.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.641 ' HB2' HD13 ' A' ' 86' ' ' ILE . . . -46.44 -48.77 18.81 Favored 'General case' 0 CA--C 1.494 -1.188 0 O-C-N 124.736 1.272 . . . . 0.0 112.52 -178.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -79.34 -32.34 43.29 Favored 'General case' 0 N--CA 1.407 -2.611 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.396 -171.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 26.0 t -79.58 -1.74 39.25 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.536 ' O ' ' HB ' ' A' ' 90' ' ' THR . 25.9 mt-10 -116.49 14.18 15.53 Favored 'General case' 0 N--CA 1.418 -2.067 0 C-N-CA 125.028 1.331 . . . . 0.0 112.454 -178.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 10.0 mtpm? 66.6 9.5 6.66 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 172.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.7 m -116.8 132.83 65.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-O 121.602 0.715 . . . . 0.0 112.277 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -97.55 127.13 43.26 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.503 HG22 ' HB ' ' A' ' 96' ' ' VAL . 25.9 pt -106.56 128.99 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.018 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.056 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.456 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 12.0 ptt180 -142.21 149.37 39.58 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 121.118 0.485 . . . . 0.0 110.338 -178.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.521 ' HG ' ' H ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.59 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.175 -171.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.436 ' HA ' ' O ' ' A' ' 72' ' ' LYS . 14.8 m120 . . . . . 0 CA--C 1.498 -1.046 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.421 HD21 HD11 ' A' ' 61' ' ' LEU . 2.4 pt? -154.01 165.25 36.74 Favored 'General case' 0 C--O 1.257 1.453 0 CA-C-O 121.486 0.66 . . . . 0.0 111.375 177.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.612 HG23 ' HA ' ' A' ' 96' ' ' VAL . 0.6 OUTLIER -116.34 126.57 73.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 CA-C-N 114.638 -1.165 . . . . 0.0 108.986 175.105 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.417 HG12 ' HA ' ' A' ' 54' ' ' VAL . 73.2 t -95.77 121.08 45.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.696 -176.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 3.9 mtpm? -134.61 140.98 46.48 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -147.66 175.07 11.18 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -86.33 -13.46 46.5 Favored 'General case' 0 C--N 1.315 -0.934 0 O-C-N 123.813 0.696 . . . . 0.0 109.999 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 79.2 t -120.3 129.56 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 177.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.725 ' O ' HG22 ' A' ' 54' ' ' VAL . 16.1 tt0 -58.7 -48.3 81.59 Favored 'General case' 0 C--O 1.193 -1.904 0 O-C-N 123.291 0.369 . . . . 0.0 111.834 -175.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -73.26 -0.57 53.57 Favored Glycine 0 C--N 1.283 -2.379 0 C-N-CA 118.893 -1.622 . . . . 0.0 114.477 -175.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.3 t -86.48 -20.37 28.19 Favored 'General case' 0 N--CA 1.415 -2.221 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 177.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.725 HG22 ' O ' ' A' ' 51' ' ' GLN . 6.0 m -76.8 -44.22 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.181 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 173.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -63.04 -48.06 80.33 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.215 -1.357 . . . . 0.0 111.321 -177.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.42 -35.23 78.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.583 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.506 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 40.3 tp -78.56 -37.86 41.64 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.239 -178.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.506 HG21 ' HB2' ' A' ' 76' ' ' ALA . 49.8 t -58.44 -44.66 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 120.625 0.25 . . . . 0.0 110.452 176.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.0 -22.26 66.72 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.676 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.53 -16.01 20.29 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.712 0.768 . . . . 0.0 109.951 -177.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.506 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -97.13 -32.84 11.75 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.25 -175.261 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -73.02 -20.33 61.02 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.028 0.442 . . . . 0.0 110.586 177.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt . . . . . 0 C--N 1.326 -0.449 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.194 -177.55 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.44 -0.951 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 57.3 tttp -150.38 154.55 37.97 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.474 HG12 HG13 ' A' ' 58' ' ' VAL . 1.4 pp -93.69 154.45 3.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.635 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 40.3 mm -115.69 -33.32 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-O 121.142 0.496 . . . . 0.0 111.1 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -160.83 134.52 6.83 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -171.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.506 ' HB2' HG21 ' A' ' 58' ' ' VAL . . . -113.51 133.44 55.23 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 176.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 47' ' ' LYS . . . -151.94 130.64 12.35 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.307 -177.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.4 p -93.39 93.89 4.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-O 123.2 1.476 . . . . 0.0 110.148 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -177.84 175.49 47.55 Favored Glycine 0 N--CA 1.403 -3.558 0 CA-C-N 113.68 -1.6 . . . . 0.0 109.488 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.498 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -74.11 178.48 5.02 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 174.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.426 HG21 HG21 ' A' ' 118' ' ' ILE . 3.5 mp -84.27 108.83 16.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 69.6 p -101.04 166.92 10.56 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.512 -0.875 . . . . 0.0 108.992 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -59.53 -33.78 71.82 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.775 0.798 . . . . 0.0 109.508 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.1 m -67.44 -31.44 71.62 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.877 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -73.15 -34.76 66.26 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 121.901 0.858 . . . . 0.0 109.828 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.502 HD13 ' HB2' ' A' ' 111' ' ' ALA . 70.7 mt -66.55 -26.84 38.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 114.524 -1.216 . . . . 0.0 112.846 -176.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 88.3 p -55.49 -38.32 68.99 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 120.823 0.344 . . . . 0.0 110.507 175.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -73.14 -33.55 65.57 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.028 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.98 -62.16 1.89 Allowed 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.54 -177.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 4.3 t -70.58 -17.09 62.91 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-O 121.306 0.574 . . . . 0.0 111.129 178.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.82 -55.08 9.33 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 32.6 p -97.53 -8.32 29.38 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 121.017 -0.273 . . . . 0.0 110.767 -176.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . 0.265 0.0 OUTLIER 78.84 30.45 0.35 Allowed 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 127.021 2.128 . . . . 0.0 110.241 -176.799 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -92.6 140.56 29.42 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 113.969 -1.469 . . . . 0.0 110.23 -176.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.411 HG23 ' O ' ' A' ' 117' ' ' ASP . 43.0 mm -94.02 140.44 16.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.612 ' HA ' HG23 ' A' ' 45' ' ' ILE . 11.5 t -95.8 129.5 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -177.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 13.1 tt -127.78 135.99 61.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -137.24 158.23 24.25 Favored Glycine 0 N--CA 1.417 -2.61 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 177.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -117.25 102.7 9.49 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -176.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 59.0 t30 69.75 -31.55 0.21 Allowed 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 124.222 1.009 . . . . 0.0 112.924 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.457 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 1.7 m -49.51 -42.58 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 C-N-CA 124.028 0.931 . . . . 0.0 113.396 177.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.598 ' HA ' ' HG ' ' A' ' 120' ' ' LEU . 49.9 mtp180 69.94 176.44 0.07 OUTLIER Pre-proline 0 CA--C 1.537 0.456 0 O-C-N 123.886 0.741 . . . . 0.0 112.65 175.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.476 ' HG3' HD12 ' A' ' 118' ' ' ILE . 9.3 Cg_endo -99.25 177.55 0.33 Allowed 'Trans proline' 0 N--CA 1.432 -2.104 0 C-N-CA 121.828 1.685 . . . . 0.0 112.581 178.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -82.84 155.5 24.13 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 168.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.457 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -59.09 -28.84 66.87 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 120.755 0.312 . . . . 0.0 111.642 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.572 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 28.1 m-80 -81.1 -35.39 31.71 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 177.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.4 -42.9 95.85 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 120.799 0.333 . . . . 0.0 110.843 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 17.0 pttp -62.98 -20.69 65.51 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-O 121.089 0.471 . . . . 0.0 110.91 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.572 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 24.8 mtm180 -84.25 -51.68 6.83 Favored 'General case' 0 N--CA 1.392 -3.372 0 C-N-CA 124.593 1.157 . . . . 0.0 109.228 175.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -51.33 -51.52 53.66 Favored 'General case' 0 CA--C 1.477 -1.841 0 C-N-CA 125.34 1.456 . . . . 0.0 110.503 -178.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.502 ' HB2' HD13 ' A' ' 86' ' ' ILE . . . -49.49 -48.55 47.86 Favored 'General case' 0 CA--C 1.502 -0.877 0 O-C-N 124.842 1.339 . . . . 0.0 112.206 -177.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -78.14 -33.02 50.64 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.384 -172.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 48.0 t -81.44 5.77 16.65 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 176.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.512 ' O ' ' HB ' ' A' ' 90' ' ' THR . 12.3 mt-10 -123.46 12.76 9.41 Favored 'General case' 0 N--CA 1.417 -2.105 0 C-N-CA 124.771 1.228 . . . . 0.0 112.339 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 10.4 mmmm 65.62 10.81 7.01 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 174.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.3 m -115.69 132.97 63.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-O 121.574 0.702 . . . . 0.0 112.492 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.411 ' O ' HG23 ' A' ' 95' ' ' ILE . 28.1 t70 -94.81 126.16 39.94 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.367 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.574 HG22 ' HB ' ' A' ' 96' ' ' VAL . 7.8 pt -94.11 131.86 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-O 121.408 0.623 . . . . 0.0 110.518 178.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 7.0 tpp180 -102.7 115.85 31.41 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.958 -177.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.598 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.307 -1.239 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 177.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.558 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 57.7 m-80 . . . . . 0 N--CA 1.432 -1.358 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.404 HD12 HD11 ' A' ' 61' ' ' LEU . 78.7 mt -138.59 164.57 29.13 Favored 'General case' 0 C--O 1.245 0.849 0 CA-C-O 121.814 0.816 . . . . 0.0 112.35 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.506 HD12 ' O ' ' A' ' 75' ' ' HIS . 0.2 OUTLIER -127.0 135.39 63.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 174.464 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.444 ' CG1' ' HA ' ' A' ' 54' ' ' VAL . 92.1 t -118.61 127.91 75.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.048 -177.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 41.5 mtpt -144.92 140.89 28.59 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.76 175.18 13.14 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -178.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -84.47 -25.68 28.73 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 122.2 1.0 . . . . 0.0 108.94 177.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 99.0 t -101.61 122.54 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.246 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 174.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.709 ' O ' HG22 ' A' ' 54' ' ' VAL . 17.4 tt0 -62.9 -40.72 98.43 Favored 'General case' 0 C--O 1.192 -1.941 0 CA-C-O 120.602 0.239 . . . . 0.0 111.411 -175.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -73.75 -3.03 62.28 Favored Glycine 0 C--N 1.29 -2.0 0 C-N-CA 118.314 -1.898 . . . . 0.0 114.151 -177.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.4 m -80.72 -24.02 39.08 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 176.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.709 HG22 ' O ' ' A' ' 51' ' ' GLN . 3.3 m -77.14 -47.09 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.767 0 CA-C-N 114.579 -1.191 . . . . 0.0 107.827 176.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -57.13 -48.04 79.64 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.295 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.48 -31.2 72.15 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.333 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.442 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 24.3 tp -79.78 -41.3 26.81 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.239 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 54' ' ' VAL . 53.2 t -53.56 -43.96 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.512 0.725 . . . . 0.0 111.921 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.88 -29.07 70.29 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.44 -13.07 28.39 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 121.325 0.583 . . . . 0.0 110.106 -177.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -96.13 -33.65 11.98 Favored 'General case' 0 N--CA 1.418 -2.064 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.494 -176.174 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -75.52 -14.69 60.42 Favored 'General case' 0 C--N 1.313 -1.002 0 O-C-N 122.066 -0.396 . . . . 0.0 111.59 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt . . . . . 0 C--N 1.308 -1.238 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -178.157 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.7 t . . . . . 0 N--CA 1.423 -1.817 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 58.8 tttp -153.06 158.5 42.05 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.844 -174.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.441 HG12 HG13 ' A' ' 58' ' ' VAL . 1.2 pp -93.94 152.29 3.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 -177.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.454 HD11 ' OD1' ' A' ' 43' ' ' ASN . 27.7 mm -115.69 -27.26 2.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.839 177.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.506 ' O ' HD12 ' A' ' 45' ' ' ILE . 3.5 t60 -157.69 135.91 11.0 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -169.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -142.48 129.34 20.58 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.426 ' O ' ' HA ' ' A' ' 47' ' ' LYS . . . -161.91 159.37 26.63 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 120.714 0.293 . . . . 0.0 110.477 -178.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.8 p -94.58 103.46 14.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 175.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -175.88 175.81 47.42 Favored Glycine 0 N--CA 1.425 -2.08 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -177.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.546 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -90.19 178.62 6.12 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.448 HD11 ' HA3' ' A' ' 98' ' ' GLY . 3.7 mp -82.38 108.16 15.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 69.5 p -100.42 169.13 9.3 Favored 'General case' 0 N--CA 1.421 -1.885 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -58.83 -28.66 66.25 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.804 0.842 . . . . 0.0 110.254 176.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.0 t -71.58 -37.41 71.02 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.485 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -70.93 -36.05 72.49 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 121.634 0.73 . . . . 0.0 110.225 -177.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.55 HG21 ' HA ' ' A' ' 111' ' ' ALA . 54.3 mt -69.35 -34.6 63.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.426 -177.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 66.5 m -63.99 -19.36 65.11 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 120.471 -0.492 . . . . 0.0 112.152 174.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.41 HD21 HG21 ' A' ' 74' ' ' ILE . 2.2 tm? -79.9 -36.04 37.05 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 173.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.93 -54.18 49.83 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.31 -177.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.508 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 10.1 t -74.52 -12.88 60.59 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.917 178.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.76 -58.7 3.12 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.95 0.405 . . . . 0.0 111.815 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 26.4 m -98.12 5.14 48.92 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.432 -177.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.1 m120 72.43 33.05 1.51 Allowed 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 122.094 0.949 . . . . 0.0 110.041 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -94.75 170.26 9.57 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 113.938 -1.483 . . . . 0.0 109.71 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 36.6 pt -130.93 148.08 33.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 173.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.474 ' HA ' HG23 ' A' ' 45' ' ' ILE . 3.4 t -100.62 126.79 54.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.973 -175.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.593 ' HA ' ' O ' ' A' ' 119' ' ' ARG . 66.0 mt -112.13 135.78 50.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.448 ' HA3' HD11 ' A' ' 81' ' ' ILE . . . -132.55 140.16 11.58 Favored Glycine 0 N--CA 1.434 -1.486 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.745 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -107.36 100.12 9.58 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -176.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.2 t30 72.91 -36.19 0.35 Allowed 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 125.332 1.453 . . . . 0.0 111.922 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.403 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 3.5 m -50.76 -50.63 22.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 124.698 1.199 . . . . 0.0 112.664 177.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.546 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 76.4 mtp180 67.73 177.21 0.06 OUTLIER Pre-proline 0 CA--C 1.559 1.312 0 O-C-N 123.731 0.644 . . . . 0.0 111.541 176.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.47 ' HG3' HD12 ' A' ' 118' ' ' ILE . 5.3 Cg_endo -94.82 173.58 1.31 Allowed 'Trans proline' 0 CA--C 1.5 -1.183 0 C-N-CA 121.59 1.527 . . . . 0.0 113.985 -177.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -77.48 160.91 28.33 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 113.965 -1.471 . . . . 0.0 107.335 168.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.486 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -67.35 -29.68 69.29 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -176.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.521 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 10.3 m-80 -86.72 -35.55 19.17 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.08 -50.42 66.83 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.441 175.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 61.2 pttt -56.97 -24.71 55.16 Favored 'General case' 0 CA--C 1.565 1.527 0 C-N-CA 122.697 0.399 . . . . 0.0 112.075 -178.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.521 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 14.1 mtm180 -86.27 -46.84 9.96 Favored 'General case' 0 N--CA 1.386 -3.628 0 C-N-CA 125.201 1.401 . . . . 0.0 108.93 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.11 -42.39 69.39 Favored 'General case' 0 C--O 1.201 -1.477 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.425 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.55 ' HA ' HG21 ' A' ' 86' ' ' ILE . . . -48.78 -44.86 39.27 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 124.475 1.109 . . . . 0.0 111.406 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -77.82 -32.83 52.46 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 114.874 -1.057 . . . . 0.0 112.277 -175.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 48.3 t -83.13 4.86 24.66 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 176.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.508 ' O ' ' HB ' ' A' ' 90' ' ' THR . 23.2 mt-10 -123.1 12.08 9.57 Favored 'General case' 0 CA--C 1.464 -2.341 0 C-N-CA 124.496 1.118 . . . . 0.0 112.883 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 26.7 mtpp 66.25 7.99 5.28 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 173.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.1 m -115.41 155.47 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.324 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -174.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -111.99 124.68 52.92 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.457 -178.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.47 HD12 ' HG3' ' A' ' 103' ' ' PRO . 9.3 pt -96.16 133.07 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.626 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.593 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 41.0 ttt85 -119.36 125.32 48.74 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.458 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.285 -2.209 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.085 -177.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 72' ' ' LYS . 18.2 t30 . . . . . 0 N--CA 1.419 -1.994 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 93.8 mt -123.36 172.86 8.36 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 122.146 0.974 . . . . 0.0 113.106 -172.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.658 HG23 ' HA ' ' A' ' 96' ' ' VAL . 1.1 tt -122.21 134.99 63.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 114.55 -1.204 . . . . 0.0 110.162 178.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 98.6 t -110.14 120.94 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 CA-C-O 121.496 0.665 . . . . 0.0 110.543 -177.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 28.1 mtpp -140.62 114.61 9.06 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.289 1.036 . . . . 0.0 109.614 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -131.05 167.02 19.78 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.575 -176.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -73.08 -35.59 66.68 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.997 0.903 . . . . 0.0 109.02 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 88.5 t -95.56 124.7 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 176.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.734 ' O ' HG22 ' A' ' 54' ' ' VAL . 24.1 tt0 -62.63 -40.52 97.26 Favored 'General case' 0 C--O 1.194 -1.858 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.071 -177.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -75.67 0.67 60.55 Favored Glycine 0 C--N 1.279 -2.617 0 C-N-CA 118.241 -1.933 . . . . 0.0 114.071 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.4 t -87.53 -22.77 24.66 Favored 'General case' 0 N--CA 1.418 -2.059 0 N-CA-C 106.036 -1.839 . . . . 0.0 106.036 174.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.734 HG22 ' O ' ' A' ' 51' ' ' GLN . 3.9 m -73.0 -43.81 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.847 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 174.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -57.57 -54.87 41.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.222 -1.354 . . . . 0.0 110.636 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.65 -41.05 89.68 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.211 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.5 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 40.3 tp -73.38 -37.92 65.83 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 120.049 -0.661 . . . . 0.0 110.67 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.468 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 39.9 t -59.01 -45.17 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.58 -19.73 64.01 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.661 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.3 -10.91 20.79 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.697 0.76 . . . . 0.0 109.957 -177.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.5 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -105.27 -27.94 11.23 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 114.638 -1.164 . . . . 0.0 110.21 -175.125 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 4.2 pt20 -84.16 -11.35 56.72 Favored 'General case' 0 C--N 1.315 -0.904 0 O-C-N 121.904 -0.497 . . . . 0.0 111.422 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt . . . . . 0 C--N 1.317 -0.809 0 CA-C-O 121.327 0.584 . . . . 0.0 110.038 179.906 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 39.0 t . . . . . 0 N--CA 1.417 -2.109 0 N-CA-C 103.237 -2.875 . . . . 0.0 103.237 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 4.5 ttpm? -141.04 164.04 31.34 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.661 -171.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.407 HG23 ' HG ' ' A' ' 61' ' ' LEU . 1.6 pp -100.03 158.35 3.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.714 176.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.3 mt -117.62 -41.57 2.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.999 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -154.56 131.42 10.82 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.626 -169.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -124.99 125.12 43.39 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 124.215 1.006 . . . . 0.0 108.449 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 47' ' ' LYS . . . -148.57 145.91 28.04 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.3 p -94.87 94.83 4.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-O 122.754 1.264 . . . . 0.0 110.049 177.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.24 175.09 47.36 Favored Glycine 0 N--CA 1.404 -3.445 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.597 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -89.22 175.47 7.34 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.416 ' CG2' HD11 ' A' ' 86' ' ' ILE . 1.7 mp -72.87 116.95 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 CA-C-O 121.19 0.519 . . . . 0.0 110.151 -177.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.9 t -123.43 155.51 37.3 Favored 'General case' 0 N--CA 1.403 -2.778 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.48 -26.98 68.67 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -173.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.4 t -65.14 -29.0 69.81 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.278 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -82.04 -32.58 30.39 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.542 0.687 . . . . 0.0 109.522 177.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.637 HD13 ' HB2' ' A' ' 111' ' ' ALA . 41.5 mt -68.17 -29.87 45.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.253 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.407 ' HA ' ' OE2' ' A' ' 114' ' ' GLU . 42.6 m -58.8 -24.31 61.67 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 174.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -76.54 -34.45 58.53 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 175.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.407 ' HB3' HG21 ' A' ' 116' ' ' VAL . . . -56.42 -57.23 13.21 Favored 'General case' 0 C--O 1.191 -1.984 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.039 -177.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.626 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 1.9 t -66.29 -30.63 71.09 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 120.37 -0.532 . . . . 0.0 112.095 176.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.02 -55.83 25.23 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -177.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 33.7 m -101.34 5.11 42.13 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.972 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 64.36 37.71 8.22 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.828 0.851 . . . . 0.0 109.965 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -93.78 156.47 16.65 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.284 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.1 mp -108.19 136.5 43.5 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 176.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.658 ' HA ' HG23 ' A' ' 45' ' ' ILE . 14.3 t -93.58 103.93 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -176.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 51.4 mt -94.82 112.37 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.824 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -103.18 134.98 12.07 Favored Glycine 0 N--CA 1.414 -2.777 0 N-CA-C 109.984 -1.247 . . . . 0.0 109.984 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.414 ' C ' ' H ' ' A' ' 101' ' ' VAL . 98.4 m-85 -104.15 94.45 5.38 Favored 'General case' 0 C--N 1.281 -2.399 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.237 -173.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 71.69 -22.72 0.19 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 125.626 1.571 . . . . 0.0 112.995 178.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.574 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 2.7 m -54.62 -48.99 70.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 178.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.597 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 37.2 mtp180 72.6 171.14 0.11 Allowed Pre-proline 0 CA--C 1.552 1.048 0 O-C-N 123.863 0.727 . . . . 0.0 111.822 178.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.451 ' HG3' HD12 ' A' ' 118' ' ' ILE . 13.7 Cg_endo -100.62 -173.17 0.11 Allowed 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.43 2.087 . . . . 0.0 113.504 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -106.75 176.89 5.02 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.275 -1.33 . . . . 0.0 107.444 170.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.505 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -74.2 -12.11 60.48 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 113.701 1.001 . . . . 0.0 113.701 -173.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.474 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 8.8 t30 -101.33 -40.35 7.16 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.07 -46.12 82.74 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 123.355 0.41 . . . . 0.0 110.882 175.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -54.38 -34.56 61.46 Favored 'General case' 0 CA--C 1.562 1.433 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.798 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.505 ' HG3' ' O ' ' A' ' 105' ' ' ALA . 15.7 mtm180 -79.45 -49.77 11.8 Favored 'General case' 0 N--CA 1.386 -3.642 0 C-N-CA 126.118 1.767 . . . . 0.0 109.541 -178.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.55 -43.69 68.64 Favored 'General case' 0 C--O 1.203 -1.355 0 CA-C-N 113.944 -1.48 . . . . 0.0 110.53 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.637 ' HB2' HD13 ' A' ' 86' ' ' ILE . . . -50.56 -47.22 57.88 Favored 'General case' 0 CA--C 1.489 -1.382 0 O-C-N 124.532 1.145 . . . . 0.0 111.356 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -79.23 -30.59 43.28 Favored 'General case' 0 C--N 1.277 -2.583 0 CA-C-N 114.754 -1.112 . . . . 0.0 112.691 -172.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 35.2 t -84.68 4.72 31.21 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-O 122.069 0.937 . . . . 0.0 108.511 176.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.626 ' O ' ' HB ' ' A' ' 90' ' ' THR . 23.3 mt-10 -118.21 17.01 14.02 Favored 'General case' 0 CA--C 1.46 -2.493 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.581 177.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 47.7 mtmt 66.55 7.83 5.37 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 174.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.407 HG21 ' HB3' ' A' ' 89' ' ' ALA . 11.3 m -117.62 171.92 5.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.951 -176.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -131.67 143.68 50.46 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.525 HG22 ' HB ' ' A' ' 96' ' ' VAL . 5.6 pt -101.98 138.01 27.78 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.519 179.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 13.6 ttm180 -114.46 111.84 22.05 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -172.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.401 ' CD1' ' HA ' ' A' ' 102' ' ' ARG . 3.1 mm? . . . . . 0 CA--C 1.478 -1.818 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.067 -174.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.462 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 40.7 m-80 . . . . . 0 CA--C 1.494 -1.179 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.1 mt -138.21 167.97 20.71 Favored 'General case' 0 C--O 1.249 1.042 0 CA-C-O 122.212 1.006 . . . . 0.0 112.595 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.456 HG21 HG22 ' A' ' 96' ' ' VAL . 0.6 OUTLIER -130.79 140.11 49.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-N 113.865 -1.516 . . . . 0.0 108.243 176.214 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.449 ' CG1' ' HA ' ' A' ' 54' ' ' VAL . 95.4 t -111.24 124.48 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.751 0 CA-C-O 121.538 0.685 . . . . 0.0 111.642 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 68.2 mttm -134.92 144.25 47.36 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.354 -1.294 . . . . 0.0 108.573 176.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -163.38 159.73 22.73 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 177.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -69.06 -32.98 72.83 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.584 0.706 . . . . 0.0 111.051 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 76.2 t -91.96 126.08 44.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.696 ' O ' HG22 ' A' ' 54' ' ' VAL . 13.6 tt0 -62.15 -50.21 72.78 Favored 'General case' 0 C--O 1.198 -1.631 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -173.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.65 0.4 56.39 Favored Glycine 0 C--N 1.29 -2.006 0 C-N-CA 118.537 -1.792 . . . . 0.0 114.427 -175.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 43.0 m -82.09 -24.87 34.96 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 175.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.696 HG22 ' O ' ' A' ' 51' ' ' GLN . 4.1 m -74.97 -46.67 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.313 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.194 175.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -63.37 -46.37 86.81 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.989 -177.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.35 -36.78 84.85 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.241 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 34.4 tp -73.26 -39.98 64.98 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.809 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.49 HG21 ' HB2' ' A' ' 76' ' ' ALA . 53.3 t -57.95 -40.01 74.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 122.738 0.415 . . . . 0.0 110.912 176.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.88 -6.98 45.67 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -105.28 -34.9 7.73 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.436 ' HB3' HG13 ' A' ' 73' ' ' ILE . 0.4 OUTLIER -72.49 -32.43 66.18 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.987 -175.48 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -73.02 -18.07 61.38 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.046 0.451 . . . . 0.0 110.812 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.444 -0.76 0 CA-C-O 121.319 0.58 . . . . 0.0 111.199 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.1 t . . . . . 0 N--CA 1.438 -1.03 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -139.94 158.0 44.77 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.604 0.716 . . . . 0.0 111.78 -173.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.436 HG13 ' HB3' ' A' ' 61' ' ' LEU . 1.7 pp -94.42 159.68 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.301 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.6 mp -125.66 -28.49 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.814 175.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.409 ' CD2' HD12 ' A' ' 45' ' ' ILE . 3.7 t60 -150.41 132.76 15.54 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 120.882 0.372 . . . . 0.0 110.121 -170.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.49 ' HB2' HG21 ' A' ' 58' ' ' VAL . . . -123.86 140.48 52.94 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 47' ' ' LYS . . . -159.08 140.79 13.39 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.427 ' HB ' ' HA ' ' A' ' 51' ' ' GLN . 3.6 p -94.67 92.93 3.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-O 122.785 1.279 . . . . 0.0 107.552 175.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -177.36 176.2 47.95 Favored Glycine 0 N--CA 1.398 -3.899 0 CA-C-N 114.427 -1.26 . . . . 0.0 110.643 -177.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.64 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -83.96 -168.98 2.36 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 103' ' ' PRO . 3.3 mp -86.57 108.32 17.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.584 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 18.3 p -101.78 151.15 22.4 Favored 'General case' 0 N--CA 1.414 -2.253 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.111 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -45.59 -53.94 8.38 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.341 1.457 . . . . 0.0 113.618 -177.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.3 t -76.08 -14.43 60.2 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 120.68 0.276 . . . . 0.0 111.516 -174.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -77.57 -35.34 53.19 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.548 HD13 ' HB2' ' A' ' 111' ' ' ALA . 40.7 mt -59.73 -26.62 35.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-N 114.379 -1.282 . . . . 0.0 112.078 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.7 m -58.18 -21.57 47.95 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 175.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -80.22 -35.69 35.86 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 174.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.01 -53.54 55.74 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.577 -176.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.51 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 3.3 t -70.58 -24.7 62.82 Favored 'General case' 0 CA--C 1.557 1.247 0 O-C-N 122.017 -0.427 . . . . 0.0 111.707 177.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.32 -52.57 38.83 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -175.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.6 p -105.26 -2.37 24.14 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 122.05 0.929 . . . . 0.0 109.231 -176.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.442 HD22 ' HA ' ' A' ' 93' ' ' ASN . 1.9 t-20 66.73 41.17 3.02 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.223 -1.808 . . . . 0.0 109.365 -177.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -94.24 130.18 40.59 Favored 'General case' 0 N--CA 1.413 -2.32 0 CA-C-N 113.597 -1.638 . . . . 0.0 106.952 177.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 37.8 pt -93.89 142.66 13.0 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.375 0 C-N-CA 119.112 -1.035 . . . . 0.0 108.996 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.484 ' HB ' HG22 ' A' ' 118' ' ' ILE . 10.6 t -93.53 106.37 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.316 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -175.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.498 ' HA ' ' O ' ' A' ' 119' ' ' ARG . 65.5 mt -101.58 117.6 47.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 177.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 120' ' ' LEU . . . -123.32 176.32 16.67 Favored Glycine 0 C--N 1.289 -2.037 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -178.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -148.09 115.93 6.39 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.359 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 8.4 t30 73.91 -27.56 0.19 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 125.586 1.554 . . . . 0.0 113.09 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.456 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 7.8 m -60.92 -53.17 52.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 C-N-CA 124.382 1.073 . . . . 0.0 113.778 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.64 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 61.9 mtp180 73.83 168.47 0.12 Allowed Pre-proline 0 N--CA 1.482 1.132 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 176.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 9.4 Cg_endo -98.41 176.04 0.45 Allowed 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 122.036 1.824 . . . . 0.0 115.006 -177.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.529 ' HB2' ' H ' ' A' ' 107' ' ' ALA . 65.5 m-20 -67.82 159.43 30.35 Favored 'General case' 0 C--O 1.249 1.067 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 168.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.459 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -66.74 -29.43 69.4 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 176.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.592 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 83.9 m-20 -84.95 -27.22 26.68 Favored 'General case' 0 C--O 1.205 -1.27 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.541 175.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.529 ' H ' ' HB2' ' A' ' 104' ' ' ASP . . . -70.11 -41.46 73.96 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.458 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 13.7 ptmm? -59.75 -21.65 61.01 Favored 'General case' 0 CA--C 1.556 1.174 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.404 178.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.592 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 96.1 mtt180 -87.28 -53.8 4.64 Favored 'General case' 0 N--CA 1.384 -3.741 0 C-N-CA 125.44 1.496 . . . . 0.0 109.849 177.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -50.28 -45.27 54.25 Favored 'General case' 0 C--O 1.196 -1.72 0 C-N-CA 124.978 1.311 . . . . 0.0 111.036 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.548 ' HB2' HD13 ' A' ' 86' ' ' ILE . . . -50.49 -46.69 57.2 Favored 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 124.194 0.934 . . . . 0.0 111.886 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -79.75 -29.52 40.55 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.949 -172.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 32.5 t -82.67 3.23 29.87 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.51 ' O ' ' HB ' ' A' ' 90' ' ' THR . 19.1 mt-10 -122.39 11.84 10.05 Favored 'General case' 0 CA--C 1.474 -1.972 0 C-N-CA 124.896 1.278 . . . . 0.0 112.82 -178.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 56.9 mttp 65.89 12.21 8.22 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 174.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.4 m -120.62 135.28 61.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-O 121.454 0.645 . . . . 0.0 112.557 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -96.51 124.4 40.49 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.455 176.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.484 HG22 ' HB ' ' A' ' 96' ' ' VAL . 9.6 pt -92.91 124.55 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.029 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 176.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 41.5 mtm180 -123.23 103.61 8.64 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-O 122.207 1.003 . . . . 0.0 111.494 -171.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.532 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.411 -2.387 0 CA-C-N 113.943 -1.481 . . . . 0.0 110.802 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.548 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 57.5 m-80 . . . . . 0 CA--C 1.493 -1.228 0 CA-C-O 120.441 0.162 . . . . 0.0 111.419 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 91.4 mt -136.8 160.31 39.23 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-O 122.042 0.925 . . . . 0.0 112.28 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.549 HG23 ' HA ' ' A' ' 96' ' ' VAL . 0.1 OUTLIER -121.14 130.38 74.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 171.434 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 81.4 t -105.19 133.28 49.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.763 -177.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -144.63 134.38 23.6 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -150.9 168.46 24.44 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -80.39 -28.37 37.93 Favored 'General case' 0 C--N 1.316 -0.854 0 O-C-N 123.971 0.794 . . . . 0.0 109.279 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 90.0 t -96.3 124.88 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 174.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.715 ' O ' HG22 ' A' ' 54' ' ' VAL . 16.2 tt0 -64.22 -49.28 72.6 Favored 'General case' 0 C--O 1.19 -2.075 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -173.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.57 1.94 33.79 Favored Glycine 0 C--N 1.292 -1.886 0 C-N-CA 119.278 -1.439 . . . . 0.0 113.648 -177.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.2 t -83.49 -22.19 32.58 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 177.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.715 HG22 ' O ' ' A' ' 51' ' ' GLN . 4.7 m -81.91 -45.8 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.967 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.263 175.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -60.48 -47.49 85.88 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 114.691 -1.141 . . . . 0.0 111.536 -177.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.69 -32.27 73.7 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.087 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.524 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 25.8 tp -76.47 -39.81 52.19 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.882 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.411 HG13 HG12 ' A' ' 73' ' ' ILE . 24.8 t -53.3 -44.71 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 123.652 0.781 . . . . 0.0 111.573 177.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.84 -21.25 65.2 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.27 -8.52 21.19 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.401 0.62 . . . . 0.0 110.433 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.524 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -97.67 -43.04 7.35 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-N 115.03 -0.987 . . . . 0.0 108.876 -176.879 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -66.06 -20.01 66.03 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.859 0.361 . . . . 0.0 111.414 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.3 pttp . . . . . 0 N--CA 1.439 -0.983 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.99 -175.155 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 41.4 t . . . . . 0 N--CA 1.424 -1.763 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -140.39 153.6 46.4 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 120.069 -0.653 . . . . 0.0 111.021 -175.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.411 HG12 HG13 ' A' ' 58' ' ' VAL . 1.5 pp -94.32 141.77 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.071 175.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.403 ' CD1' ' HB3' ' A' ' 43' ' ' ASN . 67.4 mt -111.23 -25.44 3.52 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.472 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.537 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.451 ' O ' HD12 ' A' ' 45' ' ' ILE . 6.1 t60 -161.56 142.86 11.28 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -171.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -146.4 127.32 14.49 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -147.78 153.35 39.11 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.225 -176.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.2 p -94.06 94.57 4.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 122.207 1.003 . . . . 0.0 110.848 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.09 174.43 46.77 Favored Glycine 0 N--CA 1.42 -2.421 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 176.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.541 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -85.58 176.66 8.07 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 173.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.0 mt -79.2 112.55 17.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 122.07 0.148 . . . . 0.0 110.74 -170.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 67.6 p -107.76 165.93 11.07 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.434 ' O ' ' HB ' ' A' ' 86' ' ' ILE . 13.1 pt-20 -66.69 -23.83 66.18 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -174.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.2 t -76.35 -24.82 54.24 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.151 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -70.37 -37.81 74.64 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.532 ' CG2' ' HA ' ' A' ' 111' ' ' ALA . 48.2 mm -56.59 -38.86 59.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 113.868 -1.514 . . . . 0.0 111.35 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.7 m -58.66 -28.37 65.66 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.29 -178.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -76.02 -37.22 58.67 Favored 'General case' 0 C--O 1.251 1.157 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.97 -46.98 87.69 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.135 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.496 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 7.5 t -77.8 -23.06 49.21 Favored 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.138 177.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.04 -67.68 0.43 Allowed 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -176.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 33.5 t -99.01 4.88 47.29 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.283 -175.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 70.76 68.64 0.19 Allowed 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 124.405 1.082 . . . . 0.0 112.189 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -119.86 166.87 12.72 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 113.992 -1.458 . . . . 0.0 108.546 174.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 47.9 mm -121.38 144.49 30.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 174.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.549 ' HA ' HG23 ' A' ' 45' ' ' ILE . 19.9 t -94.63 119.76 43.09 Favored 'Isoleucine or valine' 0 C--O 1.249 1.035 0 CA-C-O 120.974 0.416 . . . . 0.0 110.097 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.1 mp -107.94 111.32 35.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 174.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -99.5 136.39 12.66 Favored Glycine 0 N--CA 1.413 -2.89 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -95.41 93.37 7.19 Favored 'General case' 0 C--N 1.29 -1.996 0 C-N-CA 118.543 -1.263 . . . . 0.0 109.665 -176.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 54.59 28.91 10.52 Favored 'General case' 0 C--O 1.212 -0.918 0 C-N-CA 123.856 0.862 . . . . 0.0 111.621 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 m -96.58 -46.71 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.984 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -175.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.541 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 63.5 mtm180 75.39 155.09 0.15 Allowed Pre-proline 0 N--CA 1.471 0.583 0 C-N-CA 124.0 0.92 . . . . 0.0 111.455 178.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -89.59 167.73 5.0 Favored 'Trans proline' 0 N--CA 1.432 -2.099 0 C-N-CA 121.475 1.45 . . . . 0.0 115.269 -175.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -75.36 156.66 35.24 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 112.6 -2.091 . . . . 0.0 106.906 170.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.507 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -61.27 -32.72 72.55 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.499 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 77.6 m-20 -87.01 -24.9 24.49 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.63 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.41 -44.03 79.8 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.609 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 17.2 ptpt -57.67 -35.2 70.25 Favored 'General case' 0 CA--C 1.562 1.437 0 O-C-N 123.575 0.547 . . . . 0.0 110.465 177.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.499 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 98.2 mtt180 -72.49 -55.91 6.24 Favored 'General case' 0 N--CA 1.385 -3.686 0 C-N-CA 125.762 1.625 . . . . 0.0 109.402 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -53.82 -47.47 70.86 Favored 'General case' 0 C--O 1.198 -1.626 0 CA-C-N 113.806 -1.543 . . . . 0.0 110.067 -177.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.532 ' HA ' ' CG2' ' A' ' 86' ' ' ILE . . . -48.54 -48.09 38.78 Favored 'General case' 0 CA--C 1.489 -1.386 0 O-C-N 124.618 1.199 . . . . 0.0 111.47 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -77.36 -35.44 54.57 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.872 -174.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 45.4 t -77.61 -3.13 39.3 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 177.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.496 ' O ' ' HB ' ' A' ' 90' ' ' THR . 16.3 mt-10 -113.28 11.94 18.78 Favored 'General case' 0 CA--C 1.468 -2.188 0 C-N-CA 124.388 1.075 . . . . 0.0 112.386 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 55.3 mttp 67.48 11.77 8.55 Favored 'General case' 0 N--CA 1.416 -2.148 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 174.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.7 m -119.85 118.77 58.18 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 121.769 0.795 . . . . 0.0 112.602 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -94.22 124.92 38.55 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.514 HG22 ' HB ' ' A' ' 96' ' ' VAL . 8.4 pt -94.21 144.29 9.95 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-O 121.182 0.515 . . . . 0.0 111.059 -176.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -126.91 132.59 50.85 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.204 0.526 . . . . 0.0 109.87 -176.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.502 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.3 -1.574 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.028 -173.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 . . . . . 0 N--CA 1.439 -0.979 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 95.8 mt -137.19 158.34 44.66 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.613 0.72 . . . . 0.0 112.114 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.706 HG23 ' HA ' ' A' ' 96' ' ' VAL . 0.4 OUTLIER -122.04 132.73 70.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.808 170.509 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 97.7 t -111.05 126.84 68.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.944 -176.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.491 ' O ' ' HA2' ' A' ' 98' ' ' GLY . 74.1 mttt -137.0 147.7 46.43 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.283 -0.872 . . . . 0.0 108.964 173.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.21 170.74 19.81 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 120.827 0.346 . . . . 0.0 110.562 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -72.7 -29.87 63.74 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.438 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 75.8 t -113.32 134.15 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.645 ' O ' HG22 ' A' ' 54' ' ' VAL . 12.4 tt0 -60.36 -52.37 65.55 Favored 'General case' 0 C--O 1.2 -1.514 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -175.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.65 5.15 31.75 Favored Glycine 0 C--N 1.292 -1.875 0 C-N-CA 118.327 -1.892 . . . . 0.0 114.305 -176.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.0 m -88.38 -21.03 24.54 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 174.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.645 HG22 ' O ' ' A' ' 51' ' ' GLN . 3.6 m -76.26 -46.04 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 174.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -67.0 -35.6 80.29 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.475 -1.239 . . . . 0.0 112.079 -176.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.73 -33.65 75.57 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.303 0.573 . . . . 0.0 110.257 176.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 31.3 tp -79.87 -45.99 17.64 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 54' ' ' VAL . 56.1 t -55.88 -44.21 77.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 124.037 0.935 . . . . 0.0 112.264 179.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.66 -20.84 65.23 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -177.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.1 -28.78 13.59 Favored 'General case' 0 C--O 1.202 -1.426 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.71 -33.82 60.35 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 114.023 -1.444 . . . . 0.0 110.265 -176.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -72.64 -20.66 61.23 Favored 'General case' 0 C--N 1.315 -0.908 0 O-C-N 122.061 -0.399 . . . . 0.0 111.159 177.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? . . . . . 0 C--N 1.318 -0.761 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 179.109 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.432 -1.354 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -137.5 157.48 46.46 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-O 121.803 0.811 . . . . 0.0 110.589 -174.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 pp -93.83 157.97 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.177 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.413 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 74.3 mt -119.99 -31.04 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.463 177.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.499 ' CD2' HD12 ' A' ' 45' ' ' ILE . 6.4 t60 -151.55 131.97 13.78 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -171.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -139.24 129.31 25.15 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.108 0.963 . . . . 0.0 109.458 -175.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -154.08 157.59 39.21 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.505 -178.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.491 ' HB ' ' HA ' ' A' ' 51' ' ' GLN . 5.1 p -94.49 94.99 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-O 122.132 0.968 . . . . 0.0 108.611 176.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -175.57 175.95 47.33 Favored Glycine 0 N--CA 1.401 -3.698 0 C-N-CA 120.186 -1.006 . . . . 0.0 110.858 -177.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.584 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -87.46 173.12 9.31 Favored 'General case' 0 C--N 1.282 -2.35 0 O-C-N 124.112 0.536 . . . . 0.0 109.721 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.526 HD13 HD11 ' A' ' 120' ' ' LEU . 1.9 mp -75.49 107.76 6.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.65 152.66 22.85 Favored 'General case' 0 N--CA 1.401 -2.91 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.047 -178.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.432 ' HG3' ' HB2' ' A' ' 110' ' ' ALA . 41.7 tt0 -54.24 -45.39 72.31 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 124.029 0.831 . . . . 0.0 112.547 -174.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.9 p -69.8 -18.71 63.49 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -81.51 -25.37 36.01 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-O 121.603 0.716 . . . . 0.0 110.128 177.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.556 HG21 ' HA ' ' A' ' 111' ' ' ALA . 42.0 mt -72.51 -20.57 19.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.681 178.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.0 m -60.13 -26.8 66.55 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.05 175.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -79.64 -38.58 33.46 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.97 177.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.01 -58.68 6.4 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.338 -176.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.613 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 2.3 t -68.15 -28.22 67.11 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.507 177.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.04 -65.49 0.68 Allowed 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.19 0.519 . . . . 0.0 111.514 -177.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.5 m -93.69 6.0 49.78 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.888 -176.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 67.87 33.0 4.94 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.901 0.858 . . . . 0.0 109.937 177.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.53 153.1 18.05 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.439 -178.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 41.4 mm -107.72 141.21 23.52 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.146 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.706 ' HA ' HG23 ' A' ' 45' ' ' ILE . 10.7 t -94.8 120.47 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 65.8 mt -112.94 120.28 62.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 177.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 47' ' ' LYS . . . -139.83 171.06 24.0 Favored Glycine 0 N--CA 1.427 -1.902 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 178.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.444 ' C ' ' H ' ' A' ' 101' ' ' VAL . 30.4 p90 -158.77 134.57 8.87 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 117.66 0.73 . . . . 0.0 111.324 -178.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 72.84 -23.46 0.21 Allowed 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 125.403 1.481 . . . . 0.0 112.874 178.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.511 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 2.3 m -77.64 -49.71 21.56 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.099 177.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.584 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 53.0 mtm180 72.68 170.82 0.11 Allowed Pre-proline 0 C--N 1.352 0.692 0 O-C-N 124.164 0.915 . . . . 0.0 111.368 177.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -91.99 169.46 2.92 Favored 'Trans proline' 0 N--CA 1.443 -1.455 0 CA-C-N 120.534 1.226 . . . . 0.0 113.718 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -79.0 149.61 32.17 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 169.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.573 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -59.3 -26.53 65.05 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.625 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 16.7 m120 -80.01 -30.7 39.66 Favored 'General case' 0 C--N 1.315 -0.926 0 O-C-N 121.847 -0.533 . . . . 0.0 109.863 177.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.67 -43.05 63.62 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.256 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 21.2 ptmt -59.81 -24.71 64.36 Favored 'General case' 0 CA--C 1.559 1.324 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.735 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.625 ' HB2' ' O ' ' A' ' 106' ' ' ASN 0.287 38.4 mtm180 -77.51 -56.77 4.25 Favored 'General case' 0 N--CA 1.395 -3.176 0 C-N-CA 125.935 1.694 . . . . 0.0 108.217 175.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.432 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . . . -49.46 -47.88 48.02 Favored 'General case' 0 CA--C 1.482 -1.648 0 CA-C-N 113.545 -1.661 . . . . 0.0 111.362 -176.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.556 ' HA ' HG21 ' A' ' 86' ' ' ILE . . . -48.07 -42.76 29.51 Favored 'General case' 0 CA--C 1.505 -0.777 0 O-C-N 124.518 1.136 . . . . 0.0 111.349 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -84.29 -23.7 30.19 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -173.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 30.8 t -85.59 -1.67 57.36 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-O 123.173 1.463 . . . . 0.0 107.254 174.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.613 ' O ' ' HB ' ' A' ' 90' ' ' THR . 35.2 mt-10 -120.56 13.0 11.65 Favored 'General case' 0 N--CA 1.404 -2.754 0 CA-C-N 113.638 -1.619 . . . . 0.0 112.811 -177.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 92.4 mttt 63.09 13.0 6.42 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 172.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.2 m -119.14 138.53 49.53 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-O 121.875 0.845 . . . . 0.0 112.777 -176.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -99.52 126.57 45.49 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.919 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.445 HG22 ' HB ' ' A' ' 96' ' ' VAL . 6.5 pt -94.05 133.79 33.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.255 0.55 . . . . 0.0 111.369 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -98.39 122.01 41.04 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.652 -177.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.526 HD11 HD13 ' A' ' 81' ' ' ILE . 3.8 mm? . . . . . 0 C--N 1.307 -1.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.617 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 . . . . . 0 CA--C 1.486 -1.504 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 74.7 mt -140.15 155.19 47.07 Favored 'General case' 0 C--O 1.258 1.51 0 O-C-N 123.717 0.636 . . . . 0.0 110.513 174.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.503 HG23 ' HA ' ' A' ' 96' ' ' VAL . 0.4 OUTLIER -120.6 135.07 62.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.03 176.63 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 72.5 t -109.7 126.87 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.869 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.334 -176.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.426 ' O ' ' HA2' ' A' ' 98' ' ' GLY . 23.1 mmtp -142.06 119.35 11.5 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 125.09 1.356 . . . . 0.0 109.858 -179.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -140.18 164.42 30.1 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -178.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.17 -17.08 44.13 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -178.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 86.1 t -105.03 122.59 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.354 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 175.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.751 ' O ' HG22 ' A' ' 54' ' ' VAL . 15.4 tm0? -58.14 -48.88 78.88 Favored 'General case' 0 C--O 1.202 -1.421 0 C-N-CA 122.948 0.499 . . . . 0.0 111.686 -174.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.77 0.8 81.06 Favored Glycine 0 C--N 1.285 -2.273 0 C-N-CA 117.693 -2.194 . . . . 0.0 113.912 -176.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 70.7 m -86.96 -20.86 26.68 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 176.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.751 HG22 ' O ' ' A' ' 51' ' ' GLN . 9.3 m -72.23 -43.23 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.449 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 172.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -62.68 -42.81 99.82 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.968 177.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.04 -35.05 78.95 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.923 0.392 . . . . 0.0 110.676 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.473 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 24.8 tp -76.57 -38.96 54.1 Favored 'General case' 0 C--O 1.208 -1.112 0 C-N-CA 120.456 -0.497 . . . . 0.0 109.711 177.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 54' ' ' VAL . 45.2 t -57.8 -44.49 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 122.746 0.419 . . . . 0.0 110.693 175.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.67 -18.18 64.74 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 123.229 0.612 . . . . 0.0 111.62 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.56 -19.71 15.37 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.153 0.501 . . . . 0.0 109.799 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -88.85 -36.85 15.77 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.034 -175.523 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -65.43 -26.16 67.84 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.011 0.434 . . . . 0.0 110.328 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.879 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.027 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.9 t . . . . . 0 N--CA 1.471 0.589 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -139.58 160.34 40.09 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 175.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.425 HG23 ' HG ' ' A' ' 61' ' ' LEU . 1.4 pp -94.43 164.05 2.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.828 178.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 70.7 mt -120.24 -41.67 2.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 121.523 0.677 . . . . 0.0 110.453 175.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.471 ' CD2' HD12 ' A' ' 45' ' ' ILE . 2.4 t60 -144.17 131.92 21.31 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.909 -168.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -142.88 134.96 27.18 Favored 'General case' 0 CA--C 1.503 -0.848 0 C-N-CA 124.26 1.024 . . . . 0.0 108.472 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.484 ' O ' HG11 ' A' ' 54' ' ' VAL . . . -160.82 164.86 31.08 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.481 ' HB ' ' HA ' ' A' ' 51' ' ' GLN . 7.1 p -93.34 98.51 8.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-O 122.423 1.106 . . . . 0.0 109.542 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.25 172.93 45.9 Favored Glycine 0 N--CA 1.406 -3.341 0 C-N-CA 120.052 -1.071 . . . . 0.0 110.572 -178.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.619 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -88.68 -166.86 1.7 Allowed 'General case' 0 N--CA 1.412 -2.33 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.489 HG13 HG11 ' A' ' 96' ' ' VAL . 2.6 mp -91.33 120.81 40.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 177.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.403 ' HA ' ' HB2' ' A' ' 107' ' ' ALA . 10.9 p -121.23 158.32 28.35 Favored 'General case' 0 C--N 1.317 -0.833 0 O-C-N 123.314 0.384 . . . . 0.0 110.157 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.73 -39.57 77.6 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -176.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.1 m -75.59 -8.74 57.53 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 120.913 0.387 . . . . 0.0 111.544 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -95.51 -30.99 13.55 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.502 HG21 ' HA ' ' A' ' 111' ' ' ALA . 31.0 mm -58.18 -31.96 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-N 114.46 -1.245 . . . . 0.0 111.355 174.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 25.8 m -58.53 -31.57 68.05 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.603 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -72.86 -35.23 67.16 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 176.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 94' ' ' ALA . . . -58.03 -52.92 63.54 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.29 -178.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.486 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 3.4 t -71.93 -30.96 65.87 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.995 177.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.76 -63.05 1.43 Allowed 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 40.6 m -97.62 5.26 49.68 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -175.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.1 m120 67.34 28.07 8.0 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.629 0.728 . . . . 0.0 110.88 178.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . -94.46 129.85 41.07 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 36.2 pt -93.47 150.52 3.91 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.503 ' HA ' HG23 ' A' ' 45' ' ' ILE . 18.3 t -94.11 112.56 27.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-O 121.349 0.595 . . . . 0.0 109.551 -176.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 54.9 mt -98.88 98.1 6.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 47' ' ' LYS . . . -94.78 151.57 20.16 Favored Glycine 0 N--CA 1.427 -1.965 0 C-N-CA 119.998 -1.096 . . . . 0.0 111.852 -176.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.405 ' C ' ' H ' ' A' ' 101' ' ' VAL . 23.8 m-85 -125.22 118.37 25.87 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -176.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 64.8 t30 70.08 -33.22 0.25 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 125.449 1.5 . . . . 0.0 113.018 178.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 0.7 OUTLIER -53.35 -71.74 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 117.739 2.496 . . . . 0.0 117.739 -177.673 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.619 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 0.0 OUTLIER 84.33 164.03 0.11 Allowed Pre-proline 0 N--CA 1.478 0.949 0 C-N-CA 124.573 1.149 . . . . 0.0 111.178 -170.225 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.409 ' HD3' HD21 ' A' ' 120' ' ' LEU . 2.1 Cg_endo -88.65 171.43 5.08 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 C-N-CA 121.446 1.431 . . . . 0.0 113.509 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -83.33 155.46 23.55 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 113.728 -1.578 . . . . 0.0 107.142 169.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.448 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -60.64 -24.39 65.51 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -178.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.588 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 22.3 m-80 -89.81 -27.8 19.73 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.403 ' HB2' ' HA ' ' A' ' 82' ' ' THR . . . -71.77 -38.39 70.36 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.163 -178.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -61.79 -27.04 68.47 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.961 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.588 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 62.6 mtp180 -79.38 -55.22 5.23 Favored 'General case' 0 N--CA 1.383 -3.779 0 C-N-CA 125.382 1.473 . . . . 0.0 109.623 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.18 -46.54 69.01 Favored 'General case' 0 C--O 1.198 -1.623 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.872 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.502 ' HA ' HG21 ' A' ' 86' ' ' ILE . . . -48.53 -48.29 38.49 Favored 'General case' 0 CA--C 1.491 -1.319 0 O-C-N 124.413 1.071 . . . . 0.0 111.918 -178.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -78.7 -33.91 46.51 Favored 'General case' 0 N--CA 1.401 -2.884 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.844 -172.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 32.2 t -77.2 -0.38 24.91 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.486 ' O ' ' HB ' ' A' ' 90' ' ' THR . 21.0 mt-10 -120.23 11.47 11.57 Favored 'General case' 0 N--CA 1.405 -2.684 0 CA-C-N 114.389 -1.278 . . . . 0.0 112.558 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 52.8 mttp 67.68 8.86 6.67 Favored 'General case' 0 N--CA 1.42 -1.955 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 173.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.1 m -112.32 127.1 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.63 0 CA-C-O 121.722 0.773 . . . . 0.0 112.413 -178.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -94.75 122.66 37.6 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.011 -178.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 16.8 pt -106.59 138.44 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.465 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -151.51 147.22 26.56 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.466 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 2.9 mm? . . . . . 0 C--N 1.292 -1.906 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -170.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.427 ' HB3' HD11 ' A' ' 74' ' ' ILE . 0.9 OUTLIER . . . . . 0 CA--C 1.502 -0.879 0 N-CA-C 111.226 0.084 . . . . 0.0 111.226 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.49 ' HA ' ' HB1' ' A' ' 94' ' ' ALA . 4.4 pp -158.56 167.21 30.21 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 177.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.66 HG23 ' HA ' ' A' ' 96' ' ' VAL . 0.5 OUTLIER -119.5 137.21 54.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 C-N-CA 123.536 0.734 . . . . 0.0 110.889 179.151 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 65.3 t -109.1 125.35 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.282 -177.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.502 ' HE3' ' HB3' ' A' ' 77' ' ' ALA . 14.6 mmmm -138.02 122.42 18.32 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -137.92 169.04 18.48 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -177.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -81.49 -32.2 32.57 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 123.984 0.802 . . . . 0.0 109.099 -177.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.445 ' HB ' ' HB2' ' A' ' 53' ' ' SER . 96.2 t -98.08 128.75 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.985 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 174.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.771 ' O ' HG22 ' A' ' 54' ' ' VAL . 16.3 tt0 -62.3 -43.62 98.4 Favored 'General case' 0 C--O 1.191 -1.987 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.305 -175.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -75.19 -0.13 60.56 Favored Glycine 0 C--N 1.291 -1.924 0 C-N-CA 118.388 -1.863 . . . . 0.0 113.268 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.445 ' HB2' ' HB ' ' A' ' 50' ' ' VAL . 34.0 t -83.88 -23.36 31.29 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 178.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.771 HG22 ' O ' ' A' ' 51' ' ' GLN . 9.2 m -74.8 -46.54 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.158 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 172.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -56.44 -46.42 80.3 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.328 1.051 . . . . 0.0 112.241 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.88 -43.68 81.5 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.801 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.489 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 27.3 tp -74.14 -45.43 48.84 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.202 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 54' ' ' VAL . 46.6 t -54.05 -43.77 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.128 0.971 . . . . 0.0 112.493 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.42 -28.18 69.8 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.94 -26.9 18.2 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -76.1 -39.02 56.21 Favored 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 113.962 -1.472 . . . . 0.0 110.37 -176.126 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -69.88 -21.74 63.3 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.822 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? . . . . . 0 N--CA 1.444 -0.771 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -178.295 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.8 t . . . . . 0 N--CA 1.425 -1.719 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -151.15 153.22 34.58 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.415 0.626 . . . . 0.0 110.306 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 pp -94.11 155.86 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.792 176.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.427 HD11 ' HB3' ' A' ' 43' ' ' ASN . 3.4 mp -115.79 -41.72 3.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-O 121.438 0.637 . . . . 0.0 109.466 177.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -143.27 122.76 13.17 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.93 -169.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -131.69 135.57 46.98 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 124.422 1.089 . . . . 0.0 108.496 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.502 ' HB3' ' HE3' ' A' ' 47' ' ' LYS . . . -161.84 163.03 29.57 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 -178.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.6 p -93.51 96.93 6.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 122.405 1.098 . . . . 0.0 109.651 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.81 175.08 47.49 Favored Glycine 0 N--CA 1.406 -3.334 0 N-CA-C 108.332 -1.907 . . . . 0.0 108.332 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.605 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -89.78 -160.72 0.71 Allowed 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 177.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.495 ' O ' ' HA ' ' A' ' 103' ' ' PRO . 33.6 mt -89.12 105.89 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.008 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -176.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 70.6 p -99.43 156.75 16.86 Favored 'General case' 0 N--CA 1.411 -2.411 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -53.14 -32.69 48.93 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 123.473 0.709 . . . . 0.0 109.947 175.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.1 m -67.42 -30.79 70.63 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.048 0.939 . . . . 0.0 111.593 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -71.98 -35.02 69.39 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-O 121.849 0.833 . . . . 0.0 109.055 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.517 HD13 ' HB2' ' A' ' 111' ' ' ALA . 61.2 mt -68.97 -31.65 51.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.749 -178.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.4 m -54.21 -35.13 62.05 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.567 174.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -75.5 -34.84 60.87 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.256 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.71 -56.96 15.19 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.611 -176.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.523 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 5.8 t -71.51 -19.83 62.14 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.822 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.99 -62.62 1.36 Allowed 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.227 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.9 m -95.36 6.5 48.84 Favored 'General case' 0 C--O 1.201 -1.462 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.425 -174.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . 0.272 0.0 OUTLIER 69.89 30.19 3.78 Favored 'General case' 0 N--CA 1.505 2.306 0 C-N-CA 126.213 1.805 . . . . 0.0 111.33 177.033 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.49 ' HB1' ' HA ' ' A' ' 44' ' ' LEU . . . -94.23 162.5 13.83 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 113.186 -1.824 . . . . 0.0 109.183 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.496 HD13 ' H ' ' A' ' 95' ' ' ILE . 0.2 OUTLIER -121.66 156.29 25.83 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 173.414 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.66 ' HA ' HG23 ' A' ' 45' ' ' ILE . 29.3 t -94.41 126.84 46.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -175.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 11.6 tt -125.69 116.08 45.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 175.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 47' ' ' LYS . . . -120.66 161.15 14.91 Favored Glycine 0 N--CA 1.406 -3.308 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -121.44 100.08 6.83 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 118.843 -1.143 . . . . 0.0 110.194 -178.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 59.21 30.35 20.09 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 122.171 0.986 . . . . 0.0 111.945 176.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.503 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 3.4 m -97.81 -47.09 12.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 114.482 -1.235 . . . . 0.0 112.163 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.605 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 17.4 mtm-85 76.67 156.33 0.15 Allowed Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 124.388 1.075 . . . . 0.0 111.496 177.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 10.1 Cg_endo -99.83 174.4 0.37 Allowed 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.445 2.096 . . . . 0.0 115.193 -175.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.409 ' HB2' ' H ' ' A' ' 107' ' ' ALA . 43.6 m-20 -69.3 154.36 42.16 Favored 'General case' 0 C--O 1.251 1.142 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 170.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.513 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -60.25 -35.62 75.9 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 120.82 0.343 . . . . 0.0 110.54 179.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.576 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 84.2 m-20 -82.57 -25.73 33.02 Favored 'General case' 0 C--O 1.201 -1.468 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.975 175.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.409 ' H ' ' HB2' ' A' ' 104' ' ' ASP . . . -66.69 -45.48 78.69 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.813 177.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 20.8 pttm -57.45 -23.36 49.27 Favored 'General case' 0 CA--C 1.571 1.779 0 CA-C-O 120.842 0.353 . . . . 0.0 110.698 177.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.576 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 71.6 mtp180 -84.53 -53.24 5.55 Favored 'General case' 0 N--CA 1.389 -3.506 0 C-N-CA 125.921 1.688 . . . . 0.0 109.201 177.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.07 -48.74 43.86 Favored 'General case' 0 C--O 1.186 -2.242 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.793 -178.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.517 ' HB2' HD13 ' A' ' 86' ' ' ILE . . . -48.56 -43.96 36.16 Favored 'General case' 0 CA--C 1.503 -0.83 0 O-C-N 124.284 0.99 . . . . 0.0 111.466 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -82.71 -27.4 31.22 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 114.913 -1.039 . . . . 0.0 112.315 -173.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 35.3 t -88.23 5.09 43.3 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 176.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.523 ' O ' ' HB ' ' A' ' 90' ' ' THR . 20.5 mt-10 -120.96 11.53 11.04 Favored 'General case' 0 CA--C 1.46 -2.497 0 CA-C-N 114.374 -1.285 . . . . 0.0 112.926 -178.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 68.4 mmtt 62.13 22.29 13.02 Favored 'General case' 0 N--CA 1.418 -2.043 0 O-C-N 124.144 0.903 . . . . 0.0 112.83 174.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.1 m -124.4 174.2 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.091 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -121.33 135.38 55.1 Favored 'General case' 0 CA--C 1.49 -1.352 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.917 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.464 HG22 ' HB ' ' A' ' 96' ' ' VAL . 19.3 pt -102.99 123.56 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.135 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 167.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -102.65 120.07 39.92 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.503 HD21 ' H ' ' A' ' 101' ' ' VAL . 2.4 tm? . . . . . 0 N--CA 1.421 -1.914 0 C-N-CA 119.951 -0.699 . . . . 0.0 110.764 -176.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.522 ' OD1' HD11 ' A' ' 74' ' ' ILE . 40.2 m-80 . . . . . 0 CA--C 1.485 -1.539 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.435 HD12 HD11 ' A' ' 61' ' ' LEU . 80.9 mt -133.41 160.16 38.2 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.682 0.753 . . . . 0.0 111.121 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.529 HG23 ' HA ' ' A' ' 96' ' ' VAL . 0.5 OUTLIER -124.97 133.4 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.852 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.419 173.215 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.589 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 99.4 t -113.34 127.67 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.925 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.846 -176.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -135.2 128.48 32.08 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 124.13 0.972 . . . . 0.0 108.807 -177.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -148.53 168.09 23.66 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.953 -178.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -70.1 -21.93 63.07 Favored 'General case' 0 C--O 1.242 0.699 0 O-C-N 123.946 0.778 . . . . 0.0 111.308 -178.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.4 m -130.13 140.1 49.78 Favored 'Isoleucine or valine' 0 C--O 1.246 0.892 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.594 173.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.617 ' O ' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -68.56 -6.77 27.34 Favored 'General case' 0 C--O 1.191 -1.978 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -176.825 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.39 -13.27 57.44 Favored Glycine 0 N--CA 1.422 -2.29 0 C-N-CA 118.261 -1.924 . . . . 0.0 112.318 177.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.4 m -81.82 -28.98 32.84 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 176.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.617 HG22 ' O ' ' A' ' 51' ' ' GLN . 15.8 m -70.6 -44.9 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.903 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.674 174.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.611 ' HG2' ' O ' ' A' ' 51' ' ' GLN . 67.8 mm-40 -59.58 -45.48 91.73 Favored 'General case' 0 C--O 1.214 -0.789 0 O-C-N 123.42 0.45 . . . . 0.0 111.391 178.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.07 -42.15 84.9 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 123.348 0.405 . . . . 0.0 111.448 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.432 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 32.2 tp -75.4 -42.31 54.06 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.229 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.508 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 36.0 t -55.99 -45.75 80.33 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.681 0 C-N-CA 123.136 0.574 . . . . 0.0 111.185 176.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.3 -16.84 61.57 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.68 -27.87 13.79 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.435 HD11 HD12 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -80.35 -30.0 37.97 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 113.775 -1.557 . . . . 0.0 110.569 -175.069 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 4.0 pt20 -83.75 -19.25 35.46 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 121.985 -0.447 . . . . 0.0 111.434 177.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt . . . . . 0 C--N 1.32 -0.675 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.344 -177.399 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.3 t . . . . . 0 N--CA 1.427 -1.598 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 26.7 ttpp -154.56 158.13 39.33 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.061 0.458 . . . . 0.0 110.472 -178.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 pp -93.82 156.27 3.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -173.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.522 HD11 ' OD1' ' A' ' 43' ' ' ASN . 26.7 mm -119.74 -32.44 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.464 0.65 . . . . 0.0 110.13 178.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.497 ' CD2' HD12 ' A' ' 45' ' ' ILE . 1.9 t60 -149.67 124.52 9.89 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.471 -168.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.589 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -135.96 132.25 36.15 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -155.78 155.66 33.44 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.54 -177.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.523 ' HB ' ' HB3' ' A' ' 51' ' ' GLN . 5.5 p -94.15 94.27 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 CA-C-O 122.823 1.296 . . . . 0.0 110.537 177.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.7 175.09 47.47 Favored Glycine 0 N--CA 1.405 -3.413 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.493 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . . . -82.87 167.98 17.53 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 176.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.491 HG21 HG21 ' A' ' 118' ' ' ILE . 2.4 mp -71.22 120.35 19.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -177.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.448 HG22 ' OD2' ' A' ' 85' ' ' ASP . 13.0 t -119.71 168.89 10.61 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -57.6 -34.94 69.78 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.949 0.5 . . . . 0.0 111.9 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.9 t -62.21 -29.86 70.68 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.046 0.539 . . . . 0.0 110.514 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.448 ' OD2' HG22 ' A' ' 82' ' ' THR . 49.4 m-20 -75.36 -39.41 59.31 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.414 ' CG2' ' HA ' ' A' ' 111' ' ' ALA . 39.5 mm -63.66 -32.9 58.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.515 -178.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 39.6 m -60.59 -24.05 65.16 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.527 176.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.428 HD21 HG21 ' A' ' 74' ' ' ILE . 2.4 tm? -87.98 -37.07 16.68 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.83 -58.73 6.18 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.947 -176.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.536 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 3.4 t -70.73 -26.56 63.44 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.494 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.18 -59.64 4.18 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.343 0.592 . . . . 0.0 111.901 -178.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.8 t -97.08 4.62 51.24 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.807 -175.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 67.7 32.76 5.27 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.822 0.82 . . . . 0.0 110.299 178.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -94.5 132.9 38.67 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.459 -178.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 36.3 pt -94.83 152.03 3.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 176.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.558 ' HB ' HG22 ' A' ' 118' ' ' ILE . 16.7 t -100.97 123.69 54.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.42 -172.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 7.3 tp -108.44 111.44 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 173.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -103.78 146.34 16.36 Favored Glycine 0 N--CA 1.43 -1.76 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -178.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.4 ' C ' ' H ' ' A' ' 101' ' ' VAL . 90.0 m-85 -121.84 108.98 14.11 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 117.026 0.413 . . . . 0.0 111.121 -175.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.603 ' O ' ' HD3' ' A' ' 102' ' ' ARG . 8.2 t30 67.66 -34.22 0.24 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 126.558 1.943 . . . . 0.0 113.493 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.493 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 1.7 m -51.35 -54.72 10.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 117.149 2.277 . . . . 0.0 117.149 -178.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.603 ' HD3' ' O ' ' A' ' 100' ' ' ASN . 1.0 OUTLIER 76.77 170.4 0.11 Allowed Pre-proline 0 N--CA 1.483 1.193 0 C-N-CA 123.958 0.903 . . . . 0.0 110.539 -171.743 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.516 ' HG3' HD12 ' A' ' 118' ' ' ILE . 9.2 Cg_endo -96.03 174.83 0.9 Allowed 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 121.712 1.608 . . . . 0.0 113.009 177.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -82.03 150.44 27.59 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 167.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.52 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -58.88 -30.3 67.65 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.539 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 16.5 m120 -81.08 -33.06 33.65 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 119.966 -0.693 . . . . 0.0 110.036 177.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.34 -42.62 98.96 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.239 177.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 20.9 ptmt -65.32 -26.29 67.99 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.984 178.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.539 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 53.6 mtp180 -75.52 -52.64 10.19 Favored 'General case' 0 N--CA 1.392 -3.353 0 C-N-CA 124.365 1.066 . . . . 0.0 109.027 177.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -53.02 -49.37 66.39 Favored 'General case' 0 C--O 1.195 -1.801 0 CA-C-N 113.947 -1.479 . . . . 0.0 110.091 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.414 ' HA ' ' CG2' ' A' ' 86' ' ' ILE . . . -47.04 -48.28 22.21 Favored 'General case' 0 CA--C 1.507 -0.681 0 O-C-N 124.568 1.167 . . . . 0.0 112.449 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.418 ' C ' ' H ' ' A' ' 114' ' ' GLU . 2.8 tm-20 -76.08 -38.79 56.6 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.3 -173.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 26.6 t -76.41 4.23 9.47 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.527 1.156 . . . . 0.0 108.707 178.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.536 ' O ' ' HB ' ' A' ' 90' ' ' THR . 15.2 mt-10 -123.21 14.06 9.69 Favored 'General case' 0 N--CA 1.398 -3.066 0 CA-C-N 114.466 -1.243 . . . . 0.0 113.019 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 96.7 mttt 66.2 7.54 4.91 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 173.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.5 m -114.25 147.01 18.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 C-N-CA 120.358 -0.537 . . . . 0.0 112.378 -175.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -113.09 128.7 56.56 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.702 -177.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.558 HG22 ' HB ' ' A' ' 96' ' ' VAL . 7.7 pt -97.74 133.82 38.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.079 177.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -118.33 134.77 54.76 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -178.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 0 CA--C 1.505 -0.758 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -174.228 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.651 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 61.1 m-80 . . . . . 0 N--CA 1.434 -1.233 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 4.1 pp -151.06 162.49 40.74 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.4 0.619 . . . . 0.0 112.57 177.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.615 HG23 ' HA ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -118.46 134.58 61.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.209 178.293 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 99.3 t -107.69 126.04 64.09 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.948 -176.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.8 mtpt -138.4 147.17 43.09 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.407 ' CB ' ' HB3' ' A' ' 99' ' ' PHE . . . -156.56 167.25 31.01 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -178.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -76.24 -22.83 54.7 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.846 0.832 . . . . 0.0 110.029 177.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 84.6 t -109.28 132.27 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 176.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.776 ' O ' HG22 ' A' ' 54' ' ' VAL . 16.2 tt0 -65.09 -46.2 82.1 Favored 'General case' 0 C--O 1.188 -2.18 0 C-N-CA 120.132 -0.627 . . . . 0.0 111.224 -176.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -73.74 2.65 39.38 Favored Glycine 0 C--N 1.294 -1.77 0 C-N-CA 118.753 -1.689 . . . . 0.0 114.394 -176.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.4 t -83.12 -26.12 31.3 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 176.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.776 HG22 ' O ' ' A' ' 51' ' ' GLN . 5.3 m -80.16 -45.87 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.918 0 CA-C-N 114.549 -1.205 . . . . 0.0 108.642 176.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -56.16 -48.44 76.3 Favored 'General case' 0 C--O 1.245 0.844 0 C-N-CA 124.867 1.267 . . . . 0.0 111.965 -176.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.51 -35.24 80.3 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.234 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 28.0 tp -76.1 -35.86 59.16 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.428 HG13 HG12 ' A' ' 73' ' ' ILE . 39.4 t -56.69 -43.87 80.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.747 174.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.39 -18.18 65.21 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.903 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.488 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -98.88 -21.4 16.32 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 122.384 1.087 . . . . 0.0 108.782 -177.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.42 -28.96 20.57 Favored 'General case' 0 C--N 1.275 -2.645 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.598 -177.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -83.75 -12.65 55.46 Favored 'General case' 0 C--N 1.313 -1.0 0 O-C-N 122.152 -0.342 . . . . 0.0 111.624 176.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 65.0 pttt . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 121.523 0.678 . . . . 0.0 110.137 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.4 t . . . . . 0 N--CA 1.429 -1.488 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -146.28 158.6 43.9 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.067 0.461 . . . . 0.0 110.565 -175.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.428 HG12 HG13 ' A' ' 58' ' ' VAL . 1.7 pp -94.03 142.82 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.715 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.412 175.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.423 HD11 ' OD1' ' A' ' 43' ' ' ASN . 34.6 mm -113.72 -27.43 2.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 CA-C-O 121.273 0.559 . . . . 0.0 109.789 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.504 ' CD2' HD12 ' A' ' 45' ' ' ILE . 5.5 t60 -160.95 125.86 3.65 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.782 -171.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.572 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -129.01 130.56 46.79 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -154.76 156.66 36.71 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.383 -178.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.7 p -94.54 97.76 7.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-O 121.947 0.879 . . . . 0.0 108.905 176.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -175.5 170.9 44.01 Favored Glycine 0 N--CA 1.413 -2.839 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.666 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . . . -84.74 -176.11 6.08 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 120.838 0.352 . . . . 0.0 110.635 -178.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.521 ' HB ' ' HB3' ' A' ' 103' ' ' PRO . 3.8 mm -87.86 97.9 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.672 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 9.7 t -98.71 147.04 25.27 Favored 'General case' 0 N--CA 1.411 -2.424 0 C-N-CA 119.749 -0.78 . . . . 0.0 109.719 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.463 ' N ' ' HB2' ' A' ' 107' ' ' ALA . 0.0 OUTLIER -47.31 -39.31 14.44 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 125.111 1.364 . . . . 0.0 112.53 178.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.9 m -78.8 -11.8 60.0 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -174.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -98.34 -23.52 15.58 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -177.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.559 HD13 ' HB2' ' A' ' 111' ' ' ALA . 38.6 mt -66.06 -22.18 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.644 177.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 47.3 t -49.59 -35.49 21.0 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.928 172.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.434 ' O ' HD22 ' A' ' 88' ' ' LEU . 2.0 tm? -70.17 -32.57 70.58 Favored 'General case' 0 C--O 1.25 1.083 0 CA-C-O 120.748 0.309 . . . . 0.0 110.843 179.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.47 -61.68 2.32 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.201 -176.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.563 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 4.8 t -66.02 -25.34 67.02 Favored 'General case' 0 CA--C 1.561 1.375 0 O-C-N 122.012 -0.43 . . . . 0.0 111.783 178.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.24 -55.7 16.98 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.143 0.497 . . . . 0.0 112.176 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 34.3 p -97.01 -4.62 39.4 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.238 0.542 . . . . 0.0 111.072 -176.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.452 HD22 ' N ' ' A' ' 93' ' ' ASN . 0.8 OUTLIER 72.63 33.45 1.36 Allowed 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.805 -178.834 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.651 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -94.34 134.49 36.78 Favored 'General case' 0 N--CA 1.419 -2.018 0 CA-C-N 114.008 -1.451 . . . . 0.0 109.931 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 35.0 pt -94.07 144.4 9.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 176.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.615 ' HA ' HG23 ' A' ' 45' ' ' ILE . 15.6 t -94.95 119.79 43.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 C-N-CA 120.186 -0.605 . . . . 0.0 110.93 -173.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.637 ' HA ' ' O ' ' A' ' 119' ' ' ARG . 24.4 pt -111.91 117.18 54.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-O 121.498 0.666 . . . . 0.0 109.748 174.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -110.9 157.22 15.1 Favored Glycine 0 N--CA 1.437 -1.281 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.825 -176.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.407 ' HB3' ' CB ' ' A' ' 48' ' ' ALA . 67.8 t80 -132.07 110.82 10.98 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -175.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.495 ' O ' ' HD3' ' A' ' 102' ' ' ARG . 27.5 t-20 70.68 -30.4 0.2 Allowed 'General case' 0 N--CA 1.506 2.354 0 C-N-CA 125.085 1.354 . . . . 0.0 114.029 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.666 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 2.5 m -58.57 -56.55 15.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 N-CA-C 117.765 2.506 . . . . 0.0 117.765 -177.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.533 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 0.6 OUTLIER 75.04 159.26 0.16 Allowed Pre-proline 0 N--CA 1.494 1.738 0 C-N-CA 124.359 1.064 . . . . 0.0 112.003 -174.642 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.521 ' HB3' ' HB ' ' A' ' 81' ' ' ILE . 4.0 Cg_endo -88.75 170.12 5.36 Favored 'Trans proline' 0 CA--C 1.502 -1.095 0 C-N-CA 122.466 2.111 . . . . 0.0 113.261 176.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -87.73 169.45 12.09 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 171.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.448 ' HA ' ' HE3' ' A' ' 108' ' ' LYS . . . -70.98 -11.45 60.98 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 -173.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.502 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 37.0 t30 -104.37 -34.11 8.4 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 176.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.463 ' HB2' ' N ' ' A' ' 83' ' ' GLU . . . -58.25 -44.34 88.3 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.152 0.501 . . . . 0.0 110.521 175.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.448 ' HE3' ' HA ' ' A' ' 105' ' ' ALA . 18.0 ptpt -59.15 -22.84 61.56 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.032 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.502 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 40.4 mtm180 -93.25 -50.38 5.51 Favored 'General case' 0 N--CA 1.38 -3.932 0 C-N-CA 126.108 1.763 . . . . 0.0 109.886 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.15 -45.59 68.48 Favored 'General case' 0 CA--C 1.48 -1.715 0 C-N-CA 125.551 1.541 . . . . 0.0 110.858 -177.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.559 ' HB2' HD13 ' A' ' 86' ' ' ILE . . . -49.48 -48.19 47.94 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 124.505 1.128 . . . . 0.0 111.163 -179.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -78.45 -28.78 46.68 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.461 -174.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 40.2 t -79.29 -3.91 48.25 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 176.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.563 ' O ' ' HB ' ' A' ' 90' ' ' THR . 27.2 mt-10 -114.08 11.2 17.59 Favored 'General case' 0 CA--C 1.464 -2.329 0 CA-C-N 114.253 -1.34 . . . . 0.0 112.498 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 55.4 mtpt 68.5 15.04 9.17 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 174.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.9 m -121.28 170.95 10.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -135.48 147.23 48.8 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 176.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.447 HG22 ' HB ' ' A' ' 96' ' ' VAL . 15.0 pt -110.4 140.67 28.46 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.299 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.871 -178.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.637 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 75.2 mtp180 -131.2 123.2 27.97 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -176.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.481 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.292 -1.916 0 O-C-N 121.796 -0.565 . . . . 0.0 112.143 -177.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.2 m120 . . . . . 0 CA--C 1.5 -0.957 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.47 HD12 HD11 ' A' ' 61' ' ' LEU . 56.9 mt -140.8 160.11 40.75 Favored 'General case' 0 C--O 1.246 0.884 0 CA-C-O 121.756 0.788 . . . . 0.0 112.813 177.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.469 HD12 ' O ' ' A' ' 75' ' ' HIS . 0.2 OUTLIER -131.87 133.28 61.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 125.461 1.504 . . . . 0.0 107.259 177.893 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.406 HG13 HD23 ' A' ' 57' ' ' LEU . 67.1 t -112.7 138.85 40.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.207 -176.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 60.6 mttp -137.52 160.48 39.01 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 123.71 0.804 . . . . 0.0 109.267 173.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -168.5 171.52 8.91 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -82.08 -37.28 26.61 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 91.8 t -97.51 127.84 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.335 176.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.698 ' O ' HG22 ' A' ' 54' ' ' VAL . 50.1 tt0 -57.43 -45.62 84.46 Favored 'General case' 0 C--O 1.204 -1.295 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -176.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.92 -0.97 61.37 Favored Glycine 0 C--N 1.283 -2.375 0 C-N-CA 118.155 -1.974 . . . . 0.0 113.908 -177.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.1 t -85.87 -18.13 33.67 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 175.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.698 HG22 ' O ' ' A' ' 51' ' ' GLN . 3.7 m -82.37 -46.36 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.949 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 174.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -60.68 -47.18 87.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.309 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.79 -33.95 76.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.585 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.496 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 37.1 tp -76.62 -37.4 56.45 Favored 'General case' 0 C--O 1.209 -1.068 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.526 HG21 ' HB2' ' A' ' 76' ' ' ALA . 43.5 t -60.09 -41.41 86.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 123.234 0.614 . . . . 0.0 110.954 176.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.73 -25.94 68.15 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.541 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.96 -24.65 19.19 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.496 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -85.12 -30.13 24.27 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.468 -175.585 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -78.45 -13.22 59.94 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.048 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.931 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.099 177.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.44 HG12 ' H ' ' A' ' 72' ' ' LYS . 3.5 t . . . . . 0 N--CA 1.469 0.517 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.44 ' H ' HG12 ' A' ' 71' ' ' VAL . 88.0 tttt -150.69 157.22 42.71 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 175.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.409 HG12 HG13 ' A' ' 58' ' ' VAL . 1.4 pp -93.61 154.09 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.793 177.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 65.2 mt -112.35 -40.08 3.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-O 121.787 0.803 . . . . 0.0 109.734 177.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.469 ' O ' HD12 ' A' ' 45' ' ' ILE . 2.1 t60 -145.77 137.71 25.29 Favored 'General case' 0 N--CA 1.409 -2.497 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.463 -165.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.526 ' HB2' HG21 ' A' ' 58' ' ' VAL . . . -125.25 134.21 52.4 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 177.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 47' ' ' LYS . . . -144.27 131.68 20.9 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -178.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.1 p -94.85 93.57 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.969 0 CA-C-O 122.765 1.269 . . . . 0.0 107.699 175.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.95 176.36 48.02 Favored Glycine 0 N--CA 1.397 -3.93 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -176.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.536 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . . . -81.07 175.9 10.27 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.458 HD13 HD11 ' A' ' 120' ' ' LEU . 1.7 mp -76.93 105.32 5.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.1 p -104.58 156.51 17.9 Favored 'General case' 0 N--CA 1.403 -2.814 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.26 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.51 -33.16 72.22 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 123.953 0.901 . . . . 0.0 110.482 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.3 m -68.53 -22.42 64.51 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.849 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -97.72 -27.55 14.29 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 118.782 -1.167 . . . . 0.0 109.67 -178.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.543 HD13 ' HB2' ' A' ' 111' ' ' ALA . 79.5 mt -59.09 -27.02 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 CA-C-O 121.817 0.818 . . . . 0.0 110.433 174.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 34.2 m -50.59 -33.76 23.29 Favored 'General case' 0 CA--C 1.561 1.383 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.783 172.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -82.39 -35.31 27.83 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 176.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.81 -58.58 6.73 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.425 -175.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.457 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 9.6 t -78.85 -11.23 59.99 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.773 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.21 -49.14 29.57 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.394 -177.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 34.2 m -105.31 -3.63 22.53 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.102 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 71.54 35.61 1.44 Allowed 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 122.103 0.954 . . . . 0.0 110.62 -176.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -95.12 129.52 42.19 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 176.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.7 pt -93.93 144.13 10.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.487 ' HB ' HG22 ' A' ' 118' ' ' ILE . 16.5 t -102.01 132.33 48.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.766 -173.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 18.7 tt -111.87 137.88 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.782 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 173.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -132.56 146.64 18.39 Favored Glycine 0 N--CA 1.432 -1.587 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.412 ' C ' ' H ' ' A' ' 101' ' ' VAL . 91.9 m-85 -124.14 114.26 19.43 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -174.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 71.5 -36.35 0.36 Allowed 'General case' 0 N--CA 1.505 2.3 0 C-N-CA 124.458 1.103 . . . . 0.0 112.938 178.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.536 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 4.5 m -62.05 -51.23 74.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 124.982 1.313 . . . . 0.0 113.271 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.493 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 23.6 mtm180 68.32 179.03 0.05 OUTLIER Pre-proline 0 CA--C 1.551 1.012 0 O-C-N 123.74 0.65 . . . . 0.0 110.111 178.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -95.36 176.91 0.85 Allowed 'Trans proline' 0 N--CA 1.444 -1.411 0 CA-C-N 121.034 1.405 . . . . 0.0 113.942 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -86.75 155.13 20.46 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 106.274 -1.751 . . . . 0.0 106.274 169.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.531 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -58.02 -30.74 66.36 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 123.074 0.549 . . . . 0.0 112.086 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.572 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 25.2 t30 -82.81 -35.7 26.2 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.91 -44.75 92.0 Favored 'General case' 0 C--O 1.206 -1.212 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.744 178.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 20.1 pttm -59.39 -29.09 67.47 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-O 121.118 0.485 . . . . 0.0 110.001 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.572 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 20.5 mtm180 -74.76 -52.66 10.92 Favored 'General case' 0 N--CA 1.384 -3.754 0 C-N-CA 123.793 0.837 . . . . 0.0 109.059 179.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.83 -51.82 62.32 Favored 'General case' 0 C--O 1.194 -1.856 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.067 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.543 ' HB2' HD13 ' A' ' 86' ' ' ILE . . . -50.7 -48.5 58.65 Favored 'General case' 0 CA--C 1.5 -0.944 0 O-C-N 124.284 0.99 . . . . 0.0 112.143 -176.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -81.23 -25.33 36.74 Favored 'General case' 0 N--CA 1.403 -2.82 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.291 -172.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 46.9 t -87.9 5.8 38.71 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 175.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.465 ' O ' ' HB2' ' A' ' 115' ' ' LYS . 20.5 mt-10 -123.67 17.08 9.55 Favored 'General case' 0 CA--C 1.463 -2.382 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.826 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 70.5 mmtt 66.14 8.52 5.58 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 173.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.5 m -114.52 125.03 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-O 121.775 0.797 . . . . 0.0 113.044 -176.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -94.18 120.74 34.86 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.288 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.487 HG22 ' HB ' ' A' ' 96' ' ' VAL . 8.6 pt -93.55 131.81 39.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-O 121.089 0.471 . . . . 0.0 109.947 179.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -100.39 118.82 37.41 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.119 0.485 . . . . 0.0 109.744 -176.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.458 HD11 HD13 ' A' ' 81' ' ' ILE . 3.2 mm? . . . . . 0 CA--C 1.474 -1.976 0 CA-C-O 121.264 0.554 . . . . 0.0 111.102 -178.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.757 ' HB3' HD11 ' A' ' 74' ' ' ILE . 17.7 m120 . . . . . 0 N--CA 1.428 -1.526 0 CA-C-O 120.63 0.252 . . . . 0.0 111.277 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.2 pp -152.39 162.35 41.31 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.919 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.613 HG23 ' HA ' ' A' ' 96' ' ' VAL . 0.1 OUTLIER -117.08 136.36 54.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 123.278 0.631 . . . . 0.0 110.636 178.626 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.411 ' CG1' ' HA ' ' A' ' 54' ' ' VAL . 85.9 t -102.06 128.07 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.015 -175.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.415 ' HB2' ' HA2' ' A' ' 98' ' ' GLY . 27.6 mmmt -134.57 136.54 43.07 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.192 -176.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.16 165.19 29.86 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -88.93 -12.56 41.3 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.606 0.717 . . . . 0.0 109.41 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 88.2 t -108.14 122.73 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 174.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.75 ' O ' HG22 ' A' ' 54' ' ' VAL . 47.8 tt0 -63.27 -40.87 98.6 Favored 'General case' 0 C--O 1.197 -1.681 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.876 -175.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.19 4.88 53.23 Favored Glycine 0 C--N 1.278 -2.66 0 C-N-CA 117.672 -2.204 . . . . 0.0 115.158 -176.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.8 m -87.58 -29.95 20.87 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 172.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.75 HG22 ' O ' ' A' ' 51' ' ' GLN . 12.2 m -76.55 -44.07 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 CA-C-N 114.869 -1.059 . . . . 0.0 109.011 176.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -55.34 -50.63 69.14 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.421 -178.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.42 -42.11 88.24 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.411 -176.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.598 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 32.3 tp -68.4 -41.36 80.6 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.944 -177.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.513 HG13 HG12 ' A' ' 73' ' ' ILE . 39.6 t -57.47 -43.69 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 122.627 0.371 . . . . 0.0 111.04 175.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.413 ' O ' ' HE3' ' A' ' 63' ' ' LYS . . . -65.34 -23.08 66.9 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.263 -177.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.41 -23.82 16.42 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.598 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -81.7 -37.25 27.65 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.269 -176.048 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -66.58 -21.21 66.14 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.046 0.451 . . . . 0.0 110.897 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.413 ' HE3' ' O ' ' A' ' 59' ' ' ALA . 18.3 ptpt . . . . . 0 C--N 1.313 -1.001 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.2 t . . . . . 0 N--CA 1.449 -0.509 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 21.6 ttmm -146.75 153.42 40.21 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 121.605 0.717 . . . . 0.0 111.42 -177.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.513 HG12 HG13 ' A' ' 58' ' ' VAL . 1.3 pp -94.97 169.21 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.509 174.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.757 HD11 ' HB3' ' A' ' 43' ' ' ASN . 3.3 mp -135.41 -32.03 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 172.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -151.1 133.45 15.41 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-O 121.234 0.54 . . . . 0.0 110.235 -168.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.5 ' HB2' HG21 ' A' ' 58' ' ' VAL . . . -124.55 141.44 52.09 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 178.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -151.02 135.42 16.96 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.377 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.8 p -93.41 92.01 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 CA-C-O 123.295 1.521 . . . . 0.0 107.906 175.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.8 175.69 47.5 Favored Glycine 0 N--CA 1.41 -3.072 0 N-CA-C 108.653 -1.779 . . . . 0.0 108.653 -177.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.621 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . . . -82.6 -179.19 7.35 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 175.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.422 ' CG2' HD11 ' A' ' 86' ' ' ILE . 3.5 mp -81.8 118.76 30.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 O-C-N 122.04 -0.412 . . . . 0.0 110.641 -178.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.458 ' O ' HG13 ' A' ' 86' ' ' ILE . 25.7 p -119.81 160.28 22.93 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 178.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.43 ' HG3' ' HA ' ' A' ' 107' ' ' ALA . 1.6 mp0 -54.07 -50.88 65.77 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.722 0.809 . . . . 0.0 112.501 -173.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.5 m -66.42 -19.38 65.78 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.398 0.618 . . . . 0.0 111.582 -176.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -86.27 -31.43 21.65 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -177.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.777 HD13 ' HB2' ' A' ' 111' ' ' ALA . 29.0 mt -73.11 -24.51 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.863 176.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.406 ' HA ' ' OE2' ' A' ' 114' ' ' GLU . 37.6 m -56.21 -24.6 43.05 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.094 175.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -76.56 -35.06 58.42 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 175.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.418 ' HB3' HG21 ' A' ' 116' ' ' VAL . . . -57.5 -55.54 33.53 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.406 -176.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.525 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 8.9 t -71.81 -24.91 61.81 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.118 179.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.23 -62.03 1.63 Allowed 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.014 0.435 . . . . 0.0 111.937 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 43.3 m -91.75 3.84 54.18 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -177.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 69.52 31.57 3.68 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.733 0.778 . . . . 0.0 109.807 177.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -93.92 139.24 31.15 Favored 'General case' 0 N--CA 1.419 -1.987 0 CA-C-N 114.451 -1.249 . . . . 0.0 109.714 -177.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 45.9 mm -94.73 142.96 12.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 176.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.613 ' HA ' HG23 ' A' ' 45' ' ' ILE . 24.8 t -94.26 118.44 40.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -176.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.534 ' HA ' ' O ' ' A' ' 119' ' ' ARG . 27.1 pt -115.71 116.28 51.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-O 121.586 0.708 . . . . 0.0 109.644 176.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.415 ' HA2' ' HB2' ' A' ' 47' ' ' LYS . . . -113.22 166.88 12.19 Favored Glycine 0 N--CA 1.428 -1.863 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.892 -177.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -133.17 112.63 11.89 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -177.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 60.52 14.32 4.78 Favored 'General case' 0 N--CA 1.502 2.146 0 C-N-CA 124.713 1.205 . . . . 0.0 113.112 178.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.621 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 1.5 m -96.59 -50.33 11.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 -173.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.576 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 0.0 OUTLIER 75.49 163.65 0.14 Allowed Pre-proline 0 N--CA 1.479 0.994 0 C-N-CA 124.232 1.013 . . . . 0.0 111.968 -175.302 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -97.21 166.19 0.92 Allowed 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 121.974 1.783 . . . . 0.0 113.179 174.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -71.73 152.55 42.68 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 169.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.447 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -63.73 -25.01 68.0 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 117.912 0.323 . . . . 0.0 111.515 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.539 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 29.9 m-80 -88.62 -26.79 21.72 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.989 -0.684 . . . . 0.0 109.76 177.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.43 ' HA ' ' HG3' ' A' ' 83' ' ' GLU . . . -67.86 -44.34 77.33 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 121.025 0.441 . . . . 0.0 110.3 177.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.403 ' HE3' ' HA ' ' A' ' 105' ' ' ALA . 17.6 ptpt -62.16 -21.57 65.17 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.922 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.539 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 56.2 mtp180 -83.84 -51.3 7.31 Favored 'General case' 0 N--CA 1.39 -3.474 0 C-N-CA 125.129 1.372 . . . . 0.0 109.378 176.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -52.02 -48.23 64.62 Favored 'General case' 0 CA--C 1.489 -1.381 0 CA-C-N 114.403 -1.271 . . . . 0.0 110.642 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.777 ' HB2' HD13 ' A' ' 86' ' ' ILE . . . -51.72 -36.09 45.52 Favored 'General case' 0 CA--C 1.502 -0.885 0 C-N-CA 124.742 1.217 . . . . 0.0 112.17 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -78.78 -38.46 38.43 Favored 'General case' 0 N--CA 1.418 -2.029 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.788 -175.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.8 t -73.02 -9.26 58.54 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 175.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.525 ' O ' ' HB ' ' A' ' 90' ' ' THR . 28.7 mt-10 -106.4 7.8 31.3 Favored 'General case' 0 CA--C 1.472 -2.056 0 C-N-CA 124.869 1.268 . . . . 0.0 114.009 -177.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 93.1 mttt 67.31 7.62 5.65 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 172.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.418 HG21 ' HB3' ' A' ' 89' ' ' ALA . 4.3 m -121.63 141.26 42.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -177.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -100.26 133.31 44.85 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-O 121.403 0.62 . . . . 0.0 109.794 179.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.475 HG22 ' HB ' ' A' ' 96' ' ' VAL . 6.1 pt -97.21 139.69 19.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.596 178.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.534 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 64.9 ttt180 -131.85 128.54 38.88 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.406 ' N ' HD13 ' A' ' 120' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.293 -1.859 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.432 ' HB3' ' CD1' ' A' ' 74' ' ' ILE . 10.4 m120 . . . . . 0 N--CA 1.42 -1.962 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 49.3 mt -141.69 174.94 10.1 Favored 'General case' 0 C--O 1.249 1.069 0 CA-C-O 121.53 0.681 . . . . 0.0 111.428 178.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.8 tt -136.41 143.33 35.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.963 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.517 HG23 HG21 ' A' ' 73' ' ' ILE . 96.6 t -127.89 122.83 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -149.54 121.63 8.29 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.587 179.021 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -131.73 175.66 9.0 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.163 -174.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -81.02 -29.13 35.19 Favored 'General case' 0 C--O 1.246 0.916 0 O-C-N 124.014 0.821 . . . . 0.0 109.815 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 80.7 t -101.88 130.09 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.364 174.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.756 ' O ' HG22 ' A' ' 54' ' ' VAL . 22.6 tm0? -64.72 -40.64 95.67 Favored 'General case' 0 C--O 1.197 -1.68 0 C-N-CA 122.822 0.449 . . . . 0.0 111.984 -174.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.4 2.8 86.6 Favored Glycine 0 C--N 1.29 -2.011 0 C-N-CA 118.114 -1.994 . . . . 0.0 112.988 178.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.2 t -82.59 -28.45 30.86 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 105.677 -1.971 . . . . 0.0 105.677 178.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.756 HG22 ' O ' ' A' ' 51' ' ' GLN . 12.9 m -69.69 -46.96 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.646 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.259 175.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -60.06 -39.54 86.39 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -177.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.91 -36.35 76.81 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 123.604 0.565 . . . . 0.0 110.796 178.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 42.3 tp -85.04 -41.72 15.51 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.714 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 54' ' ' VAL . 47.9 t -55.36 -41.23 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.099 0.96 . . . . 0.0 112.264 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.32 -17.79 64.35 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 120.736 0.303 . . . . 0.0 111.748 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.27 -27.38 14.54 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.25 -28.57 34.7 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.596 -175.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -75.93 -23.46 55.46 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.249 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt . . . . . 0 C--N 1.316 -0.859 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.63 -177.666 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.0 t . . . . . 0 CA--C 1.509 -0.622 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -142.41 155.43 45.12 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.517 HG21 HG23 ' A' ' 46' ' ' VAL . 1.6 pp -94.14 155.08 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.336 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.116 178.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.45 ' N ' HD12 ' A' ' 74' ' ' ILE . 3.8 mp -123.83 -31.43 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.969 0.89 . . . . 0.0 109.948 178.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -133.21 105.91 7.28 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.996 -170.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -116.33 114.68 24.66 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.059 178.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.516 ' O ' ' HA ' ' A' ' 47' ' ' LYS . . . -147.82 158.61 44.11 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.709 -177.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.9 p -94.0 101.39 12.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-O 121.859 0.837 . . . . 0.0 109.88 177.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.32 171.89 44.87 Favored Glycine 0 N--CA 1.417 -2.576 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.915 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.575 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -82.24 -152.79 0.11 Allowed 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 174.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.465 HD13 HD11 ' A' ' 120' ' ' LEU . 2.4 mp -91.41 111.36 23.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 C-N-CA 118.732 -1.187 . . . . 0.0 109.36 176.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.5 p -108.73 165.18 11.74 Favored 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 175.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -60.02 -35.74 75.73 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 121.38 0.609 . . . . 0.0 111.124 -176.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.3 p -69.03 -23.6 64.09 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.12 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -74.28 -41.35 61.35 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 177.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.533 HD13 ' HB2' ' A' ' 111' ' ' ALA . 44.2 mt -66.86 -34.7 71.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-N 114.242 -1.344 . . . . 0.0 111.424 -178.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.454 ' HA ' ' OE2' ' A' ' 114' ' ' GLU . 46.9 m -67.73 -9.09 40.8 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.488 178.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -92.92 -32.67 14.49 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 173.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.11 -53.26 59.33 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.44 -177.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 9.8 t -74.03 -13.57 60.88 Favored 'General case' 0 CA--C 1.561 1.379 0 CA-C-O 121.136 0.493 . . . . 0.0 110.414 178.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.65 -66.19 0.87 Allowed 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -176.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.429 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 27.1 p -101.51 5.65 41.97 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 120.748 0.309 . . . . 0.0 111.533 -176.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . 0.491 0.0 OUTLIER 70.3 57.54 0.27 Allowed 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 127.13 2.172 . . . . 0.0 114.118 -179.462 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -105.3 167.99 9.37 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 113.357 -1.747 . . . . 0.0 108.509 174.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 47.7 mm -124.13 131.57 72.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 176.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.599 ' HB ' HG22 ' A' ' 118' ' ' ILE . 12.0 t -94.11 102.59 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -176.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 13.3 tt -97.93 140.53 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.924 177.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.461 ' HA3' HD11 ' A' ' 81' ' ' ILE . . . -134.36 146.45 18.44 Favored Glycine 0 N--CA 1.414 -2.772 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 178.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -119.54 109.24 15.47 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -177.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 66.7 t30 71.81 -39.07 0.44 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 126.022 1.729 . . . . 0.0 112.41 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.3 m -45.29 -47.65 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 126.302 1.841 . . . . 0.0 114.986 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.575 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 36.1 mtp180 73.57 170.14 0.11 Allowed Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 123.485 0.714 . . . . 0.0 112.055 179.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -96.9 168.46 0.95 Allowed 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 121.911 1.741 . . . . 0.0 114.594 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -75.74 153.3 37.12 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 113.215 -1.811 . . . . 0.0 106.769 168.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.509 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -59.15 -35.2 73.1 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.549 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 18.2 m120 -79.58 -27.49 41.15 Favored 'General case' 0 CA--C 1.488 -1.429 0 C-N-CA 119.346 -0.941 . . . . 0.0 110.592 178.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.26 -46.42 77.17 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.766 177.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 19.9 pttp -59.51 -23.18 62.59 Favored 'General case' 0 CA--C 1.565 1.557 0 CA-C-O 120.965 0.412 . . . . 0.0 111.588 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.549 ' HB2' ' O ' ' A' ' 106' ' ' ASN 0.254 58.4 mtp180 -82.54 -51.2 8.01 Favored 'General case' 0 N--CA 1.393 -3.278 0 C-N-CA 125.821 1.648 . . . . 0.0 109.316 176.928 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.532 ' HB1' ' OE1' ' A' ' 114' ' ' GLU . . . -54.23 -48.5 71.01 Favored 'General case' 0 CA--C 1.471 -2.091 0 C-N-CA 125.914 1.686 . . . . 0.0 110.839 -176.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.533 ' HB2' HD13 ' A' ' 86' ' ' ILE . . . -48.17 -45.59 33.69 Favored 'General case' 0 CA--C 1.504 -0.797 0 O-C-N 124.867 1.354 . . . . 0.0 110.578 -179.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -72.92 -30.27 63.77 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 114.542 -1.208 . . . . 0.0 112.903 -174.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.1 t -92.28 5.27 51.13 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.532 ' OE1' ' HB1' ' A' ' 110' ' ' ALA . 7.9 mt-10 -117.9 7.04 12.27 Favored 'General case' 0 N--CA 1.406 -2.662 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -175.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 29.7 mmmt 68.2 5.74 4.85 Favored 'General case' 0 N--CA 1.42 -1.936 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 174.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.1 m -122.18 145.26 29.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -114.66 143.66 44.68 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 118.726 -1.189 . . . . 0.0 109.761 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.599 HG22 ' HB ' ' A' ' 96' ' ' VAL . 8.7 pt -98.1 131.1 45.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.187 -176.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -98.5 124.83 43.47 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.516 -174.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.465 HD11 HD13 ' A' ' 81' ' ' ILE . 3.5 mm? . . . . . 0 CA--C 1.502 -0.865 0 CA-C-O 121.873 0.844 . . . . 0.0 112.867 -178.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.61 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 91.3 m-20 . . . . . 0 N--CA 1.416 -2.159 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.3 pp -150.12 164.69 34.94 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.549 HG23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -119.88 132.88 68.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.368 178.612 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 93.3 t -107.1 126.96 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.058 -177.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 42.5 mtpt -139.23 134.75 33.12 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.211 176.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.78 168.39 23.82 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -178.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -80.2 -18.73 48.77 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.855 0.836 . . . . 0.0 110.421 -178.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 69.4 t -104.76 123.19 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 175.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.792 ' O ' HG22 ' A' ' 54' ' ' VAL . 10.8 tt0 -68.64 -29.78 68.34 Favored 'General case' 0 C--O 1.195 -1.78 0 CA-C-O 121.137 0.494 . . . . 0.0 111.413 -174.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.95 2.59 87.15 Favored Glycine 0 C--N 1.284 -2.36 0 C-N-CA 117.125 -2.464 . . . . 0.0 112.642 177.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.4 t -86.84 -31.07 21.01 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 176.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.792 HG22 ' O ' ' A' ' 51' ' ' GLN . 11.9 m -67.48 -43.4 87.41 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.866 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.423 175.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -66.27 -39.93 89.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.413 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.27 -37.04 79.25 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.747 177.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.513 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 26.6 tp -77.46 -41.68 38.71 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 120.532 -0.467 . . . . 0.0 109.766 177.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 54' ' ' VAL . 32.1 t -53.57 -45.82 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 123.57 0.748 . . . . 0.0 112.079 177.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.34 -26.56 68.51 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.58 -22.83 17.37 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -178.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.513 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -82.55 -35.53 27.11 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.47 -175.621 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -67.72 -27.04 66.46 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.112 0.482 . . . . 0.0 110.57 178.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.1 ptpp? . . . . . 0 CA--C 1.538 0.502 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.32 179.12 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.5 t . . . . . 0 N--CA 1.431 -1.416 0 N-CA-C 103.382 -2.822 . . . . 0.0 103.382 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.462 ' HG2' ' N ' ' A' ' 73' ' ' ILE . 87.9 tttt -139.92 161.5 37.44 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.354 0.597 . . . . 0.0 111.142 -176.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.462 ' N ' ' HG2' ' A' ' 72' ' ' LYS . 1.7 pp -93.51 148.52 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.759 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.612 177.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 73.2 mt -119.57 -27.63 2.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-O 121.68 0.753 . . . . 0.0 110.06 176.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.534 ' CD2' HD12 ' A' ' 45' ' ' ILE . 3.0 t60 -154.67 132.28 11.34 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.357 -172.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -134.66 131.03 37.25 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.404 ' O ' HG11 ' A' ' 54' ' ' VAL . . . -149.79 156.98 42.75 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.955 -178.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.3 p -93.5 94.42 4.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-O 122.521 1.153 . . . . 0.0 110.295 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.7 176.02 47.79 Favored Glycine 0 N--CA 1.417 -2.572 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.549 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -91.81 -175.38 4.12 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 176.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.494 HG21 HG21 ' A' ' 118' ' ' ILE . 3.2 mp -74.3 111.84 10.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 119.433 -0.907 . . . . 0.0 108.847 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.8 p -117.61 152.97 34.07 Favored 'General case' 0 N--CA 1.42 -1.972 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.702 -178.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -50.33 -41.83 51.85 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.026 0.53 . . . . 0.0 111.588 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.1 m -62.83 -28.12 69.79 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.614 -177.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -86.17 -29.33 23.32 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-O 121.341 0.591 . . . . 0.0 110.94 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.52 HG21 ' HA ' ' A' ' 111' ' ' ALA . 59.2 mt -65.87 -25.72 36.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.699 177.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 38.0 m -59.84 -30.7 69.13 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.917 177.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -78.25 -35.78 47.78 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 175.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.05 -58.91 5.39 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.966 -176.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.564 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 9.8 t -71.24 -24.61 62.22 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.478 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.17 -62.67 1.61 Allowed 'General case' 0 C--N 1.342 0.273 0 CA-C-O 120.944 0.402 . . . . 0.0 111.76 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.7 m -96.37 5.44 50.91 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.627 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 65.85 40.88 4.03 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.216 1.006 . . . . 0.0 110.314 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.61 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -94.51 136.45 34.79 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-N 114.206 -1.361 . . . . 0.0 109.081 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.1 mp -93.88 140.23 16.9 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.549 ' HA ' HG23 ' A' ' 45' ' ' ILE . 14.5 t -94.77 117.54 38.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -178.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.54 ' HA ' ' O ' ' A' ' 119' ' ' ARG . 0.2 OUTLIER -112.17 122.86 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 174.3 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -115.37 146.47 18.83 Favored Glycine 0 N--CA 1.426 -1.997 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.159 -177.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -105.6 94.62 5.3 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 118.468 -1.293 . . . . 0.0 109.664 -177.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 63.78 8.64 3.9 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 124.946 1.298 . . . . 0.0 112.866 177.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.471 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 3.6 m -78.89 -49.38 20.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.101 -178.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.549 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 72.7 mtp180 69.59 154.64 0.15 Allowed Pre-proline 0 N--CA 1.477 0.915 0 O-C-N 123.889 0.743 . . . . 0.0 112.82 175.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -91.07 173.69 2.78 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 121.991 1.794 . . . . 0.0 112.47 178.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -89.71 168.28 12.23 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 167.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.543 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -56.58 -28.61 60.63 Favored 'General case' 0 C--O 1.206 -1.203 0 C-N-CA 122.824 0.449 . . . . 0.0 111.041 178.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.644 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 23.1 p30 -72.41 -46.47 55.01 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.21 -34.8 76.92 Favored 'General case' 0 C--N 1.292 -1.922 0 O-C-N 122.096 -0.378 . . . . 0.0 111.563 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 18.1 pttp -63.08 -27.7 69.57 Favored 'General case' 0 CA--C 1.563 1.478 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.318 175.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.644 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 63.5 mtp180 -75.37 -50.28 16.41 Favored 'General case' 0 N--CA 1.405 -2.698 0 C-N-CA 125.212 1.405 . . . . 0.0 109.239 176.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.24 -50.6 66.8 Favored 'General case' 0 C--O 1.201 -1.47 0 CA-C-N 114.118 -1.401 . . . . 0.0 110.269 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.52 ' HA ' HG21 ' A' ' 86' ' ' ILE . . . -49.33 -48.6 46.32 Favored 'General case' 0 CA--C 1.502 -0.886 0 O-C-N 124.587 1.179 . . . . 0.0 111.602 -178.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -79.13 -29.8 43.35 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.864 -173.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 28.7 t -77.19 -6.94 54.92 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 175.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.564 ' O ' ' HB ' ' A' ' 90' ' ' THR . 26.2 mt-10 -114.73 9.32 16.37 Favored 'General case' 0 N--CA 1.411 -2.422 0 CA-C-N 114.471 -1.241 . . . . 0.0 112.912 -177.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 29.2 mmtp 64.46 15.57 9.65 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 174.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.3 m -120.34 131.76 71.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.461 0.648 . . . . 0.0 112.565 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -94.59 130.39 41.06 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.077 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.494 HG21 HG21 ' A' ' 81' ' ' ILE . 15.1 pt -94.85 128.6 45.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.06 179.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.54 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 98.1 mtt180 -122.16 111.69 17.29 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.672 0.749 . . . . 0.0 110.743 -175.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.509 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.286 -2.154 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.148 -177.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 . . . . . 0 C--O 1.237 0.4 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.4 mt -135.23 168.78 18.54 Favored 'General case' 0 C--O 1.248 0.976 0 CA-C-O 121.789 0.804 . . . . 0.0 111.925 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.472 HG12 ' CE ' ' A' ' 47' ' ' LYS . 1.1 tt -133.18 132.9 58.54 Favored 'Isoleucine or valine' 0 C--O 1.249 1.028 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.198 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.647 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 84.4 t -113.74 131.96 64.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.565 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.472 ' CE ' HG12 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -142.97 148.03 36.17 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 178.444 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.59 158.13 28.51 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 177.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -78.95 -12.33 60.03 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.039 -0.665 . . . . 0.0 110.044 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 99.1 t -109.86 134.12 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 174.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.738 ' O ' HG22 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -69.01 -46.63 67.52 Favored 'General case' 0 C--O 1.202 -1.447 0 C-N-CA 122.431 0.292 . . . . 0.0 110.558 -172.332 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.06 -1.19 67.66 Favored Glycine 0 C--N 1.286 -2.196 0 C-N-CA 118.479 -1.82 . . . . 0.0 114.285 -177.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.7 m -80.17 -29.42 38.74 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 106.282 -1.748 . . . . 0.0 106.282 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.738 HG22 ' O ' ' A' ' 51' ' ' GLN . 5.7 m -72.37 -42.44 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.498 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.354 176.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -54.47 -47.86 72.48 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 124.128 0.893 . . . . 0.0 110.592 178.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.77 -40.03 91.02 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.658 -178.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 34.4 tp -78.94 -36.66 41.33 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.593 -178.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.425 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 43.4 t -59.98 -43.6 92.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 122.727 0.411 . . . . 0.0 110.493 177.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.12 -14.85 62.48 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.61 -13.15 16.64 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.497 0.665 . . . . 0.0 109.294 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.419 ' HG ' HG23 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -99.7 -38.67 8.61 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.397 -176.148 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 4.1 pt20 -74.11 -5.9 44.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.303 0.573 . . . . 0.0 111.128 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.245 0.856 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.117 177.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.6 t . . . . . 0 N--CA 1.436 -1.145 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -124.27 158.08 33.37 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.52 0.676 . . . . 0.0 111.444 -172.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.419 HG23 ' HG ' ' A' ' 61' ' ' LEU . 1.5 pp -93.84 149.76 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.942 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.803 174.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 53.6 mt -120.63 -24.23 2.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-O 121.565 0.698 . . . . 0.0 110.796 178.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -150.41 117.45 5.94 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.63 -172.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.647 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -120.78 129.69 53.7 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 176.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.41 ' O ' HG11 ' A' ' 54' ' ' VAL . . . -145.72 153.53 41.07 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.974 -178.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.444 ' HB ' ' HA ' ' A' ' 51' ' ' GLN . 3.0 p -93.84 93.26 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.704 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 175.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.87 176.49 48.03 Favored Glycine 0 N--CA 1.401 -3.697 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.79 -175.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.598 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -90.49 -157.08 0.46 Allowed 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 175.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.509 HG21 HG21 ' A' ' 118' ' ' ILE . 2.9 mp -83.06 103.74 10.76 Favored 'Isoleucine or valine' 0 C--O 1.254 1.329 0 C-N-CA 118.854 -1.138 . . . . 0.0 108.242 177.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 44.1 p -101.7 159.73 15.07 Favored 'General case' 0 N--CA 1.409 -2.508 0 C-N-CA 119.417 -0.913 . . . . 0.0 108.808 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -60.21 -26.27 66.26 Favored 'General case' 0 CA--C 1.559 1.315 0 CA-C-O 121.466 0.65 . . . . 0.0 109.949 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.6 m -71.97 -22.06 61.5 Favored 'General case' 0 CA--C 1.555 1.146 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.154 178.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -81.48 -33.05 32.18 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-O 121.628 0.728 . . . . 0.0 109.276 178.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.563 HD13 ' HB2' ' A' ' 111' ' ' ALA . 67.8 mt -72.63 -33.13 43.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.25 -178.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.9 p -61.01 -17.29 51.36 Favored 'General case' 0 CA--C 1.557 1.214 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 175.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.451 ' O ' HD22 ' A' ' 88' ' ' LEU . 1.9 tm? -92.22 -33.13 14.8 Favored 'General case' 0 C--O 1.25 1.104 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 174.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.93 -58.94 5.57 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.25 -176.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.405 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 11.2 t -79.29 -4.27 49.95 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-O 121.421 0.629 . . . . 0.0 110.649 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.84 -67.31 0.79 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.039 0.447 . . . . 0.0 112.191 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.4 t -104.85 5.95 33.44 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.391 0.615 . . . . 0.0 109.921 -176.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 74.07 72.12 0.11 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.482 1.113 . . . . 0.0 113.324 178.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -128.33 135.69 49.94 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 173.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.0 tt -94.49 140.79 16.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.793 ' HB ' HG22 ' A' ' 118' ' ' ILE . 49.4 t -94.45 99.45 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.392 0 CA-C-O 121.587 0.708 . . . . 0.0 110.946 -174.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 119' ' ' ARG . 42.7 mm -94.11 144.2 10.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 174.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.426 ' HA3' HD11 ' A' ' 81' ' ' ILE . . . -143.02 158.72 27.28 Favored Glycine 0 C--N 1.293 -1.821 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.06 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -122.38 95.04 4.48 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.243 -177.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . 0.254 95.4 m-20 55.6 -5.09 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 -179.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.448 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 1.7 m -62.93 -45.02 99.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 C-N-CA 123.65 0.78 . . . . 0.0 110.159 176.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.598 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 58.9 mtm180 70.88 161.66 0.15 Allowed Pre-proline 0 C--O 1.213 -0.849 0 CA-C-N 114.783 -1.099 . . . . 0.0 113.125 173.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.472 ' HG3' HD12 ' A' ' 118' ' ' ILE . 11.1 Cg_endo -94.68 170.41 1.61 Allowed 'Trans proline' 0 N--CA 1.441 -1.602 0 C-N-CA 121.479 1.453 . . . . 0.0 114.291 -177.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -74.07 155.35 38.6 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 167.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.576 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -61.67 -36.29 80.44 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.563 0.697 . . . . 0.0 110.193 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.511 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 2.7 t-20 -74.83 -37.76 62.19 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.032 177.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.33 -48.39 81.8 Favored 'General case' 0 C--O 1.214 -0.775 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.48 176.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.576 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 14.8 pttp -59.23 -28.63 66.86 Favored 'General case' 0 CA--C 1.565 1.541 0 CA-C-O 120.982 0.42 . . . . 0.0 111.89 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.511 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 49.3 mtp180 -75.4 -49.59 18.49 Favored 'General case' 0 N--CA 1.386 -3.655 0 C-N-CA 125.5 1.52 . . . . 0.0 109.306 178.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -55.22 -48.01 74.51 Favored 'General case' 0 C--O 1.198 -1.618 0 CA-C-N 113.903 -1.498 . . . . 0.0 110.07 -179.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.563 ' HB2' HD13 ' A' ' 86' ' ' ILE . . . -48.09 -44.07 31.31 Favored 'General case' 0 CA--C 1.496 -1.115 0 O-C-N 124.68 1.237 . . . . 0.0 111.121 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -75.87 -37.5 58.84 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.748 -174.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 34.0 t -80.41 5.07 16.04 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 122.047 0.927 . . . . 0.0 108.568 178.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' ' 115' ' ' LYS . 25.1 mt-10 -121.23 9.76 10.5 Favored 'General case' 0 N--CA 1.404 -2.762 0 CA-C-N 114.442 -1.254 . . . . 0.0 112.839 -178.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 60.3 mmtt 65.87 10.82 7.19 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 173.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.1 m -115.22 156.42 16.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 C-N-CA 119.831 -0.748 . . . . 0.0 111.744 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -112.57 138.19 49.71 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.329 -177.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.793 HG22 ' HB ' ' A' ' 96' ' ' VAL . 9.9 pt -108.38 113.88 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.628 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 173.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.417 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 50.8 ttp180 -113.31 97.92 6.78 Favored 'General case' 0 N--CA 1.414 -2.27 0 CA-C-O 122.211 1.005 . . . . 0.0 109.719 -175.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.524 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.29 -1.998 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.768 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 17.0 m120 . . . . . 0 CA--C 1.5 -0.944 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 69.87 119.86 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.822 0.849 . . . . 0.0 110.816 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -96.86 118.86 34.21 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.817 -176.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 69.99 96.88 0.07 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.745 1.218 . . . . 0.0 112.032 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -91.91 110.8 22.16 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 176.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -134.54 -144.54 5.06 Favored Glycine 0 N--CA 1.422 -2.238 0 C-N-CA 119.631 -1.271 . . . . 0.0 113.071 -176.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -96.86 138.47 34.36 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -94.79 97.64 10.19 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 176.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.41 61.11 4.24 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 116.32 -0.4 . . . . 0.0 112.4 -177.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 33.8 t -114.08 -31.5 6.33 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.045 0.45 . . . . 0.0 110.343 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.4 m -93.68 11.31 29.44 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.601 0.715 . . . . 0.0 110.814 -178.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -86.93 -12.56 47.29 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.977 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.4 m -105.35 -177.98 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.53 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -75.41 142.45 43.05 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.242 0.544 . . . . 0.0 110.392 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.5 mt -96.77 100.05 11.61 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.158 -172.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 48.2 mm-40 -124.11 -173.31 2.73 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 177.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.22 169.88 12.78 Favored 'General case' 0 C--O 1.246 0.917 0 C-N-CA 120.819 -0.353 . . . . 0.0 111.636 175.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 69.43 30.51 4.09 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -169.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 -65.35 -33.37 75.82 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 113.544 -1.662 . . . . 0.0 110.627 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.4 ' O ' HG12 ' A' ' 21' ' ' VAL . 33.0 t -75.91 -42.08 49.99 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' ' 20' ' ' SER . 2.9 p 57.66 145.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 127.157 2.183 . . . . 0.0 112.43 -177.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.421 ' HD2' HG23 ' A' ' 23' ' ' THR . 9.7 tmtt? 70.86 -65.31 0.34 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.098 0.959 . . . . 0.0 109.508 -177.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.421 HG23 ' HD2' ' A' ' 22' ' ' LYS . 38.0 p -88.77 12.23 15.57 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 122.018 0.914 . . . . 0.0 110.013 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.562 ' HD2' ' O ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -71.8 151.27 43.62 Favored 'General case' 0 C--O 1.247 0.931 0 CA-C-N 114.583 -1.189 . . . . 0.0 111.281 179.185 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.483 HG21 ' HB2' ' A' ' 28' ' ' ASP . 14.4 p -166.94 144.63 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.0 m -87.71 -61.73 1.65 Allowed 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -133.07 111.01 10.61 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -177.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.483 ' HB2' HG21 ' A' ' 25' ' ' VAL . 31.8 t70 -117.9 -22.36 7.95 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.356 0.598 . . . . 0.0 111.292 -178.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -82.8 105.89 14.18 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.067 0.461 . . . . 0.0 110.839 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.3 mt -74.01 152.22 40.08 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.389 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -89.07 138.16 31.66 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.346 0.593 . . . . 0.0 111.892 -173.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 33' ' ' GLN . 14.3 tp10 -88.77 -32.22 18.0 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 174.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' A' ' 32' ' ' GLU . 14.1 mm100 78.68 150.04 0.11 Allowed 'General case' 0 C--N 1.356 0.85 0 C-N-CA 125.006 1.322 . . . . 0.0 111.458 -177.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.5 pp -76.99 159.88 4.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.076 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -161.89 113.4 1.69 Allowed 'General case' 0 C--O 1.247 0.952 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -174.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -83.62 83.05 8.04 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.522 0.677 . . . . 0.0 112.444 -177.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -127.44 17.88 6.13 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 175.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -71.91 -61.34 1.82 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 114.818 -0.691 . . . . 0.0 110.538 -176.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 24.4 mmt -79.5 -24.59 42.18 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.023 -176.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt 71.78 169.2 0.32 Allowed 'General case' 0 C--O 1.24 0.601 0 CA-C-N 113.792 -1.549 . . . . 0.0 110.782 -175.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -108.96 115.5 30.19 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.5 tp -94.14 119.0 32.36 Favored 'General case' 0 N--CA 1.423 -1.799 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.909 -172.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.47 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 89.0 m-20 -109.59 146.73 34.23 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -155.27 165.62 36.1 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-O 121.513 0.673 . . . . 0.0 112.191 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.57 HD13 ' CD2' ' A' ' 75' ' ' HIS . 0.1 OUTLIER -118.43 134.56 61.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 174.591 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 65.5 t -103.84 129.99 55.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.414 -178.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.472 ' HE2' ' HB3' ' A' ' 77' ' ' ALA . 64.4 mttt -141.38 139.27 33.46 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 121.442 0.639 . . . . 0.0 111.149 176.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.72 166.38 33.01 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -82.22 -21.77 36.2 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.996 0.427 . . . . 0.0 110.082 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 94.3 t -99.25 124.09 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 174.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.771 ' O ' HG22 ' A' ' 54' ' ' VAL . 17.3 tt0 -63.77 -40.87 97.74 Favored 'General case' 0 C--O 1.2 -1.546 0 CA-C-O 120.871 0.367 . . . . 0.0 111.56 -174.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.02 5.18 63.27 Favored Glycine 0 C--N 1.278 -2.683 0 C-N-CA 117.639 -2.22 . . . . 0.0 113.647 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.9 t -84.26 -32.28 24.51 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 173.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.771 HG22 ' O ' ' A' ' 51' ' ' GLN . 4.0 m -72.71 -46.8 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.766 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.772 177.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -63.4 -39.48 94.63 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.504 -177.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.42 -37.47 87.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.825 0.345 . . . . 0.0 110.695 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.41 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 31.3 tp -75.08 -42.02 57.6 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.507 HG21 ' HB2' ' A' ' 76' ' ' ALA . 70.3 t -58.78 -42.48 85.57 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.52 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.948 177.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.433 ' O ' ' HE3' ' A' ' 63' ' ' LYS . . . -65.11 -16.87 63.96 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.99 -25.25 14.38 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 122.187 0.994 . . . . 0.0 108.399 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.431 ' HB3' HG13 ' A' ' 73' ' ' ILE . 0.6 OUTLIER -83.13 -36.26 24.93 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.168 -176.197 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -71.91 -22.35 61.5 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 122.801 0.44 . . . . 0.0 111.228 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.433 ' HE3' ' O ' ' A' ' 59' ' ' ALA . 19.0 ptpt -90.94 5.1 50.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.201 0.524 . . . . 0.0 110.772 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 31.8 mm -78.25 102.07 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 175.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -132.41 17.84 4.41 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-O 121.473 0.654 . . . . 0.0 109.517 176.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 36.0 m -62.06 137.74 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.436 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -70.92 125.72 27.61 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.41 -177.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.6 -88.71 0.41 Allowed Glycine 0 N--CA 1.432 -1.58 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.564 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.6 t -98.46 109.9 24.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.59 126.99 41.25 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 119.915 -0.714 . . . . 0.0 110.466 177.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 39.5 t -126.47 126.36 68.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -147.98 154.31 40.15 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.365 0.603 . . . . 0.0 110.776 -175.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.431 HG13 ' HB3' ' A' ' 61' ' ' LEU . 1.6 pp -93.9 147.94 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.68 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.625 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.8 mm -112.5 -22.18 5.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.978 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.57 ' CD2' HD13 ' A' ' 45' ' ' ILE . 5.3 t60 -162.48 149.11 13.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -172.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.507 ' HB2' HG21 ' A' ' 58' ' ' VAL . . . -140.41 144.34 36.11 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 178.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.472 ' HB3' ' HE2' ' A' ' 47' ' ' LYS . . . -165.52 149.78 8.49 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 117.904 0.32 . . . . 0.0 110.874 177.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.2 p -94.31 93.67 4.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 122.604 1.192 . . . . 0.0 109.083 177.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -177.09 176.4 48.05 Favored Glycine 0 N--CA 1.408 -3.192 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -177.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.661 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -93.11 -175.35 3.83 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 176.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 103' ' ' PRO . 3.0 mp -77.83 110.9 14.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.064 -0.655 . . . . 0.0 110.016 -176.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.7 p -110.74 147.81 33.62 Favored 'General case' 0 N--CA 1.408 -2.543 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.187 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -45.7 -44.49 13.59 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 125.125 1.37 . . . . 0.0 112.95 -178.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.9 t -64.15 -33.96 76.96 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 122.556 0.342 . . . . 0.0 111.785 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -78.18 -26.21 47.52 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 121.007 0.432 . . . . 0.0 111.718 -177.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.536 HG21 ' HA ' ' A' ' 111' ' ' ALA . 50.8 mt -64.71 -35.48 75.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.952 177.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 57.6 m -61.17 -24.55 66.39 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 175.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -74.96 -37.63 61.9 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 173.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.606 ' HA ' ' O ' ' A' ' 94' ' ' ALA . . . -55.22 -51.23 67.23 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.9 -177.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.417 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 8.9 t -77.14 -15.98 59.33 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 120.596 -0.441 . . . . 0.0 111.099 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.69 -62.13 1.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.062 0.458 . . . . 0.0 111.102 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 68.1 m -91.6 1.3 57.24 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.954 -177.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.2 m120 69.35 23.33 6.22 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.907 0.86 . . . . 0.0 109.38 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.606 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . -94.72 117.2 29.75 Favored 'General case' 0 C--O 1.194 -1.844 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.688 -177.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 44.3 pt -92.38 156.69 3.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 118.378 -1.329 . . . . 0.0 109.782 -177.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.439 HG11 HG13 ' A' ' 81' ' ' ILE . 10.5 t -94.45 116.92 36.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.215 -173.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 6.5 tp -101.08 109.25 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.928 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 173.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -105.9 140.57 15.19 Favored Glycine 0 N--CA 1.414 -2.789 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.047 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -98.68 94.4 6.63 Favored 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 118.238 -1.385 . . . . 0.0 109.281 -176.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 66.8 t30 58.61 14.78 3.27 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 125.489 1.516 . . . . 0.0 111.822 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.508 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 6.5 m -78.91 -49.6 19.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -173.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.661 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 62.6 mtm180 77.87 158.96 0.15 Allowed Pre-proline 0 N--CA 1.482 1.17 0 O-C-N 123.818 0.699 . . . . 0.0 112.756 174.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.478 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 15.4 Cg_endo -100.16 178.79 0.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.546 2.164 . . . . 0.0 114.934 -176.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.494 ' HB2' ' H ' ' A' ' 107' ' ' ALA . 11.4 m-20 -73.83 159.91 32.21 Favored 'General case' 0 C--O 1.25 1.084 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 167.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.505 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -67.63 -28.22 67.54 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.079 0.466 . . . . 0.0 109.892 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.621 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 20.0 t-20 -85.9 -36.32 19.99 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.796 176.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.494 ' H ' ' HB2' ' A' ' 104' ' ' ASP . . . -59.51 -43.81 93.3 Favored 'General case' 0 C--O 1.207 -1.152 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.823 176.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 105' ' ' ALA . 0.0 OUTLIER -57.83 -30.04 65.43 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-O 120.785 0.326 . . . . 0.0 111.602 179.08 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.621 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 91.1 mtt180 -76.29 -52.31 10.24 Favored 'General case' 0 N--CA 1.386 -3.638 0 C-N-CA 125.29 1.436 . . . . 0.0 108.385 178.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -52.73 -45.96 67.21 Favored 'General case' 0 C--O 1.201 -1.484 0 CA-C-N 113.672 -1.603 . . . . 0.0 110.577 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.536 ' HA ' HG21 ' A' ' 86' ' ' ILE . . . -47.68 -53.06 16.12 Favored 'General case' 0 CA--C 1.501 -0.936 0 O-C-N 124.749 1.281 . . . . 0.0 110.915 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -78.55 -25.52 45.45 Favored 'General case' 0 C--N 1.271 -2.841 0 CA-C-N 114.558 -1.201 . . . . 0.0 112.529 -173.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 41.6 t -86.39 5.34 35.4 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 177.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.518 ' O ' ' HB2' ' A' ' 115' ' ' LYS . 19.2 mt-10 -123.3 13.11 9.54 Favored 'General case' 0 CA--C 1.462 -2.409 0 CA-C-N 114.612 -1.176 . . . . 0.0 111.737 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.518 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 56.4 mtpt 68.85 12.61 8.7 Favored 'General case' 0 N--CA 1.417 -2.086 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 175.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.434 ' O ' ' HB1' ' A' ' 111' ' ' ALA . 3.0 m -126.16 112.49 30.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -93.87 141.07 28.93 Favored 'General case' 0 CA--C 1.498 -1.022 0 C-N-CA 118.29 -1.364 . . . . 0.0 108.352 177.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.421 ' H ' HG12 ' A' ' 118' ' ' ILE . 6.3 pt -102.06 145.01 12.53 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.601 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.541 -174.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 57.3 mtp180 -122.03 128.48 51.46 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -178.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.448 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -162.45 159.74 25.45 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.621 -177.194 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 66.4 t60 62.08 31.46 17.85 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 122.258 1.027 . . . . 0.0 109.281 172.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -76.42 42.31 0.27 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 114.784 -1.098 . . . . 0.0 112.878 -175.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 56.3 mt -64.59 -55.83 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 175.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 6.0 tp -177.66 119.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.584 174.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -104.75 108.15 19.48 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 104.539 -2.393 . . . . 0.0 104.539 168.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -77.2 78.61 3.73 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 122.129 0.966 . . . . 0.0 112.174 -170.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.4 p -84.67 -10.39 11.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.816 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 59.7 mt -85.06 97.36 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.258 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 68.5 122.6 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.05 1.34 . . . . 0.0 113.414 176.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -86.67 99.44 11.75 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 169.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.457 ' O ' ' HG2' ' A' ' 132' ' ' GLU . 48.3 mm -82.0 82.96 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 CA-C-O 121.503 0.668 . . . . 0.0 111.516 -177.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 131' ' ' ILE . 5.4 mm-40 169.99 137.94 0.02 OUTLIER 'General case' 0 CA--C 1.489 -1.382 0 C-N-CA 130.0 3.32 . . . . 0.0 105.458 174.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 63.8 19.14 11.58 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 122.087 0.946 . . . . 0.0 109.358 -172.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -119.99 148.97 42.89 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-N 114.713 -1.13 . . . . 0.0 108.304 -177.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 44.6 ttm . . . . . 0 C--N 1.286 -2.173 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 -179.096 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 . . . . . 0 CA--C 1.492 -1.276 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -172.76 -43.04 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 69.5 132.79 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.648 1.179 . . . . 0.0 112.768 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 59.18 81.27 0.17 Allowed 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.112 0.965 . . . . 0.0 111.702 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -151.94 -51.55 0.12 Allowed 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.525 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -108.48 91.87 0.7 Allowed Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.3 t -103.67 65.43 0.83 Allowed 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -174.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.503 ' HA ' HG21 ' A' ' 13' ' ' VAL . 31.0 mtt180 -166.99 165.29 15.93 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 124.916 1.286 . . . . 0.0 110.23 174.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 174.66 160.38 22.62 Favored Glycine 0 N--CA 1.428 -1.896 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -176.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.7 m -51.32 97.09 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 125.462 1.505 . . . . 0.0 113.667 -174.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.5 m 57.12 19.11 4.53 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.909 1.284 . . . . 0.0 114.408 174.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -95.93 -15.5 22.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.328 0.585 . . . . 0.0 110.894 178.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.503 HG21 ' HA ' ' A' ' 8' ' ' ARG . 30.1 m -134.04 168.59 23.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 176.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 72.28 21.37 3.85 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.101 0.961 . . . . 0.0 112.185 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.8 mp -73.56 110.0 7.51 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 175.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 -91.7 -47.13 7.53 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.391 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 60.97 -69.76 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.231 1.412 . . . . 0.0 112.358 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 68.51 -59.2 0.46 Allowed 'General case' 0 C--O 1.22 -0.494 0 C-N-CA 125.807 1.643 . . . . 0.0 112.999 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . 0.316 13.7 ptm180 51.4 -77.49 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.522 1.929 . . . . 0.0 115.113 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.442 ' O ' HG22 ' A' ' 21' ' ' VAL . 37.3 p -85.42 -11.44 54.4 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.442 HG22 ' O ' ' A' ' 20' ' ' SER 0.271 5.6 m 67.29 0.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 127.927 2.491 . . . . 0.0 111.425 -176.388 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -89.92 -43.13 10.79 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 35.5 p -80.45 13.01 2.65 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.275 -1.329 . . . . 0.0 112.723 -175.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -78.58 -25.79 45.36 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.372 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.6 p -173.75 -15.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.997 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t 64.1 -147.65 0.29 Allowed 'General case' 0 C--O 1.253 1.247 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 -175.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.9 mt 61.61 41.98 11.62 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 122.044 0.926 . . . . 0.0 109.783 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -83.57 38.3 0.62 Allowed 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.55 -178.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -79.97 -20.55 45.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.82 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 65.9 tp -110.93 86.88 2.41 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -119.3 -12.08 9.46 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.252 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -73.5 153.16 40.44 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.771 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -75.78 134.47 40.42 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.4 mm -59.01 123.85 12.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 176.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -72.46 -29.43 63.67 Favored 'General case' 0 C--N 1.315 -0.917 0 O-C-N 123.439 0.462 . . . . 0.0 111.977 -172.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 74.98 -23.09 0.24 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.791 1.236 . . . . 0.0 113.611 176.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 174.63 -176.95 46.9 Favored Glycine 0 N--CA 1.426 -1.999 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -134.85 145.48 48.34 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 27.0 ttt -144.25 135.66 25.66 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -67.33 -59.04 3.74 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -174.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' A' ' 70' ' ' ARG . 30.4 tt0 -130.62 121.43 25.59 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-O 121.262 0.553 . . . . 0.0 110.223 -174.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -94.95 143.2 26.66 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.047 -0.978 . . . . 0.0 109.207 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.502 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 94.1 m-20 -109.72 128.05 55.02 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -178.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 89.6 mt -135.29 169.65 17.14 Favored 'General case' 0 C--O 1.252 1.194 0 CA-C-O 122.016 0.912 . . . . 0.0 111.894 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.573 HG23 ' HA ' ' A' ' 96' ' ' VAL . 0.8 OUTLIER -131.61 139.73 49.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 114.259 -1.337 . . . . 0.0 109.944 177.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 93.7 t -117.88 130.67 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-O 121.161 0.505 . . . . 0.0 110.775 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 79' ' ' GLY . 35.5 mtmm -142.35 144.47 33.2 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.017 173.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -150.48 170.77 18.29 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -82.7 -19.7 37.53 Favored 'General case' 0 C--N 1.313 -1.007 0 O-C-N 124.065 0.853 . . . . 0.0 110.227 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.472 ' HB ' ' OG ' ' A' ' 53' ' ' SER . 95.3 t -110.54 124.26 67.16 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.971 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 173.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.714 ' O ' HG22 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -54.77 -46.61 74.41 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 123.898 0.879 . . . . 0.0 112.61 -176.348 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.19 1.7 79.44 Favored Glycine 0 C--N 1.285 -2.264 0 C-N-CA 118.099 -2.001 . . . . 0.0 114.06 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.472 ' OG ' ' HB ' ' A' ' 50' ' ' VAL . 49.1 m -82.63 -26.78 31.89 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 176.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.714 HG22 ' O ' ' A' ' 51' ' ' GLN . 3.7 m -68.57 -45.08 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.099 0 CA-C-N 114.398 -1.274 . . . . 0.0 107.885 176.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -67.09 -32.33 73.42 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.939 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.56 -34.22 77.32 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.179 0.514 . . . . 0.0 110.29 177.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.4 tp -84.01 -39.13 20.05 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.605 178.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 54' ' ' VAL . 55.6 t -55.44 -45.56 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.033 0.533 . . . . 0.0 112.029 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.19 -15.71 63.38 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.541 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -100.9 -22.16 14.89 Favored 'General case' 0 C--O 1.2 -1.521 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.27 -38.24 17.76 Favored 'General case' 0 N--CA 1.421 -1.919 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.873 -177.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -72.13 -10.02 59.22 Favored 'General case' 0 C--N 1.317 -0.82 0 O-C-N 122.073 -0.392 . . . . 0.0 110.723 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.541 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 19.1 pttp -99.25 0.39 43.07 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.537 ' HB ' ' O ' ' A' ' 71' ' ' VAL . 23.1 mm -77.26 83.82 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -140.23 -56.55 0.54 Allowed 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 114.609 -1.178 . . . . 0.0 108.88 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.7 m -90.07 15.11 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.824 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.477 ' HG3' HD13 ' A' ' 64' ' ' ILE . 9.1 mm-40 -98.87 15.37 25.75 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.872 -176.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.43 -68.76 0.29 Allowed Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 22.5 t -117.85 163.6 14.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.564 ' O ' ' HA ' ' A' ' 41' ' ' GLU . 53.9 mtp180 -98.23 113.95 26.05 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.537 ' O ' ' HB ' ' A' ' 64' ' ' ILE . 46.9 t -126.76 124.86 65.84 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 178.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -130.23 155.26 46.56 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-O 121.457 0.646 . . . . 0.0 111.231 -173.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.4 pp -94.74 148.64 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.499 176.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 76.5 mt -113.5 -30.5 2.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-O 121.478 0.656 . . . . 0.0 110.582 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -151.29 133.4 15.2 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.337 -172.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -134.96 129.49 34.3 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -151.46 159.86 43.99 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 120.53 0.205 . . . . 0.0 110.547 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.4 ' HB ' ' HA ' ' A' ' 51' ' ' GLN . 6.2 p -94.08 98.61 8.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-O 121.887 0.851 . . . . 0.0 108.803 176.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' A' ' 47' ' ' LYS . . . -176.92 175.45 47.66 Favored Glycine 0 N--CA 1.414 -2.779 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.59 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -98.41 -170.56 1.97 Allowed 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 174.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.569 HG21 HG21 ' A' ' 118' ' ' ILE . 3.7 mp -84.99 119.04 33.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 C-N-CA 119.725 -0.79 . . . . 0.0 111.374 -176.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.0 p -121.65 162.0 21.48 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.018 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.539 ' CD ' ' H ' ' A' ' 83' ' ' GLU . 2.3 mp0 -53.89 -43.82 69.98 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 124.759 1.223 . . . . 0.0 111.655 -178.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.9 t -68.72 -27.06 65.6 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.28 0.562 . . . . 0.0 110.544 -176.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -74.7 -44.26 50.93 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.326 178.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.584 HG21 ' HA ' ' A' ' 111' ' ' ALA . 56.9 mt -60.2 -27.75 40.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.448 177.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.0 t -61.07 -21.58 63.8 Favored 'General case' 0 CA--C 1.563 1.45 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.779 177.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -82.46 -37.35 25.52 Favored 'General case' 0 C--O 1.245 0.863 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 174.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.68 -60.31 3.48 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.555 -176.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.563 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 8.6 t -70.45 -22.2 62.72 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.677 178.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.6 -60.69 2.34 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 20.0 m -97.86 5.23 49.28 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.115 0.484 . . . . 0.0 110.787 -178.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 66.64 37.52 4.36 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.189 0.996 . . . . 0.0 111.203 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.502 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -94.86 139.39 31.37 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 114.363 -1.29 . . . . 0.0 108.591 178.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 49.4 mm -94.86 142.23 13.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.623 ' HB ' HG22 ' A' ' 118' ' ' ILE . 36.2 t -94.2 117.29 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.625 0 CA-C-O 121.276 0.56 . . . . 0.0 110.843 -175.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.49 130.92 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.016 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 176.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -136.01 175.38 20.9 Favored Glycine 0 N--CA 1.423 -2.197 0 N-CA-C 108.846 -1.701 . . . . 0.0 108.846 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . 0.288 21.8 p90 -141.66 107.28 5.08 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 119.084 -1.047 . . . . 0.0 113.294 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.2 t30 67.15 9.17 6.73 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 126.069 1.748 . . . . 0.0 111.373 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.495 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 4.9 m -84.12 -48.69 16.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.824 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.59 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 9.1 mtm180 73.07 163.75 0.14 Allowed Pre-proline 0 N--CA 1.485 1.307 0 C-N-CA 124.165 0.986 . . . . 0.0 111.251 176.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -95.25 168.61 1.47 Allowed 'Trans proline' 0 N--CA 1.437 -1.811 0 C-N-CA 121.901 1.734 . . . . 0.0 113.342 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -79.2 161.2 26.56 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 170.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.423 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -63.09 -24.3 67.84 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 122.713 0.405 . . . . 0.0 111.47 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.634 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 68.8 m-20 -85.68 -38.2 18.59 Favored 'General case' 0 C--O 1.206 -1.214 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 176.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.04 -41.51 99.52 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.86 0.362 . . . . 0.0 111.451 -178.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -59.87 -22.06 61.83 Favored 'General case' 0 CA--C 1.559 1.293 0 CA-C-O 121.111 0.481 . . . . 0.0 111.075 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.634 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 38.1 mtm105 -88.46 -51.78 5.54 Favored 'General case' 0 N--CA 1.38 -3.975 0 C-N-CA 125.523 1.529 . . . . 0.0 109.227 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -51.9 -47.01 64.77 Favored 'General case' 0 C--O 1.201 -1.474 0 C-N-CA 125.032 1.333 . . . . 0.0 111.171 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.584 ' HA ' HG21 ' A' ' 86' ' ' ILE . . . -49.42 -43.37 44.58 Favored 'General case' 0 CA--C 1.494 -1.187 0 O-C-N 124.279 0.987 . . . . 0.0 111.078 -179.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -82.89 -23.96 33.36 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-N 114.839 -1.073 . . . . 0.0 113.137 -173.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 38.6 t -89.07 5.89 42.37 Favored 'General case' 0 C--N 1.277 -2.565 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 175.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.563 ' O ' ' HB ' ' A' ' 90' ' ' THR . 23.7 mt-10 -125.27 15.62 8.36 Favored 'General case' 0 N--CA 1.408 -2.533 0 CA-C-N 113.953 -1.476 . . . . 0.0 112.437 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 56.2 mtpt 66.14 3.31 2.64 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 172.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.8 m -114.21 169.03 5.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 121.945 -0.472 . . . . 0.0 111.69 -176.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -130.77 137.71 49.6 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.623 HG22 ' HB ' ' A' ' 96' ' ' VAL . 10.4 pt -107.86 127.35 64.01 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.163 -178.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -129.18 136.96 50.85 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.492 -0.883 . . . . 0.0 113.24 -175.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.8 156.37 37.57 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.341 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.4 ' O ' HG12 ' A' ' 123' ' ' ILE . 57.5 t-80 68.4 -93.51 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 O-C-N 124.473 1.108 . . . . 0.0 111.867 170.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 46.12 -107.82 0.16 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.976 0.91 . . . . 0.0 112.614 -173.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 121' ' ' HIS . 47.5 mm 57.98 -79.9 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.857 1.263 . . . . 0.0 111.189 -177.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 10.0 pt -105.22 16.89 5.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-O 121.922 0.867 . . . . 0.0 108.799 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 68.17 -81.14 0.03 OUTLIER 'General case' 0 C--O 1.238 0.483 0 C-N-CA 126.289 1.836 . . . . 0.0 111.253 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -165.98 101.35 0.65 Allowed 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 19.0 m -81.79 142.36 13.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 39.3 mm -70.55 -49.23 54.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.271 -173.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 66.76 -66.36 0.19 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 125.228 1.411 . . . . 0.0 111.627 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -75.57 126.29 30.72 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 124.435 1.094 . . . . 0.0 109.92 -176.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 72.2 mt -82.54 102.57 8.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 175.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -78.73 137.45 37.78 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.633 -176.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 57.15 79.47 0.19 Allowed 'General case' 0 C--O 1.243 0.742 0 C-N-CA 125.393 1.477 . . . . 0.0 113.994 176.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.25 -59.03 1.87 Allowed 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 26.2 mmt . . . . . 0 CA--C 1.495 -1.172 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 176.063 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 . . . . . 0 CA--C 1.497 -1.092 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -81.41 85.1 6.51 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 177.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -97.44 161.28 13.86 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.299 -177.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 64.09 82.42 0.18 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.462 1.105 . . . . 0.0 111.299 -177.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 89.5 mt -93.14 -24.08 18.37 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.721 -176.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.69 55.55 3.79 Favored Glycine 0 C--N 1.314 -0.686 0 C-N-CA 120.792 -0.718 . . . . 0.0 113.757 -176.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.7 p -79.42 -32.28 42.82 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.302 0.572 . . . . 0.0 110.945 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -119.38 -52.65 2.26 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 174.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.38 110.07 0.34 Allowed Glycine 0 N--CA 1.426 -2.01 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 21.7 t -79.48 -40.05 30.69 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.2 m -71.98 -7.1 46.73 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-O 121.105 0.479 . . . . 0.0 111.64 -178.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.1 tpm_? -73.55 -22.44 60.08 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.251 0.548 . . . . 0.0 109.553 175.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.9 t -124.08 -61.73 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.434 -176.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -105.52 86.54 2.43 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.671 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.1 pp -96.21 -22.94 16.95 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.518 0.675 . . . . 0.0 110.006 177.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.478 ' OE1' ' HA ' ' A' ' 16' ' ' GLN . 8.0 mm-40 -133.97 153.98 51.41 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.359 176.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -121.0 -178.69 3.81 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.515 -175.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 67.87 15.23 9.56 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.016 0.926 . . . . 0.0 112.274 172.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -71.16 -40.07 71.51 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 174.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.9 m -112.48 97.33 6.53 Favored 'General case' 0 N--CA 1.414 -2.234 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 174.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.5 p -112.43 97.86 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.026 0 CA-C-O 122.251 1.024 . . . . 0.0 112.522 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -146.35 -63.62 0.31 Allowed 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 173.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 20.2 p -118.91 78.28 1.26 Allowed 'General case' 0 N--CA 1.416 -2.142 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.515 176.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -117.73 154.37 31.81 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.253 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.2 m -96.59 168.38 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 O-C-N 123.421 0.45 . . . . 0.0 109.869 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.5 t 70.61 7.88 6.38 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.123 1.369 . . . . 0.0 111.138 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 60.4 tp -101.95 104.79 15.5 Favored 'General case' 0 N--CA 1.427 -1.625 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 176.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -111.04 179.63 3.99 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -178.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -144.42 -3.22 0.83 Allowed 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 118.027 0.376 . . . . 0.0 111.379 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 64.9 tp -79.18 96.3 5.84 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-O 120.635 0.255 . . . . 0.0 110.849 -178.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 25.7 t80 51.34 52.97 13.71 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.109 1.364 . . . . 0.0 110.356 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.35 121.1 24.71 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -85.46 94.73 9.07 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -171.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.8 pt -91.61 -17.88 7.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 114.517 -1.219 . . . . 0.0 110.105 176.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -125.06 91.37 3.42 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 121.481 0.657 . . . . 0.0 109.46 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -168.85 142.27 2.92 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 -177.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.18 36.78 6.95 Favored Glycine 0 N--CA 1.438 -1.172 0 C-N-CA 120.242 -0.98 . . . . 0.0 110.955 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -106.08 27.55 8.5 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 123.329 1.537 . . . . 0.0 108.651 -176.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.415 ' CE ' ' HA ' ' A' ' 39' ' ' MET . 1.4 mmt -165.26 -173.58 2.9 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 103.013 -2.958 . . . . 0.0 103.013 174.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -80.94 79.87 7.53 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.875 174.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 70' ' ' ARG . 31.0 mt-10 -104.74 104.29 14.06 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.454 -176.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.19 120.97 36.33 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -99.33 128.42 45.44 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -174.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 70.9 mt -131.25 165.61 23.01 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.535 HD13 ' CD2' ' A' ' 75' ' ' HIS . 0.2 OUTLIER -131.65 136.83 56.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-N 112.817 -1.992 . . . . 0.0 107.26 175.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.601 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 92.1 t -117.31 128.18 74.67 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 176.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.57 ' HE3' ' CG ' ' A' ' 85' ' ' ASP . 12.8 ptmm? -159.43 128.06 5.14 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.44 176.28 9.49 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.894 -171.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -74.68 -32.0 62.08 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 123.948 0.78 . . . . 0.0 109.412 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 86.3 t -94.71 122.04 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.137 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.745 ' O ' HG22 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -61.48 -47.84 83.82 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 124.347 1.059 . . . . 0.0 112.595 -174.776 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.87 5.01 84.06 Favored Glycine 0 C--N 1.278 -2.684 0 C-N-CA 118.049 -2.024 . . . . 0.0 113.003 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.0 t -83.36 -29.09 28.5 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.745 HG22 ' O ' ' A' ' 51' ' ' GLN . 6.0 m -70.87 -45.87 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.397 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.653 176.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -60.24 -40.44 90.24 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.178 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.66 -39.97 95.57 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 123.574 0.546 . . . . 0.0 110.825 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 38.3 tp -75.46 -39.34 58.83 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.177 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 54' ' ' VAL . 54.6 t -57.11 -37.99 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.128 0.571 . . . . 0.0 111.44 178.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.415 ' HA ' ' NE2' ' A' ' 62' ' ' GLN . . . -69.4 -19.14 63.81 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.452 ' O ' HG12 ' A' ' 64' ' ' ILE . . . -98.03 -30.23 12.81 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.441 ' HA ' HG12 ' A' ' 64' ' ' ILE . 0.2 OUTLIER -74.17 -36.15 64.05 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.615 -175.083 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.415 ' NE2' ' HA ' ' A' ' 59' ' ' ALA . 10.8 pt20 -68.89 -21.23 64.25 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.134 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -99.85 6.73 45.3 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 60' ' ' ALA . 34.9 mm -73.17 0.22 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.751 0 CA-C-O 122.371 1.081 . . . . 0.0 110.618 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -65.2 119.0 10.07 Favored 'General case' 0 C--O 1.247 0.924 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.033 175.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.0 m -128.41 -166.58 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 177.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -80.28 114.23 19.03 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 118.067 0.394 . . . . 0.0 110.026 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 94.23 -43.61 2.37 Favored Glycine 0 C--O 1.243 0.7 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.685 177.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.9 t -106.4 132.62 53.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.483 ' O ' ' HA ' ' A' ' 41' ' ' GLU . 21.2 ptt180 -142.44 111.34 6.34 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-O 122.118 0.961 . . . . 0.0 110.786 176.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.7 t -103.62 131.67 51.68 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -149.43 158.17 43.94 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.141 0.496 . . . . 0.0 110.241 -178.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.445 HG12 HG13 ' A' ' 58' ' ' VAL . 1.5 pp -94.54 144.17 10.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.073 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.401 ' N ' HD12 ' A' ' 74' ' ' ILE . 3.5 mp -112.69 -22.73 4.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-O 122.058 0.933 . . . . 0.0 109.438 177.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.535 ' CD2' HD13 ' A' ' 45' ' ' ILE . 2.0 t60 -148.13 139.05 23.17 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -172.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.601 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -140.33 136.69 33.46 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 177.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -163.2 156.93 19.83 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 118.608 0.64 . . . . 0.0 111.426 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.3 p -101.04 94.42 3.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-O 121.774 0.797 . . . . 0.0 109.273 175.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -177.02 173.31 46.2 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 119.365 -1.398 . . . . 0.0 113.304 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.476 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -81.58 170.02 16.36 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 124.159 0.984 . . . . 0.0 108.856 176.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.43 HD13 HD11 ' A' ' 120' ' ' LEU . 1.8 mp -72.82 118.21 17.62 Favored 'Isoleucine or valine' 0 C--O 1.245 0.816 0 CA-C-N 118.505 0.593 . . . . 0.0 110.363 -177.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 70.7 p -118.7 158.58 25.26 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -50.19 -34.22 21.91 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.23 0.612 . . . . 0.0 112.089 176.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.9 m -62.2 -40.28 95.55 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.127 0.489 . . . . 0.0 110.43 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.57 ' CG ' ' HE3' ' A' ' 47' ' ' LYS . 46.5 m-20 -71.88 -38.96 69.91 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.321 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.6 HD13 ' HB2' ' A' ' 111' ' ' ALA . 58.8 mt -67.2 -29.75 46.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.977 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 27.8 m -58.08 -35.17 71.0 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.194 174.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -72.44 -34.37 67.73 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.149 177.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.414 ' HB3' HG21 ' A' ' 116' ' ' VAL . . . -55.09 -61.96 1.97 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.028 -176.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.573 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 9.2 t -69.5 -21.31 63.69 Favored 'General case' 0 CA--C 1.568 1.655 0 O-C-N 121.583 -0.698 . . . . 0.0 111.054 177.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.89 -52.62 34.38 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 54.1 m -98.78 -2.87 36.93 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.721 178.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.1 m120 68.65 37.32 2.53 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 122.36 1.076 . . . . 0.0 109.376 -176.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.99 155.93 16.53 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 113.99 -1.459 . . . . 0.0 108.401 178.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 117' ' ' ASP . 46.2 mm -111.67 135.06 52.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.662 ' HB ' HG22 ' A' ' 118' ' ' ILE . 19.4 t -93.59 123.62 45.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.218 0.532 . . . . 0.0 109.834 -174.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 35.6 pt -104.55 157.63 5.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.65 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -171.66 172.93 44.88 Favored Glycine 0 N--CA 1.419 -2.449 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 175.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -161.54 133.38 5.63 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 73.28 -41.08 0.49 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.26 1.424 . . . . 0.0 111.872 177.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.6 m -65.59 -51.17 66.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 C-N-CA 124.339 1.055 . . . . 0.0 111.631 176.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.476 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 35.4 mtm180 66.72 178.97 0.05 OUTLIER Pre-proline 0 CA--C 1.566 1.576 0 C-N-CA 123.364 0.666 . . . . 0.0 112.051 174.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.452 ' HG3' HD12 ' A' ' 118' ' ' ILE . 21.6 Cg_endo -99.48 176.21 0.35 Allowed 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 122.327 2.018 . . . . 0.0 113.865 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -82.16 156.94 24.21 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 168.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.545 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -61.82 -31.18 71.39 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 120.849 0.357 . . . . 0.0 110.489 178.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.579 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 5.4 m-20 -77.8 -36.31 50.44 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.269 175.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.09 -44.06 97.48 Favored 'General case' 0 C--O 1.211 -0.948 0 O-C-N 121.981 -0.45 . . . . 0.0 111.27 176.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.53 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 14.4 ptmm? -59.83 -29.21 68.1 Favored 'General case' 0 CA--C 1.563 1.445 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.579 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 95.4 mtt180 -73.03 -51.37 18.44 Favored 'General case' 0 N--CA 1.395 -3.179 0 C-N-CA 124.643 1.177 . . . . 0.0 108.997 176.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -52.86 -49.03 66.63 Favored 'General case' 0 C--O 1.194 -1.852 0 CA-C-N 113.7 -1.591 . . . . 0.0 110.226 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.6 ' HB2' HD13 ' A' ' 86' ' ' ILE . . . -47.99 -50.76 26.4 Favored 'General case' 0 CA--C 1.483 -1.613 0 O-C-N 124.717 1.26 . . . . 0.0 111.2 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -81.24 -24.77 37.12 Favored 'General case' 0 C--N 1.27 -2.873 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.915 -172.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 38.3 t -87.66 5.45 39.58 Favored 'General case' 0 C--N 1.275 -2.646 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 175.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.573 ' O ' ' HB ' ' A' ' 90' ' ' THR . 24.7 mt-10 -123.35 19.43 9.75 Favored 'General case' 0 CA--C 1.466 -2.255 0 CA-C-N 114.411 -1.268 . . . . 0.0 111.572 177.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 65.6 mttm 67.0 4.63 3.65 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 173.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.414 HG21 ' HB3' ' A' ' 89' ' ' ALA . 5.4 m -113.98 163.94 10.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 121.683 -0.635 . . . . 0.0 112.106 -175.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.41 ' O ' HG23 ' A' ' 95' ' ' ILE . 4.0 m-20 -125.89 142.96 51.27 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 177.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.662 HG22 ' HB ' ' A' ' 96' ' ' VAL . 4.8 pt -105.05 138.74 28.56 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.914 178.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -104.64 112.83 26.06 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.519 -175.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.43 HD11 HD13 ' A' ' 81' ' ' ILE . 3.1 mm? -110.59 134.68 52.19 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.475 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 66.31 75.23 0.33 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.685 174.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 29.0 mmm180 -103.04 10.03 38.27 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.733 -178.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 39.1 pt -110.33 147.92 14.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.704 HD13 ' H ' ' A' ' 124' ' ' ILE . 0.2 OUTLIER -83.67 97.5 4.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-O 122.2 1.0 . . . . 0.0 109.932 175.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -88.06 74.24 8.91 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.791 0.805 . . . . 0.0 110.435 -175.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -141.8 29.93 1.69 Allowed 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.127 177.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 97.9 t 74.17 103.72 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.766 -175.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 27.8 pt -88.11 -1.14 8.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.562 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -80.82 -9.21 59.84 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.061 175.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -82.96 124.91 30.83 Favored 'General case' 0 N--CA 1.416 -2.152 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.655 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.439 ' HB ' ' O ' ' A' ' 134' ' ' ALA . 37.2 pt -81.53 -24.85 10.02 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 69.3 -77.44 0.05 Allowed 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 125.677 1.591 . . . . 0.0 111.548 176.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -144.92 13.7 1.48 Allowed 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.507 0.67 . . . . 0.0 109.92 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.439 ' O ' ' HB ' ' A' ' 131' ' ' ILE . . . -113.4 123.24 49.61 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.211 -176.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 49.0 tpp . . . . . 0 C--N 1.297 -1.678 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 176.451 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 61.4 m-20 . . . . . 0 CA--C 1.507 -0.674 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 62.58 87.55 0.1 Allowed 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.344 1.058 . . . . 0.0 112.48 177.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -98.17 168.56 10.17 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.889 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -60.01 146.46 42.63 Favored 'General case' 0 C--O 1.246 0.911 0 C-N-CA 123.388 0.675 . . . . 0.0 110.168 177.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.3 mt -86.86 -35.21 19.15 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.674 -176.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 178.41 104.25 0.18 Allowed Glycine 0 N--CA 1.428 -1.853 0 C-N-CA 118.663 -1.732 . . . . 0.0 114.773 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.7 m -95.75 97.11 9.44 Favored 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 171.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -70.7 -14.54 62.49 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -172.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 146.73 -72.73 0.31 Allowed Glycine 0 CA--C 1.503 -0.71 0 C-N-CA 118.186 -1.959 . . . . 0.0 114.679 173.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.8 m -62.43 141.15 58.5 Favored 'General case' 0 C--O 1.249 1.059 0 CA-C-O 120.509 0.195 . . . . 0.0 111.29 -176.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.2 m 77.7 -60.11 0.44 Allowed 'General case' 0 C--O 1.249 1.046 0 C-N-CA 125.51 1.524 . . . . 0.0 109.53 -177.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.403 ' HG2' HG13 ' A' ' 13' ' ' VAL . 73.4 ttt180 59.28 -69.22 0.03 OUTLIER 'General case' 0 C--N 1.344 0.348 0 C-N-CA 127.256 2.222 . . . . 0.0 113.192 176.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.403 HG13 ' HG2' ' A' ' 12' ' ' ARG . 14.6 m -121.26 -13.99 7.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.54 -176.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -124.34 107.65 11.37 Favored 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -91.28 103.23 15.91 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -117.8 81.4 1.66 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 122.268 1.032 . . . . 0.0 109.351 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -98.7 30.44 3.3 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.272 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -80.06 76.07 6.8 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 176.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -87.39 -35.97 18.03 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.118 0.485 . . . . 0.0 110.293 -175.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.9 p -88.8 2.24 53.87 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.419 176.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . 0.306 27.6 m 45.86 51.67 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.725 0 C-N-CA 125.948 1.699 . . . . 0.0 113.235 -177.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.8 tppt? -116.1 158.09 23.73 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.3 p 55.56 18.2 2.63 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 125.326 1.45 . . . . 0.0 113.542 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.416 ' HD2' ' C ' ' A' ' 24' ' ' ARG . 3.1 ppt_? -110.2 6.55 22.74 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.936 -174.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.6 m -79.22 165.09 3.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.015 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.3 t -142.82 -65.56 0.39 Allowed 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.194 -177.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.6 mt -123.47 109.81 14.31 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 120.999 0.428 . . . . 0.0 110.619 -177.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -75.18 -19.91 59.59 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.301 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.8 t70 65.46 -162.64 0.26 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.975 1.71 . . . . 0.0 110.524 176.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 87.2 mt 60.15 37.26 20.9 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.621 1.169 . . . . 0.0 110.469 -178.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -81.6 -41.61 21.27 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.207 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -99.79 153.95 18.72 Favored 'General case' 0 C--O 1.247 0.943 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.009 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -99.74 119.94 38.93 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.0 pt -85.72 158.51 3.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.551 -178.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.2 ptpp? -71.98 116.17 12.07 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.446 175.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -124.64 -48.8 1.78 Allowed 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -177.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.79 47.47 3.72 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.275 -178.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -107.31 -166.4 1.15 Allowed 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 69.24 27.23 5.21 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.938 1.295 . . . . 0.0 108.32 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -77.93 149.28 34.21 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.471 ' HG2' ' HB2' ' A' ' 70' ' ' ARG . 29.8 mt-10 -93.81 149.17 21.46 Favored 'General case' 0 C--N 1.283 -2.293 0 CA-C-O 121.488 0.661 . . . . 0.0 112.072 -169.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -103.29 104.5 14.63 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 114.484 -1.234 . . . . 0.0 108.095 176.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.432 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 92.0 m-20 -99.69 136.15 40.05 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.3 mt -134.42 164.91 26.39 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 122.304 1.05 . . . . 0.0 113.51 -176.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.631 HD13 ' CD2' ' A' ' 75' ' ' HIS . 0.2 OUTLIER -123.01 139.79 48.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.356 175.63 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 66.4 t -112.23 130.02 66.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.342 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -136.93 144.4 43.41 Favored 'General case' 0 CA--C 1.492 -1.277 0 C-N-CA 123.926 0.89 . . . . 0.0 109.951 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.18 165.1 29.95 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 177.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -84.97 -17.08 38.76 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 120.924 0.392 . . . . 0.0 110.699 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 87.3 t -101.69 127.09 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 173.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.719 ' O ' HG22 ' A' ' 54' ' ' VAL . 49.7 tt0 -61.41 -51.69 67.72 Favored 'General case' 0 C--O 1.196 -1.725 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -173.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.51 0.94 53.78 Favored Glycine 0 C--N 1.28 -2.539 0 C-N-CA 118.205 -1.95 . . . . 0.0 113.724 -175.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.4 t -82.88 -24.98 32.95 Favored 'General case' 0 N--CA 1.417 -2.081 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 177.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.719 HG22 ' O ' ' A' ' 51' ' ' GLN . 5.2 m -77.37 -46.45 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.256 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.355 176.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -66.12 -38.61 88.62 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.442 -176.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.85 -38.23 87.44 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.926 0.393 . . . . 0.0 110.548 177.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.479 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 34.9 tp -73.85 -42.25 61.08 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.48 HG21 ' HB2' ' A' ' 76' ' ' ALA . 53.5 t -57.0 -41.12 76.77 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 C-N-CA 123.16 0.584 . . . . 0.0 111.335 177.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.05 -24.21 67.62 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.38 -20.35 17.2 Favored 'General case' 0 C--O 1.207 -1.173 0 CA-C-O 121.511 0.672 . . . . 0.0 109.39 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -90.75 -28.1 18.5 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.073 -175.4 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -77.94 -24.06 48.36 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 122.157 -0.34 . . . . 0.0 110.409 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -87.28 2.17 50.98 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.123 -178.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 29.3 mm -81.52 107.04 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 173.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -143.59 119.51 10.62 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.272 -178.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 46.3 t 53.49 92.72 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 C-N-CA 125.195 1.398 . . . . 0.0 114.218 175.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -124.25 21.08 8.84 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 122.63 1.205 . . . . 0.0 107.904 173.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.72 -25.91 26.16 Favored Glycine 0 C--O 1.224 -0.483 0 N-CA-C 107.721 -2.152 . . . . 0.0 107.721 -171.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 41.3 t -121.05 153.92 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.617 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 175.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.471 ' HB2' ' HG2' ' A' ' 41' ' ' GLU . 58.0 mtt-85 -120.93 117.7 28.0 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 178.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 32.8 t -130.3 136.28 58.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.8 ttmp? -167.59 162.71 14.37 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.41 HG13 ' HB3' ' A' ' 61' ' ' LEU . 1.5 pp -93.69 150.5 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.606 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.42 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 37.2 mm -115.28 -28.93 2.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 CA-C-O 121.365 0.602 . . . . 0.0 109.666 178.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.631 ' CD2' HD13 ' A' ' 45' ' ' ILE . 3.8 t60 -149.39 140.4 22.92 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -171.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.48 ' HB2' HG21 ' A' ' 58' ' ' VAL . . . -136.67 135.15 38.0 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 177.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -158.54 141.55 14.72 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.652 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.476 ' HB ' ' HA ' ' A' ' 51' ' ' GLN . 4.5 p -93.86 93.98 4.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-O 122.793 1.282 . . . . 0.0 108.822 175.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.89 175.08 47.51 Favored Glycine 0 N--CA 1.409 -3.103 0 CA-C-N 113.855 -1.521 . . . . 0.0 109.554 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.555 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -83.07 -176.93 6.58 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 177.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.531 HG21 HG21 ' A' ' 118' ' ' ILE . 3.3 mp -78.56 110.91 14.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.512 HG22 ' OD2' ' A' ' 85' ' ' ASP . 14.0 t -113.56 165.56 12.38 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 119.576 -0.849 . . . . 0.0 109.374 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -56.92 -35.06 68.59 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.614 0.765 . . . . 0.0 111.182 -176.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.4 m -67.13 -28.54 68.23 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.523 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.512 ' OD2' HG22 ' A' ' 82' ' ' THR . 17.4 m-20 -77.37 -28.53 52.95 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-O 121.175 0.512 . . . . 0.0 110.408 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.518 ' CG2' ' HA ' ' A' ' 111' ' ' ALA . 46.0 mm -65.54 -33.15 61.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.111 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.9 m -57.01 -39.54 74.93 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.364 177.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -73.94 -39.03 64.06 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.981 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.23 -55.29 22.13 Favored 'General case' 0 C--N 1.316 -0.887 0 O-C-N 123.926 0.766 . . . . 0.0 111.877 -177.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.454 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 10.9 t -77.48 -19.01 56.58 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.419 178.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.79 -66.24 0.58 Allowed 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.057 0.456 . . . . 0.0 111.685 -177.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.6 m -95.41 2.06 54.41 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.409 -177.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.441 HD22 ' HA ' ' A' ' 93' ' ' ASN . 10.5 m120 62.43 62.92 1.08 Allowed 'General case' 0 CA--C 1.497 -1.079 0 CA-C-O 122.366 1.079 . . . . 0.0 112.332 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -120.24 134.56 55.23 Favored 'General case' 0 N--CA 1.417 -2.092 0 CA-C-N 113.244 -1.798 . . . . 0.0 107.179 176.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 32.2 pt -94.13 141.92 14.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.525 ' HB ' HG22 ' A' ' 118' ' ' ILE . 12.1 t -94.16 116.6 35.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-O 121.192 0.52 . . . . 0.0 110.149 -173.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 119' ' ' ARG . 58.0 mt -112.78 125.71 70.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 120' ' ' LEU . . . -132.24 170.25 21.9 Favored Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -145.42 117.68 8.42 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 72.72 -29.34 0.2 Allowed 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 124.78 1.232 . . . . 0.0 113.099 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.485 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 4.6 m -66.34 -48.11 81.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.563 176.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.555 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 59.8 mtm180 66.94 179.37 0.05 OUTLIER Pre-proline 0 CA--C 1.551 1.015 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.878 174.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.452 ' HG3' HD12 ' A' ' 118' ' ' ILE . 9.5 Cg_endo -98.84 168.72 0.58 Allowed 'Trans proline' 0 N--CA 1.44 -1.663 0 CA-C-N 120.838 1.335 . . . . 0.0 114.568 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -79.48 152.19 30.38 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 113.005 -1.907 . . . . 0.0 106.448 167.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.432 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -61.62 -21.07 64.05 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -176.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.534 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 54.9 t30 -94.47 -28.28 15.55 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.945 -0.702 . . . . 0.0 109.747 177.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.72 -40.8 95.95 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-O 120.965 0.412 . . . . 0.0 110.557 177.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 21.9 ptmt -61.72 -28.5 69.46 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.07 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.534 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 70.7 mtp180 -81.01 -53.09 6.72 Favored 'General case' 0 N--CA 1.385 -3.689 0 C-N-CA 125.918 1.687 . . . . 0.0 109.097 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -52.79 -45.26 67.11 Favored 'General case' 0 C--O 1.196 -1.73 0 CA-C-N 113.85 -1.523 . . . . 0.0 110.457 -178.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.518 ' HA ' ' CG2' ' A' ' 86' ' ' ILE . . . -48.58 -49.28 37.38 Favored 'General case' 0 CA--C 1.49 -1.355 0 O-C-N 124.524 1.14 . . . . 0.0 111.381 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -77.25 -35.2 55.53 Favored 'General case' 0 C--N 1.281 -2.399 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.539 -174.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 35.5 t -79.56 5.47 12.94 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-O 122.374 1.083 . . . . 0.0 108.979 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.454 ' O ' ' HB ' ' A' ' 90' ' ' THR . 19.3 mt-10 -123.75 14.54 9.36 Favored 'General case' 0 CA--C 1.46 -2.504 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.845 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 64.4 mmtt 65.85 17.94 10.98 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 173.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.0 m -120.73 171.41 9.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.362 177.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -137.15 142.35 42.22 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.531 HG21 HG21 ' A' ' 81' ' ' ILE . 10.3 pt -107.97 134.52 49.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 121.32 0.581 . . . . 0.0 111.044 -178.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.507 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 21.5 mmm180 -113.3 125.04 53.85 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -178.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.564 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 0.0 OUTLIER -147.7 136.65 22.1 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -178.331 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 42.3 t-80 67.25 3.99 3.49 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.506 1.123 . . . . 0.0 112.073 173.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 38.3 mtm-85 63.15 -66.4 0.1 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.862 1.665 . . . . 0.0 110.913 -175.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 65.4 mt -88.92 123.89 41.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 9.3 tp -88.69 153.59 3.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 176.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -79.06 72.63 5.6 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 122.221 1.01 . . . . 0.0 110.892 -178.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -96.27 -52.57 3.94 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.249 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 59.6 t -75.92 107.22 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.737 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 14.4 tt -111.79 7.11 8.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.318 -0.994 . . . . 0.0 108.318 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -61.82 110.9 1.67 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.148 -176.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -163.47 -55.83 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.273 0.559 . . . . 0.0 109.886 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.15 87.25 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.286 0 CA-C-O 122.983 1.373 . . . . 0.0 108.569 -176.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -96.81 14.41 25.29 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.236 -1.347 . . . . 0.0 110.101 -175.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -111.35 -167.05 1.13 Allowed 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.601 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 62.48 -161.96 0.29 Allowed 'General case' 0 C--O 1.247 0.93 0 C-N-CA 123.871 0.868 . . . . 0.0 111.266 176.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 23.0 ptt? . . . . . 0 C--N 1.298 -1.659 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.948 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 63.9 t30 . . . . . 0 C--O 1.235 0.317 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -63.91 99.99 0.28 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 58.79 -161.92 0.24 Allowed 'General case' 0 C--O 1.245 0.861 0 O-C-N 124.419 1.074 . . . . 0.0 111.516 173.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -89.92 171.8 9.33 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 91.2 mt -75.27 -59.56 2.69 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.534 -176.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -167.38 55.3 0.23 Allowed Glycine 0 N--CA 1.434 -1.452 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.516 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.9 p -72.41 97.88 2.14 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 122.618 0.367 . . . . 0.0 110.745 -178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -145.81 -163.77 1.81 Allowed 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 121.051 -0.259 . . . . 0.0 110.31 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.54 -119.94 5.44 Favored Glycine 0 N--CA 1.427 -1.935 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -178.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.2 m -58.91 -26.04 63.96 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 124.398 1.079 . . . . 0.0 111.759 -176.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.1 m -63.94 -19.74 65.34 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.714 0.806 . . . . 0.0 112.389 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -125.48 -20.0 4.87 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 119.484 -0.887 . . . . 0.0 112.794 -178.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.7 m -106.46 152.21 8.16 Favored 'Isoleucine or valine' 0 C--O 1.247 0.964 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.772 -178.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.0 t70 69.93 89.2 0.1 Allowed 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 124.522 1.139 . . . . 0.0 110.056 -178.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.1 mt -90.46 156.13 18.42 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.502 -176.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -93.84 -23.63 18.06 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.755 -175.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.434 ' HA ' ' HD2' ' A' ' 24' ' ' ARG . 3.6 mm-40 -62.57 174.96 0.87 Allowed 'General case' 0 C--O 1.212 -0.89 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -176.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -69.82 -1.33 9.06 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.432 0.693 . . . . 0.0 112.345 -176.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -66.65 -31.51 72.23 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 171.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.3 m -151.97 93.1 1.8 Allowed 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 174.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.6 m -58.71 89.34 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -173.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -89.06 -63.57 1.27 Allowed 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.477 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.3 t -131.22 73.2 1.53 Allowed 'General case' 0 N--CA 1.411 -2.413 0 CA-C-O 122.716 1.246 . . . . 0.0 108.171 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.456 ' HA ' ' NE ' ' A' ' 24' ' ' ARG . 3.7 mmp_? -127.39 162.53 26.1 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.195 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.3 t -106.55 122.87 61.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.0 t -109.17 115.43 30.0 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.8 mt -103.85 82.45 1.99 Allowed 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.307 -177.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -97.06 -31.74 12.34 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 174.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -95.57 148.69 22.25 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.372 -1.286 . . . . 0.0 108.589 177.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.7 mp -106.66 141.25 38.23 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.599 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -81.4 115.8 20.92 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 175.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -66.1 103.77 1.03 Allowed 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.761 0.791 . . . . 0.0 109.509 177.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.474 ' OE1' ' HA ' ' A' ' 35' ' ' LYS . 34.3 tt0 -60.62 -34.21 73.92 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 125.812 1.645 . . . . 0.0 112.945 -174.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 59.5 mt 71.57 79.61 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.504 -0.814 0 N-CA-C 103.998 -2.593 . . . . 0.0 103.998 -163.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.474 ' HA ' ' OE1' ' A' ' 33' ' ' GLN 0.293 19.8 pttm -47.31 85.28 0.0 OUTLIER 'General case' 0 C--O 1.239 0.532 0 N-CA-C 116.543 2.053 . . . . 0.0 116.543 -171.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 48.1 tp60 172.7 73.64 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 129.099 2.96 . . . . 0.0 104.55 175.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -110.64 81.9 0.29 Allowed Glycine 0 N--CA 1.419 -2.467 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.384 -177.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 74.54 -69.89 0.17 Allowed 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.262 1.025 . . . . 0.0 111.984 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 50.8 ttm 73.65 -43.3 0.54 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.455 1.502 . . . . 0.0 110.639 -178.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -84.54 86.73 7.26 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 171.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -144.23 171.65 14.01 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 114.517 -1.22 . . . . 0.0 108.599 -174.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -98.57 137.47 37.18 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-O 121.088 0.471 . . . . 0.0 109.853 -176.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.78 ' HB3' HD11 ' A' ' 74' ' ' ILE . 36.5 m-80 -130.69 140.02 50.34 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.206 177.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.8 mt -134.27 163.6 29.26 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.66 0.743 . . . . 0.0 112.012 -177.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.426 HG21 HG22 ' A' ' 96' ' ' VAL . 0.8 OUTLIER -119.95 135.12 61.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.576 174.108 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.422 ' CG1' ' HA ' ' A' ' 54' ' ' VAL . 94.3 t -112.49 123.73 68.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 121.314 0.578 . . . . 0.0 111.401 -176.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -133.51 147.79 51.64 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 124.504 1.122 . . . . 0.0 109.668 176.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.39 161.87 33.19 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -81.65 -9.25 59.71 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 122.283 1.039 . . . . 0.0 109.52 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 96.1 t -114.96 123.73 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 176.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.671 ' O ' HG22 ' A' ' 54' ' ' VAL . 48.2 tt0 -58.24 -49.77 75.93 Favored 'General case' 0 C--O 1.205 -1.259 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -176.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.59 4.0 52.62 Favored Glycine 0 C--N 1.289 -2.059 0 C-N-CA 118.58 -1.772 . . . . 0.0 113.887 -176.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.9 t -86.17 -19.46 30.05 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 176.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.671 HG22 ' O ' ' A' ' 51' ' ' GLN . 4.9 m -81.19 -46.35 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.266 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 174.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -57.43 -50.35 73.3 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.384 -1.28 . . . . 0.0 111.968 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.05 -40.76 81.76 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 123.371 0.42 . . . . 0.0 111.594 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.403 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 36.8 tp -74.34 -43.06 58.24 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.071 -178.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.537 HG21 ' HB2' ' A' ' 76' ' ' ALA . 54.6 t -59.08 -40.14 80.11 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.595 0 C-N-CA 122.885 0.474 . . . . 0.0 111.071 177.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.62 -12.08 60.89 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.6 -31.72 10.25 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 176.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -75.71 -28.48 58.6 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 114.235 -1.348 . . . . 0.0 110.923 -175.41 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -83.14 -14.19 54.04 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.682 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.24 5.43 50.07 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.863 -0.735 . . . . 0.0 111.947 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.413 ' HB ' ' O ' ' A' ' 71' ' ' VAL . 31.8 mm -71.57 90.75 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.649 0 CA-C-O 121.407 0.623 . . . . 0.0 111.457 -175.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -121.69 107.37 12.28 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.921 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.7 m -140.65 169.77 15.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 174.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -82.12 125.89 31.39 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 120.948 0.404 . . . . 0.0 111.343 -175.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.2 -38.72 2.74 Favored Glycine 0 C--O 1.246 0.883 0 CA-C-N 116.171 -0.468 . . . . 0.0 113.878 177.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.0 t -107.01 133.6 51.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 53.6 mmm-85 -135.82 137.17 41.28 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 174.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.413 ' O ' ' HB ' ' A' ' 64' ' ' ILE . 24.5 t -134.81 119.39 27.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 177.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 24.9 ttpp -139.83 160.37 40.05 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.238 0.542 . . . . 0.0 110.174 -176.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.458 HG12 HG13 ' A' ' 58' ' ' VAL . 1.6 pp -94.89 162.34 2.45 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.003 175.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.78 HD11 ' HB3' ' A' ' 43' ' ' ASN . 1.7 mp -120.52 -33.39 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 174.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -152.38 122.14 6.96 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.341 -166.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.537 ' HB2' HG21 ' A' ' 58' ' ' VAL . . . -110.81 139.48 46.08 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 176.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -156.42 132.1 9.57 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 120.178 -0.609 . . . . 0.0 111.529 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.421 ' HB ' ' HA ' ' A' ' 51' ' ' GLN . 4.4 p -93.93 93.86 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.887 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 172.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -177.53 175.86 47.77 Favored Glycine 0 N--CA 1.399 -3.814 0 N-CA-C 108.319 -1.912 . . . . 0.0 108.319 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.606 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . . . -86.41 -170.63 3.17 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.163 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.417 ' CD1' HD12 ' A' ' 120' ' ' LEU . 21.2 mt -94.1 105.7 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.007 0 CA-C-O 121.213 0.53 . . . . 0.0 109.6 -173.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.4 t -106.89 162.68 13.6 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.412 ' HG3' ' CB ' ' A' ' 110' ' ' ALA . 39.3 tt0 -60.79 -35.22 75.9 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 123.109 0.564 . . . . 0.0 111.109 -176.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.7 m -69.83 -10.95 60.35 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.664 -177.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -95.69 -31.66 13.13 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 121.6 0.714 . . . . 0.0 109.796 175.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.641 HD13 ' HB2' ' A' ' 111' ' ' ALA . 59.7 mt -69.8 -25.76 28.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.939 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.0 p -56.75 -37.19 70.7 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.7 175.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.459 HD11 HD13 ' A' ' 74' ' ' ILE . 1.9 tm? -70.86 -36.97 73.05 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 123.278 0.631 . . . . 0.0 110.191 175.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.01 -58.46 6.47 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.222 -175.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.536 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 7.0 t -71.46 -30.12 65.64 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 119.594 -0.842 . . . . 0.0 110.919 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.19 -53.08 62.35 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.061 0.545 . . . . 0.0 112.313 -177.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 31.7 t -101.44 6.91 42.68 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.432 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 9.9 p30 60.11 29.6 19.15 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.791 1.236 . . . . 0.0 111.648 177.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.47 131.64 39.96 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 113.545 -1.661 . . . . 0.0 108.632 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.4 pp -93.87 143.65 11.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.623 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.503 ' HB ' HG22 ' A' ' 118' ' ' ILE . 21.2 t -94.49 113.86 29.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.622 -174.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.456 ' HA ' ' O ' ' A' ' 119' ' ' ARG . 43.2 mm -112.91 123.41 68.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 175.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -115.08 168.79 12.65 Favored Glycine 0 N--CA 1.423 -2.212 0 C-N-CA 120.231 -0.985 . . . . 0.0 110.666 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -114.84 93.34 4.28 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.111 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 62.7 t30 60.78 10.02 2.49 Favored 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 125.796 1.639 . . . . 0.0 112.583 178.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.606 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 3.8 m -69.87 -47.97 66.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.792 -175.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.537 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 55.9 mtm180 74.8 143.57 0.1 OUTLIER Pre-proline 0 CA--C 1.548 0.873 0 O-C-N 124.251 0.969 . . . . 0.0 111.522 175.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 102' ' ' ARG . 6.4 Cg_endo -86.5 169.66 8.14 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 121.753 1.635 . . . . 0.0 114.11 -175.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -77.89 152.16 33.46 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 169.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.491 ' O ' ' HG3' ' A' ' 108' ' ' LYS . . . -60.41 -28.56 68.35 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.483 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 91.3 m-20 -85.3 -29.27 24.69 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.237 177.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.49 -45.71 86.15 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 177.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' A' ' 105' ' ' ALA . 0.0 OUTLIER -59.95 -29.63 68.54 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.265 179.761 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 62.3 mtt180 -73.1 -52.17 15.27 Favored 'General case' 0 N--CA 1.393 -3.289 0 C-N-CA 124.445 1.098 . . . . 0.0 109.62 178.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.412 ' CB ' ' HG3' ' A' ' 83' ' ' GLU . . . -53.88 -51.23 64.32 Favored 'General case' 0 C--O 1.197 -1.661 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.126 -178.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.641 ' HB2' HD13 ' A' ' 86' ' ' ILE . . . -46.44 -48.77 18.81 Favored 'General case' 0 CA--C 1.494 -1.188 0 O-C-N 124.736 1.272 . . . . 0.0 112.52 -178.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -79.34 -32.34 43.29 Favored 'General case' 0 N--CA 1.407 -2.611 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.396 -171.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 26.0 t -79.58 -1.74 39.25 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.536 ' O ' ' HB ' ' A' ' 90' ' ' THR . 25.9 mt-10 -116.49 14.18 15.53 Favored 'General case' 0 N--CA 1.418 -2.067 0 C-N-CA 125.028 1.331 . . . . 0.0 112.454 -178.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 10.0 mtpm? 66.6 9.5 6.66 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 172.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.7 m -116.8 132.83 65.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-O 121.602 0.715 . . . . 0.0 112.277 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -97.55 127.13 43.26 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.503 HG22 ' HB ' ' A' ' 96' ' ' VAL . 25.9 pt -106.56 128.99 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.018 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.056 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.456 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 12.0 ptt180 -142.21 149.37 39.58 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 121.118 0.485 . . . . 0.0 110.338 -178.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.521 ' HG ' ' H ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -151.1 140.75 21.7 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.175 -171.321 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 68.38 -43.5 0.49 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 125.134 1.374 . . . . 0.0 113.794 174.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 69.6 89.28 0.1 Allowed 'General case' 0 CA--C 1.504 -0.826 0 C-N-CA 124.736 1.215 . . . . 0.0 112.096 -178.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 9.8 tp -80.88 99.75 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.746 0 CA-C-N 114.845 -1.07 . . . . 0.0 108.541 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 63.7 mt -71.84 -38.25 64.65 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.556 -176.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -123.66 97.35 5.34 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -84.8 83.37 8.06 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.782 0.801 . . . . 0.0 110.694 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.3 p -159.31 132.01 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 113.926 -1.488 . . . . 0.0 107.315 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.8 tt -166.52 86.39 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-O 121.859 0.838 . . . . 0.0 111.122 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -167.06 69.16 0.1 Allowed 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 122.067 0.936 . . . . 0.0 109.458 175.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -107.69 -3.93 18.7 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-O 122.762 1.267 . . . . 0.0 107.856 174.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.5 pp -141.76 156.62 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.2 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 177.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -76.29 138.99 40.88 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -75.99 19.1 0.23 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -174.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.46 88.9 7.32 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 177.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 91.8 mmm . . . . . 0 C--N 1.298 -1.654 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.837 -176.798 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 10.5 p30 . . . . . 0 CA--C 1.505 -0.75 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -121.18 171.73 8.49 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 120.897 0.379 . . . . 0.0 110.415 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -112.97 137.78 50.83 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 173.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 75.33 155.1 0.16 Allowed 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.327 1.051 . . . . 0.0 110.895 -173.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.9 mp -74.76 -26.74 59.98 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.162 0.506 . . . . 0.0 110.2 -175.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 114.95 -18.23 16.7 Favored Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -177.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.2 p -77.87 92.63 4.27 Favored 'General case' 0 N--CA 1.418 -2.036 0 C-N-CA 123.818 0.847 . . . . 0.0 110.734 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 27.6 ttm-85 -131.1 21.77 4.88 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 123.101 1.429 . . . . 0.0 108.57 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.31 -44.9 2.89 Favored Glycine 0 N--CA 1.435 -1.412 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 173.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.5 m -104.49 107.94 19.13 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 176.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.654 ' HA ' ' OD1' ' A' ' 14' ' ' ASP . 66.7 m 73.53 93.16 0.08 Allowed 'General case' 0 C--O 1.244 0.785 0 CA-C-O 122.829 1.3 . . . . 0.0 112.605 -176.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -126.53 -55.83 1.41 Allowed 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 113.854 -1.521 . . . . 0.0 110.866 -175.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.5 t -116.13 -17.2 8.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.654 ' OD1' ' HA ' ' A' ' 11' ' ' SER . 10.9 p-10 -74.93 71.83 2.07 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 122.911 1.338 . . . . 0.0 109.859 176.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.0 mt -122.19 167.28 13.38 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 113.953 -1.476 . . . . 0.0 107.824 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -106.66 32.54 4.45 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 122.569 1.176 . . . . 0.0 108.517 -177.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -88.06 69.21 9.3 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.584 -1.189 . . . . 0.0 112.429 -178.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -71.48 -43.17 67.09 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 120.563 -0.455 . . . . 0.0 109.884 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 44.55 -92.84 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.475 1.91 . . . . 0.0 115.214 -177.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.4 m -96.9 30.02 2.84 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.798 0.809 . . . . 0.0 108.873 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.488 ' HB ' ' O ' ' A' ' 24' ' ' ARG 0.395 33.7 m 53.59 69.86 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 126.749 2.02 . . . . 0.0 114.251 -176.243 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -98.97 -39.51 8.52 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.456 175.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.0 p -106.42 18.63 21.69 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 121.794 0.807 . . . . 0.0 109.535 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.488 ' O ' ' HB ' ' A' ' 21' ' ' VAL . 21.8 tpp180 -139.68 120.55 14.47 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.4 m 51.05 170.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 N-CA-C 116.373 1.99 . . . . 0.0 116.373 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.1 m -143.2 15.7 1.88 Allowed 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.516 -1.22 . . . . 0.0 107.806 173.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 77.4 mt -96.58 118.23 32.62 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.785 -177.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -120.22 -5.85 9.92 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.36 0.6 . . . . 0.0 111.229 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -105.46 97.02 6.92 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.9 mp -132.48 16.9 4.42 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -117.11 155.7 28.85 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.172 -174.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -123.26 88.64 2.96 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 175.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -141.46 114.39 8.54 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -178.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 70.8 mt -88.78 -55.99 5.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.654 -178.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -156.37 -52.82 0.08 Allowed 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -172.59 -43.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.802 0.689 . . . . 0.0 109.719 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 133.86 116.11 1.65 Allowed Glycine 0 N--CA 1.434 -1.483 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 -176.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -79.03 73.41 5.58 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.898 0.856 . . . . 0.0 111.655 -175.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 65.0 mtt -120.19 108.16 13.88 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 177.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.0 tptp -145.22 112.93 6.31 Favored 'General case' 0 N--CA 1.426 -1.63 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.629 -178.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -105.42 162.76 13.17 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.999 178.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -106.89 122.1 45.73 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 177.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.436 ' HA ' ' O ' ' A' ' 72' ' ' LYS . 14.8 m120 -120.05 149.12 42.69 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -176.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.421 HD21 HD11 ' A' ' 61' ' ' LEU . 2.4 pt? -154.01 165.25 36.74 Favored 'General case' 0 C--O 1.257 1.453 0 CA-C-O 121.486 0.66 . . . . 0.0 111.375 177.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.612 HG23 ' HA ' ' A' ' 96' ' ' VAL . 0.6 OUTLIER -116.34 126.57 73.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 CA-C-N 114.638 -1.165 . . . . 0.0 108.986 175.105 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.417 HG12 ' HA ' ' A' ' 54' ' ' VAL . 73.2 t -95.77 121.08 45.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.696 -176.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 3.9 mtpm? -134.61 140.98 46.48 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -147.66 175.07 11.18 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -86.33 -13.46 46.5 Favored 'General case' 0 C--N 1.315 -0.934 0 O-C-N 123.813 0.696 . . . . 0.0 109.999 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 79.2 t -120.3 129.56 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 177.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.725 ' O ' HG22 ' A' ' 54' ' ' VAL . 16.1 tt0 -58.7 -48.3 81.59 Favored 'General case' 0 C--O 1.193 -1.904 0 O-C-N 123.291 0.369 . . . . 0.0 111.834 -175.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -73.26 -0.57 53.57 Favored Glycine 0 C--N 1.283 -2.379 0 C-N-CA 118.893 -1.622 . . . . 0.0 114.477 -175.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.3 t -86.48 -20.37 28.19 Favored 'General case' 0 N--CA 1.415 -2.221 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 177.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.725 HG22 ' O ' ' A' ' 51' ' ' GLN . 6.0 m -76.8 -44.22 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.181 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 173.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -63.04 -48.06 80.33 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.215 -1.357 . . . . 0.0 111.321 -177.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.42 -35.23 78.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.583 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.506 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 40.3 tp -78.56 -37.86 41.64 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.239 -178.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.506 HG21 ' HB2' ' A' ' 76' ' ' ALA . 49.8 t -58.44 -44.66 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 120.625 0.25 . . . . 0.0 110.452 176.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.0 -22.26 66.72 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.676 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.53 -16.01 20.29 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.712 0.768 . . . . 0.0 109.951 -177.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.506 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -97.13 -32.84 11.75 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.25 -175.261 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -73.02 -20.33 61.02 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.028 0.442 . . . . 0.0 110.586 177.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -90.11 -1.04 57.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.194 -177.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 31.8 mm -64.26 129.99 28.75 Favored 'Isoleucine or valine' 0 C--O 1.248 1.022 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.471 ' HB3' ' HG2' ' A' ' 67' ' ' GLU . 12.3 m-20 -65.09 159.07 24.14 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.893 -176.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.0 m -91.36 -9.59 10.18 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 CA-C-O 121.536 0.684 . . . . 0.0 110.266 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.471 ' HG2' ' HB3' ' A' ' 65' ' ' ASP . 11.1 pt-20 -86.6 139.05 31.19 Favored 'General case' 0 C--O 1.254 1.312 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.325 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.2 -79.31 1.73 Allowed Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.95 178.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.0 p -131.73 121.19 47.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 56.0 ttt180 -102.29 101.07 11.3 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 120.234 -0.587 . . . . 0.0 110.273 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.9 t -107.39 136.22 43.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 177.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 57.3 tttp -150.38 154.55 37.97 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.474 HG12 HG13 ' A' ' 58' ' ' VAL . 1.4 pp -93.69 154.45 3.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.635 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 40.3 mm -115.69 -33.32 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-O 121.142 0.496 . . . . 0.0 111.1 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -160.83 134.52 6.83 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -171.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.506 ' HB2' HG21 ' A' ' 58' ' ' VAL . . . -113.51 133.44 55.23 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 176.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 47' ' ' LYS . . . -151.94 130.64 12.35 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.307 -177.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.4 p -93.39 93.89 4.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-O 123.2 1.476 . . . . 0.0 110.148 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -177.84 175.49 47.55 Favored Glycine 0 N--CA 1.403 -3.558 0 CA-C-N 113.68 -1.6 . . . . 0.0 109.488 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.498 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -74.11 178.48 5.02 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 174.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.426 HG21 HG21 ' A' ' 118' ' ' ILE . 3.5 mp -84.27 108.83 16.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 69.6 p -101.04 166.92 10.56 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.512 -0.875 . . . . 0.0 108.992 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -59.53 -33.78 71.82 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.775 0.798 . . . . 0.0 109.508 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.1 m -67.44 -31.44 71.62 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.877 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -73.15 -34.76 66.26 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 121.901 0.858 . . . . 0.0 109.828 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.502 HD13 ' HB2' ' A' ' 111' ' ' ALA . 70.7 mt -66.55 -26.84 38.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 114.524 -1.216 . . . . 0.0 112.846 -176.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 88.3 p -55.49 -38.32 68.99 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 120.823 0.344 . . . . 0.0 110.507 175.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -73.14 -33.55 65.57 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.028 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.98 -62.16 1.89 Allowed 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.54 -177.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 4.3 t -70.58 -17.09 62.91 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-O 121.306 0.574 . . . . 0.0 111.129 178.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.82 -55.08 9.33 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 32.6 p -97.53 -8.32 29.38 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 121.017 -0.273 . . . . 0.0 110.767 -176.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . 0.265 0.0 OUTLIER 78.84 30.45 0.35 Allowed 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 127.021 2.128 . . . . 0.0 110.241 -176.799 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -92.6 140.56 29.42 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 113.969 -1.469 . . . . 0.0 110.23 -176.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.411 HG23 ' O ' ' A' ' 117' ' ' ASP . 43.0 mm -94.02 140.44 16.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.612 ' HA ' HG23 ' A' ' 45' ' ' ILE . 11.5 t -95.8 129.5 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -177.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 13.1 tt -127.78 135.99 61.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -137.24 158.23 24.25 Favored Glycine 0 N--CA 1.417 -2.61 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 177.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -117.25 102.7 9.49 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -176.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 59.0 t30 69.75 -31.55 0.21 Allowed 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 124.222 1.009 . . . . 0.0 112.924 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.457 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 1.7 m -49.51 -42.58 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 C-N-CA 124.028 0.931 . . . . 0.0 113.396 177.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.598 ' HA ' ' HG ' ' A' ' 120' ' ' LEU . 49.9 mtp180 69.94 176.44 0.07 OUTLIER Pre-proline 0 CA--C 1.537 0.456 0 O-C-N 123.886 0.741 . . . . 0.0 112.65 175.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.476 ' HG3' HD12 ' A' ' 118' ' ' ILE . 9.3 Cg_endo -99.25 177.55 0.33 Allowed 'Trans proline' 0 N--CA 1.432 -2.104 0 C-N-CA 121.828 1.685 . . . . 0.0 112.581 178.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -82.84 155.5 24.13 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 168.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.457 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -59.09 -28.84 66.87 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 120.755 0.312 . . . . 0.0 111.642 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.572 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 28.1 m-80 -81.1 -35.39 31.71 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 177.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.4 -42.9 95.85 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 120.799 0.333 . . . . 0.0 110.843 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 17.0 pttp -62.98 -20.69 65.51 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-O 121.089 0.471 . . . . 0.0 110.91 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.572 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 24.8 mtm180 -84.25 -51.68 6.83 Favored 'General case' 0 N--CA 1.392 -3.372 0 C-N-CA 124.593 1.157 . . . . 0.0 109.228 175.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -51.33 -51.52 53.66 Favored 'General case' 0 CA--C 1.477 -1.841 0 C-N-CA 125.34 1.456 . . . . 0.0 110.503 -178.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.502 ' HB2' HD13 ' A' ' 86' ' ' ILE . . . -49.49 -48.55 47.86 Favored 'General case' 0 CA--C 1.502 -0.877 0 O-C-N 124.842 1.339 . . . . 0.0 112.206 -177.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -78.14 -33.02 50.64 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.384 -172.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 48.0 t -81.44 5.77 16.65 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 176.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.512 ' O ' ' HB ' ' A' ' 90' ' ' THR . 12.3 mt-10 -123.46 12.76 9.41 Favored 'General case' 0 N--CA 1.417 -2.105 0 C-N-CA 124.771 1.228 . . . . 0.0 112.339 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 10.4 mmmm 65.62 10.81 7.01 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 174.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.3 m -115.69 132.97 63.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-O 121.574 0.702 . . . . 0.0 112.492 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.411 ' O ' HG23 ' A' ' 95' ' ' ILE . 28.1 t70 -94.81 126.16 39.94 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.367 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.574 HG22 ' HB ' ' A' ' 96' ' ' VAL . 7.8 pt -94.11 131.86 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-O 121.408 0.623 . . . . 0.0 110.518 178.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 7.0 tpp180 -102.7 115.85 31.41 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.958 -177.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.598 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -155.05 166.91 32.1 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 177.932 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.408 ' O ' ' HB2' ' A' ' 122' ' ' ARG . 40.2 t-80 -93.48 109.87 21.46 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.438 -178.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 121' ' ' HIS . 30.2 ttt180 170.09 113.72 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.766 0 O-C-N 124.93 1.394 . . . . 0.0 109.17 173.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 13.6 tt -118.2 170.96 6.94 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 178.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 9.4 tp -56.15 -23.33 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 CA-C-N 119.006 0.821 . . . . 0.0 110.921 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -83.58 74.84 10.08 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 121.829 0.823 . . . . 0.0 109.081 174.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -137.64 99.51 3.95 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.285 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 25.5 m -69.39 118.51 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.587 177.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 43.8 pt -90.78 127.08 43.45 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 CA-C-O 121.227 0.537 . . . . 0.0 110.77 -177.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -85.7 83.74 7.78 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 175.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -86.38 -32.2 21.08 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.038 -175.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 31.0 pt -126.93 154.06 36.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.279 -176.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -83.14 127.62 33.76 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 174.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -75.73 -11.89 60.08 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -174.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -108.2 149.84 28.03 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.126 0.488 . . . . 0.0 110.888 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 59.1 ttp . . . . . 0 C--N 1.304 -1.4 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.566 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 8.1 p30 . . . . . 0 CA--C 1.51 -0.577 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -87.2 -54.52 4.27 Favored 'General case' 0 C--N 1.316 -0.849 0 O-C-N 123.315 0.384 . . . . 0.0 110.703 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -131.13 -61.64 0.92 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.509 0.671 . . . . 0.0 109.708 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -101.83 164.71 11.58 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.455 -174.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 93.0 mt -87.84 -9.09 54.84 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.339 0.59 . . . . 0.0 109.896 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 102.47 7.4 45.74 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.913 -0.661 . . . . 0.0 113.421 177.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.7 p -99.57 129.3 45.71 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 122.674 -0.309 . . . . 0.0 110.707 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -60.46 -46.3 90.56 Favored 'General case' 0 C--O 1.245 0.857 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.95 77.85 1.95 Allowed Glycine 0 N--CA 1.429 -1.817 0 N-CA-C 108.386 -1.886 . . . . 0.0 108.386 173.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.4 m -64.59 138.76 58.58 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 123.324 0.65 . . . . 0.0 111.5 -175.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.7 m 70.35 35.48 2.01 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.11 0.964 . . . . 0.0 110.772 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.411 ' HE ' ' HB3' ' A' ' 12' ' ' ARG . 7.1 ptp180 -78.98 -17.38 55.51 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.679 0.752 . . . . 0.0 110.281 175.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.1 m -111.36 169.83 3.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 173.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -78.78 133.21 37.1 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 175.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.1 mt -76.38 -16.94 59.6 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -174.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -114.81 116.72 29.06 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 122.184 0.992 . . . . 0.0 111.818 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -120.42 87.02 2.67 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.968 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.564 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 25.0 mp0 -127.45 23.04 6.4 Favored 'General case' 0 CA--C 1.486 -1.506 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.477 ' O ' ' HD2' ' A' ' 19' ' ' ARG . 2.6 tmm_? -66.32 -16.18 63.84 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.411 -177.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.9 m -129.47 26.44 5.36 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 176.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.549 HG12 ' HG3' ' A' ' 24' ' ' ARG . 2.7 p -65.95 -39.25 84.07 Favored 'Isoleucine or valine' 0 C--N 1.357 0.933 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.581 -176.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.4 tptp 172.82 114.69 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 178.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.6 t 47.18 39.75 8.86 Favored 'General case' 0 CA--C 1.567 1.634 0 C-N-CA 125.149 1.38 . . . . 0.0 112.995 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.613 ' HA ' ' HE ' ' A' ' 24' ' ' ARG . 0.9 OUTLIER -95.36 -6.03 41.98 Favored 'General case' 0 C--O 1.24 0.579 0 O-C-N 120.978 -1.076 . . . . 0.0 110.552 -179.537 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.5 t -96.74 -26.49 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 172.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.0 m 60.36 82.57 0.16 Allowed 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.35 1.06 . . . . 0.0 111.899 -176.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.7 mt -130.55 19.44 5.2 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.941 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -70.5 128.06 34.85 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 177.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 76.19 14.86 2.41 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.819 1.248 . . . . 0.0 110.445 -173.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.2 mt 64.7 -83.54 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 126.059 1.744 . . . . 0.0 112.297 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.474 ' CE2' ' HA ' ' A' ' 33' ' ' GLN . 39.5 t80 -163.17 137.61 6.23 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -175.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.464 ' H ' ' CD ' ' A' ' 32' ' ' GLU . 0.2 OUTLIER -91.93 2.95 56.21 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.199 0.523 . . . . 0.0 111.197 -176.375 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.474 ' HA ' ' CE2' ' A' ' 31' ' ' PHE . 35.7 tt0 71.86 -79.32 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 125.458 1.503 . . . . 0.0 112.074 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 63.3 mt 40.44 76.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.253 1.277 0 C-N-CA 124.507 1.123 . . . . 0.0 111.964 -178.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.61 121.33 5.0 Favored 'General case' 0 N--CA 1.424 -1.745 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.014 -177.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -116.73 112.55 21.34 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 175.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -117.5 -136.67 5.66 Favored Glycine 0 C--N 1.302 -1.322 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.418 -178.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -82.76 147.97 28.11 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 123.108 0.563 . . . . 0.0 109.784 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 22.0 ptp -86.6 111.93 21.1 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.455 177.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -91.46 -21.89 20.7 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.51 -175.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -104.19 104.55 14.48 Favored 'General case' 0 N--CA 1.435 -1.208 0 O-C-N 123.897 0.748 . . . . 0.0 109.949 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.564 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 59.4 tp -97.53 110.3 22.88 Favored 'General case' 0 N--CA 1.409 -2.486 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 175.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.558 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 57.7 m-80 -94.71 152.87 18.11 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -178.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.404 HD12 HD11 ' A' ' 61' ' ' LEU . 78.7 mt -138.59 164.57 29.13 Favored 'General case' 0 C--O 1.245 0.849 0 CA-C-O 121.814 0.816 . . . . 0.0 112.35 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.506 HD12 ' O ' ' A' ' 75' ' ' HIS . 0.2 OUTLIER -127.0 135.39 63.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 174.464 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.444 ' CG1' ' HA ' ' A' ' 54' ' ' VAL . 92.1 t -118.61 127.91 75.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.048 -177.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 41.5 mtpt -144.92 140.89 28.59 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.76 175.18 13.14 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -178.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -84.47 -25.68 28.73 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 122.2 1.0 . . . . 0.0 108.94 177.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 99.0 t -101.61 122.54 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.246 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 174.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.709 ' O ' HG22 ' A' ' 54' ' ' VAL . 17.4 tt0 -62.9 -40.72 98.43 Favored 'General case' 0 C--O 1.192 -1.941 0 CA-C-O 120.602 0.239 . . . . 0.0 111.411 -175.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -73.75 -3.03 62.28 Favored Glycine 0 C--N 1.29 -2.0 0 C-N-CA 118.314 -1.898 . . . . 0.0 114.151 -177.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.4 m -80.72 -24.02 39.08 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 176.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.709 HG22 ' O ' ' A' ' 51' ' ' GLN . 3.3 m -77.14 -47.09 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.767 0 CA-C-N 114.579 -1.191 . . . . 0.0 107.827 176.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -57.13 -48.04 79.64 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.295 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.48 -31.2 72.15 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.333 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.442 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 24.3 tp -79.78 -41.3 26.81 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.239 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 54' ' ' VAL . 53.2 t -53.56 -43.96 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.512 0.725 . . . . 0.0 111.921 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.88 -29.07 70.29 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.44 -13.07 28.39 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 121.325 0.583 . . . . 0.0 110.106 -177.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -96.13 -33.65 11.98 Favored 'General case' 0 N--CA 1.418 -2.064 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.494 -176.174 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -75.52 -14.69 60.42 Favored 'General case' 0 C--N 1.313 -1.002 0 O-C-N 122.066 -0.396 . . . . 0.0 111.59 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -96.76 5.18 51.12 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -178.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.533 ' HB ' ' O ' ' A' ' 71' ' ' VAL . 23.4 mt -78.29 78.93 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -174.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -121.09 -33.15 3.78 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.339 -1.3 . . . . 0.0 108.167 170.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.3 t -72.06 -7.36 9.28 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 CA-C-N 114.408 -1.269 . . . . 0.0 112.059 -172.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -83.59 -9.04 59.17 Favored 'General case' 0 C--N 1.312 -1.048 0 O-C-N 121.689 -0.632 . . . . 0.0 110.849 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.41 13.23 63.8 Favored Glycine 0 CA--C 1.503 -0.7 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.5 p -153.07 149.85 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.974 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 64' ' ' ILE . 62.9 mtt180 -103.27 121.83 43.53 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.624 0.726 . . . . 0.0 110.959 -178.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 46.7 t -130.49 128.88 64.19 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.791 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 177.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 58.8 tttp -153.06 158.5 42.05 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.844 -174.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.441 HG12 HG13 ' A' ' 58' ' ' VAL . 1.2 pp -93.94 152.29 3.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 -177.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.454 HD11 ' OD1' ' A' ' 43' ' ' ASN . 27.7 mm -115.69 -27.26 2.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.839 177.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.506 ' O ' HD12 ' A' ' 45' ' ' ILE . 3.5 t60 -157.69 135.91 11.0 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -169.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -142.48 129.34 20.58 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.426 ' O ' ' HA ' ' A' ' 47' ' ' LYS . . . -161.91 159.37 26.63 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 120.714 0.293 . . . . 0.0 110.477 -178.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.8 p -94.58 103.46 14.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 175.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -175.88 175.81 47.42 Favored Glycine 0 N--CA 1.425 -2.08 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -177.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.546 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -90.19 178.62 6.12 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.448 HD11 ' HA3' ' A' ' 98' ' ' GLY . 3.7 mp -82.38 108.16 15.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 69.5 p -100.42 169.13 9.3 Favored 'General case' 0 N--CA 1.421 -1.885 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -58.83 -28.66 66.25 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.804 0.842 . . . . 0.0 110.254 176.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.0 t -71.58 -37.41 71.02 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.485 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -70.93 -36.05 72.49 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 121.634 0.73 . . . . 0.0 110.225 -177.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.55 HG21 ' HA ' ' A' ' 111' ' ' ALA . 54.3 mt -69.35 -34.6 63.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.426 -177.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 66.5 m -63.99 -19.36 65.11 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 120.471 -0.492 . . . . 0.0 112.152 174.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.41 HD21 HG21 ' A' ' 74' ' ' ILE . 2.2 tm? -79.9 -36.04 37.05 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 173.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.93 -54.18 49.83 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.31 -177.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.508 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 10.1 t -74.52 -12.88 60.59 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.917 178.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.76 -58.7 3.12 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.95 0.405 . . . . 0.0 111.815 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 26.4 m -98.12 5.14 48.92 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.432 -177.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.1 m120 72.43 33.05 1.51 Allowed 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 122.094 0.949 . . . . 0.0 110.041 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -94.75 170.26 9.57 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 113.938 -1.483 . . . . 0.0 109.71 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 36.6 pt -130.93 148.08 33.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 173.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.474 ' HA ' HG23 ' A' ' 45' ' ' ILE . 3.4 t -100.62 126.79 54.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.973 -175.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.593 ' HA ' ' O ' ' A' ' 119' ' ' ARG . 66.0 mt -112.13 135.78 50.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.448 ' HA3' HD11 ' A' ' 81' ' ' ILE . . . -132.55 140.16 11.58 Favored Glycine 0 N--CA 1.434 -1.486 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.745 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -107.36 100.12 9.58 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -176.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.2 t30 72.91 -36.19 0.35 Allowed 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 125.332 1.453 . . . . 0.0 111.922 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.403 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 3.5 m -50.76 -50.63 22.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 124.698 1.199 . . . . 0.0 112.664 177.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.546 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 76.4 mtp180 67.73 177.21 0.06 OUTLIER Pre-proline 0 CA--C 1.559 1.312 0 O-C-N 123.731 0.644 . . . . 0.0 111.541 176.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.47 ' HG3' HD12 ' A' ' 118' ' ' ILE . 5.3 Cg_endo -94.82 173.58 1.31 Allowed 'Trans proline' 0 CA--C 1.5 -1.183 0 C-N-CA 121.59 1.527 . . . . 0.0 113.985 -177.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -77.48 160.91 28.33 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 113.965 -1.471 . . . . 0.0 107.335 168.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.486 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -67.35 -29.68 69.29 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -176.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.521 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 10.3 m-80 -86.72 -35.55 19.17 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.08 -50.42 66.83 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.441 175.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 61.2 pttt -56.97 -24.71 55.16 Favored 'General case' 0 CA--C 1.565 1.527 0 C-N-CA 122.697 0.399 . . . . 0.0 112.075 -178.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.521 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 14.1 mtm180 -86.27 -46.84 9.96 Favored 'General case' 0 N--CA 1.386 -3.628 0 C-N-CA 125.201 1.401 . . . . 0.0 108.93 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.11 -42.39 69.39 Favored 'General case' 0 C--O 1.201 -1.477 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.425 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.55 ' HA ' HG21 ' A' ' 86' ' ' ILE . . . -48.78 -44.86 39.27 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 124.475 1.109 . . . . 0.0 111.406 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -77.82 -32.83 52.46 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 114.874 -1.057 . . . . 0.0 112.277 -175.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 48.3 t -83.13 4.86 24.66 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 176.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.508 ' O ' ' HB ' ' A' ' 90' ' ' THR . 23.2 mt-10 -123.1 12.08 9.57 Favored 'General case' 0 CA--C 1.464 -2.341 0 C-N-CA 124.496 1.118 . . . . 0.0 112.883 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 26.7 mtpp 66.25 7.99 5.28 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 173.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.1 m -115.41 155.47 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.324 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -174.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -111.99 124.68 52.92 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.457 -178.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.47 HD12 ' HG3' ' A' ' 103' ' ' PRO . 9.3 pt -96.16 133.07 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.626 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.593 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 41.0 ttt85 -119.36 125.32 48.74 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.458 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -142.6 168.41 19.8 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.085 -177.596 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.405 ' CE1' ' HB ' ' A' ' 123' ' ' ILE . 9.1 t-160 -96.8 113.46 25.02 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 177.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -75.26 -49.3 19.7 Favored 'General case' 0 C--O 1.216 -0.707 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.405 ' HB ' ' CE1' ' A' ' 121' ' ' HIS 0.291 9.3 tp 49.98 85.04 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.202 0 C-N-CA 125.538 1.535 . . . . 0.0 114.41 178.626 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 15.1 tt -165.45 -27.19 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.984 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 70.08 -74.05 0.09 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.723 1.209 . . . . 0.0 112.38 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -120.0 133.15 55.63 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 28.9 m -82.55 -30.39 9.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 C-N-CA 120.493 -0.483 . . . . 0.0 109.733 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.6 pp -136.43 169.85 19.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 C-N-CA 123.405 0.682 . . . . 0.0 109.92 176.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -140.68 168.62 19.37 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 120.79 0.329 . . . . 0.0 111.593 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -77.86 128.54 34.12 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.838 177.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 64.6 mt 73.17 -58.43 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 125.09 1.356 . . . . 0.0 110.751 -177.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -167.26 -39.97 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 123.743 0.817 . . . . 0.0 110.129 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -164.84 161.11 20.14 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -178.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -86.47 -67.3 0.82 Allowed 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 175.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 87.8 mtp . . . . . 0 C--N 1.316 -0.885 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 174.307 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 8.7 t30 . . . . . 0 CA--C 1.497 -1.08 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -87.82 100.08 12.59 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-O 121.319 0.581 . . . . 0.0 109.735 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -83.41 -38.68 21.61 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -92.12 95.01 9.51 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.735 176.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.7 pp -82.58 -20.84 35.72 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.07 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.73 90.63 1.63 Allowed Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 175.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.5 t -102.32 176.18 5.27 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 120.785 0.326 . . . . 0.0 111.063 -173.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 72.84 -58.73 0.59 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.936 1.694 . . . . 0.0 112.307 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.49 55.88 22.87 Favored Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.3 m -139.29 3.13 2.13 Favored 'General case' 0 C--N 1.314 -0.938 0 O-C-N 122.688 -0.301 . . . . 0.0 111.546 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.7 t -95.5 -5.36 43.06 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 176.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.583 ' O ' HG23 ' A' ' 13' ' ' VAL . 15.1 ptp180 -162.02 164.48 28.23 Favored 'General case' 0 N--CA 1.406 -2.659 0 N-CA-C 104.193 -2.521 . . . . 0.0 104.193 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 12' ' ' ARG . 2.5 t 169.9 109.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 C-N-CA 128.228 2.611 . . . . 0.0 108.046 174.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.7 t70 65.23 77.95 0.29 Allowed 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 122.345 1.069 . . . . 0.0 110.972 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.9 tp -100.22 -50.01 4.09 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.503 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -99.97 159.89 14.74 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.033 -176.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -126.64 133.22 51.05 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.412 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -86.37 -37.23 18.64 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 68.87 -73.11 0.09 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.676 1.59 . . . . 0.0 111.037 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 t -155.8 30.13 0.37 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.5 m 50.68 -169.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 126.447 1.899 . . . . 0.0 111.85 -172.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 87.4 tttt 72.49 -74.41 0.09 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.339 1.056 . . . . 0.0 111.195 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 23.7 p -93.88 21.16 6.87 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.24 0.543 . . . . 0.0 110.852 -178.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -56.53 -39.03 72.7 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.23 177.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.3 m -125.46 -59.6 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.863 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.9 p -171.1 148.67 2.76 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 106.311 -1.736 . . . . 0.0 106.311 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -144.93 117.4 8.54 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -93.22 99.47 12.02 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -76.19 112.75 12.99 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.75 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 49.3 tp -158.26 89.42 0.99 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.402 ' O ' ' HB2' ' A' ' 32' ' ' GLU . 71.4 t80 -118.82 76.72 1.12 Allowed 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.396 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 31' ' ' PHE . 8.5 tp10 162.94 149.52 0.01 OUTLIER 'General case' 0 C--O 1.245 0.842 0 C-N-CA 126.791 2.036 . . . . 0.0 106.729 175.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 -135.09 153.58 51.97 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 120.826 0.346 . . . . 0.0 111.928 178.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.6 tp -63.12 135.36 27.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.637 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -96.07 154.38 17.28 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -67.06 -27.7 67.6 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.928 0.87 . . . . 0.0 108.72 176.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.07 -177.48 32.61 Favored Glycine 0 N--CA 1.405 -3.426 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.917 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -83.18 72.02 10.16 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-O 121.417 0.627 . . . . 0.0 109.401 -178.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 14.9 tpt -67.27 -56.03 11.51 Favored 'General case' 0 C--O 1.243 0.742 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 178.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -127.15 122.34 33.9 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-N 114.071 -1.422 . . . . 0.0 107.746 173.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -94.65 142.36 27.53 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 174.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 47.2 tp -93.26 93.2 8.09 Favored 'General case' 0 N--CA 1.395 -3.216 0 N-CA-C 102.761 -3.051 . . . . 0.0 102.761 170.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 72' ' ' LYS . 18.2 t30 -106.57 115.97 31.12 Favored 'General case' 0 C--N 1.28 -2.413 0 CA-C-N 113.869 -1.514 . . . . 0.0 107.641 -168.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 93.8 mt -123.36 172.86 8.36 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 122.146 0.974 . . . . 0.0 113.106 -172.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.658 HG23 ' HA ' ' A' ' 96' ' ' VAL . 1.1 tt -122.21 134.99 63.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 114.55 -1.204 . . . . 0.0 110.162 178.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 98.6 t -110.14 120.94 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 CA-C-O 121.496 0.665 . . . . 0.0 110.543 -177.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 28.1 mtpp -140.62 114.61 9.06 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.289 1.036 . . . . 0.0 109.614 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -131.05 167.02 19.78 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.575 -176.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -73.08 -35.59 66.68 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.997 0.903 . . . . 0.0 109.02 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 88.5 t -95.56 124.7 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 176.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.734 ' O ' HG22 ' A' ' 54' ' ' VAL . 24.1 tt0 -62.63 -40.52 97.26 Favored 'General case' 0 C--O 1.194 -1.858 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.071 -177.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -75.67 0.67 60.55 Favored Glycine 0 C--N 1.279 -2.617 0 C-N-CA 118.241 -1.933 . . . . 0.0 114.071 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.4 t -87.53 -22.77 24.66 Favored 'General case' 0 N--CA 1.418 -2.059 0 N-CA-C 106.036 -1.839 . . . . 0.0 106.036 174.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.734 HG22 ' O ' ' A' ' 51' ' ' GLN . 3.9 m -73.0 -43.81 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.847 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 174.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -57.57 -54.87 41.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.222 -1.354 . . . . 0.0 110.636 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.65 -41.05 89.68 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.211 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.5 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 40.3 tp -73.38 -37.92 65.83 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 120.049 -0.661 . . . . 0.0 110.67 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.468 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 39.9 t -59.01 -45.17 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.58 -19.73 64.01 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.661 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.3 -10.91 20.79 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.697 0.76 . . . . 0.0 109.957 -177.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.5 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -105.27 -27.94 11.23 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 114.638 -1.164 . . . . 0.0 110.21 -175.125 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 4.2 pt20 -84.16 -11.35 56.72 Favored 'General case' 0 C--N 1.315 -0.904 0 O-C-N 121.904 -0.497 . . . . 0.0 111.422 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -86.87 5.36 37.23 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.327 0.584 . . . . 0.0 110.038 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.461 HG21 ' HB ' ' A' ' 71' ' ' VAL . 24.1 mm -83.05 93.45 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.78 0 CA-C-O 121.908 0.861 . . . . 0.0 110.81 -176.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -141.83 -41.14 0.36 Allowed 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.499 -1.228 . . . . 0.0 107.762 174.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.9 t -80.87 87.03 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 172.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 178.49 -31.36 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -170.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.31 -42.1 2.85 Favored Glycine 0 CA--C 1.501 -0.813 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.862 177.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 50.4 t -94.83 143.82 11.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 177.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 -93.74 110.8 22.42 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-O 121.447 0.641 . . . . 0.0 109.898 -178.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.461 ' HB ' HG21 ' A' ' 64' ' ' ILE . 39.0 t -110.9 116.02 51.39 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.698 0 N-CA-C 103.237 -2.875 . . . . 0.0 103.237 171.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 4.5 ttpm? -141.04 164.04 31.34 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.661 -171.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.407 HG23 ' HG ' ' A' ' 61' ' ' LEU . 1.6 pp -100.03 158.35 3.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.714 176.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.3 mt -117.62 -41.57 2.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.999 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -154.56 131.42 10.82 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.626 -169.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -124.99 125.12 43.39 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 124.215 1.006 . . . . 0.0 108.449 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 47' ' ' LYS . . . -148.57 145.91 28.04 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.3 p -94.87 94.83 4.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-O 122.754 1.264 . . . . 0.0 110.049 177.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.24 175.09 47.36 Favored Glycine 0 N--CA 1.404 -3.445 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.597 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -89.22 175.47 7.34 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.416 ' CG2' HD11 ' A' ' 86' ' ' ILE . 1.7 mp -72.87 116.95 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 CA-C-O 121.19 0.519 . . . . 0.0 110.151 -177.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.9 t -123.43 155.51 37.3 Favored 'General case' 0 N--CA 1.403 -2.778 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.48 -26.98 68.67 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -173.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.4 t -65.14 -29.0 69.81 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.278 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -82.04 -32.58 30.39 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.542 0.687 . . . . 0.0 109.522 177.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.637 HD13 ' HB2' ' A' ' 111' ' ' ALA . 41.5 mt -68.17 -29.87 45.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.253 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.407 ' HA ' ' OE2' ' A' ' 114' ' ' GLU . 42.6 m -58.8 -24.31 61.67 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 174.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -76.54 -34.45 58.53 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 175.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.407 ' HB3' HG21 ' A' ' 116' ' ' VAL . . . -56.42 -57.23 13.21 Favored 'General case' 0 C--O 1.191 -1.984 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.039 -177.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.626 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 1.9 t -66.29 -30.63 71.09 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 120.37 -0.532 . . . . 0.0 112.095 176.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.02 -55.83 25.23 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -177.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 33.7 m -101.34 5.11 42.13 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.972 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 64.36 37.71 8.22 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.828 0.851 . . . . 0.0 109.965 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -93.78 156.47 16.65 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.284 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.1 mp -108.19 136.5 43.5 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 176.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.658 ' HA ' HG23 ' A' ' 45' ' ' ILE . 14.3 t -93.58 103.93 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -176.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 51.4 mt -94.82 112.37 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.824 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -103.18 134.98 12.07 Favored Glycine 0 N--CA 1.414 -2.777 0 N-CA-C 109.984 -1.247 . . . . 0.0 109.984 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.414 ' C ' ' H ' ' A' ' 101' ' ' VAL . 98.4 m-85 -104.15 94.45 5.38 Favored 'General case' 0 C--N 1.281 -2.399 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.237 -173.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 71.69 -22.72 0.19 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 125.626 1.571 . . . . 0.0 112.995 178.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.574 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 2.7 m -54.62 -48.99 70.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 178.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.597 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 37.2 mtp180 72.6 171.14 0.11 Allowed Pre-proline 0 CA--C 1.552 1.048 0 O-C-N 123.863 0.727 . . . . 0.0 111.822 178.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.451 ' HG3' HD12 ' A' ' 118' ' ' ILE . 13.7 Cg_endo -100.62 -173.17 0.11 Allowed 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.43 2.087 . . . . 0.0 113.504 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -106.75 176.89 5.02 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.275 -1.33 . . . . 0.0 107.444 170.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.505 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -74.2 -12.11 60.48 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 113.701 1.001 . . . . 0.0 113.701 -173.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.474 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 8.8 t30 -101.33 -40.35 7.16 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.07 -46.12 82.74 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 123.355 0.41 . . . . 0.0 110.882 175.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -54.38 -34.56 61.46 Favored 'General case' 0 CA--C 1.562 1.433 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.798 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.505 ' HG3' ' O ' ' A' ' 105' ' ' ALA . 15.7 mtm180 -79.45 -49.77 11.8 Favored 'General case' 0 N--CA 1.386 -3.642 0 C-N-CA 126.118 1.767 . . . . 0.0 109.541 -178.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.55 -43.69 68.64 Favored 'General case' 0 C--O 1.203 -1.355 0 CA-C-N 113.944 -1.48 . . . . 0.0 110.53 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.637 ' HB2' HD13 ' A' ' 86' ' ' ILE . . . -50.56 -47.22 57.88 Favored 'General case' 0 CA--C 1.489 -1.382 0 O-C-N 124.532 1.145 . . . . 0.0 111.356 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -79.23 -30.59 43.28 Favored 'General case' 0 C--N 1.277 -2.583 0 CA-C-N 114.754 -1.112 . . . . 0.0 112.691 -172.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 35.2 t -84.68 4.72 31.21 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-O 122.069 0.937 . . . . 0.0 108.511 176.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.626 ' O ' ' HB ' ' A' ' 90' ' ' THR . 23.3 mt-10 -118.21 17.01 14.02 Favored 'General case' 0 CA--C 1.46 -2.493 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.581 177.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 47.7 mtmt 66.55 7.83 5.37 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 174.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.407 HG21 ' HB3' ' A' ' 89' ' ' ALA . 11.3 m -117.62 171.92 5.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.951 -176.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -131.67 143.68 50.46 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.525 HG22 ' HB ' ' A' ' 96' ' ' VAL . 5.6 pt -101.98 138.01 27.78 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.519 179.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 13.6 ttm180 -114.46 111.84 22.05 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -172.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.401 ' CD1' ' HA ' ' A' ' 102' ' ' ARG . 3.1 mm? -111.3 123.14 49.6 Favored 'General case' 0 CA--C 1.478 -1.818 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.067 -174.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 31.5 t-80 68.55 94.57 0.07 Allowed 'General case' 0 CA--C 1.544 0.749 0 O-C-N 124.754 1.284 . . . . 0.0 111.114 175.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 63.89 -173.35 0.17 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.39 1.076 . . . . 0.0 111.923 -176.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 29.6 pt -102.18 -172.78 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 O-C-N 122.017 -0.427 . . . . 0.0 110.802 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 47.0 mm -70.37 -49.37 54.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 CA-C-O 121.162 0.506 . . . . 0.0 109.813 -175.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -81.41 101.75 10.05 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 172.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -74.07 101.09 3.79 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.861 -170.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 60.6 t -103.64 121.72 55.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.873 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.2 mp -88.09 111.56 22.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -79.85 105.54 11.22 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -132.45 107.62 8.61 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.548 0.69 . . . . 0.0 109.835 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 22.7 pt -122.44 -11.15 8.07 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.74 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.81 10.07 12.24 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.75 -1.113 . . . . 0.0 109.657 -177.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -83.07 106.29 14.76 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.906 -175.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -110.06 -13.08 14.45 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.876 0.846 . . . . 0.0 108.955 174.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 89.3 mtp . . . . . 0 C--N 1.31 -1.126 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 -179.001 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 24.7 p30 . . . . . 0 CA--C 1.512 -0.503 0 N-CA-C 110.677 -0.12 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 58.32 -165.06 0.18 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.789 0.436 . . . . 0.0 111.216 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -91.57 114.85 27.49 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 173.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -69.99 120.5 15.8 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.7 pp -139.87 177.72 7.76 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 120.654 0.264 . . . . 0.0 111.329 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -177.71 -45.08 0.07 OUTLIER Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.618 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.0 p -69.51 81.01 0.4 Allowed 'General case' 0 C--O 1.246 0.908 0 CA-C-O 121.63 0.729 . . . . 0.0 112.924 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 8' ' ' ARG . 36.4 mmt180 -117.4 132.58 56.55 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 176.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.33 80.33 1.43 Allowed Glycine 0 N--CA 1.421 -2.304 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 -173.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.0 m -65.27 -30.56 71.44 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.593 0.711 . . . . 0.0 110.612 -177.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 36.8 t -132.12 96.97 4.02 Favored 'General case' 0 N--CA 1.411 -2.421 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -141.32 -159.98 1.03 Allowed 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 37.1 t 66.45 63.5 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 C-N-CA 124.643 1.177 . . . . 0.0 108.249 -174.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.4 t70 72.56 119.65 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 113.509 -1.678 . . . . 0.0 111.875 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.9 mt -84.98 169.88 13.58 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.93 -176.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.54 134.93 45.47 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.676 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.3 -178.08 5.04 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.842 -175.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.437 ' HA ' ' HG3' ' A' ' 24' ' ' ARG . 8.4 tt0 76.6 -12.04 1.09 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.543 1.137 . . . . 0.0 112.928 177.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -50.75 -42.73 57.83 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -176.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.0 t -108.51 4.53 24.26 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.4 t 45.0 69.3 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.538 0 C-N-CA 124.965 1.306 . . . . 0.0 110.524 -171.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.3 tptt -135.04 141.63 46.19 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 103.913 -2.625 . . . . 0.0 103.913 175.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.6 p 61.46 29.16 18.29 Favored 'General case' 0 C--N 1.313 -0.981 0 O-C-N 124.127 0.892 . . . . 0.0 110.326 -176.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.437 ' HG3' ' HA ' ' A' ' 18' ' ' GLN . 24.5 mmm180 -113.34 22.81 13.87 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.098 -177.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.1 t -75.36 -30.7 22.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.768 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.7 m 60.34 84.34 0.12 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.23 1.012 . . . . 0.0 112.426 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -94.03 75.0 4.11 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -101.75 -22.96 14.28 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.398 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -81.04 -17.44 50.2 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 122.198 0.999 . . . . 0.0 109.055 178.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.7 mp -101.88 139.92 36.87 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 176.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -118.35 144.15 46.1 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -89.5 97.2 11.06 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -120.41 69.12 0.86 Allowed 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.2 mp -97.52 -60.36 2.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.716 -176.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -81.79 94.25 7.0 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.51 -175.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.483 ' O ' ' HD2' ' A' ' 40' ' ' LYS . 60.2 tt0 -96.62 -46.32 6.36 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 173.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -136.92 100.61 0.32 Allowed Glycine 0 N--CA 1.422 -2.29 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.668 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -129.23 96.14 4.23 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 176.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 62.8 mtm 63.41 32.77 14.26 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -175.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.483 ' HD2' ' O ' ' A' ' 36' ' ' GLN . 61.7 tttp -81.01 -43.56 19.41 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.407 -172.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -113.33 99.18 7.6 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.728 -171.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -118.33 130.21 55.89 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 174.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.462 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 40.7 m-80 -127.5 136.25 51.49 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.785 -178.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.1 mt -138.21 167.97 20.71 Favored 'General case' 0 C--O 1.249 1.042 0 CA-C-O 122.212 1.006 . . . . 0.0 112.595 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.456 HG21 HG22 ' A' ' 96' ' ' VAL . 0.6 OUTLIER -130.79 140.11 49.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-N 113.865 -1.516 . . . . 0.0 108.243 176.214 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.449 ' CG1' ' HA ' ' A' ' 54' ' ' VAL . 95.4 t -111.24 124.48 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.751 0 CA-C-O 121.538 0.685 . . . . 0.0 111.642 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 68.2 mttm -134.92 144.25 47.36 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.354 -1.294 . . . . 0.0 108.573 176.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -163.38 159.73 22.73 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 177.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -69.06 -32.98 72.83 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.584 0.706 . . . . 0.0 111.051 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 76.2 t -91.96 126.08 44.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.696 ' O ' HG22 ' A' ' 54' ' ' VAL . 13.6 tt0 -62.15 -50.21 72.78 Favored 'General case' 0 C--O 1.198 -1.631 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -173.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.65 0.4 56.39 Favored Glycine 0 C--N 1.29 -2.006 0 C-N-CA 118.537 -1.792 . . . . 0.0 114.427 -175.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 43.0 m -82.09 -24.87 34.96 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 175.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.696 HG22 ' O ' ' A' ' 51' ' ' GLN . 4.1 m -74.97 -46.67 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.313 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.194 175.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -63.37 -46.37 86.81 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.989 -177.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.35 -36.78 84.85 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.241 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 34.4 tp -73.26 -39.98 64.98 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.809 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.49 HG21 ' HB2' ' A' ' 76' ' ' ALA . 53.3 t -57.95 -40.01 74.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 122.738 0.415 . . . . 0.0 110.912 176.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.88 -6.98 45.67 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.52 ' O ' HG12 ' A' ' 64' ' ' ILE . . . -105.28 -34.9 7.73 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 175.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.436 ' HB3' HG13 ' A' ' 73' ' ' ILE . 0.4 OUTLIER -72.49 -32.43 66.18 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.987 -175.48 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -73.02 -18.07 61.38 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.046 0.451 . . . . 0.0 110.812 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.8 5.76 48.71 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 121.319 0.58 . . . . 0.0 111.199 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.52 HG12 ' O ' ' A' ' 60' ' ' ALA . 17.9 mm -92.71 7.18 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-O 122.867 1.318 . . . . 0.0 107.61 175.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -78.92 78.39 5.36 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.337 177.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.6 m -119.98 -176.67 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.631 -175.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -75.46 141.27 43.15 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.607 -178.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 86.99 -60.95 4.39 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.98 -0.554 . . . . 0.0 113.106 177.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.4 t -126.04 112.19 29.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 -176.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -108.34 117.33 33.87 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 176.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.518 ' O ' ' HB ' ' A' ' 64' ' ' ILE . 44.1 t -115.14 107.28 22.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 174.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -139.94 158.0 44.77 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.604 0.716 . . . . 0.0 111.78 -173.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.436 HG13 ' HB3' ' A' ' 61' ' ' LEU . 1.7 pp -94.42 159.68 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.301 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.6 mp -125.66 -28.49 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.814 175.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.409 ' CD2' HD12 ' A' ' 45' ' ' ILE . 3.7 t60 -150.41 132.76 15.54 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 120.882 0.372 . . . . 0.0 110.121 -170.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.49 ' HB2' HG21 ' A' ' 58' ' ' VAL . . . -123.86 140.48 52.94 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 47' ' ' LYS . . . -159.08 140.79 13.39 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.427 ' HB ' ' HA ' ' A' ' 51' ' ' GLN . 3.6 p -94.67 92.93 3.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-O 122.785 1.279 . . . . 0.0 107.552 175.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -177.36 176.2 47.95 Favored Glycine 0 N--CA 1.398 -3.899 0 CA-C-N 114.427 -1.26 . . . . 0.0 110.643 -177.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.64 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -83.96 -168.98 2.36 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 103' ' ' PRO . 3.3 mp -86.57 108.32 17.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.584 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 18.3 p -101.78 151.15 22.4 Favored 'General case' 0 N--CA 1.414 -2.253 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.111 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -45.59 -53.94 8.38 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.341 1.457 . . . . 0.0 113.618 -177.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.3 t -76.08 -14.43 60.2 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 120.68 0.276 . . . . 0.0 111.516 -174.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -77.57 -35.34 53.19 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.548 HD13 ' HB2' ' A' ' 111' ' ' ALA . 40.7 mt -59.73 -26.62 35.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-N 114.379 -1.282 . . . . 0.0 112.078 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.7 m -58.18 -21.57 47.95 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 175.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -80.22 -35.69 35.86 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 174.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.01 -53.54 55.74 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.577 -176.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.51 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 3.3 t -70.58 -24.7 62.82 Favored 'General case' 0 CA--C 1.557 1.247 0 O-C-N 122.017 -0.427 . . . . 0.0 111.707 177.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.32 -52.57 38.83 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -175.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.6 p -105.26 -2.37 24.14 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 122.05 0.929 . . . . 0.0 109.231 -176.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.442 HD22 ' HA ' ' A' ' 93' ' ' ASN . 1.9 t-20 66.73 41.17 3.02 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.223 -1.808 . . . . 0.0 109.365 -177.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -94.24 130.18 40.59 Favored 'General case' 0 N--CA 1.413 -2.32 0 CA-C-N 113.597 -1.638 . . . . 0.0 106.952 177.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 37.8 pt -93.89 142.66 13.0 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.375 0 C-N-CA 119.112 -1.035 . . . . 0.0 108.996 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.484 ' HB ' HG22 ' A' ' 118' ' ' ILE . 10.6 t -93.53 106.37 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.316 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -175.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.498 ' HA ' ' O ' ' A' ' 119' ' ' ARG . 65.5 mt -101.58 117.6 47.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 177.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 120' ' ' LEU . . . -123.32 176.32 16.67 Favored Glycine 0 C--N 1.289 -2.037 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -178.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -148.09 115.93 6.39 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.359 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 8.4 t30 73.91 -27.56 0.19 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 125.586 1.554 . . . . 0.0 113.09 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.456 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 7.8 m -60.92 -53.17 52.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 C-N-CA 124.382 1.073 . . . . 0.0 113.778 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.64 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 61.9 mtp180 73.83 168.47 0.12 Allowed Pre-proline 0 N--CA 1.482 1.132 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 176.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 9.4 Cg_endo -98.41 176.04 0.45 Allowed 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 122.036 1.824 . . . . 0.0 115.006 -177.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.529 ' HB2' ' H ' ' A' ' 107' ' ' ALA . 65.5 m-20 -67.82 159.43 30.35 Favored 'General case' 0 C--O 1.249 1.067 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 168.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.459 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -66.74 -29.43 69.4 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 176.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.592 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 83.9 m-20 -84.95 -27.22 26.68 Favored 'General case' 0 C--O 1.205 -1.27 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.541 175.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.529 ' H ' ' HB2' ' A' ' 104' ' ' ASP . . . -70.11 -41.46 73.96 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.458 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 13.7 ptmm? -59.75 -21.65 61.01 Favored 'General case' 0 CA--C 1.556 1.174 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.404 178.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.592 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 96.1 mtt180 -87.28 -53.8 4.64 Favored 'General case' 0 N--CA 1.384 -3.741 0 C-N-CA 125.44 1.496 . . . . 0.0 109.849 177.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -50.28 -45.27 54.25 Favored 'General case' 0 C--O 1.196 -1.72 0 C-N-CA 124.978 1.311 . . . . 0.0 111.036 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.548 ' HB2' HD13 ' A' ' 86' ' ' ILE . . . -50.49 -46.69 57.2 Favored 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 124.194 0.934 . . . . 0.0 111.886 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -79.75 -29.52 40.55 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.949 -172.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 32.5 t -82.67 3.23 29.87 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.51 ' O ' ' HB ' ' A' ' 90' ' ' THR . 19.1 mt-10 -122.39 11.84 10.05 Favored 'General case' 0 CA--C 1.474 -1.972 0 C-N-CA 124.896 1.278 . . . . 0.0 112.82 -178.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 56.9 mttp 65.89 12.21 8.22 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 174.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.4 m -120.62 135.28 61.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-O 121.454 0.645 . . . . 0.0 112.557 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -96.51 124.4 40.49 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.455 176.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.484 HG22 ' HB ' ' A' ' 96' ' ' VAL . 9.6 pt -92.91 124.55 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.029 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 176.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 41.5 mtm180 -123.23 103.61 8.64 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-O 122.207 1.003 . . . . 0.0 111.494 -171.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.532 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -119.0 138.66 52.66 Favored 'General case' 0 N--CA 1.411 -2.387 0 CA-C-N 113.943 -1.481 . . . . 0.0 110.802 -179.384 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 72.21 -49.33 0.69 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.361 1.064 . . . . 0.0 111.347 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -118.71 131.56 56.14 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 123.669 0.788 . . . . 0.0 109.117 176.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 28.0 pt -112.15 128.74 68.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 173.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 11.5 tt -133.64 141.16 45.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -178.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 54.57 59.08 4.35 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.841 0.856 . . . . 0.0 113.037 -176.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -111.41 164.9 12.44 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 177.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . 0.266 11.9 p -80.82 74.84 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-O 122.782 1.277 . . . . 0.0 113.348 -175.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.7 tt -115.58 -40.58 2.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 113.878 -1.51 . . . . 0.0 107.095 172.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -98.26 100.79 12.11 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 105.439 -2.059 . . . . 0.0 105.439 172.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -65.17 -49.1 71.11 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 115.621 1.712 . . . . 0.0 115.621 -169.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 9.3 tp -134.81 129.98 52.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 C-N-CA 118.385 -1.326 . . . . 0.0 113.333 -173.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -95.56 100.58 12.3 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 169.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -97.42 6.26 48.49 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.72 -174.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 70.23 -47.98 0.63 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 125.097 1.359 . . . . 0.0 112.306 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 46.8 tpp . . . . . 0 C--N 1.303 -1.428 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 177.021 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 . . . . . 0 CA--C 1.496 -1.102 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -89.67 82.48 6.31 Favored 'General case' 0 CA--C 1.481 -1.703 0 CA-C-O 121.98 0.895 . . . . 0.0 110.283 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -165.96 83.79 0.31 Allowed 'General case' 0 C--N 1.276 -2.603 0 CA-C-N 113.395 -1.729 . . . . 0.0 109.463 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -149.75 93.7 2.07 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 174.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 pp -80.13 -12.87 59.62 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.835 0.826 . . . . 0.0 110.484 -178.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 176.79 171.93 40.92 Favored Glycine 0 N--CA 1.416 -2.697 0 N-CA-C 108.735 -1.746 . . . . 0.0 108.735 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.9 m -73.88 -31.05 62.96 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 121.588 0.709 . . . . 0.0 109.221 177.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 23.7 tpp180 -73.08 115.14 12.03 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.952 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.94 66.56 3.92 Favored Glycine 0 N--CA 1.438 -1.181 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 176.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.1 t -88.83 -1.04 57.89 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 122.699 0.4 . . . . 0.0 110.552 -175.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.2 t -104.45 0.81 29.32 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -108.99 -12.18 14.89 Favored 'General case' 0 CA--C 1.516 -0.358 0 O-C-N 121.983 -0.448 . . . . 0.0 111.687 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.9 m -128.8 97.34 3.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.079 0.466 . . . . 0.0 109.944 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.5 t70 66.6 98.89 0.05 OUTLIER 'General case' 0 C--O 1.235 0.326 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.538 -176.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.454 ' HG ' ' NE2' ' A' ' 18' ' ' GLN . 4.4 mm? -65.87 148.74 51.3 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.724 -175.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -86.65 137.33 32.56 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 173.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 63.16 -154.65 0.33 Allowed 'General case' 0 C--O 1.243 0.734 0 O-C-N 124.041 0.838 . . . . 0.0 109.418 -173.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.454 ' NE2' ' HG ' ' A' ' 15' ' ' LEU . 14.3 mt-30 66.41 18.58 10.88 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.495 1.118 . . . . 0.0 110.261 179.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -80.08 -25.37 40.06 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.566 0.698 . . . . 0.0 109.381 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.3 t -102.49 0.23 33.33 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 176.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.401 ' O ' ' HG2' ' A' ' 24' ' ' ARG 0.27 10.0 m 58.74 -13.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 C-N-CA 128.151 2.58 . . . . 0.0 116.155 178.039 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 46.9 pttt -64.47 -39.35 93.64 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 178.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.1 p -98.58 89.31 4.35 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-O 121.331 0.586 . . . . 0.0 111.392 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 21' ' ' VAL . 13.1 ptm180 -150.53 136.33 18.28 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.157 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.3 t -133.81 108.01 11.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 177.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.4 m -97.93 -65.42 0.96 Allowed 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.214 0.53 . . . . 0.0 109.96 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -162.55 44.29 0.13 Allowed 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 104.174 -2.528 . . . . 0.0 104.174 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -65.49 117.0 7.36 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 113.514 -1.675 . . . . 0.0 110.247 -178.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -84.16 -2.78 57.44 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.397 0.618 . . . . 0.0 110.028 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.7 mp -89.02 74.31 8.14 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -99.36 -24.14 14.91 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -83.38 74.88 10.03 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.269 177.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -90.26 2.77 55.1 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 122.468 1.128 . . . . 0.0 109.38 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 24.2 pt -122.51 159.5 25.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-N 113.968 -1.469 . . . . 0.0 107.067 178.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -94.45 110.57 22.35 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.875 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -81.08 -36.83 29.91 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.845 -177.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 179.05 95.52 0.1 OUTLIER Glycine 0 N--CA 1.435 -1.418 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.14 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -119.15 140.78 49.58 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 26.2 mmt 68.22 167.54 0.26 Allowed 'General case' 0 C--O 1.246 0.893 0 C-N-CA 125.792 1.637 . . . . 0.0 112.227 -177.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -125.9 -171.57 2.41 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.549 -175.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -94.67 119.54 33.47 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.348 0.594 . . . . 0.0 111.089 -173.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.57 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 2.5 tm? -102.98 113.9 27.75 Favored 'General case' 0 N--CA 1.411 -2.395 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 176.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.548 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 57.5 m-80 -108.51 145.58 34.53 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.419 -175.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 91.4 mt -136.8 160.31 39.23 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-O 122.042 0.925 . . . . 0.0 112.28 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.549 HG23 ' HA ' ' A' ' 96' ' ' VAL . 0.1 OUTLIER -121.14 130.38 74.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 171.434 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 81.4 t -105.19 133.28 49.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.763 -177.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -144.63 134.38 23.6 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -150.9 168.46 24.44 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -80.39 -28.37 37.93 Favored 'General case' 0 C--N 1.316 -0.854 0 O-C-N 123.971 0.794 . . . . 0.0 109.279 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 90.0 t -96.3 124.88 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 174.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.715 ' O ' HG22 ' A' ' 54' ' ' VAL . 16.2 tt0 -64.22 -49.28 72.6 Favored 'General case' 0 C--O 1.19 -2.075 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -173.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.57 1.94 33.79 Favored Glycine 0 C--N 1.292 -1.886 0 C-N-CA 119.278 -1.439 . . . . 0.0 113.648 -177.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.2 t -83.49 -22.19 32.58 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 177.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.715 HG22 ' O ' ' A' ' 51' ' ' GLN . 4.7 m -81.91 -45.8 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.967 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.263 175.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -60.48 -47.49 85.88 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 114.691 -1.141 . . . . 0.0 111.536 -177.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.69 -32.27 73.7 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.087 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.524 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 25.8 tp -76.47 -39.81 52.19 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.882 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.411 HG13 HG12 ' A' ' 73' ' ' ILE . 24.8 t -53.3 -44.71 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 123.652 0.781 . . . . 0.0 111.573 177.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.84 -21.25 65.2 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.27 -8.52 21.19 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.401 0.62 . . . . 0.0 110.433 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.524 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -97.67 -43.04 7.35 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-N 115.03 -0.987 . . . . 0.0 108.876 -176.879 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -66.06 -20.01 66.03 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.859 0.361 . . . . 0.0 111.414 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -87.71 -0.47 56.95 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.99 -175.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.464 ' HB ' ' HB ' ' A' ' 71' ' ' VAL . 16.3 mt -84.14 93.83 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -140.9 23.62 2.23 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.7 m -97.72 145.5 9.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 114.206 -1.361 . . . . 0.0 112.692 -171.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 63.63 13.4 7.29 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 125.237 1.415 . . . . 0.0 111.995 175.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.59 -9.72 60.67 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.522 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.5 t -93.49 109.04 21.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -177.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 80.5 mtm180 -106.28 111.01 23.42 Favored 'General case' 0 N--CA 1.42 -1.962 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.078 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.57 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 41.4 t -114.22 129.72 69.72 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 177.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -140.39 153.6 46.4 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 120.069 -0.653 . . . . 0.0 111.021 -175.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.411 HG12 HG13 ' A' ' 58' ' ' VAL . 1.5 pp -94.32 141.77 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.071 175.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.403 ' CD1' ' HB3' ' A' ' 43' ' ' ASN . 67.4 mt -111.23 -25.44 3.52 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.472 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.537 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.451 ' O ' HD12 ' A' ' 45' ' ' ILE . 6.1 t60 -161.56 142.86 11.28 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -171.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -146.4 127.32 14.49 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -147.78 153.35 39.11 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.225 -176.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.2 p -94.06 94.57 4.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 122.207 1.003 . . . . 0.0 110.848 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.09 174.43 46.77 Favored Glycine 0 N--CA 1.42 -2.421 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 176.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.541 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -85.58 176.66 8.07 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 173.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.0 mt -79.2 112.55 17.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 122.07 0.148 . . . . 0.0 110.74 -170.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 67.6 p -107.76 165.93 11.07 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.434 ' O ' ' HB ' ' A' ' 86' ' ' ILE . 13.1 pt-20 -66.69 -23.83 66.18 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -174.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.2 t -76.35 -24.82 54.24 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.151 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -70.37 -37.81 74.64 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.532 ' CG2' ' HA ' ' A' ' 111' ' ' ALA . 48.2 mm -56.59 -38.86 59.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 113.868 -1.514 . . . . 0.0 111.35 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.7 m -58.66 -28.37 65.66 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.29 -178.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -76.02 -37.22 58.67 Favored 'General case' 0 C--O 1.251 1.157 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.97 -46.98 87.69 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.135 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.496 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 7.5 t -77.8 -23.06 49.21 Favored 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.138 177.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.04 -67.68 0.43 Allowed 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -176.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 33.5 t -99.01 4.88 47.29 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.283 -175.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 70.76 68.64 0.19 Allowed 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 124.405 1.082 . . . . 0.0 112.189 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -119.86 166.87 12.72 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 113.992 -1.458 . . . . 0.0 108.546 174.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 47.9 mm -121.38 144.49 30.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 174.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.549 ' HA ' HG23 ' A' ' 45' ' ' ILE . 19.9 t -94.63 119.76 43.09 Favored 'Isoleucine or valine' 0 C--O 1.249 1.035 0 CA-C-O 120.974 0.416 . . . . 0.0 110.097 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.1 mp -107.94 111.32 35.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 174.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -99.5 136.39 12.66 Favored Glycine 0 N--CA 1.413 -2.89 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -95.41 93.37 7.19 Favored 'General case' 0 C--N 1.29 -1.996 0 C-N-CA 118.543 -1.263 . . . . 0.0 109.665 -176.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.53 ' OD1' ' HA ' ' A' ' 121' ' ' HIS . 90.9 m-20 54.59 28.91 10.52 Favored 'General case' 0 C--O 1.212 -0.918 0 C-N-CA 123.856 0.862 . . . . 0.0 111.621 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 m -96.58 -46.71 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.984 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -175.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.541 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 63.5 mtm180 75.39 155.09 0.15 Allowed Pre-proline 0 N--CA 1.471 0.583 0 C-N-CA 124.0 0.92 . . . . 0.0 111.455 178.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -89.59 167.73 5.0 Favored 'Trans proline' 0 N--CA 1.432 -2.099 0 C-N-CA 121.475 1.45 . . . . 0.0 115.269 -175.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -75.36 156.66 35.24 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 112.6 -2.091 . . . . 0.0 106.906 170.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.507 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -61.27 -32.72 72.55 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.499 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 77.6 m-20 -87.01 -24.9 24.49 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.63 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.41 -44.03 79.8 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.609 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 17.2 ptpt -57.67 -35.2 70.25 Favored 'General case' 0 CA--C 1.562 1.437 0 O-C-N 123.575 0.547 . . . . 0.0 110.465 177.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.499 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 98.2 mtt180 -72.49 -55.91 6.24 Favored 'General case' 0 N--CA 1.385 -3.686 0 C-N-CA 125.762 1.625 . . . . 0.0 109.402 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -53.82 -47.47 70.86 Favored 'General case' 0 C--O 1.198 -1.626 0 CA-C-N 113.806 -1.543 . . . . 0.0 110.067 -177.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.532 ' HA ' ' CG2' ' A' ' 86' ' ' ILE . . . -48.54 -48.09 38.78 Favored 'General case' 0 CA--C 1.489 -1.386 0 O-C-N 124.618 1.199 . . . . 0.0 111.47 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -77.36 -35.44 54.57 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.872 -174.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 45.4 t -77.61 -3.13 39.3 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 177.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.496 ' O ' ' HB ' ' A' ' 90' ' ' THR . 16.3 mt-10 -113.28 11.94 18.78 Favored 'General case' 0 CA--C 1.468 -2.188 0 C-N-CA 124.388 1.075 . . . . 0.0 112.386 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 55.3 mttp 67.48 11.77 8.55 Favored 'General case' 0 N--CA 1.416 -2.148 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 174.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.7 m -119.85 118.77 58.18 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 121.769 0.795 . . . . 0.0 112.602 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -94.22 124.92 38.55 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.514 HG22 ' HB ' ' A' ' 96' ' ' VAL . 8.4 pt -94.21 144.29 9.95 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-O 121.182 0.515 . . . . 0.0 111.059 -176.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -126.91 132.59 50.85 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.204 0.526 . . . . 0.0 109.87 -176.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.502 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -160.89 163.82 31.69 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.028 -173.278 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.53 ' HA ' ' OD1' ' A' ' 100' ' ' ASN . 28.3 t-80 71.88 113.63 0.06 Allowed 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.704 1.252 . . . . 0.0 112.727 174.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -81.1 144.58 31.6 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.647 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 25.2 pt -93.52 158.76 2.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.237 -177.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 36.0 mt 67.75 23.94 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.538 0 CA-C-O 122.915 1.341 . . . . 0.0 108.976 -176.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -102.21 -62.96 1.2 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.612 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -86.68 21.91 2.07 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 122.76 1.267 . . . . 0.0 109.647 -178.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.4 p -78.69 -13.91 13.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 176.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.8 mt -99.46 32.78 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 177.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -60.68 -34.91 75.04 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.855 177.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -96.25 117.45 30.8 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 171.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 49.7 mt -66.03 -30.26 49.41 Favored 'Isoleucine or valine' 0 C--O 1.244 0.807 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -170.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -83.44 -1.37 53.37 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -92.21 83.57 5.1 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.88 -22.19 18.78 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.554 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 92.1 mmm . . . . . 0 CA--C 1.499 -0.996 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 176.414 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 . . . . . 0 CA--C 1.505 -0.768 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -101.61 164.39 11.77 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -154.47 74.5 0.95 Allowed 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 176.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -103.45 131.27 50.69 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.144 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.1 mp -105.53 -5.18 20.43 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.497 0.665 . . . . 0.0 109.558 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.83 -89.06 1.39 Allowed Glycine 0 N--CA 1.433 -1.528 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.24 177.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.5 t -165.14 101.4 0.75 Allowed 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 121.942 0.877 . . . . 0.0 110.255 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -142.74 168.43 19.74 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 148.23 129.45 1.86 Allowed Glycine 0 N--CA 1.423 -2.184 0 C-N-CA 119.928 -1.129 . . . . 0.0 112.616 177.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.7 t -98.83 -33.85 10.72 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 177.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.1 t -76.31 -5.88 49.02 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.104 -177.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -82.17 -9.77 59.4 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 174.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.4 t -107.16 -51.86 7.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 176.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -97.58 99.05 10.43 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.6 mp -99.76 -59.44 1.71 Allowed 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.339 0.59 . . . . 0.0 111.309 -178.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -109.92 -46.46 3.47 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.943 -177.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -84.56 140.69 31.23 Favored 'General case' 0 CA--C 1.483 -1.634 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.045 -176.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.401 ' OE1' ' HG2' ' A' ' 24' ' ' ARG . 28.5 tt0 67.9 -60.02 0.41 Allowed 'General case' 0 CA--C 1.537 0.451 0 O-C-N 124.821 1.326 . . . . 0.0 112.79 178.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 56.65 -79.81 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.223 1.809 . . . . 0.0 113.345 -176.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.3 t -135.65 37.11 2.89 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . 0.456 34.1 m 62.03 62.53 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 126.454 1.902 . . . . 0.0 115.357 -178.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -93.55 -68.89 0.78 Allowed 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 171.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.428 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 8.9 p -93.06 86.71 5.48 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.184 178.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.428 ' HB2' ' O ' ' A' ' 23' ' ' THR . 3.0 tpp180 177.57 -28.41 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.637 -177.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 36.0 m -128.05 160.3 38.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 120.833 0.349 . . . . 0.0 111.119 -175.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.8 m -112.71 155.91 23.7 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.368 178.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 57.2 tp -138.26 142.13 39.88 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 177.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -94.18 132.38 38.78 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.154 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -100.42 -37.2 8.94 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 176.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.1 mp -97.32 137.29 36.54 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.13 177.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -128.71 148.05 50.8 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -93.75 128.56 40.04 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.095 0.474 . . . . 0.0 111.947 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -112.37 128.06 56.19 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 60.8 mt -125.87 132.11 71.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -173.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -119.22 173.77 6.74 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-O 121.178 0.513 . . . . 0.0 111.827 177.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -98.08 167.01 11.15 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.876 -177.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 144.14 -20.79 2.11 Favored Glycine 0 N--CA 1.432 -1.604 0 C-N-CA 119.876 -1.154 . . . . 0.0 113.751 176.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -136.89 144.4 43.51 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.284 -176.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 85.3 mmm 79.58 156.84 0.15 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.712 1.605 . . . . 0.0 112.327 176.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? 64.41 27.44 13.6 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.05 0.94 . . . . 0.0 109.885 -173.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -98.46 94.71 6.86 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.103 -176.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -100.23 94.91 6.46 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 176.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -96.84 134.62 39.92 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 114.539 -1.209 . . . . 0.0 109.053 -175.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 95.8 mt -137.19 158.34 44.66 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.613 0.72 . . . . 0.0 112.114 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.706 HG23 ' HA ' ' A' ' 96' ' ' VAL . 0.4 OUTLIER -122.04 132.73 70.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.808 170.509 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 97.7 t -111.05 126.84 68.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.944 -176.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.491 ' O ' ' HA2' ' A' ' 98' ' ' GLY . 74.1 mttt -137.0 147.7 46.43 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.283 -0.872 . . . . 0.0 108.964 173.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.21 170.74 19.81 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 120.827 0.346 . . . . 0.0 110.562 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -72.7 -29.87 63.74 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.438 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 75.8 t -113.32 134.15 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.645 ' O ' HG22 ' A' ' 54' ' ' VAL . 12.4 tt0 -60.36 -52.37 65.55 Favored 'General case' 0 C--O 1.2 -1.514 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -175.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.65 5.15 31.75 Favored Glycine 0 C--N 1.292 -1.875 0 C-N-CA 118.327 -1.892 . . . . 0.0 114.305 -176.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.0 m -88.38 -21.03 24.54 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 174.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.645 HG22 ' O ' ' A' ' 51' ' ' GLN . 3.6 m -76.26 -46.04 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 174.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -67.0 -35.6 80.29 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.475 -1.239 . . . . 0.0 112.079 -176.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.73 -33.65 75.57 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.303 0.573 . . . . 0.0 110.257 176.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 31.3 tp -79.87 -45.99 17.64 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 54' ' ' VAL . 56.1 t -55.88 -44.21 77.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 124.037 0.935 . . . . 0.0 112.264 179.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.66 -20.84 65.23 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -177.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.47 ' O ' HG12 ' A' ' 64' ' ' ILE . . . -98.1 -28.78 13.59 Favored 'General case' 0 C--O 1.202 -1.426 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.71 -33.82 60.35 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 114.023 -1.444 . . . . 0.0 110.265 -176.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -72.64 -20.66 61.23 Favored 'General case' 0 C--N 1.315 -0.908 0 O-C-N 122.061 -0.399 . . . . 0.0 111.159 177.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? -97.19 6.14 48.94 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 179.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.603 ' HB ' ' O ' ' A' ' 71' ' ' VAL . 18.7 mm -83.12 81.07 1.56 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-O 121.81 0.814 . . . . 0.0 109.416 177.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.447 ' O ' ' HG2' ' A' ' 70' ' ' ARG . 3.4 t70 -101.25 -53.48 3.01 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.235 177.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.4 t 62.02 -79.59 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.47 0 C-N-CA 125.046 1.338 . . . . 0.0 111.882 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -176.91 -71.21 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -99.94 -50.87 1.32 Allowed Glycine 0 CA--C 1.492 -1.406 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.86 -176.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.0 t -93.35 109.02 21.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 -176.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.447 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 67.9 mtt180 -114.53 133.85 55.47 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -178.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.603 ' O ' ' HB ' ' A' ' 64' ' ' ILE . 23.0 t -122.91 110.92 27.86 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 178.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -137.5 157.48 46.46 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-O 121.803 0.811 . . . . 0.0 110.589 -174.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 pp -93.83 157.97 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.177 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.413 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 74.3 mt -119.99 -31.04 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.463 177.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.499 ' CD2' HD12 ' A' ' 45' ' ' ILE . 6.4 t60 -151.55 131.97 13.78 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -171.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -139.24 129.31 25.15 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.108 0.963 . . . . 0.0 109.458 -175.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -154.08 157.59 39.21 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.505 -178.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.491 ' HB ' ' HA ' ' A' ' 51' ' ' GLN . 5.1 p -94.49 94.99 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-O 122.132 0.968 . . . . 0.0 108.611 176.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -175.57 175.95 47.33 Favored Glycine 0 N--CA 1.401 -3.698 0 C-N-CA 120.186 -1.006 . . . . 0.0 110.858 -177.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.584 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -87.46 173.12 9.31 Favored 'General case' 0 C--N 1.282 -2.35 0 O-C-N 124.112 0.536 . . . . 0.0 109.721 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.526 HD13 HD11 ' A' ' 120' ' ' LEU . 1.9 mp -75.49 107.76 6.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.65 152.66 22.85 Favored 'General case' 0 N--CA 1.401 -2.91 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.047 -178.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.432 ' HG3' ' HB2' ' A' ' 110' ' ' ALA . 41.7 tt0 -54.24 -45.39 72.31 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 124.029 0.831 . . . . 0.0 112.547 -174.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.9 p -69.8 -18.71 63.49 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -81.51 -25.37 36.01 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-O 121.603 0.716 . . . . 0.0 110.128 177.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.556 HG21 ' HA ' ' A' ' 111' ' ' ALA . 42.0 mt -72.51 -20.57 19.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.681 178.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.0 m -60.13 -26.8 66.55 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.05 175.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -79.64 -38.58 33.46 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.97 177.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.01 -58.68 6.4 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.338 -176.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.613 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 2.3 t -68.15 -28.22 67.11 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.507 177.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.04 -65.49 0.68 Allowed 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.19 0.519 . . . . 0.0 111.514 -177.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.5 m -93.69 6.0 49.78 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.888 -176.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 67.87 33.0 4.94 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.901 0.858 . . . . 0.0 109.937 177.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.53 153.1 18.05 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.439 -178.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 41.4 mm -107.72 141.21 23.52 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.146 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.706 ' HA ' HG23 ' A' ' 45' ' ' ILE . 10.7 t -94.8 120.47 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 65.8 mt -112.94 120.28 62.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 177.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 47' ' ' LYS . . . -139.83 171.06 24.0 Favored Glycine 0 N--CA 1.427 -1.902 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 178.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.444 ' C ' ' H ' ' A' ' 101' ' ' VAL . 30.4 p90 -158.77 134.57 8.87 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 117.66 0.73 . . . . 0.0 111.324 -178.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 72.84 -23.46 0.21 Allowed 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 125.403 1.481 . . . . 0.0 112.874 178.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.511 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 2.3 m -77.64 -49.71 21.56 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.099 177.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.584 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 53.0 mtm180 72.68 170.82 0.11 Allowed Pre-proline 0 C--N 1.352 0.692 0 O-C-N 124.164 0.915 . . . . 0.0 111.368 177.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -91.99 169.46 2.92 Favored 'Trans proline' 0 N--CA 1.443 -1.455 0 CA-C-N 120.534 1.226 . . . . 0.0 113.718 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -79.0 149.61 32.17 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 169.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.573 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -59.3 -26.53 65.05 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.625 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 16.7 m120 -80.01 -30.7 39.66 Favored 'General case' 0 C--N 1.315 -0.926 0 O-C-N 121.847 -0.533 . . . . 0.0 109.863 177.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.67 -43.05 63.62 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.256 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 21.2 ptmt -59.81 -24.71 64.36 Favored 'General case' 0 CA--C 1.559 1.324 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.735 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.625 ' HB2' ' O ' ' A' ' 106' ' ' ASN 0.287 38.4 mtm180 -77.51 -56.77 4.25 Favored 'General case' 0 N--CA 1.395 -3.176 0 C-N-CA 125.935 1.694 . . . . 0.0 108.217 175.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.432 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . . . -49.46 -47.88 48.02 Favored 'General case' 0 CA--C 1.482 -1.648 0 CA-C-N 113.545 -1.661 . . . . 0.0 111.362 -176.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.556 ' HA ' HG21 ' A' ' 86' ' ' ILE . . . -48.07 -42.76 29.51 Favored 'General case' 0 CA--C 1.505 -0.777 0 O-C-N 124.518 1.136 . . . . 0.0 111.349 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -84.29 -23.7 30.19 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -173.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 30.8 t -85.59 -1.67 57.36 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-O 123.173 1.463 . . . . 0.0 107.254 174.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.613 ' O ' ' HB ' ' A' ' 90' ' ' THR . 35.2 mt-10 -120.56 13.0 11.65 Favored 'General case' 0 N--CA 1.404 -2.754 0 CA-C-N 113.638 -1.619 . . . . 0.0 112.811 -177.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 92.4 mttt 63.09 13.0 6.42 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 172.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.2 m -119.14 138.53 49.53 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-O 121.875 0.845 . . . . 0.0 112.777 -176.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -99.52 126.57 45.49 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.919 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.445 HG22 ' HB ' ' A' ' 96' ' ' VAL . 6.5 pt -94.05 133.79 33.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.255 0.55 . . . . 0.0 111.369 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -98.39 122.01 41.04 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.652 -177.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.526 HD11 HD13 ' A' ' 81' ' ' ILE . 3.8 mm? -128.68 164.77 22.2 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.617 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -67.35 125.98 27.82 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 106.257 -1.756 . . . . 0.0 106.257 169.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -63.84 140.52 58.88 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 123.906 0.754 . . . . 0.0 112.643 -173.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.9 mp -119.04 121.03 65.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 173.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 63.6 mt -93.2 94.49 4.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 C-N-CA 119.911 -0.716 . . . . 0.0 109.107 178.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 68.96 -82.86 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.416 1.486 . . . . 0.0 110.51 -178.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -149.82 143.92 25.66 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 20.6 m -92.95 168.8 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 176.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 32.4 pt -78.49 85.22 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 122.58 1.181 . . . . 0.0 109.216 173.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -89.63 8.0 33.63 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 113.876 -1.511 . . . . 0.0 109.566 -174.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -69.99 124.57 24.4 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.598 177.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 7.7 tt -73.22 -52.51 21.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -176.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -91.23 70.3 6.14 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 123.08 1.419 . . . . 0.0 112.082 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -115.72 21.17 14.12 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 112.905 -1.952 . . . . 0.0 108.485 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -111.55 81.75 1.5 Allowed 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.244 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 43.9 tpp . . . . . 0 C--N 1.304 -1.395 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 178.631 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 62.9 t30 . . . . . 0 N--CA 1.474 0.77 0 CA-C-O 121.274 0.559 . . . . 0.0 109.896 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.24 -51.58 67.17 Favored 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 124.32 1.048 . . . . 0.0 111.147 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 66.72 157.5 0.12 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.617 1.167 . . . . 0.0 112.882 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -93.1 -55.77 3.21 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.2 mt -150.25 139.18 20.97 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 124.05 0.94 . . . . 0.0 108.928 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.2 -166.74 34.14 Favored Glycine 0 C--N 1.303 -1.273 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.6 p 58.34 172.47 0.06 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.249 1.419 . . . . 0.0 114.096 -178.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 65.44 -81.42 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.66 1.184 . . . . 0.0 112.548 177.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.65 -47.49 86.19 Favored Glycine 0 CA--C 1.501 -0.782 0 N-CA-C 111.969 -0.452 . . . . 0.0 111.969 -175.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.5 p -77.92 2.92 15.92 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.154 0.502 . . . . 0.0 111.816 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.1 m -118.24 11.06 13.05 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 121.133 0.492 . . . . 0.0 110.619 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -128.69 11.33 6.18 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.408 0.623 . . . . 0.0 109.362 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.0 m -77.82 132.03 33.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.847 -173.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 59.86 40.26 19.48 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 114.916 -1.038 . . . . 0.0 113.575 176.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.3 mt -79.01 85.72 4.92 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 172.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -78.08 94.35 4.67 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.444 -177.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -111.88 -170.27 1.62 Allowed 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.209 -177.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.513 ' HA ' ' HG3' ' A' ' 24' ' ' ARG . 9.0 tt0 83.46 -20.17 0.34 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.566 1.546 . . . . 0.0 112.496 178.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -49.44 -43.58 44.86 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 124.253 1.021 . . . . 0.0 112.165 -177.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.5 m -122.09 15.87 10.74 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.029 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.6 m 44.11 23.47 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.824 0 C-N-CA 125.734 1.614 . . . . 0.0 114.174 -176.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.7 tptm -67.55 -53.11 31.16 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 123.944 0.897 . . . . 0.0 110.92 -174.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 20.1 p -103.49 31.53 4.32 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-O 121.356 0.598 . . . . 0.0 110.286 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.592 ' HA ' ' NE ' ' A' ' 24' ' ' ARG . 4.6 mmp_? -99.57 101.21 12.36 Favored 'General case' 0 CA--C 1.485 -1.521 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -174.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.7 t -102.52 94.96 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.343 0 N-CA-C 104.114 -2.55 . . . . 0.0 104.114 167.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.1 m -67.71 -31.04 70.7 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.495 -174.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.543 HD22 HD22 ' A' ' 30' ' ' LEU . 27.3 mt -109.82 82.52 1.61 Allowed 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -73.65 -37.53 65.28 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.756 -175.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -130.08 -75.93 0.54 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.543 HD22 HD22 ' A' ' 27' ' ' LEU . 17.1 tp 51.91 41.55 29.58 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.882 1.273 . . . . 0.0 111.881 177.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -67.88 111.79 4.55 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 67.97 101.56 0.05 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.63 1.172 . . . . 0.0 109.451 -171.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -94.03 140.75 29.34 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 121.721 0.772 . . . . 0.0 112.947 -174.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.2 tp -131.7 -17.86 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 CA-C-N 114.436 -1.256 . . . . 0.0 107.634 170.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 62.5 mttp 72.05 -70.29 0.16 Allowed 'General case' 0 C--N 1.357 0.919 0 C-N-CA 125.647 1.579 . . . . 0.0 110.18 -177.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -144.79 148.81 34.51 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -83.75 61.37 4.75 Favored Glycine 0 C--N 1.312 -0.798 0 N-CA-C 111.886 -0.486 . . . . 0.0 111.886 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -167.08 134.42 2.44 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 123.891 0.877 . . . . 0.0 109.092 -178.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 51.9 ttm -131.93 91.4 2.97 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 174.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -88.19 169.32 11.99 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.343 178.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -94.59 94.23 8.05 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 170.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.522 ' HB2' ' HA ' ' A' ' 71' ' ' VAL . 1.3 pt? -132.17 92.13 3.06 Favored 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -143.48 131.85 22.14 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.659 -168.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 74.7 mt -140.15 155.19 47.07 Favored 'General case' 0 C--O 1.258 1.51 0 O-C-N 123.717 0.636 . . . . 0.0 110.513 174.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.503 HG23 ' HA ' ' A' ' 96' ' ' VAL . 0.4 OUTLIER -120.6 135.07 62.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.03 176.63 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 72.5 t -109.7 126.87 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.869 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.334 -176.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.426 ' O ' ' HA2' ' A' ' 98' ' ' GLY . 23.1 mmtp -142.06 119.35 11.5 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 125.09 1.356 . . . . 0.0 109.858 -179.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -140.18 164.42 30.1 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -178.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.17 -17.08 44.13 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -178.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 86.1 t -105.03 122.59 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.354 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 175.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.751 ' O ' HG22 ' A' ' 54' ' ' VAL . 15.4 tm0? -58.14 -48.88 78.88 Favored 'General case' 0 C--O 1.202 -1.421 0 C-N-CA 122.948 0.499 . . . . 0.0 111.686 -174.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.77 0.8 81.06 Favored Glycine 0 C--N 1.285 -2.273 0 C-N-CA 117.693 -2.194 . . . . 0.0 113.912 -176.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 70.7 m -86.96 -20.86 26.68 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 176.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.751 HG22 ' O ' ' A' ' 51' ' ' GLN . 9.3 m -72.23 -43.23 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.449 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 172.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -62.68 -42.81 99.82 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.968 177.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.04 -35.05 78.95 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.923 0.392 . . . . 0.0 110.676 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.473 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 24.8 tp -76.57 -38.96 54.1 Favored 'General case' 0 C--O 1.208 -1.112 0 C-N-CA 120.456 -0.497 . . . . 0.0 109.711 177.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 54' ' ' VAL . 45.2 t -57.8 -44.49 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 122.746 0.419 . . . . 0.0 110.693 175.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.67 -18.18 64.74 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 123.229 0.612 . . . . 0.0 111.62 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.56 -19.71 15.37 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.153 0.501 . . . . 0.0 109.799 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.477 ' HA ' HG12 ' A' ' 64' ' ' ILE . 0.2 OUTLIER -88.85 -36.85 15.77 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.034 -175.523 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -65.43 -26.16 67.84 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.011 0.434 . . . . 0.0 110.328 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.59 6.18 48.22 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.027 -179.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.477 HG12 ' HA ' ' A' ' 61' ' ' LEU . 31.8 mm -73.07 84.95 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 175.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -160.14 92.32 0.99 Allowed 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.404 HG12 ' HG2' ' A' ' 67' ' ' GLU . 24.1 t -120.41 -76.48 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.404 ' HG2' HG12 ' A' ' 66' ' ' VAL . 9.3 pt-20 -162.62 133.16 4.73 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 114.285 -1.325 . . . . 0.0 107.761 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.99 -65.41 3.56 Favored Glycine 0 C--N 1.314 -0.641 0 N-CA-C 111.8 -0.52 . . . . 0.0 111.8 178.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.7 p -94.86 118.05 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 CA-C-O 122.044 0.926 . . . . 0.0 109.841 178.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -137.4 127.39 25.83 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 177.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.522 ' HA ' ' HB2' ' A' ' 42' ' ' LEU . 9.9 t -145.49 156.21 13.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -139.58 160.34 40.09 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 175.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.425 HG23 ' HG ' ' A' ' 61' ' ' LEU . 1.4 pp -94.43 164.05 2.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.828 178.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 70.7 mt -120.24 -41.67 2.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 121.523 0.677 . . . . 0.0 110.453 175.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.471 ' CD2' HD12 ' A' ' 45' ' ' ILE . 2.4 t60 -144.17 131.92 21.31 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.909 -168.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -142.88 134.96 27.18 Favored 'General case' 0 CA--C 1.503 -0.848 0 C-N-CA 124.26 1.024 . . . . 0.0 108.472 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.484 ' O ' HG11 ' A' ' 54' ' ' VAL . . . -160.82 164.86 31.08 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.481 ' HB ' ' HA ' ' A' ' 51' ' ' GLN . 7.1 p -93.34 98.51 8.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-O 122.423 1.106 . . . . 0.0 109.542 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.25 172.93 45.9 Favored Glycine 0 N--CA 1.406 -3.341 0 C-N-CA 120.052 -1.071 . . . . 0.0 110.572 -178.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.619 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -88.68 -166.86 1.7 Allowed 'General case' 0 N--CA 1.412 -2.33 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.489 HG13 HG11 ' A' ' 96' ' ' VAL . 2.6 mp -91.33 120.81 40.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 177.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.403 ' HA ' ' HB2' ' A' ' 107' ' ' ALA . 10.9 p -121.23 158.32 28.35 Favored 'General case' 0 C--N 1.317 -0.833 0 O-C-N 123.314 0.384 . . . . 0.0 110.157 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.73 -39.57 77.6 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -176.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.1 m -75.59 -8.74 57.53 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 120.913 0.387 . . . . 0.0 111.544 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -95.51 -30.99 13.55 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.502 HG21 ' HA ' ' A' ' 111' ' ' ALA . 31.0 mm -58.18 -31.96 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-N 114.46 -1.245 . . . . 0.0 111.355 174.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 25.8 m -58.53 -31.57 68.05 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.603 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -72.86 -35.23 67.16 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 176.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 94' ' ' ALA . . . -58.03 -52.92 63.54 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.29 -178.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.486 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 3.4 t -71.93 -30.96 65.87 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.995 177.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.76 -63.05 1.43 Allowed 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 40.6 m -97.62 5.26 49.68 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -175.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.1 m120 67.34 28.07 8.0 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.629 0.728 . . . . 0.0 110.88 178.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . -94.46 129.85 41.07 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 36.2 pt -93.47 150.52 3.91 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.503 ' HA ' HG23 ' A' ' 45' ' ' ILE . 18.3 t -94.11 112.56 27.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-O 121.349 0.595 . . . . 0.0 109.551 -176.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 54.9 mt -98.88 98.1 6.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 47' ' ' LYS . . . -94.78 151.57 20.16 Favored Glycine 0 N--CA 1.427 -1.965 0 C-N-CA 119.998 -1.096 . . . . 0.0 111.852 -176.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.405 ' C ' ' H ' ' A' ' 101' ' ' VAL . 23.8 m-85 -125.22 118.37 25.87 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -176.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 64.8 t30 70.08 -33.22 0.25 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 125.449 1.5 . . . . 0.0 113.018 178.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 0.7 OUTLIER -53.35 -71.74 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 117.739 2.496 . . . . 0.0 117.739 -177.673 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.619 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 0.0 OUTLIER 84.33 164.03 0.11 Allowed Pre-proline 0 N--CA 1.478 0.949 0 C-N-CA 124.573 1.149 . . . . 0.0 111.178 -170.225 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.409 ' HD3' HD21 ' A' ' 120' ' ' LEU . 2.1 Cg_endo -88.65 171.43 5.08 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 C-N-CA 121.446 1.431 . . . . 0.0 113.509 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -83.33 155.46 23.55 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 113.728 -1.578 . . . . 0.0 107.142 169.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.448 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -60.64 -24.39 65.51 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -178.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.588 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 22.3 m-80 -89.81 -27.8 19.73 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.403 ' HB2' ' HA ' ' A' ' 82' ' ' THR . . . -71.77 -38.39 70.36 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.163 -178.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -61.79 -27.04 68.47 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.961 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.588 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 62.6 mtp180 -79.38 -55.22 5.23 Favored 'General case' 0 N--CA 1.383 -3.779 0 C-N-CA 125.382 1.473 . . . . 0.0 109.623 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.18 -46.54 69.01 Favored 'General case' 0 C--O 1.198 -1.623 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.872 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.502 ' HA ' HG21 ' A' ' 86' ' ' ILE . . . -48.53 -48.29 38.49 Favored 'General case' 0 CA--C 1.491 -1.319 0 O-C-N 124.413 1.071 . . . . 0.0 111.918 -178.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -78.7 -33.91 46.51 Favored 'General case' 0 N--CA 1.401 -2.884 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.844 -172.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 32.2 t -77.2 -0.38 24.91 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.486 ' O ' ' HB ' ' A' ' 90' ' ' THR . 21.0 mt-10 -120.23 11.47 11.57 Favored 'General case' 0 N--CA 1.405 -2.684 0 CA-C-N 114.389 -1.278 . . . . 0.0 112.558 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 52.8 mttp 67.68 8.86 6.67 Favored 'General case' 0 N--CA 1.42 -1.955 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 173.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.1 m -112.32 127.1 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.63 0 CA-C-O 121.722 0.773 . . . . 0.0 112.413 -178.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -94.75 122.66 37.6 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.011 -178.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 16.8 pt -106.59 138.44 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.465 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -151.51 147.22 26.56 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.466 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 2.9 mm? -107.32 162.75 13.62 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -170.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 40.1 t-80 76.16 -57.04 0.57 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 113.53 -1.668 . . . . 0.0 113.015 169.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 52.9 mtt-85 44.29 83.16 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 9.5 tp -101.7 2.04 10.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-O 122.418 1.104 . . . . 0.0 108.502 176.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.1 mm -76.25 90.04 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.277 -178.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 79.7 t80 177.94 -50.25 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -111.57 107.52 16.71 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 106.255 -1.758 . . . . 0.0 106.255 175.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 91.4 t 78.92 103.94 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.508 0 O-C-N 124.619 1.199 . . . . 0.0 108.274 -170.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 70.6 mt 78.96 87.9 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 C-N-CA 124.876 1.27 . . . . 0.0 111.509 -176.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -119.91 -28.52 5.16 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 173.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -83.15 32.89 0.44 Allowed 'General case' 0 C--O 1.242 0.704 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.56 -178.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 9.1 tp -84.99 -12.14 11.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 176.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -122.71 143.28 49.9 Favored 'General case' 0 N--CA 1.425 -1.675 0 CA-C-N 113.987 -1.46 . . . . 0.0 108.318 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -143.69 118.25 9.76 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.67 81.03 8.6 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.333 0.587 . . . . 0.0 109.636 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 24.7 mmt . . . . . 0 C--N 1.305 -1.344 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.219 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 . . . . . 0 N--CA 1.469 0.519 0 CA-C-O 120.774 0.321 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -129.76 137.07 50.33 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -178.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -90.55 80.44 6.02 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.939 0.876 . . . . 0.0 110.743 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -84.1 120.09 25.75 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -83.9 91.35 7.56 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -176.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.17 -179.95 16.23 Favored Glycine 0 C--N 1.301 -1.412 0 N-CA-C 110.091 -1.203 . . . . 0.0 110.091 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.0 t 49.24 -165.53 0.03 OUTLIER 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 125.551 1.54 . . . . 0.0 112.153 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.418 ' HD3' ' C ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -132.58 -49.32 0.9 Allowed 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 176.213 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.04 83.9 0.04 OUTLIER Glycine 0 N--CA 1.421 -2.337 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.2 m -58.78 -61.95 2.23 Favored 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 123.295 0.638 . . . . 0.0 110.08 -177.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.4 m -89.61 63.0 6.08 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 121.479 0.657 . . . . 0.0 112.021 -176.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -155.58 -38.57 0.08 Allowed 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.578 173.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.7 m -89.07 -36.14 8.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 174.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -122.15 116.59 24.46 Favored 'General case' 0 N--CA 1.424 -1.755 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.153 179.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.554 ' O ' ' HG2' ' A' ' 19' ' ' ARG . 5.8 mp -113.98 117.96 32.78 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 174.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -52.51 -34.17 48.37 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.807 0.843 . . . . 0.0 111.187 -175.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -73.32 -53.6 10.42 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.898 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.484 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 34.3 tt0 -63.17 -29.62 70.93 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.782 -175.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.554 ' HG2' ' O ' ' A' ' 15' ' ' LEU . 31.5 mmm180 -65.49 -34.32 78.0 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.083 0.468 . . . . 0.0 111.528 -176.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.3 m -113.55 17.75 18.09 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . 0.266 34.7 m 48.17 16.83 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 C-N-CA 127.213 2.205 . . . . 0.0 115.171 -177.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -73.18 134.77 44.5 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 72.1 p 69.85 -0.73 2.59 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 125.889 1.676 . . . . 0.0 112.362 -175.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -103.29 -60.07 1.61 Allowed 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 174.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.7 t -103.88 93.78 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 107.229 -1.396 . . . . 0.0 107.229 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.3 m -117.17 156.43 27.68 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.321 -176.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.6 pp -112.47 13.76 20.19 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.616 0.722 . . . . 0.0 109.449 177.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.3 t70 65.45 -91.24 0.03 OUTLIER 'General case' 0 C--O 1.242 0.682 0 C-N-CA 125.22 1.408 . . . . 0.0 109.511 -174.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.7 t70 175.5 117.61 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 176.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 pp -137.18 -13.97 1.56 Allowed 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 66.51 -67.44 0.16 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.646 1.178 . . . . 0.0 110.408 -174.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -151.23 -64.03 0.19 Allowed 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 173.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 50.29 81.55 0.06 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.741 1.216 . . . . 0.0 111.791 175.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 24.7 pt -114.12 163.32 11.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-O 120.76 0.314 . . . . 0.0 110.947 -178.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -93.98 -174.75 3.5 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -178.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -138.9 74.07 1.46 Allowed 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 122.151 0.977 . . . . 0.0 109.586 171.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.39 38.94 3.12 Favored Glycine 0 CA--C 1.509 -0.336 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.741 -176.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -84.54 175.83 9.02 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.8 mtt -74.93 -55.01 6.22 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 173.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.8 tttp 61.47 23.87 14.07 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.137 0.975 . . . . 0.0 110.371 174.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -115.73 111.57 20.77 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.214 -178.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.459 ' C ' HD22 ' A' ' 43' ' ' ASN . 3.0 mm? -115.83 112.05 21.39 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 171.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.459 HD22 ' C ' ' A' ' 42' ' ' LEU . 0.9 OUTLIER -122.21 144.6 48.87 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.226 -172.706 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.49 ' HA ' ' HB1' ' A' ' 94' ' ' ALA . 4.4 pp -158.56 167.21 30.21 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 177.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.66 HG23 ' HA ' ' A' ' 96' ' ' VAL . 0.5 OUTLIER -119.5 137.21 54.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 C-N-CA 123.536 0.734 . . . . 0.0 110.889 179.151 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 65.3 t -109.1 125.35 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.282 -177.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.502 ' HE3' ' HB3' ' A' ' 77' ' ' ALA . 14.6 mmmm -138.02 122.42 18.32 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -137.92 169.04 18.48 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -177.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -81.49 -32.2 32.57 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 123.984 0.802 . . . . 0.0 109.099 -177.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.445 ' HB ' ' HB2' ' A' ' 53' ' ' SER . 96.2 t -98.08 128.75 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.985 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 174.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.771 ' O ' HG22 ' A' ' 54' ' ' VAL . 16.3 tt0 -62.3 -43.62 98.4 Favored 'General case' 0 C--O 1.191 -1.987 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.305 -175.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -75.19 -0.13 60.56 Favored Glycine 0 C--N 1.291 -1.924 0 C-N-CA 118.388 -1.863 . . . . 0.0 113.268 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.445 ' HB2' ' HB ' ' A' ' 50' ' ' VAL . 34.0 t -83.88 -23.36 31.29 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 178.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.771 HG22 ' O ' ' A' ' 51' ' ' GLN . 9.2 m -74.8 -46.54 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.158 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 172.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -56.44 -46.42 80.3 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.328 1.051 . . . . 0.0 112.241 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.88 -43.68 81.5 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.801 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.489 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 27.3 tp -74.14 -45.43 48.84 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.202 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 54' ' ' VAL . 46.6 t -54.05 -43.77 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.128 0.971 . . . . 0.0 112.493 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.42 -28.18 69.8 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.94 -26.9 18.2 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -76.1 -39.02 56.21 Favored 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 113.962 -1.472 . . . . 0.0 110.37 -176.126 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -69.88 -21.74 63.3 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.822 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.421 ' O ' HG12 ' A' ' 66' ' ' VAL . 7.3 ptpp? -93.55 2.09 56.52 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -178.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.2 mt -82.52 -15.31 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 121.952 0.882 . . . . 0.0 108.967 177.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -57.45 -24.79 57.74 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.294 1.038 . . . . 0.0 112.056 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.421 HG12 ' O ' ' A' ' 63' ' ' LYS . 7.1 p -88.83 -3.73 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.412 0 CA-C-O 121.223 0.535 . . . . 0.0 111.372 -177.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -93.11 172.89 8.02 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.13 -36.1 92.98 Favored Glycine 0 C--O 1.247 0.958 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 176.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.4 t -94.3 103.6 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 105.458 -2.053 . . . . 0.0 105.458 173.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 25.5 mtm180 -94.17 98.5 11.0 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.572 0.701 . . . . 0.0 110.762 -173.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 17.8 t -102.27 137.77 29.0 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -151.15 153.22 34.58 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.415 0.626 . . . . 0.0 110.306 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 pp -94.11 155.86 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.792 176.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.427 HD11 ' HB3' ' A' ' 43' ' ' ASN . 3.4 mp -115.79 -41.72 3.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-O 121.438 0.637 . . . . 0.0 109.466 177.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -143.27 122.76 13.17 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.93 -169.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -131.69 135.57 46.98 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 124.422 1.089 . . . . 0.0 108.496 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.502 ' HB3' ' HE3' ' A' ' 47' ' ' LYS . . . -161.84 163.03 29.57 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 -178.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.6 p -93.51 96.93 6.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 122.405 1.098 . . . . 0.0 109.651 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.81 175.08 47.49 Favored Glycine 0 N--CA 1.406 -3.334 0 N-CA-C 108.332 -1.907 . . . . 0.0 108.332 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.605 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -89.78 -160.72 0.71 Allowed 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 177.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.495 ' O ' ' HA ' ' A' ' 103' ' ' PRO . 33.6 mt -89.12 105.89 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.008 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -176.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 70.6 p -99.43 156.75 16.86 Favored 'General case' 0 N--CA 1.411 -2.411 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -53.14 -32.69 48.93 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 123.473 0.709 . . . . 0.0 109.947 175.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.1 m -67.42 -30.79 70.63 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.048 0.939 . . . . 0.0 111.593 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -71.98 -35.02 69.39 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-O 121.849 0.833 . . . . 0.0 109.055 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.517 HD13 ' HB2' ' A' ' 111' ' ' ALA . 61.2 mt -68.97 -31.65 51.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.749 -178.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.4 m -54.21 -35.13 62.05 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.567 174.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -75.5 -34.84 60.87 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.256 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.71 -56.96 15.19 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.611 -176.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.523 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 5.8 t -71.51 -19.83 62.14 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.822 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.99 -62.62 1.36 Allowed 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.227 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.9 m -95.36 6.5 48.84 Favored 'General case' 0 C--O 1.201 -1.462 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.425 -174.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . 0.272 0.0 OUTLIER 69.89 30.19 3.78 Favored 'General case' 0 N--CA 1.505 2.306 0 C-N-CA 126.213 1.805 . . . . 0.0 111.33 177.033 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.49 ' HB1' ' HA ' ' A' ' 44' ' ' LEU . . . -94.23 162.5 13.83 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 113.186 -1.824 . . . . 0.0 109.183 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.496 HD13 ' H ' ' A' ' 95' ' ' ILE . 0.2 OUTLIER -121.66 156.29 25.83 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 173.414 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.66 ' HA ' HG23 ' A' ' 45' ' ' ILE . 29.3 t -94.41 126.84 46.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -175.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 11.6 tt -125.69 116.08 45.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 175.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 47' ' ' LYS . . . -120.66 161.15 14.91 Favored Glycine 0 N--CA 1.406 -3.308 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -121.44 100.08 6.83 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 118.843 -1.143 . . . . 0.0 110.194 -178.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 59.21 30.35 20.09 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 122.171 0.986 . . . . 0.0 111.945 176.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.503 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 3.4 m -97.81 -47.09 12.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 114.482 -1.235 . . . . 0.0 112.163 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.605 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 17.4 mtm-85 76.67 156.33 0.15 Allowed Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 124.388 1.075 . . . . 0.0 111.496 177.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 10.1 Cg_endo -99.83 174.4 0.37 Allowed 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.445 2.096 . . . . 0.0 115.193 -175.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.409 ' HB2' ' H ' ' A' ' 107' ' ' ALA . 43.6 m-20 -69.3 154.36 42.16 Favored 'General case' 0 C--O 1.251 1.142 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 170.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.513 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -60.25 -35.62 75.9 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 120.82 0.343 . . . . 0.0 110.54 179.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.576 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 84.2 m-20 -82.57 -25.73 33.02 Favored 'General case' 0 C--O 1.201 -1.468 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.975 175.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.409 ' H ' ' HB2' ' A' ' 104' ' ' ASP . . . -66.69 -45.48 78.69 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.813 177.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 20.8 pttm -57.45 -23.36 49.27 Favored 'General case' 0 CA--C 1.571 1.779 0 CA-C-O 120.842 0.353 . . . . 0.0 110.698 177.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.576 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 71.6 mtp180 -84.53 -53.24 5.55 Favored 'General case' 0 N--CA 1.389 -3.506 0 C-N-CA 125.921 1.688 . . . . 0.0 109.201 177.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.07 -48.74 43.86 Favored 'General case' 0 C--O 1.186 -2.242 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.793 -178.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.517 ' HB2' HD13 ' A' ' 86' ' ' ILE . . . -48.56 -43.96 36.16 Favored 'General case' 0 CA--C 1.503 -0.83 0 O-C-N 124.284 0.99 . . . . 0.0 111.466 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -82.71 -27.4 31.22 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 114.913 -1.039 . . . . 0.0 112.315 -173.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 35.3 t -88.23 5.09 43.3 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 176.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.523 ' O ' ' HB ' ' A' ' 90' ' ' THR . 20.5 mt-10 -120.96 11.53 11.04 Favored 'General case' 0 CA--C 1.46 -2.497 0 CA-C-N 114.374 -1.285 . . . . 0.0 112.926 -178.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 68.4 mmtt 62.13 22.29 13.02 Favored 'General case' 0 N--CA 1.418 -2.043 0 O-C-N 124.144 0.903 . . . . 0.0 112.83 174.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.1 m -124.4 174.2 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.091 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -121.33 135.38 55.1 Favored 'General case' 0 CA--C 1.49 -1.352 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.917 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.464 HG22 ' HB ' ' A' ' 96' ' ' VAL . 19.3 pt -102.99 123.56 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.135 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 167.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -102.65 120.07 39.92 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.503 HD21 ' H ' ' A' ' 101' ' ' VAL . 2.4 tm? -144.23 136.24 26.26 Favored 'General case' 0 N--CA 1.421 -1.914 0 C-N-CA 119.951 -0.699 . . . . 0.0 110.764 -176.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.434 ' N ' HD13 ' A' ' 120' ' ' LEU . 19.5 t-80 68.94 -71.28 0.12 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.645 1.178 . . . . 0.0 113.453 173.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -85.97 81.18 8.61 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 122.534 1.159 . . . . 0.0 111.338 -176.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 54.3 mt -98.01 119.79 46.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 15.0 tt -86.44 -16.76 9.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-O 121.752 0.787 . . . . 0.0 110.147 -178.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.416 ' CG ' ' HA ' ' A' ' 129' ' ' GLU . 95.1 m-85 -92.1 168.91 11.04 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.23 176.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -100.23 -37.7 8.81 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-O 120.935 0.398 . . . . 0.0 110.122 -175.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 34.3 t -113.56 -64.12 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.104 -176.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.566 HG13 ' H ' ' A' ' 129' ' ' GLU . 9.3 pt -140.6 -60.96 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -173.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.566 ' H ' HG13 ' A' ' 128' ' ' ILE . 31.4 tt0 -177.6 39.98 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 -175.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -71.86 98.24 1.97 Allowed 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.723 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.5 pp -77.94 170.14 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 114.659 -1.155 . . . . 0.0 113.447 -173.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -79.54 -84.91 0.09 Allowed 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.551 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 160.5 -21.53 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 125.104 1.362 . . . . 0.0 108.66 -176.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 79.96 -82.24 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 125.64 1.576 . . . . 0.0 108.853 -176.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 C--N 1.307 -1.246 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 175.764 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 . . . . . 0 N--CA 1.468 0.449 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -126.49 149.84 49.1 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 176.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 74.0 t80 60.64 87.19 0.09 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.29 1.036 . . . . 0.0 109.796 -177.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -85.33 77.34 9.98 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 121.733 -0.604 . . . . 0.0 111.469 -176.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 75.7 mt 53.03 -96.77 0.06 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.38 1.072 . . . . 0.0 112.859 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.26 94.81 1.84 Allowed Glycine 0 N--CA 1.437 -1.256 0 N-CA-C 110.546 -1.021 . . . . 0.0 110.546 177.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.0 p -78.95 105.76 10.51 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 123.036 0.534 . . . . 0.0 110.817 -178.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 57.22 79.73 0.18 Allowed 'General case' 0 C--O 1.243 0.75 0 CA-C-O 122.273 1.035 . . . . 0.0 111.59 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.41 ' C ' ' H ' ' A' ' 11' ' ' SER . . . 130.29 -179.61 16.75 Favored Glycine 0 N--CA 1.429 -1.773 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -177.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.0 m 66.33 -24.66 0.1 Allowed 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 124.738 1.215 . . . . 0.0 113.784 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.41 ' H ' ' C ' ' A' ' 9' ' ' GLY . 14.4 p -147.27 20.41 1.22 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.324 0.583 . . . . 0.0 110.411 -178.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -165.99 116.78 1.02 Allowed 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -176.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.6 t 69.14 -62.1 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.895 1.278 . . . . 0.0 110.418 -176.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -99.69 144.2 29.04 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.161 176.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.3 mt -125.39 -45.64 1.8 Allowed 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 174.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -172.13 37.09 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 104.972 -2.233 . . . . 0.0 104.972 176.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -108.71 -162.77 0.83 Allowed 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 113.578 -1.646 . . . . 0.0 110.895 -168.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 69.59 -70.05 0.15 Allowed 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 124.844 1.258 . . . . 0.0 110.935 -178.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 51.29 -81.0 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 125.703 1.601 . . . . 0.0 113.701 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.6 p -109.4 -2.43 17.76 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 122.061 -0.399 . . . . 0.0 111.505 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.47 HG23 ' H ' ' A' ' 22' ' ' LYS 0.34 27.5 m 51.76 -77.06 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 C-N-CA 126.619 1.968 . . . . 0.0 115.859 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.47 ' H ' HG23 ' A' ' 21' ' ' VAL . 53.2 tptt 47.22 -92.89 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.205 1.802 . . . . 0.0 113.267 -176.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 20.9 p -76.46 -15.28 59.95 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.21 0.529 . . . . 0.0 111.35 -177.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -65.53 -20.84 66.5 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 178.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 22' ' ' LYS . 34.0 m -86.87 -41.82 15.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.888 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.7 m -160.89 143.13 12.49 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 124.271 1.028 . . . . 0.0 108.337 177.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.9 mp -101.09 138.09 38.58 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -178.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.6 t70 69.18 175.87 0.28 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.2 1.4 . . . . 0.0 111.909 176.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -94.8 -34.02 12.65 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 123.235 0.614 . . . . 0.0 109.494 177.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.9 mp -105.19 167.05 9.98 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.952 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -104.6 -54.81 2.45 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 64.27 -174.23 0.17 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 175.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.53 ' HA ' ' OE1' ' A' ' 33' ' ' GLN . 10.5 mm-40 72.55 19.36 4.16 Favored 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 125.189 1.396 . . . . 0.0 111.142 -176.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.6 mm -75.11 -38.52 42.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 174.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 67.32 -77.76 0.04 OUTLIER 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 113.387 -1.733 . . . . 0.0 112.268 176.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -139.75 141.21 36.85 Favored 'General case' 0 N--CA 1.413 -2.308 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -175.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.22 -161.43 24.46 Favored Glycine 0 N--CA 1.418 -2.553 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 175.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -82.46 -38.8 23.43 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 4.3 mpp? 51.04 -94.42 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 113.918 -1.492 . . . . 0.0 112.34 -172.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp 61.41 21.27 11.87 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 122.596 1.189 . . . . 0.0 108.776 -174.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.453 ' OE1' ' HB3' ' A' ' 70' ' ' ARG . 3.7 tp10 -140.45 127.51 20.85 Favored 'General case' 0 N--CA 1.409 -2.52 0 CA-C-N 113.239 -1.8 . . . . 0.0 106.714 -173.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 3.6 mm? -94.66 101.46 13.32 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 175.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.522 ' OD1' HD11 ' A' ' 74' ' ' ILE . 40.2 m-80 -94.24 144.65 25.33 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.103 -174.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.435 HD12 HD11 ' A' ' 61' ' ' LEU . 80.9 mt -133.41 160.16 38.2 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.682 0.753 . . . . 0.0 111.121 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.529 HG23 ' HA ' ' A' ' 96' ' ' VAL . 0.5 OUTLIER -124.97 133.4 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.852 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.419 173.215 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.589 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 99.4 t -113.34 127.67 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.925 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.846 -176.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -135.2 128.48 32.08 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 124.13 0.972 . . . . 0.0 108.807 -177.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -148.53 168.09 23.66 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.953 -178.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -70.1 -21.93 63.07 Favored 'General case' 0 C--O 1.242 0.699 0 O-C-N 123.946 0.778 . . . . 0.0 111.308 -178.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.4 m -130.13 140.1 49.78 Favored 'Isoleucine or valine' 0 C--O 1.246 0.892 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.594 173.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.617 ' O ' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -68.56 -6.77 27.34 Favored 'General case' 0 C--O 1.191 -1.978 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -176.825 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.39 -13.27 57.44 Favored Glycine 0 N--CA 1.422 -2.29 0 C-N-CA 118.261 -1.924 . . . . 0.0 112.318 177.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.4 m -81.82 -28.98 32.84 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 176.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.617 HG22 ' O ' ' A' ' 51' ' ' GLN . 15.8 m -70.6 -44.9 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.903 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.674 174.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.611 ' HG2' ' O ' ' A' ' 51' ' ' GLN . 67.8 mm-40 -59.58 -45.48 91.73 Favored 'General case' 0 C--O 1.214 -0.789 0 O-C-N 123.42 0.45 . . . . 0.0 111.391 178.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.07 -42.15 84.9 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 123.348 0.405 . . . . 0.0 111.448 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.432 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 32.2 tp -75.4 -42.31 54.06 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.229 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.508 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 36.0 t -55.99 -45.75 80.33 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.681 0 C-N-CA 123.136 0.574 . . . . 0.0 111.185 176.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.3 -16.84 61.57 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.68 -27.87 13.79 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.435 HD11 HD12 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -80.35 -30.0 37.97 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 113.775 -1.557 . . . . 0.0 110.569 -175.069 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 4.0 pt20 -83.75 -19.25 35.46 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 121.985 -0.447 . . . . 0.0 111.434 177.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -96.37 5.93 49.86 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.344 -177.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.8 mm -58.95 103.18 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 121.419 0.628 . . . . 0.0 109.54 177.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -101.69 81.34 2.14 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.869 0.842 . . . . 0.0 110.1 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.2 t -134.79 126.35 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.596 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 176.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -88.14 148.81 24.25 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.864 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.95 -70.43 3.17 Favored Glycine 0 C--N 1.301 -1.366 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.7 t -99.35 93.2 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 176.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.453 ' HB3' ' OE1' ' A' ' 41' ' ' GLU . 29.8 ttm180 -103.28 139.98 38.01 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 28.3 t -120.06 124.89 73.58 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 178.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 26.7 ttpp -154.56 158.13 39.33 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.061 0.458 . . . . 0.0 110.472 -178.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 pp -93.82 156.27 3.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -173.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.522 HD11 ' OD1' ' A' ' 43' ' ' ASN . 26.7 mm -119.74 -32.44 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.464 0.65 . . . . 0.0 110.13 178.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.497 ' CD2' HD12 ' A' ' 45' ' ' ILE . 1.9 t60 -149.67 124.52 9.89 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.471 -168.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.589 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -135.96 132.25 36.15 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -155.78 155.66 33.44 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.54 -177.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.523 ' HB ' ' HB3' ' A' ' 51' ' ' GLN . 5.5 p -94.15 94.27 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 CA-C-O 122.823 1.296 . . . . 0.0 110.537 177.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.7 175.09 47.47 Favored Glycine 0 N--CA 1.405 -3.413 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.493 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . . . -82.87 167.98 17.53 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 176.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.491 HG21 HG21 ' A' ' 118' ' ' ILE . 2.4 mp -71.22 120.35 19.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -177.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.448 HG22 ' OD2' ' A' ' 85' ' ' ASP . 13.0 t -119.71 168.89 10.61 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -57.6 -34.94 69.78 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.949 0.5 . . . . 0.0 111.9 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.9 t -62.21 -29.86 70.68 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.046 0.539 . . . . 0.0 110.514 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.448 ' OD2' HG22 ' A' ' 82' ' ' THR . 49.4 m-20 -75.36 -39.41 59.31 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.414 ' CG2' ' HA ' ' A' ' 111' ' ' ALA . 39.5 mm -63.66 -32.9 58.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.515 -178.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 39.6 m -60.59 -24.05 65.16 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.527 176.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.428 HD21 HG21 ' A' ' 74' ' ' ILE . 2.4 tm? -87.98 -37.07 16.68 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.83 -58.73 6.18 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.947 -176.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.536 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 3.4 t -70.73 -26.56 63.44 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.494 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.18 -59.64 4.18 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.343 0.592 . . . . 0.0 111.901 -178.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.8 t -97.08 4.62 51.24 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.807 -175.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 67.7 32.76 5.27 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.822 0.82 . . . . 0.0 110.299 178.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -94.5 132.9 38.67 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.459 -178.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 36.3 pt -94.83 152.03 3.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 176.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.558 ' HB ' HG22 ' A' ' 118' ' ' ILE . 16.7 t -100.97 123.69 54.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.42 -172.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 7.3 tp -108.44 111.44 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 173.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -103.78 146.34 16.36 Favored Glycine 0 N--CA 1.43 -1.76 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -178.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.4 ' C ' ' H ' ' A' ' 101' ' ' VAL . 90.0 m-85 -121.84 108.98 14.11 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 117.026 0.413 . . . . 0.0 111.121 -175.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.603 ' O ' ' HD3' ' A' ' 102' ' ' ARG . 8.2 t30 67.66 -34.22 0.24 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 126.558 1.943 . . . . 0.0 113.493 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.493 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 1.7 m -51.35 -54.72 10.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 117.149 2.277 . . . . 0.0 117.149 -178.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.603 ' HD3' ' O ' ' A' ' 100' ' ' ASN . 1.0 OUTLIER 76.77 170.4 0.11 Allowed Pre-proline 0 N--CA 1.483 1.193 0 C-N-CA 123.958 0.903 . . . . 0.0 110.539 -171.743 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.516 ' HG3' HD12 ' A' ' 118' ' ' ILE . 9.2 Cg_endo -96.03 174.83 0.9 Allowed 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 121.712 1.608 . . . . 0.0 113.009 177.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -82.03 150.44 27.59 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 167.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.52 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -58.88 -30.3 67.65 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.539 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 16.5 m120 -81.08 -33.06 33.65 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 119.966 -0.693 . . . . 0.0 110.036 177.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.34 -42.62 98.96 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.239 177.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 20.9 ptmt -65.32 -26.29 67.99 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.984 178.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.539 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 53.6 mtp180 -75.52 -52.64 10.19 Favored 'General case' 0 N--CA 1.392 -3.353 0 C-N-CA 124.365 1.066 . . . . 0.0 109.027 177.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -53.02 -49.37 66.39 Favored 'General case' 0 C--O 1.195 -1.801 0 CA-C-N 113.947 -1.479 . . . . 0.0 110.091 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.414 ' HA ' ' CG2' ' A' ' 86' ' ' ILE . . . -47.04 -48.28 22.21 Favored 'General case' 0 CA--C 1.507 -0.681 0 O-C-N 124.568 1.167 . . . . 0.0 112.449 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.418 ' C ' ' H ' ' A' ' 114' ' ' GLU . 2.8 tm-20 -76.08 -38.79 56.6 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.3 -173.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 26.6 t -76.41 4.23 9.47 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.527 1.156 . . . . 0.0 108.707 178.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.536 ' O ' ' HB ' ' A' ' 90' ' ' THR . 15.2 mt-10 -123.21 14.06 9.69 Favored 'General case' 0 N--CA 1.398 -3.066 0 CA-C-N 114.466 -1.243 . . . . 0.0 113.019 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 96.7 mttt 66.2 7.54 4.91 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 173.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.5 m -114.25 147.01 18.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 C-N-CA 120.358 -0.537 . . . . 0.0 112.378 -175.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -113.09 128.7 56.56 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.702 -177.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.558 HG22 ' HB ' ' A' ' 96' ' ' VAL . 7.7 pt -97.74 133.82 38.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.079 177.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -118.33 134.77 54.76 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -178.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -118.06 132.74 56.34 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -174.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 7.2 t60 70.34 -67.84 0.23 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.684 1.594 . . . . 0.0 110.975 173.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 14.3 tpp180 178.23 -61.51 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 7.5 tp -154.4 -46.5 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 C-N-CA 120.336 -0.545 . . . . 0.0 112.117 172.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 38.6 pt -123.02 161.72 24.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.318 -177.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -149.82 91.05 1.75 Allowed 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 123.874 0.87 . . . . 0.0 108.893 178.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -135.09 144.2 47.05 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.131 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.7 p -163.21 142.61 2.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 177.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 57.3 mt 62.63 90.65 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.245 0.862 0 C-N-CA 124.218 1.007 . . . . 0.0 110.11 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -91.61 -21.19 20.95 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.898 0.856 . . . . 0.0 109.129 -175.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -78.76 96.67 5.65 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.951 178.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 61.5 mt -82.55 -45.96 19.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.48 -169.51 2.79 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.577 -179.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 66.35 -165.18 0.23 Allowed 'General case' 0 C--O 1.247 0.963 0 O-C-N 124.016 0.822 . . . . 0.0 111.04 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 73.78 128.89 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.18 1.392 . . . . 0.0 111.21 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 93.2 mmm . . . . . 0 C--N 1.297 -1.687 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.936 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.499 ' O ' HD23 ' A' ' 5' ' ' LEU . 3.3 m-20 . . . . . 0 C--O 1.212 -0.901 0 N-CA-C 110.821 -0.066 . . . . 0.0 110.821 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -71.39 -43.94 65.9 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 178.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -95.64 116.13 28.41 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 170.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 65.38 101.42 0.04 OUTLIER 'General case' 0 C--O 1.244 0.778 0 C-N-CA 124.531 1.132 . . . . 0.0 110.461 -173.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.499 HD23 ' O ' ' A' ' 1' ' ' ASN . 86.9 mt -70.22 102.12 2.03 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.943 -178.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.54 143.54 21.74 Favored Glycine 0 N--CA 1.424 -2.13 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.8 p -89.3 5.35 45.35 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 120.846 0.355 . . . . 0.0 110.689 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 68.82 24.65 6.46 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.464 1.106 . . . . 0.0 111.32 178.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 177.84 -167.24 37.98 Favored Glycine 0 N--CA 1.43 -1.707 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.557 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.8 p -106.39 -163.41 0.92 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.7 t -64.5 106.57 1.17 Allowed 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 175.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -138.69 -45.69 0.49 Allowed 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.296 -177.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 62.1 t -150.34 -42.07 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 103.938 -2.616 . . . . 0.0 103.938 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -73.15 173.62 9.15 Favored 'General case' 0 C--O 1.253 1.239 0 CA-C-N 112.962 -1.926 . . . . 0.0 108.617 174.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.6 mp 66.36 -103.68 0.09 Allowed 'General case' 0 C--N 1.316 -0.864 0 O-C-N 124.18 0.925 . . . . 0.0 110.282 -177.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.566 ' HA ' HH21 ' A' ' 24' ' ' ARG . 40.1 mt-30 60.72 -53.64 0.09 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 126.05 1.74 . . . . 0.0 115.217 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -56.42 137.21 53.31 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -173.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -84.43 -54.32 4.84 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.39 173.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? 62.35 -77.66 0.03 OUTLIER 'General case' 0 C--O 1.216 -0.664 0 C-N-CA 125.808 1.643 . . . . 0.0 112.483 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.7 m -131.0 23.78 4.93 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -178.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . 0.352 7.7 p 47.37 73.38 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.157 0 C-N-CA 125.83 1.652 . . . . 0.0 113.164 -177.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.584 ' HG3' ' H ' ' A' ' 23' ' ' THR . 55.0 pttt -90.97 -70.6 0.67 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.882 178.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.584 ' H ' ' HG3' ' A' ' 22' ' ' LYS . 2.6 p -97.86 8.82 44.07 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 122.313 1.054 . . . . 0.0 110.42 -179.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.566 HH21 ' HA ' ' A' ' 16' ' ' GLN . 25.1 mmt180 -99.34 19.79 14.86 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.406 177.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.7 p -59.44 115.93 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-O 121.7 0.762 . . . . 0.0 109.069 177.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.4 p -117.69 91.81 3.67 Favored 'General case' 0 N--CA 1.41 -2.462 0 CA-C-N 114.909 -1.042 . . . . 0.0 112.092 -174.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 82.1 mt -106.61 91.51 3.72 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 175.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 76.1 -27.92 0.18 Allowed 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 124.698 1.199 . . . . 0.0 111.642 -176.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -64.85 104.84 0.9 Allowed 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 124.056 0.942 . . . . 0.0 108.881 175.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 55.9 tp 72.74 -60.86 0.52 Allowed 'General case' 0 C--O 1.244 0.803 0 C-N-CA 125.093 1.357 . . . . 0.0 111.963 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -96.27 127.05 41.93 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 120.613 0.244 . . . . 0.0 110.656 -177.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.404 ' HG2' ' H ' ' A' ' 34' ' ' ILE . 46.6 tt0 -141.74 148.02 38.32 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -84.68 -24.83 28.82 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 117.826 0.284 . . . . 0.0 111.096 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.404 ' H ' ' HG2' ' A' ' 32' ' ' GLU . 52.8 mt 64.58 -82.34 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.287 1.435 . . . . 0.0 112.468 177.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -168.72 -76.87 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -177.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . 0.252 2.0 mp0 52.89 -84.54 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.437 0 N-CA-C 115.611 1.708 . . . . 0.0 115.611 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.75 -45.69 2.52 Favored Glycine 0 C--N 1.306 -1.094 0 N-CA-C 106.94 -2.464 . . . . 0.0 106.94 -170.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 61.34 -91.41 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 126.52 1.928 . . . . 0.0 111.792 171.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 54.8 ttm -149.85 12.71 0.78 Allowed 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -86.89 -33.42 19.76 Favored 'General case' 0 C--O 1.211 -0.972 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -101.78 106.92 17.99 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.486 -176.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 60.2 tp -110.38 104.94 13.77 Favored 'General case' 0 N--CA 1.41 -2.457 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 177.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.651 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 61.1 m-80 -99.83 155.62 17.56 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 4.1 pp -151.06 162.49 40.74 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.4 0.619 . . . . 0.0 112.57 177.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.615 HG23 ' HA ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -118.46 134.58 61.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.209 178.293 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 99.3 t -107.69 126.04 64.09 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.948 -176.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.8 mtpt -138.4 147.17 43.09 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.407 ' CB ' ' HB3' ' A' ' 99' ' ' PHE . . . -156.56 167.25 31.01 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -178.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -76.24 -22.83 54.7 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.846 0.832 . . . . 0.0 110.029 177.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 84.6 t -109.28 132.27 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 176.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.776 ' O ' HG22 ' A' ' 54' ' ' VAL . 16.2 tt0 -65.09 -46.2 82.1 Favored 'General case' 0 C--O 1.188 -2.18 0 C-N-CA 120.132 -0.627 . . . . 0.0 111.224 -176.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -73.74 2.65 39.38 Favored Glycine 0 C--N 1.294 -1.77 0 C-N-CA 118.753 -1.689 . . . . 0.0 114.394 -176.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.4 t -83.12 -26.12 31.3 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 176.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.776 HG22 ' O ' ' A' ' 51' ' ' GLN . 5.3 m -80.16 -45.87 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.918 0 CA-C-N 114.549 -1.205 . . . . 0.0 108.642 176.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -56.16 -48.44 76.3 Favored 'General case' 0 C--O 1.245 0.844 0 C-N-CA 124.867 1.267 . . . . 0.0 111.965 -176.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.51 -35.24 80.3 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.234 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 28.0 tp -76.1 -35.86 59.16 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.428 HG13 HG12 ' A' ' 73' ' ' ILE . 39.4 t -56.69 -43.87 80.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.747 174.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.39 -18.18 65.21 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.903 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.488 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . -98.88 -21.4 16.32 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 122.384 1.087 . . . . 0.0 108.782 -177.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.42 -28.96 20.57 Favored 'General case' 0 C--N 1.275 -2.645 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.598 -177.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -83.75 -12.65 55.46 Favored 'General case' 0 C--N 1.313 -1.0 0 O-C-N 122.152 -0.342 . . . . 0.0 111.624 176.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 65.0 pttt -87.3 2.47 50.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.523 0.678 . . . . 0.0 110.137 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 30.2 mm -79.18 -42.16 23.44 Favored 'Isoleucine or valine' 0 C--O 1.243 0.744 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 58.06 -101.98 0.14 Allowed 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 125.064 1.346 . . . . 0.0 113.481 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.457 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 30.2 t -128.23 -6.6 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.497 -173.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -60.78 108.57 0.87 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.146 0.578 . . . . 0.0 112.474 -173.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.07 -89.89 1.09 Allowed Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.1 t -107.69 145.37 15.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 177.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.457 ' HG2' ' HA ' ' A' ' 66' ' ' VAL . 16.2 mtp180 -93.76 93.06 7.77 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.656 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 13.4 t -104.88 124.24 59.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -177.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -146.28 158.6 43.9 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.067 0.461 . . . . 0.0 110.565 -175.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.428 HG12 HG13 ' A' ' 58' ' ' VAL . 1.7 pp -94.03 142.82 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.715 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.412 175.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.423 HD11 ' OD1' ' A' ' 43' ' ' ASN . 34.6 mm -113.72 -27.43 2.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 CA-C-O 121.273 0.559 . . . . 0.0 109.789 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.504 ' CD2' HD12 ' A' ' 45' ' ' ILE . 5.5 t60 -160.95 125.86 3.65 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.782 -171.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.572 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -129.01 130.56 46.79 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -154.76 156.66 36.71 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.383 -178.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.7 p -94.54 97.76 7.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-O 121.947 0.879 . . . . 0.0 108.905 176.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -175.5 170.9 44.01 Favored Glycine 0 N--CA 1.413 -2.839 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.666 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . . . -84.74 -176.11 6.08 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 120.838 0.352 . . . . 0.0 110.635 -178.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.521 ' HB ' ' HB3' ' A' ' 103' ' ' PRO . 3.8 mm -87.86 97.9 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.672 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 9.7 t -98.71 147.04 25.27 Favored 'General case' 0 N--CA 1.411 -2.424 0 C-N-CA 119.749 -0.78 . . . . 0.0 109.719 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.463 ' N ' ' HB2' ' A' ' 107' ' ' ALA . 0.0 OUTLIER -47.31 -39.31 14.44 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 125.111 1.364 . . . . 0.0 112.53 178.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.9 m -78.8 -11.8 60.0 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -174.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -98.34 -23.52 15.58 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -177.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.559 HD13 ' HB2' ' A' ' 111' ' ' ALA . 38.6 mt -66.06 -22.18 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.644 177.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 47.3 t -49.59 -35.49 21.0 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.928 172.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.434 ' O ' HD22 ' A' ' 88' ' ' LEU . 2.0 tm? -70.17 -32.57 70.58 Favored 'General case' 0 C--O 1.25 1.083 0 CA-C-O 120.748 0.309 . . . . 0.0 110.843 179.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.47 -61.68 2.32 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.201 -176.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.563 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 4.8 t -66.02 -25.34 67.02 Favored 'General case' 0 CA--C 1.561 1.375 0 O-C-N 122.012 -0.43 . . . . 0.0 111.783 178.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.24 -55.7 16.98 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.143 0.497 . . . . 0.0 112.176 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 34.3 p -97.01 -4.62 39.4 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.238 0.542 . . . . 0.0 111.072 -176.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.452 HD22 ' N ' ' A' ' 93' ' ' ASN . 0.8 OUTLIER 72.63 33.45 1.36 Allowed 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.805 -178.834 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.651 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -94.34 134.49 36.78 Favored 'General case' 0 N--CA 1.419 -2.018 0 CA-C-N 114.008 -1.451 . . . . 0.0 109.931 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 35.0 pt -94.07 144.4 9.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 176.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.615 ' HA ' HG23 ' A' ' 45' ' ' ILE . 15.6 t -94.95 119.79 43.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 C-N-CA 120.186 -0.605 . . . . 0.0 110.93 -173.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.637 ' HA ' ' O ' ' A' ' 119' ' ' ARG . 24.4 pt -111.91 117.18 54.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-O 121.498 0.666 . . . . 0.0 109.748 174.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -110.9 157.22 15.1 Favored Glycine 0 N--CA 1.437 -1.281 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.825 -176.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.407 ' HB3' ' CB ' ' A' ' 48' ' ' ALA . 67.8 t80 -132.07 110.82 10.98 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -175.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.495 ' O ' ' HD3' ' A' ' 102' ' ' ARG . 27.5 t-20 70.68 -30.4 0.2 Allowed 'General case' 0 N--CA 1.506 2.354 0 C-N-CA 125.085 1.354 . . . . 0.0 114.029 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.666 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 2.5 m -58.57 -56.55 15.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 N-CA-C 117.765 2.506 . . . . 0.0 117.765 -177.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.533 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 0.6 OUTLIER 75.04 159.26 0.16 Allowed Pre-proline 0 N--CA 1.494 1.738 0 C-N-CA 124.359 1.064 . . . . 0.0 112.003 -174.642 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.521 ' HB3' ' HB ' ' A' ' 81' ' ' ILE . 4.0 Cg_endo -88.75 170.12 5.36 Favored 'Trans proline' 0 CA--C 1.502 -1.095 0 C-N-CA 122.466 2.111 . . . . 0.0 113.261 176.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -87.73 169.45 12.09 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 171.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.448 ' HA ' ' HE3' ' A' ' 108' ' ' LYS . . . -70.98 -11.45 60.98 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 -173.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.502 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 37.0 t30 -104.37 -34.11 8.4 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 176.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.463 ' HB2' ' N ' ' A' ' 83' ' ' GLU . . . -58.25 -44.34 88.3 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.152 0.501 . . . . 0.0 110.521 175.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.448 ' HE3' ' HA ' ' A' ' 105' ' ' ALA . 18.0 ptpt -59.15 -22.84 61.56 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.032 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.502 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 40.4 mtm180 -93.25 -50.38 5.51 Favored 'General case' 0 N--CA 1.38 -3.932 0 C-N-CA 126.108 1.763 . . . . 0.0 109.886 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.15 -45.59 68.48 Favored 'General case' 0 CA--C 1.48 -1.715 0 C-N-CA 125.551 1.541 . . . . 0.0 110.858 -177.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.559 ' HB2' HD13 ' A' ' 86' ' ' ILE . . . -49.48 -48.19 47.94 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 124.505 1.128 . . . . 0.0 111.163 -179.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -78.45 -28.78 46.68 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.461 -174.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 40.2 t -79.29 -3.91 48.25 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 176.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.563 ' O ' ' HB ' ' A' ' 90' ' ' THR . 27.2 mt-10 -114.08 11.2 17.59 Favored 'General case' 0 CA--C 1.464 -2.329 0 CA-C-N 114.253 -1.34 . . . . 0.0 112.498 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 55.4 mtpt 68.5 15.04 9.17 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 174.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.9 m -121.28 170.95 10.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -135.48 147.23 48.8 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 176.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.447 HG22 ' HB ' ' A' ' 96' ' ' VAL . 15.0 pt -110.4 140.67 28.46 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.299 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.871 -178.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.637 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 75.2 mtp180 -131.2 123.2 27.97 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -176.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.481 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -146.54 172.13 14.03 Favored 'General case' 0 C--N 1.292 -1.916 0 O-C-N 121.796 -0.565 . . . . 0.0 112.143 -177.495 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 70.72 23.34 4.59 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 122.087 0.946 . . . . 0.0 110.723 174.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -61.96 -11.98 16.05 Favored 'General case' 0 CA--C 1.562 1.423 0 CA-C-N 114.892 -1.049 . . . . 0.0 113.304 -175.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 13.0 tt -74.25 1.25 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.417 0 CA-C-O 122.29 1.043 . . . . 0.0 110.844 -179.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 10.2 tp -73.47 -15.74 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 173.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -73.29 126.06 29.24 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 174.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -138.31 -179.74 5.97 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.5 p -79.72 -17.69 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 176.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.47 ' O ' HD12 ' A' ' 128' ' ' ILE . 2.8 pp -77.94 122.96 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 CA-C-O 121.979 0.895 . . . . 0.0 110.771 175.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -126.32 -72.37 0.65 Allowed 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.548 -176.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -96.69 -30.31 13.3 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 73.1 mt -86.14 112.8 23.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.289 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 59.51 83.02 0.14 Allowed 'General case' 0 CA--C 1.537 0.48 0 O-C-N 124.345 1.028 . . . . 0.0 112.623 176.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -72.03 157.76 37.22 Favored 'General case' 0 C--O 1.245 0.858 0 CA-C-N 114.564 -1.198 . . . . 0.0 112.149 -177.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -99.02 -11.45 21.5 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.618 -177.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 53.7 ttm . . . . . 0 C--N 1.306 -1.312 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.4 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 . . . . . 0 CA--C 1.5 -0.963 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 57.49 92.16 0.03 OUTLIER 'General case' 0 C--O 1.246 0.891 0 O-C-N 124.2 0.938 . . . . 0.0 111.924 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -70.47 -29.55 66.13 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.047 -175.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.93 -177.66 3.46 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 177.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -78.13 -10.82 59.8 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -171.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 106.82 115.83 4.06 Favored Glycine 0 N--CA 1.42 -2.412 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -175.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.67 73.82 7.62 Favored 'General case' 0 N--CA 1.42 -1.956 0 CA-C-O 122.716 1.246 . . . . 0.0 112.748 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -85.9 5.16 34.2 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.051 176.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.45 ' O ' ' HG2' ' A' ' 12' ' ' ARG . . . -156.49 129.83 2.54 Favored Glycine 0 N--CA 1.408 -3.172 0 N-CA-C 107.408 -2.277 . . . . 0.0 107.408 175.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 21.3 t -87.36 -11.15 50.2 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 122.075 0.94 . . . . 0.0 108.874 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.1 p -83.62 19.74 1.56 Allowed 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.926 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 9' ' ' GLY . 13.9 ptm180 -121.4 10.95 10.62 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.158 0.504 . . . . 0.0 109.93 177.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 51.7 t -92.04 99.4 9.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -178.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 70.97 106.42 0.06 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.781 1.233 . . . . 0.0 111.436 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.4 mp -107.6 132.84 52.85 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 73.35 130.25 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 O-C-N 124.596 1.185 . . . . 0.0 111.972 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.02 107.11 8.0 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -177.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.441 ' O ' ' HB ' ' A' ' 21' ' ' VAL . 9.7 tt0 -87.97 -6.45 58.0 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 123.284 0.634 . . . . 0.0 112.644 -175.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -78.3 -24.59 46.62 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 173.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.4 m -98.16 63.29 1.57 Allowed 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 168.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.441 ' HB ' ' O ' ' A' ' 18' ' ' GLN . 9.5 p -68.37 1.58 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.125 0 CA-C-N 114.195 -1.366 . . . . 0.0 114.174 -169.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -54.29 -43.98 71.55 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.003 0.43 . . . . 0.0 111.078 176.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.4 p -99.03 14.9 27.58 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.846 0.832 . . . . 0.0 111.682 -178.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.569 ' HA ' ' NE ' ' A' ' 24' ' ' ARG . 4.2 mmp_? -116.63 8.01 13.73 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.674 174.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 63.9 t 70.96 104.22 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-N 113.991 -1.459 . . . . 0.0 112.498 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.4 t -158.68 165.82 33.47 Favored 'General case' 0 N--CA 1.421 -1.895 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 177.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -124.73 -177.92 3.98 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -133.57 153.61 51.52 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 176.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -77.42 130.34 36.93 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.077 0.465 . . . . 0.0 111.544 -172.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.7 tp -99.99 153.85 18.86 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.221 -175.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -107.81 138.54 43.87 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 177.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.57 113.11 24.88 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.06 176.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -96.12 88.08 4.73 Favored 'General case' 0 C--N 1.288 -2.086 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.052 178.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.2 tp -107.2 91.16 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.226 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -85.09 90.07 7.77 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -115.3 169.31 9.23 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.973 -176.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.48 127.67 5.54 Favored Glycine 0 N--CA 1.434 -1.454 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.032 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -137.24 99.66 4.04 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 67.3 mtt -111.27 6.58 20.64 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.765 -177.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -78.47 96.1 5.31 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.649 -178.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -98.89 117.77 34.15 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.425 HD23 ' H ' ' A' ' 42' ' ' LEU . 1.5 pt? -137.39 92.73 2.73 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-O 121.524 0.678 . . . . 0.0 109.683 -176.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -147.1 143.25 28.16 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -177.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.47 HD12 HD11 ' A' ' 61' ' ' LEU . 56.9 mt -140.8 160.11 40.75 Favored 'General case' 0 C--O 1.246 0.884 0 CA-C-O 121.756 0.788 . . . . 0.0 112.813 177.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.469 HD12 ' O ' ' A' ' 75' ' ' HIS . 0.2 OUTLIER -131.87 133.28 61.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 125.461 1.504 . . . . 0.0 107.259 177.893 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.406 HG13 HD23 ' A' ' 57' ' ' LEU . 67.1 t -112.7 138.85 40.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.207 -176.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 60.6 mttp -137.52 160.48 39.01 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 123.71 0.804 . . . . 0.0 109.267 173.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -168.5 171.52 8.91 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -82.08 -37.28 26.61 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 91.8 t -97.51 127.84 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.335 176.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.698 ' O ' HG22 ' A' ' 54' ' ' VAL . 50.1 tt0 -57.43 -45.62 84.46 Favored 'General case' 0 C--O 1.204 -1.295 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -176.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.92 -0.97 61.37 Favored Glycine 0 C--N 1.283 -2.375 0 C-N-CA 118.155 -1.974 . . . . 0.0 113.908 -177.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.1 t -85.87 -18.13 33.67 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 175.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.698 HG22 ' O ' ' A' ' 51' ' ' GLN . 3.7 m -82.37 -46.36 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.949 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 174.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -60.68 -47.18 87.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.309 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.79 -33.95 76.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.585 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.496 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 37.1 tp -76.62 -37.4 56.45 Favored 'General case' 0 C--O 1.209 -1.068 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.526 HG21 ' HB2' ' A' ' 76' ' ' ALA . 43.5 t -60.09 -41.41 86.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 123.234 0.614 . . . . 0.0 110.954 176.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.73 -25.94 68.15 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.541 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.96 -24.65 19.19 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.496 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -85.12 -30.13 24.27 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.468 -175.585 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -78.45 -13.22 59.94 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.048 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.74 5.47 51.3 Favored 'General case' 0 C--O 1.247 0.931 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.099 177.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.438 HG12 ' HA ' ' A' ' 61' ' ' LEU . 35.3 mm -74.74 75.2 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 122.701 1.238 . . . . 0.0 109.84 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -146.2 -47.8 0.2 Allowed 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 177.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.4 m -91.28 83.7 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 CA-C-N 114.376 -1.284 . . . . 0.0 107.607 168.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -169.24 -171.66 1.34 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 104.14 -2.541 . . . . 0.0 104.14 -174.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -76.66 -34.58 43.48 Favored Glycine 0 N--CA 1.44 -1.095 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 178.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 9.0 p -120.53 163.41 18.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 177.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.425 ' HA ' HG22 ' A' ' 64' ' ' ILE . 3.9 ptm180 -125.13 130.99 53.32 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 176.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.44 HG12 ' H ' ' A' ' 72' ' ' LYS . 3.5 t -154.18 172.42 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 -177.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.44 ' H ' HG12 ' A' ' 71' ' ' VAL . 88.0 tttt -150.69 157.22 42.71 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 175.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.409 HG12 HG13 ' A' ' 58' ' ' VAL . 1.4 pp -93.61 154.09 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.793 177.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 65.2 mt -112.35 -40.08 3.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-O 121.787 0.803 . . . . 0.0 109.734 177.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.469 ' O ' HD12 ' A' ' 45' ' ' ILE . 2.1 t60 -145.77 137.71 25.29 Favored 'General case' 0 N--CA 1.409 -2.497 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.463 -165.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.526 ' HB2' HG21 ' A' ' 58' ' ' VAL . . . -125.25 134.21 52.4 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 177.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 47' ' ' LYS . . . -144.27 131.68 20.9 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -178.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.1 p -94.85 93.57 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.969 0 CA-C-O 122.765 1.269 . . . . 0.0 107.699 175.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.95 176.36 48.02 Favored Glycine 0 N--CA 1.397 -3.93 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -176.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.536 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . . . -81.07 175.9 10.27 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.458 HD13 HD11 ' A' ' 120' ' ' LEU . 1.7 mp -76.93 105.32 5.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.1 p -104.58 156.51 17.9 Favored 'General case' 0 N--CA 1.403 -2.814 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.26 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.51 -33.16 72.22 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 123.953 0.901 . . . . 0.0 110.482 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.3 m -68.53 -22.42 64.51 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.849 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -97.72 -27.55 14.29 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 118.782 -1.167 . . . . 0.0 109.67 -178.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.543 HD13 ' HB2' ' A' ' 111' ' ' ALA . 79.5 mt -59.09 -27.02 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 CA-C-O 121.817 0.818 . . . . 0.0 110.433 174.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 34.2 m -50.59 -33.76 23.29 Favored 'General case' 0 CA--C 1.561 1.383 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.783 172.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -82.39 -35.31 27.83 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 176.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.81 -58.58 6.73 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.425 -175.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.457 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 9.6 t -78.85 -11.23 59.99 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.773 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.21 -49.14 29.57 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.394 -177.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 34.2 m -105.31 -3.63 22.53 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.102 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 71.54 35.61 1.44 Allowed 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 122.103 0.954 . . . . 0.0 110.62 -176.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -95.12 129.52 42.19 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 176.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.7 pt -93.93 144.13 10.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.487 ' HB ' HG22 ' A' ' 118' ' ' ILE . 16.5 t -102.01 132.33 48.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.766 -173.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 18.7 tt -111.87 137.88 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.782 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 173.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -132.56 146.64 18.39 Favored Glycine 0 N--CA 1.432 -1.587 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.412 ' C ' ' H ' ' A' ' 101' ' ' VAL . 91.9 m-85 -124.14 114.26 19.43 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -174.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 71.5 -36.35 0.36 Allowed 'General case' 0 N--CA 1.505 2.3 0 C-N-CA 124.458 1.103 . . . . 0.0 112.938 178.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.536 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 4.5 m -62.05 -51.23 74.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 124.982 1.313 . . . . 0.0 113.271 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.493 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 23.6 mtm180 68.32 179.03 0.05 OUTLIER Pre-proline 0 CA--C 1.551 1.012 0 O-C-N 123.74 0.65 . . . . 0.0 110.111 178.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -95.36 176.91 0.85 Allowed 'Trans proline' 0 N--CA 1.444 -1.411 0 CA-C-N 121.034 1.405 . . . . 0.0 113.942 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -86.75 155.13 20.46 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 106.274 -1.751 . . . . 0.0 106.274 169.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.531 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -58.02 -30.74 66.36 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 123.074 0.549 . . . . 0.0 112.086 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.572 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 25.2 t30 -82.81 -35.7 26.2 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.91 -44.75 92.0 Favored 'General case' 0 C--O 1.206 -1.212 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.744 178.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 20.1 pttm -59.39 -29.09 67.47 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-O 121.118 0.485 . . . . 0.0 110.001 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.572 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 20.5 mtm180 -74.76 -52.66 10.92 Favored 'General case' 0 N--CA 1.384 -3.754 0 C-N-CA 123.793 0.837 . . . . 0.0 109.059 179.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.83 -51.82 62.32 Favored 'General case' 0 C--O 1.194 -1.856 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.067 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.543 ' HB2' HD13 ' A' ' 86' ' ' ILE . . . -50.7 -48.5 58.65 Favored 'General case' 0 CA--C 1.5 -0.944 0 O-C-N 124.284 0.99 . . . . 0.0 112.143 -176.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -81.23 -25.33 36.74 Favored 'General case' 0 N--CA 1.403 -2.82 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.291 -172.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 46.9 t -87.9 5.8 38.71 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 175.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.465 ' O ' ' HB2' ' A' ' 115' ' ' LYS . 20.5 mt-10 -123.67 17.08 9.55 Favored 'General case' 0 CA--C 1.463 -2.382 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.826 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 70.5 mmtt 66.14 8.52 5.58 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 173.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.5 m -114.52 125.03 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-O 121.775 0.797 . . . . 0.0 113.044 -176.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -94.18 120.74 34.86 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.288 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.487 HG22 ' HB ' ' A' ' 96' ' ' VAL . 8.6 pt -93.55 131.81 39.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-O 121.089 0.471 . . . . 0.0 109.947 179.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -100.39 118.82 37.41 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.119 0.485 . . . . 0.0 109.744 -176.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.458 HD11 HD13 ' A' ' 81' ' ' ILE . 3.2 mm? -114.87 172.64 6.92 Favored 'General case' 0 CA--C 1.474 -1.976 0 CA-C-O 121.264 0.554 . . . . 0.0 111.102 -178.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 35.4 t-80 -77.56 104.56 8.17 Favored 'General case' 0 N--CA 1.413 -2.315 0 CA-C-N 114.531 -1.213 . . . . 0.0 108.899 174.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -95.69 -169.91 2.04 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.516 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 50.3 mm 79.9 -38.96 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 124.921 1.288 . . . . 0.0 108.907 -174.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 67.0 mt 69.41 -51.89 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 125.904 1.681 . . . . 0.0 114.46 171.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.402 ' HB3' ' HB ' ' A' ' 128' ' ' ILE . 63.4 m-85 -78.94 -1.42 35.2 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 122.579 0.352 . . . . 0.0 111.387 -176.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 72.62 -79.18 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.076 1.35 . . . . 0.0 108.51 -175.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 45.2 t -143.15 81.42 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 175.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.402 ' HB ' ' HB3' ' A' ' 125' ' ' TYR . 63.4 mt -140.92 82.97 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 174.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 55.21 88.01 0.04 OUTLIER 'General case' 0 C--O 1.242 0.678 0 C-N-CA 125.184 1.394 . . . . 0.0 112.139 -177.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -57.12 118.11 4.7 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.873 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . 0.259 1.7 pp -62.03 92.46 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -176.59 168.4 2.65 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 103.312 -2.848 . . . . 0.0 103.312 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -97.61 2.62 50.12 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 118.689 0.677 . . . . 0.0 110.355 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 66.82 97.18 0.05 Allowed 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.897 1.279 . . . . 0.0 111.154 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 CA--C 1.509 -0.632 0 C-N-CA 124.552 1.141 . . . . 0.0 110.549 178.574 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 . . . . . 0 CA--C 1.493 -1.234 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 71.94 154.31 0.14 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.46 1.504 . . . . 0.0 112.649 178.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -137.54 178.04 7.41 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -79.24 78.01 5.74 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 122.745 1.26 . . . . 0.0 111.737 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.6 mt -121.81 13.29 10.69 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 176.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.19 87.92 1.57 Allowed Glycine 0 N--CA 1.419 -2.467 0 CA-C-N 114.502 -1.226 . . . . 0.0 112.339 -174.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -90.41 116.8 28.63 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 175.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -132.54 122.21 24.47 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -177.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.522 ' O ' ' HG2' ' A' ' 12' ' ' ARG . . . -94.11 51.64 2.19 Favored Glycine 0 N--CA 1.434 -1.483 0 C-N-CA 121.125 -0.56 . . . . 0.0 113.089 -174.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.7 m -65.39 -39.0 91.7 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.785 0.802 . . . . 0.0 109.663 177.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.2 p -81.39 15.63 1.95 Allowed 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 114.557 -1.201 . . . . 0.0 113.964 -173.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.522 ' HG2' ' O ' ' A' ' 9' ' ' GLY . 19.3 ptt180 -99.15 -7.03 27.2 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 122.146 0.974 . . . . 0.0 108.438 174.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.1 t -94.99 137.58 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 176.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.5 t70 67.25 77.43 0.27 Allowed 'General case' 0 C--N 1.32 -0.693 0 O-C-N 124.698 1.249 . . . . 0.0 109.521 -176.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.3 mt -106.18 79.99 1.46 Allowed 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.747 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -88.27 -36.08 16.91 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -158.09 -83.37 0.05 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.985 174.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 63.75 -44.9 0.26 Allowed 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -40.37 -58.55 1.51 Allowed 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 -171.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.453 ' C ' ' H ' ' A' ' 22' ' ' LYS . 48.3 p -89.5 0.83 56.61 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.662 -0.648 . . . . 0.0 111.847 -176.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . 0.312 35.8 m 55.86 -6.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 C-N-CA 127.567 2.347 . . . . 0.0 115.236 -175.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.453 ' H ' ' C ' ' A' ' 20' ' ' SER . 62.8 tttp -54.2 -65.23 0.61 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.724 1.61 . . . . 0.0 111.274 -177.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.8 p -86.31 1.32 51.45 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.852 0.834 . . . . 0.0 111.487 -177.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.3 tpm_? -84.02 -42.33 16.3 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.621 179.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.0 t -97.0 -44.0 12.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.147 -177.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.4 m -127.63 170.63 12.45 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.202 -175.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.5 mp -121.55 117.82 27.72 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 174.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -79.99 66.23 5.41 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -177.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -173.16 107.02 0.15 Allowed 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 176.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.426 ' H ' HD23 ' A' ' 30' ' ' LEU . 2.4 pt? -66.28 136.61 56.08 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.706 -178.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -73.8 126.09 29.6 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.402 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -86.36 123.53 31.7 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.313 0.578 . . . . 0.0 109.622 -177.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -96.12 -25.71 15.76 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.883 -178.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 68.1 mt -125.62 104.89 13.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.577 -176.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -138.77 105.61 5.4 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 176.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -94.29 133.75 37.5 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -99.03 179.07 31.05 Favored Glycine 0 C--N 1.308 -1.018 0 C-N-CA 120.361 -0.924 . . . . 0.0 112.28 -178.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -93.2 126.23 38.21 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 51.0 ttm -109.21 125.35 52.14 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.375 -177.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -77.8 152.88 33.27 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.053 -176.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -115.31 117.51 30.65 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 169.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -93.76 114.33 26.58 Favored 'General case' 0 N--CA 1.42 -1.937 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 -177.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.757 ' HB3' HD11 ' A' ' 74' ' ' ILE . 17.7 m120 -105.39 149.51 26.04 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.277 -176.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.2 pp -152.39 162.35 41.31 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.919 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.613 HG23 ' HA ' ' A' ' 96' ' ' VAL . 0.1 OUTLIER -117.08 136.36 54.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 123.278 0.631 . . . . 0.0 110.636 178.626 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.411 ' CG1' ' HA ' ' A' ' 54' ' ' VAL . 85.9 t -102.06 128.07 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.015 -175.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.415 ' HB2' ' HA2' ' A' ' 98' ' ' GLY . 27.6 mmmt -134.57 136.54 43.07 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.192 -176.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.16 165.19 29.86 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -88.93 -12.56 41.3 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.606 0.717 . . . . 0.0 109.41 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 88.2 t -108.14 122.73 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 174.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.75 ' O ' HG22 ' A' ' 54' ' ' VAL . 47.8 tt0 -63.27 -40.87 98.6 Favored 'General case' 0 C--O 1.197 -1.681 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.876 -175.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.19 4.88 53.23 Favored Glycine 0 C--N 1.278 -2.66 0 C-N-CA 117.672 -2.204 . . . . 0.0 115.158 -176.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.8 m -87.58 -29.95 20.87 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 172.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.75 HG22 ' O ' ' A' ' 51' ' ' GLN . 12.2 m -76.55 -44.07 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 CA-C-N 114.869 -1.059 . . . . 0.0 109.011 176.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -55.34 -50.63 69.14 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.421 -178.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.42 -42.11 88.24 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.411 -176.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.598 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 32.3 tp -68.4 -41.36 80.6 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.944 -177.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.513 HG13 HG12 ' A' ' 73' ' ' ILE . 39.6 t -57.47 -43.69 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 122.627 0.371 . . . . 0.0 111.04 175.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.413 ' O ' ' HE3' ' A' ' 63' ' ' LYS . . . -65.34 -23.08 66.9 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.263 -177.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.41 -23.82 16.42 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.598 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -81.7 -37.25 27.65 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.269 -176.048 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -66.58 -21.21 66.14 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.046 0.451 . . . . 0.0 110.897 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.413 ' HE3' ' O ' ' A' ' 59' ' ' ALA . 18.3 ptpt -97.94 6.24 47.94 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 20.6 mm -74.74 79.28 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.651 0 CA-C-O 122.015 0.912 . . . . 0.0 110.566 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -136.22 10.72 3.27 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 176.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.5 p -72.79 -10.48 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 CA-C-N 113.906 -1.497 . . . . 0.0 112.514 -173.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -138.14 -170.07 2.71 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.78 -0.575 . . . . 0.0 110.263 -177.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -76.19 -19.38 78.54 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 121.505 -0.379 . . . . 0.0 112.169 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.2 t -95.07 118.9 42.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 176.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -95.11 124.37 39.11 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -177.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.2 t -124.58 135.78 62.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 21.6 ttmm -146.75 153.42 40.21 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 121.605 0.717 . . . . 0.0 111.42 -177.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.513 HG12 HG13 ' A' ' 58' ' ' VAL . 1.3 pp -94.97 169.21 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.509 174.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.757 HD11 ' HB3' ' A' ' 43' ' ' ASN . 3.3 mp -135.41 -32.03 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 172.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -151.1 133.45 15.41 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-O 121.234 0.54 . . . . 0.0 110.235 -168.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.5 ' HB2' HG21 ' A' ' 58' ' ' VAL . . . -124.55 141.44 52.09 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 178.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -151.02 135.42 16.96 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.377 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.8 p -93.41 92.01 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 CA-C-O 123.295 1.521 . . . . 0.0 107.906 175.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.8 175.69 47.5 Favored Glycine 0 N--CA 1.41 -3.072 0 N-CA-C 108.653 -1.779 . . . . 0.0 108.653 -177.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.621 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . . . -82.6 -179.19 7.35 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 175.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.422 ' CG2' HD11 ' A' ' 86' ' ' ILE . 3.5 mp -81.8 118.76 30.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 O-C-N 122.04 -0.412 . . . . 0.0 110.641 -178.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.458 ' O ' HG13 ' A' ' 86' ' ' ILE . 25.7 p -119.81 160.28 22.93 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 178.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.43 ' HG3' ' HA ' ' A' ' 107' ' ' ALA . 1.6 mp0 -54.07 -50.88 65.77 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.722 0.809 . . . . 0.0 112.501 -173.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.5 m -66.42 -19.38 65.78 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.398 0.618 . . . . 0.0 111.582 -176.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -86.27 -31.43 21.65 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -177.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.777 HD13 ' HB2' ' A' ' 111' ' ' ALA . 29.0 mt -73.11 -24.51 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.863 176.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.406 ' HA ' ' OE2' ' A' ' 114' ' ' GLU . 37.6 m -56.21 -24.6 43.05 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.094 175.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -76.56 -35.06 58.42 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 175.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.418 ' HB3' HG21 ' A' ' 116' ' ' VAL . . . -57.5 -55.54 33.53 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.406 -176.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.525 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 8.9 t -71.81 -24.91 61.81 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.118 179.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.23 -62.03 1.63 Allowed 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.014 0.435 . . . . 0.0 111.937 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 43.3 m -91.75 3.84 54.18 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -177.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 69.52 31.57 3.68 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.733 0.778 . . . . 0.0 109.807 177.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -93.92 139.24 31.15 Favored 'General case' 0 N--CA 1.419 -1.987 0 CA-C-N 114.451 -1.249 . . . . 0.0 109.714 -177.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 45.9 mm -94.73 142.96 12.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 176.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.613 ' HA ' HG23 ' A' ' 45' ' ' ILE . 24.8 t -94.26 118.44 40.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -176.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.534 ' HA ' ' O ' ' A' ' 119' ' ' ARG . 27.1 pt -115.71 116.28 51.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-O 121.586 0.708 . . . . 0.0 109.644 176.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.415 ' HA2' ' HB2' ' A' ' 47' ' ' LYS . . . -113.22 166.88 12.19 Favored Glycine 0 N--CA 1.428 -1.863 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.892 -177.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -133.17 112.63 11.89 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -177.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.404 ' H ' ' HB2' ' A' ' 121' ' ' HIS . 80.5 m-20 60.52 14.32 4.78 Favored 'General case' 0 N--CA 1.502 2.146 0 C-N-CA 124.713 1.205 . . . . 0.0 113.112 178.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.621 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 1.5 m -96.59 -50.33 11.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 -173.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.576 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 0.0 OUTLIER 75.49 163.65 0.14 Allowed Pre-proline 0 N--CA 1.479 0.994 0 C-N-CA 124.232 1.013 . . . . 0.0 111.968 -175.302 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -97.21 166.19 0.92 Allowed 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 121.974 1.783 . . . . 0.0 113.179 174.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -71.73 152.55 42.68 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 169.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.447 ' O ' ' HG3' ' A' ' 109' ' ' ARG . . . -63.73 -25.01 68.0 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 117.912 0.323 . . . . 0.0 111.515 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.539 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 29.9 m-80 -88.62 -26.79 21.72 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.989 -0.684 . . . . 0.0 109.76 177.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.43 ' HA ' ' HG3' ' A' ' 83' ' ' GLU . . . -67.86 -44.34 77.33 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 121.025 0.441 . . . . 0.0 110.3 177.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.403 ' HE3' ' HA ' ' A' ' 105' ' ' ALA . 17.6 ptpt -62.16 -21.57 65.17 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.922 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.539 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 56.2 mtp180 -83.84 -51.3 7.31 Favored 'General case' 0 N--CA 1.39 -3.474 0 C-N-CA 125.129 1.372 . . . . 0.0 109.378 176.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -52.02 -48.23 64.62 Favored 'General case' 0 CA--C 1.489 -1.381 0 CA-C-N 114.403 -1.271 . . . . 0.0 110.642 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.777 ' HB2' HD13 ' A' ' 86' ' ' ILE . . . -51.72 -36.09 45.52 Favored 'General case' 0 CA--C 1.502 -0.885 0 C-N-CA 124.742 1.217 . . . . 0.0 112.17 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -78.78 -38.46 38.43 Favored 'General case' 0 N--CA 1.418 -2.029 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.788 -175.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.8 t -73.02 -9.26 58.54 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 175.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.525 ' O ' ' HB ' ' A' ' 90' ' ' THR . 28.7 mt-10 -106.4 7.8 31.3 Favored 'General case' 0 CA--C 1.472 -2.056 0 C-N-CA 124.869 1.268 . . . . 0.0 114.009 -177.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 93.1 mttt 67.31 7.62 5.65 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 172.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.418 HG21 ' HB3' ' A' ' 89' ' ' ALA . 4.3 m -121.63 141.26 42.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -177.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -100.26 133.31 44.85 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-O 121.403 0.62 . . . . 0.0 109.794 179.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.475 HG22 ' HB ' ' A' ' 96' ' ' VAL . 6.1 pt -97.21 139.69 19.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.596 178.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.534 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 64.9 ttt180 -131.85 128.54 38.88 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.406 ' N ' HD13 ' A' ' 120' ' ' LEU . 0.0 OUTLIER -143.52 138.06 28.92 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.239 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.404 ' HB2' ' H ' ' A' ' 100' ' ' ASN . 49.1 t60 61.36 81.4 0.19 Allowed 'General case' 0 C--O 1.243 0.737 0 O-C-N 124.469 1.105 . . . . 0.0 110.01 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.85 93.2 3.15 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.9 tp -91.04 93.52 4.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 15.0 tt -67.52 -29.8 46.68 Favored 'Isoleucine or valine' 0 C--O 1.245 0.868 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.359 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 53.7 t80 69.38 158.49 0.17 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.791 1.236 . . . . 0.0 111.342 176.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 72.49 -58.82 0.58 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.858 1.263 . . . . 0.0 113.139 178.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.9 m -95.06 24.56 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 121.971 0.891 . . . . 0.0 109.778 178.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 10.4 tp -84.6 -10.73 11.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.675 -176.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -90.72 -59.26 2.22 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -112.14 98.36 7.28 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 176.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.5 mp -73.22 -40.33 57.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 174.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -122.01 128.46 51.45 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 113.77 -1.559 . . . . 0.0 107.316 173.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -80.01 -65.24 1.03 Allowed 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.099 0.476 . . . . 0.0 110.092 -177.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -137.09 -33.26 0.76 Allowed 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 14.2 tpt . . . . . 0 C--N 1.307 -1.252 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 178.396 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 . . . . . 0 CA--C 1.503 -0.853 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -99.86 -17.31 17.69 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 119.163 -1.015 . . . . 0.0 111.239 175.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -82.49 131.82 35.21 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 176.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 67.75 25.88 7.92 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.437 1.095 . . . . 0.0 109.082 -173.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 89.4 mt 70.18 177.84 0.26 Allowed 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.808 1.243 . . . . 0.0 111.364 -178.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.568 ' HA2' ' NH2' ' A' ' 12' ' ' ARG . . . 137.59 -80.33 0.29 Allowed Glycine 0 CA--C 1.49 -1.484 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 -175.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.0 m -59.34 -37.4 77.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.83 0.824 . . . . 0.0 108.869 172.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -85.64 116.12 23.73 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 174.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 139.28 -72.3 0.43 Allowed Glycine 0 N--CA 1.423 -2.201 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -178.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 29.2 m 58.5 -81.63 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.433 1.093 . . . . 0.0 113.242 178.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.9 t -81.14 91.67 6.17 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 176.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.603 ' O ' HG23 ' A' ' 13' ' ' VAL . 26.9 ptt180 -156.81 135.56 11.66 Favored 'General case' 0 N--CA 1.424 -1.755 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.588 -177.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 12' ' ' ARG . 37.2 t 158.86 82.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 130.413 3.485 . . . . 0.0 106.261 169.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -150.88 96.22 2.31 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 113.74 -1.573 . . . . 0.0 107.707 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -156.41 108.3 2.51 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.85 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.427 ' HA ' ' NH1' ' A' ' 24' ' ' ARG . 15.7 mm100 -69.3 -68.07 0.43 Allowed 'General case' 0 N--CA 1.424 -1.775 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.392 178.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 58.57 -78.41 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.799 0 O-C-N 125.417 1.698 . . . . 0.0 112.03 177.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 65.72 -81.29 0.03 OUTLIER 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 124.574 1.15 . . . . 0.0 109.524 -177.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 50.68 -77.48 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.62 1.568 . . . . 0.0 113.15 -177.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.0 p -103.47 -6.08 22.18 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 122.205 -0.309 . . . . 0.0 111.327 178.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.6 m 55.83 21.12 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 C-N-CA 126.827 2.051 . . . . 0.0 113.148 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -67.34 -17.96 64.96 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -176.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 23.0 p -121.75 11.49 10.47 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.427 ' NH1' ' HA ' ' A' ' 16' ' ' GLN . 19.7 mtp180 -120.15 144.58 47.59 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.4 m -61.36 110.38 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.867 0.841 . . . . 0.0 111.169 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.5 m -92.32 -41.44 10.37 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.2 -176.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 82.1 mt -118.17 137.04 53.25 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.102 -177.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -82.35 -49.29 10.17 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.238 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -63.3 -34.17 77.12 Favored 'General case' 0 CA--C 1.495 -1.167 0 O-C-N 123.815 0.697 . . . . 0.0 112.559 -178.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 56.6 tp -79.95 109.03 14.0 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -95.89 170.85 9.01 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.725 -178.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -81.21 -29.25 34.59 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -104.11 123.71 47.76 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.506 -1.224 . . . . 0.0 110.92 -175.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.6 pp -101.51 174.17 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.308 176.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.456 ' HD3' ' N ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -153.47 98.53 2.25 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.349 0.595 . . . . 0.0 110.712 -178.575 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -116.48 -46.22 2.78 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.9 0.857 . . . . 0.0 109.606 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 160.59 73.66 0.02 OUTLIER Glycine 0 N--CA 1.427 -1.957 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 -177.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -87.68 -0.33 56.74 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.045 0.45 . . . . 0.0 111.379 -174.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -86.33 142.11 28.73 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.578 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -86.0 -15.93 39.89 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 70' ' ' ARG . 7.3 mt-10 -95.7 95.3 8.24 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 114.26 -1.336 . . . . 0.0 110.072 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.46 ' HB3' HG22 ' A' ' 71' ' ' VAL . 56.7 tp -94.22 155.64 16.94 Favored 'General case' 0 N--CA 1.411 -2.388 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.039 -177.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.432 ' HB3' ' CD1' ' A' ' 74' ' ' ILE . 10.4 m120 -122.82 147.91 45.99 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.358 -177.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 49.3 mt -141.69 174.94 10.1 Favored 'General case' 0 C--O 1.249 1.069 0 CA-C-O 121.53 0.681 . . . . 0.0 111.428 178.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.8 tt -136.41 143.33 35.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.963 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.517 HG23 HG21 ' A' ' 73' ' ' ILE . 96.6 t -127.89 122.83 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -149.54 121.63 8.29 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.587 179.021 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -131.73 175.66 9.0 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.163 -174.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -81.02 -29.13 35.19 Favored 'General case' 0 C--O 1.246 0.916 0 O-C-N 124.014 0.821 . . . . 0.0 109.815 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 80.7 t -101.88 130.09 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.364 174.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.756 ' O ' HG22 ' A' ' 54' ' ' VAL . 22.6 tm0? -64.72 -40.64 95.67 Favored 'General case' 0 C--O 1.197 -1.68 0 C-N-CA 122.822 0.449 . . . . 0.0 111.984 -174.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.4 2.8 86.6 Favored Glycine 0 C--N 1.29 -2.011 0 C-N-CA 118.114 -1.994 . . . . 0.0 112.988 178.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.2 t -82.59 -28.45 30.86 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 105.677 -1.971 . . . . 0.0 105.677 178.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.756 HG22 ' O ' ' A' ' 51' ' ' GLN . 12.9 m -69.69 -46.96 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.646 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.259 175.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -60.06 -39.54 86.39 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -177.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.91 -36.35 76.81 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 123.604 0.565 . . . . 0.0 110.796 178.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 42.3 tp -85.04 -41.72 15.51 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.714 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 54' ' ' VAL . 47.9 t -55.36 -41.23 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.099 0.96 . . . . 0.0 112.264 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.32 -17.79 64.35 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 120.736 0.303 . . . . 0.0 111.748 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.27 -27.38 14.54 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.25 -28.57 34.7 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.596 -175.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -75.93 -23.46 55.46 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.249 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -94.15 6.1 49.64 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.63 -177.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 34.3 mm -70.0 93.01 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-O 121.939 0.876 . . . . 0.0 111.959 -177.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -126.3 -22.31 4.05 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.427 -1.261 . . . . 0.0 108.793 171.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.1 m -65.34 172.77 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.251 1.181 0 CA-C-N 114.325 -1.307 . . . . 0.0 112.234 -177.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 74.24 -59.9 0.54 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.352 1.461 . . . . 0.0 109.065 -177.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 150.86 33.11 0.04 OUTLIER Glycine 0 N--CA 1.433 -1.563 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.3 p -147.59 142.9 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.543 ' O ' ' HA ' ' A' ' 41' ' ' GLU . 14.3 tpt180 -107.61 102.17 11.43 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 -178.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.46 HG22 ' HB3' ' A' ' 42' ' ' LEU . 20.0 t -118.87 137.44 52.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -178.021 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -142.41 155.43 45.12 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.517 HG21 HG23 ' A' ' 46' ' ' VAL . 1.6 pp -94.14 155.08 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.336 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.116 178.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.45 ' N ' HD12 ' A' ' 74' ' ' ILE . 3.8 mp -123.83 -31.43 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.969 0.89 . . . . 0.0 109.948 178.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -133.21 105.91 7.28 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.996 -170.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -116.33 114.68 24.66 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.059 178.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.516 ' O ' ' HA ' ' A' ' 47' ' ' LYS . . . -147.82 158.61 44.11 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.709 -177.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.9 p -94.0 101.39 12.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-O 121.859 0.837 . . . . 0.0 109.88 177.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.32 171.89 44.87 Favored Glycine 0 N--CA 1.417 -2.576 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.915 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.575 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -82.24 -152.79 0.11 Allowed 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 174.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.465 HD13 HD11 ' A' ' 120' ' ' LEU . 2.4 mp -91.41 111.36 23.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 C-N-CA 118.732 -1.187 . . . . 0.0 109.36 176.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.5 p -108.73 165.18 11.74 Favored 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 175.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -60.02 -35.74 75.73 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 121.38 0.609 . . . . 0.0 111.124 -176.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.3 p -69.03 -23.6 64.09 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.12 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -74.28 -41.35 61.35 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 177.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.533 HD13 ' HB2' ' A' ' 111' ' ' ALA . 44.2 mt -66.86 -34.7 71.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-N 114.242 -1.344 . . . . 0.0 111.424 -178.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.454 ' HA ' ' OE2' ' A' ' 114' ' ' GLU . 46.9 m -67.73 -9.09 40.8 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.488 178.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -92.92 -32.67 14.49 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 173.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.11 -53.26 59.33 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.44 -177.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 9.8 t -74.03 -13.57 60.88 Favored 'General case' 0 CA--C 1.561 1.379 0 CA-C-O 121.136 0.493 . . . . 0.0 110.414 178.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.65 -66.19 0.87 Allowed 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -176.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.429 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 27.1 p -101.51 5.65 41.97 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 120.748 0.309 . . . . 0.0 111.533 -176.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . 0.491 0.0 OUTLIER 70.3 57.54 0.27 Allowed 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 127.13 2.172 . . . . 0.0 114.118 -179.462 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -105.3 167.99 9.37 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 113.357 -1.747 . . . . 0.0 108.509 174.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 47.7 mm -124.13 131.57 72.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 176.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.599 ' HB ' HG22 ' A' ' 118' ' ' ILE . 12.0 t -94.11 102.59 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -176.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 13.3 tt -97.93 140.53 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.924 177.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.461 ' HA3' HD11 ' A' ' 81' ' ' ILE . . . -134.36 146.45 18.44 Favored Glycine 0 N--CA 1.414 -2.772 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 178.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -119.54 109.24 15.47 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -177.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 66.7 t30 71.81 -39.07 0.44 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 126.022 1.729 . . . . 0.0 112.41 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.3 m -45.29 -47.65 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 126.302 1.841 . . . . 0.0 114.986 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.575 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 36.1 mtp180 73.57 170.14 0.11 Allowed Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 123.485 0.714 . . . . 0.0 112.055 179.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -96.9 168.46 0.95 Allowed 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 121.911 1.741 . . . . 0.0 114.594 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -75.74 153.3 37.12 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 113.215 -1.811 . . . . 0.0 106.769 168.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.509 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -59.15 -35.2 73.1 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.549 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 18.2 m120 -79.58 -27.49 41.15 Favored 'General case' 0 CA--C 1.488 -1.429 0 C-N-CA 119.346 -0.941 . . . . 0.0 110.592 178.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.26 -46.42 77.17 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.766 177.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 19.9 pttp -59.51 -23.18 62.59 Favored 'General case' 0 CA--C 1.565 1.557 0 CA-C-O 120.965 0.412 . . . . 0.0 111.588 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.549 ' HB2' ' O ' ' A' ' 106' ' ' ASN 0.254 58.4 mtp180 -82.54 -51.2 8.01 Favored 'General case' 0 N--CA 1.393 -3.278 0 C-N-CA 125.821 1.648 . . . . 0.0 109.316 176.928 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.532 ' HB1' ' OE1' ' A' ' 114' ' ' GLU . . . -54.23 -48.5 71.01 Favored 'General case' 0 CA--C 1.471 -2.091 0 C-N-CA 125.914 1.686 . . . . 0.0 110.839 -176.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.533 ' HB2' HD13 ' A' ' 86' ' ' ILE . . . -48.17 -45.59 33.69 Favored 'General case' 0 CA--C 1.504 -0.797 0 O-C-N 124.867 1.354 . . . . 0.0 110.578 -179.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -72.92 -30.27 63.77 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 114.542 -1.208 . . . . 0.0 112.903 -174.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.1 t -92.28 5.27 51.13 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.532 ' OE1' ' HB1' ' A' ' 110' ' ' ALA . 7.9 mt-10 -117.9 7.04 12.27 Favored 'General case' 0 N--CA 1.406 -2.662 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -175.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 29.7 mmmt 68.2 5.74 4.85 Favored 'General case' 0 N--CA 1.42 -1.936 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 174.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.1 m -122.18 145.26 29.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -114.66 143.66 44.68 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 118.726 -1.189 . . . . 0.0 109.761 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.599 HG22 ' HB ' ' A' ' 96' ' ' VAL . 8.7 pt -98.1 131.1 45.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.187 -176.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -98.5 124.83 43.47 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.516 -174.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.465 HD11 HD13 ' A' ' 81' ' ' ILE . 3.5 mm? -123.01 175.26 6.69 Favored 'General case' 0 CA--C 1.502 -0.865 0 CA-C-O 121.873 0.844 . . . . 0.0 112.867 -178.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.44 ' O ' HG12 ' A' ' 123' ' ' ILE . 47.4 t-80 -69.84 155.0 41.21 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.509 -1.678 . . . . 0.0 108.041 174.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.6 ttp180 -52.23 115.85 1.93 Allowed 'General case' 0 C--O 1.246 0.897 0 C-N-CA 123.628 0.771 . . . . 0.0 110.62 176.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 121' ' ' HIS . 47.9 mm -119.35 108.65 24.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 28.3 pt -69.02 132.53 32.97 Favored 'Isoleucine or valine' 0 C--O 1.268 2.065 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.676 178.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 67.47 -159.01 0.22 Allowed 'General case' 0 CA--C 1.557 1.227 0 O-C-N 124.728 1.267 . . . . 0.0 107.665 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 29.2 p30 -140.34 172.33 12.88 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 28.8 m -106.09 18.42 5.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -175.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 32.9 pt -127.82 23.1 2.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-O 121.709 0.766 . . . . 0.0 109.402 -178.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.24 -4.77 52.27 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -169.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.04 -18.45 24.56 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.074 178.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 66.2 mt 63.19 88.31 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.048 -177.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -77.92 -56.55 4.4 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 177.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -122.42 -59.48 1.63 Allowed 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.295 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 62.8 118.93 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.092 1.357 . . . . 0.0 112.851 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.294 -1.805 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.564 -178.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.9 p30 . . . . . 0 N--CA 1.464 0.264 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -107.64 111.15 23.23 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -178.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -110.86 -26.44 9.33 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-N 113.925 -1.489 . . . . 0.0 107.048 173.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -89.26 -23.52 22.3 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.6 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 89.6 mt 66.57 31.55 7.81 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.099 0.959 . . . . 0.0 109.661 177.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -139.52 -112.7 1.04 Allowed Glycine 0 N--CA 1.424 -2.146 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -177.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.5 m 71.01 -38.16 0.41 Allowed 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 125.0 1.32 . . . . 0.0 113.915 176.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 51.9 mtm180 -53.41 -54.45 36.68 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 123.958 0.903 . . . . 0.0 112.271 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -117.64 44.47 1.43 Allowed Glycine 0 N--CA 1.435 -1.404 0 C-N-CA 121.225 -0.512 . . . . 0.0 112.986 -177.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 38.0 m -68.8 -51.65 38.66 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.206 0.527 . . . . 0.0 110.315 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.4 m -96.3 41.96 1.1 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.798 0.839 . . . . 0.0 110.074 -177.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -66.38 -18.48 65.38 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -173.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 19.4 m -94.84 2.87 9.4 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.893 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.5 t70 70.38 99.12 0.06 Allowed 'General case' 0 CA--C 1.5 -0.945 0 C-N-CA 124.423 1.089 . . . . 0.0 110.588 -176.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.6 mt -80.52 107.44 13.32 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -106.34 -19.76 13.6 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.987 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -60.42 109.07 0.91 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.624 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.41 ' HA ' ' HG3' ' A' ' 24' ' ' ARG . 44.3 tt0 69.26 11.84 8.26 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.945 1.298 . . . . 0.0 110.306 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -101.52 -36.32 8.84 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.0 p -73.79 -33.31 64.17 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.171 178.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . 0.317 20.7 m 58.39 -16.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 127.659 2.383 . . . . 0.0 116.819 177.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.5 ptpp? -54.17 -36.06 62.96 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.146 0.498 . . . . 0.0 112.045 178.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.5 p -100.6 22.85 11.2 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 123.619 0.768 . . . . 0.0 110.858 -178.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.41 ' HG3' ' HA ' ' A' ' 18' ' ' GLN . 3.0 mmp_? -128.98 -42.2 1.4 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.307 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.6 m -77.9 -13.63 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.151 0.501 . . . . 0.0 111.233 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.0 p -93.06 168.5 11.08 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.3 tt -122.35 -63.71 1.26 Allowed 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -96.09 172.66 7.85 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -178.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -71.24 -57.22 4.69 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 123.068 0.547 . . . . 0.0 109.969 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 47.0 tp 64.32 9.25 4.74 Favored 'General case' 0 CA--C 1.562 1.438 0 C-N-CA 124.591 1.156 . . . . 0.0 113.637 177.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -88.87 -12.84 40.69 Favored 'General case' 0 C--N 1.318 -0.768 0 O-C-N 120.824 -1.172 . . . . 0.0 111.898 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.12 143.76 49.49 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 121.247 -0.181 . . . . 0.0 110.862 176.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.4 tp60 -166.86 -61.68 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -178.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 59.8 mt -99.08 131.22 46.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.4 mttm 79.5 80.2 0.05 Allowed 'General case' 0 CA--C 1.501 -0.904 0 C-N-CA 125.198 1.399 . . . . 0.0 110.816 -176.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -76.76 -39.96 49.94 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 113.585 -1.643 . . . . 0.0 108.303 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.21 -170.61 42.82 Favored Glycine 0 N--CA 1.415 -2.718 0 N-CA-C 107.55 -2.22 . . . . 0.0 107.55 -179.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -85.64 -69.27 0.67 Allowed 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 117.778 0.789 . . . . 0.0 109.303 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 53.49 78.33 0.15 Allowed 'General case' 0 C--O 1.24 0.565 0 CA-C-N 114.156 -1.383 . . . . 0.0 108.034 -174.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -73.87 146.76 43.84 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.479 -175.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.53 ' HB3' ' ND2' ' A' ' 43' ' ' ASN . 58.8 mm-40 -94.16 105.59 17.58 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.644 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.435 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 3.7 mm? -94.02 94.15 8.26 Favored 'General case' 0 CA--C 1.486 -1.518 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 176.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.61 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 91.3 m-20 -124.46 146.87 48.68 Favored 'General case' 0 C--N 1.28 -2.455 0 CA-C-N 113.294 -1.775 . . . . 0.0 107.317 -174.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.3 pp -150.12 164.69 34.94 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.549 HG23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -119.88 132.88 68.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.368 178.612 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 93.3 t -107.1 126.96 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.058 -177.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 42.5 mtpt -139.23 134.75 33.12 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.211 176.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.78 168.39 23.82 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -178.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -80.2 -18.73 48.77 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.855 0.836 . . . . 0.0 110.421 -178.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 69.4 t -104.76 123.19 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 175.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.792 ' O ' HG22 ' A' ' 54' ' ' VAL . 10.8 tt0 -68.64 -29.78 68.34 Favored 'General case' 0 C--O 1.195 -1.78 0 CA-C-O 121.137 0.494 . . . . 0.0 111.413 -174.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.95 2.59 87.15 Favored Glycine 0 C--N 1.284 -2.36 0 C-N-CA 117.125 -2.464 . . . . 0.0 112.642 177.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.4 t -86.84 -31.07 21.01 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 176.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.792 HG22 ' O ' ' A' ' 51' ' ' GLN . 11.9 m -67.48 -43.4 87.41 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.866 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.423 175.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -66.27 -39.93 89.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.413 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.27 -37.04 79.25 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.747 177.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.513 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 26.6 tp -77.46 -41.68 38.71 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 120.532 -0.467 . . . . 0.0 109.766 177.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 54' ' ' VAL . 32.1 t -53.57 -45.82 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 123.57 0.748 . . . . 0.0 112.079 177.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.34 -26.56 68.51 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.58 -22.83 17.37 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -178.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.513 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -82.55 -35.53 27.11 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.47 -175.621 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -67.72 -27.04 66.46 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.112 0.482 . . . . 0.0 110.57 178.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.1 ptpp? -88.68 5.59 42.46 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.32 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.438 ' HB ' ' O ' ' A' ' 71' ' ' VAL . 39.7 mm -76.71 -23.3 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 178.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -69.14 105.27 2.41 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-O 121.475 0.655 . . . . 0.0 110.112 176.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 31.5 m -127.53 -173.07 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 176.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.8 102.17 11.42 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 121.414 0.625 . . . . 0.0 110.801 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 118.21 -42.1 1.89 Allowed Glycine 0 C--N 1.314 -0.646 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.496 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.6 t -115.69 134.05 60.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.435 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -152.56 125.65 8.57 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 120.697 0.284 . . . . 0.0 110.943 -179.73 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.438 ' O ' ' HB ' ' A' ' 64' ' ' ILE . 34.5 t -142.6 129.65 18.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 103.382 -2.822 . . . . 0.0 103.382 171.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.462 ' HG2' ' N ' ' A' ' 73' ' ' ILE . 87.9 tttt -139.92 161.5 37.44 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.354 0.597 . . . . 0.0 111.142 -176.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.462 ' N ' ' HG2' ' A' ' 72' ' ' LYS . 1.7 pp -93.51 148.52 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.759 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.612 177.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 73.2 mt -119.57 -27.63 2.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-O 121.68 0.753 . . . . 0.0 110.06 176.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.534 ' CD2' HD12 ' A' ' 45' ' ' ILE . 3.0 t60 -154.67 132.28 11.34 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.357 -172.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -134.66 131.03 37.25 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.404 ' O ' HG11 ' A' ' 54' ' ' VAL . . . -149.79 156.98 42.75 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.955 -178.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.3 p -93.5 94.42 4.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-O 122.521 1.153 . . . . 0.0 110.295 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.7 176.02 47.79 Favored Glycine 0 N--CA 1.417 -2.572 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.549 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -91.81 -175.38 4.12 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 176.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.494 HG21 HG21 ' A' ' 118' ' ' ILE . 3.2 mp -74.3 111.84 10.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 119.433 -0.907 . . . . 0.0 108.847 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.8 p -117.61 152.97 34.07 Favored 'General case' 0 N--CA 1.42 -1.972 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.702 -178.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -50.33 -41.83 51.85 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.026 0.53 . . . . 0.0 111.588 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.1 m -62.83 -28.12 69.79 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.614 -177.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -86.17 -29.33 23.32 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-O 121.341 0.591 . . . . 0.0 110.94 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.52 HG21 ' HA ' ' A' ' 111' ' ' ALA . 59.2 mt -65.87 -25.72 36.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.699 177.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 38.0 m -59.84 -30.7 69.13 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.917 177.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -78.25 -35.78 47.78 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 175.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.05 -58.91 5.39 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.966 -176.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.564 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 9.8 t -71.24 -24.61 62.22 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.478 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.17 -62.67 1.61 Allowed 'General case' 0 C--N 1.342 0.273 0 CA-C-O 120.944 0.402 . . . . 0.0 111.76 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.7 m -96.37 5.44 50.91 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.627 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 65.85 40.88 4.03 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.216 1.006 . . . . 0.0 110.314 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.61 ' HA ' ' O ' ' A' ' 43' ' ' ASN . . . -94.51 136.45 34.79 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-N 114.206 -1.361 . . . . 0.0 109.081 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.1 mp -93.88 140.23 16.9 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.549 ' HA ' HG23 ' A' ' 45' ' ' ILE . 14.5 t -94.77 117.54 38.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -178.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.54 ' HA ' ' O ' ' A' ' 119' ' ' ARG . 0.2 OUTLIER -112.17 122.86 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 174.3 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -115.37 146.47 18.83 Favored Glycine 0 N--CA 1.426 -1.997 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.159 -177.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -105.6 94.62 5.3 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 118.468 -1.293 . . . . 0.0 109.664 -177.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 63.78 8.64 3.9 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 124.946 1.298 . . . . 0.0 112.866 177.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.471 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 3.6 m -78.89 -49.38 20.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.101 -178.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.549 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 72.7 mtp180 69.59 154.64 0.15 Allowed Pre-proline 0 N--CA 1.477 0.915 0 O-C-N 123.889 0.743 . . . . 0.0 112.82 175.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -91.07 173.69 2.78 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 121.991 1.794 . . . . 0.0 112.47 178.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -89.71 168.28 12.23 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 167.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.543 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -56.58 -28.61 60.63 Favored 'General case' 0 C--O 1.206 -1.203 0 C-N-CA 122.824 0.449 . . . . 0.0 111.041 178.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.644 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 23.1 p30 -72.41 -46.47 55.01 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.21 -34.8 76.92 Favored 'General case' 0 C--N 1.292 -1.922 0 O-C-N 122.096 -0.378 . . . . 0.0 111.563 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 18.1 pttp -63.08 -27.7 69.57 Favored 'General case' 0 CA--C 1.563 1.478 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.318 175.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.644 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 63.5 mtp180 -75.37 -50.28 16.41 Favored 'General case' 0 N--CA 1.405 -2.698 0 C-N-CA 125.212 1.405 . . . . 0.0 109.239 176.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.24 -50.6 66.8 Favored 'General case' 0 C--O 1.201 -1.47 0 CA-C-N 114.118 -1.401 . . . . 0.0 110.269 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.52 ' HA ' HG21 ' A' ' 86' ' ' ILE . . . -49.33 -48.6 46.32 Favored 'General case' 0 CA--C 1.502 -0.886 0 O-C-N 124.587 1.179 . . . . 0.0 111.602 -178.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -79.13 -29.8 43.35 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.864 -173.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 28.7 t -77.19 -6.94 54.92 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 175.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.564 ' O ' ' HB ' ' A' ' 90' ' ' THR . 26.2 mt-10 -114.73 9.32 16.37 Favored 'General case' 0 N--CA 1.411 -2.422 0 CA-C-N 114.471 -1.241 . . . . 0.0 112.912 -177.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 29.2 mmtp 64.46 15.57 9.65 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 174.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.3 m -120.34 131.76 71.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.461 0.648 . . . . 0.0 112.565 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -94.59 130.39 41.06 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.077 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.494 HG21 HG21 ' A' ' 81' ' ' ILE . 15.1 pt -94.85 128.6 45.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.06 179.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.54 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 98.1 mtt180 -122.16 111.69 17.29 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.672 0.749 . . . . 0.0 110.743 -175.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.509 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -129.65 148.43 51.54 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.148 -177.786 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 29.8 t60 67.62 -74.68 0.07 Allowed 'General case' 0 N--CA 1.477 0.913 0 O-C-N 124.303 1.002 . . . . 0.0 111.158 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -91.29 90.29 7.67 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 122.231 1.015 . . . . 0.0 111.075 -175.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 44.5 mm -85.32 -26.94 6.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 40.9 pt -126.53 163.8 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 CA-C-N 114.083 -1.417 . . . . 0.0 107.249 177.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -86.62 107.78 18.32 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 176.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -75.15 98.8 3.79 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.533 0.682 . . . . 0.0 112.294 -176.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 46.4 t -94.16 -53.19 8.69 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 172.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 55.6 mt 56.78 75.39 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-N 113.079 -1.873 . . . . 0.0 112.444 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.5 17.1 5.92 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 122.877 1.322 . . . . 0.0 107.915 174.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -119.35 10.16 11.85 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 112.743 -2.026 . . . . 0.0 109.476 -176.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 72.3 mt 71.09 123.42 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 124.677 1.191 . . . . 0.0 112.364 -175.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -103.6 126.54 50.81 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 172.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -125.76 113.28 17.09 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -172.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -135.39 -80.49 0.43 Allowed 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 172.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 54.4 mtm . . . . . 0 CA--C 1.496 -1.098 0 C-N-CA 126.466 1.906 . . . . 0.0 107.009 172.636 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 N--CA 1.476 0.837 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -142.04 60.96 1.46 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -172.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -93.16 -19.97 20.94 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 115.03 -0.987 . . . . 0.0 109.207 177.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -106.65 127.96 53.78 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.737 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.544 ' HG ' ' NE2' ' A' ' 18' ' ' GLN . 2.9 mm? -119.83 -77.56 0.58 Allowed 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 177.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.3 126.28 11.36 Favored Glycine 0 N--CA 1.434 -1.44 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -178.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.4 m -71.94 -24.38 61.61 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 121.639 0.733 . . . . 0.0 109.851 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -79.05 98.5 6.51 Favored 'General case' 0 C--O 1.245 0.859 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 173.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 139.31 167.18 10.88 Favored Glycine 0 N--CA 1.411 -2.968 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.2 m -158.28 22.16 0.24 Allowed 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 -178.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.1 m 64.15 36.39 9.62 Favored 'General case' 0 C--N 1.351 0.634 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -170.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -103.09 -54.26 2.65 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.857 -178.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.13 4.34 2.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.427 ' HB2' HE21 ' A' ' 16' ' ' GLN . 9.1 p-10 -114.2 109.68 18.78 Favored 'General case' 0 N--CA 1.417 -2.085 0 CA-C-N 113.496 -1.684 . . . . 0.0 110.424 -173.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.6 mp -101.67 97.96 8.31 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 177.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.427 HE21 ' HB2' ' A' ' 14' ' ' ASP . 72.8 mm-40 -105.02 150.15 25.19 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -178.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -149.96 101.87 3.07 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -179.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.544 ' NE2' ' HG ' ' A' ' 5' ' ' LEU 0.295 41.8 mt-30 -130.52 52.76 2.0 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-O 122.367 1.079 . . . . 0.0 112.573 175.075 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -106.18 -48.35 3.61 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 170.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.9 p -111.23 7.1 21.04 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.317 -1.311 . . . . 0.0 109.478 175.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.7 m 47.29 35.34 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 126.507 1.923 . . . . 0.0 114.038 177.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -112.97 152.29 29.57 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 70.9 p 62.76 11.35 4.85 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.804 1.242 . . . . 0.0 112.417 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -72.2 -23.37 61.24 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.956 -176.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.9 t -89.68 -53.1 9.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 176.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.6 t 72.85 -56.14 0.66 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.037 1.335 . . . . 0.0 112.063 177.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 79.7 mt 62.36 66.33 0.8 Allowed 'General case' 0 CA--C 1.503 -0.844 0 C-N-CA 123.989 0.916 . . . . 0.0 111.545 -176.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -85.33 -27.78 25.69 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 174.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -117.29 141.1 48.73 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 173.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.3 tp -125.98 10.13 7.56 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.967 -172.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 62.59 83.05 0.16 Allowed 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.425 0.631 . . . . 0.0 109.811 -171.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -50.19 -45.13 53.29 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.297 -1.32 . . . . 0.0 114.189 -177.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -112.66 161.86 16.36 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.032 -177.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.3 pt -82.04 131.96 32.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.128 0.49 . . . . 0.0 110.623 -178.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -85.43 -37.89 19.27 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.348 0.594 . . . . 0.0 109.669 178.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -111.13 136.88 49.52 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.65 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -115.95 175.6 15.95 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 178.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -90.09 176.14 6.89 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 86.7 mtp -73.77 134.15 43.39 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.45 -178.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -90.15 -56.81 3.07 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.776 -175.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.77 124.3 48.05 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.439 -178.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -122.47 99.08 6.22 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 169.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -107.77 140.94 40.08 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -171.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.4 mt -135.23 168.78 18.54 Favored 'General case' 0 C--O 1.248 0.976 0 CA-C-O 121.789 0.804 . . . . 0.0 111.925 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.472 HG12 ' CE ' ' A' ' 47' ' ' LYS . 1.1 tt -133.18 132.9 58.54 Favored 'Isoleucine or valine' 0 C--O 1.249 1.028 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.198 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.647 ' O ' ' HA ' ' A' ' 76' ' ' ALA . 84.4 t -113.74 131.96 64.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.565 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.472 ' CE ' HG12 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -142.97 148.03 36.17 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 178.444 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.59 158.13 28.51 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 177.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -78.95 -12.33 60.03 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.039 -0.665 . . . . 0.0 110.044 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 99.1 t -109.86 134.12 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 174.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.738 ' O ' HG22 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -69.01 -46.63 67.52 Favored 'General case' 0 C--O 1.202 -1.447 0 C-N-CA 122.431 0.292 . . . . 0.0 110.558 -172.332 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.06 -1.19 67.66 Favored Glycine 0 C--N 1.286 -2.196 0 C-N-CA 118.479 -1.82 . . . . 0.0 114.285 -177.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.7 m -80.17 -29.42 38.74 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 106.282 -1.748 . . . . 0.0 106.282 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.738 HG22 ' O ' ' A' ' 51' ' ' GLN . 5.7 m -72.37 -42.44 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.498 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.354 176.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -54.47 -47.86 72.48 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 124.128 0.893 . . . . 0.0 110.592 178.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.77 -40.03 91.02 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.658 -178.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 34.4 tp -78.94 -36.66 41.33 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.593 -178.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.425 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 43.4 t -59.98 -43.6 92.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 122.727 0.411 . . . . 0.0 110.493 177.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.12 -14.85 62.48 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.61 -13.15 16.64 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.497 0.665 . . . . 0.0 109.294 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.419 ' HG ' HG23 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -99.7 -38.67 8.61 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.397 -176.148 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 4.1 pt20 -74.11 -5.9 44.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.303 0.573 . . . . 0.0 111.128 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.22 -5.34 50.17 Favored 'General case' 0 C--O 1.245 0.856 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.117 177.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.6 mm -86.69 77.5 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -131.5 -67.29 0.7 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.215 -174.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.7 m -89.53 -4.37 10.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.68 0.752 . . . . 0.0 109.992 177.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -90.31 86.52 6.51 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.345 -178.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 76.78 -74.26 1.81 Allowed Glycine 0 CA--C 1.525 0.682 0 CA-C-N 115.395 -0.82 . . . . 0.0 113.801 178.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 43.8 t -135.59 156.36 38.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -175.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -93.94 107.24 19.16 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.138 0.494 . . . . 0.0 110.044 176.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.6 t -117.04 113.36 42.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 175.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -124.27 158.08 33.37 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.52 0.676 . . . . 0.0 111.444 -172.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.419 HG23 ' HG ' ' A' ' 61' ' ' LEU . 1.5 pp -93.84 149.76 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.942 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.803 174.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 53.6 mt -120.63 -24.23 2.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-O 121.565 0.698 . . . . 0.0 110.796 178.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -150.41 117.45 5.94 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.63 -172.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.647 ' HA ' ' O ' ' A' ' 46' ' ' VAL . . . -120.78 129.69 53.7 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 176.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.41 ' O ' HG11 ' A' ' 54' ' ' VAL . . . -145.72 153.53 41.07 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.974 -178.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.444 ' HB ' ' HA ' ' A' ' 51' ' ' GLN . 3.0 p -93.84 93.26 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.704 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 175.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.87 176.49 48.03 Favored Glycine 0 N--CA 1.401 -3.697 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.79 -175.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.598 ' HB1' ' O ' ' A' ' 102' ' ' ARG . . . -90.49 -157.08 0.46 Allowed 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 175.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.509 HG21 HG21 ' A' ' 118' ' ' ILE . 2.9 mp -83.06 103.74 10.76 Favored 'Isoleucine or valine' 0 C--O 1.254 1.329 0 C-N-CA 118.854 -1.138 . . . . 0.0 108.242 177.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 44.1 p -101.7 159.73 15.07 Favored 'General case' 0 N--CA 1.409 -2.508 0 C-N-CA 119.417 -0.913 . . . . 0.0 108.808 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -60.21 -26.27 66.26 Favored 'General case' 0 CA--C 1.559 1.315 0 CA-C-O 121.466 0.65 . . . . 0.0 109.949 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.6 m -71.97 -22.06 61.5 Favored 'General case' 0 CA--C 1.555 1.146 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.154 178.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -81.48 -33.05 32.18 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-O 121.628 0.728 . . . . 0.0 109.276 178.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.563 HD13 ' HB2' ' A' ' 111' ' ' ALA . 67.8 mt -72.63 -33.13 43.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.25 -178.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.9 p -61.01 -17.29 51.36 Favored 'General case' 0 CA--C 1.557 1.214 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 175.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.451 ' O ' HD22 ' A' ' 88' ' ' LEU . 1.9 tm? -92.22 -33.13 14.8 Favored 'General case' 0 C--O 1.25 1.104 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 174.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.93 -58.94 5.57 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.25 -176.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.405 ' HB ' ' O ' ' A' ' 114' ' ' GLU . 11.2 t -79.29 -4.27 49.95 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-O 121.421 0.629 . . . . 0.0 110.649 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.84 -67.31 0.79 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.039 0.447 . . . . 0.0 112.191 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.4 t -104.85 5.95 33.44 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.391 0.615 . . . . 0.0 109.921 -176.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 74.07 72.12 0.11 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.482 1.113 . . . . 0.0 113.324 178.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -128.33 135.69 49.94 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 173.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.0 tt -94.49 140.79 16.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.793 ' HB ' HG22 ' A' ' 118' ' ' ILE . 49.4 t -94.45 99.45 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.392 0 CA-C-O 121.587 0.708 . . . . 0.0 110.946 -174.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 119' ' ' ARG . 42.7 mm -94.11 144.2 10.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 174.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.426 ' HA3' HD11 ' A' ' 81' ' ' ILE . . . -143.02 158.72 27.28 Favored Glycine 0 C--N 1.293 -1.821 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.06 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -122.38 95.04 4.48 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.243 -177.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . 0.254 95.4 m-20 55.6 -5.09 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 -179.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.448 ' HB ' ' HA ' ' A' ' 80' ' ' ALA . 1.7 m -62.93 -45.02 99.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 C-N-CA 123.65 0.78 . . . . 0.0 110.159 176.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.598 ' O ' ' HB1' ' A' ' 80' ' ' ALA . 58.9 mtm180 70.88 161.66 0.15 Allowed Pre-proline 0 C--O 1.213 -0.849 0 CA-C-N 114.783 -1.099 . . . . 0.0 113.125 173.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.472 ' HG3' HD12 ' A' ' 118' ' ' ILE . 11.1 Cg_endo -94.68 170.41 1.61 Allowed 'Trans proline' 0 N--CA 1.441 -1.602 0 C-N-CA 121.479 1.453 . . . . 0.0 114.291 -177.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -74.07 155.35 38.6 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 167.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.576 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -61.67 -36.29 80.44 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.563 0.697 . . . . 0.0 110.193 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.511 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 2.7 t-20 -74.83 -37.76 62.19 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.032 177.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.33 -48.39 81.8 Favored 'General case' 0 C--O 1.214 -0.775 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.48 176.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.576 ' HG2' ' O ' ' A' ' 105' ' ' ALA . 14.8 pttp -59.23 -28.63 66.86 Favored 'General case' 0 CA--C 1.565 1.541 0 CA-C-O 120.982 0.42 . . . . 0.0 111.89 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.511 ' HB2' ' O ' ' A' ' 106' ' ' ASN . 49.3 mtp180 -75.4 -49.59 18.49 Favored 'General case' 0 N--CA 1.386 -3.655 0 C-N-CA 125.5 1.52 . . . . 0.0 109.306 178.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -55.22 -48.01 74.51 Favored 'General case' 0 C--O 1.198 -1.618 0 CA-C-N 113.903 -1.498 . . . . 0.0 110.07 -179.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.563 ' HB2' HD13 ' A' ' 86' ' ' ILE . . . -48.09 -44.07 31.31 Favored 'General case' 0 CA--C 1.496 -1.115 0 O-C-N 124.68 1.237 . . . . 0.0 111.121 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -75.87 -37.5 58.84 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.748 -174.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 34.0 t -80.41 5.07 16.04 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 122.047 0.927 . . . . 0.0 108.568 178.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' ' 115' ' ' LYS . 25.1 mt-10 -121.23 9.76 10.5 Favored 'General case' 0 N--CA 1.404 -2.762 0 CA-C-N 114.442 -1.254 . . . . 0.0 112.839 -178.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 60.3 mmtt 65.87 10.82 7.19 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 173.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.1 m -115.22 156.42 16.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 C-N-CA 119.831 -0.748 . . . . 0.0 111.744 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -112.57 138.19 49.71 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.329 -177.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.793 HG22 ' HB ' ' A' ' 96' ' ' VAL . 9.9 pt -108.38 113.88 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.628 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 173.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.417 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 50.8 ttp180 -113.31 97.92 6.78 Favored 'General case' 0 N--CA 1.414 -2.27 0 CA-C-O 122.211 1.005 . . . . 0.0 109.719 -175.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.524 ' HG ' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -116.62 142.35 47.0 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.768 -179.46 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 67.86 19.72 9.47 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 59.14 -92.0 0.03 OUTLIER 'General case' 0 C--N 1.345 0.38 0 C-N-CA 125.938 1.695 . . . . 0.0 112.03 -176.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 64.8 mt -136.63 -82.28 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.515 HG22 ' H ' ' A' ' 126' ' ' ASN . 35.6 mm 61.27 -77.49 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 124.658 1.183 . . . . 0.0 111.128 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 57.24 20.15 5.51 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.515 ' H ' HG22 ' A' ' 124' ' ' ILE . 5.6 t30 -87.6 59.51 5.49 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 122.207 1.003 . . . . 0.0 109.009 177.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 28.5 m -127.36 -0.12 3.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 113.098 -1.865 . . . . 0.0 106.807 172.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.1 mp -94.5 113.08 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 174.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -77.19 -13.07 60.0 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.185 -176.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 68.24 96.31 0.06 Allowed 'General case' 0 CA--C 1.513 -0.481 0 C-N-CA 125.316 1.447 . . . . 0.0 110.618 176.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 65.9 mt 72.07 104.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 124.894 1.278 . . . . 0.0 109.84 -176.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -76.94 83.45 3.48 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.479 0.657 . . . . 0.0 110.026 177.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -153.14 108.87 3.29 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.611 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.59 -24.76 31.37 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 176.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 20.1 mmt . . . . . 0 C--N 1.307 -1.258 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 -179.729 . . . . . . . . 0 0 . 1 stop_ save_